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The Laboratory is governed by a Board of Trustees of up to 35 members that meets three or four times
a year. Authority to act for the Board of Trustees between meetings is vested in the Executive Committee
of the Board of Trustees. The Executive Committee is composed of the Officers of the Board and any
other members who may be elected to the Executive Committee by the Board of Trustees. Additional
standing and ad hoc committees are appointed by the Board of Trustees to provide guidance and advice
in specific areas of the Laboratory's operations.
Representation on the Board of Trustees itself is divided between business and community leaders
and scientists from major educational and research institutions.
The Laboratory is chartered as an educational and research institution by the Board of Regents of
the Education Department of the State of New York. It is authorized to operate a graduate program
under the name “Cold Spring Harbor Laboratory, Watson School of Biological Sciences” and thereat to
confer the degrees of Doctor of Philosophy (Ph.D.), Master of Science (M.S.), and Doctor of Science
(Sc.D.), Honorary.
It is designated as a "public charity" under Section 501(c)(3) of the Internal Revenue Code.
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PRESIDENT’S REPORT
On the same day in February 1809, two individuals were born, who, by virtue of their intellect and the course of
events, would greatly influence contemporary thinking and establish principles that would be debated long after
they were gone. Abraham Lincoln, through skillful political leadership and with sound moral compass, saved the
union of the United States and set in motion what would be a longer than expected struggle for equality in
America. Charles Darwin expanded on ideas about evolution that emerged in the early part of the 19th century
to articulate a revolutionary approach to thinking about how species arise and evolve. In 2009, Cold Spring
Harbor Laboratory will take special pride in celebrating the achievements of Charles Darwin, recognizing that our
work is connected to his in a direct line of descent, for the very beginnings of the Laboratory can be traced to
the scientific urge “to investigate experimentally the origin of species.” 
Those words were used in a proposal for the construction of a permanent Station for Experimental Evolu tion
at our current location in the early years of the 20th century. The goal was to apply Darwin’s theory and test
Mendel’s laws in animal and plant breeding experiments. When such a Station opened its doors in 1904, thanks
to a grant from the Carnegie Institution of Washington, the idea that gave rise to Cold Spring Harbor Laboratory
was already 14 years old. At an old fish hatchery on the edge of an intertidal zone, a field station of the Brooklyn
Institute of Arts and Sciences had been established in 1890 to study how life, per Darwin’s theory, had adapted
to fill a diversity of ecological niches.
The Laboratory has itself evolved since its days of affiliation with the Brooklyn Institute and the Carnegie
Institution. Although evolution in the natural world is selected from a wide variety of nondirected mutations, in
the case of our institution, change has been deeply purposeful. From its beginnings in the observation-based
study of evolution, to its focus on genetics under Charles Davenport beginning in 1904, to its historic role in the
1940s and 1950s in incubating molecular genetics and molecular biology under the leadership of the geneticist
Milislav Demerec, Cold Spring Harbor Laboratory has taken the lead in setting the agenda for the advancement
of biological science. 
Progress in science depends on a variety of factors: intellectual and conceptual breakthroughs, technological
leaps, firm financial backing, and lots of hard work by scientists who have a passion for what they do. Advances
cannot be predicted, and sometimes serendipity is a real factor in our movement forward. But the experience of
more than a century demonstrates that the process of discovery is continuous and that it exerts an inexorable force
on institutions such as ours to adapt or risk falling away from the leading edge in generating knowledge.
The current phase in our evolution is being given palpable, physical expression in the six new interconnect-
ed laboratory buildings that comprise our Hillside Research Complex, now nearly finished. These beautifully con-
ceived and executed structures underlie the future evolution of research at the Laboratory. They announce, first,
our intention to build on our expertise in cancer research, an area in which we have earned great respect since
1968, thanks to the vision of James D. Watson. Among the new structures is one that will be home to the CSHL
Cancer Center and house important research that investigates the relationship between cancer genetics and
therapeutic strategies. An adjacent building will focus on tumor microenvironment and metastasis, both areas
that are key to developing new therapeutic strategies. 
There are two other messages that these new buildings send regarding CSHL’s evolution. One is about how
we are adapting to changes in the way science is performed; the other is about how biological science advances
along an endless frontier, to use a phrase made famous by Vannevar Bush, the father of modern American pub-
lic science policy.
No one involved in biological research needs to be reminded of the impact that advances in information technol-
ogy have had on the pace and nature of the work. Science moves ahead much more rapidly today than it ever has,
and in our fields of biology, much of the research is now performed by groups larger than ever before, comprised of
members representing a diverse range of fields and disciplines. Multidisciplinary team science has come to dominate
the research landscape and CSHL has adapted well to its advent. Our Meetings and Courses and Banbury programs
facilitate such an approach to team-based science because CSHL continues to be the crossroads for life scientists
across many disciplines, a place of intellectual ferment and vigor at the very center of the action. 
The author lists on many of the hundreds of research papers published by our faculty this past year offer evi-
dence of the multidisciplinary richness of the science that we do. CSHL is a place where collegiality thrives, a
1
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fact that many Laboratory visitors comment upon each year. One can see it at the in-house lectures given every
week on our campus, and perhaps most vividly at the Friday noontime lectures, which more often than not
attract overflow audiences of faculty and postdocs listening intently to results obtained by their neighbors, on
topics entirely outside of their own fields of expertise. Regular exposure to the ideas of others is a condition of
successful team science at CSHL, and I believe it is at the core of great discoveries.
Carefully planned strategic investments in our research program also aid in realizing potential synergies and
in taking advantage of new opportunities, many of them interdisciplinary. Perhaps the most important of our
investments this past year involved two new areas of research, in neuroscience and quantitative biology. The
neuroscience program is a case study of how disciplines once regarded as distinct from one another yield
insights that constitute new sources of institutional strength. For instance, a wholly independent line of work cen-
tering on the human genetics of cognitive dysfunction has emerged in our neuroscience effort and is now merg-
ing with separate studies on brain anatomy, neuronal development, and behavioral analysis of normal cognition.
Our genetics research, which is already shedding new light on the complex genetic causation of illnesses
such as autism, schizophrenia, and bipolar depression, emerged from techniques developed at CSHL to study
the genetics of cancer and adds a new dimension to the neuroscience effort at CSHL to understand long-term
memory and cognitive processes such as attention, decision making, and working memory. That effort, which
will expand into new buildings at the Hillside Research Complex, seeks to understand the structure and func-
tion of neural circuits whose activity makes possible complex behaviors and the cellular biology underlying these
circuits. It also explores how the brain as an ensemble of circuits responds to external stimuli and how the pro-
cessing of these stimuli serves as the basis of cognition. What is now particularly pleasing is that the genetics of
psychiatric diseases in humans is starting to merge with basic studies on rodent cognition and neuronal devel-
opment, a program that has been built up over the past five or so years. The genes implicated in autism, schiz-
ophrenia, and depression are becoming focal points for understanding what they do in the normal brain and how
alterations in these genes affect complex cognitive behaviors.
The latter thrust, in systems neuroscience, is one area in which mathematical and statistical insights are cer-
tain to help drive research forward. We are reminded of “the endless frontier”—the startlingly new approaches to
science that the human mind continues to generate that exert a kind of positive adaptive pressure. Such adapta-
tion is no more apparent than in the requirement in all our research programs for sophisticated, quantitative analy-
sis of large data sets. 
Events in 2008 realized a major step forward with the hiring of the first members of what will be a distinctive
feature of the research program at the Laboratory—our new Center for Quantitative Biology. A brainchild of
Michael Wigler, it was made possible by forward-looking and sizable grants from the Simons and Starr founda-
tions. The Center will become the home base for outstanding scientists who are primarily focused on mathemat-
ical and computational approaches to biology, applying their insights in the formulation of research hypotheses
pertinent to all of the areas in which the Laboratory specializes: cancer, neuroscience, and plant biology. One par-
ticularly interesting aspect of this area of research that has already emerged from the studies of the center’s first
new faculty member, Gurinder (“Mickey”) Atwal, is the quantitative analysis of mutations in the human population,
informing us in new ways about the processes of evolution and natural selection. 
The Laboratory, then, is succeeding in its missions as it continues to adapt, both proactively and in response
to external events. One of the major external events that has already altered our behavior during the last year
has been the global crisis in the financial system that clearly will impact our work over the near term. Our signif-
icant reliance on fund-raising to support the cutting-edge research of our very productive faculty, including many
in the earliest stages of their independent careers, will be a constant challenge. 
Ironically, this crisis is occurring at a moment when a new president has been elected, fulfilling the dreams of
Abraham Lincoln and all too many who have followed. It is a time of major crisis that rivals some of the most seri-
ous in the nation’s history. Fortunately, the new administration has renewed this nation’s commitment to including
science in its policy making, while recognizing that science is not the only arbitrator of a vibrant political system. 
On a more practical note, the public sector’s commitment to funding scientific research will in part reverse the
significant cuts in funding that we have endured during the past seven years. Because it is not possible to predict
the course of macroeconomic events any more than discoveries in science, we have already taken strong mea-
sures at the Laboratory to trim, save, and conserve wherever possible. But confidence in the future is not out of
place with a new federal administration in place, our supporters continuing to recognize the importance of our sci-
ence, and our scientists continuing to be among the most productive and innovative in their fields of endeavor.  
2
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3HIGHLIGHTS OF THE YEAR
Research
Research at Cold Spring Harbor Laboratory continues to flourish. This will surprise no one in
the community of scientists, within which our reputation ranks among those of the very best
life science research institutions worldwide. This fact was reflected once again in an annual
survey by Thompson Scientific’s Essential Science Indicators, which reported in 2008 that
CSHL is in the top 1% of institutions most cited in published research and that our faculty is
ranked by peers among the top three in terms of its influence in shaping the fields of mole-
cular biology and genetics. Much of this is due to the sound guidance of our research admin-
istration, which con sists of a very effective team headed by Director of Research David L.
Spector and includes Research Exec u tive Committee members Greg Han non, Scott Lowe,
and Tony Zador, who receive outstanding administrative assistance from Sydney Gary and
Walter Goldschmidts.
The Laboratory’s achievements in 2008 are particularly noteworthy when considered in the
context of the current funding environment. Against a backdrop of limited resources and a
contraction in federal grant funding, scientists in all of the areas in which CSHL concen-
trates—cancer, neuroscience, and plant biology—reported a steady stream of significant
research results throughout the year. Although these are comprehensively described on our
website, it is useful to briefly review a few among the many to illustrate the richness of our sci-
entists’ cumulative achievements in 2008 and the continuing overall success of our research
program.
Compensating for a Missing Gene in SMA
The neuromuscular disease called spinal muscular atrophy (SMA) can lead to death in chil-
dren before the age of two. It is traced to a protein deficiency caused by mutations in the
gene SMN1, which in turn leads to serious damage in growing nerve cells and the muscles
that these cells control. This past year, Adrian Krainer and colleagues at CSHL and Isis
Pharmaceuticals induced cells to replenish the deficient protein by activating a poorly
expressed relative of SMN1 called SMN2 that resides in the human genome. This was done
by inducing alternative splicing of a second copy of the SMN2 gene so that it now included
a missing piece that makes it more active and able to prevent disease progression. Adrian
and his team sought to change the splicing by introducing synthetic molecules called anti-
sense oligonucleotides (ASOs). The team injected their most potent ASOs into
mice that had an added, human version of SMN2. As they had hoped, the
gene produced much more of the RNA for the critical protein, including the
section that is usually omitted in SMN2, in tissues where the ASOs accumu-
late. They now seek to determine whether the ASOs really benefit growing ani-
mals with SMA and how and when they should be administered to affect the
nervous system. This research follows a decade or more of fundamental
research by Adrian and his colleagues regarding the understanding of control
mechanisms of RNA splicing. Without this knowledge, the advances in thera-
peutic strategies would not be possible.
A. Krainer
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Causal Link between a Tumor-suppressor Gene and Liver Cancer
In a project that attests to the spirit of cooperation among our laboratories, no
fewer than five CSHL teams joined forces in 2008 to confirm that a gene called
DLC1 is a tumor suppressor. In an effort spearheaded by Scott Lowe, they
demonstrated in living mice that deletion, loss, or inactivation of the gene precip-
itates events culminating in an aggressive type of liver cancer closely related to
common human epithelial cancers of the liver. Tumor suppressor genes have a
vital role in intracellular signaling networks that protect against uncontrolled cell
growth and proliferation. Such genes can be rendered inactive by a variety of DNA
alterations. DLC1, a gene whose acronym reflects prior suspicions that it was
“deleted in liver cancer,” was known to be located in a region of chromosome 8
that has been observed to be missing in past studies of mammalian liver cancer
cells. Importantly, the team’s success in tracing the pathway by which DLC1 func-
tions in both healthy and pathological states suggests a highly specific new target for future
anticancer drugs. Using a mechanism called RNA interference (RNAi) to control the expres-
sion of specific genes, the team effectively turned off the DLC1 “switch” in living mice cells
and, in so doing, was able to isolate one particular signaling intermediary whose presence
was both necessary and sufficient to set the cell on an uncontrolled growth path. This essen-
tial molecular intermediary, a potential drug target, is called RhoA.
Role of Rare Gene Mutations in Schizophrenia
In 2008, Jonathan Sebat and colleagues from the University of Wash ing ton and
the National Institute of Mental Health contributed an important finding to our
rapidly growing knowledge about the genetics of schi zo phrenia. They identified
multiple, individually rare gene mutations in individuals with this devastating illness
that may help to explain its causation in at least a subset of cases. Jonathan and
the team screened the genomes of patients and healthy controls for gene copy-
number variations (CNVs)—a type of structural variation in the genome charac-
terized by the presence of either too many or too few copies of particular genes.
They found that deletions, dis ruptions, and duplications of normal genes were
three to four times more frequent in patients compared with controls. The study
suggested that rare mutations not only are common in schizophrenia, but are also
often quite powerful. In a preliminary effort to discover the role of these rare muta-
tions in disease etiology, the team found, intriguingly, that more than half of the disrupted
genes were involved in pathways involved in neuronal development and regulation.
Rethinking the Neural Code
Anthony Zador, a neuroscientist who is interested in how neural cir-
cuitry in our brains gives rise to astonishing system properties such
as consciousness and perception, per formed a simple yet powerful
experiment this past year that produced a surprising and important
result. Tony wanted to determine the shortest possible time interval
be tween neuronal signals or “spike trains” that an animal’s cortex
could distinguish and use to make a decision. The remarkable
answer, observ ed in the auditory cortex of living rats, proved to be
S. Lowe
J. Sebat
4
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three one-thousandths of a second (3 ms). These data provide support for an alternative the-
ory of how information is processed in the brain, sometimes called the “neural code.” The
prevailing theory is based on the ob serva tion that neurons spike more quickly when they are
transmitting information. This supports a “rate code” model, which stipulates that informa-
tion is contained within the spiking rate of the neuron. However, Tony's experiment lends cre-
dence to a “timing code” model, wherein information is encoded within the precise pattern
of spiking, which can be deduced by examining how spikes are distributed over time. 
How the Brain Decides What to Believe
The laboratory of Adam Kepecs is also making important and original contributions
to the study of the brain’s system properties. Adam and his colleagues point out that
even the simplest decisions involve the integration of sensory and memory in for -
mation with emotional and motivational attributes, requiring the concerted action of
millions of neurons across brain regions. Their current work seeks to elucidate the
neurocomputational principles of decision making and attempts to capture elusive
attributes such as emotion, motivation, or confidence. This past year, Adam, with
Zachary Mainen and colleagues at CSHL, discovered neural signals for confidence
in decision making in the rat prefrontal cortex. Their study suggests that confidence
estimation is a fundamental information-processing mechanism in the brain, not a
complex function specific to humans but a core component of decision making.
They speculate that it is found throughout the animal kingdom, shared widely across species,
and not strictly confined to those, such as humans, that are self-aware.
Epigenetic “Reprogramming” of Plant Cells
Transposons are bits of DNA that can jump around in the genome and disrupt normal gene
function and regulation. Under normal conditions, genomic chaos, found to occur in cancer
and other diseases, is prevented in various ways, among which are a series of mechanisms
that scientists call epigenetic. These mechanisms modify the expression of genes without
altering their DNA sequence. Among the pioneers in the study of epigenetics is Robert Mar -
tien ssen, a worthy successor to the late Barbara McClintock, the Nobel Laureate who, in dis-
covering “controlling elements,” vividly demonstrated at CSHL what we could learn about
genetics by studying plant systems. This past year, Rob’s team continued their ambitious
project to map the changing epigenetic landscape of “immortalized” or continuously di viding
plant cells. They succeeded in describing epigenetic alterations that allow trans-
posons to escape normal regulatory controls. Transposons in plant genomes are
normally rendered inactive via RNAi, which is orchestrated by small interfering
RNAs (siRNAs) that target heterochromatin (densely packed, genetically inactive
regions of DNA). In immortalized plant cells, Rob’s team found that epigenetic
changes resulting in a loss of heterochromatin and transposon “reactivation” are
not due to a loss of proteins regulating heterochromatin. They found in stead that
they were due to a change in the population of siRNAs produced in the continu-
ously dividing cells. This suggests that siRNA-driven heterochromatin restructur-
ing may lead to the formation of “epialleles”—epigenetic variations in gene expres-
sion patterns that stem from the creation of particular states in the chromosomes
of cells, thereby changing the patterns of gene expression in related cells.
A. Kepecs
R. Martienssen
5
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Small RNAs Involved in Transmission of Epigenetic Information: Genome Defense
One way in which epigenetic information is known to be passed from parent
to offspring is through the pattern of chemical “caps” added onto certain “let-
ters” of the DNA sequence, ensuring that the sequence is “silenced.” In some
cases, enzymes that add these caps are guided to DNA by small RNA mole-
cules. Greg ory Hannon, a leader in the study of small RNAs, discovered (in
part, with Leemor Joshua-Tor at CSHL) the cellular machinery that “dices”
and “slices” double-stranded RNAs into gene-regulating single-stranded mi-
and si-RNAs. Greg’s team has now discovered that a class of small RNAs
carries epigenetic information and has demonstrated how, in one instance,
they pass on the trait of fertility from mother to offspring in fruit flies. This was
only one of several discoveries made by Greg’s team this year, most involving
small RNAs, which, he has observed, are far more diverse as a class than ini-
tially suspected and act in more ways than anyone imagined when they were
first described about a decade ago. In 2008, the Hannon team described a new class of
small RNAs that partner with the protein Argonaute 2. Using advanced sequencing technol-
ogy, they found that these small RNA partners modify gene activity and sup press transpos-
able elements, thus serving as a genome defense mechanism in cells that are destined to
become the germ line for the next generation. These studies have help ed to explain old and
intriguing observations that when certain strains of animals are mated, their offspring are not
fertile, a process called hybrid dysgenesis.
New Perspectives on “Noncoding” Portions of the Genome
Discovering where and how functional information is stored in
ge nomes represents a frontier of re search that underlies all life
sciences and clinical research. Without this information, the bio-
logical and clinical effects of disease-causing mu ta tions in
humans and other organisms can only be partially understood.
Recently, detailed analyses regarding which genomic segments
are transcribed into RNA and the functional roles of these RNAs
have revealed the fact that our current models of how genomes
are organized and regulated remain rudimentary. As one of the
leaders of the National Institutes of Health’s project ENCODE
(ENCyclo pedia Of DNA Elements), Thomas Gingeras—who
rejoined our faculty in 2008—has determined that almost all of
the human genome can be transcribed into RNA and that most
of these RNA products are not made to be translated into pro-
teins. Rather, non-protein-coding RNAs are used in a variety of functions ranging from regu-
lation of expression of protein-coding genes to acting as scaffolds upon which large protein
complexes are assembled. As reported in a front-page feature in the Science Times section
of The New York Times on November 11, Tom’s research is helping scientists to significant-
ly revise long-standing notions about such basic questions as what constitutes a gene.
Histone Modifications with “Personality”
Michael Zhang’s group has developed a series of computational tools that make use of sta-
tistical pattern-recog nition techniques to identify exons, promoters, and posttranslational
G. Hannon
T. Gingeras
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modification signals in large genomic DNA se quences. They also study alternative
splicing of exons and collaborate with other labs to charac terize splicing
enhancers and si lencers. This past year, Michael’s group was part of a team that
published a comprehensive analysis of modi fication patterns in histones. Using a
new technology called ChIP-Seq, they identified 39 histone modifications, includ-
ing a “core set” of 17 modifications that tended to occur together and were asso-
ciated with genes observed to be active. The various modifications showed dis-
tinctive “personalities,” each preferentially associating with particular regulatory
regions of genes. They developed a better promoter prediction algorithm by tak-
ing into account such epigenetic information. They also worked with Professors Li
at the University of Chicago and Krainer at CSHL to discover that one of the steps
in turning genetic information into proteins leaves genetic fingerprints, even on
regions of the DNA that are not in volved in coding for the final protein. They estimated that
such fingerprints affect at least a third of the genome and suggested that although most DNA
does not code for proteins, much of it is nonetheless biologically important enough to have
persisted during evolution. In addition, with Adrian Krainer, Michael’s team succeeded in
defining the regulatory networks of two related tissue-specific (brain and muscle) splicing fac-
tors, Fox-1 and Fox-2. 
Three CSHL Studies Appear in Cell—in a Single Issue
Three separate research teams each led by our faculty reported results in the November 26
issue of the journal Cell—a reflection of the caliber and relevance of the work that is routine-
ly performed at the Labor atory. It is unusual for multiple, unrelated studies emanating from
the same institution to appear in a single issue of this prestigious journal, and it is truly re -
markable for three teams to report on different projects in the pages of a single issue, given
the relatively small size of our faculty, now at 47. A team consisting of Scott Powers, Gregory
Han non, W. Richard McCom bie, Michael Wigler, and corresponding author Scott Lowe
reported 13 new tumor-suppressor genes in liver cancer, which they revealed using a pow-
erful new approach to validate linkages between suspect genes and their functional contri-
butions to cancer. A second CSHL study in the same issue of Cell by Senthil Muthuswamy
and colleagues demonstrated that normal function of the protein Scribble allows breast
epithelial cells to form duct-like structures and resist cancer formation. They were also able
to show that when Scribble stops functioning, the tissue loses its shape and the earliest
stages of cancers ensue. The results constitute first steps toward identifying a new class of
molecules and pathways that can be targeted by anticancer therapies to prevent precan-
cerous lesions from turning into malignant tumors. In the third CSHL paper, a team in David
Spector’s lab shed light on possible functions of noncoding RNA molecules, announcing the
discovery of a previously unknown mechanism in the nucleus that sends different parts of the
noncoding RNA molecule MALAT1 to different cellular destinations. 
Cold Spring Harbor Laboratory Board of Trustees 
The Board of Trustees welcomed five new members: Leo A. Guthart, founder and manager
of Topspin Partners, a venture and private equity firm based on Long Island; Thomas Lehr -
man, president and founder of Boli ven, LLC, an internet start-up focusing on innovation,
consulting, and venture investing in technology businesses; Marilyn Simons, Ph.D., president
of the Simons Foundation, which funds basic research and education programs in mathe-
M. Zhang
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matics and physical and life sciences; and Paul Taub man, managing director of Morgan
Stanley. Charles L. Sawyers, M.D., Howard Hughes Medical Investiga tor and head of the
Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center,
was elected a Scientific Trust ee. In addition, the ranks of our honor ary trus tees grew with the
addition of Norris Darrell, Senior Counsel, Sulli van & Cromwell LLP and CSHL Chan cel lor
Emeritus James D. Watson, Ph.D. 
On behalf of CSHL and the Board of Trustees, I thank departing Scien tific Trustee Robert
E. Wittes, M.D., for his service. Dr. Wittes was elected to the Board of Trustees as a Scientific
Trustee in February 2004 and served on the Tenure and Appointments Committee from 2004
to 2008 and the Research Committee from 2004 to 2008. He stepped down in November
2008.
We are grateful to members of the Cold Spring Harbor Laboratory Asso ci ation (CSHLA),
who came together often in 2008, cultivating new friends and raising funds to support the
research of scientists who are at the early and most innovative stages of their careers in
research at CSHL. Despite the difficult economy, CSHLA members raised more than $1.1
million for the annual fund. 
Highlights from the CSHLA this past year included dancing to the latest Latin rhythms, an
evening of education about skin stem cells, and a special thank you to major donors. The
April The Lab Goes Latin dinner and dance event was a lively change from our traditional
spring jazz benefit. We applaud co-chairs Lisa and Tim Broadbent and Kate and John Fried -
man for the tremendous energy and creativity that they put into this successful event. In early
June, many of our new association members hosted dinner parties in their homes for visit-
ing and CSHL scientists as part of the annual CSHL Symposi um’s Dorcas Cummings pub-
lic lecture. Research ers and guests from the local community enjoyed the presentation on
skin stem cells given by Elaine Fuchs, Ph.D., head of the Laboratory of Mam malian Cell
Biology and Develop ment at The Rockefeller University. 
The rain did not dampen attendance by a record number of Associ ation members and
major donors at a lovely reception held in their honor at the home of CSHL Trustee Stephen
Lessing and his wife Sandra in nearby Lloyd Harbor, New York.
I thank Pien Bosch, who served with exceptional dedication and success as President of
the CSHL Association in 2007 and 2008. I look forward to the continued involvement of Pien
and her husband Hans at CSHL and welcome all of the new friends that the Association
directors and members introduce to the CSHL community.
Research and Education Management
We are proud of our continuing commitment to strategic and fiscal management of our
research and education programs, which must evolve constantly to meet the challenges of
contemporary science and society. This year, we established an independent Scientific
Advisory Coun cil (SAC) that is comprised of scientific leaders from top research universities
and institutes. SAC will advise this institution on im portant issues related to research and
education that will be necessary to main tain CSHL as a world leader. The nine-member SAC
is chaired by Fred erick W. Alt, a Howard Hughes Medi cal Investiga tor, member of the Nation -
al Academy of Sciences, Professor of Pedi atrics at Children’s Hospital Boston, and Profes-
sor of Genetics and Scientific Direc tor of the Immune Disease Institute at Harvard Medical
School. Fred taught the influential molecular cloning course at CSHL in the 1980s. Other
SAC members include Cornelia Bargmann, The Rocke feller Uni ver sity; David Bot stein,
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Princeton Uni ver sity; Joanne Chory, Salk Insti tute for Biological Studies; Carol Greider, Johns
Hopkins School of Medi cine; Leonid Kruglyak, Prince ton Univer sity; Markus Meister, Harvard
Uni versity; Tony Pawson, Samuel Lunen feld Research Institute; and Max Wicha, University
of Michigan. 
CSHL hosted the inaugural conference of the iPlant Collaborative, a National Science
Foundation–funded $50 million project to create a virtual center in cyberspace for plant sci-
ences, researchers, and students. The kickoff conference, entitled “Bringing Plant and
Computing Scientists Together to Solve Plant Biology’s Grand Challenges,” took place April
7–9, 2008. In addition to CSHL, institutions in the iPlant Col laborative in clude the Univer sity
of Arizona, Ari zona State Uni ver sity, the University of North Carolina at Wilmington, and
Purdue Univer sity.
CSHL Education Programs Expand
This year, through the skillful leadership of David Stewart, Execu tive Director of the Meetings
and Courses program, we established a wholly owned subsidiary called Cold Spring Harbor
Conferences Asia, to develop and operate an annual program of scientific conferences mod-
eled after the CSHL meeting format. Our own in-house legal counsel John Maroney and his
staff have been instrumental in this initiative. 
Located on a 25-acre campus beside Dushu Lake in the eastern part of the city of Suzhou,
which is in the Golden Triangle region of Shanghai on the lower reaches of the Yangtze River, the
600,000-square-foot ultramodern conference center and hotel currently under construction is
funded by the Suzhou Industrial Park. 
9
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Cold Spring Harbor Conferences Asia appointed a distinguished Scien tific Advisory Board
of 20 academic scientists from Asia, Europe, Canada, and the United States, which held its
inaugural meeting in Suzhou in October 2008. Cold Spring Harbor Asia plans to begin a pro-
gram of international scientific conferences at the Suzhou Dushu Lake site in 2010. 
Our foray into Asia recognizes the global nature of advanced science and builds on exist-
ing strengths of the CSHL Meetings and Courses program, which currently attracts more
than 8000 scientists to our campus each year for exceptional scientific exchange and dis-
cussion, free of commercial or regional/national bias. We have a successful record of inter-
national educational partnerships and collaborations in Europe that include programs with
the European Molecu lar Biology Organization in Germany and the Wellcome Trust in England.
The year 2008 was an inaugural one for the CSHL Personal Genomes meeting, whose
time had finally come, thanks to advances in technology that are now making economical
and efficient sequencing a reality. Our Chancellor Emeritus James D. Watson was one of only
four whose individual genome had been sequenced and assembled at the time of the meet-
ing. He and J. Craig Venter were honored at CSHL’s third annual Double Helix Medals Dinner
on Novem ber 6 for making their personal genome se quences available to the public. As more
genomes are se quenc ed and anal yzed, the CSHL Per sonal Ge nomes meeting will surely
become an increasingly important venue for discussion linking personal genome data of hu -
mans and the genomes of many other species, as well as the societal issues associated with
the accumulation of such personal data.
In September 2008, together with New York City Department of Edu cation Chancellor Joel
I. Klein, we officially opened an important extension of our DNA Learning Center, called the
Harlem DNA Lab, at the John S. Roberts Education Complex in East Harlem. The Harlem
DNA Lab is CSHL’s first New York City–based education facility. It is amazing to think that it
was only 20 years ago this year that we opened the Dolan DNA Learning Center facility in
the village of Cold Spring Harbor. Since then, CSHL has provided hands-on educational
experiences in genetics to more than 325,000 children and teachers on Long Island. During
10
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the last two decades, Dolan DNA Learning Center Executive Director David
Micklos and his team have profoundly influenced the way in which biology and
genetics are taught in schools, not only in New York, but around this country and
around the globe.
The Harlem DNA Lab is now bringing the latest knowledge and cut ting-edge
tools and techniques of modern biology to New York City’s middle and high
school students and teachers. With generous funding from the Howard Hughes
Medical Insti tute (HHMI) and initial support from the Dana Foundation, Jerome L.
Greene Foundation, The Goldman Sachs Foun dation, and William Town send
Porter Foundation, New York City’s 8th and 9th grade science teachers will
receive professional development in genetics and biotechnology in order to boost
student performance in science.
In this anniversary year for the DNALC we also cut the ribbon on the Laurie L.
Landeau Multimedia Studio to support the next phase in the de vel op ment of the
DNALC’s Biomedia Group as a world leader in biology education. The studio contains the
latest equipment for high-quality video production and is designed with separate sets for
interviews, news reporting, and lab demonstrations. Many thanks to CSHL Trustee,
Education Com mittee chairperson, and long-time friend Laurie J. Landeau, V.M.D., for mak-
ing this possible. 
The year 2008 was a multiple anniversary year for our Chancellor Emeritus James D.
Watson, who not only celebrated his 80th birthday and 40-year wedding anniversary with Liz
Watson, but also marked 40 years of dedicated contributions to the Labora tory. His imprint
on CSHL spans every aspect of the Laboratory’s life, ranging from financial stability, to beau-
tiful landscapes, an expanded research program, the growth of professional education pro-
grams, and the establishment of the Watson School of Biological Sciences and the Dolan
DNA Learning Center. 
Liz Watson marked the year with the release of her new book Grounds for Knowledge,
published by CSHL Press, which, under the leadership of John Inglis, continues in its com-
mitment to publishing excellence. The publication coincided with the designation by the
Public Gardens Associ ation of America of the CSHL Bung town Road campus as a botani-
cal garden. Liz’s book, filled with beautiful prose and the stunning photography of CSHL
Director of Facilities Peter Stahl, showcases the landscapes of our shoreline location. As a
campus community, we celebrated and joined with friends in the international scientific com-
munity to reminisce with Jim and Liz on several occasions this year, including an employee
picnic honoring the Watsons in August 2008. Groundbreaking on the Hillside Campus ex -
pansion project began in 2005, but this year, we witnessed the most dramatic progress yet
in this monumental capital project that will increase our research capacity in cancer, neuro-
science, and bioinformatics by nearly 40%. At the beginning of the year, only the foundations
for the six-building research complex were in place. By year’s end, all of the internal piping
and wiring were installed; the concrete superstructure was complete, exterior block walls
were erected, and the roof structure and sheathing were in place, enclosing the buildings
and ensuring that interior work continued through the winter months.
All the work on building structures could readily be seen at a glance as it progressed. Much
less obvious was the enormous amount of work taking place inside the structures. Electricians
and steamfitters worked hard, installing electrical and mechanical systems, including the two
high-pressure boilers that will ultimately heat the six-building complex. These two areas were
by far the most complex components of the project, and the impressive progress made in
these areas is essential to the timely completion of the Hillside Campus.
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The final touches were also put on the new chiller plant, and much of the underlying infra-
structure—drainage systems, electrical conduit and wiring, water and sewer piping—was
installed underground.
The Nassau County Chapter of the New York State Society of Professional Engineers pre-
sented CSHL with the Project of the Year Award for the engineering and innovative environ-
mental design of the storm water management system for the Hillside Campus. CSHL was
recognized for achieving a balance between development and the environment. The unique
and functional storm water management system not only is effective at protecting the sur-
rounding ecosystems, but also provides a visually pleasing backdrop for the Laboratory.
We thank Vice President and Chief Facilities Officer Art Brings and the Facilities
Department for all of these great results and the minimal disruption to our daily operations
and quality of life on campus as the work has proceeded.
Awards and Honors
CSHL professor and Dean of the Watson School of Biological Sciences Leemor
Joshua-Tor was one of 56 newly named HHMI Investigators in 2008. She joins approx-
imately 300 HHMI Investigators in the Institute’s flagship program, who lead HHMI lab-
oratories at 64 institutions. In addition to Leemor, HHMI Investigators at CSHL include
Gregory J. Hannon, Ph.D. and Scott Lowe, Ph.D.
For leadership in computational approaches and leveraging emerging sequence
technology to link candidate genes and their function with agricultural traits and
germplasm improvement, CSHL adjunct assistant professor Doreen Ware received the
2008 Scientist of the Year Award for the North Atlantic Area from the United States
Department of Agriculture. 
CSHL postdoctoral fellow Alexei Aravin was a 2008 finalist in the second annual
New York Academy of Sciences Blavatnik Awards for Young Scientists. Sixteen young
scientists from the New York tristate area were selected for their outstanding work as
postdoctoral fellows and young faculty members. Five winners were chosen after three
rounds of review of the 16 finalists, who represented a wide scientific and institutional
spectrum in engineering, physics, and biology at nine different institutions in New York,
New Jersey, and Connecticut.
Thompson Scientific’s Essential Science Indicators ranked the research conducted
at CSHL among the most cited in the world. The analysis, reported in the
January/February issues of Science Watch, placed CSHL in the top 1% of institutions
most cited and identified our research as having significant impact on molecular biolo-
gy and genetics research from 2002 to 2006. This follows the previous ranking of
CSHL by Science Watch as the top institution in the world in molecular biology and
genetics during the decade from 1993 to 2002, based on citation impact. 
I was honored to be elected this year to the American Academy of Arts and Sciences, joining
other inductees who included CSHL friend and science philanthropist James H. Simons.
At the 2008 Watson School of Biological Sciences Commencement Con vocation on April 13, we
confer red the degree of Doctor of Philos ophy to Hiroki Asari, Rebecca Bish, François Bolduc,
Monica Dus, Angélique Girard, Christopher Harvey, and Wei Wei. Claire Biot and Adrienne Jones
received the Master of Science degree. The Watson School  also bestowed honorary degrees on
three distinguished recipients. The first is one of the world’s most successful entre preneurs, who
established the Allen Brain Institute that has mapped the gene architecture of the brain—Microsoft
L. Joshua-Tor
D. Ware
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cofounder Paul G. Allen. The remaining two include the Nobel Prize–winning neuroscientist Dr. Eric
Kandel and a clinician whose ability to translate the complexities of the brain’s biology into house-
hold concepts has made him a cultural icon: Dr. Oliver Sacks.
The 2008 incoming class is the 10th of the Watson School and represents a record number of
students—a total of 15—who come to Long Island from Australia, France, Germany, Italy, South
Korea, Russia, and Turkey, in addition to the United States. This year, we also established the
Gonzalo Rio Arronte Fellowship, to be held by a qualified Mexican graduate student. Candidates
for the fellowship will be preselected by the Universidad Nacional Autónoma de México and the
Fundación Gonzalo Río Arronte and presented to the Watson School Admissions Committee,
which will make the final decision on admission. The fellow will be expected to have a role in the
development of genomic sciences in Mexico upon completion of his or her graduate and post-
doctoral training. 
For the seventh consecutive year, CSHL received the highest possible rating from Charity
Navigator for its financial organizational efficiency and capacity.
As a private nonprofit research and education institution, we are proud to be recognized for
achieving the highest standards of financial responsibility. These standards distinguish CSHL as an
institution prepared to meet the expectations of public and private donors, who demand account-
ability, transparency, and quantifiable results from their contributions to nonprofit organizations.
Thank you to CSHL Chief Operating Officer Dill Ayres and Comptroller Lari Russo for their commit-
ment to ensuring the highest standards for CSHL.
Development
With the hard work of the Development department, led by Charlie Prizzi, Cold Spring Harbor
Laboratory's fund-raising efforts saw much success in 2008. The $200 million goal for the
Hillside Campus Campaign was surpassed and more than $41 million was raised in unre-
stricted and program support. Generous philanthropic gifts resulted in the establishment of
the Center for Quantitative Biology at Cold Spring Harbor Laboratory, which will be based in
the newly constructed David H. Koch Laboratory.
Watson School Commencement Convocation
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The Simons Foundation and The Stanley Medical Research Institute have continued to
fund programs aimed at uncovering the genetics behind autism, schizophrenia, and bipolar
disorder. Additionally, a generous commitment was made by HHMI to help expand the labo-
ratory space for the CSHL Meetings and Courses program so that more scientists will have
the opportunity to participate in our world-renown ed educational programs. 
On behalf of CSHL, our Board of Trustees, and our Development de part ment, I would like to
acknowledge all those who helped us to achieve our goals. Please refer to the back of this Annual
Report for a complete list of our generous supporters.
The Robertson Research Fund
The Robertson Research Fund continues to serve as a vital internal re source of support for our sci-
entists. In 2008, it supported research in the labs of Grigori Enikolopov, Josh Huang, Leemor
Joshua-Tor, Rob Martienssen, Senthil Muthuswamy, Bill Tansey, Anthony Zador, and Yi Zhong.
Start-up research support was also provided by the Fund to four new investigators: Hiroyasu
Furukawa, Raffaella Sordel la, Lloyd Trotman, and Glenn Turner. In addition, the Robertson Research
Fund continues to support the annual CSHL In-House Symposium and our programs for post-
doctoral fellows and graduate students, the laboratory seminar program, and faculty recruitment.
Library and Archives 
History of Biotechnology Meeting
While renovations progressed on schedule to the Carnegie Building, the home of the CSHL
Library and Ar chives, there was also much progress in the expanded mission of this vital
CSHL resource. Under the aegis of The Genentech Center for the History of Molecular
Biology and Biotech nol ogy at CSHL, Library and Archives, in cooperation with the Banbury
meetings program that is run by Jan Wit kowski, hosted a milestone meeting entitled
“Biotechnology: Past, Present, and Future.” From September 21 to 23, scientists, entrepre-
neurs, and venture capitalists discussed the academic discoveries that gave rise to our mod-
ern biotechnology industry, and along with distinguished sociologists, economists, and his-
torians, they discussed the importance of gathering and preserving primary documentary
source materials that will enable historians of today and tomorrow to study the emergence of
a field that has transformed the life sciences, business, and health care since its advent in the
1970s. I am pleased to note that our own Library and Archives department, under Ludmila
Pollock, has already established a valuable repository for materials of lasting historical value,
including an extensive and growing oral history archive.
Building Projects
Hillside Research Laboratory Campus
Progress on the construction of the six new research buildings of the Hill side Research
Complex has been excellent. The Nancy and Frederick DeMat teis, David H. Koch, and
William L. and Marjorie A. Matheson Laboratory buildings have progressed substantially
toward their anticipated completion by the spring of 2009. The Donald E. Axinn, Leslie and
Jean Quick, and Wendt Family Laboratory buildings are expected to be ready for occupan-
cy by mid-2009. The landscaping surrounding the complex was significantly enhanced this
year, and much-needed parking facilities have already been put to use.
14
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Access to the new complex is now possible via a roadway connecting to the Grace park-
ing lot. As part of this project, we made the decision to re con figure the lot for improved traf-
fic flow and safety. Despite adding an additional traffic lane to better accommodate bus and
van traffic associated with the Meetings and Courses program, we were able to increase
green space in the area by more than 5000 square feet.
Renovation was also begun on teaching facilities in the Delbruck Laboratory. Structural
problems ne ces sitated reconstruction of the building’s circa-1927 center section, requiring
the entire top floor and roof section to be completely removed and rebuilt. Generous fund-
ing from HHMI allowed CSHL to completely modernize the entire historic teaching suite that
is used for courses to train scientists on the latest technologies and techniques. These ren-
ovations and improvements are expected to be complete by the spring of 2009.
As noted above, we have made significant progress on the Carnegie Building renovation.
Although we had originally hoped to complete the project by the end of 2008, design alter-
ations and the challenges of working within an existing, historic structure made that impos-
sible. The project is expected to be completed and ready for occupation in 2009.
We also undertook renovation and improvement of the circa-1937 Robertson House, locat-
ed on the Banbury estate and primarily serving participants invited to high-level meetings at the
Banbury Conference Center. Principal among the planned renovations was the replacement of
the house’s original electrical system in preparation for the installation of central air conditioning.
The torrid weather of recent summers has made the house all but uninhabitable during the
hottest part of the year. When completed in 2009, the house will have been completely fresh-
ened with new washrooms, refurnished, air-conditioned, and equipped with telephones and
internet connections in each room. I thank Art Brings and Peter Stahl and all who worked on this
difficult project to maintain Robertson House as a grand residence and doing so under budget.
CSHL has also continued its long-standing program of general campus improvements.
The four-year project to upgrade and replace the building management system is now half
15
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complete. The Jones Laboratory was renovated for course use during the Delbruck
Laboratory renovations. Updates and changes were also made to various office areas to bet-
ter suit the needs of the Laboratory’s staff.
Special Events
National DNA Day
We celebrated the sixth annual congressionally designated National DNA Day on April 25, with
walking tours of CSHL and festive signs on campus and throughout the village of Cold Spring
Harbor. We thank the Cold Spring Harbor Library and Environmental Center and the Cold
Spring Harbor Main Street Associ ation for their participation.
Emerson String Quartet Concert
Cold Spring Harbor Laboratory, Stony Brook University, and Brook haven National Laboratory
hosted an evening of “Perfect Harmony” on April 1 to celebrate music, partnerships, and
possibilities for increased research collaboration among the three scientific institutions on
Long Island. Guests listened to the Emer son String Quartet and were treated to an appear-
ance by pianist Gilbert Kalish.
Gavin Borden Visiting Fellows
The 14th Annual Gavin Borden Visiting Fellow Lecture, in memory of the publisher of
Molecular Biology of the Cell, was held on April 14. The lecture was presented by Tania
Baker, who in addition to being an alumna of the CSHL Undergraduate Research Program
is the Edwin C. Whitehead Professor of Biology at the Massachu setts Institute of Technology
and an HHMI Investigator.
The Lab Goes Latin
This year’s The Lab Goes Latin event marked the 10th
anniversary of the Cold Spring Harbor Laboratory
Association’s spring benefit. Held on May 10 at the Nature
Conservancy in Cold Spring Harbor, it featured a packed
dance floor with music by the urban salsa band Yerba Buena.
The event raised more than $200,000 for CSHL’s cancer and
neuroscience research programs.
Symposium
The 73rd Symposium, on “Control and Regulation of Stem Cells,” brought more then 300
researchers from around the world together at CSHL to discuss the latest findings in stem
cell biology. 
During the Symposium, the traditional Dorcas Cummings Memorial Lecture for scientists
and guests from the community was delivered by Elaine Fuchs, Rebecca C. Lancefield
Professor and head of the Laboratory of Mammalian Cell Biology and Development at The
Rockefeller University.
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Women’s Partnership for Science
This year’s event attracted 150 women from the surrounding community, New York City, and
Connecti cut to the home of Mr. and Mrs. Daniel P. Davison on June 22. They gathered to
promote and support women pursuing careers in biomedical research. Guests participated
in their own tabletop experiments on organic and genetically modified foods. The instructors
were young educators from Cold Spring Harbor Laboratory’s Dolan DNA Learning Center
(DNALC); Erin McKechnie, a plant and soil specialist; and Elna Gottlieb, an earth science
specialist. 
Topping Ceremony
On July 22, CSHL celebrated the topping of the highest structure in the soon-
to-be-opened Hillside Research Complex. Distinguished guests, elected offi-
cials, colleagues, friends, and members of Long Island’s talented construction
trades gathered to commemorate the occasion. They proudly observed as a
10-foot-6-inch square by 13-foot-high 5000-pound stainless steel pyramid
was lifted by crane and secured to its new home atop an 85-foot tower that
is called the Laurie and Leo Guthart Discovery Tower. In addition to the pyra-
mid, a steel beam autographed by hundreds of CSHL staff and visitors is part
of the foundation for the crown. 
Paul Liam Harrison Exhibit
Paul Liam Harrison exhibited his artwork at CSHL during the Dynamic Organization of
Nuclear Function meeting on September 16. For several years, his practice has become in -
creasingly collaborative and has engaged with developments in and around the biosciences
and, in particular, cell and gene research. The exhibit was a collection of works entitled
“Designs for Life.”  
Harlem DNA Lab Opening
On September 23, New Yorkers celebrated the opening of the Harlem DNA Lab, a state-of-
the-art education facility located in the John S. Roberts Educational Complex in East Harlem,
New York. Joel I. Klein, New York City Department of Education Chan cellor, and Peter Bruns,
Vice President for Grants and Special Programs at HHMI, joined school principal Maria
Aviles, DNALC Executive Director David Micklos, myself, and local leaders in opening
remarks followed by a community tour of the teaching lab. 
DNALC 20th Anniversary
On November 1, The Dolan DNA Learning Center celebrated the acc om plishments of
Executive Director David Micklos and his staff in transforming science education during the
last two decades. The event included the dedication of the Laurie J. Landeau Multimedia
Studio.
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The Double Helix Medals Dinner
The Double Helix Medals Dinner was held on November 6 at the Man da r in Oriental,
New York. Medals were presented to Drs. Marilyn and James Simons for corporate
leadership, Sherry Lansing for humanitarianism, and James D. Watson, Ph.D. and
J. Craig Venter, Ph.D. for scientific research. A total of $3.6 million was raised at the
gala, which was co chaired by the Hon. and Mrs. Alan J. Blinken, Mr. and Mrs. Alan
C. Green berg, Dr. Arthur D. Levinson, Mr. and Mrs. David M. Rubenstein, Mr. and
Mrs. Herbert J. Siegel, and Mr. and Mrs. Erwin P. Staller.
CSHL Public Lectures
January 21
Bruce Stillman, CSHL President: The Future of Molecular Medicine at The Secret Science
Club public science and art lecture series in Brooklyn, New York.
August 4
Scott Lowe, Professor and HHMI Investigator: The Latest from the Frontlines of Cancer Research
at The Secret Science Club public science and art lecture series in Brooklyn, New York.
October 21 
WLIW-TV “Healthy Minds” host Dr. Jeffrey
Borenstein; Josh Huang, CSHL Professor;
Jonathan Sebat, CSHL Assistant Professor;
Linda Van Aelst, CSHL Professor; and Anthony
Zador, CSHL Professor: Autism: The Latest
Genetic and Neuroscience Research and What
it Means for Patients and Families.
October 28
Jonathan Sebat, CSHL Assistant Pro fessor
and Anil K. Malhotra, Director, Psychiatry Re -
search, Zucker Hillside Hospital and Associate
Professor of Psychiatry, Albert Einstein College
of Medicine: Bipolar Disorder: Cracking the
Code.
November 11
CSHL trustee and poet Don Axinn: Travel in My
Borrowed Lives.
CSHL Public Concerts
April 12 
Jennifer and Angela Chun with Nelson Padgett,
violins and piano
May 3
Soukhovetski and Vassily Primakov, piano duo
CSHL’s Double Helix Medal
Harlem DNA Lab announcement
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May 17 
Anastasia Khitruk and Elizaveta Kopelman, violin and piano
August 30
Martin and Kristina Kasik, piano duo
September 20 
Alexander Fiterstein and Steven Beck, clarinet and piano
September 27 
Soyeon Lee, piano
October 4
Krista River and Judith Gordon, soprano and piano
Laboratory Employees
New Staff
Thanks to a superb recruiting effort led by CSHL Director of Re search David L. Spector, we
were pleased to introduce the following new faculty into the CSHL community this year. 
Tom Gingeras, Ph.D., CSHL professor, is an established leader in the field of functional
genomics who has developed high-throughput microarray technologies and powerful com-
putation approaches to understand how genomes are organized and regulated. Before join-
ing CSHL, Tom was Vice President for Biological Research at Affymetrix, Inc., California.
Assistant Professor Gurinder “Mickey” Atwal, Ph.D., is the first faculty appointment for the
new Center for Quantitative Biology at CSHL. He will integrate computational, analytical, and
experimentally derived data to approach several questions concerning the evolution and
diversity of genomes. His projects include identifying changes in the genome that modify risk
in cancer and autism; developing statistical tools for the analysis of interactions among
genetic polymorphisms identified in large-scale genetic and epidemiological studies; and
developing computational methods to detect networks of genes that have responded to
evolutionary selection pressures.
Assistant Professor Bo Li, Ph.D., who completed his postdoctoral training at CSHL and
at U.C. San Diego with Robert Malinow, studies neural synapses, specifically focusing on
how synaptic dysfunction contributes to psychiatric disorders such as schizophrenia and
depression. He uses a number of methodologies, including electrophysiology, genetics, and
behavioral analyses, with a long-term goal of developing methods that allow for the manip-
ulation of activity in specific brain circuits to correct disease-related behaviors.
Assistant Professor Zachary Lipp man, Ph.D., studies the molecular mechanisms control-
ling reproductive fitness in plants. He uses genomic ap proaches to determine what controls
flower, fruit, and seed production in tomato and Arabidopsis. His research will not only pro-
vide insights into plant evolution and domestication, but will also develop new tools for plant
breeding. Zach joins us from the Faculty of Agriculture at Hebrew University of Jerusalem and
is a Watson School graduate.
Associate Professor Pavel Olsten is both an M.D. and a Ph.D., whose re search will pro-
vide a critical bridge connecting CSHL’s genetics and neuroscience programs. He has devel-
oped a high-throughput approach involving cutting-edge imaging technology to monitor
brain function at the level of synaptic circuits. He is studying how specific genetic mutations
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and variations affect neural circuits in mouse models of schizophrenia and autism. Pavel was
previously an Assistant Professor at Northwest ern University.
Associate Professor Darryl Pappin, Ph.D., comes to CSHL to head the proteomics core
facility on our campus. Proteomics is the large-scale study of proteins, and Darryl brings an
impressive record of developing new methods for identifying and analyzing proteins in com-
plex biological samples. Before joining us, he was a Scientific Fellow at Applied Biosystems,
Ap plera Corporation.
Florin Albeanu, Ph.D., is a CSHL Fellow who received his doctorate from Harvard Medical
School. Florin is an expert in imaging neuronal circuits in awake behaving rodents. Working
in the olfactory system, he plans on using fiber-optic imaging and electrophysiological
recordings to under stand how neuronal circuits code information from the environment and
how these circuits are shaped by sensory experience.
Ivan Iossifov, Ph.D., is a CSHL Fellow in Quantitative Biology from Columbia University.
Ivan has devised computational methods to reliably extract knowledge about molecular inter-
actions from the biomedical literature and combine this data with results from high-through-
put biological experiments. In this way, he has built a framework to predict pathways or net-
works of interacting genes that contribute to common hereditary disorders. He is interested
in applying his methods to improve conventional genetic analyses to detect correlations
between specific mutations and common complex hereditary disorders such as schizophre-
nia, bipolar disorder, and autism.
CSHL Fellow Christopher Vakoc, M.D., Ph.D., is interested in how changes to the struc-
ture and organization of chromatin are related to cancer progression. He uses biochemical
approaches to study specific modifications associated with leukemia and colon carcinoma.
He did his doctoral training at Children’s Hospital of Philadelphia.
Joining the administrative leadership of CSHL this year was Hans-Erik Aronson, Director
of Information Technology. Hans-Erik was previously at the Center for Computational Biology
and Bioinformatics at Colum bia University. His own training in biochemistry and molecular
biophysics, combined with his experience in design, implementation, and delivery of emerg-
ing technologies, will be critical to the success of individual scientific research projects as well
as to the operations of the entire Laboratory, which increasingly de pends on the strength of
our information technology infrastructure and dedicated staff. 
Promotions
Congratulations to Zhenyu Xuan, Ph.D., who was promoted this year to
Assistant Research Professor and to Jim Hicks, Ph.D., who is now a CSHL
Research Professor.
Departures
During the course of the year, several faculty members took on new chal-
lenges at other institutions. Hollis T. Cline holds the position of Professor in
both the Department of Cell Biol o gy and Chemical Physiology at the Scripps Research
Institute. Rober to Mal i now is a Professor, Section of Neurobiology, and Professor, Neuro-
sciences at UC San Diego. Zachary Mainen is Principal Investigator at the Champalimaud
Foundation. Vivek Mittal is currently Associate Professor, Cardiothoracic Surgery, and
Director, Lehman Brothers Lung Cancer Laboratory at Weill Cornell Medical Center.
J. Hicks
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Community Outreach
CSHL employees continue to actively participate in local and national community service
events, including lab-wide blood drives in February, August, and December and the
American Cancer Society’s Daffodil Days in the spring. This year, CSHL employees donated
400 pounds of food to the Long Island Cares Harry Chapin Food Bank. Our campus also
participated in the national campaign to donate used cell phones for conversion to 911
emergency-use cell phones that will be distributed to those in need by the Secure the Call
Foundation. These efforts are organized by our dedicated Human Resources Department
ably led by Katie Raftery. In addition to participating in local Long Island school activities,
every year CSHL is proud to sponsor Cold Spring Harbor Library and Environmental Center
kickoff festivities for the children’s summer reading program. 
CSHL campus walking tours were open to the public most Saturdays from March through
November. Our specially trained team of tour guides, which includes CSHL graduate stu-
dents and postdoctoral fellows, provides guests with scientific insights and personal per-
spectives that enrich the public’s understanding of CSHL.
Looking Forward
The year 2008 was notable for the many accomplishments that I have highlighted here. The
year was perhaps even more notable for the ability of this institution to manage its research
and education programs in the face of significant external economic uncertainty. I credit the
Labor atory’s Principal Investigators, who are committed not only to scientific excellence but to
the responsible management of their laboratory budgets and staff. The research administra-
tion team that we have built has succeeded in establishing a new standard for meshing the
creativity required in scientific pursuit with the realities of fiscal and regulatory requirements.
CSHL’s education programs have never been as strong and broad, reaching from middle
and high school ages to undergraduates, graduates, postdoctoral students, and profes-
sional de velopment for accomplished scientists. None of this would be feasible if not for the
operational efficiencies and accomplishments of the Laboratory’s administrative departments
and their staff who provide critical support to our scientists and educators. In addition to
those departments already mentioned, let me thank the entire Facilities Department, the
Office of Sponored Programs, the Office of Technology Transfer, the Public Affairs
Department, and the Pur chasing Department for their great work. Despite a tough external
environment, CSHL thrived as an institution and a community in 2008. 
Thank you to our Trustees, faculty, staff, and many supporters for your hard work. As I
look to the future, I remain confident that scientific re search and education are a source of
strength for the troubled national economy—a source that has yet to be tapped to its fullest
potential. CSHL stands ready to push biomedical research forward to reach its fullest poten-
tial. With a sharp focus on our core mission, CSHL is poised to do even more for the future
of science and society than we have in the many years of our very fruitful past.  
Bruce Stillman, Ph.D., F.R.S.
President
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CHIEF OPERATING OFFICER’S REPORT
We will forever remember 2008 as the year the bubble burst—driving the economy and the financial
markets into chaos while leaving nonprofit institutions and universities around the world to cope with
unprecedented depreciation of endowment funds. I am reminded of the somewhat tasteless joke,
“Other than that, Mrs. Lincoln, how did you enjoy the show?” The analogy stems from the fact that
2008 was, in many respects, a very good year for Cold Spring Harbor Laboratory.
Construction of the Hillside Campus laboratory complex was near completion at year’s end. The
exteriors of the handsome 100,000 square foot, six-building research facility are finished, with final
touches being applied to the interior spaces. The landscaping is nearly complete as well, with more
than 500 new trees having been planted around the site. It is pleasing to be able to report that the
project will come in within budget. Timing is everything, and we are fortunate that the project was in
its final stages before the economic storm reached its full fury, allowing us to avoid the dilemma fac-
ing many universities with half-completed construction projects. 
In 2006, we announced the ambitious plan to raise $200 million in support of the construction,
faculty recruitment, start-up, and additional endowment. Again, we were fortunate to reach and sur-
pass our goal before the massive loss of wealth in the public equity markets occurred late in the year.
We are particularly grateful to our Trustees and the scores of friends who supported this campaign
so generously, making it possible to reach this impressive milestone. 
As you can see from the “President’s Report,” the Laboratory programs progressed in 2008 with
unabated excellence. We saw high-profile research results and publications, well-attended meetings
and courses, and the opening of a DNA Learning Center in Harlem. The Watson School continues
to attract the best and brightest Ph.D. students to our campus and the Laboratory Press raises our
institutional profile in the scientific community with its excellent list of journals, books, and online
research protocols. The Carnegie Building, currently undergoing renovation, will be home to our
expanding Library and Archives. 
For the fiscal year ended 12/31/08, the Laboratory operating budget reached $123.5 million—an
8% increase over the prior year. Our objective each year is to balance the operating budget after full
depreciation expense ($7 million in 2008) or, at a minimum, to be cash neutral after netting depreci-
ation expense against cash expenditures on capital improvements. Fortunately, we were able to
achieve this goal again this year. The primary contributing factors were (1) the success in unrestrict-
ed fund-raising via the Annual Fund, President’s Council, and the Double Helix Medals dinner in New
York City, (2) greater than expected private research grant income, and (3) vigorous efforts to man-
age overhead, administrative, and operating expenses. Much progress has been made during the
last several years in the management of the grant process, research budgets, and general expens-
es, all to the benefit of the Laboratory’s financial health. 
Despite the progress and the fortunate timing on construction and fund-raising, we now face
unprecedented financial and operating challenges as a direct result of the decline in the capital mar-
kets. In June of 2008, while our endowment had declined a relatively modest 3% year to date, we
experienced a bump in the road that was an omen of things to come. The “auction rate securities”
market, a $400 billion market for institutional paper, seized up and ultimately disappeared. The
impact on the Laboratory was very real, because our 2006 $55 million bond issue consisted of this
type of security. For a brief period of time, until we were able to convert the bonds to a different mode,
the Laboratory was forced to pay extraordinarily high rates of interest in order to entice investors to
buy our paper. This was ironic in view of the fact that the Laboratory’s credit rating had recently been
upgraded to a very healthy AA– status. The failure of the auction rate market was a precursor to the
22
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general crisis in the credit markets, the extreme stress on the banking system, the precipitous decline
in stock values, and the economic slowdown, all of which accelerated at an alarming rate during the
second half of the year. 
There was nowhere to hide for institutional endowments. The Laboratory endowment investment
return was a negative 24% for our calendar fiscal year. Although certainly discouraging, it was not as
bad as many, given a substantial allocation to fixed-income investments that held their value. Also on
the positive side, we have maintained a very liquid investment portfolio and hold no “frozen” assets
or private equity investments. Nevertheless, when we account for the spending on the fund, the mar-
ket value has declined to approximately $220 million, down from its high of nearly $315 million only
one and a half years ago. We also are party to an “interest rate swap” agreement that was entered
into in 2006 to provide long-term protection against high interest rates on the Laboratory’s variable-
rate long-term debt. As rates have dropped to historic lows, the “mark-to-market” valuation of this
contract represents a liability to the Laboratory and has required us to post cash collateral with the
bank counterparty until such time as rates move up and the liability decreases in value.
The dilemma now facing all institutions that rely on endowment funds is the budgetary impact
these declines will have in the coming years. Like most universities, the Laboratory annually spends
a percentage of the average market value of the endowment funds calculated over the most recent
12 calendar quarters. When we average in a year such as 2008 and confront the prospect of anoth-
er down year ahead, we very quickly face big holes in the operating budget that are difficult to fill.
Spending from the endowment represents about 12% of the Laboratory’s annual operating budget,
much lower than most universities. On the other hand, private philanthropy represents approximate-
ly 25% of the budget and is a revenue stream that will certainly be under pressure given the state of
the economy. 
As we look ahead to 2009, Management will be forced to take prudent and tough measures. At
the very least, administrative hiring will be curtailed and expenses, already having been substantially
cut, will need to be further reduced. At a time when a great deal has been asked of a dedicated staff,
we will undoubtedly be asking more. Austerity is not a pleasant prospect, but it is what the times
demand. 
Dill Ayres
Chief Operating Officer
24
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LONG-TERM SERVICE
The following employees celebrated milestone anniversaries in 2008: 
40 years James Watson
30 years Patricia Maroney, Christopher Mc Evoy, Beatrice Toliver, Michael H. Wigler
25 years Joan Ebert, Margaret Falkowski, Daniel Jusino
20 years Margot Bennett, Francis T. Bowdren, Nancy Dawkins-Pisani, Maryliz M.
Dickerson, Grigori N. Enikolopov, Jeffrey Goldblum, Kim Gronachan, Salvador
Henriquez, Louis Jagoda, Ronnie Packer, Margaret Stellabotte, Arne Stenlund
15 years Pamela Lancellotti, Wayne Pav, David J. Stewart
(Back row) Arne Stenlund, David J. Stewart, David Spector, James Watson, Bruce Stillman. (Middle row) Salvador
Henriquez, Joan Ebert, Beatrice Toliver, Michael H. Wigler, Nancy Dawkins-Pisani, Christopher Mc Evoy, Louis
Jagoda, Grigori N. Enikolopov. (Seated) Kim Gronachan, Patricia Maroney, Daniel Jusino, Margaret Falkowski,
Ronnie Packer, Maryliz M. Dickerson.
25
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See previous page for photos of the following scientific staff:
Row 1: T. Hige (Turner Lab); I. Hakker (Zhong Lab); B. Czech (Hannon Lab); 
E. Ghiban (McCombie Lab)
Row 2: S. Wu (Huang Lab); R. Zhao (Spector Lab); M. Monaco (Stein Lab); 
J.J. Han (Martienssen Lab)
Row 3: Y. Hua (Krainer Lab); G. Collins (Tansey Lab); K. Cook (Wigler Lab); 
A. Bhandari (Sebat Lab)
Row 4: A. Husbands (Timmermans Lab); S.D. Akshinthala (Muthuswamy Lab); 
M. Gierszewska, K. Hrecka (Skowronski Lab); Y.J. Yang (Hannon Lab)
Row 5: M. Feigin, V.A. Calleja (Muthuswamy Lab); V. Krizhanovsky (Lowe Lab); 
A. Reid (Zador Lab); A. Kepecs, D. Kvitsiani (Kepecs Lab)
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CANCER: GENETICS
Cancer Genetics focuses on understanding the genetic basis of cancer, cancer progression, and devel-
opment of resistance to chemotherapy.
Gregory Hannon is a pioneer in the study of RNA interference (RNAi) in mammalian systems. In RNAi,
double-stranded RNA molecules induce gene silencing. Hannon is credited with the discovery of two
enzymes, called Dicer and Slicer, critical in the RNAi machinery. (The work on Slicer was performed with
Leemor Joshua-Tor.) His team has led the way in using RNAi to study cancer biology and genetics. They
have generated a library of short-hairpin RNAs that researchers at CSHL and elsewhere apply broadly in
gene-si lencing studies. This year, the lab made a host of discoveries, including that of a new class of small
RNAs, which was found in fruit flies to modify gene activity and suppress mobile genomic elements, thus
serving as a defense mechanism. They also discovered 180 previously unrecognized microRNAs spe-
cific to mon otremes in work stemming from a collaborative effort to sequence the platypus genome. The
lab also ex plained a new way in which epigenetic information is inherited, discovering in fruit flies a class
of small RNAs maternally inherited that determines an offspring’s fertility trait. 
Scott Lowe’s laboratory studies cancer gene networks and determines how genetic lesions affecting
these networks contribute to tumor development and resistance to therapy. This year, they continued to
study cellular senescence, a potentially powerful mechanism for suppressing tu mors, showing that it
helps to limit wound-healing responses, a finding which suggests that it might act outside cancer to
maintain tissue homeostasis following damage. Lowe also has adapted RNAi tech nology to produce
animal mod els in which genes can be switched on and off in a spatial, temporal, and reversi ble manner
and used this to identify and characterize new genes that modulate tumor cell respon ses to chemo ther-
apy. He spear headed an effort with other CSHL investi gators to integrate ge nomic studies on human liver
cancers with RNAi-based screening in a mouse model to identify 13 new tumor suppressor genes. These
studies suggest a means of functionally annotating cancer genes and holds promise of producing new
insights into the genetic basis of tumor diversity that can ultimately be exploited to tailor treatments to
individual patients.
Robert Lucito, collaborating with Michael Wigler, has had an important role in developing innovative
technologies, including representational difference analysis (RDA), representational oligonucleotide
microarray analysis (ROMA), and comparative genome hybridization (CGH), that have proven to be valu-
able to cancer researchers worldwide. Also an ex perimentalist, Lucito has conducted studies using these
techniques to detect copy-number changes in large sets of human ovarian and pancreatic cancer tissue
samples. The lab also has turned its attention to epigenetics, specifically to the study of methylation
throughout the genome. When methyl groups in sufficient numbers attach to cytosine bases in DNA, the
packing of DNA into the chromosomes can be altered, reducing the levels at which the methylated genes
are expressed. Under circumstances that Lucito is now exploring, this may be a means by which nor-
mally protective tumor suppressor genes are turned off, rendering cells tumorigenic.
Alea Mills is studying genetic pathways important in cancer and aging, identifying the genetic players
and determining how aberrations in their functions culminate in human disease. Recently, through inno-
vative use of a technique called “chromosome engineering,” the Mills group identified a tumor suppres-
sor gene that had eluded investigators for three decades. The tumor-suppressing gene, called Chd5, was
shown by Mills to regulate an extensive cancer-preventing network. The epigenetic role of Chd5 in devel-
opment, cancer, and stem cell maintenance is currently being investigated. The Mills lab is also studying
the p63 protein, which regulates development, tumorigenesis, cellular senescence, and aging, in vivo.
Their progress during the last year indicates that cellular senescence has tumor-suppressing effects, a
finding that indicates potentially important new avenues for anticancer therapies.
The discovery that stem-like cells involved in developmental decisions such as cell-fate determination
can give rise to certain types of cancer has provided a new theme for cancer research. The identification
of cancer stem cells with vital roles in tumor progression, maintenance, and recurrence has suggested
29
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that at least some cancers arise from malfunctioning developmental programs. The re search of CSHL fel-
low Patrick Paddi son, which seeks to discover more about how molecular pathways promote or contain
“stemness,” may therefore provide insight into cancer biology and point to new therapeutic strategies.
Using in vivo functional-genetics approaches, Paddison is attempting to identify genes required for self-
renewal and lineage specification in embryonic and adult stem cells in humans and rodents. He seeks to
determine if these genes are involved in stem-cell-driven cancers. His lab is also studying how to apply
RNAi technologies to create cell types that one day might be used in cell replacement therapies.
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The Hannon lab continues to investigate the biology of
small RNA and to apply small RNAs as tools to under-
stand cancer. Through collaborations with the McCombie
and Gingeras labs here at CSHL and other labs, we have
expanded our efforts in genomics, particularly working
to devise increasingly powerful ways to probe the cancer
genome and to understand the diversity of small non-
coding RNAs. These studies have required increasingly
complex computational strategies, pushing efforts of the
group toward the development of new tools for harness-
ing the power of next-generation sequencing.
The last year has seen many changes in the makeup
of the lab. Julius Brennecke departed to assume a posi-
tion as a group leader at the IMBA in Vienna, and Liz
Murchison joined Jenny Graves and the Sanger Center
as a postdoctoral fellow. Jose Silva joined the faculty of
Columbia University. Monica Dus, Angélique Girard,
and Despina Siolas each received their Ph.D.s. Monica
left for a postdoctoral position with Greg Suh at New
York University, and Despina returned to complete the
medical school component of her M.D./Ph.D. program.
Hannah Bender, a longtime visitor working on the Tas-
manian Devil project, returned to Jenny Graves’ lab.
We were joined by several new postdoctoral fellows.
Andres Canela, who will continue to pursue his interests
in cancer genome structure, came to us from the CNIO.
Camila Dos Santos came from Mitch Weiss’ lab, bring-
ing her experience in hematopoiesis but changing her
focus to mammary stem cell biology. Vasily Vagin
joined us from Phil Zamore’s lab where he had done
fundamental work on small RNA pathways in the germ
line. Nobu Hiramatsu came as a fellow from Japan to
work on drug resistance mechanisms in lung cancer.
Several graduate students joined the lab this year,
namely, Paloma Guzzardo, Antoine Molaro, Ralph
Burgess, Marek Kudla, and Ben Czech. Nik Rozhkov
joined the fly group as a visiting student. Finally, Assaf
Gordon joined our computational group, and he has
worked tirelessly to make powerful informatics tools
more accessible to the lab overall.
This year has seen many interesting stories emerge or
initiate, and they are described in more detail below.
RNA INTERFERENCE MECHANISMS AND APPLICATIONS
G. Hannon A. Aravin B. Czech P. Guzzardo I. Ibarra A. Molaro N. Shostak
J. Brennecke C. Dos Santos A.D. Haase F. Karginov F. Rollins V. Sotirova
R. Burgess Y. Erlich X. He M. Kudla M. Rooks O. Tam
A. Canela M. Evgenev N. Hiramatsu C. Malone N. Rozhkov V. Vagin
K. Chang K. Fejes Toth I. Hotta K. Marran E. Rozhkova E. Zelentsova
S. Cheloufi A. Gordon
THE BIOLOGY OF SMALL RNAS
The Biology of Argonaute Proteins
S. Cheloufi
The genetic knockouts of Argonaute family members
Ago2, Ago1, Ago3, and Ago4 demonstrate that Ago2 is
the only Argonaute protein required for embryonic
development. Ago2’s unique role during embryogenesis
could be explained by its specific association with small
RNAs, its expression level and profile, or its specific
catalytic activity. A set of independent point mutant alle-
les of Ago2 demonstrates that the catalytic activity of
Ago2 is dispensable for embryonic development but is
essential after birth. Preliminary evidence demonstrates
that Ago2 does not associate with specific microRNAs
(miRNAs) and that the expression pattern of Ago2 in
the embryo is likely to be the key to its unique function
during embryonic development. Inactivation of Ago2
catalytic activity rescues the early lethality of Ago2 past
the organogenesis stage of embryonic development but
is lethal a few hours after birth. The requirement of the
catalytic activity of Ago2 at birth is still a mystery. We
are currently investigating the requirement of Ago2
catalysis in lung development at birth. Preliminary data
demonstrate that the point mutant lungs are immature
and result in respiratory distress and cyanosis. This
mouse model provides an essential tool for investigating
cleaving small RNAs and their targets.
Small RNA-mediated Epigenetic
Inheritance
C. Malone, J. Brennecke
Small RNA-directed silencing processes or RNA inter-
ference (RNAi) pathways participate vitally in chro-
matin regulation, repression of gene expression, viral
defense, and silencing of selfish genetic elements.
At the core of each pathway acts an Argonaute pro-
tein, which in its active form is loaded with a single-
stranded 21–30-nucleotide small RNA, guiding the
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Mechanisms of piRNA Biogenesis
A. Haase
We characterized two predicted nucleases involved in
piRNA silencing. In addition to the Piwi proteins them-
selves, two putative nucleases have been linked to the
piRNA pathway through genetic analyses. Zucchini
(Zuc) encodes a protein with similarity to phospholipase
D/nucleases (Koonin, Trends Biochem. Sci. 21: 242
[1996]; Ponting and Kerr, Protein Sci. 5: 914 [1996]),
and Squash (Squ) shows limited similarity to RNase HII
(Itaya, Proc. Natl. Acad. Sci. 87: 8587 [1990]). Mutants
in these genes were initially isolated in a screen for
female sterility. Recent studies have indicated that flies
lacking either protein individually have some defects in
piRNA-mediated transposon suppression (Schupbach
and Wieschaus, Genetics 129: 1119 [1991]; Pane et al.,
Dev. Cell 12: 851 [2007]). We are evaluating Squ and
Zuc as candidate piRNA-processing enzymes. First, we
are characterizing small RNA populations in mutants by
deep sequencing. (Heterozygote flies serve as control.)
Char - acterization of small RNAs by deep sequencing
has proven to be a powerful phenotyping tool for piRNA
pathway mutants and has allowed assignment of many
pathway components to germ-line versus somatic path-
ways and to the feed-forward piRNA amplification loop
(C. Malone et al., submitted). Second, we are investi-
gating the enzymatic activities of Zucchini and Squash
using recombinant proteins in vitro. Third, flies express-
ing tagged transgenes are used to identify the respective
ribonucleoproteins (RNPs) in the female and male germ
line. Taken together, in vivo and in vitro analyses aim to
elucidate the functions of these two predicted nucleases
in piRNA biogenesis and to characterize their molecu-
lar mechanisms of action. 
Common themes and differences exist in piRNA
silencing in germ-line stem cells (GSCs) and their
somatic niche. The expression of Aub and Ago3 is
restricted to the GSC, where they are engaged in a feed-
forward amplification loop of an initial piRNA signal,
whereas in the male and female germ line, Piwi acts in
GSCs and the surrounding somatic cells of the female
germ cell niche and solely in somatic cells of the male
germ line in Drosophila. We want to elucidate Piwi-only
piRNA pathways in the somatic germ cell niche and
investigate the relationship of Piwi to Aub and Ago3 in
GSCs. To investigate Piwi pathways in GSCs and
somatic cells of the GSC niche differentially, we have
generated transgenic flies expressing a tagged Piwi pro-
tein under the control of the Gal4-UASp system, which
allows tissue-specific expression of the transgene using
different Gal4 drivers. (Alternatively, specific cell types
Argonaute protein complex to RNA targets with com-
plementary nucleotide signatures. A variety of small-
RNA-generat ing pathways act upstream of distinct
Argonautes, resulting in the specialization of Argonaute
effector complexes for the identity of their targets. We
are interested in the in vivo functions of Argonaute pro-
teins in Dro sophila, especially those acting to protect
the genome against selfish genetic elements such as
transposons.
We have gained recent insight into the Piwi path-
way, which seems to have specifically evolved to fight
transposable elements, by investigating a remarkable
phenomenon termed “hybrid dysgenesis.” Here,
crosses between two strains of Drosophila melano -
gaster produce sterile progeny. The reason for this is
that one strain has gained control over a single trans-
poson, whereas the other strain has not. We have now
determined that Drosophila mothers epigenetically
deposit Piwi protein complexes to offspring, imparting
the ability to the progeny to effectively silence active
transposable elements. Therefore, we have discovered
that Piwi proteins and their bound small RNAs are the
molecular basis underlying the phenomenon of hybrid
dysgenesis.
A New Action of Penelope
N. Rozhkov, A. Aravin, R. Sachidanandam, E. Rozhkova,
E. Zelentsova, N. Shostak, M. Evgenev 
Three independent systems of hybrid dysgenesis are
known in D. melanogaster; they are the P-M, I-R, and
H-E systems. A fourth system is known in Drosophila
virilis, where an unusual transposon, Penelope, has a
key role and appears to be responsible for mobilization
of the other five transposable elements. These elements
belong to different transposon classes and unrelated
families.
We have shown that Penelope in D. virilis is processed
mainly into small interfering RNAs (siRNAs) (21
nucleotides) in contrast with other transposons that are tar-
geted both by siRNA and Piwi-interacting RNA (piRNA)
(23–29 nucleotides) pathways. It was therefore interest-
ing to investigate how Penelope behaves in distant species
such as D. melanogaster. These two species diverged from
each other 40–60 million years ago. Penelope, injected in
D. melanogaster, contributes only to the 21-nucleotide
siRNA fraction. Thus, we suggest that D. melanogaster
exposed to Penelope as a novel element can be used as a
model system to study how the RNAi machinery adapts to
invasion of new transposons or viruses. 
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from germ-line tissues can be purified using biochemi-
cal fractionations.)
Overall, we aim to gain new insights into the molec-
ular mechanism of transposon control and germ cell
maintenance, as well as a deeper understanding of the
functions and mechanisms of small RNA silencing path-
ways. 
Proteomic Approaches to the
piRNA Pathway
V. Vagin, A. Aravin
To better understand the mechanism of the production
and function of piRNAs, we take advantage of trans-
genic animals expressing the FLAG-HA-tagged version
of PIWIs. We purified all PIWI complexes from the fly
and mouse germ lines. Very conservative proteins were
identified in the mouse and fly PIWI complexes. Muta-
tions in components of PIWI complexes lead to mouse
and fly sterility, similar to mutations in PIWI genes. 
Currently, we are analyzing the role of Tudor proteins
in piRNA biogenesis in the mouse, using mutants for
corresponding genes (in collaboration with Dr. Chuma,
Kyoto University, and Dr. Wang, University of Pennsyl-
vania). In parallel, we are studying the phenotype of the
mutation in the Tudor gene in flies. 
Genetic Approaches to Small
RNA Pathways in Flies
I. Hotta
To identify components of the three Argonaute-dependent
small RNA (siRNA, miRNA, and endogenous siRNA
[endo-siRNA]) pathways in Drosophila S2 cells, we have
undertaken a comparative and comprehensive genome-
wide RNAi screen. Among candidates emerging from the
screens, we identified subsets that act positively or nega-
tively on siRNA, endo-siRNA, and miRNA pathways.
Endogenous siRNAs in Drosophila
B. Czech [in collaboration with R. Zhou, Harvard Medical
School]
Small RNA pathways perform crucial functions in gene
regulation, defense against viruses, transposon silencing,
and formation of heterochromatin. The core effector com-
plex of each small RNA pathway comprises an Argonaute
protein associated with a single-stranded 19–30-
nucleotide small RNA that guides the Argonaute protein
to target transcripts sharing sequence complementarity.
These small RNAs are categorized according to their
mechanisms of biogenesis and the Argonaute protein to
which they bind. Thus far, two classes of endogenous
small RNAs have been identified in D. melanogaster:
miRNAs, which associate with AGO1 and are required
for proper development, and piRNAs, which act in con-
cert with the Piwi clade proteins Piwi, Aub, and AGO3 to
suppress mobile genetic elements. However, the endoge-
nous binding partners of AGO2 have remained enigmatic.
Using biochemistry and deep sequencing of AGO2
immunoprecipitates, we showed that Drosophila gener-
ates a third endogenous small RNA class: endo-siRNAs.
endo-siRNAs arise both from convergent transcription
units and from structured genomic loci in a tissue-specific
fashion and have the capacity to target virus transcripts,
transposons, and protein-coding genes. We furthermore
identified the double-stranded RNA (dsRNA)-binding
protein Loquacious (Loqs)—thus far only known as an
miRNA biogenesis factor—as being required for the bio-
genesis of endo-siRNAs derived from structured loci. Fol-
lowing up on our systematic analysis, we found that a
specific isoform of Loqs, that is distinct from the one
shown to facilitate processing or pre-miRNAs, is respon-
sible for endo-siRNA processing. Deep-sequencing data
and northern blots indicate that this specific isoform is
also required for the production of endo-siRNAs derived
from sources other than structured loci (e.g., endo-
siRNAs targeting repeat sequences).
piRNA Clusters in Mammals
A. Aravin, A. Molaro
We investigated the biogenesis and function of piRNA in
the mouse germ line. piRNAs are derived from extended
genomic regions referred to as piRNA clusters. Using a
recombineering approach, we inserted an artificial
sequence (green fluorescent protein [GFP]) in two piRNA
clusters. Modified piRNA clusters were introduced in the
mouse genome as transgenes by pronuclei injection (in
collaboration with Dr. Sang Yong Kim, Cold Spring Har-
bor Laboratory). Transgenic animals will be used to gain
further insight into the mechanisms of piRNA biogenesis.
We also investigated the function of piRNA in the estab-
lishment of de novo DNA methylation using piRNA
reporter constructs where sequences complementary to
abundant endogenous piRNAs were inserted in the pro-
moter region of the gene expressed in the germ line. To
test the association of the protein partner of piRNA,
MIWI2 protein, with chromatin, we performed chromatin
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immunoprecipitation (ChIP) analysis on sorted germ cells.
Using small RNA cloning and high-throughput sequenc-
ing, we investigated the dynamics of piRNA populations
during prenatal mouse development when de novo methy-
lation patterns are established. 
New Classes of Small RNAs
K. Fejes-Toth, V. Sotirova, A. Gordon [in collaboration with
T. Gingeras, Cold Spring Harbor Laboratory]
The transcriptomes of eukaryotic cells are very complex.
Noncoding RNAs dwarf the number of protein-coding
genes and include classes that are well understood and
classes whose nature, extent, and functional roles are
obscure. We aimed to characterize the small RNA (<200
nucleotides) transcriptome of human cell lines. Deep
sequencing of small RNAs from HeLa and HepG2 cells
revealed a remarkable breadth of species that arose both
from within annotated genes and from unannotated inter-
genic regions. Overall, small RNAs tended to align with
CAGE tags that mark the 5′ ends of capped, long RNA
transcripts. We have developed complex cloning strate-
gies to characterize the biochemical properties of small
RNAs and preferentially include or exclude species bear-
ing different 5′ ends. These experiments revealed that
many small RNAs, including the previously described
promoter-associated small RNAs (PASRs), appeared to
possess cap structures. An extensive class of both small
RNAs and CAGE tags are distributed across internal
exons of annotated protein-coding and -noncoding genes,
sometimes crossing exon–exon junctions. These data indi-
cate that processing of mature mRNAs through an as yet
unknown mechanism may generate complex populations
of both long and short RNAs whose apparently capped 5′
ends coincide. 
Supplying synthetic PASRs corresponding to the c-
myc transcriptional start site reduced mycmRNA abun-
dance. Although some functional analyses indicate that
at least PASRs do regulate the expression of the under-
lying coding genes, the possible regulatory function of
these small RNAs needs further analysis. 
SMALL RNAS AND CANCER
The miR-34 Family in Cancer
X. He
miR-34a lies in the p53 pathway and has been proposed
to be a mediator of its tumor suppressive effects. We
have generated constitutive knockout alleles of mir-34a
in which the primary miRNA transcript is replaced by
lacZ (the gene encoding β-galactosidase). The genotyp-
ing of targeted C57/BL6 embryonic stem (ES) cells has
been accomplished by southern blot and polymerase
chain reaction (PCR). Correct targeted ES cell clones
were microinjected into the albino C57/BL6-derived
blastocysts by the animal facility here at CSHL. The
chimeric mice have been born and bred for germ-line
transmission. Knockout mice have been recovered from
the offspring, and the phenotypes of mir-34a-null mouse
embryonic fibroblasts (MEFs) have been character-
ized. We have also targeted BL6/129 hybrid ES cells
with the same constitutive knockout construct, and we
are generating mice using the tetraploid–ES cell com-
plementation method. In this approach, correct targeted
ES cells were injected into 4n blastocysts, the ES cells
gave rise to the epiblast, and the 4n host cells gave rise
only to the placenta. This method allows us to study the
consequences of mir-34a loss at an accelerated pace
without the need for a chimeric intermediate. The cor-
rectly targeted ES cell clones were recovered at a rate
of 30%, injected into 4n blastocysts by the animal facil-
ity, and the mir-34a-null mice have been identified. We
are now studying the impact of miR-34a loss on p53
network function and tumorigenesis.
Roles of Argonaute and mRNA-binding
Proteins in mRNA Control
F. Karginov, M. Kudla
Argonautes, the main components of the RNA-induced
silencing complex (RISC), perform posttranscriptional
regulation of most messenger RNA (mRNA). Guided
by the imperfect complementarity of specific bound
miRNAs to mRNAs, Agos cause translational repres-
sion or mRNA decay in a spatially and temporally
defined manner, thus participating in many biological
processes, such as differentiation, development, and dis-
ease. Although the core principles of Ago–miRNA–
mRNA interactions have been established, many
fundamental questions remain: What are the detailed
rules of miRNA–mRNA interactions? How are these
interactions regulated by other mRNA-binding proteins
in various cellular processes, including stress response?
What are the individual roles of the four mammalian
Agos, particularly the catalytic activity of Ago2? 
We are addressing these questions by a combination of
biochemical and genomic techniques. In the past, we have
developed a biochemical method to identify miRNA tar-
gets, and Ago-interacting mRNAs in general, by
immunoprecipitation. Currently, we are using the method
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to shed light on the role of Argonaute in translational reg-
ulation during the stress response. Furthermore, we are
studying the role of the endonuclease activity of Ago by
genome-wide 5′ RACE (rapid amplification of cDNA
ends) approaches. In addition, we are constructing a tran-
scriptome-wide library of 3′UTRs (untranslated regions)
to functionally interrogate their interactions with Arg-
onautes and other mRNA-binding proteins. This tool will
allow us to not only identify mRNAs that respond to par-
ticular miRNAs or mRNA-binding proteins, but also
investigate their interactions on the mRNA.
Genetic Vulnerabilities of
Human Cancers
K. Chang, K. Marran
We have shown that large-scale loss-of-function pooled
screens using shRNA libraries can identify genes essen-
tial for survival or proliferation of human breast epithe-
lial cells. Extending this approach during the past year,
we have demonstrated the feasibility of using our
shRNA libraries to perform genome-wide synthetic-
lethal analysis for modifiers of drug (rapamycin) sensi-
tivity in cancer cells. This analysis has enabled us to
identify potentially new drug combinations with rapa-
mycin by targeting new pathways that regulate phos-
phoinositol-3 kinase/mammalian target of rapamycin
(PI3K/mTOR) signaling.
Furthering our screening capabilities, we have initi-
ated a multi-institutional (CSHL; University of Califor-
nia, Los Angeles; Harvard Medical School; Baylor
College of Medicine; Cancer Research UK; Fox Chase
Cancer Institute; and the University of Michigan Com-
prehensive Cancer Center) collaborative effort to target
breast cancer molecular subtypes using an integrative
approach with the goal of yielding clinical impacts for
improving the effectiveness of targeted breast cancer
therapies. Our contribution to this cause is to perform
genome-wide synthetic-lethal analysis for identifying
critical targetable pathways in the three therapeutic cat-
egories: ER-positive, Her2-positive, and triple-negative
disease. Our hope is to develop more rationally designed
combination therapies that will eventually lead to new
trials in the clinic implemented by translational mem-
bers of our team.
Another area of application of RNAi screens is in the
understanding of the molecular and pathological basis
of pancreatic cancer. We and other laboratories here at
CSHL are initiating a new collaborative program with
the goal of developing new targeted therapies for this
lethal disease.
Mechanisms of Tarceva Resistance
F. Rollins
This work has been in two major areas, both making use
of the RNAi expertise of the Hannon lab. The first proj-
ect is an RNAi screen using the Hannon-Elledge RNAi
library to investigate modifiers of cellular response to
targeted therapeutics. The current focus is on Tarceva
(erlotinib; OSI Pharmaceuticals/Genentech), an FDA-
approved agent for treatment of non-small-cell lung can-
cer and pancreatic cancer. The goal is to identify the
genetic reasons underlying sensitivity to Tarceva and to
make it a more powerful therapeutic. The second area
of my research is to identify compounds for delivering
RNAi molecules in vivo, which focuses on the use of
different compounds to induce RNAi silencing of spe-
cific target genes, as well as carrier compounds used to
deliver RNA molecules to cells in mice.
miRNAs and Breast Cancer
I. Ibarra, C. Dos Santos
Studies profiling miRNA expression in a heterogeneous
murine mammary progenitor cell line (Comma-Dβ
cells) by our group demonstrated that several miRNAs
are differentially expressed in a self-renewing popula-
tion (cells expressing ALDH-1), as compared to a more
differentiated population. These findings led to the
hypothesis that miRNA signatures provide a convenient
strategy to classify and localize rare cell populations
within a heterogeneous population and also suggested
that manipulation of miRNA expression patterns might
be useful for expanding or depleting stem cell and can-
cer stem cell populations, perhaps with therapeutic ben-
efits. The classification of stem cells according to
miRNA expression might demonstrate several advan-
tages over traditional surface marker methods. Their
ability to control the level of hundreds of different tar-
gets according to their presence, absence, or concentra-
tion represents a functional strategy to classify and mark
cells according to their specification. 
The stem-like mammary progenitor miRNA profile
identified not only depletes miRNAs particular to this
population, but also specific abundant miRNAs. These
miRNAs could have an important role in the regulation of
self-renewing properties, cell-stage maintenance, and dif-
ferentiation. Therefore, manipulating the levels of abun-
dant miRNAs present in mammary stem cells would also
lead to a better understanding of the relationship between
miRNAs and stem cells. Recently, cholesterol-conjugated
single-stranded RNA complementary to miRNAs,
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referred to as antagomirs, have being applied to silenced
miRNAs. However, studies analyzing in vivo delivery of
cholesterol-conjugated molecules suggested that signifi-
cant amounts of cholesterol-conjugated antagomirs failed
to immediately associate with lipoproteins and therefore
cannot be transported to cells, suggesting that delivery of
lipophilic conjugated molecules is efficient but not flaw-
less. Attemp ting to find new approaches for an efficient
antagomir delivery, we initiated a collaboration with San-
taris Pharma, which developed a new generation of syn-
thetic nonconjugated antago mirs, smaller than
conventional antagomirs (~7 nucleo tides). Theoretically,
such small molecules should easily go through the cell
membrane. Our preliminary results from in vitro and in
vivo studies strongly suggest that a 7-mer antagomir is
functional and demonstrates a potential role as a thera-
peutic agent.
NEXT-GENERATION SEQUENCING
APPROACHES TO CANCER,
DEVELOPMENT, AND EVOLUTION
Structural Variation in Human Cancer
A. Canela
The goal is to create an adeno-associated virus (AAV)
vector for our shRNA library that will allow the use of
shRNA and shRNA screenings in neuroscience. In col-
laboration with the Wigler lab here at CSHL, I am also
evaluating the importance in breast cancer of genes
involved in CNV (copy-number variations, character-
ized by the Wigler lab) by shRNA screenings and
sequencing-by-synthesis technology.
We are characterizing structural variation in breast
cancer genomes focusing on regions containing chromo-
somal rearrangements identified by comparative genomic
hybridization (CGH) analysis (in collaboration with the
Wigler lab). These regions are recovered from tumor
genomes by array capture, and the precise structure of the
genomic rearrangement is deciphered at single-base res-
olution by next-generation sequencing. These studies will
provide the first deeply detailed picture of chromosomal
alterations in breast cancers.
Analysis of DNA Methylation States 
during Development and Differentiation
A. Molaro, O. Tam, M. Rooks, E. Hodges
DNA methylation is an important marker of transcrip-
tional regulation in the cell, and its presence correlates
strongly with a repression of associated genes. This
methylation pattern is dynamic, and it can be altered dra-
matically during the development and differentiation of
the cell. Profiling of DNA methylation at various stages
of development and differentiation could provide great
insight into the cellular changes underlying these events.
The Hannon lab has recently developed techniques to
analyze DNA methylation patterns throughout the ge nome,
using a combination of microarray-based DNA enrichment
and high-throughput deep sequencing. To enhance the
capability of this technology, we investigated the possibil-
ity of working with lower amounts of DNA (as low as 1
ng), therefore allowing the study of low-abundance mate-
rial (such as germ cells and developing embryos).
We have successfully generated bisulfite-converted
DNA libraries from 2000 cells and are in the process of
reducing the amount by tenfold. We have also designed
microarrays that will enrich for genes and regions that
have been implicated in stem cell maintenance, lineage
specification, and repetitive element silencing, allowing
us to analyze the methylation states at these loci. Our ulti-
mate goal is to apply the technology to the study of DNA
methylation patterns in preimplantation embryos, germ
cell development, and hematopoietic differentiation.
Alta-Cyclic: A Self-optimizing Base Caller
for Next-generation Sequencing
Y. Erlich [in collaboration with P. Mitra and D. McCombie,
Cold Spring Harbor Laboratory]
Next-generation sequencers are revolutionizing biologi-
cal research—they impact many aspects of genomics.
Nevertheless, these sequencers are error-prone and suffer
from shorter reading lengths as compared to conventional
sequencers. We sought to improve the base-calling pro-
cedure for Illumina Genome Analyzers to obtain more
accurate and longer sequence reads. Such an improve-
ment would boost overall output per run, increase
genomic coverage, and improve the ability to detect
sequence variants. Longer reads also increase mapping
precision and may even enable de novo genome assembly.
Inspired by ideas from communication theory, we
analyzed the sequencing platform’s nonstationary dis-
tortion factors, because these accumulate throughout the
run and reduce accuracy in later sequencing cycles. On
the basis of our analyses, a model that describes two
main signal distortions was created. The first distortion
is due to chemical imperfections, dubbed as “phasing,”
that induce heterogeneity in the nascent strand lengths
across the DNA cluster. The heterogeneity reduces the
purity of the signal from the interrogated position and
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increases every cycle. The second distortion is an
observed change in the spectral overlap between fluo-
rophores as a function of cycle that induces a substan-
tial bias toward certain base calls in later cycles. 
We developed a novel base caller named Alta-Cyclic
that is designed to specifically address these distortions.
Alta-Cyclic works in two stages: the training stage and
the base-calling stage. During the training stage, Alta-
Cyclic learns run-specific noise patterns according to our
model and finds an optimized solution that reduces the
effect of these noise sources. The optimization is mainly
achieved by supervised learning using a rich DNA library
with a known reference genome. Alta-Cyclic then enters
the base-calling stage and reports all of the sequences
from the run with optimized parameters.
Benchmarking Alta-Cyclic with respect to the Illu-
mina base caller after a long run of 78 cycles revealed a
substantial increase in the number of correct base calls.
For instance, in the case of a Phi-X library, Alta-Cyclic
reported more than fourfold, 78-nucleotide-long, fully
correct reads that comprised 22% of the total sequences.
For comparison, the Illumina base caller reported only
5% of the total sequences without any misdetection. 
Alta-Cyclic follows the open source philosophy for the
benefit of the whole genomics community. The source
code, installation, and usage instructions are available on
our website: http://hannonlab.cshl.edu/Alta-Cyclic/main.
html. The code is compatible with the current Illumina
input and output formats and supports cluster computing
using the Sun Grid Engine. The details of the mathemati-
cal modeling and the supervised learning algorithm are
hidden from the users, allowing them to focus on the bio-
logical meaning of their data. In terms of development
perspective, a great effort was made to write the base caller
in a modular and scalable approach to allow future devel-
opment by us or other users. In addition, every Alta-Cyclic
installation constantly collects data regarding successful
optimization parameters. The collected information is
reported back to a central repository and will be used to
enhance the training phase in later versions.
SUDOKU MULTIPLEXING: MASSIVE
PARALLEL GENOTYPING WITH 
NEXT-GENERATION SEQUENCERS
DNA Sudoku: Indexed Applications of
Next-generation Sequencing
Y. Erlich, K. Chang, M. Rooks
Next-generation sequencers have the potential to geno-
type in parallel DNA libraries that are composed of
many different specimens—a practice known as multi-
plexing. A major requirement of a multiplexing scheme
is the ability to associate each sequenced genotype with
its original specimen. Current schemes rely on labeling
each specimen uniquely using a short DNA tag, a
process dubbed DNA bar coding. Unfortunately, unique
bar coding of each specimen is expensive and labor-
intensive; therefore, it is only practical for small-scale
multiplexing experiments. 
During the past year, we have developed a novel
strategy called Sudoku Multiplexing. This strategy dra-
matically reduces the bar-coding procedures and
expands the practical limits on multiplexing, realizing
the sequencers’ full potential. The power of Sudoku
Multiplexing stems from encoding pools of specimens
instead by assigning unique bar codes. To maintain the
identity of the specimens, which may be lost in the pool-
ing, the pools are constructed in a combinatorial way;
each specimen is pooled several times, but each time, it
is pooled with a different subset of specimens. We used
a simple yet powerful theorem in number theory, called
the Chinese Reminder Theorem, to create this combi-
natorial pooling design. The simplicity of the theorem
allows for a straightforward translation of the encoding
scheme to movements of a liquid-handling robot that
carries the pooling procedure.
In the decoder side, the output of a multiplexed
sequencing experiment is a set of combinatorial con-
straints, each of which corresponds to a different pool. A
constraint can be thought of something such as “speci-
mens #1, #6, #11, #16 can have sequences of type I, IV,
V, VII.” Indeed, a single constraint is not enough to deci-
pher which sequence was derived from each specimen.
However, an additional constraint such as “specimens #1,
#7, #13, #19 can have sequences of type II, III, V, VI”
automatically means that specimen #1 is associated with
the sequence of type V. In addition, it reduces the uncer-
tainty regarding the other specimen-sequence assign-
ments. Thus, by combining constraints, one can eliminate
the uncertainties and associate each specimen with its
derived sequence. This situation is quite similar to the
popular game Sudoku, where numbers are assigned to a
grid using a set of constraints. However, both Sudoku and
decoding the multiplexed sequences fall into the class of
hard combinatorial optimization problems, where a
tractable algorithm for any given input is unknown. We
are currently developing a decoder that is based on a mes-
sage-passing algorithm that has had substantial success
in solving such optimization problems, even for quite dif-
ficult inputs. This algorithm combines the constraints in
a soft way and gradually converges into the correct
assignment combination (or close to it).
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We demonstrated the power of our method by geno-
typing 40,000 bacterial colonies that comprise an
shRNA library of 16,000 different fragments. The geno-
typing was carried by a single Solexa run and used only
384 bar codes and less than 2000 PCRs. Our method
also has extensive implications for medical genetics,
organ donor banks, prenatal screens, and population
genetics studies.
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Cancer arises through an evolutionary process whereby
normal cells acquire mutations that erode growth con-
trols, leading to the inappropriate expansion of aberrantly
proliferating cells. Such mutations can involve activation
of oncogenes or inactivation of tumor-suppressor genes,
each contributing one or more new capabilities to the
developing cancer cell. However, cancer is not an
inevitable consequence of oncogenic mutations; instead,
cells acquiring such mutations can be eliminated or kept
in check by innate tumor-suppressor programs that can
be activated in these damaged cells. Our laboratory stud-
ies tumor-suppressor networks controlling apoptosis and
senescence and how their disruption influences malig-
nant behavior. We previously showed that apoptosis and
cellular senescence are potent barriers to oncogene-driven
tumorigenesis and that each contributes to the antitumor
action of many chemotherapeutic drugs. Thus, not only
do mutations that disrupt apoptosis and senescence pro-
mote tumor progression, but, depending on the particular
lesion, they can also reduce the efficacy of cancer therapy. 
To facilitate our research, we are combining
advanced genetic and genomic tools that enable us to
explore various aspects of cancer biology in a compre-
hensive way. For example, we have recently developed
new mouse cancer models based on the genetic manip-
ulation of stem and progenitor cells ex vivo followed by
transplantation of the altered cells into the appropriate
organ of syngeneic recipient mice. This approach allows
us to rapidly study the impact of many genes and gene
combinations on tumorigenesis in a “mosaic” setting
where tumor-initiating cells are embedded in normal tis-
sues. Furthermore, we have developed powerful meth-
ods for using RNA interference (RNAi) to suppress
gene function in vivo in either a stable or reversible
manner. Current efforts in the laboratory strive to inte-
grate mosaic mouse models, RNAi, and cancer
genomics to identify new components of tumor-sup-
pressor gene networks and characterize their impact on
tumorigenesis and treatment response. In addition, we
are developing new RNAi methods to explore the role of
tumor-suppressor genes in tumor maintenance and the
cell death mechanisms involved in tumor regression.
TUMOR-SUPPRESSOR NETWORKS
S. Lowe C. Bialucha L. Dow L. Lintault P. Premsrirut M. Spector
A. Chicas S. Ebbesen B. Ma A. Rappaport M. Taylor
Y. Chien C. Fellmann K. McJunkin M. Saborowski W. Xue
N. Dawkins-Pisani C. He C. Miething C. Scuoppo Z. Zhao
K. Diggins-Lehet V. Krizhanovsky T. Pardee J. Simon J. Zuber
Control of Cell Survival
C. Bialucha, K. Diggins-Lehet, C. Miething, C. Scuoppo, 
J. Simon [in collaboration with G. Hannon and A Krainer, Cold
Spring Harbor Laboratory; J. Pelletier, McGill University; and 
former laboratory members H. Wendel, Memorial 
Sloan-Kettering Cancer Center, and A. Bric] 
Normal cells possess intrinsic tumor-suppressor mecha-
nisms that limit the consequences of aberrant proliferation.
For example, deregulated expression of c-Myc or disrup-
tion of the retinoblastoma (Rb) pathway in normal cells
can force aberrant S-phase entry and predispose cells to
apoptotic cell death. Conversely, many oncogenic pathways
promote cell survival by countering apoptosis. We have
previously shown that oncogenes can engage the ARF-p53
tumor-suppressor pathway to promote apoptosis and that
disruption of this pathway through loss of tumor suppres-
sors or enforced expression of prosurvival genes cooper-
ates with oncogenes to transform normal cells in vitro and
promote tumorigenesis in vivo. We are currently interested
in identifying additional components of these programs
and understanding how they function in a tumor-suppres-
sor network (see, e.g., Tworkowski et al. 2008).
Much of our current work on apoptosis and survival
signaling exploits the Eµ-myc transgenic mouse model.
This model is a model of B-cell lymphoma, where dis-
ruption of the ARF-p53 pathway, or overexpression of the
prosurvival gene Bcl-2, cooperates to dramatically accel-
erate lymphomagenesis. More recently, we have used the
Eµ-mycmodel to demonstrate that prosurvival signaling
through the phosphoinositol-3 kinase (PI3K)/Akt path-
way can substitute for Bcl-2 in accelerating lymphoma-
genesis. During the past several years, we have been
identifying components of this signaling network and
studying whether they would serve as useful targets for
therapeutic intervention. For example, we collaborated
with Jerry Pelletier to identify a crucial role for the
tuberosclerosis gene TSC2 in suppressing Myc-induced
lymphomagenesis (Mills et al. 2008). Moreover, we col-
laborated with former laboratory member H. Guido Wen-
del to implicate the TSC complex regulator Rheb as a
potent human oncogene (Mavrakis et al. 2008) and also
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damage, oxidative stress, or suboptimal cell culture con-
ditions. These observations have led us to propose that
senescence acts in parallel to apoptosis as a cellular
response to stress and acts in a similar way to suppress
tumorigenesis and mediate responses to chemotherapy. 
Our laboratory was the first to demonstrate that dereg-
ulated mitogenic oncogenes could drive cells into a senes-
cent state thereby preventing transformation and that
senescence could contribute to the outcome of chemother-
apy in vivo. On the basis of the hypothesis that senescence
is an important tumor-suppressive mechanism in vivo, we
continue to study the roles and regulation of senescence.
On the one hand, we have continued to explore how the
p53 tumor-suppressor pathway activates a gene expres-
sion program to trigger senescence; on the other hand, we
are interested in how the Rb tumor suppressor represses
gene expression in senescent cells. Interestingly, regarding
the latter, we are performing large-scale gene expression
profiling experiments to identify Rb-regulated genes that
are unique to the senescent state. These studies imply that
Rb acts, primarily, to suppress genes involved in DNA
replication, particularly in cells undergoing cell cycle exit
into senescence. We believe that this may be crucial to its
tumor-suppressive role and continue to work on the mech-
anism of this effect. 
We also continue to be interested in the biology of
senescence and its potential roles beyond cancer. Although
senescent cells have been observed in some aged and
damaged tissues, their functional contribution to non-
cancer pathologies has not been examined. This year, we
showed that senescent cells accumulate in murine livers
treated to produce fibrosis, a precursor pathology to cir-
rhosis (Krizhanovsky et al. 2008; Krizhanovsky, in press).
The senescent cells are derived primarily from activated
hepatic stellate cells that initially proliferate in response
to liver damage and produce much of the extracellular
matrix deposited in the fibrotic scar. In mice lacking p53,
a key senescence regulator, stellate cells continue to pro-
liferate, leading to excessive liver fibrosis. Furthermore,
senescent-activated stellate cells exhibit a gene expression
profile consistent with cell cycle exit, reduced secretion
of extracellular matrix components, enhanced secretion of
extracellular matrix–degrading enzymes, and enhanced
immune surveillance. Accordingly, natural killer cells, a
major component of the innate immune system, preferen-
tially kill senescent-activated stellate cells in vitro and are
required to efficiently eliminate these cells in vivo, thereby
facilitating the resolution of fibrosis.
The results described above suggest that the senescence
program acts physiologically to limit the fibrogenic
response to acute tissue damage and raise the possibility
that it acts in other wound-healing responses as well. We
with Adrian Krainer at CSHL to study how alterative
splice factors modulate mammalian target of rapamycin
(mTOR) activity (Karni et al. 2008).
Many of the downstream effects of the PI3K/Akt path-
way appear to affect translation initiation. Indeed, we pre-
viously showed that the translation initiation factor eIF4E
is a potent oncogene in vivo and can promote resistance
to certain cancer therapies and later showed that its onco-
genic activity correlates with its ability to activate trans-
lation and become phosphorylated on Ser-209. These
results suggest that translational control of cell survival
might be a therapeutic target and, indeed, our collabora-
tor Jerry Pelletier used these model systems to test new
inhibitors of translation initiation to show that they have
antitumor activity in the Eµ-myc system (Bordeleau et al.
2008). Dr. Pelletier has recently joined the laboratory on
a sabbatical, and future efforts will thus continue to exam-
ine the role of translation in survival signaling, in onco-
genesis, and as a therapeutic target. 
In a different approach, we have performed an RNAi-
based screen (see below) to identify new tumor suppressors
whose loss accelerates Myc-induced lymphomagenesis.
One gene we identified as a potent tumor suppressor was
RAD17, which acts to mediate DNA-damage responses to
replicative stress. We showed that short hairpin RNAs
(shRNAs) suppressing RAD17 attenuate Myc-induced
apoptosis and enable Myc-expressing cells to more rapidly
proliferate. Further characterization of the mechanism by
which RAD17 suppression contributes to tumorigenesis is
under way. We anticipate that other genes identified in this
screen may also mediate apoptosis in response to Myc.
Roles and Regulation of
Cellular Senescence 
A. Chicas, Y. Chien, M.V. Krizhanovsky, J. Simon, W. Xue [in
collaboration with Z. Yuan and M. Zhang, Cold Spring Harbor
Laboratory; E. Hernando, New York University; and former lab-
oratory members M. Narita, CRUK-Cambridge; L. Zender,
Helmholtz-Gemeinschaft; and M. McCurrach]
Cellular senescence was originally described as a process
that accompanies replicative exhaustion in cultured human
fibroblasts and is characterized by a series of poorly
understood markers. Senescent cells remain metabolically
active, but they are unable to proliferate and display
changes in gene expression that could alter tissue physi-
ology. As such, they are genetically “dead” and cannot
contribute to tumor development. Although “replicative”
senescence is triggered by telomere attrition and can be
prevented by telomerase, an identical end point can be pro-
duced acutely in response to activated oncogenes, DNA
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are also following up on work from 2007 showing that p53-
deficient liver carcinoma cells could undergo senescence
following p53 reactivation in vivo and that this program
triggers an immune response that attacks the senescent
tumor cells (Krizhanovsky, in press). Thus, we are contin-
uing to explore the interplay between senescence and the
immune system in the immune surveillance of developing
tumor cells as well as in influencing tissue biology. 
Mouse Models of Human Cancer
C. Bialucha, K. Diggins-Lehet, L. Dow, S. Ebbesen, L. Lintault,
C. Miething, A. Rappaport, M. Saborowski, C. Scuoppo, J.
Simon, M. Taylor, Z. Zhao, and J. Zuber [in collaboration with 
S. Kogan, University of California, San Francisco; C. Cordon-
Cardo, Columbia University; and former laboratory member 
L. Zender, Helmholtz-Gemeinschaft]
Cancer is a heterogeneous disease that involves the accu-
mulation of oncogenic mutations that each confers an
advantage to the developing cancer cell. Moreover, it is
now apparent that malignant tumors are not merely a col-
lection of genetically identical cancer cells, but an organ
that incorporates and is influenced by cellular and molec-
ular components derived from normal tissue. As a conse-
quence, the tissue microenvironment can have a dramatic
effect on the tumor progression. Such issues place con-
straints on the utility of in vitro models to study all aspects
of cancer development relevant to disease progression in
patients. Therefore, to address these complexities, we have
relied extensively on the generation and analysis of mouse
models of human cancer. 
Most mouse cancer models involve the generation of
mouse strains that constitutively or conditionally harbor
a cancer-promoting lesion in the germ line. The produc-
tion of animals prone to the development of complex can-
cers typically involves the intercrossing of multiple
cancer-prone strains that, although effective, can be time
consuming and expensive. To address this issue, we have
incorporated an additional approach that relies on the iso-
lation of stem and progenitor cells from various murine
tissues, their genetic manipulation in vitro using retro-
virus-mediated transduction, followed by their retrans-
plantation into syngeneic (immunocompetent) recipients.
This approach is both flexible and rapid, because many
combinations of cancer-predisposing lesions can be used
to produce cancers in mice in a physiologic tissue com-
partment, without the time and expense of intercrossing
many germ-line strains. Moreover, the resulting animals
are “mosaics” in that the developing tumor cells are sur-
rounded by a normal tissue microenvironment, much as
would occur in human cancer progression.
Our initial use of “mosaic” mouse models involved
modifications of the Eµ-myc lymphoma system
described above, where hematopoietic stem and pro-
genitor cells are isolated from bone marrow of fetal liv-
ers, manipulated in vitro, and then transplanted into
lethally irradiated recipient mice. Indeed, we first used
this system to characterize p53 effector functions rele-
vant in lymphomagenesis and to document the utility of
stable RNAi to mimic tumor-suppressor gene loss in
vivo. More recently, we developed a mosaic model of
hepatocellular carcinoma. Here, liver progenitor cells
(hepatoblasts) are isolated, genetically modified in vitro,
and transplanted into the livers of recipient animals. This
system enabled us to explore the role of tumor suppres-
sor gene loss in the maintenance of malignant progres-
sion and, in doing so, to identify a new form of
immunosurveillance relevant to carcinoma biology. This
year, we used these models in a number of important
collaborations (Bordeleau et al. 2008; Gyrd-Hansen et
al. 2008; Mills et al. 2008; Keng et al., in press; Laska
et al., in press; Xu et al., in press; Ma et al., in press].
On the basis of the success of the mosaic approach,
we have begun to develop additional mosaic mouse mod-
els to explore new aspects of cancer biology. For exam-
ple, using procedures that parallel the Eµ-myc system
described above, we have developed a series of mouse
models of acute myeloid leukemia that harbor combina-
tions of genetic alterations that occur in human patients.
Interestingly, these models show general pathology and
treatment responses as the corresponding human cancers
(Zuber et al., in press), giving us confidence that these
models can teach us about elements of cancer relevant
to human patients. In addition, we are developing a
mosaic model of breast cancer based on the isolation of
mammary stem and progenitor cells and retransplantion
of altered cells into cleared fat pads of recipient animals.
As discussed below, we are using these models as tools
for cancer gene discovery as well as for drug target iden-
tification and validation. 
Integrated Approaches to
Cancer Gene Discovery
C. Bialucha, K. Diggins-Lehet, S. Ebbesen, L. Lintault, B. Ma,
C. Miething, A. Rappaport, M. Saborowski, C. Scuoppo, J.
Simon, W. Xue, and J. Zuber [in collaboration with A. Kraznitz,
M. Wigler, J. Hicks, L. Van Aelst, R. Sordella, G. Hannon, and
S. Powers, Cold Spring Harbor Laboratory; J. Luk, Hong Kong
University; and C. Cordon-Cardo, Columbia University]
Because of its simplicity and ease of use, the mosaic
mouse-modeling approach lends itself to rapid charac-
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terization of cancer genes. We presume that most genes
that modulate cancer in humans will do so in mice, and
thus we have developed procedures that integrate
genomic information from human tumors with mouse
mosaic models to identify and characterize functionally
relevant cancer genes. This effort was initiated in 2006,
when we developed a system to rapidly clone and
express functional shRNAs in mosaic mouse models. In
the last year, we began to incorporate RNAi technology
into our efforts to identify new cancer genes. Owing to
its ability to suppress gene expression, we previously
showed that RNAi serves as a rapid approach to mimic
the consequences of tumor-suppressor gene loss. 
In our first attempts to use RNAi for tumor-suppres-
sor gene discovery, we used our mosaic model of hepa-
tocellular carcinoma (HCC) to validate a tumor- sup-
pressor gene on human chromosome 8p. Deletions on
chromosome 8p are common in human tumors, sug-
gesting that one or more tumor-suppressor genes reside
in this region. One of these genes is deleted in liver can-
cer 1 (DLC1), which encodes a Rho-GTPase-acti vating
protein. We showed that DLC1 knockdown cooperates
with Myc to promote HCC in mice and that reintroduc-
tion of wild-type DLC1 into hepatoma cells with low
DLC1 levels suppresses tumor growth in situ (Xue et
al. 2008). Cells with reduced DLC1 protein contain
increased GTP-bound RhoA, and enforced expression
of a constitutively activated RhoA allele mimics DLC1
loss in promoting hepatocellular carcinogenesis. Con-
versely, down-regulation of RhoA selectively inhibits
tumor growth of hepatoma cells with disabled DLC1.
Our data validate DLC1 as a potent tumor-suppressor
gene and suggest that its loss creates a dependence on
the RhoA pathway that may be targeted therapeutically.
They also illustrate the utility of stable RNAi to reveal
new tumor-suppressor genes.
In addition to probing tumor-suppressor genes in
vivo in a one-by-one manner, our laboratory (together
with Drs. Hannon, Kraznitz, Hicks, Wigler, and Powers
at CSHL) also performed in vivo screens to multiplex
the analysis of candidate tumor-suppressor genes. In one
example, we compiled pools of shRNAs targeting the
mouse orthologs of genes recurrently deleted in a series
of human HCCs and tested their ability to promote
tumorigenesis in a mosaic mouse model (Zender et al.
2008). In contrast to randomly selected shRNA pools,
many deletion-specific pools accelerated hepatocar-
cinogenesis in mice. Through further analysis, we iden-
tified and validated 13 tumor-suppressor genes, 12 of
which had not been linked to cancer previously. One
gene, XPO4, encodes a nuclear export protein whose
substrate, EIF5A2, is amplified in human tumors,
required for proliferation of XPO4-deficient tumor cells,
and promotes HCC in mice. These results establish the
feasibility of in vivo RNAi screens and illustrate how
combining cancer genomics, RNAi, and mosaic mouse
models can facilitate the functional annotation of the
cancer genome. 
In another example of this general approach, we per-
formed an RNAi screen for new tumor-suppressor genes
in the Eµ-myc mouse model described above. Pools of
shRNAs targeting a focused set of cancer-relevant genes
were introduced into hematopoietic progenitor cells
derived from Eµ-myc transgenic mice and screened for
their ability to promote lymphomagenesis following
engraftment into syngeneic recipients. More than 20
candidate tumor-promoting shRNAs were isolated,
including those targeting established tumor suppressors.
Among the novel tumor suppressors were Rad17 (see
above), whose reduced expression or loss is associated
with lymphoma development and poor prognosis and
therapy response in human patients. Some of these new
tumor suppressors may have pro-oncogenic activities in
other contexts, and a surprising number encode secreted
proteins. The results of this screen are currently being
finalized, and we have initiated a second-generation
screen to extend our analyses.
Our results establish the feasibility of in vivo RNAi
screens and illustrate how combining cancer genomics,
RNAi, and mosaic mouse models can facilitate the func-
tional annotation of the cancer genome. Most current
efforts to catalog cancer genes rely solely on genomic
approaches. Although they are powerful, genomic
approaches can be expensive and yield candidates based
only on statistical criteria. Virtually all candidates must
be functionally validated in various in vitro or in vivo
models, which is slow and likewise expensive. Through
incorporation of our screening approach, it is possible to
rapidly filter genomic information for genes that impact
cancer development in vivo and thus focus follow-up
studies on those that might be most clinically useful.
Although our studies to date used mouse models of
HCC and lymphoma and focused only on focal dele-
tions, this relatively high-throughput approach could be
expanded to other mouse models or include shRNA
pools targeting genes affected by larger deletions, pro-
moter methylation, or point mutations. Moreover,
through exploitation of the emerging libraries of full-
length cDNAs, it should be possible to perform parallel
screens for oncogenes involved in genomic amplifica-
tions. Indeed, such efforts are currently under way. We
believe that such integrative approaches will provide a
cost-effective strategy for functional annotation of the
cancer genome.
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Molecular Genetics of Drug
Sensitivity and Resistance
C. He, C. Miething, T. Pardee, A. Rappaport, J. Simon, 
M. Spector, M. Taylor, Z. Zhao, and J. Zuber [in 
collaboration with S. Kogan, University of California, 
San Francisco; E. Dolan, University of Chicago; and former 
laboratory members D. Burgess and Michael Hemann, 
Massachusetts Institute of Technology] 
Our laboratory has a long-standing interest in under-
standing genetic determinants that influence the cellular
response to conventional chemotherapy, with the goal
of identifying mechanisms of drug resistance and devel-
oping new drug targets. These efforts involve a combi-
nation of experiments using RNAi to characterize drug
sensitivity and resistance genes, genomic approaches
designed to identify genes that are linked to poor treat-
ment responses in patients, and animal-modeling stud-
ies to test new drugs and drug combinations that might
circumvent drug resistance. 
Acute myeloid leukemia (AML) is an aggressive
form of leukemia that displays a heterogeneous response
to front-line chemotherapy, and many patients eventu-
ally acquire drug resistance. Owing to the tractability of
AML models and the importance of the disease, we
have had a long-standing interest in modeling the
pathology and treatment sensitivity of this disease. To
this end, we produced mosaic AML models that harbor
common AML genotypes, established an induction
chemotherapy protocol for mice, and integrated sensi-
tive imaging methods to monitor leukemia response in
vivo. We then used these tools to characterize genotype-
response relationships in AML and to explore the under-
lying molecular basis for these effects. We see that a
subtype of leukemia linked to poor treatment response
in the clinic (harboring genetic translocations of the
MLL gene) responds poorly to chemotherapy in mice
and that this results, surprisingly, from an attenuated p53
response. Our studies provide insights into the differen-
tial response patterns of human leukemia, suggest
strategies for improving the use of conventional
chemotherapy, and produce tractable preclinical systems
for testing new therapeutic strategies. Indeed, develop-
ing rational strategies to target these otherwise refrac-
tory leukemias is a major goal of current research. 
To complement our mouse-modeling efforts, we have
also initiated genomic studies to characterize genetic
alterations associated with refractory or relapse AML.
These studies are based on interactions with clinical col-
leagues at St. Jude Children’s Hospital and the Univer-
sity of Chicago, as well as recently established
interactions with Dr. Steven Allen at North Shore Uni-
versity Hospital on Long Island. We are using compar-
ative genomic hybridization methods as well as next-
generation sequencing technology to analyze leukemia
specimens from patients that show poor responses to
chemotherapy, and we intend to verify their ability to
promote drug resistance to chemotherapy in mice. We
hope to use this information to better inform the use of
chemotherapy in the clinic and, eventually, to develop
strategies to circumvent drug resistance. 
Finally, we are integrating RNAi technology into our
mouse-modeling efforts to identify and study factors
that modulate sensitivity to cancer therapy. As a first
step in this analysis, we performed a focused RNAi
screen using the Eµ-myc lymphoma model to explore
the genetic basis for heterogeneous responses to topoi-
somerase poisons (common chemotherapeutic agents
used in the clinic). These experiments identified Top2A
expression levels as a major determinant of the response
to the topoisomerase 2 poison doxorubicin and showed
that suppression of Top2A produces resistance to dox-
orubicin in vitro and in vivo. In addition, suppression
of  Top1 produces resistance to the topoisomerase 1 poi-
son camptothecin, again leading to drug resistance in
vivo. Unexpectedly, Top1 knockdown enhanced sensi-
tivity to doxorubicin, leading to improved survival of
tumor-bearing mice. These results highlight the poten-
tial utility of combining RNAi with mouse models to
identify determinants of therapeutic outcome in vivo
and form a blueprint for additional studies to uncover
mechanisms of drug sensitivity and resistance.
Modulation of Gene Expression
In Vivo Using RNAi
N. Dawkins-Pisani, L. Dow, C. Fellmann, B. Ma, K. McJunkin,
C. Miething, P. Premsrirut, and J. Zuber [in collaboration with 
G. Hannon, Cold Spring Harbor Laboratory; E. Hernando, New
York University; and C. Cordon-Cardo, Columbia University] 
Together with Gregory Hannon at CSHL, we continue
to develop improvements in RNAi technology with a
specific interest in using this approach to probe various
aspects of cancer biology. We previously showed that
pol II promoters expressing rationally designed primary
microRNA (pri-miRNA)-based shRNAs (shRNAmir)
produce potent, stable, and regulatable gene knockdown
in cultured cells and in animals, even when present at a
single copy in the genome. As indicated above, we have
used these tools to characterize tumor-suppressor genes,
as well as to study the role of particular genes in the
maintenance of malignant progression. During the past
year, we continued to develop new methods for improv-
027_051_Res_CancGenet:LAR_Template_2007  6/9/09  3:57 PM  Page 43
44
ing RNAi technology, particularly for applications in
vivo. For example, we continue to develop improved
vectors for expressing miRNA-based shRNAs in stable
and conditional systems, thereby facilitating their use in
genetic screens, and to study the role of particular genes
in the maintenance of malignant progression. In addi-
tion, we have initiated studies with the Hannon group
to develop shRNAs with optimal potency. These efforts,
if successful, have the potential to revolutionize RNAi
technology by enabling the production of genome-wide
shRNA libraries with validated gene knockdown. 
One of our most aggressive efforts of technology
development is in the area of transgenic mice. We pre-
viously showed that it was possible to produce trans-
genic mice based on pronuclear injection of a linear
fragment encoding an miR30-based shRNA down-
stream from the tet-responsive element (TRE). We ini-
tially developed transgenic mice based on a tet-
responsive miR30-based p53 shRNA, crossed them to a
variety of tet-trans-activator transgenic strains, and then
showed that the presence or absence of doxycycline (a
tetracycline analog) could reversibly knock down p53
expression in a tissue-specific manner. Now, we have
produced a second generation of transgenic technology
that rapidly generates fully transgenic founders with a
defined genomic integration. In this generation of mice,
the miR-shRNA is separated from the TRE by a green
fluorescent protein (GFP) cDNA, conferring better
shRNA processing as well as a simple marker for spa-
tial and temporal induction of the TRE cassette. This
improved system also obviates the need for any screen-
ing of different founder mice because the integration
site is constant; together, these advances have drastically
improved consistency, cost, and speed of generating
inducible RNAi transgenic mice. We are currently
developing a number of transgenic lines that condition-
ally express shRNAs capable of silencing tumor sup-
pressors or potential drug targets. With improved
tet-trans-activator lines, also under construction, we
believe that this system can be used to spatially and tem-
porally control the expression of any endogenous gene. 
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In addition to genetic mutation such as amplification
and deletion, epigenetic aberrations are frequent events
that can have far-reaching effects in the phenotype of a
cancer cell. A common epigenetic modification is the
methylation of cytosine residues that are next to gua-
nine residues. It has been shown that methylation pres-
ent in the DNA of the transcriptional control region has
been involved in the silencing of gene expression of
tumor supressors in cancer. We have adapted ROMA
(representational oligonucleotide microarray analysis)
to methylation detection oligonucleotide microarray
analysis (MOMA). The present array queries all CpG
islands within the genome. To detect methylation, input
DNA (either tumor or normal) is cleaved with MspI and
then ligated to polymerase chain reaction (PCR) adap-
tors and divided into two samples. One sample is
digested with the endonuclease McrBC, which recog-
nizes and cleaves methylated DNA, with the promiscu-
ous recognition sequence A/GmC(N40–3000)A/GmC
(Gast et al., Biol. Chem. 378: 975 [1997]) depleting
methylated sequences. The other sample, the reference,
is mock-digested. Both samples are amplified by PCR,
differentially labeled, and hybridized to the array.
This methodology was used on cell lines, and 11 of 11
methylation measurements were validated by bisulfite
sequencing confirming its accuracy. Although the stan-
dard method of methylation profiling of a tumor is to use
matched normals, many tumor banks contain tumor sam-
ples without matched normals. Using a set of matched
tumor normals (12 normals, 12 tumors) and a set of
matched and unmatched tumor normals (12 normals, 28
tumors), we developed statistical criteria for identifying
CpG islands most significantly altered between tumor
and normal even when unmatched. We looked at all per-
mutations comparing matched and unmatched tumors to
all normals and found that all tumors generally varied
similarly from the normals whether matched or
unmatched. In other words, all tumors are similarly dif-
ferent from normal. We then moved onto the analysis of
a larger set of 40 breast tumors, compared to 12 normal
breast samples, and 11 ovarian tumors, compared to 7
normal ovarian samples. Using the statistical criteria
developed, we obtained a list of 916 significant alter-
ations in breast cancer and 151 in ovarian cancer, many
METHYLATION OLIGONUCLEOTIDE MICROARRAY ANALYSIS
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of which have previously been documented to have
altered methylation in cancer, again demonstrating the
ability of this methodology to detect CpG methylation
in cancer. For example, the MTSS1 (metastasis suppres-
sor 1) gene is known to be preferentially methylated in
several cancers including breast cancer, and its lack of
expression correlates well to increased Her2 expression.
Genes that we identified as being hypermethylated in the
ovarian and breast tumors include several HOX genes
and protocadherins, which are known to be methylated in
many tumor types. In addition to genes known to
undergo methylation, we have found new targets of
methylation. We also detected for the first time promoter
methylation of a microRNA (miRNA) gene, has-mir-9-
3, occurring in more than half of the breast tumors. The
expression of this miRNA has been shown to be down-
regulated transcriptionally in breast and other cancers.
Studies suggest that the methylation profile can be
used to readily distinguish tumor samples from normal
samples. To confirm and extend these observations, we
performed hierarchical clustering on the 100 most sig-
nificantly altered CpG islands between breast tumors
and normals and ovarian tumors and normals. In all
sample sets, the normals segregated from tumors. We
also used a supervised machine-learning classifier to
identify the sensitivity and specificity of using methy-
lation to differentiate breast tumor samples from nor-
mals (the ovarian tumor data set was too small to
perform this analysis) and used a “leave-one-out” cross-
validation to calculate the sensitivity and specificity.
Using only ten CpG islands, we achieved a classifica-
tion accuracy of 94%. Sensitivity for tumor detection
was 92.5% (37/40), and specificity for tumor detection
was 100%, demonstrating that tissue can be identified
potentially as tumor or normal based on a relatively
small number of methylation alterations. In addition, a
subset of the breast tumors have been shown to segre-
gate into six subclasses based on expression analysis
data, and hierarchical clustering performed on methy-
lation data recapitulated these subclasses, demonstrating
that methylation data can be used to stratify tumor sam-
ples. We propose that methylation data can be used to
identify biomarkers that stratify with clinical parame-
ters and will be studying this in the future.
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significant advances in surgical management and
chemotherapy during the past few decades, the survival
rate has not improved significantly. Currently, the 5-year
survival for patients with advanced disease is less than
30%. A major impediment to successful treatment is the
lack of therapeutic strategies that are effective against
resistant tumors. Common and important genetic aber-
rations in ovarian carcinoma are poorly understood.
Approximately 25% of patients will present with pri-
mary platinum-resistant disease and will have very poor
outcomes. Additionally, all patients who recur will ulti-
mately develop acquired platinum resistance.
We hypothesize that the tumors will have taken
advantage of epigenetic mechanisms to become resist-
ant to therapy and/or increase their ability to survive.
Epigenetic modification such as CG dinucleotide
methylation can have far-reaching effects on cellular
phenotypes. We have used MOMA to analyze two sets
of ovarian tumors—55 from Dr. Douglas Levine of
Memorial Sloan-Kettering Cancer Center and 75 from
Dr. Anne-Lise Borresen-Dale from the Norwegian
Radium Hospital. Both samples sets have associated
expression and copy-number data. Thus far, we have
analyzed the methylation data and have begun the fur-
ther analysis of identifying candidate regions that can
segregate the tumors based on clinical variables such as
platinum resistance. We have used clustering algorithms
to analyze the data, and the normal samples clearly sep-
arate from the tumor samples. We can also see that the
stage-2 tumors (tumors that have had less time to grow)
have less methylation than the stage-3 and -4 tumors
(tumors that have had more time to grow). This demon-
strates that the tumors that have had more time to grow
have had more time to accumulate alterations in the
genome. Unfortunately, thus far, stages 3 and 4 could
not be segregated further based on the methylation
changes. We are continuing to analyze these data using
different algorithms to identify either a pattern or spe-
cific events that can segregate the various stages and
grades of the tumors. 
We then analyzed the samples based on several clin-
ical variables including survival and Carboplatin resist-
ance. We identified islands that underwent methylation
alteration and could segregate the samples based on the
respective variable. We then compared the methylation
data and expression data in a pairwise method to iden-
tify the genes whose promoters have undergone a
methylation change and a corresponding expression
alteration. We then used other methods including liter-
ature matching and pathway analysis to identify inter-
esting candidates. These candidates will feed into two
model systems that use short hairpin RNA (shRNA)
We compared methylation status between promoter-
specific islands (TSS-CGIs) and nonpromoter islands
(non-TSS-CGIs), as well as nonisland CpG dinu-
cleotides (non-CGIs), because this could be informative
with respect to tumor evolution. We found that the
methylation events that were frequently found were
methylation of specific TSS-CGIs and non-TSS-CGIs
and demethylation of non-CGIs. What was interesting
was that for the class of non-TSS-CGIs, although we
found some islands frequently methylated, the vast
majority were demethylated. However, this demethyla-
tion was random, and rarely were the same islands
demethylated in multiple tumors. This greater prepon-
derance of demethylation in cancer without recurrence
suggests that the demethylation of non-TSS-CGIs is
more of a random event in the genome, compared to the
methylation of TSS-CGIs being specific. Perhaps this
is a result of the methylation of TSS-CGIs being posi-
tively selected during carcinogenesis in order to silence
tumor suppressor genes, whereas the demethylation is
not being selected for and the majority appears to be
random. More than likely, methyltransferases are used
for methylation, but it is unclear how demethylation
occurs within an environment of methylation. It is pos-
sible that it is as simple as the methylation process on a
whole being deregulated, resulting in some regions
being aberrantly methylated and others not being methy-
lated. Because we are looking at the tumor after its evo-
lution, we only see the cells most successful at survival.
The methylation of specific genes is selected for and the
majority of the other methylation events are not
observed because they are unselected. This will be the
subject of future studies.
Methylome Analysis of
Ovarian Cancer
C. Tang, S. Khan, S. Kamalakaran, J. Byrnes, N. Dimitrova
This year, in the United States alone, more than 25,500
women will be diagnosed with ovarian cancer, and more
than 16,000 women will die of this disease. Five-year
survival rates for women diagnosed with stage 1 or 2
ovarian cancer are 90% and 70%, respectively. Unfor-
tunately, there is no reliable screening test for the early
detection of ovarian cancer, and less than 35% of
women are diagnosed before stage 3, with 5-year sur-
vival for stage 3 or 4 being less than 25%. Ovarian can-
cer is the leading cause of death from gynecologic
cancer and the fifth most frequent cause of cancer-
related death for women in the United States. Despite
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clones to mimic the transcription repression brought on
by promoter methylation. The first will be a tissue cul-
ture system that will be used to test for genes that when
methylated increase platinum resistance. Pools of
shRNA clones will be introduced into cells, challenged
with Carboplatin, and then allowed to grow. The cells
that survive will be collected and the shRNA clones
present will be identified. The second system, using a
mouse model, will be to study genes that segregate with
survival. Pools of shRNA clones will be introduced into
immortalized mouse ovarian surface epithelial cells.
These cells will be injected into a syngeneic mouse
against the ovaries—a test pool on one ovary and a con-
trol on the other ovary. Growth characteristics will be
monitored for the mice. These systems will identify the
genes that when methylated affect the growth of the
tumor and will address the critical problem of Carbo-
platin resistance in ovarian cancer. 
Copy-number Analysis of
Pancreatic Cancer
R. Lucito, S. Chen, J. Byrnes, N. Cutter
Of an estimated 30,000 cases of pancreatic cancer this
year, 29,700 patients will succumb to the disease.
Although the number of cases is low, compared to sev-
eral other cancers such as colon, lung, or breast cancer,
the survival rate for pancreatic cancer is one of the low-
est. Treatments can extend survival or alleviate pain, but
they seldom cure the patient. In fact, the mean survival
time is ~6 months. Because the life span after diagnosis
is very short, the number of patients that receive tumor
resections is very low. This translates to few samples
available for analysis. Because of this, we are collabo-
rating with many clinicians to put together a useful tumor
bank of pancreatic tissue for analysis. Currently, we are
collaborating with Dr. Ralph Hruban of Johns Hopkins,
Dr. Daniel Von Hoff of the Arizona Cancer Center, and
Dr. Vijay Yajnic of Massachusetts General, who will be
providing pancreatic specimens, clinical information,
and expertise. To date, we have analyzed 98 samples. We
have confirmed many of the known mutated regions and
have identified less-characterized regions.
One region on chromosome 19q12 that is amplified is
interesting because there has been confusion in the liter-
ature as to which gene in the region is the oncogene in
respect to pancreatic cancer. There are a number of
tumors and cell lines that have this region amplified, but
two primary tumors are the most informative for defin-
ing the epicenter or common region of mutation. We
have previously shown that the gene p21-activated kinase
or PAK4 was overexpressed at the RNA level, over pro-
duced at the protein level, and overactivated as a kinase
in cells with genomic amplification. This protein was
also shown by others to transform cells when activated. 
To elucidate the function of PAK4 in the tumor, we
have used shRNA constructs to knock down the level of
PAK4 in cells with the amplicon to determine the effect
on tumorigenicity. After knocking down the level of
PAK4 in the cells, we collected RNA and performed
expression analysis to determine whether there was a
change in the cellular environment. Tumors are very het-
erogeneous, including their expression repertoire.
Therefore, we performed this analysis for three separate
cell lines with this region genomically amplified and
used the results from all three to filter out noise and
determine which were in common. Of the genes found
with expression affected by PAK4, one interesting can-
didate is DUSP22 (JSP1), a phosphatase that is involved
in selective activation of the mitogen-activated protein
kinase (MAPK)/Jnk pathway, a pathway described
below to be important for cell survival. Another is
SMAD3, which is the binding partner of the tumor sup-
pressor SAMD4, which is deleted or inactivated in
~50% of pancreatic tumors. 
We have taken cells with PAK4 shRNA that have
activated K-RAS and have introduced these cells into
nude mice; we found that the tumorigenicity of the cells
is 40% lower with decreased PAK4 activity. We have
also determined that one function of PAK4 is to increase
the invasiveness of cells. Clearly, PAK4 is required for
some RAS ability to transform cells; however, RAS is
complex. To better control the readout of the RAS acti-
vation, we have also added activated PAK4 and activated
K-RAS to NIH-3T3 cells and are comparing the cells
transcriptionally to identify the genes PAK4 activates
that are in common with those genes that RAS activates.
By performing these experiments, we hope to identify
the role of PAK4 in tumor cell transformation. 
Mutational Analysis of
Phosphatases
E. Lum, T. Auletta [in collaboration with N. Tonks, Cold Spring
Harbor Laboratory]
The goal of this collaborative study is to integrate gene
discovery technology with experimental strategies devel-
oped in Dr. Tonks’ lab for the characterization of the pro-
tein tyrosine phosphatase (PTP) family of enzymes, to
investigate how tyrosine phosphorylation-dependent sig-
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naling pathways are disrupted in cancer. We have taken
advantage of several different forms of genomic data to
determine which PTPs are affected in cancer cells. 
We first used genomic copy-number data and identi-
fied the PTPs, LAR, PTPσ and VHY amplified in ovar-
ian tumor specimens. LAR and PTPσ a are receptor-like
PTPs, display features of cell adhesion molecules, have
been implicated in regulating the function of adhesion
complexes that control cell–cell interactions, and may be
disrupted in cancer. VHY is a dual-specificity phos-
phatase that the Tonks lab has implicated in the activation
of a signaling pathway (the JNK pathway) that has a crit-
ical role in the control of cell survival. MKP5 is another
dual-specificity phosphatase that functions in the inacti-
vation of the p38 and JNK MAPKs.
We also used expression data to determine which
PTPs undergo either up-regulation (putative oncogenes)
or repression (putative tumor suppressors) in cancer.
Expression data from ovarian cancer cell lines and pri-
mary tumors were used to determine if any of the PTPs
described above found in regions of copy-number vari-
ation were aberrantly expressed. PTPσ and LAR
showed the most significant expression changes, mak-
ing them the best candidates. In addition to our analysis
of PTPs that have undergone alterations with gene copy
number, we conducted transcriptional expression analy-
sis on the remaining phosphatases. Two sets of expres-
sion data were used to remove genes found in only one
set; 15 phosphatases showed overexpression and/or
underexpression in both sets. Of these, three overlap-
ping phosphatases were found to show significant
change, including DUSP6, PTPRK, and PTPRZ1.
Interestingly, a binding partner, Liprin, for the recep-
tor PTP LAR, is highly amplified and displays altered
gene expression. Liprin was shown originally to be
important for targeting LAR to focal adhesions and for
clustering the PTP at these sites regulating cytoskeletal
function and interactions with extracellular matrix. This
observation not only highlights the potential significance
of LAR in ovarian cancer, but also, and more generally,
introduces an interesting extension of the primary project,
i.e., an analysis of the proteins that interact with the PTPs. 
With the development of MOMA and the generation
of methylation data for breast and ovarian cancer, we
have recently identified PTPs that are methylated and
by associating expression data have determined which
are transcriptionally repressed. We have identified
PTPN6 as a target in ovarian cancer. Interestingly, this
PTP is an antagonist of VHY and suppresses the JNK
pathway. We are currently looking to determine whether
JNK is activated in cells with methylation of PTPN6.
We have also expanded our extension of analysis of
PTPs in cancer into the proteins with which PTPs inter-
act by studying a gene whose promoter is methylated in
breast cancer. This protein MTSS1 interacts with RTPδ,
a receptor-like PTP that cooperates in cytoskeletal reor-
ganization. RNA interference technology was used to
show that when this gene was suppressed as found in
the cancer cells, the cells gained invasive potential. The
literature suggests that this gene may synergize with
ERBB2 activation. Therefore, MTSS1 was suppressed
by introduction of shRNA in cells that have an inducible
ERBB2 pathway and the cells were grown in a three-
dimensional culture. After activation, the cells grew
faster and the growth restriction in three dimensions was
lost, with the central cavity filling with cells and in
many cases the acini overgrowing. 
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The Mills laboratory creates novel mouse models and
uses them to elucidate the genetic and molecular basis
of human disease. Research areas include (1) determin-
ing the role of the chromatin remodeler CHD5 in can-
cer and stem cell function and (2) investigating the role
of the p53-related protein p63 in development, cancer,
and aging.
CHD5 IS A TUMOR SUPPRESSOR MAPPING TO 1P36
Deletions encompassing 1p36, a portion of the genome
residing on human chromosome 1, were first reported
more than three decades ago. Since then, analyses of
late-stage tumors have indicated that 1p36 is frequently
deleted in a variety of human cancers, including those of
the brain and blood and epithelial malignancies such as
those of the breast, colon, and prostate. Although this
had suggested that an important cancer-preventing gene
maps to this locus, the gene responsible had not been
identified. We recently identified CHD5 as a novel
tumor suppressor mapping to 1p36. By using chromo-
some engineering to generate models with gain and loss
of the region of the genome corresponding to human
1p36 and studying cancer predisposition or protection,
we pinpointed a 4.3-Mb region of the genome with
potent tumor suppressive activity. We discovered that
whereas loss of this region led to a variety of cancers in
vivo, gain of the same interval triggered excessive tumor
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suppression.Using a combination of genetic and molec-
ular analyses, we identified the chromatin remodeling
protein chromodomain, helicase, DNA-binding domain
protein 5 (Chd5) as the tumor suppressor. We found that
Chd5 functions as a master regulator that facilitates
p16/Rb- and p19/p53-modulated pathways (Fig. 1). We
are currently (1) assessing the spectrum of tumors that
develop in mice heterozygous for the region encom-
passing Chd5 and extending these findings to human
cancers, (2) investigating the role of CHD5 in stem
cells, and (3) determining the mechanism whereby
Chd5 regulates chromatin dynamics. Thus far, we have
identified a novel tumor suppressor. Our current studies
aimed at elucidating the tumor suppressive role of Chd5
should pave the way for designing more effective anti-
cancer therapies for a wide variety of human cancers.
FUNCTION OF THE P53 HOMOLOG P63
p63 deficiency is tumor protective. The discovery that
the p53 tumor suppressor is a member of a multigene
family that also includes p63 and p73 revolutionized the
p53 field. p63 is a transcription factor that is structurally
quite similar to p53; however, in contrast to p53, p63 is
rarely inactivated in human cancers. We previously iden-
tified p63 and generated a number of p63-deficient
mouse models, which allowed us to determine that
despite their similarities, p63 and p53 perform very dif-
FIGURE 1 Chd5 is a master regulator of a tumor suppressive network. We
propose that Chd5 induces chromatin remodeling events at the Ink4/Arf locus
that facilitate expression of both p16 and p19. p16 and p19 are tumor sup-
pressors that are responsible for enabling Rb- and p53-mediated tumor sup-
pressive pathways. Thus, Chd5 functions as a circuit breaker that is
necessary for this extensive tumor suppressive network to prevent cancer.
p16 and p19 also regulate stem cell renewal, suggesting that Chd5 regulates
the intimate relationship between stem cells and cancer. 
027_051_Res_CancGenet:LAR_Template_2007  6/9/09  3:57 PM  Page 50
51
and developed age-related pathology. By generating a
new model that allowed us to turn p63 off specifically in
proliferating cells of stratified epithelia such as the skin,
we discovered an unanticipated link among p63, cellu-
lar senescence, and aging. Remarkably, p63 deficiency
triggers cellular senescence and leads to aging in vivo.
This suggested a mechanism for the low tumor inci-
dence of p63+/– mice: Cellular senescence effectively
removes aberrantly proliferating cells, thereby protect-
ing from cancer. A further understanding of how p63-
mediated pathways modulate stem cells and how this
affects aging and tumorigenesis is currently under way.
This work is expected to provide a clearer understand-
ing of the mechanism of cellular senescence that will
ultimately impact our understanding of tumorigenesis
and stem cell homeostasis during aging.
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ferent functions in vivo: p63 is essential for develop-
ment of stratified epithelia, whereas p53 is dispensable
during embryogenesis but functions as a potent tumor
suppressor in the adult. More recently, we found that in
contrast to the high incidence of spontaneous tumors in
p53+/– mice, p63+/– mice were not predisposed to cancer.
In fact, p63 heterozygosity decreased the high tumor
incidence of p53+/– mice, indicating that haploid levels
of p63 may even be tumor protective. This indicated that
p63 does not perform a role equivalent to that of p53 in
tumor suppression and that reduced p63 provides a
novel tumor suppressive mechanism. This finding has
important clinical implications, because it suggests that
modulation of p63-mediated pathways offers an effec-
tive strategy for anticancer therapy. We are currently
working on determining which of the six different p63
proteins modulate the tumor suppressive mechanism of
cellular senescence. 
p63 links cellular senescence and aging. Over the
course of the tumor study outlined above, we discovered
that p63+/– mice had a significant reduction in life span
027_051_Res_CancGenet:LAR_Template_2007  6/9/09  3:57 PM  Page 51
52
CANCER: GENE EXPRESSION AND PROLIFERATION
Gene Expression and Proliferation focuses on the regulation of gene expression, cell-division cycle con-
trol, and chromosome structure in normal and cancer cells.
The research of Thomas Gingeras and colleagues is adding significantly to our knowledge of where
and how functional information is stored in genomes. This will help us to understand the biological and
clinical effects of disease-causing gene mutations in humans and other organisms. Gingeras is a leader
of the National Institutes of Heath ENCODE (ency clopedia of DNA elements) project. His research has
already revealed that nearly all of the human genome can be transcribed into RNA and that most RNA
products are not made to be translated into proteins. Rather, “noncoding” RNAs are proving to be
involved in a variety of other important biological functions. Some regulate protein-coding gene expres-
sion. Others serve as scaffolds upon which large protein complexes are assembled. The lab’s research
is helping scientists to significantly change long-standing notions about both genes and genomes, revi-
sions so sweeping that they promise to change our very definition of the gene.
The laboratory of Leemor Joshua-Tor focuses on cell regulatory mechanisms, including protein com-
plexes involved in nucleic acid regulatory processes. The lab uses X-ray crystallography to obtain three-
dimensional structures of individual proteins and atomic-level views of their interactions with other
molecules. This past year, they clarified how yeast cells, through the action of genes, adjust their metab-
olism in response to changes in their sources of food. This research suggests how the metabolic state
of a cell is linked to the expression of its genes in a way that impacts biological processes of many kinds,
ranging from cancer to aging. Joshua-Tor, who in 2008 was named a Howard Hughes Medical Institute
Investigator, is well known for her work on the helicase enzyme, which acts to unwind DNA strands dur-
ing the DNA self-replication process, and, in research with Gregory Hannon at CSHL, for revealing struc-
tures that help to explain the gene-silencing mechanisms of RNA interference. 
Adrian Krainer and colleagues study the mechanisms of RNA splicing, the ways in which they go
awry in disease, and the means by which faulty splicing can be corrected. Their approach has borne fruit
in the study of spinal muscular atrophy (SMA), a genetic neuromuscular disease. Their ability to correct
an mRNA splicing defect in SMA that makes a gene called SMN2 only partially functional forms the basis
of a potentially powerful therapeutic approach, now being tested in mouse models. They have also stud-
ied a splicing factor, SF2/ASF, that can cause cells to become cancerous and have now shown how it
acts on proteins in a group called the PI3K-mTOR (phosphoinositol-3-kinase–mammalian target of
rapamycin) pathway, known for its involvement in cancers. Mea surement of SF2/ASF levels could even-
tually lead to identification of pa tients who will respond well to drugs that block the pathway. With Michael
Zhang, Krainer this year also demonstrated a means of identifying the many genomic targets for a par-
ticular type of splicing factor and how splicing patterns of those targets change.
Scientists do not yet understand how dormant metastatic lesions, after they have colonized distant
organs, grow into large lethal lesions. Vivek Mittal studies angiogenesis in the tumor microenvironment,
which is composed of both malignant and nonmalignant cells. Among the latter are bone-marrow-derived
endothelial progenitor cells, or EPCs, which, Mittal has demonstrated, become involved selectively in
tumor blood vessel growth. This year, Mittal and colleagues, using mouse models, showed that the lev-
els of a protein called Id-1 increase dramatically in EPCs when tumors are present. Using  RNAi to block
the expression of Id-1 in living mice, the team was able to prevent mobilization of EPCs to metastasis
sites, thereby inhibiting an “angiogenic switch,” a key mechanism that causes formation of blood ves-
sels in tumors and triggers tumor growth.
David L. Spector’s lab studies the spatial organization and regulation of gene expression. Their in
vivo approach is exemplified in a live cell gene expression system that has made possible examination
in real time of the recruitment of members of the gene expression and silencing ma chineries. A current
research focus is the distribution of nuclear Polycomb proteins, known to keep genes in a silent state.
The team seeks to target these proteins to segments of DNA as a means of selectively silencing spe-
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cific genes. Another focus is the study of noncoding RNAs retained in the nucleus. This past year, the lab
discovered a nu clear mechanism that proces ses noncoding RNAs. MALAT1, a noncoding nuclear RNA,
was observ ed to split into two segments, the smaller of which mi grated into the cy to plasm. A longer
remnant remained in the nucleus, ac cumulating in zones called nuclear speckles. The nuclear-retained
MALAT1 transcript is up-regulated in tumors that have the propensity to metastasize. Although it is not
clear what the processed parts of the original RNA do, their disparate destinations in the cell suggest that
they serve different functions.
Papillomaviruses, a large viral family that induces cell proliferation at the site of infection, usually give
rise to benign tumors. But certain types of human papillomaviruses (HPVs) generate tumors that progress
toward malignancy. Among these are HPVs that cause most cervical cancers. Arne Stenlund and col-
leagues have obtained a detailed understanding of processes required for initiation of DNA replication
from the papillomavirus, using this system to gain a general biochemical understanding applicable in
other systems. Members of the Stenlund lab also pursue studies aimed at developing an effective small-
molecule inhibitor of HPVs that might someday be used by women who do not receive the preventive
anti-HPV vaccine now available or those already infected with HPV who would not be helped by the vac-
cine.
Bruce Stillman’s lab studies the process by which DNA is copied within cells before they divide in
two. Working with yeast and human cells, Stillman and colleagues have identified many of the cellular pro-
teins that function at the DNA replication fork during the S phase, the portion of the cell division cycle at
which DNA synthesis occurs. Among these proteins are those that facilitate the assembly of chromatin,
the protein–DNA complexes that form the chromosomes. The prime focus of current research, however,
is the mechanism that initiates the entire process of DNA replication in eukaryotic cells. At the heart of
this mechanism is a protein that binds to “start” sites on the chromosomes, called the ORC or origin
recognition complex. Stillman’s re search has demonstrated that ORC is also involved in the process of
segregating the duplicated chromosomes in mitosis. They have found ORC at centrosomes and cen-
tromeres, structures that orchestrate chromosome separation in mitosis.
Years ago, William Tansey ob served that the destruction of transcription factors is intimately tied to their
ability to activate transcription, which raised the intriguing question of how the very first step in the life of
a protein was functionally related to the very last step, proteolysis—the protein’s destruction by a molec-
ular complex called the proteosome. The key link, he demonstrated, is ubiquitin, a molecule with which
proteins must be tagged before they can enter the proteosome for destruction. Having linked ubiquitin
and proteolysis to the activity of transcription factors, Tansey and colleagues have focused on the broader
question of how ubiquitin affects transcription. This year, they discovered a means by which ubiquitin can
regulate transcription without engaging the proteolytic machinery, specifically by acting as a wedge to pull
apart and thereby inactivate RNA polymerase, the enzyme that orchestrates transcription. They are now
exploring the biological context in which this nonproteolytic regulatory function of ubiquitin is brought to
bear. 
The function of DNA within cells is heavily influenced by its packaging with protein, a complex known
as chromatin. The regulation of chromatin structure is essential for specifying which genes should be
switched “on” or “off” in a given cell type. Alterations of chromatin structure that have been observed in
cancer cells promote uncontrolled cell growth and progression of the disease. The research of CSHL Fel-
low Christopher Vakoc aims to understand how changes in chromatin contribute to the pathogenesis of
acute leukemia, a cancer of blood cells. Using genome-wide mapping of chromatin structure together
with a functional-genetics approach, Vakoc seeks to uncover novel chromatin pathways involved in can-
cer. By evaluating the reversibility of chromatin states in living organisms, he hopes to reveal novel ther-
apeutic targets that may improve leukemia treatment.
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The gene has long been considered the basic functional
unit of heredity in cells. The molecular structure of a gene
has been fundamentally influenced by the model
described by Jacob and Monod in their report (J. Mol.
Biol. 3: 318 [1961]) on gene organization and regulation.
Using this basic model of a gene, the organization and
regulation of genomes have been studied and elaborated
upon by several generations of molecular biologists.
However, the advent of more genome-wide investigations
made possible by means of novel experimental (e.g., sec-
ond-generation sequencing and high-density arrays) and
computational methods has provided a much more com-
plex and elegant vision of the organization and regulation
of eukaryotic genes and genomes. Our studies have cen-
tered on this emerging new organization and regulation as
well as epigenetic influences on gene expression. We have
sought a better definition of the basic unit of genetic
information and to understand the gene in this new con-
text. A first step to achieve a better understanding is to
determine a complete parts list and genomic location of
the functional elements in genomes. Our efforts toward
this end have been to catalog the sites of transcription,
characterize the RNA products made at these locations,
determine the regulatory sites controlling these tran-
scriptional products, and determine the function and fates
of the non-protein-coding transcripts made by genomes.
Results from these and other similar studies are having a
significant influence on our understanding of how per-
turbations in DNA structure and RNA processing lead to
many of our complex disease conditions.
TRANSCRIPTOME OF HUMAN CELLS
The NHGRI-sponsored Encyclopedia of DNA Elements
(ENCODE) project has focused during the last 6 years on
identifying and cataloging the functional elements found
in the human genome. Our group has been a member of
this consortium since its inception in 2002. One of the key
functional elements to be identified and characterized is
the transcriptomes of human cells. Investigators from
seven international institutions—Gregory Hannon
(CSHL), Yoshihide Haya shizaki (co-PI) and Piero Carn-
ORGANIZATIONAL REGULATION OF EUKARYOTIC
TRANSCRIPTIONS
T.R. Gingeras K. Bell J. Drenkow W. Lin
C. Davis D. Fagegaltier H. Wang
A. Dobin S. Jha C. Zaleski
inci (co-PI) (RIKEN), Yijun Ruan (co-PI) and Chia Lin
Wei (co-PI) (Genome Institute of Singapore), Stylianos
Antonarakis (co-PI) (University of Geneva) and Alexan-
dre Reymond (co-PI) (University of Lausanne), and
Roderic Guigo (Center for Genomic Regulation)—are
collaborating with our group to generate a comprehensive
set of subcellular compartment-specific long (>200
nucleotides) and short (<200 nucleo tides) polyad enylated
(poly[A]+) and nonpolyadenylated (poly[A]–) RNA maps
for each of the two cell lines (K562 and GM12878) and
for several primary and transformed cell lines in succeed-
ing years. Long and short RNA (poly[A]+ and poly[A]–)
maps from six subcellular compartments (nucleus, nuclear
matrix, nucleolus, chromatin, cytoplasm, and polysomes)
have been constructed. Additionally, the 5′ and 3′ termini
of these transcripts have been identified by construction of
both CAP analysis of gene expression (CAGE) and
paired-end diTAG (PET) maps. (A path to all maps and
raw and processed data can be obtained from
http://www.genome. gov/10005107.) Finally, with the use
of a combination of 5′ and 3′ rapid amplification of cDNA
ends (RACE) reactions, reverse transcriptase–polymerase
chain reaction (RT-PCR), and cloning and sequencing, the
full-length structures of several thousand compartment-
specific noncoding RNAs are being determined to assist
in determining their possible function.
TRANSCRIPTOMES OF FLY CELLS
The NHGRI-sponsored model genomes (mod)ENCODE
project has focused during the last 2 years on identifying
and cataloging the functional elements found in the fly
and worm genomes. Our group is a member of a con-
sortium of five laboratories—P. Cherbas/L. Cherbas
(Indiana University), S. Celniker (Lawrence Berkeley
National Laboratory), M. Brent (Washington Univer-
sity), B. Gravely (University of Connecticut), and N. Per-
rimon (Harvard University)—focused on ultimately
characterizing the transcriptomes of Drosophila
melanogaster during each of 30 time points of develop-
ment in 50 cell lines and in 30 diverse tissues.
During this year, 34 RNA samples (5 cell lines and
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We implemented a system for classifying transcript
models according to their level of supporting EST and
cDNA data (one of our key deliverables) that will be dis-
played as a color code on the main modENCODE
browser. There are nine levels of confirmation, of which
the top three are as follows. 
• Level 1 (11,133 transcripts): A full-insert cDNA has
all splice sites in common with the model (neither
has a site not contained in the other).
• Level 2 (3481 transcripts): A single assembly of
cDNA sequences (including ESTs) has all splice
sites in common with the model.
• Level 3 (2426 transcripts): Multiple, nonoverlapping
assemblies of cDNA sequences confirm all splice
sites, but there may be gaps in the coverage of exons.
These may include incorrectly split or merged genes.
The remaining six levels describe models with one
or more unconfirmed splice sites and single-exon genes.
We also changed our pipeline to make it easier to com-
pare our annotations with those provided by FlyBase.
One of the major challenges and opportunities of the
year has been the emergence of RNA-seq as primary
data. This required a refocusing of effort that is now
starting to pay off through validation of novel splice
sites.
POSTTRANSCRIPTIONAL PROCESSING
OF RNAS INTO SHORT, CAPPED RNAS
The results from our laboratory and those from many
others have indicated that the number of individual non-
coding RNAs greatly exceeds the number of protein-
coding transcripts. The functional roles of most of these
noncoding transcripts are still unclear. Two years ago, we
proposed that the fate of a large proportion of the
detected long noncoding RNA transcripts was to be
processed into short functional RNAs (Kapranov et al.,
Science 316: 1484 [2007]). One collection of novel short
RNA candidates that are likely derived from long RNA
precursors was found flanking both sides of transcrip-
tional initiation sites (TSSs). These we called promoter-
associated short RNAs (PASRs). In collaboration with
the Hannon laboratory here at CSHL, we analyzed this
and other classes of short RNAs found in two human cell
lines (HeLa and HepG2). Deep sequencing of small
RNAs (<200 nucleotides) from these two cell lines
revealed a remarkable breadth of short RNA species.
Short RNAs were found to arise both from within anno-
tated genes and from unannotated intergenic regions.
Overall, small RNAs tended to align with CAGE tags,
29 developmental time points, all in biological triplicate)
were processed using 38-bp resolution whole-genome
tiling arrays, and 34 RNA expression maps were gener-
ated. Our progress, including status of the RNA samples
(total and poly[A]+ RNA) and quality control data for
individual samples, can be found at http://transcriptome.
affymetrix.com/download/modENCODE/sampleQC/.
Furthermore, transcribed regions (transfrags) were iden-
tified using three different thresholds to analyze tiling
array data generated by our laboratory. These data, which
essentially complete the proposed developmental time
course, have been submitted to the modENCODE data
coordination committee (DCC).
Using the microarray data, the Cherbas group has
cataloged novel transfrags by sample and novel trans-
frag contigs (working over all RNA samples). We have
assigned expression scores to all previously annotated
exons and to the novel transfrag contigs. We have sup-
plemented the microarray data by obtaining a Nimble-
gen whole-genome tiling array for comparison of
platforms. We have also set up and are operating a Wiki
for all of the Celniker group expression data. Our analy-
sis of data from more than 25 cell lines points to the
existence of ~86,000 novel transfrag contigs covering
28 Mbp (23% of the euchromatin). Analytical efforts
relating microarray data to RNA-seq data including
paired-end RNA-seq data are ongoing. 
This year, we also generated two new updates of the
transcript annotations for a total of six versions. The lat-
est, MB6, comprises 21,504 transcript models at 12,789
loci and used expressed sequence tags (ESTs), cDNAs,
and comparative genomic data. We performed quarterly
cycles of cDNA clustering, N-SCAN-EST predictions,
RT-PCR splice junction validation experiments, and
incorporation of new ESTs. In addition, we improved
our algorithms for building models to identify and track
polycistronic genes.
To annotate overlapping genes on opposite strands,
we modified N-SCAN to predict on each strand inde-
pendently, rather than both at once. This approach
reduced accuracy too much, so we abandoned it. How-
ever, overlapping genes are now annotated because we
have integrated FlyBase annotations into our pipeline as
hypothesized gene structures, on a par with N-SCAN
predictions. They are then classified according to their
level of support (see below).
We now have scripts that submit each new annota-
tion almost automatically. We created Wiki pages show-
ing the details of our protocols. We use GBrowse
(http://mblab.wustl.edu/cgi-bin/gbrowse/fly5) to visual-
ize and validate preliminary data that are not yet ready
for submission to the DCC.
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which mark the 5′ ends of capped, long RNA transcripts.
Many small RNAs, including the previously described
PASRs, also appeared to possess cap structures as part of
their structures. An extensive class of both small RNAs
and CAGE tags were distributed across internal exons
of annotated protein-coding and noncoding genes, some-
times crossing exon–exon junctions. These data indi-
cated that processing of mature mRNAs through an as
yet unknown mechanism is likely to generate complex
populations of both long and short RNAs whose appar-
ently capped 5′ ends coincide (Fig. 1). Supplying syn-
thetic PASRs corresponding to the c-myc transcriptional
start site reduced myc mRNA abundance. 
GLOBAL TRANSCRIPTIONAL ACTIVITY IN
PLURIPOTENT EMBRYONIC STEM CELLS
Embryonic stem (ES) cells are unique in their capacities
to self-renew and to initiate differentiation into any cell
type of the three germ layers. These opposing abilities
are in part brought about by the presence of stem-cell-
specific proteins (Takahashi and Yamanaka, Cell 126:
663 [2006]). During differentiation, lineage-specific
transcription factors activate the expression of specific
sets of genes that are required for each specific lineage.
Such hierarchical activation is consistent with genetic
transcriptional networks that operate during differenti-
ation and development (Szutorisz and Dillon, Bioessays
27: 1286 [2005]). 
In addition to control by specific transcription fac-
tors, regulation via epigenetic mechanisms has recently
emerged as a key mechanism in pluripotency and line-
age. Embryonic stem (ES) cell chromatin is character-
ized by several specific features that distinguish it from
that of somatic and differentiated cells. In ES cells, het-
erochromatin is organized in larger and fewer domains,
which, as cells differentiate, become smaller, more
abundant, and hypercondensed (Meshorer and Misteli,
Nat. Rev. Mol. Cell. Biol. 7: 540 [2006]). Another strik-
ing feature of stem cell chromatin is the altered binding
of structural architectural chromatin proteins. The het-
erochromatin component HP1, the linker histone H1,
and core histones all display hyperdynamic and looser
binding to chromatin in undifferentiated ES cells than in
differentiated cells. Interestingly, this hyperdynamic
plasticity was exclusively found in pluripotent cell
types, although not in lineage-committed but undiffer-
entiated cell types, indicating that dynamic chromatin
plasticity is associated with pluripotency rather than dif-
ferentiation per se.
ES cells also contain unique histone modification
patterns. Extensive regions of the genome are bivalently
marked by transcriptionally repressive H3-triMeK27
FIGURE 1 A proposed model for the metabolism of genic transcripts into a diver-
sity of long and short RNAs. Transcription of a genic region results in a precursor
long RNA containing a 5′ cap structure. After processing into spliced RNAs, pro-
tein-coding RNAs are either destined to be translated or to be further processed.
Further processing entails cleavage followed in some cases by addition of a 5′
modification, possibly a cap structure. Additional cleavage of these intermediate
products can generate a class of short RNAs, some also bearing a cap structure. 
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but, at the same time, contain the transcription-associ-
ated histone modification H3-triMeK4 (Bernstein et al.,
Cell 125: 315 [2006]). It has been proposed that these
bivalent domains silence developmentally regulated
genes in ES cells while keeping them poised for activa-
tion as cells enter the various differentiation pathways
(Bernstein et al., Cell 125: 315 [2006]; Jorgensen et al.
Cell Cycle 5: 1411 [2006]). Repression of H3-triMeK27
appears to be mediated by the Polycomb repression
complex 2 (PRC2), which is associated with a signifi-
cant number of developmental regulators.
A commonality among several of the ES-cell-
specific chromatin properties is that they are all char-
acteristic of transcriptionally active chromatin,
including the reduction in heterochromatin domains, the
presence of bivalent histone modifications, and the
looser binding of architectural chromatin proteins. On
the basis of these features, we have suggested that ES
cell genomes are globally transcriptionally active and
express large regions of the genome indiscriminately
(Meshorer and Misteli, Nat. Rev. Mol. Cell. Biol. 7: 540
[2006]). In collaboration with the Misteli laboratory, we
are directly testing the existence of widespread tran-
scription in pluripotent ES cells. We provided several
lines of evidence in support of global, low-level tran-
scriptional activity over large regions of the genome. We
found elevated levels of total RNA and mRNA in
pluripotent mouse ES cells, and we showed that undif-
ferentiated ES cells unexpectedly express repetitive
sequences and mobile elements as well as lineage- and
tissue-specific genes at low levels. Using whole-genome
mouse tiling arrays, we showed that a larger fraction of
the genome is active in ES cells. The global transcrip-
tional activity of the ES cell genome was accompanied
by the specific up-regulation of chromatin remodeling
proteins and the global transcription machinery but not
histone-modifying activities. Our results identified a
novel hallmark of ES cell genomes, and they suggest
that loss of pluripotency and lineage specification
occurs via the reduction of the actively transcribed por-
tion of the genome.
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We study the molecular basis of nucleic acid regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of these molecular machines. Biochemistry
and molecular biology allow us to study properties that
can be correlated to protein structure and function. 
Mechanisms of RNAi
T. Schalch, C. Faehnle, C. Kuhn, C. Kuscu, J. Calarco, 
S. Goldsmith, S. Lin [in collaboration with G.J. Hannon 
and R.A. Martienssen, CSHL; J. Partridge, St. Jude
Children’s Research Hospital] 
RNA interference (RNAi) has made an enormous impact
on biology in a very short period of time. Not only are we
still discovering new cellular pathways for the regulation
of gene expression, but RNAi has become an extraordi-
narily useful and simple tool for gene silencing. Almost
from its beginnings, investigators have used genetics,
biochemistry, molecular biology, and bioinformatics to
study the mechanism of RNAi and related pathways. We
argued, however, that in order to get a true mechanistic
understanding of these pathways, we must understand
how the components of the RNAi machinery worked at
a molecular level. Therefore, we embarked on structural
and biochemical studies of key proteins in the RNAi
pathway.
During RNAi, long double-stranded RNA is processed
to yield short (~19–31 nucleotide) double-stranded RNAs
that trigger the RNAi response. These short RNAs get
incorporated into effector complexes called the RNA-
induced silencing complex (RISC), where in the mature
complexes, a single-stranded RNA—the antisense strand
of the original double-stranded RNA—is retained in the
complex. This short RNA (short interfering RNA or
microRNA) then acts to guide the RISC complex to its
target through base complementarity. The best-character-
ized pathway, and the one that is predominantly used for
gene knockdown technology, is a posttranscriptional
STRUCTURAL BIOLOGY OF NUCLEIC ACID
REGULATORY PROCESSES
L. Joshua-Tor J. Calarco S. Goldsmith C. Kuscu
E.J. Enemark C. Kuhn S. Lin
C. Faehnle P.R. Kumar T. Schalch
silencing (PTGS) pathway called “slicing.” Here, the
RISC complex is targeted to the mRNA and produces an
endonucleolytic cut in the mRNA target, thus preventing
gene expression from proceeding. Other RNAi silencing
pathways such as translational inhibition and transcrip-
tional gene silencing (TGS) are also mediated through
RISC complexes. In all cases, these complexes contain a
small single-stranded RNA and an Argonaute protein,
features that serve to define the RISC complex. 
In the past few years, we have been studying Arg-
onaute family proteins, their complexes, and their roles
in various RNAi silencing pathways. 
DNA Translocation in a Replicative
Hexameric Helicase
E.J. Enemark
During DNA replication, two complementary DNA
strands are separated and each becomes a template for
the synthesis of a new complementary strand. Strand
separation is mediated by a helicase enzyme, a molec-
ular machine that uses the energy derived from ATP
hydrolysis to separate DNA strands while moving along
the DNA. Recently, we determined a crystal structure
of the replicative helicase E1 from papillomavirus
bound to single-stranded DNA and nucleotide mole-
cules at the ATP-binding sites.
Papillomaviruses are tumor viruses that cause benign
and cancerous lesions in their host. Replication of papil-
lomavirus DNA within a host cell requires the viral E1
protein, a multifunctional protein. E1 initially partici-
pates in recognizing a specific replication origin DNA
sequence as a dimer with E2, another viral protein. Sub-
sequently, further E1 molecules are assembled at the
replication origin until two hexamers are established.
These hexamers are the active helicases that operate
bidirectionally in the replication of the viral DNA. To
unwind DNA, helicases must separate the two strands
while moving along or translocating on the DNA. On
the basis of structures of the DNA-binding domain of
E1 bound to DNA that we determined a few years ago
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in collaboration with Arne Stenlund’s lab here at CSHL,
we suggested a mechanism for DNA strand separation.
However, the mechanism that couples the ATP cycle to
DNA translocation has been unclear.
The E1 hexameric helicase adopts a ring shape with
a prominent central channel. ATP-binding (and hydrol-
ysis) sites are located at the subunit interfaces, and mul-
tiple configurations are observed within the hexamer.
These have been assigned as ATP-type, ADP-type, and
apo-type. The configuration of the site for a given sub-
unit correlates with the relative height of its DNA-bind-
ing hairpin in the staircase arrangement. The subunits
that adopt an ATP-type configuration place their hair-
pins at the top of the staircase, whereas the hairpins of
apo-type subunits occupy the bottom positions of the
staircase. The hairpins of the ADP-type subunits are
placed at intermediate positions.
A straightforward “coordinated escort” DNA-translo-
cation mechanism is inferred from the staircased DNA
binding and its correlation with the configuration at the
ATP-binding sites. Each DNA-binding hairpin maintains
continuous contact with one unique nucleotide of single-
stranded DNA and migrates downward via ATP hydrol-
ysis and subsequent ADP release at the subunit interfaces.
ATP hydrolysis occurs between subunits located toward
the top of the staircase, whereas ADP release occurs
between subunits located toward the bottom of the stair-
case. The hairpin at the bottom of the staircase releases its
associated single-stranded DNA phosphate to conclude
its voyage through the hexameric channel. Upon binding
a new ATP molecule, this subunit moves to the top of the
staircase to pick up the next available single-stranded
DNA phosphate, initiating its escorted journey through
the channel and repeating the process. For one full cycle
of the hexamer, each subunit hydrolyzes one ATP mole-
cule, releases one ADP molecule, and translocates one
nucleotide of DNA through the interior channel. A full
cycle therefore translocates six nucleotides with associ-
ated hydrolysis of six ATPs and release of six ADPs.
We performed a detailed comparison with other mul-
timeric ATPase motors that highlighted the roles of indi-
vidual site residues in the ATPase activity.
NADP Regulates the Yeast
GAL Induction System 
P.R. Kumar [in collaboration with S.A. Johnston, Arizona State
University; R. Sternglanz, Stony Brook University]
Transcriptional regulation of galactose metabolizing
genes in Saccharomyces cerevisiae depends on three
core proteins: Gal4p, the transcriptional activator that
binds to upstream activating DNA sequences (UAS
GAL
);
Gal80p, a repressor that binds to the carboxyl terminus
of Gal4p and inhibits transcription; and Gal3p, a cyto-
plasmic transducer which upon binding galactose and
ATP relieves Gal80p repression. The current model of
induction relies on Gal3p sequestering Gal80p in the
cytoplasm. However, the rapid induction of this system
implies that there is a missing factor. To understand the
molecular mechanism of the GAL regulatory system, we
have determined the structure of S. cerevisiae Gal80p
with the activation domain of Gal4p. 
The crystal structures of Gal80p reveal a three-
domain architecture with an amino-terminal domain
consisting of a Rossmann fold, normally associated with
binding of NAD(P) cofactors. The carboxy-terminal
domain consists of a large β sheet that forms an exten-
sive dimer interface with another monomer (Fig. 1). A
large cleft is apparent between these two domains. A
smaller third domain, located between the amino- and
carboxy-terminal domains, consists of three small β
strands and a helix that resemble a set of fingers at the
entrance of the cleft. Gal80p dimers form tetramers in
both crystal forms. When we soaked a crystal of
Gal80pS0:P21 (a 21-amino-acid peptide that contains the
conserved region of the carboxy-terminal activation
domain [AD] of Gal4p) with nicotinamide adenine din-
ucleotide (NAD), the structure revealed that NAD binds
to both monomers of Gal80p in the cleft formed by the
Rossmann fold. We were also able to observe extra den-
sity corresponding to the P21 peptide. The peptide
appears to interact with the nicotinamide portion of the
dinucleotide. NAD nestles between Gal80p and Gal4p,
making several key interactions with Gal80p. 
FIGURE 1 Two views of the Gal80pS0-Gal4AD-NAD dimer.
Gal80p is depicted as gray ribbons, the Gal4p AD peptide and
the NAD in stick . Disordered regions are shown as a dashed coil.
The β-sheet regions of the carboxy-terminal domains form an
extensive dimeric interface.  
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cell, and Gal80p effectively senses the metabolic state of
the cell. NADP might be acting as a “second messen-
ger” in triggering the system. Alternatively, Gal80p may
function as an oxidoreductase enzyme, actively con-
verting NADPH to NADP in the presence of a substrate,
causing it to disassociate from Gal4p. 
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In vitro pull-down assays of Gal80p with purified
recombinant GST-Gal4p containing the acidic AD in the
presence of NAD and NADH showed no change in
binding for either of these two dinucleotides. However,
when NADP and NADPH were used, a clear reduction
in binding is observed with increasing concentrations
of NADP. Alterations in the NAD(P)-binding site affects
the initial rate of GAL induction in vivo, but not overall
final expression levels. It appears that NAD might facil-
itate Gal80p binding to Gal4p, because we could only
identify Gal4p-AD with NAD bound, and NADP desta-
bilizes this interaction. The mutations, affecting both
NAD and NADP binding, would therefore disrupt both
the stabilizing effect of NAD and destabilizing effect of
NADP with a net result of faster induction for the
mutants compared to wild type.
Although we do not understand precisely how this
trigger for GAL regulation functions, nor the involve-
ment of NADP versus NAD, we speculate that switch-
ing the cell to a fermentable galactose medium causes a
change in NADP/NADPH or NADP/NAD ratios in the
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MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE-MRNA SPLICING
RNA splicing is required for correct expression of most
eukaryotic protein-coding genes. The spliceosome
selects authentic splice sites with very high fidelity,
relying on limited sequence information present
throughout introns and exons. In humans, ~75% of
genes are expressed via alternative splicing, giving rise
to multiple protein isoforms. The choice of alternative
splice sites is commonly regulated to alter gene expres-
sion, either tissue specifically or in response to a devel-
opmental program or to signaling pathways. The fact
that multiple protein isoforms can be expressed from
individual genes demonstrates that the classical “one
gene–one enzyme” paradigm is no longer valid and pro-
vides an explanation for the unexpectedly small num-
ber of genes uncovered by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well as
RNA components that are part of small nuclear ribonu-
cleoprotein (snRNP) particles. The work in our lab
focuses on the identification and molecular characteri-
zation of protein factors and sequence elements that are
necessary for the catalysis and fidelity of splicing and/or
for the regulation of alternative splice-site selection. We
are interested in how the spliceosome correctly identi-
fies the exons on pre-mRNA and how certain point
mutations in either exon or intron sequences cause aber-
rant splicing, leading to various human genetic diseases.
Related areas of interest include the remodeling of
mRNP architecture as a consequence of splicing, which
influences downstream events, such as nonsense-medi-
ated mRNA decay (NMD), the role of alternative splic-
ing misregulation in cancer, and the development of
effective methods to correct defective splicing or mod-
ulate alternative splicing. A summary of some of our
recently published studies is provided below.
SF2/ASF: A SPLICING FACTOR ONCOPROTEIN
Alternative splicing has an important role in cancer,
partly by modulating the expression of many oncogenes
and tumor suppressors, and also because inactivating
RNA SPLICING
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mutations that affect alternative splicing of various tumor
suppressor genes account for some of the inherited and
sporadic susceptibility to cancer. We previously showed
that the splicing factor SF2/ASF is an oncoprotein that is
up-regulated in many cancers and can transform immor-
tal rodent fibroblasts when slightly overexpressed. The
mammalian target of rapamycin (mTOR) signaling path-
way is activated in many cancers, and pharmacological
blockers of this pathway are in clinical trials as anti-
cancer drugs. In collaboration with Scott Lowe at CSHL,
we examined the activity of the mTOR pathway in cells
transformed by SF2/ASF and found that this splicing
factor activates the mTORC1 branch of the pathway, as
measured by S6K and eIF4EBP1 phosphorylation. This
activation is specific to mTORC1, because no activation
of Akt, an mTORC2 substrate, was detected. mTORC1
activation by SF2/ASF bypasses upstream phosphoinos-
itol-3 kinase (PI3K)/Akt signaling and is essential for
SF2/ASF-mediated transformation, because inhibition
of mTOR by rapamycin blocked transformation by
SF2/ASF in vitro and in nude mice. Moreover, short
hairpin RNA (shRNA)-mediated knockdown of mTOR,
or of the specific mTORC1 and mTORC2 components
Raptor and Rictor, abolished the tumorigenic potential
of cells overexpressing SF2/ASF. These results suggest
that clinical tumors with SF2/ASF up-regulation could
be especially sensitive to mTOR inhibitors.
ANTISENSE-CORRECTION OF SPLICING
DEFECT IN SMA
Spinal muscular atrophy (SMA) is a neurodegenerative
genetic disorder caused by the deletion or mutation of the
survival-of-motor-neuron gene SMN1. An SMN1 para-
log, SMN2, is present in all patients and differs from
SMN1 by a C to T transition in exon 7 that causes sub-
stantial skipping of this exon, such that SMN2 expresses
only low levels of functional protein. We continue to
explore strategies to increase the extent of exon-7 inclu-
sion during splicing of SMN2 transcripts, for eventual
therapeutic use in SMA. One of our strategies involves
the use of antisense oligonucleotides (ASOs), in collab-
oration with Frank Bennett (Isis Pharmaceuticals).
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conservation, splicing microarray data, and additional
computational and experimental characterization. We pre-
dicted thousands of Fox-1/2 targets with conserved bind-
ing sites, at a false discovery rate of ~24%, including
many validated experimentally, suggesting a surprisingly
extensive SRN. The preferred position of the binding sites
differs according to the alternative splicing pattern and
determines either activation or repression of exon recog-
nition by Fox-1/2. Many predicted targets are important
for neuromuscular functions and have been implicated in
several genetic diseases. We also identified instances of
binding-site creation or loss in different vertebrate line-
ages and human populations, which likely reflect fine-
tuning of gene expression regulation during evolution.
SPLICE-SITE RECOGNITION AND HUMAN GENETICS
We continued to analyze the specificity of splice-site
recognition and the relationship between splice-site muta-
tions and genetic diseases. The 5′ splice site—the highly
diverse element at the 5′ end of introns—is initially rec-
ognized via base pairing to the 5′ end of the U1 small
nuclear RNA (snRNA). However, many natural 5′ splice
sites have a poor match to the consensus sequence and are
predicted to be weak. Using genetic suppression experi-
ments in human cells, we demonstrated that some atypical
5′ splice sites are actually efficiently recognized by U1, in
an alternative base-pairing register that is shifted by one
nucleotide relative to the canonical one (Fig. 1). These
atypical 5′ splice sites are phylogenetically widespread,
and many of them are conserved. The unexpected flexi-
bility in 5′ splice site/U1 base pairing challenges an estab-
lished paradigm and has broad implications for splice-site
prediction algorithms and gene-annotation efforts in
genome projects.
In addition, shifted base pairing provides an expla-
nation for the effect of a 5′ splice-site mutation in intron
2 of RARS2, which is associated with the genetic disor-
der pontocerebellar hypoplasia. This mutation was
known to cause defective splicing, which was paradox-
ical because the mutation changes a nonconsensus
nucleotide to a consensus nucleotide. However, because
this atypical 5′ splice site base pairs with U1 in a shifted
register, the mutation weakens this interaction, account-
ing for the splicing defect.
In many other cases, including particular alleles of
Fanconi anemia, hemophilia B, neurofibromatosis, and
phenylketonuria, mutations can disrupt splicing even
though they do not disrupt the match to the splice-site
consensus. In collaboration with Ravi Sachidanandam at
CSHL, we used comparative genomics—i.e., analysis
of large-scale data sets of splice sites from five different
We systematically tested overlapping ASOs comple-
mentary to the proximal flanking intronic regions, cover-
ing 60 nucleotides upstream or downstream from exon 7.
As we did previously with exonic ASOs, we classified
them into positive, negative, and neutral with respect to
their effects on exon-7 inclusion. Several of the positive
ASOs were very potent when tested in cell-free splicing or
in transfected cells, defining silencer regions in both flank-
ing introns. We also tested them in transgenic mice that
ubiquitously express human SMN2. After intravenous
administration, 2′-O-methoxy-ethyl (MOE) ASOs are effi-
ciently internalized by cells in peripheral tissues, and they
are imported into the nucleus, where they can modulate
gene expression. We observed efficient correction of the
splicing defect in liver and kidney mRNAs and weaker but
significant correction in skeletal muscle. There was no
correction in spinal cord—the tissue we need to target for
SMA therapy—because the ASOs do not cross the blood-
brain barrier. Therefore, we have started to explore meth-
ods for direct administration to the central nervous system
(CNS), such as intracerebroventricular infusion.
The above experiments show that ASO tiling is a pow-
erful method to map cis-acting elements that influence
alternative splicing. To explore the mechanism of action
of the silencer element in intron 7—which corresponds to
an element previously dubbed ISSN1—we introduced
point mutations and assayed splicing of the resulting
minigenes in transfected cells. Combined with splicing-
factor overexpression and biochemical experiments, this
analysis demonstrated that the intron-7 splicing silencer
is composed of a bipartite motif recognized by the splic-
ing repressor heterogeneous nuclear ribonucleoprotein
(hnRNP) A1 and other closely related members of the
hnRNP A/B family.
CHARACTERIZATION OF SPLICING-
REGULATORY NETWORKS
The precise regulation of many alternative splicing events
by specific splicing factors is essential to determine tissue
types and developmental stages. However, the molecular
basis of tissue-specific alternative splicing regulation and
the properties of splicing regulatory networks (SRNs) are
poorly understood. In collaboration with Michael Zhang
at CSHL and John Castle at Rosetta Inpharmatics, we
comprehensively predicted the targets of the brain- and
muscle-specific splicing factor Fox-1 (A2BP1) and its
paralog Fox-2 (RBM9) and systematically defined the
corresponding SRNs genome-wide. It was known that
Fox-1/2 are conserved from worms to humans and specif-
ically recognize the RNA element UGCAUG. We inte-
grated Fox-1/2-binding specificity with phylogenetic
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genomes—to identify pairwise dependencies between
individual nucleotides of the 5′ splice site as a conserved
feature of the entire set of 5′ splice sites. These depend-
encies are also conserved in human– mouse pairs of
orthologous 5′ splice sites. Many disease-associated
mutations disrupt these dependencies, as can some
human single-nucleotide polymorphisms (SNPs) that
appear to alter splicing, suggesting that 5′-splice-site
SNPs have a role in complex diseases.
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FIGURE 1 Shifted base pairing between atypical 5′ splice sites
and the 5′ end of U1 small nuclear RNA. (a) Diagram of two base-
pairing registers between the 5′ splice sites (positions are num-
bered) and U1. (Light gray) Consensus nucleotides; (ψ)
pseudo uridine; (closed dot) 2,2,7-trimethylguanosine cap at the
5′ end of U1; (boxed area) upstream exon; (solid line) intron. (Ver-
tical lines) Base pairs in the canonical (C) or shifted (S) register.
Note that the atypical 5′ splice site can form seven more base
pairs to U1 in the shifted arrangement. (b) Mutations at the atyp-
ical (Atp) 5′ splice site that disrupt shifted but enhance canonical
base pairing abolish correct splicing. The human GTF2H1 and
SMN1/2minigenes are schematically represented at the top, indi-
cating the mutations introduced at the atypical 5′ splice site.
GTF2H1 intron 8 has a natural atypical 5′ splice site; intron 7 in
SMN1 or SMN2 has a canonical 5′ splice site, but we replaced
it in both genes to allow testing of the atypical 5′ splice site in two
heterologous contexts. The identity of the various spliced
mRNAs, detected by radioactive reverse transcriptase–poly-
merase chain reaction (RT-PCR), is schematically shown on the
left of the gels: (1) correctly spliced mRNA; (2) retention of the
downstream intron; (3) use of a cryptic 5′ splice site in the mid-
dle exon; (4) skipping of the middle exon; (5) activation of a cryp-
tic 5′ splice site in the first exon. (Bottom) Percentage of correct
splicing. (Nat) Natural SMN1/2 exon-7 5′ splice site. (c) Com-
pensatory U1 mutations that restore shifted but not canonical
base pairing rescue splicing at atypical 5′ splice sites. SMN1/2
minigenes carrying the +4C mutation at a heterologous atypical
5′ splice site in exon 7 were cotransfected with suppressor U1
small nuclear RNAs. The 5′ end of U1 was mutated so as to res-
cue base pairing in the canonical or the shifted arrangement.
Mutations are underlined. (d) RT-PCR analysis of RNAs from the
suppressor U1 experiment. Labels on top indicate the suppres-
sor U1 in either register. (Bottom) Percentage of exon-7 inclusion.
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Bone marrow (BM)-derived components of the tumor
microenvironment serve critical roles in regulating
tumor growth and metastasis. Tumor-derived paracrine
signals instigate the BM compartment that mobilize and
recruit discrete subsets of BM cells to the tumor bed.
Recruited proangiogenic BM-derived cells contribute
significantly to neovasculature formation and tumor
growth in adults. In addition to the perivascular contri-
bution of BM-derived hematopoietic cells, the BM-
derived endothelial progenitor cells (EPCs) provide an
additional alternative source of endothelial cells that
contribute to neovessel formation. In response to tumor
cytokines, including vascular endothelial growth factor
(VEGF), putative VEGF receptor-2 (VEGFR2)-positive
EPCs mobilize into the peripheral blood circulation,
subsequently move to the tumor bed, and incorporate
into sprouting neovessels. 
More recent investigations have shown that EPCs par-
ticipate in neovascularization during acute ischemic
injury in both humans and mice. For example, Minami et
al. (Circulation 112: 2951 [2005]) have shown that cir-
culating endothelial cells engraft luminally into 15%–
29% of the vessels of the transplanted human heart.
BM-derived endothelial cells have also been shown to
give rise to up to 16% of the neovasculature in sponta-
neous tumors growing in transgenic mice and also con-
tribute to human tumor vessels. However, since the first
description of EPCs, their identity and relative contribu-
tion to neovasculature formation have often been debated.
Much confusion has prevailed because of the extensive
variability in EPC contribution to vessel formation in a
variety of tumor model systems. The recent controversy
notwithstanding, the existence of a BM reservoir of EPCs
and their selective involvement in neovascularization have
attracted considerable interest because these cells not only
represent a novel target for therapeutic intervention but
are also being used successfully as surrogate markers for
monitoring cancer progression, as well as for optimizing
efficacy of antiangiogenic therapies such as anti-
VEGFR2 antibody therapy.
The BM compartment comprises the osteoblastic (or
endosteal) and vascular niches. The osteoblastic niche
provides a quiescent microenvironment for stem cell
maintenance, and the resident hematopoietic stem cells
THE DYNAMIC TUMOR MICROENVIRONMENT
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(HSCs) are anchored to the endosteal surface by cal-
cium-sensing receptors present on the HSC. Growing
tumors secrete soluble factors into the circulation that
switches the marrow microenvironment from a quies-
cent state to a highly proangiogenic and protumorigenic
environment. This in turn promotes the mobilization of
both vascular and hematopoietic progenitors to the
peripheral circulation, which are recruited to the tumors.
In the tumor bed, the BM-recruited cells and other stro-
mal cells (adipocytes, fibroblasts, etc.) constitute a
unique microenvironment that can modify the neoplas-
tic properties of the malignant tumor cells. 
Adult BM contributes significantly to endothelial
and lymphatic neovessel formation and tumor growth
and invasion. Among the BM-derived cells, much focus
has been directed toward the proangiogenic hematopoi-
etic mural cells that are recruited to the tumor bed,
where they exert their functions perivascularly via
paracrine release of proangiogenic cytokines. Several
populations of BM-derived hematopoietic cells have
been reported to contribute to tumor angiogenesis and
invasion. These include GR1+CD11b+ myeloid progen-
itors, tumor-associated macrophages (TAMs), Tie2-
expressing monocytes (TEMs), CXCR4+VEGFR1+
hemangiocytes, recruited BM-derived circulating cells,
PDGFR+ pericyte progenitors, vascular leukocytes, and
infiltrating mast cells and neutrophils. Despite the gen-
eral importance of these cells in tumor angiogenesis, the
precise contribution and biological function of specific
lineages remain poorly understood.
In addition to the perivascular contribution of BM-
derived hematopoietic cells, the BM-derived EPCs pro-
vide an additional source of endothelial cells that
contribute to neovessel formation. We have characterized
EPCs with a comprehensive set of endothelial, hema to -
poietic, and progenitor markers (Nolan et al. Genes Dev.
21: 1546 [2007]). Analysis of EPCs in the BM, peripheral
blood, and tumors grown in mice that were previously
transplanted with green fluorescent protein (GFP)+ BM
required the use of a distinct combination of cell surface
markers. In early tumors, BM-derived EPCs were identi-
fied as GFP+ cells expressing VE-cadherin (uniformly on
the cell surface), CD31dim, and Prominin I/AC133. These
cells also expressed VEGFR2 and lacked hematopoietic
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explaining the low contribution observed in large estab-
lished tumors in various studies. 
To directly address their functional role in supporting
tumor angiogenesis in vivo, acute and conditional
shRNA-mediated silencing of Id1 mRNA in the adult
BM resulted in EPC mobilization defects associated
with severe angiogenesis inhibition and impaired
growth of primary tumors and progression of
micrometastasis to macrometastasis, suggesting a criti-
cal role for these cells in angiogenesis-mediated tumor
growth. Alternatively, targeting transiently expressed
monomeric VE-cadherin specifically on EPCs using
radiolabeled anti-VE-cadherin antibody resulted in
severe angiogenesis inhibition and impaired tumor
growth. So, why is this relatively minor contribution so
critical for tumor growth? Notably, in addition to vessel
incorporation, we have shown that tumor-recruited
EPCs secrete proangiogenic growth factors, suggesting
that in addition to providing stability to nascent vessels,
EPCs have a paracrine role in vessel recruitment at a
critical early stage of tumor growth.
EPCs contribute significantly to tumor neoangio-
genesis, and their selective targeting may have broad
implications for the development of antiangiogenic can-
cer therapy. EPCs are being considered as useful surro-
gate markers for monitoring cancer progression, as well
as for optimizing the efficacy of antiangiogenic thera-
pies, such as anti-VEGFR2 antibody therapy. Recently,
because of interest in the role of EPCs in turning on the
“angiogenic switch,” strategies have been used in an
attempt to keep this switch in the “off” position. 
Our finding that EPCs are the main regulators of the
angiogenic switch in metastatic progression suggests that
their selective targeting may be a promising approach in
cancer patients where metastatic colonization to the lung
has already occurred; this represents a paradigm shift
and a foundation for very exciting clinical applications.
Given that in many cancer patients, metastatic spread has
already occurred by the time of primary diagnosis, this
study suggests that selectively targeting the angiogenic
switch via the endothelial progenitor cells may provide a
clinically feasible approach to blocking metastasis pro-
gression and preventing death in cancer patients. For
example, following resection of primary tumors, patients
with stage-3 breast or colon cancers are often treated
with chemotherapy to destroy dormant micrometastases.
Nonetheless, many of these patients frequently succumb
to progression of micrometastatic invasive tumors. Thus,
combinations of adjuvant chemotherapy with antiangio-
genic agents to block recruitment of the endothelial pro-
genitor cells provide a highly effective strategy to impair
establishment of metastatic lesions. 
markers including CD11b, CD45B220, and CD41.
Notably, whether EPCs are CD45– or CD45 dim remains
to be clarified. In this context, it may be important to
determine the status of CD45 on EPCs in the context of
multiple CD45 isoforms, CD45RA, CD45RB, CD45RO,
and CD45B220. Regardless, the ability of isolated EPCs
to differentiate into mature endothelial cells and lumi-
nally incorporate into sprouting neovessels in vitro was
used as a functional readout. Isolectin ensured luminal
incorporation, GFP validated BM derivation, CD31 con-
firmed endothelial cells, and CD11b gated out any
hematopoietic contamination in the CD31 channel. This
was critical because CD31 is expressed by a subset of
hematopoietic cells. Similarly, circulating EPCs in the
peripheral blood were detected as GFP+ c-Kit+VEGFR2+
VE-cadherin+ CD11b– cells. In this scenario, c-kit (prog-
enitor marker) distinguished BM-derived EPCs from cir-
culating endothelial cells that have sloughed off from
mature vessels. 
Indeed, luminally incorporated BM-derived endothe-
lial cells determined by high-resolution microscopic
analysis of multiple Z-stacks (resolution of at least 0.275–
0.35 µm, depth of 30 µm) and optical sectioning have
shown that the BM-derived endothelial cells have a sin-
gle nucleus and that the GFP and CD31 signals are local-
ized to the same individual cell, indicating that the
incorporated endothelial cell is derived from the BM.
Notably, the vessel-incorporated BM-derived endothelial
cells exhibit hallmarks of a typical mature endothelial cell
such as uniform surface expression of CD31, a charac-
teristic VE-cadherin staining at the intercellular adherens
junctions, intracellular GFP, and lack of hematopoietic
markers. 
A systematic analysis of EPC contribution to
implanted tumors (Lewis lung carcinoma, B6RV2 lym-
phoma, melanoma), spontaneous breast tumors arising
in mouse mammary tumor virus-polyoma middle T
(MMTV-PyMT) mice, and pulmonary metastases that
develop in these mice has shown that ~10%–20% of the
early tumor vessels were BM derived. So how does one
explain the extreme variability in EPC contribution to
tumor vessels in various published studies? A possible
explanation is that in addition to tumor-type depend-
ence, it is possible that the EPC contribution could be
tumor-stage specific. Indeed, a kinetic analysis of EPC
contribution as a function of tumor growth showed that
EPCs are recruited to early tumors preceding vessel for-
mation, followed by differentiation into endothelial cells
and luminal incorporation into a subset of sprouting
tumor neovessels. Noticeably, in growing tumors, these
chimeric BM-derived vessels were eventually diluted/
replaced with non-BM-derived host vessels, thereby
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Most cellular processes can trace their beginnings to the
nucleus where a gene is activated, resulting in the pro-
duction of an RNA molecule that must get processed
and transported to the cytoplasm. Although much bio-
chemical information is available regarding many of the
factors involved in gene expression, the spatial and tem-
poral aspects of gene expression and the dynamics of
the nuclear domains that the gene expression machin-
ery occupies are less well understood. During the past
year, we have focused on two main areas: (1) examining
the dynamics of gene expression/repression and DNA
repair in living cells and (2) characterizing the role of
noncoding RNAs in regulating gene expression. 
The Dynamics of Gene
Expression/Repression
and DNA Repair
M. Hübner, R. Ileng Kumaran, J. Li, R. Zhao
Our research during the past year has focused on the
spatial and temporal aspects of gene expression in liv-
ing cells. These studies were performed using a cell line
(U2OS 2-6-3) that contains a transgene stably integrated
as a 200-copy array in human chromosome 1p36 (Jan-
icki et al., Cell 116: 683 [2004]). This cell system allows
us to directly visualize gene expression (DNA, RNA,
protein) within the context of a living cell. During the
past year, using 4D–time lapse microscopy, we have
compared the kinetics at which the transcription
machinery is recruited to a specific genetic locus upon
transcriptional initiation during interphase to that
observed when transcription is initiated immediately
after mitosis. In interphase, after doxycycline addition
(1 mg/ml) to induce the locus, we observed deconden-
sation of the locus from a heterochromatic state to a
euchromatic state, followed by the accumulation of
RNA polymerase II (RNA pol II) at the locus and the
production of nascent transcripts. By plotting the rela-
tive fluorescence signal intensity of the locus over time,
we found that RNA pol II levels and mRNA production
gradually increased, taking ~180 min to reach a maxi-
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mal signal intensity. We similarly studied the kinetics of
transcriptional initiation of this genetic locus upon exit
from mitosis. In this case, we keep the locus in a tran-
scriptionally active state and allow it to naturally shut
down upon entry into mitosis. Upon exit from mitosis,
in the presence of doxycycline, RNA pol II was re -
cruited to the locus after nuclear envelope reformation
in telophase, and mRNA synthesis was first detected
~3–5 min later. In contrast to the relatively slow, grad-
ual kinetics of induction observed in interphase, RNA
pol II reached its maximal signal intensity at the locus
in only 2–4 min after transcriptional activation, with
mRNA production peaking at 15–20 min. Given that the
transcript length of the RNA derived from this locus is
3.4 kb and that transcription occurs at ~1.5 kb/min, we
are able to detect a relatively low level of transcripts at
the locus upon induction. On the basis of these data, we
conclude that the transcriptional machinery is recruited
to this same genetic locus with very different kinetics
depending on the state of the cell cycle. In particular,
we observed that a heterochromatic locus requires
markedly more time to be activated versus a locus that
is constitutively induced. Studies are currently under
way to examine the histone modifications that are pres-
ent at this locus during interphase and mitosis in order
to determine if particular histone modifications are
involved in mediating the observed difference in tran-
scriptional induction. Our study provides a real-time
view of interphase transcriptional induction and post-
mitotic reactivation at a single gene locus and provides
a system in which to study how gene expression pat-
terns are transmitted to daughter cells.
A second focus of our studies has been to examine
the assembly of the NHEJ (nonhomologous end-joining)
DNA-repair nanomachine in living cells at high resolu-
tion in order to determine the mechanism by which this
nanomachine assembles at the site of DNA breaks, its
residence time at the break, and to elucidate the process
by which it disassembles upon completion of the repair
process in interphase nuclei. An in-depth understanding
of the assembly and dynamics of the NHEJ DNA-repair
nanomachine will have significant relevance to under-
standing and regulating this process. In collaboration
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plex are present in nuclear structures called PcG bod-
ies. These bodies are associated with regions of faculta-
tive heterochromatin and colocalize with chromatin
enriched in histone H3 dimethylated and trimethylated
at lysine 27 (H3K27). Because of the role of H3K27
methylation in gene silencing, PcG bodies have been
implicated in the mitotically stable inheritance of the
inactive state of genes. PcG bodies can be found in a
wide range of cell types from cancer cell lines to pri-
mary human and mouse cell types and tissue samples
from cancer patients. They are present throughout the
cell cycle, and they attach to chromosomes during mito-
sis, thereby providing a possible mechanism for epige-
netic gene silencing. PcG bodies are enriched in the
phosphorylated form of the PRC2 protein Bmi1. During
the past year, we identified a single site (S258) respon-
sible for the majority of Bmi1 phosphorylation. Inter-
estingly, mutation of single or multiple putative
phosphorylation sites did not prevent Bmi1 from local-
izing to PcG bodies. However, when stably expressed in
mouse embryonic stem cells devoid of the Bmi1 pro-
tein, the Bmi1 mutants lead to a misregulation of Hox
genes that are crucial for cellular differentiation and
embryonic development. This suggests that Bmi1 phos-
phorylation has a role in the regulation of Hox gene
expression. We have previously shown that tethering
H3K27 methyltransferase EZH2 to a genetic locus leads
to H3K27 trimethylation, gene silencing, and the for-
mation of a PcG body. We are currently expanding these
studies to regulate an endogenous gene. In conclusion,
we have developed several in vivo approaches to exam-
ine the dynamics of gene expression/silencing and DNA
repair in living cells. Ongoing studies will elucidate the
underlying principles of these dynamics and how they
can be manipulated in vivo to regulate gene expression.
Identification and Characterization of
Nuclear Retained Noncoding RNAs
H. Sunwoo, J. Wilusz
Although it has been generally assumed that most
genetic information is expressed as and transacted by
proteins, recent evidence from genomic tiling arrays and
large-scale cDNA-cloning projects suggests that the
majority of  transcriptional output of the mammalian
genome represents RNA that does not code for proteins.
These noncoding RNAs (ncRNAs) include microRNAs,
Piwi-interacting RNAs (piRNAs), and small nucleolar
RNAs (snoRNAs) as well as a significant number of
longer transcripts, most of whose functions are
with Matthew Porteus (University of Texas Southwestern
Medical School), we have used engineered chimeric zinc
finger nucleases (ZFNs) that combine the nonspecific
cleavage domain of the Fok I restriction enodnuclease
with custom-designed zinc finger domains, specific to
unique DNA sequences. Using this approach, we first
examined whether the cyan fluorescent protein (CFP)
gene encoded in our transgene array could be cleaved by
the ZFNs to induce double-stranded breaks (DSBs),
resulting in the recruitment of the DSB-repair nanoma-
chine to the reporter locus. To do so, we first transiently
transfected U2OS-2-6-3 cells with LacI-YFP (yellow
fluorescent protein) to visualize the locus and ZFN1 and
ZFN2 expression plasmids for 24 h. Only when both
ZFN subunits are expressed is a functionally active com-
plex formed. Deconvolution microscopy showed that
when both subunits of the ZFN were expressed, they
colocalized with the stably integrated locus containing
the CFP gene. Next, we were interested in determining
if the localization of the ZFNs at this specific site in the
human genome resulted in DSBs as indicated by the
recruitment of the NHEJ/HR repair machinery. We
expressed mCherry-53BP1, a well-validated upstream
factor that is recruited in multiple copies to the sites of
DSBs before repair is initiated, in cells that expressed
either one or both subunits of the wild-type ZFN. Impor-
tantly, we could observe accumulation of mCherry-
53BP1 at the LacI-EYFP-marked locus only when both
ZFN1 and ZFN2 subunits were expressed simultane-
ously, and not in the control cells that did not express
ZFNs or that expressed only ZFN1 or ZFN2 independ-
ently. In a similar experiment, we observed the localiza-
tion of endogenous phospho (Ser-32)-H2A.X, another
marker protein for DSB repair, at the locus by indirect-
immunofluorescence analysis, when LacI-mCherry,
ZFN1, and ZFN2 were expressed for 24 h in U20S-2-6-
3 cells. In summary, these experiments demonstrate that
ZFN technology can be applied to visualize DSB repair
at a single location in the genome/nucleus of mammalian
cells. Ongoing studies are focused on examining the
recruitment of other DNA-repair proteins, including
Ku80 and XRCC4, and visualizing the dynamics of
DNA damage and repair at the site of a single copy gene.
In addition to examining the dynamics of the gene
expression and DNA-repair machineries, we have also
been interested in the silencing of endogenous genes by
Polycomb (PcG) proteins. PcG group proteins can be
divided into members of the initiation complex PRC2
(Polycomb repressive complex 2), which is involved in
establishing gene silencing, and members of the main-
tenance complex PRC1, which maintain gene silencing
during cell division. Some members of the PRC1 com-
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unknown. These longer transcripts probably do not sim-
ply represent transcriptional “noise” because many have
been shown to exhibit cell-type-specific expression,
localization to specific subcellular compartments, and
association with human diseases. Therefore, the big and
largely unanswered question that we are trying to
address is, What are the functions of these long non-
coding RNAs? 
Using microarray analysis in collaboration with J.
Mattick’s laboratory (Institute for Molecular Bioscience,
University of Queensland, St Lucia, Australia), we have
examined ncRNAs whose expression levels change after
mouse C2C12 myoblasts differentiate into myotubes.
RNA fluorescence in situ hybridization (FISH) analysis
of candidate clones revealed one clone, corresponding
to the MEN ε/β locus, which is up-regulated 3.3-fold
upon myoblast differentiation to myotubes. Two ncRNA
isoforms are produced from a single RNA pol II pro-
moter, differing in the location of their 3′ ends. MEN ε
is a 3.2-kb polyadenylated RNA, whereas MEN β is a
~20-kb transcript containing a genomically encoded
poly(A)-rich tract at its 3′ end. These RNA transcripts
are broadly expressed in adult mouse tissues and con-
served among mammals. The 3′ end of MEN β is gen-
erated by RNase P cleavage similar to what we have
observed for MALAT1 (see below). The MEN ε/β tran-
scripts are localized to nuclear paraspeckles and directly
interact with the 54-kDa nuclear RNA-binding protein
(p54/nrb). Knockdown of MEN ε/β expression results in
the disruption of nuclear paraspeckles. Furthermore, the
formation of paraspeckles, after release from transcrip-
tional inhibition by DRB treatment, was suppressed in
MEN ε/β-depleted cells. Our findings indicate that the
MEN ε/β ncRNAs are essential structural/organiza-
tional components of paraspeckles. Ongoing studies are
examining the mechanism by which these ncRNAs are
retained in the nucleus and their potential function in
myoblast differentiation.
MALAT1 is a long ncRNA that was originally identi-
fied as a transcript whose expression predicted metastasis
of non-small-cell lung tumors and was sub se quently
shown to be overexpressed in many human cancers (for
review, see  Prasanth and Spector, Genes Dev. 21: 11
[2007]). This ncRNA came to our attention because it
specifically localizes to nuclear speckles. Previous stud-
ies from our laboratory had indicated that a population of
poly(A)+ RNAs was present in nuclear speckles, but the
precise RNAs have remained unknown. During the past
year, we became interested in whether small RNAs may
be generated from the MALAT1 locus. Our pursuit of this
question resulted in the identification of a previously
unrecognized 3′-end processing mechanism by which a
single nascent transcript can yield two ncRNAs with dis-
tinct subcellular localizations. We found that the previ-
ously reported ~7-kb MALAT1 transcript is actually
cleaved to produce a nuclear-retained ~6.7-nucleotide
transcript that is localized to nuclear speckles and a 61-
nucleotide RNA that is found exclusively in the cytoplasm
(and thus we named it mascRNA, MALAT1-associated
small cytoplasmic RNA). We have shown that the ~6.7-kb
nuclear-retained ncRNA is involved in regulating the level
of pre-mRNA splicing factors that are recruited to an
inducible genetic locus. Ongoing studies are examining
the mechanism by which this regulation is occurring.
Unexpectedly, the 61-nucleotide mascRNA was found to
fold into a cloverleaf structure that is recognized by RNase
P which cleaves its 5′ end, simultaneously generating the
3′ end of the mature MALAT1 transcript and the 5′ end of
mascRNA. Upon cleavage of the 3′ end of mascRNA by
RNase Z, CCA is added posttranscriptionally to its 3′ end.
The folding of mascRNA and the mechanism by which it
is cleaved indicate that it is a tRNA-like small RNA.
Although predicted to fold similarly to a tRNA cloverleaf
secondary structure, mascRNA has a poorly conserved
anticodon loop and it is not aminoacylated in vivo, sug-
gesting that it does not function as a classic tRNA. Addi-
tionally, unlike tRNAs that are transcribed by RNA pol
III, mascRNA is generated via processing of MALAT1,
an RNA pol II transcript. Although the 3′ end of MALAT1
is not generated by a classical cleavage/polyadenylation
mechanism, the mature MALAT1 transcript does have a
poly(A)-tail-like moiety at its 3′ end. This results from a
conserved short poly(A)-rich motif that is encoded in the
genome immediately upstream of the RNase P cleavage
site. These findings have revealed a new paradigm for
how the 3′ ends of certain RNA pol II transcripts are pro-
duced. In addition, they suggest a general mechanism by
which genetic loci are able to generate multiple ncRNA
transcripts, each of which localizes to different subcellu-
lar compartments. Together, these studies have provided
new insights into the generation and function of ncRNAs.
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The papillomaviruses are a group of viruses that infect
and transform the basal epithelium, inducing prolifera-
tion of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usually
regress after some time, but certain types of human papil-
lomaviruses (HPVs) give rise to tumors that are prone to
progress toward malignancy, especially frequently cervi-
cal carcinoma. Indeed, HPV infection appears to be a nec-
essary cause of invasive cervical carcinoma and thus
represents one of the few firmly established links between
viral infections and the development of cancer. 
An impediment to the study of papillomaviruses has
been the inability to define simple in vitro cell culture sys-
tems for analysis of the viral life cycle. These viruses nor-
mally require specialized differentiating cells that only
with difficulty can be generated in cell culture. However,
for a bovine papillomavirus (BPV-1), a convenient cell
culture system exists in which viral gene expression,
oncogenic transformation, and viral DNA replication can
be studied. Thus, BPV has become a useful model for
these aspects of the viral life cycle. The DNA replication
properties of papillomaviruses show some unique and
interesting characteristics. As part of their normal life
cycle, these viruses can exist in a state of latency that is
characterized by maintenance of the viral DNA as a multi-
copy plasmid in infected cells. The copy number of the
viral DNA is tightly controlled, and the viral DNA is sta-
bly inherited under these conditions. Papillomaviruses
therefore provide a unique opportunity for studying plas-
mid replication in mammalian cells. In addition, the viral
DNA replication machinery represents one of the most
promising targets for antiviral therapy.
In previous years, we have reported the characteriza-
tion of the papillomavirus replicon and the identification
of the viral components that are required for viral DNA
replication. In recent years, we have directed our atten-
tion toward the biochemical events that are associated
with initiation of DNA replication. We are studying the
biochemical properties of the viral E1 and E2 proteins
and how these two proteins interact with the viral origin
of DNA replication and with the cellular replication
machinery to generate initiation complexes. Our studies
demonstrate that the E1 protein has all of the character-
istics of an initiator protein, including ori recognition,
DNA-dependent ATPase activity, and DNA helicase
MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
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activity. The transcription factor E2, whose precise func-
tion has remained more elusive, appears to serve largely
as a loading factor for E1. Through direct physical inter-
actions with both E1 and the ori, E2 provides sequence
specificity for the formation of the initiation complex. 
We are currently attempting to elucidate how the E1
and E2 proteins orchestrate the precise biochemical
events that precede initiation of DNA replication at the
viral ori. These events include binding of the initiator to
the ori, the initial opening of the DNA duplex (melting),
and the assembly and loading of the E1 replicative heli-
case at the replication fork. Our studies so far indicate
that these activities are generated in an ordered process
that involves the sequential assembly of E1 molecules on
the ori. This sequential assembly generates different com-
plexes with different properties that in turn recognize ori,
destabilize the double helix, and function as the replica-
tive DNA helicase. 
ATP BINDING AND HYDROLYSIS BY
THE E1 INITIATOR PROTEIN
The E1 protein is a member of the AAA+ family of pro-
teins and can bind and hydrolyze ATP. The ATP-binding
pocket is formed between two adjacent subunits in E1
oligomers. Analysis of the structure of the E1 helicase and
oligomerization domain has revealed that a total of ten
residues are likely to be involved in ATP binding and
hydrolysis. To determine the precise function of these
residues in ATP binding and hydrolysis, we mutated them
to alanine, purified the mutant proteins, and analyzed them
for the ability to bind and hydrolyze ATP. All mutant pro-
teins were structurally intact based on their ability to form
the E1
2
E2
2
–ori complex, whose formation does not
require ATP. As expected, all of the mutants, with one
exception (Y534A), showed severe defects for ATPase
activity, demonstrating a defect in either binding or hydrol-
ysis of ATP. To distinguish between the ability to bind and
to hydrolyze ATP, we tested the mutants for E1 trimer and
double trimer (DT) formation, which requires ATP bind-
ing, but not hydrolysis. Six of the mutants—K425A,
K439A, S440A, D497A, Y499A, and R538A—were
defective for trimer formation, demonstrating that these
mutants are defective for ATP binding. The remaining four
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To test this hypothesis, we used the complete set of
mutants that we generated in the E1 ATP-binding pocket.
These ten residues are involved in nucleotide contacts for
ATP binding and hydrolysis. The mutants fall into two
groups: mutants in the A side that include the Walker A
and B elements and mutants in the B side that include, for
example, the arginine finger. We tested mutants on the A
side for effects on the half-life of the E1
2
E2
2
–ori complex
and found that the mutants K439A and S440A showed
only a slight increase in half-life in the presence of ATP,
consistent with a defect in binding ATP of these mutants.
In contrast, mutations on the B side (exemplified by
R538A) showed the same ATP-dependent increase in
half-life observed for wild-type E1, indicating that the B
side is not involved in binding ATP in the E1
2
E2
2
–ori
complex. These results indicate that ATP is bound exclu-
sively to the A side in the E1
2
E2
2
–ori complex, presum-
ably because the orientation of the two helicase domains
in complex with E2 does not allow the A and B sides of
E1 to interact. Another mutant, D478A in the Walker B
motif, has an altered conformation that mimics the ATP-
bound state even in the absence of nucleotide. We tested
this mutant for E1
2
E2
2
–ori complex formation in the
absence and presence of nucleotide. Interestingly, D478A
displayed a long half-life even in the absence of
nucleotide, consistent with the idea that it is the confor-
mation of E1 that controls the half-life of the E1
2
E2
2
–ori
complex. 
These data allow us to propose a mechanism for the
release of E2 from the E1
2
E2
2
–ori complex. When E1
and E2 are bound together in the presence of ATP, the
complex has a long half-life. If ATP is hydrolyzed and
released, the resulting short half-life would allow dis-
placement of E2. However, in order for the bound ATP
to be hydrolyzed, additional E1 molecules must be
added to generate an A–B interface that can hydrolyze
the bound ATP. We have previously demonstrated that
the ori contains four E1-binding sites (E1 BS) and that
only two of these, E1 BS 2 and 4, are occupied in the
E1
2
E2
2
–ori complex. Recruitment of additional E1 mol-
ecules is therefore likely to occur through binding of E1
to the E1 BS 1 and 3, which would allow the formation
of an A–B interface that is competent for ATP hydroly-
sis. Thus, the recruitment of additional E1 molecules
would serve as the trigger for the simultaneous dis-
placement of E2 and the assembly of larger E1 com-
plexes, such as the E1 DT.
To understand the mechanism by which ATP hydrol-
ysis might destabilize the E1
2
E2
2
–ori complex, we com-
bined structural information from two different sources.
The BPV E1 helicase domain structure in the absence and
presence of nucleotide is present in the E1 hexamer struc-
mutants—D478A, D479A, N523A, and Y534A—were
active for trimer and DT formation, demonstrating that
these mutants can bind ATP. Interestingly, two of these
mutants, D478A and N523A, showed significant DT for-
mation even in the absence of nucleotide, indicating that
these mutations generate a conformational change that
mimics the nucleotide-bound state. These results are
important because they demonstrate that the residues
required for ATP binding and hydrolysis in the hexamer
structure are identical to the residues that we find are
required for ATP binding and hydrolysis in the DT, clearly
demonstrating that the same mode of ATP binding is used
in both types of complexes.
INTERACTION BETWEEN THE E1 AND THE E2
PROTEINS IN THE E12E22–ORI COMPLEX
An interaction between the E1 and E2 proteins on the ori-
gin of DNA replication is essential for initiation of repli-
cation by papillomaviruses. This interaction provides
sequence specificity for E1 by inhibiting the nonspecific
DNA-binding activity present in the E1 helicase domain.
Although we have an excellent understanding of the
nature of the E1
2
E2
2
–ori complex from existing DNA
cocrystal structures of both the E1 DNA-binding domain
(DBD) and the E2 DBD, as well as a structure of the E1
helicase domain in complex with the E2 trans-activation
domain, we currently have a very limited understanding of
how this complex, which lacks replication-related activi-
ties, is subsequently converted into the larger E1 com-
plexes, such as the E1 DT, which can open up the DNA
duplex. We have previously been able to show that
although ATP is not required for the formation of the
E1
2
E2
2
–ori complex, ATP is required for the transition
from the E1
2
E2
2
–ori complex to larger complexes that
contain only E1. To analyze the effect of ATP on the
E1
2
E2
2
–ori complex, we performed experiments by meas-
uring the half-life of the E1
2
E2
2
–ori complex in the
absence and presence of nucleotide. Unexpectedly, the
half-life of the E1
2
E2
2
–ori complex is very short in the
absence of nucleotide (~3 min) and is extended signifi-
cantly in the presence of ATP (~16 min). ATP-γ-S, which
is hydrolyzed very slowly by E1, has an effect similar to
that of ATP, indicating that the longer half-life of the
E1
2
E2
2
–ori complex depends on nucleotide binding, but
not hydrolysis. These results show that the E1
2
E2
2
–ori
complex is capable of binding ATP but fails to hydrolyze
ATP, likely because the two E1 molecules in the E1
2
E2
2
–
ori complex are not oriented in a way that allows forma-
tion of the E1-E1 interface responsible for hydrolysis of
ATP. 
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ture. We aligned the BPV E1 structures with and without
nucleotide to determine which regions of the helicase
domain change in the presence of ATP. Two elements
change their conformation dramatically when the struc-
tures with and without ATP are compared. The first, the
β-hairpin, is involved in sequence-non-specific DNA
binding by the E1 helicase domain as we have recently
demonstrated, and the second element, loop 2, has
unknown function but shows protein contacts with the E2
activation domain in the E1E2 cocrystal structure. Inter-
estingly, loop 2 is in close proximity to the carboxy-ter-
minal part of the E2 activation domain, and in the ATP
bound state, loop 2 is oriented toward the E2 trans-acti-
vation domain, whereas in the absence of nucleotide, loop
2 is twisted away from the E2 trans-activation domain.
Loop 2 therefore represents a prime candidate for a trig-
ger that alters the half-life of the E1
2
E2
2
–ori complex in
response to ATP binding by E1. 
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Research continues to focus on the mechanism of initi-
ation of DNA replication in eukaryotic cells and how
specific states of gene expression are inherited from one
cell generation to the next. In rapidly proliferating cells,
such as cancer cells, the process of duplicating the cel-
lular chromosomes begins soon after the chromosomes
are separated during mitosis. Previous research has
demonstrated that four proteins, the origin recognition
complex (ORC), Cdc6, Cdt1, and the minichromosome
maintenance MCM(2–7) hexamer proteins, are required
for establishing a prereplicative complex (pre-RC) at
sites along the chromosomes, many of which are des-
tined to become origins of DNA replication in the S
phase of the cell division cycle, the phase at which DNA
synthesis occurs. Our studies this year have continued to
expand the role of the ORC in inheritance of chromo-
somes, particularly control of duplication of centro-
somes. We have also extended the relationship between
DNA replication proteins and other cellular processes
such as DNA repair, gene transcription, and assembly
of histones.
ORC AND CONTROL OF CENTROSOME
DUPLICATION
To maintain genome integrity, DNA and centrosomes
must be duplicated exactly once before cell division.
Centrosomes are the organelles in cells that organize
microtubules (MTs) for many cellular processes, includ-
ing mitosis. Unlike chromosomes, centrosomes are not
known to contain nucleic acid, and thus, how these pro-
tein complexes duplicate and how this process is con-
trolled are unclear. Centrosomes contain a core centriole
pair that duplicates to two linked pairs that later separate
and move to opposite poles before orchestrating the
mitotic MT spindle. Centriole pairs are surrounded by
pericentriolar material (PCM) that contains numerous
proteins. A number of years ago, we demonstrated that
the Orc2 subunit was associated with centrosomes, and
depletion of Orc2 causes cells to have multiple centro-
somes in cells that are arrested in mitosis. It is likely
that the multiple centrosomes in these mitotically
arrested cells were due to DNA damage caused by pro-
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gression though S phase in the absence of Orc2 because
the chromosomes in Orc2-depleted cells were substan-
tially abnormal and spindles were not attached to kine-
tochores. We have now demonstrated that another ORC
subunit, Orc1, has a critical role in controlling the dupli-
cation of centrioles and centrosomes, but in this case, it
does so in interphase.
First, by biochemical fractionation, Orc1, Orc2, Orc3,
Orc4, and Orc5 subunits were shown to be associated
with a centrosome-enriched fraction. Orc1 depletion
using RNA interference (RNAi)-based genetics affected
disengagement of duplicated centrioles and caused
overduplication of centrioles and centrosomes. Orc1
overexpression blocked the centrosome reduplication
that occurs during prolonged S-phase arrest in the pres-
ence of hydroxyurea, an inhibitor of DNA synthesis.
Localization to centrosomes by fusing Orc1 or a frag-
ment of Orc1 that was not capable of promoting DNA
replication to a known centrosome localization domain
from another protein was sufficient to block hydroxyurea
(HU)-induced centrosome and centriole reduplication. 
Cyclin E has been shown to be required for the dupli-
cation of centrosomes, and overexpression of cyclin E is
associated with genome instability and alterations in
centrosome numbers in cells. Overexpression of cyclin
E, but not cyclin A, overrode the Orc1 control of cen-
trosome reduplication. In contrast, we found that Orc1
localization to centrosomes was promoted by its binding
to cyclin A via a sequence in the amino terminus of the
Orc1 protein. Cotransfection of Orc1 with cyclin E or
cyclin A into human cells and immunoprecipitation of
Orc1 showed that both cyclin E and cyclin A were coim-
munoprecipitated, but only cyclin A bound directly to
Orc1 in vitro. We are currently determining how cyclin
E interacts with Orc1. Nevertheless, Orc1 blocked the
kinase activity of cyclin A–CDK and cyclin E–CDK
protein kinase activity in vitro.
Altogether, our data point to Orc1 as a regulator of
cyclin-E-dependent control of centriole and centrosome
reduplication. We propose that Orc1 is present in G
1
phase of cells, and once cyclin E has promoted one round
of centriole and centrosome duplication, Orc1 blocks its
activity. Cyclin E is known to promote the initiation of
DNA replication and thus the two events—duplication
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The cyclin-dependent protein kinases (CDKs) control
entry into S and M phases and activate initiation of
DNA replication by phosphorylation of two essential
DNA replication factors, Sld2 and Sld3. Studies in the
laboratories of H. Araki (National Institute of Genetics,
Japan) and J. Diffley (Clare Hall Laboratory, Cancer
Research UK) have separately shown that addition of
phosphate residues to Sld2 and Sld3 cause them to bind
to Dbp11, and the protein complex thus formed allows
recruitment of proteins such as Cdc45 to individual ori-
gins of DNA replication just before the initiation of
DNA replication at that locus. CDKs also contribute to
prevention of rereplication in a single S phase by phos-
phorylation of the pre-RC components ORC, Cdc6, and
MCM proteins, but CDKs are not sufficient for the acti-
vation of competent pre-RCs on chromosomes. A sec-
ond cell-cycle-regulated kinase, the Cdc7-Dbf4 kinase
(DDK; Dbf4-dependent protein kinase), is also required
for initiation at each origin and for monitoring DNA
damage as DNA synthesis progresses through S phase.
Our previous studies have shown that DDK phos-
phorylates multiple subunits of the MCM(2–7) hexamer
that is part of the pre-RC and, after activation of the pre-
RC, is part of the helicase at each DNA replication fork.
We have further shown that loading of Cdc45, a com-
ponent of the active helicase, requires activation of both
S-phase CDK and DDK. More recently, we have shown
that the principal and essential DDK substrate for initi-
ation of DNA replication is the Mcm4 subunit of the
MCM(2–7) helicase. DDK binds to Mcm4 via a specific
docking site, allowing cooperative phosphorylation of
multiple sites on an adjacent DDK target sequence. The
DDK target sequence lies at the very amino terminus of
the Mcm4 protein, in a domain that we call the NSD (N-
terminal serine/threonine-rich domain), which contains
51 serine residues within a 174-amino-acid unstructured
sequence. Complete deletion of the NSD allows cells to
grow without the DDK, but the cells grow very poorly.
Alternatively, deletion of a shorter region within the
NSD allows DDK bypass and better growth of cells.
This suggests that the Mcm4 NSD has both positive and
inhibitory sequences, and deletion of the inhibitory
sequences allows cells to proliferate in the absence of
DDK under normal growth conditions. But removal of
the NSD inhibitory region in Mcm4 causes cells to
become hypersensitive to inhibition of ribonucleotide
reductase by HU, suggesting that DDK has a second
function that is genetically separable, essential only in
the presence of DNA damage in S phase. We suggest
that this function is associated with the proposed role
for DDK in the intra-S-phase checkpoint that arrests S-
phase progression when sufficient DNA damage occurs
of chromosomes and control of centrosome copy num-
ber—are linked by common regulators (Fig. 1).
CONTROL OF THE INITIATION OF DNA
REPLICATION BY THE KINASE DDK
The assembly of a multiprotein pre-RC at each individ-
ual origin controls the initiation of DNA replication
within chromosomes of eukaryotes. ORC binds to DNA
sequences that define the initiation region within chro-
mosomes and recruits a series of proteins, including
Cdc6, Cdt1, and MCM proteins that make each origin
competent for subsequent initiation of DNA replication.
Such competence is established upon mitotic exit or in
G
1
phase in rapidly proliferating cells or in G
1
phase in
cells stimulated to enter cell division from quiescence.
At least two cell-cycle-regulated protein kinase sys-
tems are required for the initiation of DNA replication.
FIGURE 1 Model for the role of Orc1 in control of DNA replica-
tion licensing and centriole and centrosome reduplication. As cells
pass through the restriction point in G1 phase and commit to cell
division, Orc1 in the nucleus has either already participated in the
licensing of DNA replication origins or is acting in cooperation with
cyclin E to form pre-RCs at origins. Cyclin E also promotes cen-
triole duplication, possibly by allowing centriole disengagement.
If cyclin E persists, then it might promote centriole reduplication.
Cyclin E is normally transient, but there is a window of opportu-
nity when cyclin E is still present at centrosomes after normal cen-
triole duplication has taken place. During this time, before cyclin
E destruction, Orc1 could block cyclin E function at centrosomes,
thereby limiting centriole duplication to once per cell cycle. Orc1
localization to centrosomes could be facilitated by cyclin A pro-
moting nuclear export of Orc1 and localization to centrosomes.
Cyclin A also promotes the destruction of the bulk of Orc1 as cells
enter S phase, the same time that cyclin E is degraded. Once
cyclin E is degraded, the possibility of reduplication is lost
because cyclin A cannot induce centriole and centrosome redu-
plication if the duplicated centrioles are engaged. It is known that
cyclin A is involved in centrosome maturation later in the cell
cycle. (Reproduced from Hemerly et al. Science 323: 789 [2009].)
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during DNA replication. Consistent with this proposed
activity, we find that in a strain in which DDK is absent
due to the Mcm4 NDS deletion, the checkpoint kinase
Rad53 is no longer phosphorylated in the presence of
HU. Rad53 phosphorylation is indicative of an activated
intra-S-phase checkpoint.
By deleting the Mcm4 NSD inhibitory sequence with
altered forms of Sld2 and Sld3 (or Cdc45) that bypass
the requirement for CDKs for initiation of DNA repli-
cation, we show that cells can now initiate DNA syn-
thesis in G
1
phase in the absence of CDK and DDK. As
shown in J. Diffley’s laboratory, the requirement of S-
CDK for DNA synthesis can be bypassed by using an
sld3-dpb11 fusion (SD fusion) and overexpression of a
phosphomimetic sld2-T84Dmutation from a galactose-
inducible promoter. When the altered mcm4 allele is
combined with a CDC7 deletion in this strain, extensive
DNA synthesis occurs in α-factor-arrested cells that do
not have active CDK. Alternatively, a strain from H.
Araki’s laboratory containing a dominant CDC45muta-
tion Cdc45JET1 that can bypass essential CDK phospho-
rylation of Sld3 and containing GAL-sld2-11D (encod-
ing a galactose-inducible phosphomimetic form of Sld2)
can also initiate DNA replication in α-factor-arrested
cells when combined with the mcm4 NSD deletion in
the absence of DDK and CDK activity. 
By combining CDK and DDK bypass mutations, we
have shown that the only essential function of DDK for
initiation of DNA replication is to phosphorylate a key
region in the amino-terminal region of Mcm4, one of
the subunits of the MCM(2–7) hexamer. Thus, the only
essential role for DDK is to block an inhibitory
sequence within Mcm4. We do not know what this
inhibitory region does, but it is possible that it blocks
Cdc45 loading onto the MCM complex. The genetically
separable function of DDK that is not bypassed by the
MCM4 mutations is only apparent in the presence of
DNA damage (Fig. 2).
ROLE OF ABF1 IN NUCLEOTIDE
EXCISION REPAIR
Our prior research involved identification of cis-acting
DNA sequences and the corresponding trans-acting pro-
teins that are responsible for the initiation of DNA repli-
cation at specific loci in the yeast genome. One such
FIGURE 2 A model for coordinated control of initiation of DNA replication. The pre-RC, which consists of ORC, Cdc6, Cdt1, and MCM(2–7),
is assembled in G1 phase of the cell cycle and licenses the initiation of DNA replication in S phase. Activation of the pre-RC occurs by
the coordinated action of two protein kinase systems: the S-phase cyclin-dependent kinase (CDK) and the Dbf4-dependent Cdc7 kinase
(DDK). Essential CDK targets are Sld2 and Sld3 that then bind Dbp11 (Tanaka et al., Nature 445: 328 [2007]; Zegerman and Diffley,
Nature 445: 281 [2007]). The essential DDK target is the amino terminus of the Mcm4 subunit of the MCM(2–7) complex that eventually
becomes part of the helicase with Cdc45 and the GINS proteins. We have shown that DDK blocks an inhibitory activity in the amino ter-
minus of Mcm4. Phosphorylation of this region by DDK blocks inhibitory activity and promotes initiation of DNA replication.
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protein, called Abf1 (ARS binding factor 1), was identi-
fied as a protein that binds the B3 element of the yeast
ARS1 origin and stimulates the initiation of DNA repli-
cation at that locus. In collaboration with Simon Reed’s
laboratory (Cardiff University, UK), we have shown that
the Abf1 protein forms a stable complex with the Rad7
and Rad16 proteins, both of which are required for
nucleotide excision repair over the global genome (GG-
NER), a repair process that removes DNA damage from
nontranscribing DNA. Again, in collaboration with
Simon Reed’s laboratory, we have now shown that bind-
ing of ABF1 to its DNA recognition sequence found at
multiple genomic locations promotes efficient GG-NER
in yeast. GG-NER adjacent to Abf1-binding sites requires
the function of Rad7 and Rad16 proteins. 
At the ARS1 locus, Abf1 contributes with ORC to
position nucleosomes at specific positions on either side
of the origin of DNA replication, allowing the pre-RC to
form in a nucleosome-free region. The latest observa-
tions show that mutation of an ABF1-binding site at the
HMLα locus causes loss of ABF1 binding and results
in a domain of reduced GG-NER efficiency on one side
of the ABF1-binding site. Even though Abf1 binding at
this site has been prevented, nucleosome positioning at
this site was not altered. Thus, the stimulation of GG-
NER adjacent to Abf1-binding sites involves a direct
recruitment by Abf1 of proteins to these sites of DNA
repair. These studies extend the many activities of Abf1,
which include roles in the initiation of DNA replication,
transcriptional gene silencing, transcriptional activation
of gene expression, and now GG-NER.
INTERACTION BETWEEN PCNA AND
THE ELONGATOR COMPLEX
Another protein we discovered as an essential DNA
replication and repair protein is the proliferating cell
nuclear antigen (PCNA in mammalian cells and Pol30
in yeast Saccharomyces cerevisiae). PCNA is a DNA
polymerase clamp for DNA polymerase δ, and in addi-
tion to tethering this polymerase to the DNA replication
fork, it binds numerous other proteins, including chro-
matin assembly factor-1 (CAF-1), that deposit histones
onto two newly replicated or repaired DNA. CAF-1 in
turn cooperates with two other histone-binding chaper-
ones, Asf1 and Rtt106, to ensure efficient inheritance
of chromatin and stable states of gene expression, such
as silenced heterochromatin at silent mating-type genes
and at telomeres. The DNA replication or DNA-repair-
coupled nucleosome assembly pathway is also impor-
tant for maintenance of genome stability.
We have identified an interaction between the Elon-
gator histone acetyltransferase protein complex and the
DNA replication–coupled nucleosome assembly path-
way. Cells lacking Elp3 (K-acetyltransferase Kat9), the
catalytic subunit of the six-subunit Elongator complex,
partially lose gene silencing at telomeres and at the HMR
silent-mating-type locus and are sensitive to the DNA-
damaging agent HU. Like deletion of the ELP3, muta-
tions of each of the four other subunits of the Elongator
complex, as well as mutations in Elp3 that compromise
the formation of the Elongator complex, also result in
loss of silencing and increased sensitivity to DNA-dam-
aging agents. Genetic epistasis analysis indicates that the
elp3∆ mutant exacerbates the DNA-damage sensitivity
of cells lacking histone chaperone Asf1, as well as dele-
tion of the gene encoding the histone H3 lysine 56 (K56)
acetyltransferase Rtt109, but the elp3∆ deletion did not
enhance the phenotype in cells lacking CAF-1. Genetic
epistasis experiments with the elp3∆ mutant and muta-
tions in specific lysine residues in histone H3 and H4
suggested that Elp3 acts via acetylation of the amino-ter-
minal tail of histone H4. Previous biochemical studies
by other investigators suggested that residue K8 in his-
tone H4 is a target of the Elongator complex.
The results suggested that Elp3 functions in the same
genetic pathway as CAF-1 to maintain genome stability.
Biochemical support for this idea was obtained when
we demonstrated an interaction both in vivo and in vitro
between the Elongator complex and PCNA. Together,
the results have uncovered a new role for the Elongator
histone acetyltransferase complex in transcriptional
gene silencing and maintenance of genome stability, and
it does so in a pathway linked to DNA replication–cou-
pled nucleosome assembly. 
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Ubiquitin (Ub)-mediated proteolysis is a process in
which the covalent attachment of Ub to target proteins
signals their destruction by the 26 proteasome. The con-
trolled destruction of proteins by this system is used to
fine-tune the levels of proteins within the cell, allow
cells to rapidly alter their protein composition in
response to particular signals, and provide rigorous con-
trol and directionality to processes such as the cell cycle.
Our particular interest centers on how Ub-mediated pro-
teolysis regulates gene transcription. In recent years, a
body of evidence has accumulated suggesting that Ub,
the proteasome, and other components of the Ub sys-
tem are involved—directly and mechanistically—in the
regulation of gene activity. We are interested in under-
standing how the Ub system regulates transcription and
the consequences of this regulation for the control of
cell growth in normal and cancer cells. 
Research in our laboratory is divided in two areas.
To study the basic processes that connect the transcrip-
tion and Ub systems, we perform biochemical and
genetic experiments using the brewer’s yeast Saccha-
romyces cerevisiae as a model. To understand the bio-
logical significance of the intersections between these
systems, we study the human oncoprotein transcription
factor Myc.
REGULATION OF MYC BY UB-MEDIATED
PROTEOLYSIS 
Myc is a basic helix-loop-helix leucine-zipper tran-
scription factor that features prominently in the control
of cell growth. Capable of acting as both a transcrip-
tional activator and repressor, Myc controls the expres-
sion of genes required for cell growth and division.
Consistent with the type of genes that it regulates, Myc
is also is a major human oncoprotein that features in
~70,000 cancer deaths in the United States each year. 
Like many transcription factors, particularly those
involved in the control of cell growth, Myc is an unsta-
ble protein that is destroyed by Ub-mediated proteolysis.
Previous work in our laboratory has revealed that the
destruction of transcription factors such as Myc can be
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intimately connected to their ability to activate tran-
scription. Specifically, we have found that the same
domain in these proteins that allows them to activate
transcription is responsible for their destruction. We
have also found that, in some cases, transcription fac-
tors need to engage the Ub system and become ubiqui-
tylated in order to function. This intimate connection
between transcription factor activity and turnover has
two important ramifications. First, it predicts that com-
ponents of the Ub–proteasome system will be directly
and intimately involved in the control of gene expres-
sion. Second, it reveals that if we study the destruction
of transcription factors, we can learn not just about acti-
vator proteolysis, but also about activator function.
Thus, we believe that by probing the mechanisms
through which Myc is destroyed by the Ub system—the
elements involved, the cellular players that control Myc
turnover, and the pathways that govern Myc stability—
we can also gain new insight into how this enigmatic
human oncoprotein functions.
For example, we and other investigators have found
that adenovirus E1A can stabilize Myc during the
course of adenovirus infection. E1A is a prototypical
viral oncoprotein that functions to regulate the expres-
sion of both viral and cellular genes. The analysis of
E1A has been instrumental in revealing critical path-
ways that lead to cellular transformation. Although the
significance of E1A-mediated stabilization of Myc was
not known, the intimate connection between transcrip-
tion factor activity and destruction led us to speculate
that this stabilization must have a functional conse-
quence. In collaboration with the Hannon and Lowe lab-
oratories here at CSHL, we therefore investigated the
mechanism through which E1A stabilizes Myc and
probed the relationship of this mechanism to the func-
tion of the E1A oncoprotein. We found that 12S E1A,
when stably expressed in U2OS cells or in nontrans-
formed IMR90 human diploid fibroblasts, promoted the
accumulation of Myc protein. We subsequently showed
that E1A expression stabilizes Myc without affecting its
ubiquitylation, and that it does so via the transcriptional
coactivator p400. This was an interesting finding,
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because although the E1A–p400 interaction was known
to be important for E1A function, the downstream tar-
get of this interaction was unknown. The functional sig-
nificance of the E1A–p400–Myc nexus was demon-
strated by (1) the observation that Myc, like p400, is
essential for E1A to induce apoptosis, (2) the finding
that E1A can stimulate expression of Myc target genes,
and (3) the finding that in vitro transformation defects
that arise upon disruption of the p400-binding site in
E1A can be ameliorated by overexpression of Myc,
arguing that the essential function of this region of E1A
is to increase Myc protein levels. Taken together, these
data reveal that interaction of E1A with p400 leads to an
increase in the levels of p400, which in turn results in a
postubiquitylation stabilization of Myc and a subse-
quent activation of Myc target genes. In essence, E1A
(via p400) “hijacks” Myc to perform an important facet
of its activities. We are excited to learn about this novel
pathway of E1A function and keen to explore the mech-
anism through which E1A regulates p400 and through
which p400 modulates Myc.
THE ROLE OF THE UBIQUITIN–PROTEASOME
SYSTEM IN GENE ACTIVITY
Our original observation of the tight relationship
between transcriptional activation and Ub-mediated
destruction of transcriptional activators predicted that, at
some level, components of the Ub–proteasome system
would be involved in transcriptional regulation. During
the past several years, work from a number of groups,
including our own, has supported this prediction. For
example, we have found that Ub ligases can be recruited
to sites of transcription, where they perform essential
steps in gene activation, including driving postinitiation
changes in the entourage of RNA-polymerase-inter -
acting proteins. Other groups have found that Ub lig-
ases can promote coactivator exchange at promoters in
vivo, as well as target stalled RNA polymerases for
destruction to clear the path for successful gene tran-
scription following DNA-damage-mediated transcrip-
tional arrest. Moreover, ubiquitylation of histones has
been linked to transcriptional repression and shown to
participate in the regulation of covalent patterns of his-
tone modifications. Our ongoing studies in this area
continue to focus on the role of activator ubiquitylation,
but we are also studying ubiquitylation of histones, the
relationship between the Ub system and pre-mRNA pro-
cessing, and the role of the proteasome in gene activity.
We are particularly interested in characterizing novel
proteins that directly connect the transcription and Ub
systems. To this end, we surveyed the literature for
examples of proteins with probable links to both sys-
tems. This analysis led us to rA9, a mammalian protein
that was identified by Dr. Jeff Corden in a two-hybrid
screen for factors that bind the carboxy-terminal domain
(CTD) of Rpb1, the largest subunit of RNA polymerase
II (pol II). rA9 contains a carboxy-terminal domain that
binds the CTD (CTD-binding domain, CBD), as well as
a series of “SR repeats,” commonly found in splicing
factors. Interestingly, we observed that rA9 also con-
tains a RING finger and a PHD domain, both of which
are associated with Ub ligase activity. The combination
of CTD binding and potential E3 activities in rA9 sug-
gested to us that it may function as a Ub ligase within
the context of transcription.
To study rA9, we asked whether a related protein is
present in the yeast S. cerevisiae. Although BLAST
searches failed to identify homologous proteins in yeast,
we were able to identify sequences that have small, but
significant, homology with the CBD in a variety of
organisms, including fungi. Within these proteins, the
region of CBD homology is located at the carboxyl ter-
minus of the protein, and—remarkably—the majority
contain either an amino-terminal RING finger or a
RING/PHD combination. We refer to proteins with this
architecture as “RC” (RING/CBD) or “RPC” (RING/
PHD/CBD) proteins (Fig. 1). The single RPC member
we chose to study in S. cerevisiaewas Asr1, a nonessen-
tial protein that has been implicated in the alcohol stress
response. 
Our studies of Asr1 have found that it is an active Ub
ligase that binds directly to pol II via the CTD of Rpb1.
We found that interaction of Asr1 with the CTD is
dependent on Ser-5 phosphorylation within the CTD, an
important observation because this phosphorylation
event occurs commensurate with the initiation of tran-
scription. Asr1 thus has the ability to hone in on the pop-
ulation of pol II that is actively engaged in gene
expression. Binding of Asr1 to pol II results in the ubiq-
uitylation of at least two subunits in the enzyme, Rpb1
and Rpb2. These ubiquitylation events, in turn, result in
the specific ejection of two additional pol II subunits,
Rpb4 and Rpb7 (Fig. 2), and are associated with inacti-
vation of polymerase function. The ability of Asr1 to
specifically interact with a discrete subset of pol II mol-
ecules demonstrates how a component of the Ub–pro-
teasome system can “sense” the modification status of
a basal transcription factor and act to alter its subunit
composition. Asr1 is thus one of the most explicit exam-
ples of how the transcription and Ub systems can inter-
sect. Importantly, our study of Asr1 also demonstrates
how ubiquitylation can modulate the composition of a
large, multiprotein, complex such as pol II. Ongoing
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H. sapiens rA9
G. gallus RPC
D. rerio RPC
S . purpuratus RPC
T. castaneum RPC
D. melanogaster RPC
N. crassa RPC
G. zeae RPC
S . pombe RPC
K. lactis RPC
S . cerevis iae Asr1
B
G. zeae XP_386932  
N. crassa XP_958606  
A. nidulans EAA61345 
A. gossypii NP_983051  
K. lactis XP_452901  
R . norvegicus AAC52658 (rA9)   
H. sapiens NP_065925 (rA9)  
S . cerevis iae NP_015418 (Asr1)  
S . pombe NP_588450  
A
FIGURE 1 The RPC group of proteins. (A) Clustal W alignment
of CBD segments from the indicated species. (B) Architecture of
RPC proteins. Proteins are depicted to scale. RING and PHD
domains are dark gray, and the CBD is medium gray. RS
domains are shown in light gray. 
FIGURE 2 Asr1-mediated ubiquitylation excludes Rpb4/7 from the RNA polymerase II (pol II) complex. (A) Asr1–TAP purification. TAP
purification was performed on extract from either untagged yeast (negative control) or yeast carrying TAP-tagged Asr1. The indicated
proteins were identified by mass spectrometry of individual bands and by shotgun analysis in solution. (B) The Asr1 complex is devoid
of Rpb4/7. Increasing amounts of Rpb1–TAP complexes were run against an Asr1–TAP preparation and probed for Rpb1, Rpb4, and
Rpb7 by Western blotting (WB). (C) Asr1 can bind pol II that includes Rpb4. Yeast extract was run over an MBP–Asr1 column, and the
indicated pol II subunits were detected by WB. Asr1–TAP and Rpb1–TAP complexes are shown for comparison. (D) The Ub ligase
activity of Asr1 excludes Rpb7 from the pol II complex. Purified pol II complexes were ubiquitylated by Asr1 and Rpb7-HA recovered
by immunoprecipitation (IP; BSA is the negative control). Coprecipitating Rpb1 complexes in the IP or supernatant (SN) were detected
by WB. (E) The RING finger of Asr1 is required to exclude Rpb4 and Rpb7 from the Asr1 complex. Asr1 and the indicated mutants were
immunoprecipitated from yeast and probed for pol II subunits by WB.
A B
D E
C
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studies are probing how negative regulation of pol II by
these ubiquitylation events impacts control of gene
expression in yeast and mammalian cells.
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CANCER: SIGNAL TRANSDUCTION
Signal Transduction focuses on signaling pathways and cell architecture in normal and cancer cells.
Yuri Lazebnik and colleagues study cell fusion in the context of the hypothesis that viruses and other
common human pathogens might cause cancer under certain conditions. They have established that
massive chromosomal instability can be engendered by a transient event causing genomic destabiliza-
tion without permanently affecting mechanisms such as mitosis or proliferation. The agent, in this
instance, is an otherwise harmless virus that causes chromosomal disruption by fusing cells whose cell
cycle is deregulated by oncogenes. The resulting cells had unique sets of chromosomes and some
proved to be capable of producing aggressive epithelial cancers in mice. This year, Lazebnik’s lab devel-
oped a means of producing hybrid cells more efficiently. Rather than use live viruses to in duce fusion, they
perfected a method of isolating viral fusogenic proteins. Using these to induce fusion under controlled
conditions, they are now exploring the consequences of cell fusion for cell viability and survival.
Changes in tissue architecture are often the first signs of cancer, but very little is known about the
genes, proteins, and pathways that regulate cellular shape and polarity. Senthil Muthuswamy has devel-
oped a new paradigm for investigating this aspect of cancer biology. Using so phisticated model systems
such three-dimensional cell culture platforms and transgenic mice, his team recently found that a pro-
tein called Scribble normally coerces breast epithelial cells into the correct organization and shape and
enforces resistance to cancer. Scribble is frequently missing in human breast cancer lesions, Muthu -
swamy’s team found, which suggests that it could be an appropriate target for therapies aimed at pre-
venting precancerous lesions from becoming invasive. The lab has also identified new drug targets in
patients with tumors that do not respond to chemo therapy. They identified an enzyme called Brk, which
is overproduced in patients with HER2-positive tumors and helps them to become resistant to drugs
such as Herceptin. 
Darryl Pappin’s lab develops chemical and computational methods for analysis of proteins and pep-
tides. These constitute fundamental tools for proteomics and can be applied across many fields of bio-
logical investigation. Proteins and peptides are typically analyzed via mass spectrometry, a method that
involves fragmenting samples by colliding them with gas atoms in a vacuum; masses of the resulting
fragments are measured, and computer algorithms match re sults with known or predicted molecules
whose amino acid sequences are either known or inferred. Pappin has developed search engines for
mass spectrometry data that enable investigators to sift hundreds of thousands of experimental spectra
at a time for database matches. He also seeks to reduce sample complexity via an approach he calls
chemical sorting. This includes the use of chelation to enrich phosphopeptides from the total peptide pool
and the use of specific affinity-tagged small-molecule inhibi tors to segregate classes of kinases or phos-
phatases for more specific mass spectroscopic analysis.
Jacek Skowronski and colleagues study mechanisms involved in the induction of AIDS by human
and simian immunodeficiency viruses (HIV and SIV), focusing on the function of accessory proteins called
Nef, Vpr, and Vpx. These virulence factors modify the cellular milieu to disrupt adaptive responses and/or
innate antiviral responses and provide an en vironment conducive for viral replication. This year, Skowron-
ski and colleagues discovered new details about how a simian strain of the AIDS virus replicates in
macrophages, a type of immune system cell. The study re veal ed how Vpx enables efficient reverse tran-
scription in the simian virus and thus overcomes an innate block that otherwise prevents viral replication.
This suggests a strategy by which a future drug might interfere with the reproductive machinery of the
virus to prevent or limit is ability to spread. 
Despite their large variety of genetic abnormalities, cancer cells have been found to be extremely sen-
sitive to the reversal of certain mutations. Raffaella Sordella and colleagues study why cells in certain
cancers are responsive to the inhibition of one particular gene or gene product. Why, for instance, do non-
small-cell lung cancer cells that have a particular epidermal growth factor (EGF) receptor mutation
respond dramatically to its inhibition by the drug Tarceva? This occurs in 15%–20% of patients, the great
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majority of whom, within 1–3 years, develop resistance. Various mutations have been implicated in about
half of resistant pa tients. Sordella and colleagues are focusing on as yet unidentified mechanisms of
resistance at work in other cases. They have preliminary in vitro data indicating a genetic signature pre-
dicting positive response to other treatment modalities. With colleagues at the National Institutes of
Health, they are testing this hypothesis in tumor samples taken from relapsed patients. 
Nicholas Tonks and colleagues study a family of enzymes called protein tyrosine phosphatases, or
PTPs, that remove phosphate groups from other proteins. By changing the phosphorylation state of pro-
teins, PTPs can profoundly affect the health of entire organisms. Tonks’ group seeks to characterize fully
the PTP family, understand how their activity modifies signaling pathways, and how those pathways are
abrogated in serious illnesses, from cancer to Parkin son’s disease. The overall goal is to identify new tar-
gets and strategies for therapeutic intervention in human disease. This year, the lab made progress in
characterizing mice in which the gene encoding JSP-1 (JNK stimulatory phosphatase 1) has been
ablated, helping to define the role of this phosphatase in regulating a critical signaling pathway in Parkin-
son’s disease. In collaboration with the Muthuswamy lab at CSHL, they also investigated new roles for
PTPs in regulating signaling events in breast cancer and have identified three PTPs as potential novel
tumor suppressors.
Several years ago, Lloyd Trotman discovered that the loss of a single copy of a master tumor-sup-
pressing gene called PTEN is sufficient to permit tumorigenesis in animal models of prostate cancer. His
team later found that complete loss of PTEN triggers senescence, a quiescent state that delays or blocks
cancer development in affected cells. Recently, the lab has been exploring the impact of varying PTEN
expression levels, alone and in conjunction with changes in other potent tumor suppressors, including
p53, in mouse models for prostate cancer. They have studied how the PTEN protein is transported into
and out of the cell nucleus and have sought out specific transport receptor proteins, identifying several
strong candidates. They have also worked to validate their cancer progression scheme in human prostate
cancer biopsy samples from the Memorial Sloan-Kettering Cancer Center, with the aim of identifying
patients who have developed tumors with metastasis-favoring mutations.
Linda Van Aelst’s lab studies how aberrations in intracellular signaling involving enzymes called small
GTPases can result in disease. They are particularly interested in Ras and Rho GTPases, which help to
control cellular growth, differentiation, and morphogenesis. Alterations affecting Ras and Rho function are
involved in cancer and various neurodevelopmental disorders. This year, Van Aelst’s team extended their
study of mutations in a Rho-associated gene called oligophren in-1, determining how they are linked to
dysfunctions in the glutamate pathway, specifically to maturation and plasticity of excitatory glutamater-
gic synapses; they are probing the implications for several illnesses. Separately, they have demonstrated
that a GTPase activator called DOCK7, previously shown to have a central role in axonal development
and morphology, is important in neuronal migration and may be involved in defects in migration that
cause developmental illness.
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During the last year, we continued to test a hypothesis
that we proposed previously. This hypothesis suggests
that viruses can contribute to carcinogenesis and tumor
progression by fusing cells. Two consequences of such
fusion are of particular interest. One is an abnormal
combination of properties in a cell that is derived from
fusion of cells with distinct properties, such as a trans-
formed cell and a bone marrow stem cell. Another con-
sequence is chromosomal instability, which is a poorly
understood consequence of cell fusion and a hallmark of
many solid cancers. We previously demonstrated that
fusing premalignant cells could produce cells that form
aggressive cancers in mice.
This last year, we focused on understanding the rules
that determine the fate of cell hybrids, which was done
for two reasons. One was our intent to facilitate pro-
duction of cell hybrids that we needed for a variety of
experiments. Another, that the fate of fused cells in the
body and even in the dish is surprisingly poorly under-
CELL-TO-CELL FUSION AS A LINK BETWEEN
VIRUSES AND CANCER
Y. Lazebnik A. Gottesman
stood, even though cell hybrids have been implicated in
carcinogenesis and are used as a tool of stem cell ther-
apy. One reason for this gap is the lack of an adequate
experimental system. Therefore, during the last year, we
developed a system in which an increase in ploidy,
induced either by cell fusion or by inhibiting cytokine-
sis, induces apoptosis and, if apoptosis is prevented,
inhibits clonogenic survival of the cells. We used this
system to outline the pathways that link the ploidy
increase to apoptosis and found that this link does not
involve the elements implicated previously and is likely
to be mediated by yet-to-be characterized pathways. We
established that apoptosis in this system can be induced
through at least two pathways and we will proceed to
dissect them.
Overall, we hope that our research will help to
develop an experimental framework to test the role of
cell fusion, ploidy increase, and chromosomal instabil-
ity in cancer. 
Yuri Lazebnik
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We are beginning to get significant insight into genes
that are altered in breast cancer, but there is almost a
complete lack of understanding of the molecular mech-
anisms that regulate the development and progression
of premalignant lesions. Pathologists use a number of
criteria to diagnose and predict prognosis of breast can-
cer. Salient among them are changes in cell number and
changes in cell and tissue architecture. Although we are
beginning to understand a lot about the mechanisms that
regulate cell proliferation, very little, if anything, is
known about the mechanisms that regulate disruption
of cell and tissue architecture. The long-term goal of our
laboratory is to gain fundamental insights into the mech-
anisms that regulate changes in cell architecture during
the development and progression of premalignant
lesions. These studies focus on an unexplored area of
cancer biology that is likely to open new avenues for
cancer diagnosis and therapy, including identification
of biomarkers and strategies for treatment of patients
with premalignant and malignant disease.
Epithelial cells within a normal breast are organized
into ducts and lobules. Each lobule consists of many indi-
vidual units referred to as an acinus. Within an acinus is
a layer of luminal and myoepithelial cells surrounding an
empty lumen. The epithelial cells surrounding this lumen
have an asymmetric distribution of membrane proteins
where the membrane that is in contact with lumen,
referred to as the apical surface, is rich in glycoproteins
and microvilli, and the membrane that is in contact with
the neighboring cell or the surrounding tissue is rich in
cell–cell and cell–matrix junctions and referred to as
basolateral surface. This characteristic organization is lost
early in premalignant disease and the tissue continues to
loose its structure and organization during progression to
malignancy. Surprisingly, we know little about what role
these changes have during the cancer process and, more
importantly, if the changes observed in premalignant
lesions are harbingers of what is yet to come.
The molecular mechanisms by which the epithelial
cells establish and maintain polarity is an active area of
investigation. Current understanding suggests that several
proteins and protein complexes function as a highly inter-
active network during establishment and maintenance of
EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy D. Akshinthala A. Lucs
V. Aranda M. Nolan
K. Bergami A. Rosenberg
S. Chatterjee L. Zhan
epithelial cell polarity. One such complex, Par6/aPKC/
Cdc42, regulates polarization processes during epithelial
morphogenesis, astrocyte migration, and axon specifica-
tion. We find that expression of Par6 in mammary epithe-
lial cells induces epidermal-growth-factor-independent
cell proliferation and development of hyperplastic three-
dimensional acini without affecting apical-basal polarity.
This was dependent on the ability of Par6 to interact with
aPKC and Cdc42 but not Lgl and Par3 and its ability to
promote sustained activation of MEK/Erk signaling.
Interestingly, Par6 is overexpressed in estrogen-receptor-
positive primary human breast cancers and in endoplas-
mic reticulum (ER)-expressing precancerous breast
lesions. Thus, deregulation of Par6 in early lesions may
provide proliferative lesions, although it may a have a role
during cancer progression by cooperating with other
oncogenic events. Whether Par6β itself or the pathways it
regulates will be excellent candidates for predictive bio-
markers or drug targets for premalignant lesions remains
to be determined.
We recognize that epithelial cells grown in traditional
monolayer cultures on plastic dishes do not have the
three-dimensional structural features observed in breast
tissue. We reason that activation of oncogenes within the
context of the three-dimensional acini is likely to serve
as an ideal platform for identifying mechanisms by
which oncogenes disrupt cell architecture and acinar
structure. We have previously shown that activation of
the oncogenic receptor tyrosine kinase ErbB2 within the
three-dimensional acinus initiated disruption of cell
polarity by disrupting the Par polarity complex. The lat-
ter is a major discovery because it identified, for the first
time, that oncogenes can directly interact with polarity
protein complexes. Inhibition of the interaction between
ErbB2 and the Par complex blocked the ability of ErbB2
to disrupt cell polarity, identifying polarity proteins as
critical regulators of the oncogenic process. These find-
ings also showed that regulators of normal cell polarity
can join the “dark side” and be involved in the biologi-
cal process that regulates carcinoma.
During the past year, we asked whether changes in
polarity proteins function as modulators of cancer by
themselves and not just function as downstream effec-
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identified, are thought to regulate various aspects of cell
polarity. Furthermore, the precise nature of the onco-
gene-induced changes in the cell polarity protein com-
plex remains to be understood. The likelihood of
identifying signaling pathways unique to altered polarity
proteins is very high because most of the polarity gene
products have domain structures consistent with their
function as signaling scaffolding molecules.
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tors of oncogenic signaling. We find that in primary
human breast cancers, genes encoding polarity proteins
such as Par6 are amplified and overexpressed and, fur-
thermore, that polarity proteins such as Scribble are mis-
localized in primary human breast tumors. We dis- 
covered that knock down of Scribble in mammary
epithelia disrupts cell polarity, blocks three-dimensional
morphogenesis, inhibits apoptosis, and induces dyspla-
sia in vivo that progresses to tumors after long latency.
Knockdown of Scribble also cooperates with oncogenes
such as Myc to transform epithelial cells in three-dimen-
sional acini and induce tumors in vivo by blocking acti-
vation of an apoptosis pathway. Like knockdown,
mislocalization of Scribble from the cell–cell junction
was sufficient to promote cell transformation. Interest-
ingly, spontaneous mammary tumors in mice and
humans possess both down-regulated and mislocalized
Scribble, suggesting a selection pressure for Scribble
inactivation. Thus, we have discovered that Scribble is a
novel regulator of breast cancer and that deregulation of
the polarity pathways promotes dysplastic and neoplas-
tic growth in mammals by disrupting morphogenesis
and inhibiting cell death. 
Research in our laboratory thus provides the strongest
support to date, by far, for the hypothesis that cell polar-
ity pathways have critical roles during initiation and pro-
gression of breast cancer. However, we have only
scratched the surface. In addition to the two polarity pro-
teins analyzed, more than 45 genes, and more likely to be
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Our interest lies in understanding the molecular mech-
anisms that underlie the pathogenesis of AIDS and, in
particular, understanding the functional consequences
of interactions between viral proteins and the regulatory
machineries in the infected cells. The main focus of our
research is to understand the functions of Nef, Vpr, and
Vpx accessory virulence factors of human and simian
immunodeficiency viruses (HIV and SIV). We have
directed a major effort toward the identification of
mechanisms and downstream effectors that mediate the
effects of Nef and Vpr in the infected cells, and our
experiments have been concentrated in two main areas. 
One major focus has been on the isolation and identi-
fication of cellular proteins that mediate the effects of Nef
on signal transduction and endocytic machineries. This has
led to the purification and microsequencing of several cel-
lular factors that associate with Nef in T lymphocytes.
Importantly, one of the Nef targets is a critical molecular
switch that regulates Rac GTPases downstream from
chemokine- and antigen-initiated signaling pathways. This
interaction enables Nef to influence multiple aspects of T-
cell function and thus provides an important mechanism by
which Nef impacts pathogenesis by primate lentiviruses. 
The other major focus has been on identification of
downstream effectors of lentiviral Vpr and Vpx acces-
sory proteins. These experiments have led to the
description of several novel cellular proteins that tightly
associate with these factors in hematopoietic cells.
Among them are E3 ubiquitin ligase complexes that reg-
ulate cell cycle progression and the repair of damaged
DNA. The observation that Vpr tightly associates with
E3 ubiquitin ligase components is interesting because
HIV replication is known to be restricted by protein
ubiquitination. Remarkably, we found that both the Vpr
and Vpx proteins target a novel substrate adaptor for
Cullin 4 and function through their associated Cullin-4
E3 ubiquitin ligase complexes. Here, we describe in
more detail our studies of lentival Vpr.
FUNCTIONS OF VPR AND VPX LENTIVIRAL
ACCESSORY FACTORS
Vpr and Vpx are multifunctional virion-associated acces-
sory proteins of simian and/or human immunodeficiency
CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Gierszewska
K. Hrecka
S. Srivastava
viruses (HIV-1, HIV-2, and SIV). One function of HIV-1
Vpr is to mediate translocation of viral reverse transcrip-
tion complexes into the nucleus in nondividing cells, such
as terminally differentiated macrophages. The other is to
perturb the cell cycle progression of the infected cell.
Both functions are thought to be important for facilitat-
ing the HIV-1 life cycle in the infected host. Unlike HIV-
1, which possesses only the vpr gene, HIV-2 and SIVmac
viruses specify both the vpx and a closely related vpx
gene. The Vpr proteins encoded by SIV and HIV-2 block
cell cycle progression in the G
2
/M phase similar to HIV-
1 Vpr but do not have the ability to promote nuclear trans-
port of the preintegration complexes in nondividing cells.
Interestingly, Vpx proteins are strictly required for the
abilities of viruses of HIV-2/SIVsm lineages to transduce
monocyte-derived cells. This probably reflects the ability
of Vpx to overcome an as yet uncharacterized block to
an early event in the virus life cycle in these cells, but the
underlying mechanisms have remained elusive. Because
Vpx and Vpr function as adaptor proteins, we thought to
identify cellular proteins that they bind, to obtain novel
insights into their functions.
VPX AND VPR ASSOCIATE WITH CATALYTIC AND
REGULATORY COMPONENTS OF CULLIN-4-BASED
E3 UBIQUITIN LIGASE COMPLEXES 
We used a combination of biochemical and proteomic
approaches to identify cellular proteins associated with
human and simian Vpx/Vpr proteins. Briefly, Vpx (or
Vpr) and its associated proteins was purified from cells
by two sequential immunoprecipitations and analyzed
by multidimensional protein identification technology
(MudPIT). MudPIT is a combination of chromato-
graphic and mass spectrometric procedures that allow
unbiased and sensitive identification of proteins in com-
plex mixtures. These experiments were performed in
collaboration with Drs. Michael Washburn, Laurence
Florens, and Selene Swanson of Stowers Institute for
Medical Research (Kansas City, Kansas). 
The MudPIT analysis identified three relatively
abundant polypeptides—DDB1, DDA1, and VprBP/
DCAF1—that were specifically and abundantly associ-
ated with SIVmac Vpx and with HIV-1 and SIVmac Vpr
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proteins. DDB1 is an obligatory subunit of all known
E3 ligase complexes assembled on a Cullin-4 (Cul4)
scaffold. VprBP/DCAF1, a known HIV-1 Vpr-binding
protein recently shown to bind DDB1, is thought to
function as one of many substrate receptors that recruit
cellular proteins for ubiquitination by the E3 enzyme.
DDA1 was also shown to bind DDB1 and has been
implicated for regulation of E3 ligase catalytic activity.
Thus, our findings tentatively linked Vpx to Cul4 RING
E3 (Cul4 E3) ubiquitin ligases. 
Our subsequent biochemical studies revealed that
DDA1, DDB1, and VprBP/DCAF1 form a ternary com-
plex, which is then targeted by Vpx, and that this complex
links Vpx proteins to the catalytic core of the ubiquitin lig-
ase organized on the Cul4 scaffold. The notion that Vpx
proteins target a Cul4-based E3 ubiquitin ligase is inter-
esting because previous evidence indicated that replica-
tion of primate lentiviruses is restricted to some extent by
protein ubiquitination. These findings raised the possibil-
ity that Vpx/Vpr promotes lentivirus replication by mod-
ulating protein ubiquitination in infected cells.
VPX USURPS VPRBP/DCAF1 TO ENABLE
MACOPHAGE TRANSDUCTION BY SIVMAC 
The ability of Vpx to enable infection of primary
macrophages is well documented, yet the immediate
downstream mediator(s) of Vpx remains unknown.
Therefore, experiments were performed to assess
whether the interaction with VprBP/DCAF1 and its
associated E3 complex is important for Vpx’s ability to
facilitate macrophage transduction by SIVmac 239.
Because this function is probably mediated by the
virion-bound Vpx molecules, we first identified Vpx
amino acid substitutions that disrupt binding to
VprBP/DCAF1 without negatively affecting Vpx incor-
poration into SIVmac 239 virions. Next, we measured
the abilities of virions containing wild-type or VprBP/
DCAF1 binding-deficient Vpx proteins to transduce
human monocyte-derived adherent macrophages. We
found that wild-type Vpx stimulated macrophage trans-
duction by up to 100-fold, whereas Vpx failed to support
macrophage infection, even though the mutant Vpx
molecules were efficiently incorporated into the virions.
In contrast, both viruses displayed similar infectivities to
primary CD4+ T lymphocytes and Jurkat T cells, indi-
cating that Vpx is required specifically for transduction
of primary macrophages. Subsequent experiments using
HIV-2 Vpx yielded similar results. These findings link
the ability of HIV-2/SIVmac Vpx to enhance macro -
phage transduction to its interaction with VprBP/
DCAF1 and its associated E3 ubiquitin ligase complex. 
VPX USES VPRBP/DCAF1 TO SUPPORT REVERSE
TRANSCRIPTION OF SIVMAC IN MACROPHAGES
To assess at which stage in the lentivirus life cycle the
replication of Vpx-deficient virus is arrested, we exam-
ined the effect of VprBP/DCAF1-binding-defective Vpx
proteins on reverse transcription (RT) of the incoming
SIVmac genomes. Interestingly, we found that RT was
defective following infection with virions lacking, or
containing mutant, Vpx proteins. Specifically, in these
cases, the steady-state levels of the early strong-stop
RTs, U3, gag, and late RTs were approximately tenfold
to 1000-fold lower compared to infections with virions
containing wild-type Vpx. Importantly, Vpx was not
required for efficient RT following infection of Jurkat T
cells. Together, these observations indicate that Vpx is
required for events that lead to an efficient initiation and
progression of RT of the SIVmac genome in macro -
phages and thus define a new function for lentiviral
Vpx.
VPRBP/DCAF1 MEDIATES MACROPHAGE
TRANSDUCTION BY SIVMAC
To obtain further insight into the role of VprBP/DCAF1,
we knocked down its expression in macrophages by
RNA interference (RNAi). We found that nontargeting,
negative control, small interfering RNAs (siRNA)
decreased transduction efficiencies by only approxi-
mately 30%, and the magnitude of this effect was con-
stant over a wide range of siRNA concentrations. These
observations indicate that nonspecific engagement of
RNAi machinery had only a minor negative effect on
macrophage transduction by SIVmac 239. In contrast,
RNAi to VprBP/DCAF1 decreased transduction effi-
ciency by approximately tenfold to 100-fold, in a dose-
dependent manner. As expected, the inefficient
transduction was associated with a very inefficient
reverse transcription of the incoming viral RNA. Of
note, VprBP/DCAF1 depletion in U2OS cells did not
compromise transduction of these cells by the SIVmac
virus regardless of the presence or absence of Vpx.
Together, these data indicate that VprBP/DCAF1 is
required for efficient RT of lentiviruses possessing Vpx
in primary macrophages.
TENTATIVE MODELS FOR THE VPX FUNCTION
Our findings support a model in which Vpx usurps the
Cul4 E3 ubiquitin ligase using the VprBP/DCAF1 to
overcome a block to lentivirus replication upon its entry
into monocyte-derived cells. How does Vpx facilitate RT
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in macrophages via its interaction with VprBP/DCAF1?
We initially considered that the VprBP-linked Cul4 E3
complex restricts SIVmac infection in macrophages and
that Vpx counters the restriction by inhibiting catalytic
activity of this E3. However, our data from RNAi exper-
iments reveal that VprBP/DCAF1 is not required for the
restriction to occur and, therefore, do not support this
possibility. Furthermore, the incoming virions probably
contain at most only several hundred Vpx molecules,
similar to Vpr, which is also virion recruited through its
interaction with Gag p6. Therefore, it is difficult to envi-
sion that the limited amounts of virion-bound Vpx would
be able to saturate and inhibit the cellular pool of
VprBP/DCAF1-associated Cul4 E3 complexes, even by
a noncompetitive mechanism.
Our evidence indicates that instead of blocking SIV-
mac replication, VprBP/DCAF1 is required for Vpx to
overcome the block, implying that Vpx uses
VprBP/DCAF1-associated E3 to enable RT in macro -
phages. Notably, the same VprBP/DCAF1-associated
ubiquitin ligase is targeted by a Vpx paralog Vpr that
stimulates the intrinsic catalytic activity of this E3. Our
findings that both Vpx and Vpr interact with VprBP/
DCAF1 in a similar manner suggest that Vpx also
usurps the VprBP/DCAF1-associated E3, probably to
inactivate a cellular factor that inhibits lentivirus repli-
cation in macrophages. Indeed, viral accessory proteins
are known to use E3 ubiquitin ligases to direct ubiqui-
tination and proteasomal degradation of cellular pro-
teins that mediate innate immunity to viral infection.
Our ongoing experiments are aimed to identify cellular
proteins whose ubiquitination is altered by Vpx. We
expect that our findings will advance the understanding
of this important virulence factor.
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Despite considerable progress achieved in the manage-
ment of lung cancer, it remains one of the leading causes
of death worldwide, with an estimated 215,020 new
cases and 161,840 deaths in 2008 and an overall 5-year
mortality rate of 85% (American Cancer Society, 2008).
Among all the different histological types, non-small-
cell lung cancer (NSCLC) is the most common type,
comprising 75%–80% of all lung cancers.
Although surgical resection has been shown to be a
highly effective treatment for NSCLC, the majority of
patients are diagnosed with regionally advanced or
metastatic disease, thus limiting therapeutic options to
chemotherapy. To date, the mainstay of treatment for
NSCLC is usually based on cytotoxic agents such as
taxane, doxorubicin, cyclophosphoamide, and platinum-
based compounds. Unfortunately, these regimens have
been shown to have very limited activity, and they are
almost always associated with high toxicity and severe
adverse effects.
In recent years, rapid advances in our understanding
of the molecular mechanisms of tumor onset and pro-
gression have led to the development of new and more
effective treatments (i.e., molecular targeted therapies)
that in some instances have dramatically improved the
outcome of certain cancers (e.g., imatinib in the treat-
ment of chronic myelogenous leukemia and gastroin-
testinal cancers, and tamoxifen and Herceptin for breast
cancer). Because of their usually very limited side
effects, they also considerably impact the quality of life
of patients. Specifically in the case of lung cancer, much
excitement has recently been generated by the finding
that a group of NSCLC patients benefited greatly from
treatment with selective epidermal growth factor recep-
tor (EGFR) inhibitors.
EGFR is a member of the Erb family of membrane
receptors, which are important mediators of cell growth,
differentiation, and survival. It has been shown to have
a pivotal role in the development and progression of
many epithelial cancers, including NSCLC, and thus,
not surprisingly, has been the focus of intense efforts to
develop new targeted therapies. The EGFR is a 170-kDa
transmembrane glycoprotein that consists of an extra-
MOLECULAR TARGETED THERAPY OF LUNG CANCER:
EGFR MUTATIONS AND RESPONSE OF EGFR INHIBITORS
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cellular moiety that recognizes and binds to specific lig-
ands: a hydrophobic trans-membrane domain involved
in the interaction of the receptor with the cell membrane
and an intracellular domain that contains tyrosine kinase
enzymatic activity. Upon ligand binding, EGFRs form
homodimers or heterodimers with other Erb family
members, activating their intrinsic kinase activity and
resulting in the dynamic modification—with phos-
phates added and removed at various rates—of several
substrates, including tyrosine residues located in their
cytoplasmic tails. These phosphotyrosine residues can
then engage specific cytosolic signaling proteins, lead-
ing to the activation of different signaling pathways
(e.g., MAPK, PI3K, STAT3/5, PLC-γ) that determine
the biological activity of EGFR in a given cell type. 
Currently, there are two major classes of anti-EGFR
agents: monoclonal antibodies (mAbs) directed against
the extracellular domain of the EGFR and low-molecu-
lar-weight tyrosine kinase inhibitors (TKIs) that inhibit
the tyrosine kinase domain of the receptor generally by
competing with ATP for the ATP-binding site. The
mechanism of action and the biological effects of mAbs
and TKIs differ, leading to diverse clinical outcomes. To
date, gefitinib (Iressa) and erlotinib (Tarceva)—two
selective EGFR inhibitors with similar chemical fea-
tures—have been demonstrated to have the most robust
effects in the treatment of NSCLC. Overall current clin-
ical trials of erlotinib in NSCLC showed an objective
response rate of 22% and an overall rate of nonprogres-
sion at 6 weeks of 52.8%. Interestingly, responses are
more commonly observed in patients of Asian ethnic-
ity, in women, in patients with bronchoalveolar adeno-
carcinoma, and in nonsmokers.
In 2004, we showed that the majority of tumors that
dramatically responded to gefitinib/erlotinib treatment
harbored previously uncharacterized mutations within
the EGFR locus. We as well as other groups were able
to determine that a large majority of EGFR mutations
affect its kinase domain. Specifically, they comprise
small in-frame deletions around codons 746–750 (54%)
and missense mutations that lead to a substitution of
leucine for arginine at codon 858 (45%). However, these
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Functional Analysis of Mutant
EGFR Signaling Pathways
T. Linsted, M. Pineda
One of the main goals of our studies is to understand
why inhibition of EGFR results in cancer cell death
(oncogene addiction). Several theories have been pro-
posed to provide a molecular explanation to cancer cell
dependency on the activity of certain oncogenes. It has
been hypothesized that the presence of selective onco-
genes (e.g., mutant EGFR) can lead to a rearrangement
of preexisting cellular signaling networks, resulting in
an increased vulnerability to apoptotic stimuli. More
recently, our colleague Dr. Jeff Settleman at Massachu-
setts General Hospital proposed an alternative theory
termed “oncogenic shock.” On the basis of this theory,
oncogenes activate proapoptotic and antiapoptotic sig-
naling pathways characterized by different kinetics of
inactivation. As a consequence of oncogene inactiva-
tion, long-lived proapoptotic pathways will not be effec-
tively balanced by prosurvival short-lived signaling
pathways. This imbalance in signaling supposedly
results in cancer cell death.
Interestingly, we and other investigators have shown
that mutant EGFRs are characterized by an augmented
kinase activity and an increased activation of AKT and
STAT prosurvival pathways. We are currently studying
the molecular mechanism underlying these qualitative
signaling differences and investigating whether and how
these same signaling pathways play a part in determin-
ing cell addiction to mutant EGFR.
Identification of New Determinants of
Erlotinib and Gefitinib Sensitivity
S. Fenoglio, Z. Yao
Retrospective studies have showed a high degree of cor-
relation between the presence of EGFR somatic muta-
tions and responses to erlotinib and gefitinib treatment.
At the same time, they also indicated that the length and
extent of the response to gefitinib and erlotinib treat-
ment are highly variable, often lasting only 6 months
and occasionally more than 4 years. The presence of
secondary mutations within the EGFR locus and ampli-
fication of the c-met gene have been specifically sug-
gested to be important mechanisms of acquired
resistance. We are interested in uncovering new deter-
minants of the cellular response to EGFR inhibition
with the goal of developing new therapeutic options for
NSCLC treatment.
mutations are rare: They are found in ~15% of unse-
lected NSCLC patients of Caucasian/African origin and
in 40% of Asian patients. These mutations are also prac-
tically absent in all other types of cancer, with the excep-
tion of cholangiocarcinoma in which they occur with a
frequency similar to that observed in lung cancer.
At the molecular level, EGFR mutations dramatically
change the biochemical properties of the receptor. We
demonstrated that they increase the sensitivity of tumor
cells to gefitinib in part by increasingly activating anti-
apoptotic pathways (i.e., AKT and STAT) on which
tumor cells become dependent.
Although patients with EGFR mutations often have
impressive and durable clinical responses, they almost
invariably develop resistance, usually within 12 months.
The first mechanism of resistance to be discovered was
the acquisition of an additional mutation in exon 20 of
EGFR, resulting in a substitution of threonine for
methionine at position 790. T790M mutations have been
identified in ~30% of cases of acquired resistance to
EGFR TKI. The 790 residue is often referred as the
“gatekeeper” residue in tyrosine kinases and is analo-
gous to resistant mutations in ABL and KIT kinases
observed in cases of imatinib resistance. At a molecular
level, it has been proposed that the presence of a methio-
nine at position 790 changes the conformation of the
receptor, altering the EGFR affinity to selective TKI.
The discovery of this secondary mutation has spurred
the pharmaceutical industry to develop second-genera-
tion EGFR inhibitors.
In addition to secondary mutations in the same
EGFR, amplification of c-MET has recently been iden-
tified as another potential acquired resistance mecha-
nism. In a preliminary study, 22% (4/18) of cases of
NSCLC with acquired resistance to gefitinib/erlotinib
have been shown to harbor c-MET amplification. Inter-
estingly, some of these tumors contained both the
T790M mutation and c-MET amplification. Although
the role of c-MET amplification in EGFR TKI-acquired
resistance has yet to be definitively proven, current stud-
ies suggest that the presence of T790M and c-MET
amplification could account for up to ~40% of all cases.
Thus, despite considerable progress in identifying
acquired resistance mechanisms, new determinants of
EGFR TKI have yet to be uncovered in the majority of
tumors that have relapsed. 
The studies conducted in our laboratory are aimed
at gaining an understanding of how and why cancer
cells become dependent on mutant EGFR for their sur-
vival and how, in instances of acquired resistance, these
same cells become refractory to EGFR selective inhi-
bition. 
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To this aim, we developed an in vitro cell-based sys-
tem that led us to the identification of SOCS2 as a
potential player in gefitinib and erlotinib primary and
acquired resistance. We are currently investigating the
molecular mechanism underlying the increased resist-
ance observed in cells overexpressing SOCS2.
Interestingly, we showed that SOCS2 expression is
regulated in NSCLC by estrogen receptor activity and
that, in the context of NSCLC, estrogen antagonizes the
oncogenic potential of mutant EGFR by regulating the
expression of SOCS2. On the basis of these data, we are
investigating whether low levels of estrogen receptor
activity and SOCS2 are required for the establishment of
tumors driven by mutant EGFR. These findings could
provide new therapeutic options and potentially explain
the observation that in postmenopausal women, in
whom levels of estrogen are particularly low, lung
tumors containing mutant EGFR are more common.
Are We Targeting the Right
Cellular Compartment?
M. Camiolo
We cannot exclude at this time the possibility that the
presence of a subpopulation of cells that are not depend-
ent on EGFR for growth or survival could be an alter-
native hypothesis to explain tumor relapse upon
erlotinib or gefitinib treatment. Recently, in fact, in
many tumors (i.e., glioblastoma, breast cancer, chronic
myelogenous leukemia), it has been shown that a sub-
population of cells displays stem cell characteristics and,
interestingly, more resistance to chemotherapy. 
We are currently investigating whether cells with
stem cell properties are present in NSCLC tumors
driven by mutant EGFR and whether these same cells
are sensitive to EGFR inhibition. 
Identification of New NSCLC Therapeutic
Targets
M. Pineda, S. Fenoglio, H. Archibald
On the basis of the successes of gefitinib and erlotinib,
our laboratory is interested in uncovering new onco-
genes that, similar to EGFR, can be used as therapeutic
targets for the treatment of NSCLC. To this aim, we are
using functional genomic screens to uncover signaling
pathways and genes on which NSCLC cells rely for
their survival.
The experience with gefitinib and erlotinib has taught
us that in some cases, molecular-targeted therapies work
in only a small subset of patients. The low frequency of
genetically defined responsive patient subsets thus sug-
gests that it will be necessary to conduct a broader sam-
pling to achieve a representation of genetic diversity. For
example, to detect a response similar to that observed in
the case of gefitinib and erlotinib treatment in NSCLC
patients (i.e., 10%), we estimate that a cell-based screen
will require a minimum of 50 cell lines.
In the past year, we collected more than 80 NSCLC-
derived cell lines. By using a compound-based screen,
we were able to classify the cell lines of our in-house col-
lection in several clusters characterized by different sen-
sitivities to a large pool of compounds targeting signaling
pathways known to be deregulated in tumors. We were
successful in identifying a subset of cell lines that display
high sensitivity to platelet-derived growth factor recep-
tor (PDGFR)-selective inhibitors, and we are currently
investigating the molecular basis of their selective sensi-
tivity. Although the benefit of a PDGFR-based therapy in
the treatment of NSCLC has yet to be elucidated, we are
attempting, in collaboration with Dr. Scott Powers’ group
here at CSHL, to identify genetic markers that can be
used in the clinic for the up-front selection of tumors that
will respond to PDGFR-selective inhibition.
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The phosphorylation of tyrosyl residues in proteins is a
key component of the regulation of signaling pathways
that control many fundamental physiological processes,
including cell proliferation and differentiation. Protein
phosphorylation is a reversible, dynamic process in
which the net level of phosphate observed in a target
substrate reflects the coordinated activity of the kinases
that phosphorylate it and the protein phosphatases that
catalyze the dephosphorylation reaction. We study the
family of protein tyrosine phosphatases (PTPs), which,
like the kinases, comprise both transmembrane recep-
tor-linked forms as well as nontransmembrane cyto-
plasmic species and represent a major family of
signaling enzymes. Overall, the objective of the lab is
to develop tools for analysis of PTP regulation and
function and integrate them with state-of-the-art cell
and animal models, to define critical tyrosine phos-
phorylation-dependent signaling events in human dis-
ease. It is anticipated that these studies will lead to
identification of novel therapeutic targets and bio-
markers at two levels. By elucidating the signaling
function of PTPs in disease models, we will reveal
examples in which the PTPs themselves, or regulators
of PTP function, are targets. Furthermore, we will use
the PTPs as probes to define critical signaling pathways
in human disease from which novel targets will be iden-
tified.
There was significant turnover in the lab during the
last year. Seung Jun Kim completed his stay as a Vis-
iting Scientist and returned to the Korea Research
Institute of Bioscience and Biotechnology at the Uni-
versity of Science and Technology in Korea. Navasona
Krishnan joined us as a postdoctoral fellow, having
completed his Ph.D. in the lab of Donald Becker at the
University of Nebraska, Lincoln. In addition, two grad-
uate students from Stony Brook began their Ph.D. stud-
ies: Mathangi Ramesh is a member of the Molecular
and Cellular Biology Program and Ming Yang is a
member of the Biochemistry and Structural Biology
Program. Finally, Xin Cheng joined us as a Research
Associate.
PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL
OF SIGNAL TRANSDUCTION
N.K. Tonks B. Boivin N. Krishnan U. Schwertassek
F. Chaudhary L. Li M. Yang
X. Cheng G. Lin X.C. Zhang
A. Haque M. Ramesh
FUNCTIONAL ANALYSIS OF THE “PTPOME”
We have now identified all of the PTP genes in the
human genome (there are ~100) and various studies
from many labs have pointed to the functional impor-
tance of PTPs in the control of cell signaling. It is now
apparent that they have the capacity to function both
positively and negatively in the regulation of signal
transduction. Furthermore, PTPs have the potential to
display exquisite substrate and functional specificity in
vivo. Nevertheless, the majority of members of the PTP
superfamily have yet to be characterized. Hence, the
PTPs remain a largely untapped resource that can be
exploited to reveal new insights into the regulation of
signal transduction. Having defined the composition of
the PTP superfamily, the overall goal of this aspect of
the work in the lab is to develop the tools and reagents
for a functional analysis of the “PTPome,” i.e., to ana-
lyze the function of members of the PTP superfamily,
under normal and pathophysiological conditions, from
the perspective of the family as a whole. We have con-
structed a library of short hairpin RNAs (shRNAs) that
targets each of the PTPs (five shRNAs for each PTP).
This will allow us to interrogate systematically the func-
tion of these signaling enzymes by RNA interference
(RNAi) in various disease models. In addition, we have
been assembling a collection of antibodies to each of
the PTPs, to facilitate analysis of protein suppression by
RNAi, and a collection of expression plasmids for each
of the PTPs, to facilitate follow-up studies on candidates
identified in RNAi screens. 
Our first application of this library is being conducted
in collaboration with Senthil Muthuswamy here at
CSHL, who is an expert in cell models of breast cancer.
HER2, a member of the epidermal growth factor recep-
tor (EGFR) family of PTKs, is overexpressed in ~25% of
breast cancer patients, which correlates with poor prog-
nosis and high invasiveness. To study systematically the
roles of the PTP family in regulating HER2 signaling, in
particular their influence on mammary epithelial cell
motility and invasiveness, we conducted a loss-of-
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inhibitory to HER2-induced migration. These are of inter-
est because if they are shown to be positive regulators of
HER2 signaling, these PTP family members may them-
selves prove to be therapeutic targets. Overall, this
approach shows great potential for shedding new light on
the roles of PTPs in the etiology of breast cancer.
REGULATION OF PTP FUNCTION BY
REVERSIBLE OXIDATION
The signature motif of the PTP family, [I/V] -
HCxxGxxR[S/T], contains an invariant Cys residue,
which, due to the unique environment of the active site,
is characterized by an extremely low pKα. This promotes
the function of this Cys residue as a nucleophile in catal-
ysis, but renders it highly susceptible to oxidation, with
concomitant abrogation of nucleophilic function and
inhibition of PTP activity. Work from several labs,
including this one, has now established that multiple
PTPs are transiently oxidized and inactivated in response
to a wide array of cellular stimuli, which represents a
novel tier of control of tyrosine-phosphorylation-depen-
dent signaling. Hence, the ability to detect reversible oxi-
dation of PTPs in vivo is critical to understanding the
complex biological role of Reactive Oxygen Species
(ROS) in the control of cellular signaling. This year, we
published a new assay to measure reversible PTP oxida-
tion in cells. The strategy involves labeling the active-
site Cys residue in those PTPs that undergo stim-
ulus-induced reversible oxidation with biotinylated small
molecules. The advantage of this approach over those
already in use is that we can now detect oxidation of all
the major subtypes from within the PTP family, in par-
ticular receptor PTPs. We are currently working on sev-
eral collaborations in order to test our assays in as broad
a range of circumstances as possible. 
Identification of an oxidation-induced cyclic sul-
phenamide modification at the active site of PTP1B
and the generation of antibodies to target the oxi-
dized conformation of the PTP. In order to explore
mechanisms by which specificity in PTP oxidation may
be achieved, we set out to develop reagents that would
recognize selectively the oxidized form of PTP1B,
which is the prototypic member of the PTP family and
has important roles in down-regulation of various PTK-
induced signaling pathways, including insulin signal-
ing. Previously, in collaboration with David Barford
(ICR London), we had used X-ray crystallography to
examine the structural consequences of oxidation on the
active site of PTP1B. We noted that after oxidation of
the catalytic Cys to sulphenic acid, there was a rapid
function screen using the PTP shRNA library. MCF10A
cells that were engineered to express a HER2-FKBP
fusion protein, the activity of which can be induced with
the small molecule dimerizer AP1510, were used in the
screen. This screen identified shRNAs to three PTPs
(PTPRG, PTPRR, and PTPN23) that enhanced motility
of MCF10A cells expressing HER2. PTPRR-directed
shRNAs enhanced cell motility in a HER2-dependent
manner, whereas shRNAs to both PTPRG and PTPN23
enhanced motility in either the presence or absence of
HER2 signaling. Interestingly, further investigation
showed that only PTPN23 shRNA induced invasion
when cells were grown on a Matrigel/collagen mixture.
However, although PTPN23 shRNA itself was sufficient
to enhance invasiveness, activation of HER2 signaling
accelerated the effects, indicating cooperation between
suppression of PTPN23 and activation of HER2. We are
currently identifying the critical PTP substrates that
underlie these effects. Although the genes for PTPRG
and PTPN23 are located at chromosome 3p21, a hot spot
for deletions in various cancers, this is the first indication
of potential roles in breast cancer.
In addition to these PTPs that may play a tumor-sup-
pressor function, there are PTPs that may play a positive
role in HER2 signaling. Although PTP1B plays a well-
established role in down-regulating insulin and leptin sig-
naling, its function is not restricted to metabolic
regulation. The PTP1B gene is located at chromosome
20q13, which is a region that is frequently amplified in
breast cancer and associated with poor prognosis. Stud-
ies from the Tremblay (McGill University, Montreal) and
Neel (Beth Israel Deaconess Medical Center, Harvard
Medical School) labs have shown that when mice
expressing activated alleles of HER2 were crossed with
PTP1B knockout mice, tumor development was delayed
and the incidence of lung metastases was decreased.
These observations suggest that PTP1B also plays a pos-
itive role in regulating signaling events associated with
breast tumorigenesis. With this in mind, we tested the
effects of suppressing PTP1B expression by RNAi on
migration of MCF10A cells expressing HER2 in the pres-
ence or absence of the activating ligand. Consistent with
such a positive function in the regulation of HER2 sig-
naling, we observed that suppression of PTP1B levels by
~60% attenuated HER2-induced migration. The PTP1B
protein has a long half-life, and difficulties in establish-
ing full suppression by RNAi are well known. Nonethe-
less, the effect on migration was striking, even with only
partial suppression of PTP1B. Interestingly, suppression
of the closely related enzyme TCPTP was without effect.
In addition, we noted that shRNAs to some dual speci-
ficity phosphatases (DSPs) and myotubularins were
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condensation reaction, which resulted in formation of a
unique cyclic sulphenamide species. The consequences
for the architecture of the active site are profound. Upon
formation of the cyclic sulphenamide, critical hydrogen
bonds are broken, which triggers residues from the
active site to adopt solvent-exposed positions in a
process that was readily reversible upon incubation of
the crystals with a reducing agent. We have shown that
insulin induces the transient oxidation and inactivation
of PTP1B (and TCPTP) and that this suppression of
PTP function by oxidation is important for an optimal
signaling response in insulin-responsive cells. Consid-
ering this, and the structural consequences of reversible
oxidation, we set out to test the hypothesis that stabi-
lization of this inactive conformation (PTP1B-OX),
which would be formed following insulin-induced pro-
duction of ROS, would augment the hormone response
by removing an inhibitory constraint on signaling. 
Our approach was to attempt to generate conforma-
tion-specific antibodies that recognize oxidation-spe-
cific epitopes in PTP1B-OX that would not be found in
the active, reduced enzyme. An important breakthrough
was our discovery that a double-point mutation at the
active site of PTP1B induced a stable conformation that
is indistinguishable in structure from the PTP1B-OX
conformation induced by H
2
O
2
, and this could therefore
be used as an antigen. We immunized chickens with
purified PTP1B-OX mutant protein and harvested
spleen and bone marrow from immunized animals in
which we had detected a robust increase in serum anti-
body titer to the purified antigen. We chose to adopt the
phage display technology, which allows rapid and effi-
cient screening of libraries of high complexity. Antibody
molecules contain discrete domains that can be pro-
duced by recombinant techniques. To generate the
library, we used the small Fv (fragment variable), which
is composed of the variable-light (V
L
) and variable-
heavy (V
H
) regions. In a single-chain variable fragment
(scFv), the two variable regions are artificially joined
with a neutral peptide linker. The recombinant antibody
scFvs are presented on the surface of bacteriophage and
can be selected from combinatorial libraries in vitro. We
used a subtractive panning strategy. PTP1B-OX mutant
protein biotinylated at the amino terminus was mixed
with the library under reducing conditions in the pres-
ence of a ~50-fold molar excess of wild-type enzyme.
The PTP1B-OX–scFv-phage complex from this mixture
was isolated on streptavidin beads and phage particles
with surface-exposed scFvs bound to PTP1B-OX were
then eluted and amplified. A total of four rounds of pan-
ning were performed to enrich the library with pools of
antibodies specific to the mutant form of the enzyme.
From these pools of scFvs, we have isolated 115 distinct
(by sequence of their hypervariable regions) candidates
that we are now testing. 
Our expectation was that scFvs that are able to bind
to and stabilize the oxidized conformation of PTP1B in
solution would inhibit its reactivation by reducing agent,
but they would have no direct inhibitory effect on phos-
phatase activity of the reduced enzyme in assays in vitro.
We established conditions under which wild-type PTP1B
could be reversibly oxidized in vitro. PTP1B was inacti-
vated following addition of H
2
O
2
; however, phosphatase
activity was completely restored upon the removal of
H
2
O
2
by a quick buffer exchange and addition of reduc-
ing agent. Purified, bacterially expressed scFvs were
incubated with PTP1B after H
2
O
2
treatment and the abil-
ity of an individual scFv to stabilize the reversibly oxi-
dized, inactive conformation of the PTP was assessed by
the ability of the antibody to inhibit the reactivation of
the enzyme by reducing agent. Thus far, we have screened
~25% of the scFv candidates, with extremely encourag-
ing results. We have found four scFvs that showed sig-
nificant inhibition of the reactivation of PTP1B-OX by
reducing agent, but did not exert any direct inhibitory
effect on activity. In order to validate this approach fur-
ther, we tested the effects of expressing one of these as a
single-chain antibody fragment “intrabody” to PTP1B,
using 293T cells as a convenient expression system. We
expressed this intrabody transiently and then tested for
effects on insulin signaling, focusing initially on the tyro-
sine phosphorylation status of the β-subunit of the insulin
receptor and IRS-1. Initial indications are that for both
substrates, expression of the intrabody had no impact on
the basal level of tyrosyl phosphorylation, but it enhanced
and extended the time course of insulin-induced phos-
phorylation, consistent with our proposed mechanism of
action. We are currently completing the screen and test-
ing further for effects on insulin signaling.
Quite apart from their significance as reagents, these
antibodies may influence strategies for development of
PTP1B-directed therapeutics. The phenotype of the
knockout mouse, together with structural and biochem-
ical data from various groups, has established PTP1B
as a key regulator of insulin and leptin signaling. Con-
sequently, it became a highly prized target in the phar-
maceutical industry for therapeutic intervention in
diabetes and obesity. Although there have been major
programs in industry focused on developing small-mol-
ecule inhibitors of PTP1B, these efforts have been frus-
trated by technical challenges arising from the chemical
properties of the PTP active site. The susceptibility of
PTPs to oxidation causes problems in high-throughput
screens. In addition, the tendency of potent inhibitors to
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be highly charged, such as nonhydrolyzable pTyr mimet-
ics, presents problems with respect to bioavailability.
Consequently, new approaches to inhibition of PTP1B
are required to reinvigorate drug development efforts.
These redox-dependent changes in conformation suggest
a novel way to think about inhibiting PTPs in a thera-
peutic context. Reversible oxidation of PTP1B gen er ates
a form of the enzyme in which the problematic chemi-
cal properties of the enzyme are circumvented and new
binding surfaces for small-molecule inhibitors are pre-
sented. Therefore, if it is possible to stabilize the oxi-
dized, inactive form of PTP1B with an appropriate
therapeutic molecule that mimics the effects of these
antibodies, this could then provide a new strategy for
PTP-directed drug development that may circumvent
the difficulties that are faced when targeting the PTP
active site with highly charged inhibitors. Stabilization
of the inactive PTP1B-OX conformation may potenti-
ate insulin signaling in a manner similar to inhibiting
the catalytically active form of the enzyme, analogous to
stabilization of the inactive form of p210 BCR-ABL by
Gleevec. In addition, if one assumes that in responding
to insulin, the cell targets for oxidation the pool of
PTP1B that is important for regulation of the signaling
response, then this strategy will also target that pool
specifically, possibly also reducing complications of
side effects that may accompany inhibition of the native
enzyme as a whole. Other PTPs, in addition to PTP1B,
have also been shown to form a cyclic sulphenamide
upon oxidation, suggesting that this approach may offer
a general strategy for inhibiting this enzyme family.
FUNCTIONAL ANALYSIS OF JSP1
Previously, we identified JNK stimulatory phosphatase
1 (JSP1) as a DSP that has the capacity to activate the
JNK mitogen-activated protein kinase (MAPK) specif-
ically, exerting its effects upstream of the MAP2K
enzyme MKK4 in the JNK signaling cascade. This illus-
trates a new potential tier of control of the JNK signal-
ing pathway and a novel aspect of the role of protein
phosphatases in the control of MAPK signaling, raising
the possibility that JSP1 may offer a new perspective on
the study of various disorders associated with aberrant
JNK signaling. We have continued our characterization
of mice that contain a targeted deletion of the jsp1 gene,
particularly with respect to the role of JSP1 as a positive
regulator of JNK signaling in the neurodegenerative
processes that lead to Parkinson’s disease. 
In addition to a single DSP catalytic domain, JSP1
contains a potential myristoylation site at its amino ter-
minus (MGNG). Among the members of the PTP fam-
ily, this is unique to JSP1 and its closest relative
DUSP15/JSP2. Recent studies in the lab have focused
on investigating the significance of this myristolyation
site. In collaboration with Tom Neubert (Skirball Insti-
tute, New York University), we used mass spectrometry
to confirm the presence of a myristoyl group at glycine
2 in the wild-type protein immunoprecipitated from cell
lysates, but not in a JSP1 mutant in which the glycine
was mutated to alanine. Using JSP1 tagged at the car-
boxyl terminus with green fluorescent protein (GFP),
we observed that the wild-type enzyme colocalized with
Golgi markers and is excluded from the nucleus,
whereas the nonmyristoylated form of JSP1 is uniformly
distributed throughout the cell. In addition, the non-
myristoylated form of the enzyme displays impaired
ability to induce JNK activation and c-Jun phosphory-
lation. Wild-type JSP1 also has a shorter half-life than
the nonmyristoylated form. Studying the impact of
myristoylation on JSP1 function proved to be difficult
because ectopic expression of the wild-type enzyme is
poorly tolerated by cells. Expression of wild-type JSP1
led to a cell phenotype reminiscent of apoptotic cell
death, which is less pronounced in cells expressing the
myristoylation site mutant. Thus, these studies indicate
an important role for myristoylation-dependent local-
ization of JSP1 in the regulation of JNK signaling.
Dephosphorylation of the carboxy-terminal tyrosyl
residue of the DNA-damage-related histone H2A.X is
mediated by the protein phosphatase Eyes Absent.
Double-stranded breaks (DSBs) are an extremely dele-
terious form of DNA damage with the potential for cell
death and carcinogenesis. Therefore, tight control over
the repair process is required. The reversible phospho-
rylation of histone H2A.X is an important component of
the cellular response to DSBs, natural or imposed, in
what is beginning to be described as an “epigenetic land-
scape” for DNA damage and repair. The variant histone
H2A.X comprises ~10% of the H2A pool in mammalian
cells and contains a unique carboxy-terminal segment
with sites of regulatory phosphorylation. Within minutes
of genotoxic stress, such as ionizing radiation, histone
H2A.X becomes phosphorylated on Ser-139 in its car-
boxy-terminal segment by members of the PIKK family
of Ser/Thr kinases, including ATM. Phosphorylated
H2A.X decorates a broad region of ~1 Mb flanking the
break, which serves as a platform for recruiting mole-
cules involved in DNA-damage repair and signaling.
These regions are referred to as γH2A.X foci. In mam-
malian cells, histone H2A.X also possesses a Tyr residue
at its carboxyl terminus (Tyr-142), which has been shown
by our collaborator David Alliss (The Rockefeller Uni-
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versity) to be constitutively phosphorylated under nor-
mal growth conditions. Following DNA damage, such as
in response to ionizing radiation, this residue becomes
dephosphorylated, while γH2A.X, the Ser-139 phospho-
rylated form, appears. Phosphorylation of Tyr-142 is cat-
alyzed by an atypical protein kinase WSTF, suppression
of which by RNAi led to a decrease in Tyr phosphoryla-
tion of H2A.X and a rapid decline in the level of γH2A.X
after ionizing radiation. Phosphorylation of Ser-139 and
formation of γH2A.X foci were also reduced in cells
expressing H2A.X in which Tyr-142 was mutated to non-
phosphorylatable Phe or Leu residues, suggesting that
the phosphorylation/dephosphorylation of these sites
may be coordinated in a poorly understood “cross-talk”
pathway. Clearly, the identity of the phosphatase(s) that
dephosphorylates Tyr-142 is a critical component of this
novel aspect of the DNA-damage response, because it
would be part of the enzyme system responsible for gov-
erning the steady-state balance of this regulatory phos-
phorylation mark.
Eyes Absent (EYA), which is known to play a major
role in tissue and organ development in many organisms,
is the first example of a transcription factor with intrin-
sic phosphatase activity. It is a member of the haloacid
dehalogenase (HAD) superfamily, which uses critical
Asp residues at the active site to catalyze dephosphory-
lation. We determined the crystal structure of the cat-
alytic domain of EYA2 and noted a striking feature: the
clustering of acidic residues around the active site to
present a negatively charged surface. This suggests that
substrates of the enzyme may have basic properties.
Other EYA family members share ~60% identity in this
region of the protein, including 100% conservation of
the surface acidic residues, consistent with them adopt-
ing a fold similar to that of EYA2. Considering the
known functions of EYA in the nucleus and the fact that
histones are recognized as highly basic proteins, we
sought to determine whether EYA could dephosphory-
late histone H2A.X as a substrate. Our data indicate that
EYA3, and likely other EYA family members (EYA 1,
2, and 4), may function as a PTP that dephosphorylates
Tyr-142 in histone H2A.X in vivo. We observed in assays
in vitro that EYA demonstrated specificity for carboxy-
terminal Tyr residue Tyr-142 in H2A.X (Fig. 1).
Although there was a robust activity against the pTyr-
142 H2A.X peptide, EYA2 and EYA3 did not dephos-
phorylate other pTyr peptides modeled on sequences that
are known to engage signaling molecules. In contrast,
PTP1B readily dephosphorylated these SH2 domain
peptide ligands, but was inactive against the pTyr-142
H2A.X peptide. In the initial reports of characterization
of the phosphatase activity of EYA, there was some dis-
agreement about whether it displayed specificity for Tyr
residues in proteins or could be viewed as a dual-speci-
ficity phosphatase. Our data provide further support for
pTyr specificity of the EYA phosphatases. In contrast to
the pTyr-142 peptide, EYA displayed ~10-fold lower
activity toward the same peptide that was phosphorylated
on the residue equivalent to Ser-139 of H2A.X. Further-
more, the presence of phosphate on the Ser residue was
inhibitory to dephosphorylation by EYA (Fig. 1). This
indicates not only a striking preference of EYA2 and
EYA3 for the dephosphorylation of pTyr-142, but also
raises the possibility that the dephosphorylation of the
FIGURE 1 Identification of histone H2A.X as a physiological substrate of Eyes Absent (EYA). (A) Dephosphorylation of histone H2A.X-
derived peptide substrates by EYA3. Shown are monophosphorylated H2A.X pTyr-142 (closed circles), monophosphorylated pSer-139
(open circles), and bisphosphorylated H2A.X pSer-139p/pTyr-142 (closed squares). Effects of suppression of eya3 by RNAi on the basal
phosphorylation of Tyr-142 in histone H2A.X (B) and DNA-damage-induced dephosphorylation of H2A.X. (C) (Upper panels) Anti-H2A.X-
pTyr-142 phospho-specific antibody; (lower panels) anti-H2A.X antibody.
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carboxy-terminal Tyr residue may be influenced by phos-
phorylation of the neighboring residue Ser-139 in a
“cross-talk” pathway. We noted that suppression of eya3
by RNAi in U2OS cells led to increased basal phospho-
rylation and abrogated DNA-damage-induced dephos-
phorylation of Tyr-142 in histone H2A.X, consistent with
a role for EYA3 as a physiological H2A.X phosphatase
(Fig. 1). In addition, suppression of eya3 was accompa-
nied by a pronounced increase in cell death. Increased
cell death has also been reported to accompany suppres-
sion of EYA family members in other systems. Most
often, γ phosphorylation of  H2A.X at Ser-139 is
equated with “sensing” DSBs, leading to DNA repair in
the context of a chromatin template. It is interesting to
note, however, that histone H2A.X not only has been
shown to function as a “caregiver” of the genome in
DNA repair, but has also been implicated in the control
of apoptosis in a poorly understood response. The impor-
tance of these observations is that not only do they pro-
vide the first indications of a physiological substrate of
EYA, but they also suggest that the interaction of EYA
and H2A.X may have a critical role in directing the
choice that a cell makes regarding whether to undergo
apoptosis or the process of DNA repair.
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PTEN is a tumor suppressor that is among the most fre-
quently lost or mutated genes of human cancer. It is unique
in directly opposing the enzymatic activity of phospho-
inositol-3 kinases (PI3K) and the downstream proto-onco-
gene Akt kinase, which promotes cell survival and
proliferation. This signaling pathway is deregulated in a
majority of, for example, breast, prostate, and brain
tumors. By modeling Pten loss in mice, we have discov-
ered how cells in the prostate can sense the complete loss
of Pten and respond to this insult by withdrawing into cel-
lular senescence, which is now recognized as an early cell-
intrinsic human antitumoral defense mechanism. However,
we found that cells fail to respond similarly to more sub-
tle deregulation of Pten protein as exemplified by its
incomplete loss and that this leads to cancer by a process
that we term “senescence bypass.” This finding, combined
with the senescence response, suggests that tumors should
favor retention of some PTEN. Indeed, many human can-
cers present with incomplete PTEN loss, entirely consis-
tent with these findings and establishing PTEN as a
haploinsufficient tumor suppressor in such tissues.
Our studies of senescence bypass mechanisms have so
far revealed two molecular scenarios. In one, tissues will
spontaneously reduce Pten levels just enough to cross the
threshold for abnormal proliferation. In the second sce-
nario, partial inactivation of Pten and of a select cooperat-
ing tumor suppressor (e.g., the nuclear body-forming
protein Pml or the cell cycle inhibitor p27) will suffice to
produce senescence-free cancers that form only in this spe-
cific combination. Importantly, analysis of human tissues
has confirmed the relevance of these two scenarios in
prostate and colon cancer patients, to name a few. Thus,
our genetic analysis of tumor progression in the mouse is
allowing us to develop and test novel conceptual and mech-
anistic frameworks for cancer initiation and progression.
Nuclear versus Cytoplasmic
Akt Activity in Cancer
M. Chen, D. Grace [in collaboration with A. Newton, University
of San Diego, California]
Through our previous studies, we have learned that not
only quantitative, but also qualitative, regulation of Akt
kinase controls Pten mutant tumorigenesis and its pro-
HAPLOINSUFFICIENCY AND SENESCENCE IN CANCER
L. Trotman M. Chen D. Grace
H. Cho J. Murn
gression via a senescence defeat or senescence bypass
pathway. The qualitative change in active Akt kinase
localization from the plasma membrane to the nucleus
is a direct consequence of loss of promyelocytic
leukemia (PML) nuclear bodies (NBs). We could show
that in mice, Pml achieves pAkt inactivation through its
ability to recruit both Akt and its phosphatase PP2a into
these bodies, resulting in specifically nuclear Akt inac-
tivation. These findings demonstrated the importance of
coordinated Akt inactivation and revealed that this
process is efficiently achieved through the phosphatase
PP2a. Furthermore, it highlighted how deregulating cel-
lular partitioning of Akt activity via control of phos-
phatases could bypass the senescence response. 
Recently, a second direct phosphatase of Akt, named
PHLPP, has been identified. PHLPP joins PTEN and PP2a
phosphatases with the potential of regulating tumorigen-
esis. In contrast to the qualitative changes mentioned
above, PHLPP controls the amplitude of Akt activation,
similar to PTEN. However, it is unclear whether (1)
PHLPP is a bona fide tumor suppressor and (2) in the con-
text of PTEN-loss, loss of PHLPP bypasses senescence
(similar to PP2a targeting) or triggers a senescence
response in vivo (similar to complete PTEN loss). We have
gathered strong evidence supporting a tumor-suppressive
role for the PHLPP gene in human cancers of various tis-
sues. To validate its role in vivo, we are crossing Phlpp
null mice with Pten mutant mice. This analysis will allow
us to define tissues where Phlpp is essential for tumor sup-
pression and answer the question if and when a tumor
wants to achieve maximal Akt pathway activation.
Nuclear PTEN and Cancer
J. Murn [in collaboration with B. Carver, W. Gerald, and C.
Sawyers, Memorial Sloan-Kettering Cancer Center, New York]
Despite its plasma membrane function, PTEN has been
consistently observed in cell nuclei, but the mechanism
and relevance of this localization have remained unclear.
We have recently resolved this paradox by demonstrating
that contrary to polyubiquitination, nuclear PTEN import
depends on its monoubiquitination and that mutation of
the main PTEN ubiquitination site abolishes import in
vitro and in patients, giving rise to inheritable Cowden’s
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apeutic approach, and thus we set out to test the thera-
peutic effect of Pten up-regulation in the prostate. An
important open question behind this approach is that
restoration of PTEN might not just antagonize but also
revert tumor growth, analogous to the concept of onco-
gene addiction, even after cells have suffered spontaneous
cooperating lesions. 
To address this issue experimentally, we have designed
reversibly inducible short-hairpin-based microRNAs in
collaboration with the labs of Drs. Lowe and Hannon here
at CSHL. As shown by Dr. Lowe’s recent work, such
hairpin designs can be used in vivo for reversible knock-
down, which permits proof-of-principle studies on the
therapeutic value of PI3K pathway control in specific
genetic contexts. Through our approach, we have
knocked down Pten levels in the mouse prostate until
tumors have formed analogous to the models mentioned
above. At this time, hairpin activity is blocked, Pten is
restored, and tumor volume is monitored for regression
using magnetic resonance imaging (MRI) methods. Of
the 250,000 American men diagnosed with prostate can-
cer each year, about half will present with partial PTEN
loss in their lesions, and thus, we expect our results to be
of great importance in establishing the genetic framework
for successful treatment of prostate cancer through PTEN
stabilization or PI3K pathway inhibition.
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disease because of low cytoplasmic PTEN stability. But
most notably, this mutant retains catalytic activity, demon-
strating that PTEN nuclear import is essential for tumor
suppression. These findings exemplify an elemental
insight into cancer biology by demonstrating how the col-
laboration of a genetic lesion (the inherited mutation)
with a posttranslational cellular response (enhanced
degradation) cooperates in tumorigenesis. Through this
analysis, we have furthermore unraveled a link between
two critical means of PTEN regulation, namely, stability
and nucleocytoplasmic shuttling. We are currently inves-
tigating the mediators of both processes in vitro by using
RNA interference (RNAi) approaches that can be
expanded to in vivo analysis. 
Regulation of PTEN Activity in Prostate
Cancer Initiation and Treatment
H. Cho, J. Murn [in collaboration with C. Miething and
P. Premsrirut, S. Lowe lab, Cold Spring Harbor Laboratory]
On the basis of our previously published work, the actual
Pten protein levels inside prostatic epithelia decide
between benign or malignant tumor formation (Trotman et
al., PLoS Biol. 3: 385 [2003]), whereas complete Pten loss
was shown to prevent tumorigenesis through the p53-
dependent senescence response until p53 mutation paves
the way for full-blown cancer. Accordingly, prostates of
mice harboring partial Pten loss spontaneously degrade
Pten to allow formation of prostate cancer. Yet, importantly,
these lesions do not go on to completely lose Pten at the
gene or protein level, a compelling illustration of their abil-
ity to maximize proliferation while avoiding the senes-
cence response caused by complete Pten loss. Our analysis
of human prostate cancer specimens also confirms fre-
quent retention of clearly reduced PTEN levels. Therefore,
by using mouse models with partial Pten loss, we found
that spontaneous and subtle further reduction of Pten lev-
els triggers activation of the downstream oncogenic kinase
Akt, illustrating that a threshold must be crossed for initi-
ation of cancer. 
It is important to note that such spontaneous down-
regulation of Pten is never observed in prostates of wild-
type animals, sometimes observed in Pten+/– prostates
(30% of mice), and is always occurring in Ptenhy/– ani-
mals (mice with one-fourth of normal Pten levels; see
Fig. 1). These observations strongly suggest that lower
Pten levels increase the probability of its spontaneous
reduction below the Akt-activating and tumor-promoting
threshold. Thus, they demonstrate the importance of sta-
ble Pten levels in a tissue even after Pten has received a
genetic hit. This finding should form the basis of a ther-
FIGURE 1 Pten haploinsufficiency and the senescence response.
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Ras and Rho family members have key roles in cellular
activities controlling cell growth control, differentiation,
and morphogenesis. Alterations that affect normal Ras
and Rho function have been found to result in the devel-
opment of several disease processes, including cancer
and neurodevelopmental disorders. Our ultimate goal is
to understand how aberrations in Ras and Rho signaling
components contribute to the development of these dis-
ease/disorder processes. Toward this end, my lab has
continued to define the functions of selected GTPases
and their regulators and effectors in models of cancer
and neurodevelopmental disorders. Below we highlight
the main projects that have been carried out during the
past year. 
A CRITICAL ROLE FOR THE RHO-LINKED
MENTAL RETARDATION PROTEIN OLIGOPHRENIN-1
IN GLUTAMATERGIC SYNAPSE MATURATION 
AND PLASTICITY
Mutations in genes encoding regulators and effectors of
Rho GTPases have been found to underlie various forms
of mental retardation (MR). Oligophrenin-1 (OPHN1),
which encodes a Rho-GTPase activating protein, was the
first identified Rho-linked MR gene. It was initially
identified by analysis of a balanced translocation t(X;12)
observed in a female patient with mild MR. Subsequent
studies have revealed the presence of OPHN1 mutations
in families with MR associated with cerebellar hypopla-
sia and lateral ventricle enlargement. All OPHN1 muta-
tions identified to date have been shown, or predicted, to
result in OPHN1 loss of function. We previously demon-
strated that the OPHN1 protein is highly expressed in
the brain, where it is found in neurons of all major
regions, including hippocampus and cortex, and it is
present in both the axon and dendrites of principal neu-
rons. Until now, however, the neuronal function of
OPHN1 has been largely elusive. We had implicated
OPHN1 in the regulation of spine morphology of CA1
hippocampal neurons, although it remained unclear
whether OPHN1 controls spine formation or mainte-
nance. Furthermore, the role of OPHN1 in the develop-
RAS AND RHO GTPASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner A. Kobayashi
J. Janas R. Packer
K. John Y.-T. Yang
N.N. Kasri
ment or function of glutamatergic synapses remains to
be elucidated. 
By temporally and spatially manipulating OPHN1
gene expression, we have now obtained evidence that
postsynaptic OPHN1 has a key role in activity-depen-
dent maturation and plasticity of excitatory synapses by
controlling their structural and functional stability.
Specifically, we find that synaptic activity through N-
methyl-D-aspartate (NMDA) receptor activation drives
OPHN1 into dendritic spines, where it forms a complex
with α-amino-3-hydroxy-5-methyl-4-isoxazolepropi -
onic acid (AMPA) receptors, and selectively enhances
AMPA-receptor-mediated synaptic transmission and
spine size by stabilizing synaptic AMPA receptors. Con-
sequently, decreased or defective OPHN1 signaling pre-
vents glutamatergic synapse maturation and causes loss
of synaptic structure, function, and plasticity. These
results indicate that normal activity-driven glutamater-
gic synapse development is impaired by perturbation of
OPHN1 function. Thus, our findings link genetic
deficits in OPHN1 to glutamatergic dysfunction and
imply that defects in early circuitry development are an
important contributory factor to this form of MR.
THE RAC ACTIVATOR DOCK7 REGULATES
NEURONAL POLARITY AND MIGRATION
DOCK7 is a member of the evolutionarily conserved
DOCK180-related protein superfamily, which we iden-
tified as a novel activator of Rac GTPases. We found
that DOCK7 is highly expressed in major regions of the
brain during early stages of development and, impor-
tantly, that the protein is asymmetrically distributed in
unpolarized hippocampal neurons and becomes selec-
tively expressed in the axon. We then obtained evidence
that DOCK7 has a critical role in the early steps of axon
formation in cultured hippocampal neurons. Knock-
down of DOCK7 expression prevents axon formation,
whereas overexpression induces the formation of mul-
tiple axons. We further demonstrated that DOCK7 and
Rac activation leads to phosphorylation and inactivation
of the microtubule destabilizing protein stathmin/Op18
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in the nascent axon and that this event is important for
axon development. Thus, our findings unveiled a novel
pathway linking the Rac activator DOCK7 to a micro-
tubule regulatory protein and they highlight the contri-
bution of microtubule dynamics to axon development. 
More recently, we set out to monitor neuronal polar-
ization during the migration of newborn developing
neurons within an intact brain structure and to establish
DOCK7’s role in this process. In particular, we imple-
mented the in utero electroporation method that enables
highly efficient introduction of vectors coexpressing
proteins or short hairpin RNAs of interest with a fluo-
rescent protein marker (e.g., EGFP or tdTomato) into
ventricular zone (VZ) cells in embryonic cerebral cor-
tices. Interestingly, we found that DOCK7 knockdown
leads to inhibition of normal cortical migration. We are
currently further determining the role of DOCK7 in the
polarization and migration of cortical neurons in brain
slices and are also assessing its involvement in the dif-
ferentiation of living cerebellar granule cells. Together,
these studies will contribute to a better understanding
of the determinants/events involved in neuronal polar-
ization, differentiation, and migration and the role of
DOCK7 in these important processes.
ROLE OF RAP1 SIGNALING IN MORPHOGENETIC
PROCESSES
The Rap1 protein, a member of the Ras family, was ini-
tially identified as an antagonist of oncogenic Ras pro-
teins; however, more recent studies indicate that the
function of Rap1 is largely Ras independent. Increasing
evidence points to a critical role for Rap1 in the control
of epithelial morphogenesis, and recent studies suggest
a dysregulation of Rap1 signaling in malignant
processes. How Rap1 proteins exert their effects in vivo
has remained largely elusive. We previously described
the identification of the mammalian junctional protein
AF-6 as a Rap1-interacting protein. To demonstrate the
physiological relevance of this interaction, we decided
to perform functional analyses of their orthologs (Rap1
and Canoe) in the more genetically tractable Drosophila
system. We found that both Rap1 and Canoe are
required for epithelial migration events in the embryo
and that Canoe acts as a downstream effector of Rap1 in
these processes. 
More recently, we identified a Drosophila Rap1-spe-
cific exchange factor, dPDZ-GEF, that is responsible for
Rap1 activation in migrating embryonic epithelia.
Canoe acts downstream from Rap1 and dPDZ-GEF in
this event. We demonstrated that dPDZ-GEF/Rap1/
Canoe signaling modulates cell shape and apicolateral
cell constriction in embryonic and wing disc epithelia.
Interestingly, our data indicate that dPDZ-GEF signal-
ing is linked to Myosin II function. Both dPDZ-GEF
and cno show strong genetic interactions with the gene
encoding Myosin II, and Myosin II distribution is
severely perturbed in epithelia of both mutants. These
findings provide a first insight into the molecular
machinery targeted by Rap signaling to modulate cell
shape in epithelial morphogenesis at different develop-
mental stages.
ROLE OF DOK PROTEINS IN MITOGENIC
AND ONCOGENIC SIGNALING
Dok-1 (also called p62dok) was initially identified as a
tyrosine-phosporylated 62-kD protein associated with
Ras-GAP in Ph+ chronic myeloid leukemia (CML)
blasts and in v-Abl-transformed B cells. This protein
was termed Dok (downstream of kinases), because it
was also found to be a common substrate of many
receptor and cytoplasmic tyrosine kinases. Subse-
quently, six additional Dok family members have been
identified. Among them, Dok-1 and Dok-2 share the
ability to bind to a negative regulator of Ras, Ras-GAP.
We previously described that Dok-1 attenuates growth-
factor-induced cell proliferation and that Dok-1 inacti-
vation in mice causes a significant shortening of the
latency of the fatal myeloproliferative disease induced
by p210bcr-abl. Strikingly, in collaboration with Dr. Pan-
dolfi’s group at Harvard Medical School, we also found
that mice lacking both Dok-1 and Dok-2 spontaneously
develop a CML-like myeloproliferative disease, likely
resulting from increased cellular proliferation and
reduced apoptosis. Thus, Dok proteins function as neg-
ative regulators of mitogenic and oncogenic signaling. 
To further delineate the function of Dok-1 in onco-
genic signaling, we examined the expression of Dok-1
protein in cells expressing various oncogene tyrosine
kinases. Interestingly, we observed that p210bcr-abl, v-Abl,
and oncogenic forms of Src induce down-regulation of
Dok-1 expression in a number of cell lines and that the
reduction in the levels of Dok-1 protein requires tyro-
sine kinase activity of these oncogenes. Inactivation of
tumor suppressors is an event that is observed in numer-
ous tumors. Because the inactivation of the Dok-1 gene
accelerates the progression of CML in mouse models,
whereas overexpression of Dok-1 dramatically inhibits
the proliferation of p210bcr-abl-expressing cells as well as
Src-induced transformation, our current findings sug-
gest that oncogene-induced down-regulation of Dok-1
might be an event that contributes to the progression of
tumorigenesis. 
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NEUROSCIENCE 
Neuroscientists at CSHL are striving to trace the remarkable process by which the developing brain gives rise
to immensely complex neural networks, catalog and comprehend the full range of human genes implicated in
mental illness, and demonstrate with great precision—in animals and humans—how genetic mutations and a
host of related cellular anomalies give rise to disease-specific pathologies. These basic science investigations
promise to spawn not only unprecedented diagnostic capabilities, but also, it is hoped, important new strate-
gies for treating and perhaps even preventing some illnesses. They are certain to help unravel the still obscure
mechanisms at work in devastating neurodevelopmental illnesses such as schizophrenia, depression, bipolar
illness and other mood disorders, and autism and related “spectrum” disorders, as well as neurodegenerative
illnesses such as Alzheimer’s and Parkinson’s diseases. The Swartz Center for Compu tational Neuroscience,
headed by Anthony Zador, and the Stanley Center for Cognitive Genomics are among the coordinating cen-
ters for this vital research.
Holly Cline’s lab is studying mechanisms in the brain controlling the growth of neurons, the generation of
synapses, and the development of organized sensory projections be tween different brain regions. To under-
stand the cellular events responsible for the stabilization of growing neuronal branches, the lab has delivered
genes of interest into neurons and assessed the effects on synaptic transmission, specifically, in nerves that con-
nect the retina and a part of the brain called the tectum involved in visual processing. Cline has learned that visual
experience is a key modifier in how these circuits are built. This year, the lab demonstrated for the first time in
living organisms (Xenopus tadpoles) that insulin receptor signaling in neurons regulates the maintenance of
synapses, contributes to the processing of sensory information, and is involved in adjusting the plasticity of
brain circuits in response to experience. 
Because biological mechanisms of memory are highly conserved through evolution, many features of human
memory are observed in simpler organisms such as fruit flies. Joshua Dubnau and colleagues identify genes
that are important for memory and conserved across phyla. The hope is that many of these will be relevant to
human memory. They recently discovered genes involved in controlling when and where specific proteins are
synthesized within a neuron. These genes likely regulate neuronal communication during learning. The lab also
seeks to discover how the neural circuitry of the fly brain works. They have recently shown that short- and long-
term memories form in different sets of neurons: One circuit provides a memory that decays quickly and the
other provides a memory that forms slowly but persists. Dubnau’s team also explores how groups of genes
interact to form memories, an approach designed to shed light on complex gene networks that likely underlie
human cognitive disorders.
Grigori Enikolopov and colleagues study stem cells in the adult brain. They have generated several models
to account for how stem cells give rise to progenitors and, ultimately, to neurons and are using these models
to determine the targets of antidepressant therapies, to identify signaling pathways that control generation of
new neurons, and to search for neuronal and neuroendocrine circuits involved in mood regulation. Recent
experiments have suggested to the team a new model of how stem cells are regulated in the adult brain, with
a focus on stem cells’ “decision” on whether to divide—and embark on a path of differentiation—or re main qui-
escent. This model also ex plains why the number of new neurons decreases with advancing age. Recently,
Eniko lopov’s group was part of a team that identified and validated the first biomarker that permits neuronal pro-
genitor cells to be tracked, noninvasively, in the brains of living human subjects. The lab is now using this dis-
covery to reveal how neurogenesis is related to the course of diseases such as depression, bipolar disorder,
Alzheimer’s, and Parkinson’s.
Hiro Furukawa’s lab is studying neurotransmission at the molecular level. They focus on two types of calci-
um ion channels: N-methyl-D-aspartate (NMDA) receptors and calcium homeostasis modulators (CALHM).
Both are involved in the regulation of neuronal activities and in the pathoge nesis of Alzheimer’s disease. NMDA
receptors are very large molecules whose three-dimensional atomic structure Furukawa’s group has undertaken
to solve by dividing them into several domains. They seek to understand the pharmacological specificity of lig-
and and modulator bindings in different subtypes of NMDA receptors in order to provide a blueprint for future
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drug design. A mutation of the gene coding for CALHM has been implicated in late-onset Alzheimer’s disease.
The team is working to reveal the mechanism by which this calcium-specific ion channel opens by uncovering
the molecule’s architecture. Such structural information promises to be useful in the design of novel drugs for
treatment of Alzheimer’s. 
Adam Kepecs studies the neurobiological principles by which the brain makes decisions. He and his col-
leagues view decisions as elementary units of behavior, from which more complex behaviors are assembled.
Yet even simple decisions involve the in tegration of sensory and memory information with emotional and moti-
vational attributes, requiring the concerted action of millions of neurons across brain regions. Therefore, they take
an integrative approach, combining experiments involving well-controlled rodent behavior with electrophysiol-
ogy, molecular perturbations, and quantitative analysis. Their current work seeks to elucidate the neurocom-
putational principles of decision-making, attempting to capture more elusive attributes such as emotion,
motivation, or confidence. This year, Kepecs, in a collaboration with Zachary Mainen and others here at CSHL,
discovered neural signals for confidence in the rat prefrontal cortex. Their study suggests that confidence esti-
mation is a fundamental information-processing mechanism in the brain, shared widely across species, and not
strictly confined to those, such as humans, who are self-aware.
The mammalian brain is a miracle of self-assembly, a process that begins prenatally and continues well into
the postnatal period. Alexei Koulakov and colleagues are trying to determine the mathematical rules by which
the brain assembles itself, with particular focus on the formation of sensory circuits such as those in volved in
visual perception and olfaction. The visual system of the mouse was chosen for study in part because its com-
ponents, in neuroanatomical terms, are well understood. What is not known is how projections are generated
that lead from the eye through the thalamus and into the visual cortex, how an individual’s experience influences
the configuration of the network, and what para meters for the process are set by genetic factors. Even less is
known about the assembly of the neural net within the mouse olfactory system, which, in the end, enables the
individual to distinguish one smell from another with astonishing specificity and to remember such distinctions
over time. These are among the challenges that engage Koulakov and his team.
Dysfunction of excitatory, glutamatergic synapses in the brain is believed to have an important role in the
pathogenesis of major psychiatric disorders, including schizophrenia and depression. But what are the causes?
Where in the brain does this dysfunction occur? How does it result in the behavioral symptoms of illness? To
address these issues, Bo Li and colleagues are studying normal synaptic plasticity and disease-related synap-
tic changes in brain circuits involved in schizophrenia and depression. Their long-term goal is to develop meth-
ods allowing the manipulation of activity in specific brain circuits in order to change disease-related behaviors.
They will use a variety of methodologies, including patch-clamp recording and calcium imaging of labeled neu-
rons, two-photon imaging of spine morphology and tagged receptors, in vivo virus injection, RNAi-based gene
silencing, activation of specific axon terminals using light-gated cation channels, activation or silencing of spe-
cific brain regions using transgenes, and assessment of the behavioral consequences of certain manipulations. 
To better understand neuronal circuits, Josh Huang and colleagues have developed novel means of visu-
alizing the structure and connectivity of different cell types at high resolution in living animals and of manipulat-
ing the function of specific cell types with re markable precision. Huang is particularly interested in circuits that
use GABA, the brain’s primary inhibitory neurotransmitter. The lab’s work has direct implications in neurologi-
cal and psychiatric illness such as autism and schizophrenia, which involve altered development and function
of GABA ergic circuits. This past year, they discovered that neurons connect to very specific partners at very spe-
cific spots in the developing cerebellum, thanks to an underlying framework of mole cu lar “guides” call ed glial
cells that nudge nerve fibers to grow in the right direction and make the right contacts. The lab also made good
progress in studying perturbations in the developing GABAergic system in a mouse model of Rett’s syndrome,
one of the autism spectrum disorders.
Zachary Mainen studies the neural basis of mammalian behavior and cognition. He focuses on under-
standing the nature of the electrical activity of single neurons, the “currency” with which genes and molecules
express themselves in the functioning brain. His lab also studies neural coding, or how information is represented
in characteristic “spikes” of neuronal electrical discharges. This year, in collaboration with Adam Kepecs and
others here at CSHL, he published results of studies in rats suggesting that the estimation of confidence that
underlies decision-making may be the product of a very basic kind of information processing in the brain, shared
widely across species. Separately, Mainen showed that the superior colliculus, a structure implicated in visu-
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ally guided eye movements, has a much more general role in spatial decision-making than previously thought.
Pavel Osten’s lab is developing several approaches to uncover pathol ogies responsible for mental disorders,
including autism spectrum disorders (ASDs) and schizophrenia, and neuro degenerative illnesses such as Parkin-
 son’s and Alzheimer’s. In neuropsychiatric disorders, Osten is exploring the link between candidate genes and
common “core” dysfunctions at the level of neural circuitry, specifically in mouse models of schizophrenia and
autism. The ability to systematically and rapidly compare brain functions, analyze which brain regions are
affected, and determine which cellular networks within these regions are altered is vital in the larger effort to
understand how genes perturb biology, giving rise to symptomatic behavi ors. Osten and collaborators are also
creating automated systems that will take a sample of brain tissue as input, generate a three-dimensional rep-
resentation of its neural circuit activity, and then map it to a brain atlas. The object is to reveal how neural cir-
cuits are wired during development, to make possible precise characterization of neu ral circuit disruptions in
mouse models.
When we learn an association, in for mation from two different sensory streams is somehow bound together
in the brain. For example, the smell of spoiled milk vividly evokes the taste of an injudicious gulp. How are odor
and taste information represented in terms of neural spike trains, and how does learning modify those repre-
sentations to form associative links among stimuli? These are among the questions that drive research in Glenn
Turner’s lab. His team addresses these questions by using a combination of electrophysiological, genetic, and
computational approaches in the fruit fly. They directly monitor activity of neurons in the brain of an intact fly with
whole-cell patch-clamp recordings. Using molecular genetics techniques, they are able to manipulate neural
activity to directly test their predictions about neural coding, at the level of both spike trains and behavior. Cur-
rently, they focus on representations of smell and taste. 
Anthony Zador and colleagues study how brain biology gives rise to higher-level properties such as com-
plex behavior. They have focused on how the cortex processes sound, how that processing is modulated by
attention, and how it is altered in pathology. In the lab’s “core assay,” the response of single neurons to sound
stimuli is examined under distinct behavioral conditions. In animal models of autism, the team is trying to link
an in ability to screen out background sounds with changes in neural circuits. Sepa rately, by showing that a very
small minority of available auditory neurons in a rat cortex react strongly when exposed to a specific sound, the
lab has challenged the standard model of sound representation. This year, Zador’s team generated evidence
supportive of an alternative theory of in for mation processing in the brain, showing that animals in the midst of
decision-making have the ability to distinguish incoming signal spikes separated by as little as 3 milliseconds.
This lends credence to a timing mod el of information processing as opposed to one based on the rate of sig-
nal firing. 
Yi Zhong’s lab studies the neural basis of learning and memory. They work with fruit fly models to study genes
involved in human cognitive disorders, including neurofibromatosis, Noonan’s syndrome, and Alz heim er’s dis-
ease. Mutations of the neuro fi bro matosis 1 (NF1) gene cause learning defects and neurofibromas—nerve-
sheath tumors that split apart nerve fibers. The lab’s analyses of Dro soph ila NF1mutants have revealed how
ex pression of the mutant gene affects a pathway crucial for learning. They have also discovered that the NF1
gene and a gene called corkscrew, both implicated in Noonan’s, share a biochemical pathway. This year, they
linked specific genet ic defects in Noonan’s with long-term memory defici encies that are among the symptoms
of the illness. They postulate a “spacing effect,” which, if addressed with remedial learning methods, might help
to address the impairment. Zhong also contributed to a study in which plaques implicated in Alzheim er’s mem-
ory loss were experimentally reduced in the fruit fly brain by overexpressing a human gene that codes for the
production of an enzyme called neprilysin, or NEP. 
How does the brain encode stimuli from the outside world to generate specific perceptions that, in turn, trig-
ger complex behaviors? How is the brain shaped by sensory experience and what modifications occur in neu-
ronal circuits that allow us to learn and remember? These are questions guiding the work of CSHL Fellow Florin
Albeanu, who is using the olfactory bulb in living mice as the subject of his current studies. Rodents depend
on olfaction for finding food and mates and avoiding predators. Airborne chemicals, translated into neuronal sig-
nals by specific receptors in the nose, are sent directly to the olfactory bulb. Although readily accessible, little is
known about the neuronal processing that occurs there. Technologi cal advances in optical imaging enable
Albeanu to monitor patterns of activity at unprecedented synaptic resolution, in real time, as animals “behave.”  
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Our research explores mechanisms regulating brain cir-
cuit development. My lab addresses this fundamental
question by examining the development of the visual
system in Xenopus tadpoles and the development of the
spinal cord in zebra fish. We focus on activity-dependent
regulation of circuit function. These studies have rele-
vance to fundamental features of circuit development.
Rapid Activity-dependent Delivery
of the Neurotrophic Protein CPG15
to the Axon Surface of Neurons in
Intact Xenopus Tadpoles
I. Cantallops, H. Clline
CPG15 (also known as Neuritin) is an activity-induced
GPI-anchored axonal protein that promotes dendritic
and axonal growth and accelerates synaptic maturation
in vivo. Here, we show that CPG15 is distributed inside
axons and on the axon surface. CPG15 is trafficked to
and from the axonal surface by membrane depolariza-
tion. To assess CPG15 trafficking in vivo, we expressed
an ecliptic pHluorin (EP)-CPG15 fusion protein in optic
tectal explants and in retinal ganglion cells of intact
Xenopus tadpoles. Depolarization by KCl increased EP-
CPG15 fluorescence on axons. Intraocular kainic acid
(KA) injection rapidly increased cell surface EP-CPG15
in retinotectal axons, but coinjection of tetrodotoxin
(TTX) and KA did not. Consistent with this, we find
that intracellular CPG15 is localized to vesicles and
endosomes in presynaptic terminals and colocalizes
with synaptic vesicle proteins. The results indicate that
the delivery of the neurotrophic protein CPG15 to the
axon surface can be regulated on a rapid timescale by
activity-dependent mechanisms in vivo.
Homer Proteins Shape Xenopus
Optic Tectal Cell Dendritic Arbor
K. Van Keuren-Jensen, H. Cline
Considerable evidence suggests that the Homer family of
scaffolding proteins contributes to synaptic organization
and function. We investigated the role of both Homer 1b,
the constitutively expressed and developmentally regu-
lated form of Homer, and Homer 1a, the activity-induced
BRAIN DEVELOPMENT AND PLASTICITY
H. Cline J. Bestman S.-L. Chiu S.-Y. Lee P. Sharma
K. Bronson J. Demas J. Lee-Osbourne W. Shen
K. Burgos M. Hiramoto J. Li V. Thirumalai
immediate-early gene, in dendritic arbor elaboration and
synaptic function of developing Xenopus optic tectal neu-
rons. We expressed exogenous Homer 1a or Homer 1b in
developing Xenopus tectal neurons. By collecting in vivo
time-lapse images of individual, enhanced green fluores-
cent protein (EGFP)-labeled and Homer-expressing neu-
rons over 3 days, we found that Homer 1b leads to a
significant decrease in dendritic arbor growth rate and
arbor size. Synaptic transmission was also altered in
developing neurons transfected with Homer 1b. Cells
expressing exogenous Homer 1b over 3 days had signifi-
cantly greater AMPA (α-amino-3-hydroxy-5-methyl-4-
isoxazole proprionic acid)  to NMDA (N-methyl-D-
aspartate) ratios, and increased AMPA miniature excita-
tory postsynaptic currents (mEPSC) frequency. These
data suggest that increasing Homer 1b expression in-
creases excitatory synaptic inputs, increases synaptic mat-
uration, and slows dendritic arbor growth rate. Exogenous
Homer 1a expression increases AMPA mEPSC frequency,
but it did not significantly affect tectal cell dendritic arbor
development. Changes in the ratio of Homer 1a to Homer
1b may signal the neuron that overall activity levels in the
cell have changed, and this in turn could affect protein
interactions at the synapse, synaptic transmission, and
structural development of the dendritic arbor.
Endogenous Dopamine Suppresses
Initiation of Swimming in Pre-feeding
Zebra Fish Larvae
V. Thirumalai
Dopamine is a key neuromodulator of locomotory cir-
cuits, yet the role that dopamine has during development
of these circuits is less well understood. We found that
dopamine depresses the activity of swim circuits in larval
zebra fish. Zebra fish larvae exhibit marked changes in
swimming behavior between 3 days postfertilization (dpf)
and 5 dpf. We found that swim episodes were fewer and of
longer durations at 3 dpf than at 5 dpf. At 3 dpf, applica-
tion of dopamine as well as bupropion, a dopamine reup-
take blocker, abolished spontaneous fictive swim epi-
sodes. Blocking D2 receptors increased frequency of
occurrence of episodes, and activation of adenylyl cyclase,
a downstream target inhibited by D2 receptor signaling,
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sponses in optic tectal neurons in living Xenopus tadpoles.
Tectal neurons transfected with dominant-negative insulin
receptor (dnIR), which reduces insulin receptor phosphor-
ylation, or morpholino against insulin receptor, which
reduces total insulin receptor protein level, have signifi-
cantly smaller light-evoked responses than controls. dnIR-
expressing neurons have reduced synapse density as as-
sessed by electron microscopy, decreased AMPA mEPSC
frequency, and altered experience-dependent dendritic
arbor structural plasticity, although synaptic vesicle release
probability, assessed by paired-pulse responses and syn-
apse maturation, assessed by AMPA/NMDA ratio and ultra-
structural criteria, are unaffected by dnIR expression. These
data indicate that insulin receptor signaling regulates circuit
function and plasticity by controlling synapse density.
The Regulation of Dendritic Arbor
Development and Plasticity by
Glutamatergic Synaptic Input:
A Review of the Synaptotrophic
Hypothesis’
H. Cline [in collaboration with K. Haas, University of British
Columbia, Canada] 
The synaptotropic hypothesis, which states that synaptic
inputs control the elaboration of dendritic (and axonal)
arbors, was articulated by Vaughn in 1989. Today, the role
of synaptic inputs in controlling neuronal structural devel-
opment remains an area of intense research activity. Sev-
eral recent studies have applied modern molecular genetic,
imaging, and electrophysiological methods to this ques-
tion and now provide strong evidence that maturation of
excitatory synaptic inputs is required for the development
of neuronal structure in the intact brain. Nevertheless,
some studies fail to show evidence that afferent inputs
affect structural development. We review data that both
support and refute the hypothesis with the expectation that
understanding the circumstances when the data do and do
not support the hypothesis will be most valuable.
NR2A and NR2B Have Distinct but
Overlapping Roles in Shaping the
Development of Dendritic Arbor
Morphology In Vivo
R.C. Ewald, K.R. Van Keuren-Jensen, C.D. Aizenman
NMDA receptors (NMDARs) are important for neuronal
development and circuit formation. The NMDAR subunits
NR2A and NR2B are biophysically distinct and differen-
tially expressed during development, but their individual
contribution to structural plasticity is unknown. Here, we
blocked the inhibitory effect of dopamine. Dopamine had
no effect on motor neuron firing properties, input imped-
ance, resting membrane potential, or the amplitude of
spike after hyperpolarization. Application of dopamine
either to the isolated spinal cord or locally within the cord
does not decrease episode frequency, whereas dopamine
application to the brain silences episodes, suggesting a
supraspinal locus of dopaminergic action. Treating larvae
with 10 µM MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahy-
dropyridine) reduced catecholaminergic innervation in the
brain and increased episode frequency. These data indi-
cate that dopamine inhibits the initiation of fictive swim-
ming episodes at 3 dpf. We found that at 5 dpf, exogen-
ously applied dopamine inhibits swim episodes, yet the
dopamine reuptake blocker or the D2 receptor antagonist
have no effect on episode frequency. These results led us
to propose that endogenous dopamine release transiently
suppresses swim circuits in developing zebra fish.
The RNA-binding Protein CPEB
Controls Dendrite Growth and
Neural Circuit Assembly In Vivo
J. Bestman
Visual system development requires experience-dependent
mechanisms that regulate neuronal structure and function,
including dendritic arbor growth, synapse formation, and
stabilization. Although RNA-binding proteins have been
shown to affect some forms of synaptic plasticity in adult
animals, their role in the development of neuronal structure
and functional circuitry is not clear. Using two-photon
time-lapse in vivo imaging and electrophysiology com-
bined with morpholino-mediated knockdown and expres-
sion of functional deletion mutants, we demonstrate that
the mRNA-binding protein cytoplasmic polyadenylation
element-binding protein1 (CPEB1) affects experience-
dependent neuronal development and circuit formation in
the visual system of Xenopus laevis. These data indicate
that sensory experience controls circuit development by
regulating translational activity of mRNAs.
Insulin Receptor Signaling Regulates
Synapse Number, Dendritic Plasticity,
and Circuit Function In Vivo
S.-L. Chiu, C.-M. Chen
Insulin receptor signaling has been postulated to have a
role in synaptic plasticity; however, the function of the
insulin receptor in the central nervous system (CNS) is not
clear. To test whether insulin receptor signaling affects
visual system function, we recorded light-evoked re-
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test whether NR2A and NR2B subunits have specific
functions in the morphological development of tectal neu-
rons in living Xenopus tadpoles. Exogenous subunit
expression and endogenous subunit knockdown shift the
synaptic NMDAR composition toward NR2A or NR2B,
as shown electrophysiologically. We analyzed the dendritic
arbor structure and found evidence for both overlapping
and distinct functions of NR2A and NR2B in dendritic
development. Control neurons obtain regions of high local
branch density in their dendritic arbor, whereas exogenous
expression of either NR2A or NR2B decreases local
branch clusters, indicating a requirement for both subunits
in dendritic arbor development. Knockdown of endoge-
nous NR2A, however, reduces local branch clusters com-
pared to knockdown of NR2B, suggesting more complex
NR2 signaling. Analysis of the underlying branch dynam-
ics shows that exogenous NR2B-expressing neurons are
more dynamic than control or exogenous NR2A-express-
ing neurons, demonstrating subunit-specific regulation of
branch dynamics. However, visual experience-dependent
increases in dendritic arbor growth rate seen in control
neurons are blocked in both exogenous NR2A- and
NR2B-expressing neurons. Furthermore, AMPAR-medi-
ated synaptic transmission is decreased in neurons with
knocked down or exogenous NMDAR composition, indi-
cating overlapping roles for NR2A and NR2B in regulat-
ing synaptic transmission. Thus, we show that NR2A and
NR2B have subunit-specific properties in dendritic arbor
development but also overlapping functions, indicating a
requirement for both subunits in neuronal development.
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Understanding complex behaviors such as memory will
require a multidisciplinary approach that will include
discovery and manipulation of the relevant genetic/cell
signaling pathways and the relevant neural circuits.
Work in genetic model systems such as Drosophila can
contribute to our understanding in several ways. First,
by enabling discovery of genes and genetic pathways
underlying behavior, such model systems provide entry
points for dissection of cellular mechanisms that are
often conserved. Second, systematic manipulation of
gene function in relevant anatomical loci of the brain
allows a conceptual integration of findings from cellu-
lar and behavioral neuroscience. Our gene discovery
efforts already have identified a role in memory for
highly conserved pathway(s) involved with subcellular
control of translational regulation. Many of these mol-
ecules have counterparts in vertebrates that also appear
to have important roles in brain function and, in some
cases, may be linked to human cognitive dysfunction.
Our genetic investigations also provide insight to inves-
tigate the neural circuitry relevant to memory because
gene expression patterns often suggest hypotheses that
can be tested spatially to restricted genetic manipula-
tions. Our recent findings demonstrate that short- and
long-term memory are supported by anatomically dis-
tinct memory traces. This too appears to reflect a fun-
damental (but poorly understood) feature of memory
formation. Finally, at the behavioral level, we are uncov-
ering properties of learned fear that may be relevant to
fear disorders in humans.
Synaptic Targets of Pumilio
J. Dubnau, W. Li 
Using a series of genome-wide screens, we identified a
role in memory for a number of mRNA-binding proteins
(Dubnau et al., Curr. Biol. 13: 286 [2003]). These include
several with known roles in mRNA localization and trans-
lational control. In humans, cellular mechanisms of local
translation are of relevance to the etiology of fragile-X
mental retardation syndrome. Our genetic studies in
Drosophila already support a role in memory for several
components of this cellular machinery. These include
GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Blum W. Li
M. Cressy H. Qin
staufen and oskar, which are known components of cel-
lular mRNA localization machinery in oocytes, and
pumilio, which is a translational repressor protein whose
vertebrate orthologs are highly conserved but largely
unstudied. Although pumilio function has been most care-
fully studied in the context of embryonic patterning, sev-
eral recent findings demonstrate that pumilio also has an
important role in the nervous system, including long-term
memory formation (see, e.g., Dubnau et al., Curr. Biol.
13: 286 [2003]; Berger et al. 2008; Chen et al. 2008). In
neurons, pumilio appears to have a role in homeostatic
control of excitability via down-regulation of para, a volt-
age-gated sodium channel, and it may more generally
modulate local protein synthesis in neurons via transla-
tional repression of eIF-4E. Aside from these, the bio-
logically relevant targets of pumilio in the nervous system
were largely unknown in any species. 
We hypothesized that pumilio might have a role in
regulating the local translation underlying synapse-spe-
cific modifications during memory formation. To iden-
tify relevant translational targets, we used an
informatics approach (in collaboration with M. Zhang’s
lab here at CSHL) to predict pumilio targets among
mRNAs whose products have synaptic localization
(Chen et al. 2008). We then used both in vitro binding
and two in vivo assays to functionally confirm the
fidelity of this informatics screening method. We found
that pumilio strongly and specifically binds to RNA
sequences in the 3′UTR (untranslated region) of four of
the predicted target genes, demonstrating the validity
of our method. We then demonstrated that one of these
predicted target sequences, in the 3′UTR of discs large
(dlg1), the Drosophila PSD95 ortholog, can function-
ally substitute for a canonical Nanos response element
(NRE) in vivo in a heterologous functional assay in the
embryo. We also demonstrated that the endogenous
dlg1 mRNA can be regulated by pumilio in a neuronal
context, the adult mushroom bodies (MBs), which is an
anatomical site of memory storage (Fig. 1). Our current
efforts focus on several additional neuronal targets of
pumilio, construction of in vivo sensors to image local
neuronal translation, and higher-throughput in vivo
approaches to fully characterize the combinatorial
action of pumilio and other regulators to control neu-
ronal translation. 
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MB neuron subtypes for each of the temporal phases of
memory (Blum and Dubnau, in press). We spatially
restricted expression of the rutabaga+ cDNA to each
of the major subtypes of MB neurons and examined
memory during a time course after training. Using this
approach, we are able to separately restore short- and
long-term memory traces to a rutabaga mutant with
expression of rutabaga in different subsets of MB neu-
rons (see, e.g., Fig. 2). Our findings suggest a model in
which the learning experience initiates two parallel
associations: a short-lived trace in MB γ neurons and a
long-lived trace in α/β neurons (Blum and Dubnau, in
press). 
Enhancer/Suppressor Screening
by Selective Breeding: Modeling
Rubenstein-Taybi Syndrome
in Drosophila
M. Cressy, J. Dubnau [in collaboration with P. Mitra and
D. Valente, Cold Spring Harbor Laboratory]
Most quantitative phenotypes have a complex genetic
etiology. Even in cases with an apparently “simple”
Mendelian inheritance, epistatic interactions within
genetic background can have profound impacts on phe-
notype. In addition to its obvious importance to our
understanding of genotype to phenotype relationships,
“sensitivity to genetic background” can impact both
severity and clinical outcome of genetic disorders.
Rubinstein-Taybi syndrome (RTS), for instance, is a rare
congenital disorder characterized in part by mental
retardation. In greater than 50% of patients, RTS is
caused by mutations in one copy of the cAMP response
element binding (CREB)-binding protein (CBP) located
in 16p13.3. Mouse models of this disorder demonstrate
that the cognitive defects of the CBP mutants can be res-
cued by pharmacological stimulation of cAMP signal-
ing. Even with this relatively simple inheritance pattern,
however, there is considerable clinical variability both
among RTS patients and between CBP mutant mice in
different genetic backgrounds.
Despite its widespread relevance, the mechanisms by
which multigene interactions modulate phenotype are ill
understood. Historically, experimental dissection of gene
interaction has depended on two strategies: forward muta-
genesis and selective breeding. Each of these approaches
has its own limitations. Forward mutagenesis has tradi-
tionally been the workhorse for the genetic dissection of
cellular mechanisms and entails a two-tiered strategy.
First is the identification of individual genes that influ-
ence a particular phenotype, followed by analysis of pair-
Neural Circuitry of Memory
A. Blum, J. Dubnau 
A common feature of memory and its underlying
synaptic plasticity is that each can be dissected into
short-lived forms involving modification or traffick-
ing of existing proteins and long-term forms that
require new gene expression. An underlying assump-
tion of this cellular view of memory consolidation is
that these different mechanisms occur within a single
neuron. At the neuroanatomical level, however, differ-
ent temporal stages of memory can engage distinct
neural circuits, a notion that has not been conceptually
integrated with the cellular view. We have investigated
this issue in the context of aversive Pavlovian olfactory
memory in Drosophila. Previous studies have demon-
strated a central role for cAMP signaling in the MB.
The Ca2+ responsive adenylyl cyclase rutabaga is
believed to be a coincidence detector in one of the three
principal classes of MB Kenyon cells. We have con-
ducted the first systematic investigation of the require-
ments for cAMP signaling in each of the three major
FIGURE 1 Dlg is repressed by overexpression of Pum in MB
Kenyon cells. An MB-expressing Gal4 line (OK107) was used to
drive expression of both UAS-mCD8::GFP and UAS-Pum trans-
genes. Shown are optical sections of the MB lobes. In wild type
(top), Dlg expression is detected both in MB lobes and AL and in
the MB peduncle (not shown). In contrast, Dlg expression is dra-
matically reduced in the MB lobes (bottom) and peduncle (not
shown) of Pum overexpressing MBs. AL glomeruli, also stained
by Dlg antibody, serve as an internal control.
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FIGURE 2 rutabaga expression in γ neurons supports short-term but not long-term memory. In contrast, rutabaga expression in α/β
neurons supports long-term but not short term memory. Memory retention was tested 2 min (a) and 3 h (b) after a single training ses-
sion as well as 24 hours after either massed (c) or spaced (d) training. Only spaced training gives CREB-dependent long-term mem-
ory. In each case, performance was compared among the following groups: rut2080 mutant males with a UAS-rut+ transgene but no
Gal4 driver (rut2080/Y;UAS-rut), rut2080 heterozygous females with a UAS-rut+ transgene but no Gal4 driver (rut2080/+;UAS-rut),
rut2080 mutant males with a UAS-rut+ transgene and either the 201Y or C739 drivers alone, or the 201Y and C739 Gal4 drivers com-
bined, and rut2080 heterozygous females with a UAS-rut+ transgene and these Gal4 lines. In contrast with the rut2080/Y;UAS-rut
mutant males, rut2080 mutant males with both a UAS-rut+ transgene and either the 201Y or 201Y combined with C739 Gal4 drivers
exhibit nearly normal levels of performance measured 2 min after training, whereas C739 expression caused no improvement (P < 0.05,
N = 6 for all groups) (a) and only expression combined with both the 201Y and C739 drivers significantly improved performance 3 h
after a single training session (P < 0.05, N = 8 for all groups) (b). Only expression combined with both the 201Y and C739 drivers sig-
nificantly improved performance 24 h after massed training (P < 0.05, N = 18 for all groups) (c). For 24 h after spaced training, expres-
sion with the C739 driver alone resulted in significant improvement of performance; however, this effect was augmented by combining
both C739 and 201Y expression (P < 0.05, N = 23 for all groups). In all cases, no significant improvements were observed in control
females that were rut2080/+;UAS-rut and contained a Gal4 line with the exception of flies carrying both the 201Y and C739 drivers com-
bined after spaced training.
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wise gene interactions via modifier screens. Although this
strategy has been tremendously successful at revealing
fundamental molecular mechanisms, it has not fully mod-
eled the complexity of gene networks underlying pheno-
type. On the other hand, multigenerational selective
breeding has been successfully used to study the genetic
architecture underlying complex phenotypes across a
wide variety of organisms. This strategy more closely
models the multigene interactions that influence pheno-
type and that may be relevant to the natural evolution of
phenotypic change. Unlike forward mutagenesis, how-
ever, when used on its own, this strategy does not eluci-
date the underlying molecular mechanisms.
We have developed a novel approach that combines
the strengths of these two methods. Our approach relies
on artificial selection over the course of multiple gen-
erations to “evolve” combinations of known and mole-
cularly tagged gene variants that interact to modify the
memory defect of the rutabaga adenylyl cyclase. This
is an attempt to model the effects of genetic back-
ground on phenotypic severity in RTS and is also
designed to use experimental evolution to mimic clas-
sical suppressor screens. We first established large pop-
ulations of animals that are homozygous for a null
mutation in the rutabaga gene. These populations were
engineered to contain controlled heterogeneity at 23
loci that were first identified via a forward mutagene-
sis (Dubnau et al., Curr. Biol. 13: 286 [2003]). Each
animal in the starting population was homozygous for
a different combination of three or four of these 23
mutations. Thus, the possible allele space is combina-
torially quite large. The second stage of this project is
multigenerational selective breeding to evolve combi-
nations of alleles that are capable of suppressing the
rutabaga learning defect. At this date, we have carried
the selection on three replicate populations for 34 gen-
erations (Fig. 3). Control populations are allowed to
drift in parallel. A robust response to selection is seen
beginning at about generation 13. The third stage of this
experiment involves a high-throughput genotyping to
FIGURE 3 Experimental evolution of rutabaga suppression:
Modeling gene interactions underlying the Rubenstein-Taybi
syndrome. (Top) Selective breeding for combinations among
23 alleles that lead to improved learning in rutabaga
mutants. Mean data are shown over 31 generations for
three replicate selected populations (Morgan, Muller, Lewis)
and three unselected populations (Bridges, Sturtevant,
Dobzhansky). All animals are homozygous null for rutabaga
and contain controlled heterogeneity at 23 loci that were first
identified in a forward mutagenesis screen (Dubnau et al.,
Curr. Biol. 13: 286 [2003]). The performance index (PI) for
each population is determined at each generation using our
standard Pavlovian olfactory learning assay. (Bottom) High-
throughput multiplex polymerase chain reaction (PCR) was
used to determine the genotypes of ~300 animals from each
population. This genotyping was performed at generation
11 and 25 for each population. Allele frequencies for each of
the 23 loci are shown. Six alleles with frequencies that are
significantly elevated in the selected strains (E4299, D0077,
E3272, E3145, D0940, and E3945) were chosen for mech-
anistic studies of pairwise and triplet interactions.
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determine allele frequencies and coinheritance patterns
across the replicate populations (Fig. 3). These data
identify at least six alleles whose frequencies are sig-
nificantly increased in the selected versus unselected
populations. We now are testing the phenotypic conse-
quences of each single, double, and triple mutant com-
bination of these six alleles.
Extinction Learning: A Model
for Posttraumatic Stress
Disorder
H. Qin, J. Dubnau
Repeated representation of the conditioned stimulus (CS)
without reinforcement of the unconditioned stimulus
(US) results in the diminishment of conditioned respond-
ing. This process is called extinction (of Pavlovian con-
ditioning). Extinction was first studied by Pavlov in 1927
and has been reported in both appetitive and aversive par-
adigms. Extinction is not simply erasing the original CS-
US association but appears to be a new learning process
that antagonizes the original memory. Although this type
of learning is important biologically, it has also received
attention because of its potential relevance to posttrau-
matic stress disorder (PTSD), in which an individual con-
tinues to fear a particular set of stimuli or a context. This
debilitating fear can be highly resistant to extinction.
We are taking advantage of the abundant molecular
and genetic tools of Drosophila melanogaster to inves-
tigate mechanisms of extinction following Pavlovian
“fear” learning. We have established a robust assay of
extinction (Fig. 4) and have tested a series of the classic
learning mutants for effects on extinction. The surpris-
ing result from this analysis is that we observed a robust
extinction learning in mutations that disrupt either
FIGURE 4 Extinction of “fear” conditioning in
Drosophila. Extinction paradigm (top panel)
involves three stages. First, animals are trained
in a Pavlovian olfactory avoidance assay using
ten sessions of spaced training. This leads to a
robust and stable long-term “fear” memory.
Second, 24 h after training, animals are sub-
jected to varying numbers of extinction learning
sessions that consist of repeated exposure to
the odors in that absence of electric shock
reinforcement. Finally, the animals are tested
for avoidance of the conditioned odor. Using 5,
15, or 30 sessions of extinction, we observed
a robust extinction of the fear avoidance (mid-
dle panel). Control groups receive exposure to
air only. Our genetic investigations of extinction
show that this form of learned safety is resist-
ant to disruption of key signaling pathways with
established roles in synaptic plasticity. These
include cAMP signaling (not shown) as well as
NMDA-R1 (bottom panel). NMDA-R1 mutant
animals (EP331) display significantly reduced
fear memory to begin with, but this residual
memory can be extinguished robustly (com-
pared with wild-type 2202U animals).
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cAMP signaling or N-methyl-D-aspartate (NMDA)
receptor function. We also observed extinction in muta-
tions that disrupt either short-term or long-lived mem-
ory. In contrast, genetic disruption of the development
of a single neural cell type appears to block extinction
(Qin and Dubnau, in prep.). These results establish an
entry point to dissect the neural circuits that serve fear
conditioning versus extinction.
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The focus of our research is on stem cells in the adult
organism and signaling molecules that control their self-
renewal and fate. Our main focus is on stem cells of the
adult nervous system. These cells retain the ability to
produce new neurons throughout adult life, a function
that may be important for learning and memory, mood
regulation, and brain repair. We use animal models to
study the fate of neural stem cells and to learn how dif-
ferent physiological stimuli—aging, disease, and thera-
pies—affect stem cells of the adult brain. We also study
stem cells of other tissues, with the goal of finding com-
monalities in the decisions that different types of stem
cells make on whether to stay quiescent, produce pro-
geny, or differentiate. We also study the signals that
mediate interactions between stem cells and their micro-
environment, with particular attention to the versatile
signaling molecule nitric oxide (NO). Finally, we are
trying to translate the knowledge that we generate with
animal models to human studies.
DEFINED STAGES OF THE NEUROGENIC
CASCADE IN THE ADULT HIPPOCAMPUS
New neurons are continuously generated in the hip-
pocampus. They are born from neural stem cells, after
proceeding through a cascade of events that include
symmetric and asymmetric divisions, exit from the cell
cycle, programmed elimination, and continuous
changes of morphology; this cascade culminates with
the young neuron establishing connections with other
cells and becoming integrated into the preexisting neu-
ronal circuitry. The generation of new neurons from
stem cells is a highly dynamic process. It responds to a
wide range of intrinsic and extrinsic factors that can
enhance or suppress neurogenesis and may affect any
step of the differentiation cascade. We aim to define
each step of the cascade and determine the targets of
important pro- or antineurogenic stimuli. Our main
approach is to generate transgenic reporter animal
lines, use them to dissect the neurogenesis cascade into
distinct stages, and then identify the steps that are
specifically affected by a particular stimulus. We have
now combined a new approach for labeling dividing
cells that greatly increases the resolution of the cell
STEM CELLS, SIGNAL TRANSDUCTION, AND BRAIN FUNCTION
G. Enikolopov M.-T. El-Daher J.-H. Park
J.M. Encinas N. Peunova
T. Michurina
cycle analysis, lineage-tracing techniques, phenotyping
progenitor cell populations, and computational model-
ing, to identify all of the major proliferative steps in the
life cycle of stem and progenitor cells in the adult hip-
pocampus. This allowed us to present a new scheme of
the neuronal differentiation cascade in the hippocam-
pus (Fig. 1); this scheme will now serve as a general
platform upon which we and other researchers will be
able to project the action of any agent that alters neu-
rogenesis. We used this scheme to identify the targets of
various antidepressant drugs and treatments, exercise,
radiation, and chemotherapeutic agents and to address
the mechanisms that control the quiescence, self-
renewal, differentiation, and death of stem cells in the
adult and aging brain.
DIVISION-COUPLED ASTROCYTIC DIFFERENTIATION
OF NEURAL STEM CELLS: A NEW MODEL FOR
ADULT HIPPOCAMPAL NEUROGENESIS
Production of new neurons in the hippocampus dramat-
ically decreases with age, and this decline may underlie
age-related cognitive impairment. The basic mechanisms
of the age-related decline in hippocampal neurogenesis
are not known. We used reporter transgenic lines, lineage
tracing, pulse-chase labeling, and computational model-
ing to demonstrate that the main mechanism driving the
age-related decrease in hippocampal neurogenesis is the
disappearance of neural stem cells via their conversion
into hippocampal astrocytes and that the disappearance
of the stem cells is linked to their division (collaboration
with Dr. Alex Koulakov at CSHL). In contrast to the con-
ventional model of continuously self-renewing stem cells
that undergo repeated cycles of division and quiescence,
our results show that upon exiting their quiescent state,
adult hippocampal stem cells rapidly undergo a series of
asymmetric divisions to produce symmetrically dividing
progeny, then exit the last cell cycle, convert into astro-
cytes, and leave the pool of stem cells; the gain in astro-
cytes is the result of the loss in stem cells. Thus, the
decrease in the number of neural stem cells in the hip-
pocampus is a division-coupled process and is a direct
consequence of their functioning to produce new neu-
rons. We now present a new scheme of the neurogenesis
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TRACKING NEUROGENESIS IN
THE LIVE BRAIN
Changes in neurogenesis are associated with a host of
conditions, including psychiatric and neurological dis-
orders. A noninvasive method would be of key impor-
tance for harnessing the full potential of neural stem cells
in health and disease; however, present imaging tech-
nologies cannot be applied for identification of neural
stem cells in the live human brain. Recently, in a collab-
orative effort with scientists at Stony Brook University
and Brookhaven National Laboratory, we developed a
new approach, based on proton magnetic resonance
spectroscopy (1H-MRS), for detecting stem and progen-
itor cells in the live human and animal brain (Manganas
et al., Science 318: 980 [2007]). Our findings open the
possibility of investigating the role of stem cells and neu-
rogenesis in a wide variety of human brain disorders and
evaluating the efficiency of therapeutic interventions.
In an important further advance, our current collabo-
ration with Dr. Helene Benveniste (Brookhaven National
Laboratory) resulted in development of a new signal-pro-
cessing protocol based on a commercial program devel-
oped specifically for the automatic quantitation of in
vivo proton magnetic resonance (MR) spectra and is thus
easier to reproduce. We have already used this approach
to follow the changes in the live brain after electrocon-
vulsive shock, combined with double S-phase analysis
of cell division. These experiments confirmed our pre-
vious data, generated with a different signal-processing
protocol, thus further validating the approach. They also
pointed to additional markers of neurogenesis and helped
to correlate the MRS signal with a specific division
phase of the neurogenesis cascade. Importantly, these
new results produced a robust experimental framework
for detecting neurogenesis in the live brain. We will now
cascade in the adult hippocampus. We also propose a
“disposable stem cell” model to explain the disappear-
ance of hippocampal neural stem cells, the appearance of
new astrocytes, the remodeling of the neurogenic niche,
and the age-related decline in the production of new neu-
rons.
NEUROGENIC TARGETS OF
ANTIDEPRESSANT THERAPIES
Emerging evidence indicates a close link between the
action of a diverse range of antidepressant therapies and
augmented generation of new neurons in the adult hip-
pocampus. Moreover, recent findings suggest that adult
hippocampal neurogenesis not only accompanies but is
required for the behavioral effects of antidepressants.
We used the information on the stages of the neuronal
differentiation cascade (above) to determine the cell
populations targeted by various antidepressant therapies
in the adult and developing brain. We aim to determine
whether different types of treatments that regulate mood
converge on the same step in the cascade or if each has
their own target populations, to determine the changes
in division/differentiation cascades induced by these
treatments and to identify signaling molecules that
translate the treatments into an increased number of new
neurons. We have now determined the neurogenic tar-
gets of antidepressant drugs, electroconvulsive shock,
deep brain stimulation, physical exercise, cosmic radi-
ation, and aging. We are now using this information and
the model of stem cell quiescence that we have devel-
oped (above) to identify signals that control the quies-
cence and self-renewal of stem cells, which direct the
differentiation cascade in the adult brain and which can
be used to repair the damaged and aging brain.
FIGURE 1 Neurogenic cascade in the dentate gyrus.
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apply this approach as a powerful noninvasive method
for studying the role of neurogenesis in the live animal
and human brain.
STEM CELLS IN NONNEURAL TISSUES
Adult tissues undergo continuous cell turnover in
response to stress, damage, or physiological demand.
New differentiated cells are generated from dedicated
or facultative stem cells or from self-renewing differen-
tiated cells. Adult stem cells are often morphologically
unspecialized, can survive for a long time or undergo
long-term self-renewal, and are located in specialized
niches that restrict their division and support their undif-
ferentiated status. A number of approaches for identifi-
cation and isolation of adult stem cells include
immunophenotyping, using their label-retaining or
drug-excluding properties, and selective marking. We
generated a series of reporter transgenic mouse lines
where stem and progenitor cells are marked by fluores-
cent proteins (including GFP, CFPnuc, H2B-GFP,
DsRedTimer, and mCherry), driven by the regulatory
elements of the nestin gene. Our original goal was to
mark stem cells of the developing and adult nervous sys-
tem, but we soon realized that the same reporter trans-
gene marks stem and progenitor cells in a range of other
organs and tissues, including nonneuronal tissues. The
list now includes as dissimilar structures as brain and
spinal cord, hair follicles, liver, pancreas, skeletal mus-
cle, testis, ciliary margin of the eye, and anterior pitu-
itary. This observation points to a close (and yet
unexplained) relationship between expression of nestin
and stem-like properties of cell populations in these tis-
sues. It also provides a means of isolating adult stem
and progenitor cells, tracing their lineage, and studying
the mechanisms controlling their quiescence, division,
self-renewal, and differentiation.
We recently used the nestin-expressing feature to
identify and isolate stem cells of the adult anterior pitu-
itary, a key regulator of the endocrine balance in the
adult organism (collaboration with Dr. Geoffrey Rosen-
feld, University of California, San Diego). We detected
nestin-expressing cells in the perilumenal region of the
mature anterior pituitary and, using genetic inducible
fate mapping, demonstrated that they correspond to
stem cells and serve to generate subsets of all six ter-
minally differentiated endocrine cell types of the pitu-
itary gland. Moreover, we found that similar stem-like
undifferentiated cells are present in pituitary carcino-
mas and may represent cancer stem cells. 
When following the lineage of adult stem cells of the
anterior pituitary, we discovered that their role in the
adult gland reflects a novel strategy for tissue mainte-
nance, distinct from the strategies used by dedicated stem
cells (such as hematopoietic stem cells in the bone mar-
row, stem cells in the bulge of the hair follicle, and neu-
ral stem cells in the neurogenic regions of the adult
brain), by facultative stem cells (such as oval cells of the
liver), or by dividing differentiated cells (such as hepa-
tocytes and pancreatic β cells). In the pituitary, adult
stem cells arise as a separate lineage, do not have a role
in embryonic development, and contribute minimally to
the pituitary of the newborn; however, they start func-
tioning soon after birth, colonizing the organ that ini-
tially entirely consisted of differentiated cells derived
from embryonic precursors and contributing prominently
to the adult gland. As a result, adult anterior pituitary
becomes a mosaic organ with two phenotypically simi-
lar subsets of endocrine cells that have different origins
and different life histories. These parallel but distinct lin-
eages of differentiated cells in the gland may help the
maturing organism to adapt to changes in the metabolic
regulatory landscape. We are now investigating whether
the contribution of adult pituitary stem cells is modu-
lated by strong physiological and pathological stimuli.
NO, STEM CELLS, AND DEVELOPMENT
Much of our interest is related to a versatile signaling
molecule, nitric oxide (NO), a crucial regulator of
vasodilation, immunity, and neurotransmission. We
found that in several developmental and differentiation
contexts, NO suppresses cell division, thus helping to
control the balance between proliferation and differen-
tiation. It thus arises as a regulator of stem cell activity
in a range of tissues. For instance, it acts as a negative
regulator of cell division in the developing and adult
nervous system, such that by manipulating NO levels,
we can change the number of neural stem and progeni-
tor cells. Furthermore, we found that the neuronal NO
synthase isoform (nNOS), usually associated with brain
function, regulates hematopoiesis in vitro and in vivo.
nNOS is expressed in adult bone marrow and fetal liver
and is enriched in stromal cells, and there is a strong
correlation between expression of nNOS in a panel of
stromal cell lines and the ability of these cell lines to
support hematopoietic stem cells; NO donors can fur-
ther increase this ability. Moreover, hematopoietic pro-
genitor cells of the bone marrow and spleen are
regulated by nNOS, and in the nNOS knockout line that
we generated, we found an increased number of these
progenitors. These findings extend the role of nNOS
beyond its action in the brain and suggest a model where
nNOS, expressed in stromal cells, produces NO that acts
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as a paracrine regulator of hematopoietic stem cells.
We continue to discover the diversity of the biologi-
cal functions of NO. We are getting particularly inter-
ested in its role as a regulator of morphogenesis during
early development. We found recently that during early
development, NO coordinates two major morphogenetic
processes: cell division and cell movement. Inhibition
of NO synthase during early development of Xenopus
increases proliferation in the neuroectoderm and inhibits
convergent extension in the axial mesoderm and neu-
roectoderm, indicating that during development, NO
suppresses division and facilitates movement of cells.
We further found that NO controls these processes
through two separate signaling pathways. Both of these
pathways rely on RhoA-ROCK signaling but can be dis-
tinguished by the involvement of either guanylate
cyclase or the planar cell polarity regulator Dishevelled.
Concurrent control by NO helps to ensure that the cru-
cial processes of cell proliferation and morphogenetic
movements are coordinated during early development. 
We have discovered yet another role of NO and nNOS
during early development: their function as regulators of
planar polarity of cilia. We found that in the Xenopus
embryo, cilia gradually acquire a planar distribution and
that suppression of XNOS1 (an ortholog of nNOS) activ-
ity destroys this planarity. We then determined the key
partners of XNOS1 and found a new mode of establish-
ing planar polarity by function-dependent stabilization
of cilia growth. In addition to revealing a new role for
NO, these findings highlight developing Xenopus as a
model for the studies of mucosecretory epithelium, crit-
ical for human health and disease.
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The research in my group is aimed at understanding the
molecular basis of cellular signal transduction pathways
that are triggered and regulated by cell surface receptors,
ion channels, transporters, and intramembrane enzymes.
In particular, we elucidate the molecular mechanisms
underlying neurotransmission and neurodegenerative dis-
eases in the brain. Toward this end, we conduct structural
and functional studies on neurotransmitter receptors, ion
channels, transporters, and intramembrane enzymes,
which mediate and regulate the strength of neurotrans-
mission. To achieve our goals, we use X-ray crystallog-
raphy to determine the three-dimensional structures of
target proteins and test structure-based mechanistic
hypotheses by site-directed mutagenesis in combination
with biochemical and biophysical techniques including
electrophysiology. Our group is currently focused on
understanding the structure and function of two classes
of calcium channels: the N-methyl-D-aspartate receptor
(NMDAR) and the calcium homeostasis modulator
(CALHM), dysfunctions of which are highly implicated
in the pathogenesis of Alzheimer’s disease.
STRUCTURE AND FUNCTION OF NMDARS
NMDARs are multimeric ligand-gated ion channels
composed of NR1 and NR2 subunits that bind glycine
and L-glutamate, respectively (Dingledine et al., Phar-
macol. Rev. 51: 7 [1999]). The four distinct NR2 sub-
units, designated A through D, control ion channel
properties, particularly the speed of deactivation kinet-
ics, and show differential spatial and temporal expres-
sion patterns in specific neuronal circuits (Monyer et
al., Neuron 12: 529 [1994]). The large extracellular
region of NMDARs is composed of an amino-terminal
domain (ATD) (Paoletti and Neytin, Curr. Opin. Phar-
macol. 7: 39 [2007]) and a ligand-binding domain
(S1S2) that bind allosteric modulator compounds and
neurotransmitter ligands, respectively. The aim of our
research is to determine the molecular structures of the
extracellular region of NMDARs to understand how
subtype specificity is defined through the architectures
of S1S2 and how binding of modulators such as zinc to
ATD can down-regulate ion channel function. 
MOLECULAR ANALYSIS OF NEURONAL RECEPTORS
AND ION CHANNELS
H. Furukawa E. Karakas
N. Simorowski
MECHANISM OF SPECIFICITY AND SLOW
DEACTIVATION IN NR2D-CONTAINING NMDARS
We established an expression/purification protocol to
obtain a sufficient amount of NR2D proteins in 2007. In
2008, we crystallized and solved the structures of
NR2D S1S2 in complex with various ligands including
L- and D-glutamate, aspartate, NMDA, and NHP5G.
The structure revealed the molecular elements that
define NMDA-subtype specificity and the pattern of
protein conformational variations between the L-gluta-
mate-bound form and the rest of the receptor-ligand
binary complexes (Fig. 1). Using patch-clamp record-
ing, we found that the effect of slow deactivation, which
is a hallmark of NR2D function, is elicited by L-gluta-
mate but not by other agonists. For that reason, we have
hypothesized that the protein conformation seen in the
structure of NR2D S1S2 in complex with L-glutamate
represents the slow deactivation state of the receptors.
We are currently testing this hypothesis by designing
and conducting structure-based mutagenesis around the
region of the conformational variability to further
understand the molecular mechanism for slow deacti-
vation in NR2D-containing NMDARs.
MECHANISM OF ZINC AND
PHENYLETHANOLAMINE INHIBITION
THROUGH THE AMINO-TERMINAL DOMAIN 
In 2007, we initiated an extensive expression screening
on ATDs of different subunits of the NMDARs and
found that rat NR2B ATD can be expressed in insect
cells in a sufficient amount for crystallographic studies.
In 2008, we succeeded in optimizing an expression and
purification protocol for NR2B ATD, crystallizing the
proteins and solving the crystal structures in apo and
zinc-bound states. The current crystallographic study
revealed the overall architecture of the ATD for the first
time and pinpointed the zinc-binding sites (Fig. 2). The
structure has also shown a plausible mechanism by
which phenylethanolamine compounds such as ifen-
prodil may specifically bind to NR2B ATD. 
One interesting observation is the presence of a sub-
unit association with a potential physiological implica-
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phenylethanolamines, and protons to NMDARs inhibits
ion channel activities by using a combination of X-ray
crystallography, biochemistry, and electrophysiology.
STRUCTURE AND FUNCTION OF THE
CALCIUM HOMEOSTASIS MODULATOR
Calcium homeostasis in neuronal synapses is maintained
by cell surface and endoplasmic reticulum (ER) mem-
brane proteins including NMDARs, voltage-gated cal-
cium channels, IP3 receptors, and the recently identified
calcium homeostasis modulator proteins (CALHM)
(Dreses-Werringloer et al., Cell 133: 1149 [2008]). Spa-
tiotemporal regulation of Ca2+ concentration is pivotal
for brain physiology including learning and memory for-
mation. Disruption of calcium homeostasis has long
been suggested to cause neurodegenerative diseases
including Alzheimer’s disease (AD). CALHM, identi-
fied in 2008, is the first Ca2+-regulating protein whose
allelic polymorphism is directly linked to late-onset AD.
Currently, there is little or no knowledge on the func-
tional properties of CALHM. For example, there is no
functional evidence showing what triggers the opening
of CALHM. Thus, by using biochemical, electrophysio-
logical, and structural biological approach es, we are dis-
secting the function of CALHM at a mole cu lar level.
PRECRYSTALLIZATION SCREENING
AND CHARACTERIZATION OF CALHM 
Structural study of eukaryotic integral membranes
remains a field with limited success due to difficulties in
acquiring a sufficient amount of functional protein sam-
ples suitable for crystallographic studies. To increase the
tion. We are currently designing functional experiments
to validate the physiological relevance of the NR2B
ATD dimer in the context of full-length NMDARs.
Another interesting observation is that there are multi-
ple zinc-binding sites within the NR2B ATD structure.
We are conducting site-directed mutagenesis of the zinc-
binding sites in combination with electrophysiology to
determine which zinc sites mediate allosteric inhibition
of ion channel activity. We will continue with our effort
to understand the mechanism by which bindings of zinc,
FIGURE 1 Crystal structure of NR2D S1S2. (A) Crystal structure of NR2D S1S2 in
complex with L-glutamate. (B) Ligand-binding site in complex with NMDA. The NMDA
molecule binds to NR2D through electrostatic interaction and hydrogen bonds (dots).
(C) The two distinct conformations of “hinge” for aspartate-bound and glutamate-
bound forms. The conformations of NMDA-bound and pNHP5G-bound forms are
identical to the L-aspartate-bound form. 
FIGURE 2 Crystal structure of NR2B ATD at low pH. Hexago-
nal crystals of NR2B ATD (A). The crystals diffracted the X-ray to
~2.85 Å (B). Preliminary crystal structure solved by the single
anomalous diffraction method. The NR2B ATD has a bilobed
structure with amino and carboxyl termini (NT and CT) located
at the opposite ends (C). The NR2B ATD protomers form a dimer
in the crystal (D).  
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likelihood of obtaining crystals for X-ray crystallo-
graphic study, it is critical to examine the size homo-
geneity of protein samples before crystallization. The
expression profile and size homogeneity of the proteins
depend on the nature of amino acid sequences. For that
reason, it is advantageous to assess the properties of pro-
tein constructs derived from various species with
sequence variability. My laboratory uses a green fluo-
rescence protein (GFP)-based precrystallization screen-
ing method called fluorescence-coupled size-exclusion
chromatography (FSEC) to quickly analyze cDNAs
from various species for protein expression and size
homogeneity. In this method, cDNAs encoding proteins
of interest are fused to GFP and expressed in mam-
malian, insect, and yeast cells. The GFP fusion proteins,
solubilized in a detergent such as dodecyl maltoside, are
subjected to a size-exclusion chromatography and
detected by GFP fluorescence, instead of conventional
ultraviolet (UV) absorbance. This allows the candidate
proteins to be assayed for size homogeneity without a
need for large-scale expression and purification. 
We are currently subjecting various subtypes of
CALHM cDNAs from Caenorhabditis elegans, mouse,
rat, zebrafish, chicken, and humans to FSEC precrys-
tallization screening to find a CALHM protein
amenable to a  crystallographic study.
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In many areas of the mammalian brain, GABAergic
interneurons are crucial in establishing the functional
balance, complexity, and computational architecture of
neural circuits. GABA-mediated inhibition regulates
synaptic integration, probability, and timing of action
potential generation. Furthermore, interneurons gener-
ate and maintain network oscillations that provide tem-
poral structures for orchestrating activities of neuronal
populations. The rich variety and fine details of inhibi-
tion are achieved by diverse interneuron cell types that
display distinct morphology, physiological properties,
connectivity patterns, and gene expression profiles. The
biophysical properties of different cell types are opti-
mized for generating a rich array of firing patterns and
synaptic dynamics to precisely control electrical signal-
ing in neural networks. Furthermore, interneurons dis-
play class-specific axon arbors and innervation patterns
that distribute their outputs to discrete spatial locations,
cell types, and subcellular compartments in the network.
Like glutamatergic connections, GABAergic synapses
are also modified by usage, leading to reconfiguration
of the inhibitory circuitry by experience. Understand-
ing the organization, function, and plasticity of GABA -
ergic interneurons is key to discovering the general
principles that govern how information is processed by
neural circuits. 
TOWARD A GENETIC DISSECTION
OF THE GABAERGIC SYSTEM
For decades, the heterogeneity of cell types have been a
major challenge to study the GABAergic system using
conventional anatomical and physiological techniques.
The genetic approach is ideal to dissect the complexity
of the GABA system by tapping into the intrinsic gene
regulatory mechanisms that generate and maintain the
diverse cell types. Using mouse genetic engineering
(e.g., gene targeting, bacterial artificial chromosome
[BAC] transgenics, and Cre/loxP recombination-regu-
lated gene expression), we are systematically building
genetic tools for studying GABAergic neurons. We are
generating ~20 knockin “driver lines” expressing Cre or
CONSTRUCTION AND FUNCTION OF THE
GABA INHIBITORY CIRCUITS 
Z.J. Huang Y. Fu D. Kvitsiani R. Pike
M. He M. Lazarus H. Taniguchi
D.K. Krishnan J. Lu P. Wu
S. Kuhlman A. Paul X. Wu
inducible CreER to establish “genetic access” to all
major classes of GABAergic neurons. These driver lines
will allow us to (1) visualize the morphology and con-
nectivity of GABA neurons with synapse resolution, (2)
monitor their activity and plasticity, and (3) manipulate
their function. Our initial characterization of several
lines showed that they gave expected recombination pat-
terns that recapitulated the endogenous cell-type-
specific markers. In collaboration of Dr. Sacha Nelson
at Brandeis University, we are characterizing these
driver lines and establishing a web-based platform for
disseminating mice, reagents, and expression data
(UO1-MH078844-01; NIH Neuroscience Blueprint).
These driver mice will significantly accelerate progress
in studying all aspects of the GABAergic system. 
We recently developed a general and powerful
method that combines Cre-driver mice and virus-medi-
ated gene expression to label and manipulate specific
neuron types in mice (Kuhlman and Huang 2008). We
engineered adeno-associated viruses (AAVs) that
express green fluorescent protein (GFP), dsRedExpress,
or channelrhodopsin (ChR2) upon Cre/loxP recombi-
nation-mediated removal of a transcription–translation
STOP cassette. When applied to the Pv-Cre mice, this
method allowed two-photon imaging of cortical basket
cells and perisomatic synapses in live mice. Genetic
access to specific cell types through Cre driver mice
combined with efficient delivery of conditional viral
vectors to visualize and manipulate these cell types will
herald a new era for studying the organization and func-
tion of mammalian neural circuits. 
MOLECULAR MECHANISMS UNDERLYING
SUBCELLULAR ORGANIZATION OF
GABAERGIC SYNAPSES 
Large principal neurons, such as cortical pyramidal neu-
rons and cerebellar Purkinje neurons, consist of distinct
subcellular domains (spines, dendrites, soma, axon ini-
tial segments, etc) that allow distributed and compart-
mentalized signal processing and increase the
computational power of single neurons. Superimposed
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esize that, similar to the role of glutamate in the devel-
opment of excitatory synapses, GABA signaling is an
activity-dependent mechanism that promotes and coor-
dinates pre- and postsynaptic maturation during the
development of inhibitory synapses. Because GAD67
level is coupled to neuronal inputs, activity-dependent
GABA synthesis and signaling may provide a cell-wide
as well as synaptic mechanism to sculpt GABAergic
connectivity patterns. Our discovery thus provides
major insights into the activity-dependent maturation
and plasticity of inhibitory synapses. We are currently
studying the underlying cellular and molecular mecha-
nisms. 
MATURATION OF INHIBITORY CIRCUITRY
AND CRITICAL PERIOD PLASTICITY 
Maturation of GABA inhibitory circuitry in primary
visual cortex regulates the critical period of ocular dom-
inance (OD) plasticity. We discovered a role for poly-
sialic acid (PSA), presented by the neural-cell-adhesion
molecule (NCAM), in the maturation of GABAergic
synapses, inhibitory transmission, and OD plasticity.
Our results suggest that developmental and activity-
dependent removal of PSA is a permissive mechanism
that regulates the timing of the maturation of GABA
inhibition and onset of OD plasticity (Di Cristo et al.,
Nature Neurosci. 10: 1569 [2007]). 
The cellular mechanisms by which different classes
of inhibitory interneurons regulate OD plasticity are
unknown. The cell-type-specific Cre drivers and Cre-
regulated viral vectors that we have developed provide
an unprecedented opportunity to address this important
question. By targeted multiple patch-clamp recording
of genetically labeled interneurons in visual cortical
slices, we are characterizing the functional maturation of
specific classes of interneurons during the critical
period. By manipulating inhibitory transmission in
defined classes of interneurons in vivo, we will be able
to unravel their specific contribution to OD plasticity
and the critical period. 
GENE EXPRESSION PROFILES IN
GABAERGIC CELL TYPES
We have initiated an effort to characterize gene expres-
sion profiles in several classes of GABAergic interneu-
rons using a procedure to manually purify GFP-labeled
interneuorns from our BAC transgenic reporter mice
(Sugino et al., Nature Neurosci. 9: 99 [2006]). We are
further developing efficient methods to achieve cell-
upon these anatomical and physiological compartments
is the subcellular organization of synaptic connectivity.
In particular, subcellular organization of inhibitory
synapses is essential for regulating synaptic integration,
spike timing, and back propagation in principal neurons.
Until recently, the mechanisms underlying subcellular
synapse organization were almost entirely unknown. We
have demonstrated that subcellular targeting of
GABAergic synapses is guided by genetically deter-
mined mechanisms and does not involve experience-
dependent neural activity (Di Cristo et al., Nature
Neurosci. 10: 1569 [2007]). Furthermore, we discov-
ered that the subcellular distribution of an L1 family
immunoglobulin protein (neurofascin186), recruited by
an ankyrin family membrane skeleton (ankG480), is a
key mechanism that directs basket interneurons to inner-
vate the axon initial segment of Purkinje neurons (Ango
et al., 2008). Importantly, the L1CAM and ankyrin fam-
ilies consist of different members that localize to dis-
tinct subcellular compartments. We recently discovered
that another member of L1CAMs, CHL1 (close
homolog of L1), contributes to the innervation of Purk-
inje cell dendrites by stellate interneurons (Ango et al.
2008). Our findings support the general hypothesis that
members of L1CAMs recruited to subcellular domains
by different ankyrins contribute to subcellular organi-
zation of GABAergic synapses. 
ACTIVITY-DEPENDENT MATURATION
AND PLASTICITY OF INHIBITORY
SYNAPSES AND CIRCUITS
The construction of neural circuits requires activity-
dependent regulation of neurite growth and synapse for-
mation. As key mediators of neural activity, neuro -
trans mitters are particularly well suited to sculpt con-
nections by coupling synaptic transmission with synap-
tic growth and refinement. Indeed, glutamate signaling
regulates nearly all aspects of excitatory synapse devel-
opment and plasticity. The mechanisms underlying
activity-dependent development of inhibitory synapses
and circuits are poorly understood. We have shown that
the maturation of inhibitory synapses targeted to the
soma and proximal dendrites of pyramidal neurons in
visual cortex is regulated by neural activity and visual
experience (Chattopadhyaya et al., J. Neurosci. 24: 9598
[2004]). We further discovered that GABA and its rate-
limiting synthetic enzyme GAD67 act beyond their clas-
sic roles in inhibitory transmission—they also mediate
activity-dependent maturation and plasticity of
inhibitory synapses and innervation patterns (Chat-
topadhyaya et al., Neuron 54: 889 [2007]). We hypoth-
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type-based gene expression profiling in the brain. A sys-
tematic understanding of gene expression profiles
among different classes of interneurons during devel-
opment and in response to stimulus will yield funda-
mental insight into the genetic logic underlying the
construction and function of the GABAergic system. 
GABAERGIC INTERNEURONS AND
NEURODEVELOPMENTAL DISORDERS
Genetic and epigenetic perturbations of the GABAergic
system results in altered development, function, and mal-
adaptive plasticity of neural circuits, aberrant informa-
tion processing, and cognitive deficits in a variety of
psychiatric disorders such as schizophrenia (SZ) and
autism. We have received major funding from the Simons
Autism Research Initiative to study Rett Syndrome
(RTT), the best-characterized form of the autism spec-
trum disorders, caused by mutations in the X-linked gene
MeCP2. Our general hypothesis is that MeCP2mutations
perturb the postnatal maturation of the connectivity, func-
tion, and plasticity in subsets of inhibitory interneurons
in distributed brain areas, leading to altered development,
maladaptive plasticity of neural circuits, and characteris-
tic behavioral deficits. In collaboration of Dr. Sacha Nel-
son at Brandeis University, we combine genetic,
genomic, imaging, and physiological approaches to (1)
identify the subset of GABAergic neurons in specific
brain regions that are influenced by MeCP2mutations at
defined developmental stages, and during experience-
induced plasticity; (2) characterize the impact of muta-
tions on gene expression profiles in specific classes of
neocortical interneuron; and (3) determine the impact of
mutations on the physiological properties and synaptic
innervation pattern of specific classes of neocortical
interneurons. 
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Research in our laboratory focuses on the neurobiologi-
cal mechanisms and computational principles of decision
making. We view complex behaviors as sequences of ele-
mentary decisions that can be conveniently studied in iso-
lation to expose their underlying neural processes. Yet
even simple decisions involve the integration of sensory
and memory information with emotional and motiva-
tional attributes requiring the concerted action of millions
of neurons across brain regions. Therefore, we take an
integrative approach, combining tightly controlled rodent
behavior with electrophysiological recordings to monitor
neural activity, molecular tools to perturb genetically
identified neural circuit elements, and quantitative analy-
sis to guide and sharpen the neurobiological questions.
At present, we are pursuing two broad directions. First,
we seek to understand the principles of decision making
and, in particular, how confidence estimates are com-
puted and used by the brain. Recently, we discovered neu-
ral correlates of decision confidence in the orbitofrontal
cortex of rats, and we are currently investigating both the
neural mechanisms and the algorithms by which this sig-
nal supports adaptive behavior. Second, we want to under-
stand how specific cell types participate in the neural
circuit dynamics of local processing and how different
brain regions with specialized functions coordinate their
activity. Toward these goals, we are adapting molecular
and optical tools for use in behaving mice to identify and
manipulate defined neuronal subtypes and pathways.
Ultimately, we would like to gain mechanistic insights
into decision processes in the hope that these will be of
utility not only for a basic scientific understanding, but
also for better treatments of brain dysfunctions of deci-
sion making, such as pathological gambling, drug abuse,
and anxiety disorders.
Behavioral Tasks to Study
Confidence Judgments
G. Costa, A. Lak [in collaboration with Z.F. Mainen, Instituto Gul-
benkian de Ciêcia (IGC) and Champalimaud Foundation] 
If you are asked to evaluate your confidence in something
you know—how sure are you that it is true—you can read-
ily answer. What is the neural basis for such judgments? Is
NEURAL CIRCUIT DYNAMICS UNDERLYING DECISION MAKING
A. Kepecs G. Costa S. Ranade
D. Kvitsiani J. Sanders 
knowledge about beliefs an example of the human brain’s
capacity for self-awareness? Or is there a simpler expla-
nation that might suggest a more basic yet fundamental
role for uncertainty in neural computation? To study these
questions, we are developing new behavioral tasks.
Our goal was to establish variants of our well-studied
olfactory categorization task, in which an estimate of de -
cision uncertainty or confidence about the original deci-
sion is turned into a behavioral action. We first sought to
develop a task for measuring confidence behaviorally on
a trial-by-trial basis in order to examine the neural mech-
anisms of confidence judgments. To manipulate confi-
dence, we used an olfactory mixture categorization task to
systematically vary decision uncertainty by changing the
ratio of the two components in the odor mixture. To meas-
ure confidence, we delayed reward delivery and then
measured the time an animal was willing to wait at the
reward ports. In incorrect trials (which were only signaled
by the lack of reward delivery), we noticed that rats stayed
longer following difficult (uncertain) decisions than after
easier (certain) decisions. To extend these observations to
correct choices, we introduced a small fraction of “catch”
trials for which reward was omitted. In these omitted
reward trials, rats waited longer on average than in incor-
rect trials. To make these waiting time estimates robust,
we optimized the parameters of this task to maximize the
differences in waiting time for different levels of uncer-
tainty. In this new task, the duration the rats are willing to
wait at the reward port reflects decision uncertainty.
Therefore, this task will allow us to examine how the tim-
ing of the decision to leave the reward port (“leaving deci-
sion”) depends on the uncertainty about the original
decision. This will allow us to study how access to an
internal measure of decision confidence is used in an
adaptive behavior and to examine the nature of the neu-
ral processes underlying decision confidence.
Causal Role of Orbitofrontal Cortex in
Confidence-guided Decisions
A. Lak, G. Costa [in collaboration with Z.F. Mainen, IGC]
We previously discovered neurons in the orbitofrontal
cortex (OFC) that signal decision confidence. We are
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their decision strategy even after extensive training. For
difficult decisions (those near the category boundary),
the outcome is very informative about location of the
decision boundary, whereas the outcome of pure odor
trials (far from the decision boundary) reveals little
about the boundary. Therefore, statistical principles sug-
gest that the decision boundary should be adjusted more
following difficult trials with high uncertainty than for
trials with no uncertainty. Consistent with this, we found
that rats biased their decisions toward the most recently
rewarded direction, as if their decision boundary was
shifted. Moreover, the magnitude of this bias was pro-
portional to the uncertainty of the previous decision, as
predicted. This bias, however, was only observed for dif-
ficult decisions, suggesting that the category boundary
and not the side-bias, was being updated. Therefore, our
results show that rats are “active learners,” combining
reward feedback and decision uncertainty estimates to
update their decision strategy.
These findings establish a new learning phenome-
non, in which animals appear to use their uncertainty to
adjust their learning. Future studies will examine the
neural basis of this active learning process.
Bayesian Classifier Models
for Active Learning
A. Kepecs [in collaboration with P. Shenoy, E. Chastain,
and R.P.N. Rao, University of Washington]
In the machine-learning literature, active learning is a
well-established mechanism used to increase the rate
of  learning. Active learning mechanisms are compu-
tationally advantageous because they lead to the so-
called “less is more” effect in which fewer samples lead
to better classifiers. Our recent observations show for
the first time that animals can be active learners con-
cordant with statistical learning theory. Therefore, we
sought to model the rats’ behavior using machine-
learning methods.
We applied a recent probabilistic interpretation of
support vector machine (SVM) classifiers to explain the
trial-by-trial updating of the decision boundary in a nor-
mative fashion. In Bayesian SVMs, the size of the mar-
gin for a sample provides the posterior likelihood that
the decision was correct, i.e., a measure for the classifi-
ability of the sample given the current model. The
inverse of this is a measure of uncertainty. First, we
noticed that this uncertainty measure shows the same
characteristic patterns as the firing rates of OFC neu-
rons. Second, our model reproduced the distinct behav-
pursuing these initial observations by trying to establish
that confidence-related neural activity in the OFC is
causally related to confidence judgments. 
We hypothesized that shutting off the OFC leaves the
odor-guided decision intact while impairing the use of
confidence-guided leaving decisions. Therefore, we
bilaterally implanted double cannulae to temporary
block neural activity in the lateral and ventrolateral por-
tions of the OFC. We measured rats’ confidence using
the waiting time version of our olfactory categorization
task discussed above. On testing days, rats received an
intra-OFC infusion of muscimol (a GABAergic agonist
that silences neural activity) or a saline control solution.
Our preliminary results show that the waiting time pat-
terns of the OFC-inactivated animals are disrupted with-
out affecting olfactory discrimination performance. We
are currently optimizing the inactivation methods and
cannula positions to confirm these results.
These preliminary results are consistent with studies
of human patients with orbitofrontal lesions who are
unable to judge their degree of uncertainty, indicating
that the functions of the OFC that we are investigating
in rats are conserved across species. By establishing that
the OFC is a causal contributor to a confidence-guided
decision, we hope to lay a strong foundation for a
broader examination of the neural mechanisms under-
lying confidence estimation. 
Active Learning in Rats Uses
Uncertainty Estimates 
A. Kepecs [in collaboration with N. Uchida, Harvard University
and Z.F. Mainen, IGC]
Statistical learning theory proposes that “active learn-
ers” use their uncertainty estimates to optimally set their
learning rate so as to learn more when uncertain and less
when certain. In the machine-learning literature, it is well
established that active learning based on informative dat-
apoints speeds up learning. However, little is known
about whether these principles apply to animal learning.
We tested the hypothesis that rats are active learners and
use uncertainty estimates to learn optimally.
To study this issue, we used an odor-mixture cate-
gorization task performed by rats and examined the
trial-by-trial updating of behavioral strategy. As ani-
mals learn to perform a categorization task, they use
reinforcement feedback to establish the decision
boundary, yet this boundary may be continually
updated during ongoing performance after overt learn-
ing asymptotes.
Indeed, we found that animals dynamically adjust
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iorally observed choice bias patterns shown by rats fol-
lowing correct and incorrect trials. The results provide a
new interpretation of active learning in categorization
tasks in terms of margins in Bayesian classifiers.
Sequence Processing in the
Mouse Hippocampus
J. Sanders
We are able to recall lists of items and episodes of our
lives, with the order of events appropriately preserved.
When experiencing a known pattern of events, we can
effortlessly sense when things are out of order. Our
research aims to establish how the brain represents the
order of sensory features at >1-s-long timescales. We
focus on the CA1 region of the hippocampus as a can-
didate area for both real-time sequence prediction and
order-violation detection.
Toward this end, we are developing auditory
sequence tasks that a mouse can perform while head-
fixed. In brief, a head-fixed mouse listens to a repeating
pattern of unique 2-s-long sounds, for which only the
final sound in the pattern is rewarded by water delivery.
We find that during a week’s training, the mouse licks
faster in anticipation of the reward sound. To gain
behavioral evidence that mice know the sequence, we
used a task version in which a mouse is not allowed to
lick for water except during the final sound in the pat-
tern. In this case, we found a reaction time deficit for
rare catch trials in which the reward sound alone is pre-
sented early in the sequence, compared with rare trials
for which the final two sounds are presented early. At
present, we are training mice in different sequence tasks
that will provide better behavioral evidence for sequence
prediction.
Our plan is to record neural activity in the hippocam-
pal CA1 region while mice perform sequence tasks. We
hypothesize that hippocampal neurons will represent
abstract auditory sequences, generate sequence element
predictions, and detect sequence violations. Why would
that be interesting? Currently, it is believed that the
human hippocampus is responsible for integrating mul-
timodal information into spatiotemporally delimited
episodic representations that underlie episodic memory.
On the other hand, recordings from rodent hippocampus
show “place cells” that represent unique positions in
space. By showing that such “place cells” can signal
abstract sequence information as well, we hope to link
these two disparate sets of observations and open a new
avenue for understanding hippocampal processing.
Interarea Communication Protocols in
the Rodent Brain during Foraging 
S. Ranade
The complex architecture of the mammalian brain can
be compared to the internet with its multitude of nodes
interconnected through an intricate network of wires. To
effectively communicate and route information to the
appropriate nodes, the internet uses common network
protocols. Similarly, diverse brain areas must also coor-
dinate their activity in a temporally precise manner to
process diverse sources of sensory and memory signals
in a coherent way for executing proper actions. We are
exploring the hypothesis that oscillatory activity in the
θ frequency range (4–12 Hz) can serve as the basis for
a interbrain areal communication protocol.
Rats extensively use their sense of smell and touch
(whiskers) as they navigate and explore their surround-
ings. During bouts of exploration, both sniffing and
whisking occur rhythmically at characteristic frequen-
cies within the θ range (4–12 Hz). Similarly, hippocam-
pal networks oscillate in the same frequency range.
Therefore, we asked whether these rhythms in peripheral
sensory modalities, i.e., sniffing and whisking, are coor-
dinated or independent and, if so, whether they are also
coordinated with the hippocampal θ rhythm. 
To address these questions, we simultaneously recorded
sniffing (with a thermocouple), whisking (with mystachial
EMG wires), and hippocampal θ rhythm (with micro -
wires) in freely moving rats that were engaged in cued for-
aging. A sound cue signaled the availability of a food
reward at random places in the arena. Rats engaged in
bouts of intense exploratory activity involving sniffing and
whisking as they navigated through the arena. We initially
found that on a longer timescale, sniffing and whisking
frequencies were not always correlated. However, we no -
ticed that right around the presentation of the auditory cue,
there was transient coherence between the two rhythms,
and on some occasions, these sensory rhythms were also
correlated with the hippocampal θ rhythm. Interestingly,
the locking between sniffing and whisking was not always
1:1; rather, we observed multimode locking at 2:1, 3:1, or
1:2, such that the protraction phase of whisking was always
coincident with the inhalation phase of sniffing.
Our initial findings thus suggest that although these
distributed sensorimotor and subcortical rhythms are not
always correlated, they can be transiently synchronized
following a salient behavioral event. Therefore, θ
rhythms may be used in interareal communication to
establish a common carrier frequency. We are pursuing
this question further by refining the foraging task to bet-
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ter control the animal’s behavioral state. We would also
like to directly test whether synchronization of various
rhythms at θ frequency results in better information
transfer in terms of spiking activity in the hippocampus
and primary sensory areas in the brain.
Developing New Spectral Variants of
Channelrhodopsin-2
J. Sanders 
Channelrhodopsin2 (ChR2), a light-gated cation chan-
nel from algae, is revolutionizing the way that we study
neural circuits. A neuron expressing ChR2 will fire pre-
cisely timed action potentials in response to pulses of
light, restricting stimulation to genetically defined cell
types. Whereas multicolored variants of green fluores-
cent protein (GFP) have clear utility in studying gene
expression patterns, variants of ChR2 that respond to
different wavelengths of light would allow direct con-
trol and comparison of two distinct population of neu-
rons or neural pathways. 
We first BLAST-searched ChR2 against the J. Craig
Venter Institute’s Global Ocean Sampling Expedition
database and found several full-length sequence frag-
ments that have high homology with ChR2. From the
most similar sequences in the database, we used homol-
ogy with bacteriorhodopsin to eliminate sequences lack-
ing the key residue for covalent bonding to retinal and
other distinguishing features common to nonphotoreac-
tive “opsin-like” protein families. Our remaining hits did
not match known sequences, but they were most similar
to opsin proteins in algae and dinoflagellates. We had
full-length DNA fragments of these top hits synthesized
and successfully cloned them into mammalian expres-
sion vectors. We also used structural homology with bac-
teriorhodopsin and literature on bacteriorhodopsin’s
known single-nucleotide “spectral switch” to synthesize
a series of point mutants of ChR2, which we believe may
have altered spectral selectivity. We created gene-gun
bullets for two of ChR2’s oceanic homologs and eight
point-mutants. All of these constructs were successfully
expressed cultured hippocampal slices and appeared to
be inserted into cell membranes.
We plan to test these constructs by recording from
Xenopus oocytes and hippocampal cells while scanning
through different wavelengths of light. Any large shift in
spectral selectivity or other desirable change in channel
kinetics will warrant further characterization of the
ChR2 variant in order to determine its usefulness as an
optogenetic tool. 
Neural Circuit Dynamics of Genetically
Identified Neurons in Behaving Mice
D. Kvitsiani, S. Ranade [in collaboration with Z.J. Huang,
Cold Spring Harbor Laboratory]
In vitro studies of neural circuits provide a picture of the
brain with exquisite precision in neural connections
between specific neural cell types. In contrast, successes
in systems neuroscience have come from relating single-
neuron activity with perception and behavior, without
knowing the identity of the recorded neurons. Our goal is
to bridge this gap by developing a method to determine
the molecular identity of the neurons recorded during
behavior in order to examine the neural circuit dynamics.
The availability of genetically targetable fluorescent
markers and activity reporters has revolutionized cellu-
lar neuroscience, and similarly, the recently character-
ized ChR2, a light-sensitive cation channel, promises to
do the same for systems neuroscience. Using ChR2,
genetically defined neuron classes can be made light
activatable so that one can optically control the genera-
tion of spikes with millisecond precision. To take advan-
tage of these molecular tools, we are developing
methods to simultaneously optically activate and elec-
trophysiologically record genetically defined neuron
types in behaving mice.
We managed to obtain a genetic system to label spe-
cific classes of interneurons with high efficiency and
specificity. We used the mouse knockin line expressing
Cre protein under the endogenous parvalbumin (PV) pro-
moter in combination with adeno-associated virus (AAV)
injections. We made AAVs that carry the ChR2-coding
sequence under a strong ubiquitous promoter interspersed
by a floxed transcriptional stop cassette (loxp-STOP-
loxp). This way, we have managed to have a high and very
specific expression of the ChR2 protein (>90% speci-
ficity) in hippocampal PV interneurons. We also made
an additional mouse line that expresses Cre in calretinin-
positive interneurons. In parallel, we also generated a
reporter mouse line to express the ChR2 protein in a Cre-
dependent manner. We inserted the ChR2-coding
sequence preceded by a CAGGS promoter and the loxP-
STOP-loxP sequence into the Rosa26 locus. Therefore,
in combination with any cell-type-specific Cre driver, we
should be able to target ChR2 proteins in those specific
neurons. These mouse lines are currently being charac-
terized. This work was done in Josh Huang’s lab.
We next performed pilot experiments in anesthetized
animals to verify that we can optically stimulate and
electrically record PV interneurons at the same time. We
saw light-evoked responses in some neurons and local
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field potential deflections that confirm the validity of
our approach. This encouraged us to quickly move to
freely behaving animals. 
We designed a new “drive” that can house up to ten
independently movable electrodes and/or fiberoptics.
This new drive is lightweight (~4 g) and thus can be
chronically implanted on the head of a mouse. We also
designed custom-built fiber-optic connectors that can
be mounted on the drive and pass light from external
sources (LED or laser). Currently, these tools enable us
to optically stimulate neurons and electrophysiologically
record them at the same time in freely moving mice. 
We aim to use these tools to understand how the
diversity of hippocampal inhibitory neuron types under-
lies distinct neural circuit dynamics. Specifically, it is
known that the hippocampus exhibits different states of
activity organized into oscillations spanning multiple
timescales. These neural population oscillations are
known to change depending on a behavioral state of an
animal—from active exploration to different sleep
states. We hypothesize that PV interneurons regulate the
θ rhythm (because they can directly inhibit excitatory
principal cells), whereas CR interneurons regulate the γ
rhythm (because they tend to inhibit other interneurons).
Therefore, CR and PV interneurons might have com-
plementary roles in controlling neural population
rhythms. We plan to test the functional roles of these
interneuron classes by characterizing their activity using
optical tagging and stimulation to observe their impact
on global neural activity and behavior.
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Our laboratory develops theoretical models for various
processes occuring in the brain. We work in parallel on
three important topics. First, we have proposed a model
for combining genetic information and experience
(nature and nurture) during neural development. This
model has been tested in simple circuits forming in the
brain that can be modified genetically, surgically, and
pharmacologically. Second, we have applied dimension-
reduction techniques to the database of odor character
profiles that contains vast amounts of information about
human olfactory perception. The goal of this research
is to find the organizing principle that can explain
human olfaction. Third, we have been working on the
mathematical description of adult neural stem cell dif-
ferentiation and proliferation in hippocampus. These
models can describe the evolution in time of various
markers that experimental researchers use to study the
division/differentiation cascade. By comparing the com-
putational/theoretical models to experimental data, one
can understand changes occurring in neurogenesis due
to aging and antidepressant therapies. 
Optimal Axonal and Dendritic
Branching Strategies during
Development of Neural Circuitry
D. Tsigankov, A. Koulakov
In developing brain, axons and dendrites are capable of
connecting to each other with high precision. Recent
advances in imaging allowed monitoring of the axon,
dendrite, and synapse dynamics in vivo. It was observed
that the majority of axon and dendrite branches formed
are retracted later during the development. In this study,
we computationally analyze different axonal and den-
dritic branching strategies that minimize the number of
transient branches required to establish the connectivity
with particular precision. We apply these branching rules
to the development of retinotectal topographic connec-
tivity and find that axons and dendrites have different
optimal branching strategies. The axonal optimal strat-
egy is to form new branches in the vicinity of existing
synapses, whereas the optimal rule for dendrites is to
THEORETICAL AND COMPUTATIONAL NEUROSCIENCE 
A. Koulakov D. Tsigankov
form new branches preferentially in the vicinity of
synapses with correlated presynaptic and postsynaptic
electric activity. We show that an experimentally
observed different reaction to the N-methyl-D-aspartate
(NMDA) receptor block in the dynamics of axonal and
dendritic branching implies that these two branching
strategies are implemented in the developing brain. We
suggest that the difference in branching strategies of
axons and dendrites could be detected by measuring the
spatial correlations between synapses and branch points
on the developing arbors. We thus predict that these cor-
relations should be reduced for dendrites but not for
axons under the conditions of the NMDA receptor block.
The Structure of Human
Olfactory Space
A. Koulakov [in collaboration with A. Enikolopov, Cold Spring
Harbor Laboratory, and D. Rinberg, HHMI Janelia Farm] 
We analyze the psychophysical responses of human
observers to an ensemble of monomolecular odorants.
Each odorant is characterized by a set of 146 perceptual
descriptors obtained from a database of odor character
profiles. Each odorant is therefore represented by a
point in highly multidimensional sensory space. In this
work, we study the arrangement of the odorants in this
perceptual space. We argue that the odorants densely
sample a two-dimensional curved surface embedded in
the multidimensional sensory space. This surface can
be approximated by the exterior of a spherical wedge
(Fig. 1). We suggest that this two-dimensional surface
represents the relevant manifold sampled by the human
olfactory system, thereby providing a definition of
olfactory sensory space. We also developed a computa-
tional method for relating the position of a particular
odorant on the two-dimensional surface to its physico-
chemical descriptors. On the basis of this analysis, we
conclude that one of the parameters describing the two-
dimensional surface is correlated with the count of car-
bon atoms in the odorant molecule, whereas the other
parameter is related to the molecule’s polarity or
hydrophobicity. 
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behavior, pathophysiology, brain repair, and the
response to drugs that modulate mood. New neurons are
produced from a limited population of stem cells whose
number declines with age. What factors determine the
rate of decline in the hippocampal stem cell population?
How can the rate of production of new neurons be var-
ied? In this study, we have shown that soon after a stem
cell is used for production of new neurons, it becomes
an astrocyte, i.e., it leaves the pool of neuroprogenitors.
Therefore, one can think of the stem cells as disposable:
Once they are used, they cannot be reused. The decline
in the number of stem cells therefore occurs in a use-
dependent manner. Does it mean that the more neurons
are produced, the faster the stem cells are lost? Not nec-
essarily. The sequence of transformations that a cell
must undergo before if becomes a new neuron is very
complex. One of the steps involves an intermediate form
of neuroprogenitors that are called amplifying cells.
These cells divide rapidly, about once per day, to make
more neurons. It turns out that antidepressant drugs,
such as Prozac, affect the divisions of the intermediate
amplifying cells without much impact on primary (dis-
posable) stem cells. Together with the experimental
group of Grisha Enikolopov at CSHL, we have devel-
oped a computational model for the division/differenti-
ation cascade that leads to the production of new
neurons. Comparing the computational model to exper-
imental results leads to detailed information about the
changes occuring in the neurogenesis cascade due to
antidepressant drugs, aging, and other therapies. Our
approach will provide unique insight into the computa-
tional properties of the neural stem cells and their
importance for mental health. 
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Disposable Tissue Hypothesis:
A New Model for Hippocampal
Neurogenesis
G. Enikolopov, J. Encinas, A. Koulakov 
New neurons are continuously generated throughout the
life of an animal in at least two areas of the mammalian
brain: olfactory bulb and hippocampal dentate gyrus.
Hippocampal neurogenesis dynamically responds to a
multitude of extrinsic stimuli and may be important for
FIGURE 1 Structure of human olfactory space. The odors
(crosses) cluster around a two-dimensional curved surface in the
perceptual space. The two-dimensional surface exists in a 146
dimensional space of various perceptual descriptors. The param-
eters defining the positions on the surface (X and Y) are related
to the molecule’s chemical composition and hydrophobicity. 
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Frontal Control of Impulsive Action
M. Murakami
Inhibition of behavior is as important as its generation,
and impulsivity is a common central feature of patholo-
gies including attention deficit hyperactivity disorder,
drug addiction, and obsessive compulsive disorder. Con-
sider the situation in which you wait for a bus but it is
delayed. You have no idea when it will arrive. Another
option is to take a cab, which costs much more but is
available immediately. How long do you wait for the
bus? When do you give up waiting for the bus and
decide to take the cab? In such circumstances, your
brain must compute the costs and benefits of the choices
and use that information to choose an action—waiting
or giving up. In this study, we are investigating the role
of medial prefrontal cortex (mPFC) and secondary
motor cortex (M2) in deciding whether to wait or not.
The aim of the project is to understand how the frontal
cortex is involved in inhibiting impulsive actions. The
specific aims are to (1) reveal the activity of frontal cor-
tical neurons while rats are engaged in impulse control
task and (2) examine the effect of inactivating subregions
of the frontal cortex on impulse control behavior.
In our task, a rat is faced with a waiting problem sim-
ilar to the “bus or cab” dilemma. There are two nose
poke ports; one is for waiting and the other is for deliv-
ering water reward. A short delay (400 msec) after a rat
pokes in the waiting port, a first tone is played, and this
signals the availability of a small reward at the reward
port. If the rat goes to a reward port after the first tone,
it receives a small amount of water reward. If the rat
waits longer in the waiting port, instead of going to the
reward port, then a second tone is played after a random
delay period of up to several seconds. If the rat goes to
the reward port after this second tone, it receives a larger
amount of water reward. In this task, after the first tone
is played, the rat is confronted with a choice between
going to the reward port to get a small reward or wait-
ing for a second tone to get a large reward. 
In 2008, we recorded from neurons in the mPFC and
the secondary M2 while rats were performing the impulse
control task. We found that the activity of subpopulations
of mPFC and M2 neurons predict the impulse control
THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen G. Felsen S. Ranade
A. Kepecs M. Smear
M. Murakami
performance of rats in the task, which suggests a role for
those frontal areas in withholding impulsive action. 
To examine the causal role of the frontal cortex in
withholding impulsive action, we examined the effect of
reversible inactivation of the mPFC on impulse control
behavior. Inactivation of the mPFC impairs the ability of
rats to inhibit impulsive action. These results suggest a
role of the frontal cortex in withholding impulsive actions. 
Behavioral results showed that the time a rat is will-
ing to wait for a given set of reward amounts and delays
varies randomly from trial to trial. In some trials, the rat
will respond immediately after the first tone; in others,
it will withhold responding until after the second tone,
and still in others, it will wait well past the first tone,
but give up before the second.
Motor Planning in the Rat
Superior Colliculus
G. Felsen
The superior colliculus (SC) has an important role in
spatial orienting across many species. We recently
recorded SC activity in freely moving rats performing a
spatial choice task. In this task, an odor cue delivered at
a central port determines whether water will be deliv-
ered upon entry into the left or right reward port. As
soon as the rat decides on the identity of the odor, it exits
the odor port, orients left or right, and enters the selected
reward port. We found that the activity of single SC neu-
rons during the 100 msec preceding odor port exit is
predictive of the rat’s choice (left vs. right) and that this
activity is necessary for normal movement production.
We now ask whether this activity is related to the ini-
tiation of movement or to some aspect of planning the
movement (e.g., selecting the direction of movement).
Conceivably, the movement could be planned in a sepa-
rate region (or regions) upstream, and the SC would sim-
ply be responsible for initiating the planned movement.
Alternatively, the SC could be involved in the planning
itself. We addressed this issue in two ways. First, we rea-
soned that if the SC were involved only in movement ini-
tiation, its activity should be independent of the stimulus.
We therefore asked whether some feature of the stimulus
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was encoded in the SC activity, in addition to the move-
ment direction. We found that preceding the movement
initiation, a subset of cells encoded the identity of the
odor in addition to the upcoming movement, potentially
linking the stimulus and the action. This suggests that the
SC is not simply responsible for initiating movement.
Next, we recorded SC activity in a new set of rats
performing a delayed-response version of the spatial
choice task. In each trial of this task, the rat was required
to remain in the odor port for 500 or 1000 msec follow-
ing odor presentation before initiating its movement
toward the water port. Presumably, the rat still selects
the direction of movement within a few hundred mil-
liseconds, as in the reaction-time task. Thus, this task
allows us to dissociate the time corresponding to the
decision from the time of movement initiation. We
found that the activity of many choice-predictive cells
peaked soon after odor presentation began and remained
elevated until the rat exited the odor port. The timing of
this activity is more consistent with a role for the SC in
selecting or planning movements, rather than simply ini-
tiating them. Thus, the SC may be a critical component
of the circuit for movement planning.
Diversity and Precision of Neural Activity
in Serotonergic Brain Stem Nuclei
S. Ranade
Serotonin is a neurotransmitter implicated in a diverse
range of physiological functions and behaviors as well
as psychiatric disorders including depression and anxi-
ety. Serotonin is released by neurons in a set of brain
stem nuclei called the raphe nuclei. The raphe system is
by far the most complex divergent neuromodulatory sys-
tem in the brain. Our current understanding of serotonin
function has been gained mostly from pharmacology and
lesion studies. Neuronal recordings from animals per-
forming well-controlled behavioral tasks have greatly
increased our knowledge of dopamine and norepineph-
rine function, but there have been few recordings from
raphe neurons during behavioral tasks. We hypothesize
that such studies will yield novel insights about raphe
function, particularly at fast timescales.
In this project, we recorded from raphe nuclei in rats
performing a two-alternative choice odor discrimination
task (as described above). Rats were trained to associate
individual odors with water reward at one of two choice
ports. Correct responses were rewarded probabilistically
after a variable delay. This paradigm allowed us to study
sensory, motor, and reward-related responses with high
temporal precision by aligning to nose poke events.
Raphe neurons showed diverse firing properties with
respect to waveform characteristics, firing rate, and
sleep state modulation. Neuronal responses were ana-
lyzed with respect to four epochs: odor sampling, move-
ment, reward anticipation, and reward consumption.
Firing rates of >70% neurons were modulated during at
least one behavioral epoch, with a large fraction tuned
to multiple events. Many neurons responded to behav-
ioral events within 100 msec, whereas some were even
more precisely time-locked (order 20 msec), showing a
very strong (>40 sp/s) phasic response, apparently to the
click produced by the water valve opening.
A wide range of event-tuning characteristics were
observed in the recorded population. During odor sam-
pling, approximately one-third of units showed a decrease
in firing rate. A subset of neurons also showed odor-
induced activation that, in rare cases, was stimulus selec-
tive. During the movement epoch, an equal proportion of
neurons showed enhancement and suppression of firing.
There were few instances of direction-selective tuning. A
large proportion of neurons (~40%) were inhibited during
reward anticipation. A small subset of neurons (10%)
showed changes in firing rate around the time of expected
reward. Putative serotonin neurons showed no obvious
association with a specific response profile.
These recordings demonstrate that raphe neurons are
rapidly and precisely modulated by diverse behavioral
events. This is in accord with the known diversity of sero-
tonin function and the difficulty in accounting for it with
a simple unified theory. Functional diversity of raphe
responses likely reflects in part the diversity of intrinsic
properties and synaptic connectivity of neurons within the
nucleus. Classification of units into putative serotonin and
nonserotonin neurons did not yield any obvious simplifi-
cation of response diversity, highlighting the need for
methods relating firing patterns to precise identification
of neuronal cell types. Finally, the observed functional
diversity of raphe neurons is consistent with the possibil-
ity that significant information processing may occur
within the raphe itself. Future studies will focus on devel-
oping novel molecular genetic approaches to selectively
label and record activity of populations of raphe neurons
that are biochemically homogeneous and/or share similar
connectivity patterns.
Studying the “Where” Problem
in Mammalian Olfaction
M. Smear
Localizing the source of an odor often matters as much
as identifying it: Distinguishing a meal from a predator
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is futile if you avoid the former or approach the latter.
Although our understanding of odor identification—the
“what” problem of olfaction—has progressed consider-
ably, the “where” problem of olfaction has received rel-
atively little attention. We know that rats excel at
odor-guided navigation, but we do not know what
behavioral strategies and neural circuits they use. A
critical challenge to elucidating the neural mechanisms
underlying odor tracking is reducing the behavior to a
form suitable to psychophysical techniques. To this end,
we have designed an “olfactorium,” which is essentially
a two-armed maze in which the rat has to navigate to
the correct arm based on concentration cues. Using a
photoionization detector, we can obtain a statistical
characterization of odor-concentration patterns with
high spatial, temporal, and concentration resolution. In
addition, we can precisely track the nose position of a
freely moving rat at video-rate time resolution in real
time. By combining odor-concentration measurements
with tracked trajectories, we hope to reconstruct the
time-varying odor-concentration pattern experienced by
a navigating rat and thereby reverse-engineer its navi-
gation strategies. In the future, we intend to exploit
rodent neuroscience’s growing arsenal of tools for elec-
trophysiology and transgenesis in the context of olfacto-
spatial psychophysics to understand the neural circuitry
of odor source localization.
The Neural Representation and
Impact of Decision Confidence
A. Kepecs, H. Zariwala, N. Uchida
If you are asked to evaluate your confidence in something
you know—how sure are you that it is true—you can
readily answer. What is the neural basis for such judg-
ments? Is knowledge about beliefs an example of the
human brain’s capacity for self-awareness? Or is there a
simpler explanation that might suggest a more basic yet
fundamental role for uncertainty in neural computation?
We addressed these questions by experimentally
manipulating the difficulty of perceptual decisions and
searched for a neural correlate of rats’ confidence about
getting a reward. We trained rats in a two-choice odor-
mixture categorization task that is well suited for study-
ing decision-making in rodents. In this task, rats report
the dominant odor-mixture component by entering dif-
ferent choice ports. Their performance is nearly perfect
for pure odors and drops systematically with mixture
ratio (difficulty). Using this task, we could systemati-
cally manipulate the uncertainty of individual discrim-
inations by varying odor-mixture ratio. We found a pop-
ulation of neurons in the orbitofrontal cortex (OFC)
whose firing tracked the difficulty of the decision and,
surprisingly, could even anticipate the outcomes of dif-
ferent trials of the same difficulty. We were able to con-
cisely explain this pattern of data using a simple model
of decision confidence. We then devised a behavior that
showed that rats could actually report their confidence
when probed with a subsequent decision. This demon-
strated that rats, like humans, sometimes know how cer-
tain they are in their answers. Taken together, our results
support the idea that decision confidence may be a
widespread and fundamental element of neural pro-
cessing contributing to adaptive behavior.
We began to extend these observations by testing
whether confidence-related neural activity in the OFC is
causally related to confidence judgments. Specifically, we
began to test whether the OFC has a primary role in con-
fidence-guided behaviors by inactivating it. We hypothe-
size that shutting off the OFC leaves the odor-guided
behavior intact while impairing the use of confidence
information to guide leaving decisions. In collaboration
with Erin Romberg (2007 Undergraduate Research Pro-
gram participant), we are testing this hypothesis. Our pre-
liminary results suggest that lesions of the OFC indeed
significantly impair rats’ ability to report confidence by
waiting for delayed rewards without affecting olfactory
discrimination performance. Notably, these findings are
consistent with studies of human patients with
orbitofrontal lesions who are unable to judge the degree of
uncertainty, indicating that the functions of the OFC that
we are investigating in rats are conserved across species.
These results suggest that a dynamic representation
of and access to an internal measure of decision confi-
dence is fundamental to adaptive behavior—even in
rats—and provide insights into the nature of the neural
processes underlying decision-making. Our findings
establish neuronal correlates and behavioral assays that
lay a foundation for a broader examination of the neu-
ral mechanisms underlying confidence estimation.
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How does the brain process sensory information to pro-
duce a behavioral output? How does experience modify
those internal representations? We address these ques-
tions in the appealingly simple olfactory system of the
fruit fly. This is an extremely powerful model system
because it allows us to combine genetic manipulations
of neural activity with electrophysiological and imag-
ing-based measures of neural activity. Our overall goal
is to understand how olfactory information is repre-
sented in terms of neural spike trains and how associa-
tive learning modifies these representations. 
There are three primary research directions in the lab.
The first is to understand how the olfactory system is
able to create distinct perceptions of the huge number of
different odors in the environment. How the brain cre-
ates these distinct perceptions is the basis of how the
accuracy of memory formation and recall is achieved.
The second question is how olfactory cues can be used
to localize an odor source. Insect disease vectors typi-
cally locate their hosts by smell, but relatively little is
known about how insects follow rapidly varying plumes
of odor to their source. The third avenue is to investigate
how olfactory associations are formed during learning. 
COMBINATORIAL CODING IN
THE OLFACTORY SYSTEM
Distinguishing different odors presents a particularly
challenging problem for the nervous system because
odors are so chemically diverse. To detect such a variety
of compounds, species have evolved a large array of
olfactory receptors. In mammals, there are ~1000 of
these olfactory receptors, whereas in Drosophila, an
appealingly simpler model system, there are only 62. It
is thought that olfactory information is encoded combi-
natorially and that combining information across sen-
sory channels expands the range of possible olfactory
percepts beyond the raw number of sensory channels. 
For combinatorial coding to be an effective strategy,
there must be neurons at deeper layers in the brain that
respond selectively to specific combinations of input
activity. Highly selective neurons that carry sparse stim-
ulus representations are a general feature of brain areas
involved in learning and memory, including hippocam-
NEURAL CODING IN THE DROSOPHILA OLFACTORY SYSTEM
G. Turner R. Campbell K. Honegger
E. Demir E. Gruntman
T. Hige
pus and cerebellum, and considerable theoretical work
predicts that sparse codes are optimized for memory
storage. We are testing the hypothesis that it is the neu-
rons in the learning and memory center of the Drosoph -
ila brain, the mushroom body (MB), that respond
selectively to particular combinations of input activity. 
To determine whether different sensory channels con-
verge on individual MB neurons, we are stimulating spe-
cific neurons at the upstream layer of the olfactory
pathway and recording responses in MB neurons. To do
this, we use an approach that allows us to activate neurons
with light. We use genetic techniques to express an ion
channel that activates neurons when illuminated with blue
light. We have built a customized light delivery system
that allows us to deliver blue light in precisely timed
flashes, and we found that we can control electrical activ-
ity very accurately in Drosophila neurons. Using this
approach to stimulate precisely defined sets of neurons
at an early stage of the olfactory pathway, we are deter-
mining the number of different inputs  an individual MB
neuron integrates  (i.e., how combinatorial is the olfac-
tory code). Because we have such precise control over
neural activity with this method, we are also asking what
is the minimal amount of activity that the animal can
detect. This is a very basic parameter for understanding
neural coding in any system: Is one spike interpretable
by the deeper layers of the brain or is it within the oper-
ating noise of the system, so perhaps only 10 or 100
spikes are significant. Understanding (1) how many dif-
ferent inputs there are to a given MB neuron and (2) what
are the relevant strengths of those inputs will reveal two
of the most important aspects underlying the combinato-
rial code and how it is integrated to generate highly selec-
tive neuronal responses that are a hallmark of learning
and memory centers in the brain.
ODOR SOURCE LOCALIZATION
Insects typically locate mates and prey using olfactory
cues; understanding how they achieve this could there-
fore open up new strategies for controlling insects that
act as disease vectors. We are using a combination of
behavioral experiments and electrophysiological record-
ings to investigate the neural mechanisms of odor local-
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basic mechanisms underlying those changes. We have
been examining the role that neuromodulatory path-
ways, such as dopamine, have in learning and memory.
We find that one particular neuromodulator increases
the activity of neurons that send olfactory information
to the fly’s learning and memory center. This increase in
activity could have multiple effects on learning and
memory. One possibility is that it causes stronger neu-
ral responses to olfactory stimuli, which could facilitate
olfactory learning. Alternatively, it could have a direct
effect on the strength of the synaptic connections that
the olfactory neurons make in the learning and memory
center. We are testing these possibilities, with a focus
on linking neuromodulator effects with the general
process of synaptic plasticity. 
We are also directly examining how synaptic con-
nections among neurons can be strengthened or weak-
ened by neural activity in the fly brain. Using the
light-activated ion channel mentioned above, we can
precisely control the activity of neurons that send input
to the MB. Our preliminary data suggest that when we
activate these inputs with a particular timing, the input
synapses strengthen. This could enable neurons that ini-
tially respond only to a taste to begin to respond to an
odor once synapses of olfactory inputs are strengthened.
These observations are preliminary, but they are impor-
tant because they give us a sense of how learning could
take place.
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ization. To study odor-driven locomotion, we have devel-
oped an apparatus to precisely measure the movements
of a fly under conditions where we can precisely control
the odor stimuli it encounters. The fly is tethered via its
thorax to a small wire, and its legs make contact with a
tiny ball that floats frictionless on a stream of air. The leg
movements of the fly translate into rotational movements
of the ball, which we can use to reconstruct the overall
walking trajectory of the fly as we present various types
of olfactory stimuli: (1) an odor stream from one side of
the animal, (2) rising/falling odor gradients, and (3) rapid
pulses with increasing/decreasing interpulse intervals. We
have shown that flies have a directional response to odor
in this behavioral apparatus, and we are testing the rele-
vant cues that drive this behavior.
We are investigating the neural mechanisms underly-
ing odor localization by recording neural activity while
presenting flies with a rapidly fluctuating odor stream.
Preliminary experiments suggest that MB neurons very
rapidly adapt to such fluctuating odor stimuli. Thus, MB
neurons may accurately represent odor identity, but
changes in odor concentration may be encoded in other
layers of the olfactory pathway. We plan to explore other
layers of the olfactory system to determine whether and
how they represent changes in odor concentration. We are
also very interested in investigating the mechanisms that
enable MB neurons to create concentration-invariant rep-
resentations, because these are likely to be very useful for
olfactory memory—in our memory, the smell of an apple
is an apple over a wide range of intensities.
OLFACTORY LEARNING AND MEMORY
Our goal here is to identify the changes in neural activ-
ity that occur during learning and to understand the
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My laboratory is interested in how neural circuits under-
lie normal processing and attention in the auditory cor-
tex and how this processing is disrupted in cognitive
disorders such as autism. To address these questions, we
use a combination of computational, electrophysiologi-
cal, and imaging techniques at the molecular, synaptic,
cellular, circuit, and behavioral levels.
Disruption of Auditory
Cortical Circuits by Autism
Candidate Genes
T. Hromadka, Q. Xiong
Autism is a highly heritable disorder thought to arise
through disruption of neural circuits. Many candidate
genes have been implicated, but how these genes lead to
the autistic phenotype remains unclear. We hypothesize
that the circuit defect underlying autism involves an
imbalance between excitatory and inhibitory neural
activity. To test this hypothesis, we are using in vitro
and in vivo methods to assess circuit dysfunction in the
auditory cortex. Previous work from my laboratory has
shown that excitation and inhibition are exquisitely bal-
anced in the auditory cortex, and so this assay should be
a very sensitive measure of disruption in animal mod-
els in which autism candidate genes have been dis-
rupted. 
Effect of Engaging in an Auditory
Task on Responses in the
Auditory Cortex 
G. Otazu, Y. Yang, L. Tai
Although systems involved in attentional selection have
been studied extensively, much less is known about non-
selective systems. To study these preparatory mecha-
nisms, we have compared activity in the auditory cortex
elicited by sounds while rats performed an auditory task
(“engaged”) with those elicited by identical stimuli
NEURAL CIRCUITRY OF UNDERLYING NORMAL AND
ABNORMAL PROCESSING IN THE CORTEX 
A. Zador K. Borges H. Oviedo Q. Xiong
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G. Otazu
while subjects were awake but not performing a task
(“passive”). Surprisingly, we found that engagement
suppressed responses, an effect opposite in sign to that
elicited by selective attention. In the auditory thalamus,
engagement enhanced spontaneous firing rates but did
not affect evoked responses. These results demonstrate
that in auditory cortex, neural activity cannot be viewed
simply as a limited resource allocated in greater meas-
ure as the state of the animal passes from somnolent to
passively listening to engaged and attentive, but that
instead, the engaged condition possesses a characteris-
tic and distinct neural signature in which sound-evoked
responses are paradoxically suppressed (Otazu et al., in
press).
Role of Interneurons in
Auditory Cortex Function
K. Borges, A. Reid
Fast synaptic inputs to neurons in the auditory cortex
are either inhibitory or excitatory. Cortical interneurons
are tremendously diverse. One interneuron subclass,
defined molecularly by the expression of parvalbumin
(“PV+”), seems ideally positioned to mediate the fast
component of the characteristic barrage of inhibition
elicited by a sound. We are testing the hypothesis that
PV+ inhibitory interneurons mediate fast sound-evoked
inhibitory synaptic currents in the auditory cortex. 
Our proposal seeks to establish a causal link
between a physiological property—the fast sound-
evoked inhibition that contributes to receptive field
dynamics—and a component of the underlying corti-
cal circuitry. We approach the problem at three differ-
ent levels, from brain slices through in vivo physiology
to behavior. Although we are currently focusing on the
role of one particular interneuron subclass (PV+), our
approach combining electrophysiological and molecu-
lar tools can readily be generalized to other subclasses
and can be extended to probe the circuitry underlying
other sensory- and behaviorally elicited neuronal
responses.
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of neurons in the rat auditory cortex (ACx). ACx pyram-
idal neurons project to multiple brain regions, including
the amygdala, the posterior parietal cortex, or the con-
tralateral ACx, and presumably carry different informa-
tion about auditory stimuli to these centers. To target ACx
neurons specifically based on their projection pattern, we
inserted the ChR2-coding region into a herpes simplex
virus (HSV). The HSV travels in a retrograde fashion
through the axons of infected neurons. ChR2-tagged neu-
rons, i.e., neurons projecting to the infected area, can be
identified by their low latency and reliable spiking
response to a brief light flash. Thus, for example, we have
used this approach to identify the subpopulation of layer-
5 ACx neurons that project to the contralateral cortex. 
This approach is general, in that any population to
which expression of ChR2 can be genetically restricted
can be tagged. Promising future applications include
tagging of different subpopulations of neurons based on
promoters (e.g., for subclasses of inhibitory interneu-
rons) and tagging of neurons in different cortical layers. 
Mapping of Auditory Cortex
Circuitry Using Laser-scanning
Photostimulation
H. Oviedo [in collaboration with I. Bureau and K. Svoboda, Cold
Spring Harbor Laboratory]
It is widely assumed that the organization of the sensory
cortex can be described by a “canonical” circuit.
According to this view, sensory input from the thalamus
arrives at cortical layer 4, propagates to layer 2/3, and
then descends to layer 5 before exiting a brain region.
However, until recently, it has been technically difficult
to test this hypothesis directly. We are applying a new
approach—laser-scanning photostimulation—to map the
circuitry within the rodent auditory cortex. Using this
approach, we can directly compare the circuitry within
the auditory cortex with that of other sensory cortices,
such as the better-studied barrel cortex. Preliminary
results indicate that although the auditory cortex is
organized according to many of the same general prin-
ciples, the detailed structure appears to be quite different. 
Using Cortical Timing Information
to Guide Behavior
Y. Yang, G. Otazu, M. DeWeese
It is well established that animals can exploit the fine
temporal structure of some stimuli; for example, inter-
Temporal Expectation Modulates
Neuronal Responses in the 
Auditory Cortex
S. Jaramillo 
When a stimulus occurs at a predictable instant in time,
anticipation of the stimulus improves the speed and accu-
racy with which it is detected. We have developed a two-
alternative-choice task paradigm in freely moving rats to
study the neural mechanisms underlying this phenome-
non in the auditory system. Behavioral measurements
confirm that valid expectations improved both reaction
times and detection thresholds. We are also using
tetrodes to record responses from single neurons in the
auditory cortex of rats performing the task. Responsive
neurons often showed an increase in evoked response to
tones immediately preceding the expected moment of
appearance of the target, when compared to responses to
the same tones occurring long before the expected target.
In addition, grouping behavioral trials according to the
subject’s reaction time reveals  correlations between the
strength of the neuronal responses and performance.
Identifying Neurons with Channel-
rhodopsin-2 during In Vivo Recording
S. Lima, T. Hromadka
Neural circuits consist of a heterogeneous mixture of
neurons with different neuroanatomical projections and
patterns of molecular expression. Recordings of neural
activity in behaving animals reveal tremendous func-
tional heterogeneity as well: Nearby neurons often
respond very differently to the same stimulus or action.
However, little is known about how this structural cir-
cuit-level heterogeneity contributes to function, in part
because of the technical difficulty of identifying neu-
rons during in vivo recordings in behaving animals. 
To overcome this difficulty, we have developed a
technique that allows us to “tag” subpopulations of neu-
rons for identification during in vivo electrophysiolog-
ical recordings. The tag is a light-gated ion channel—the
algal protein channelrhodopsin-2 (ChR2)—whose
expression can be genetically restricted to a subpopula-
tion of neurons. In the subpopulation of neurons
expressing ChR2, a brief flash of blue light triggers a
single action potential with millisecond precision.
We are using this approach to test the hypothesis that
neuroanatomical connectivity represents one important
structural correlate of the functional diversity in the rodent
cortex. To do this, we restrict ChR2 expression to subsets
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aural time differences of less than 1 msec are used for
spatial localization of sound. It is also clear that cortical
neurons can lock with millisecond precision to the fine
temporal structure of some stimuli. However, it has been
difficult to establish whether the fine temporal structure
of cortical responses can be used in a behavioral con-
text to guide decisions. Indeed, in the case of spatial
localization of sound, the relevant interaural time dif-
ference cues are processed below the level of the cortex
by means of specialized circuitry.
We have therefore adopted a direct approach to probe
the precision with which cortical timing information can
be used to guide behavior in the rat (Yang et al. 2008). To
bypass subcortical auditory pathways, we stimulate the
primary auditory cortex directly, using transient biphasic
current trains delivered via chronically implanted intra-
cortical microelectrodes. The behavioral paradigm we
use is a two-alternative-choice task in which stimulus 1
consists of the simultaneous stimulation of two intracor-
tical sites (A and B) and stimulus 2 consists of sequen-
tial stimulation of the two sites separated by a brief
interval dT (A–dT–B). After the subjects are trained to
perform to criterion (1–2 weeks) with the initial long
interstimulus interval (dT > 50 msec) for stimulus 2, we
probe the subjects’ psychophysical threshold by reducing
dT, until the subjects can no longer distinguish between
the two stimuli. Our experiments indicate that the cor-
tex can make use of information on a timescale as short
as 3 msec (Yang et al. 2008). 
Sparse Representation of
Sounds in the Auditory Cortex
T. Hromadka
How do neuronal populations in the auditory cortex rep-
resent acoustic stimuli? Although sound-evoked neural
responses in the anesthetized auditory cortex are mainly
transient, recent experiments in the unanesthetized
preparation have emphasized subpopulations with other
response properties. To quantify the relative contribu-
tions of these different subpopulations in the awake
preparation, we have estimated the representation of
sounds across the neuronal population using a repre-
sentative ensemble of stimuli. We used a cell-attached
recording with a glass electrode, a method for which
single-unit isolation does not depend on neuronal activ-
ity, to quantify the fraction of neurons engaged by
acoustic stimuli (tones, frequency-modulated sweeps,
white noise bursts, and natural stimuli) in the primary
auditory cortex of awake head-fixed rats. We find that
the population response is sparse, with stimuli typically
eliciting high firing rates (>20 spikes/sec) in less than
5% of the neurons at any instant. Some neurons had
very low spontaneous firing rates (<0.01 spikes/sec). At
the other extreme, some neurons had driven rates in
excess of 50 spikes/sec. Interestingly, the overall popu-
lation response was well described by a lognormal dis-
tribution, rather than the exponential distribution that is
often reported. These results represent the first quanti-
tative evidence for sparse representations of sounds in
the unanesthetized auditory cortex. Our results are com-
patible with a model in which most neurons are silent
much of the time and in which representations are com-
posed of small dynamic subsets of highly active neu-
rons (Hromadka et al. 2008; Koulakov et al. 2009).
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We combine genetic and functional analyses in the study
of the neuronal and molecular bases of learning and
memory in Drosophila. We are involved in three proj-
ects to identify new molecular and neuronal events that
are essential in learning and memory. One project is
related to the normal and pathological function of the
gene corkscrew that is associated with Noonan syn-
drome (NS). This syndrome shows a number of devel-
opmental defects including mental retardation. We are
interested in how point mutations associated with NS
affect the so-called “spacing effect” in memory forma-
tion. In the second project, we are studying the roles of
the Aβ42 peptide associated with Alzheimer’s disease in
the modulation of synaptic plasticity and memory loss
in Drosophila. The third project is related to the inte-
gration of sensory information in the mushroom body
(MB), a higher olfactory center that is essential for
olfactory associative learning. In this project, we are
examining the functional imaging of airflow response
in the Drosophila MB.
Corkscrew Activity in Drosophila
Regulates the Intertraining
Interval Needed for Long-term
Memory Formation
M. PaganiI
NS is a genetic disorder comprising a range of devel-
opmental and cognitive abnormalities. One cause is
gain-of-function (GOF) mutations in PTPN11, which
encodes the tyrosine phosphatase SHP-2. To gain
insights into these cognitive alterations, we used trans-
genic Drosophila NS models inducibly expressing the
fly SHP-2 ortholog, corkscrew (CSW). Our studies
revealed that GOF CSW impairs long-term memory
(LTM) formation even when first expressed in adult-
hood. A universal property of LTM induction is the
requirement for repeated training sessions spaced over
time. The molecular basis of this spacing effect is com-
pletely unknown. We demonstrated that wild-type CSW
overexpression dramatically shortened the interval
between training sessions required for LTM induction.
NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong J. Beshel M. Pagani
H.-C. Chiang L. Wang
I. Hakker C. Xu
Conversely, the LTM formation defect in the NS fly
models could be rescued by increasing the interval
between trials. Thus, we provide the first evidence that
the spacing effect has a molecular basis and that
CSW/SHP-2 is key in its regulation. This project is a
collaboration with Drs. Oishi and Gelb at Mount Sinai.
PI3 Kinase Modulates Aβ
Peptide Aggregation and
Memory Loss in a Drosophila
Model of Alzheimer’s Disease
H.-C. Chiang, L. Wang, I. Hakker
Expression of a secretary form of β-amyloid peptide 42
(Aβ42) in the Drosophila brain recapitulates major fea-
tures of Alzheimer’s disease (AD), including age-depen-
dent memory loss, neurodegeneration, and accumulation
of Aβ fibril deposits. To gain insight into the molecular
basis underlying memory loss, we initiated our study by
examining synaptic plasticity, which shows that long-
term depression is enhanced by expression of Aβ42 and
that such enhancement is linked to increased phospho-
inositol-3 kinase (PI3K) activity. To confirm this electro-
physiological finding, we directly assessed insulin-
stimulated PI3K activity, which revealed an elevated basal
level of PI3K activity in Aβ42-expressing neurons and
unresponsiveness of these neurons to further insulin stim-
ulation. Because AD brain tissues are known to be
insulin-resistant, this observation led us to test the behav-
ioral effects of such molecular alteration. Genetic silenc-
ing or pharmacological inhibition of PI3K activity
significantly rescues age-dependent memory loss
induced by expression of Aβ42. This conclusion is further
supported by genetically manipulating the activity of
dPTEN, a phosphatase-antagonizing PI3K activity. Fur-
ther investigation indicates that accumulation of Aβ42
oligomers (dimmer and trimmer) and Aβ42 fibril deposits
is significantly reduced. Thus, this study suggests that the
PI3K pathway has a critical role in mediating the Aβ42
toxic effects on synaptic plasticity and on memory loss in
association with modifying Aβ42 aggregation, but it has
no effects on Aβ42-induced neurodegeneration.
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Neural Representations of Airflow
in the Drosophila Mushroom Body
A. Mamiya, J. Beshel, C. Xu
The Drosophila MB is a higher olfactory center where
olfactory and other sensory information are thought to be
associated. However, how MB neurons of Drosophila
respond to sensory stimuli other than odor is not known.
Here, we characterized the responses of MB neurons to
a change in airflow, a stimulus associated with odor per-
ception. In vivo calcium imaging from MB neurons
revealed surprisingly strong and dynamic responses to
an airflow stimulus. This response was dependent on the
movement of the third antennal segment, suggesting that
Johnston’s organ may be detecting the airflow. The calyx,
the input region of the MB, responded homogeneously to
airflow on. However, in the output lobes of the MB, dif-
ferent types of MB neurons responded with different pat-
terns of activity to airflow on and off. Furthermore,
detailed spatial analysis of the responses revealed that
even within a lobe that is composed of a single type of
MB neuron, there are subdivisions that respond differ-
ently to airflow on and off. These subdivisions within a
single lobe were organized in a stereotypic manner
across flies. For the first time, we could show that
changes in airflow affect MB neurons significantly and
that these effects are spatially organized into divisions
smaller than previously defined MB neuron types.
Mario Pagani
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BIOINFORMATICS AND GENOMICS 
Bioinformaticians in literally doz ens of labs are devising new capabilities that their colleagues are putting
to novel uses in their experiments. These technologies, it is universally acknowledged, are prerequisites
for satisfactory progress in diverse areas of research, from cancer to neurological diseases such as
Alzheimer’s and Parkinson’s to neuropsychiatric illnesses such as schizophrenia and autism to all aspects
of plant biology and genetics. At the Lita Annenberg Hazen Genome Sequencing Center, directed by W.
Richard McCombie, CSHL scientists have been among the leaders in devising, refining, and up dating
techniques that enabled the sequencing of human and other “mod el” genomes earlier in this de cade.
They are currently generating the technical and conceptual means for labs worldwide to use a new gen-
eration of sequencers that are paving the way to low-cost individual genomes and an era of personal-
ized medicine. 
The insights of W. Richard McCombie and colleagues have led to the introduction and optimization
of novel methods of high-throughput genome se quenc ing. His team has made it possible to catalog vari-
ation among individual organisms in a way that would have been unthinkable at the beginning of the
decade. Having brought online a new generation of Solexa sequencers at CSHL this past year, McCom-
bie’s team optimized their function to a level at which 10 billion DNA bases (single “rungs” on the dou-
ble-helical DNA “ladder”) can be se quenced in a typical day, and on some days as many as 20 billion.
McCombie has been a leader of efforts to sequence the flowering plant Arabidopsis thaliana, the fission
yeast Schizosaccharomyces pombe, and Homo sapiens. New projects are under way to sequence genes
of special interest, including DISC1, a strong candidate gene for schizophrenia, and genomic regions
likely implicated in bipolar illness. With the Mem or ial Sloan-Kettering Cancer Center, they are using a
method called hybrid re se quencing, developed with Greg Hannon here at CSHL, to look at mutations in
samples collected from patients with prostate cancer.
Jonathan Sebat’s laboratory is studying the role of genetic variation, and particularly gene copy-num-
ber variation, in schizophrenia, autism, and other neuropsychiatric illnesses. This past year, Sebat and col-
laborators dis cov er ed that a significantly in creas ed rate of rare structural mutations exists in the genomes
of individuals with schizophrenia as compared with healthy controls. They found, moreover, that the muta-
tions were powerful, increasing individual risk 10–20 times, and that in people with schizophrenia, the
genes disrupted by the mutations nearly half the time were involved in pathways known to be important
in brain development. One implication is that the universe of genetic risk factors for schizophrenia con-
sists of many different rare mutations, each one present in comparatively few individuals or even a sin-
gle one. Thus, the paradox: Despite the large constellation of rare mutations contributing to the disease,
one must sift through thousands of cases before any one of them is likely to appear more than once. In
prior work, Sebat, in collaboration with Michael Wigler at CSHL, discovered that spontaneous muta-
tions—genetic errors in children that do not occur in either parent—are far more common in autism than
previously thought. 
Lincoln Stein’s lab is developing databases, data analysis tools, and user interfaces to organize, man-
age, and visualize the vast body of information being generated by biologists. One of the unsolved mys-
teries of the genome is how its genes are precisely regulated to promote orderly growth and development
and respond to changes in the environment. The modENCODE project (model organism encyclopedia
of DNA elements) is an international consortium organized to find and characterize the elements that
regulate the genomes of the fruit fly and the roundworm. Last year, the Stein lab established the mod-
ENCODE Data Coordi na tion Center, which is responsible for collecting, integrating, and publishing the
information collected by the consortium in a form that can be extended and combined with information
from other human and model organism genome databases.
The HapMap project is another focus of Stein’s lab, a database of hu man single-base-pair variations.
Last year, the HapMap database was ex panded from information on the genetic variability of 4 popula-
tions to 11 human populations, including individuals from Africa, Asia, Europe, Mexico, and the Indian
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subcontinent. The variability information is integrated with recently published information on more than
50 susceptibility re gions in 20 common human diseases, including diabetes, rheumatoid arthritis, Crohn’s
disease, coronary artery disease, and bipolar disorder. 
The Stein lab also manages and cur ates the WormBase and Reactome data bases. WormBase, a
database of the genome and biology of the roundworm Caenorhabditis elegans, gives users quick access
to the large C. elegans literature. It has been integrated by Stein’s group with an open-source online
publication called WormBook, which now has 140 monograph “chapters” that link to gene entry data in
WormBase. Reactome, an interactive database of fundamental biological path ways in humans, inte-
grates the peer- reviewed literature with high-throughput genomic information, includ ing a growing data-
base of protein– protein interactions (now covering more than half of the annotated genome). Finally,
Stein’s group has be gun work on the iPlant Collaborative, an effort to better enable plant biology
researchers to collaborate in cyberspace.
Using multidisciplinary approaches that combine computational analysis, modeling, and prediction
with ex per i mental verification, Doreen Ware’s lab seeks a deeper understanding of ge nome organization
in plants. By look ing comparatively across the ge nomes of plants in the same lineage, Ware and col-
leagues seek answers to such questions as, How are genes conserved and lost over time? What are the
fates of duplicated genes? Her team also studies gene regulation in plants, specifically looking at cis-reg-
ulatory ele ments and characterizing microRNA genes and their targets. This past year, the lab has been
responsible for providing annotations of the maize genome for an international consortium. Within their
own lab, they have also brought new, fully sequenced genomes into an existing integrated data frame-
work, to enhance the power of their comparative studies. This framework now en compasses the
genomes of Arabidopsis, maize, rice, sorghum, grape, and pop lar. They have devoted special attention
to examining diversity within species, particularly maize and grape, in assays that make use of powerful
new genotyping technology. 
144
143-160_Bioinf:LAR_Template_2007  6/9/09  4:12 PM  Page 144
145
EXPANDING OUR ABILITY TO EXAMINE
GENOME VARIATION
The genomic analysis we are carrying out is a dramatic
departure from the genomics of pre-2007. It uses all new
instruments, lab operations, and software for analyses. To
do this analysis, we had to build substantial infrastructure
in the areas of lab tools and procedures, human resources,
and computational resources. Now in place, these capa-
bilities are beginning to radically change the way in which
we can find variation in genome structure that might be
associated with phenotypic change such as human disease.
Building Infrastructure
L. Cardone, D. Rebolini, S. Mavruk, M. Kramer, D. Lewis
The major lab resource that we needed to put in place
was “next-generation sequencing” capability. These
instruments became generally available in the late win-
ter to spring of 2007, but we were able to obtain an early
test version in December 2006. We had the instrument
in production use by late January–early February 2007,
making us one of the first sites in the world to develop
this capability. We have upgraded these instruments and
merged them in the same physical space with instru-
ments obtained from other funding sources to achieve a
considerable economy of scale.
To perform the next-generation sequencing on a
large scale, we hired a number of staff including tech-
nicians and postdoctoral fellows and trained them in the
necessary skills. The technicians underwent extensive
training as they learned to use the new sequencing
instruments as well as to diagnose problems as they
arose. The postdoctoral fellows have developed new
ways to carry out the isolation of regions of the genome
of interest from patient samples and developed
advanced methods of data analysis.
The development of the appropriate computational
analysis for next-generation sequencing was a substan-
tial challenge: Network capabilities needed to be
upgraded, software was installed and made operational
on large compute clusters, and large, high-speed stor-
DEVELOPMENT OF NEXT-GENERATION
SEQUENCING TECHNOLOGY
W.R. McCombie J. Busuttil E. Ghiban S. Mavruk S. Pierce
Y. Cai M. Kramer S. Muller D. Rebolini
L. Cardone D. Lewis J. Parla L. Spiegel
M. Chen
age arrays were tested and placed into use. All of these
steps were performed and are now in place. As a result,
we have world-class sequencing capabilities and are
applying them primarily to psychiatric genetics.
DEVELOPMENT OF CAPABILITIES
We began with a single sequencing instrument in Janu-
ary 2007. At that time, we were learning how to operate
the instrument, prepare samples, analyze data, and trou-
bleshoot. Initial efforts with the instruments produced
mixed results. However, as we worked through the var-
ious issues, our results became more consistent. By mid
to late 2007, we had increased the number of instru-
ments, and although the instruments themselves were
becoming more reliable, we were facing considerable
issues of consistency in quality as we scaled up. We
began a very focused quality-control program in late
2007. This, in combination with improvements to the
instruments and chemistry, has led to a dramatic
improvement in se quencing capabilities (Fig. 1).
In addition to building our sequencing capacity, we
had to develop methods to target areas of the genome as
well as to use the sequencing capacity efficiently. One of
the problems with using the instruments efficiently was
that the sequencer produces much more data than are
needed in many cases. Thus, the cost of sequencing a
sample is much greater than it need be. To solve this prob-
lem, we developed a method to bar-code samples. We
developed custom adaptors for sequencing that have a
molecular bar code imbedded in them in addition to the
sequences required for Illumina sequencing. This allows
us to make libraries from multiple patients with a distinct
bar code associated with each patient. We can then pool
the patient samples in a single lane for sequencing and,
when the data are obtained, use the bar-code sequences to
disambiguate the data and associate them with the proper
input patient sample. This has allowed both a significant
increase in speed and a decrease in cost per patient on the
DISC1 (disrupted in schizophrenia 1) project. As an
example, in addition to allowing the technicians in the lab
to process more samples, bar coding has cut the cost of
143-160_Bioinf:LAR_Template_2007  6/9/09  4:12 PM  Page 145
146
Polymerase, XL (Applied Biosystems) in a production-
level setting. rTth DNA Polymerase, XL is actually a
blend of a polymerase with high processivity and a poly-
merase that confers fidelity due to its 3′-5′ exonuclease
activity. The proofreading activity is important for min-
imizing nucleotide misincorporations that might lead to
premature termination of DNA synthesis.
The nature of our target amplification using long-
range PCR is also a result of primer design. We use
Primer3 software to design our primers based on the
specifications that we require for optimal target ampli-
fication. Our targets are covered in a tiling fashion using
primer sets that have an ~1-kb overlap. Following the
separate PCR amplification of each section of a
genomic target, the reactions performed for each indi-
vidual are pooled using normalization to promote even
coverage of the target. Through our optimization of
long-range PCR, we have also determined that it is crit-
ical to remove any primer-dimer artifacts produced dur-
ing amplification. Primer-dimers that are particularly
large are fully viable sequencing substrates, and we
found that significant levels of primer-dimers dramati-
cally reduce the actual coverage of target regions corre-
sponding to the primer sequences. We use AMPure
(Agencourt) to remove primer-dimers from amplicon
pools before sequencing, thus allowing us to obtain
more even and more accurate target coverage and to
reduce the sequencing wasted on nontarget material.
In our DISC1 project, we have been working on the
resequencing of an ~550-kb region of human chromo-
sequencing reagents for a single DISC1 patient from
about $800 to about $165. Without working to achieve
such savings, we would not be able to sequence adequate
numbers of individuals.
Analysis of Variation in the
Region of the DISC1 Gene
J. Parla, E. Ghiban, S. Muller, M. Kramer [in collaboration
with D. Porteous, D. Blackwood, W. Muir, and I. Deary, Univer-
sity of Edinburgh, and P. Visscher, University of Queensland]
One method for isolating specific genomic regions for
sequencing is to use polymerase chain reaction (PCR).
Improvements to PCR through the discovery and engi-
neering of DNA polymerases with distinct activities that
can meet different experimental requirements, as well as
through the development of PCR additives that enhance
the capabilities of PCR, have enabled the efficient ampli-
fication of challenging targets. In particular, the avail-
ability of DNA polymerases that can readily amplify
targets >10 kb has been critical for improving the feasi-
bility of projects that require the amplification of large
regions of the genome from large groups of individuals.
During our investigation of the feasibility of long-
range PCR for targeted resequencing, we evaluated sev-
eral DNA polymerases marketed for the amplification
of long targets. Our minimal requirements included reli-
ability, robustness, and scalability. As a result of our
screening efforts, we are now routinely using rTth DNA
FIGURE 1 Comparison of total bases generated versus total high-quality bases for monthly Illu-
mina runs from August 2007 through mid January 2009. Note that output drops during partial
weeks around the Thanksgiving and Christmas–New Year’s holidays. We use the quality meas-
ure of Q30 to indicate a very high-quality sequence for the purposes of pushing the limits on
quality.  Much lower-quality bases are still quite useful, but focusing on the more stringent Q30
metric provides constant pressure to improve production quality.
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some 1 that includes DISC1. This region has been
strongly implicated in cognitive disorders by our collab-
orators Drs. Porteous, Blackwood, and Muir (St Clair et
al., Lancet 336: 13 [1990]; Millar et al., Hum. Mol.
Genetics 9: 1415 [2000]). Our initial study included 40
DNA samples from patients diagnosed with schizophre-
nia and from normal controls. These sequencers were
very new. The goals of this initial study were severalfold:
What was the best way to prepare samples for sequenc-
ing? What were the best ways to analyze data? What
sequence coverage was necessary for high-confidence
polymorphism detection? The purpose of our pilot was
to answer these questions as well as to find any other
problems that needed to be addressed experimentally or
computationally. The results from this pilot study were
quite promising, because we were able to cover up to 98%
of our target region at 30x or greater coverage depth. We
found that a minimum of 20x–30x sequence coverage
depth would be necessary for the accurate identification
of genetic polymorphisms. The accuracy of the sequenc-
ing at that level was confirmed by comparison with data
from a subset of the same patients analyzed with differ-
ent methods in the Porteous lab. We were able to optimize
the steps in our process, find elements that we needed to
avoid, and place ourselves in a position to confidently
scale up the project.
Once we had proven that the targeted resequencing of
DISC1 using long-range PCR and Illumina sequencing
was possible, we decided to increase this project to a
production scale. This began in 2008, and we are cur-
rently analyzing a set of 984 DNA samples that repre-
sent schizophrenia, bipolar disorder, major depression,
and normal controls. To enhance our data sets, we are
including a set of 1072 DNA samples obtained by the
Lothian Birth Cohort study. This large study was
designed to track the progression of mental skills from
childhood to adulthood. The breadth of cataloged phe-
notypic information represented by the Lothian Birth
Cohort study will add to our ability to interpret the
genotypic data that we are generating for our study of
the function of DISC1 in cognition.
We have made significant progress in our large-scale
DISC1 resequencing project. We are currently main-
taining a throughput of 20 individuals PCR-amplified
per day and an average of ~84 individuals sequenced
per week using the sample bar coding and multiplexing
described above. We have completed the PCR amplifi-
cation of DISC1 from a total of 768 individuals across
both of our sample sets. These samples are now at dif-
ferent stages of sequencing and analysis, ranging from
preparation for sequencing to preparation for genetic
variation analysis. A summary is shown in Table 1. Our
sequencing results have shown that we can effectively
multiplex up to five individuals on a given lane for
sequencing, which has been able to produce adequate
and evenly distributed data. We are frequently able to
obtain >90% coverage of DISC1 at 20x depth or better
and cover the vast majority of exons. Exons that are not
completely covered at our required depth are often only
partially missing. These gaps in coverage are likely a
result of a low percentage of failed PCRs during the
tiled DISC1 amplification, which is sensitive to the
quality of the DNA template. We are considering the use
of Sanger sequencing to help fill in these coverage gaps.
Our sequence coverage of DISC1 from the first ~400
patients that have been analyzed is shown in Figure 2.
We estimate that we will complete the sequencing of
these samples by spring–early summer 2009.
For polymorphism detection and identification, we
have been considering various programs. A few pro-
grams are available that can be used for analyzing Illu-
mina data, but we have put the most effort into
comparing the use of the program that we developed in-
house to Mapping and Assembly with Quality (Maq).
We have become increasingly in favor of using Maq for
genetic variation analysis due to the dedicated bioinfor-
matics personnel that continually update the program
with improvements and the success that other groups
have had with the program. At this point, we have just
initiated our Maq analysis of the data from our pilot
DISC1 study and will compare our Maq results to those
we have already obtained using our in-house program.
Developing Tools to Analyze the Genetic
Variation in the Synaptome
J. Parla, E. Ghiban, L. Spiegel, M. Kramer [in collaboration 
with Greg Hannon, HHMI/Cold Spring Harbor Laboratory; 
E. Hodges and Z. Xuan, Cold Spring Harbor Laboratory; J.
Potash and F. Goes, Johns Hopkins University School of Medi-
cine; and S. Grant, Wellcome Trust Sanger Institute]
To effectively use the power of massively parallel
sequencing, in terms of both cost and machine time,
TABLE 1 Current Status of DISC1 Patient Samples at Each
Stage of the Sequencing Pipeline
Patients amplified 768
Libraries completed 695
Patients sequenced 695
Patients base called 613
Patients SNP called 317
We are currently comparing variation analysis programs and will
catch up on that final portion of the analysis once a decision has been
reached on which method to use going forward.
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complementary tools are needed to maximize their
capacity. This can be achieved through methods that
direct sequencing efforts to genomic regions of high
interest. PCR is suitable for this in some cases, such as
DISC1, in which a large contiguous region of introns and
exons is being targeted, but it is not appropriately scala-
ble for all applications. Specifically, the Illumina GA
was capable of generating nearly 3 Gb of sequence per
run. For targets such as small genomes (~100 million
bases), this amount of sequence output provides ade-
quate depth and is suitably cost-effective. However, com-
plete shotgun sequencing is currently impractical for the
larger and more complex mammalian genomes, and sim-
plification of the DNA fragment population (genome
partitioning) is still required to boost coverage depth of
the informative regions. We have developed an econom-
ical and focused method for genomic target capture and
directed resequencing that enables sequence variation to
be cataloged throughout large subsets of the nonrepeti-
tive genome. To do this, we exploited the flexibility of
highly parallel in situ oligonucleotide synthesis plat-
forms to create a substrate for hybrid selection, and in
contrast to reduced representation techniques, our
approach is “programmable” for any specified genomic
region. Our strategy combines microarray-based hybrid
selection with massively parallel sequencing on the Illu-
mina GAII to yield a flexible and practical mutation dis-
covery strategy. These methods are already proving to be
highly competitive in both efficiency and cost, in con-
trast to other target selection techniques including long-
range and multiplex PCRs. 
We were one of a small number of groups that pub-
lished a method on targeted genome sequencing at the
end of 2007 (Hodges et al., Nat. Genet. 39: 1522
[2007]). Subsequently, this has been an area of intense
research by multiple groups around the world, and sig-
nificant effort is being undertaken using the strategy to
capture genes in many disease or basic science rese-
quencing projects. We have continued to make very sig-
nificant improvements to the technique and to maintain
a position as one of the leaders in the field. Previous
attempts at a “candidate gene approach” for finding
genes involved in cognitive disorders have been limited
by technology in terms of both the number of genes that
can be examined and the number of patients that can be
examined. The combination of the new sequencing tech-
nology and the hybrid selection approach that we devel-
oped and described above eliminates that limitation.
FIGURE 2 Percentage of the DISC1 target region covered in 380 patient samples. The vast majority of the samples have
a minimum of 85% of the region covered at a 30x sequencing depth. Samples for which we have obtained significantly
<85% coverage of DISC1 at 30x generally represent instances of sporadic issues experienced with sample multiplexing
and sequencing, rather than with DISC1 amplification.
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Dr. Seth Grant of the neuroscience group at Cam-
bridge University and the Wellcome Trust Sanger Insti-
tute in the United Kingdom has developed a concept
that he calls the “synaptome,” which entails identifica-
tion of the proteins that function in the synapse, the
basic functional unit of the nervous system. There is
considerable reason to believe that at least some of the
genes involved with cognitive disorders encode proteins
that function in the synapse. First, from a basic biology
standpoint, most functions of the neurons are localized
at the synapse. Second, some drugs with efficacy in con-
ditions such as depression and bipolar disorder target
synaptic components. In fact, many previous targets of
psychiatric genetics investigations were synaptic com-
ponents. In the past, these were genes targeted singly or
a few at a time, but now we can target all 1200–1500
genes in the synapse at the same time.
As an initial test, we designed two capture arrays to
study ~1200 genes in the synapse (~17,000 exons plus
promoters). We performed capture and sequencing (at
a coverage lower than necessary) to simply get a basic
idea of capture performance. We found that ~95% of the
bases in the target were sequenced at least once in the
experiment. Following this result, we decided to focus
on one of the two arrays while we optimized protocols
to increase the speed and efficiency of optimization.
We synthesized one array including one-half of the
synaptome genes plus 60 genes that had been associated
with bipolar disorder based on genome-wide association
studies. The latter set of genes had been specified by our
collaborators Drs. James Potash and Fernando Goes of
the Mood Disorder Clinic at Johns Hopkins University.
We then tested this capture array on the control samples.
Selected results are shown in Table 2. 
We are still optimizing this array and its use but have
started an initial pilot study on 30 bipolar-affected
patients from our Johns Hopkins collaborators. We are
applying to the National Institutes of Health for addi-
tional funding to scale-up this project. Our collabora-
tors are Dr. Potash, his colleagues at Johns Hopkins, and
Dr. Grant. Our goal in this project will be to sequence
the synaptome of 800 bipolar patients and 400 controls
to identify genetic alterations.
Detailed Analysis of Gene Expression in
Regions of the Human Brain
M. Chen, J. Parla, Y. Cai, M. Kramer [in collaboration with G.
Hannon, HHMRI/Cold Spring Harbor Laboratory; Z. Xuan and
M. Zhang, Cold Spring Harbor Laboratory; and R. Yolke, Johns
Hopkins University School of Medicine]
The most recent approach that we are implementing is the
sequencing of cDNAs and small RNAs from the brains of
normal and affected individuals. There are several reasons
for pursuing this approach, although it is limited by the
availability of samples. We will be able to look for muta-
tions in the coding regions of large numbers of expressed
genes in each patient (5000–10,000). We will also be able
to look for changes in gene expression, possible fusion
genes, and gene splicing changes with these data. 
The role of small RNAs has only recently been appre-
ciated. They are quite important in some types of devel-
opment and thus of interest due to the likely developmental
origins of cognitive disorders. Our work would be one, if
not the first, large-scale examination of small RNAs from
the brains of patients with cognitive disorders. 
Finally is the value of deep-brain cDNA sequence
data in the search for infectious agents that might be the
environmental trigger of cognitive disorders. Deep
TABLE 2 Statistics for Target Capture of Coriell Control Sample NA19775 with Increasing Numbers of Reads 
Capture of Coriell sample NA19775
1 lane 2 lanes 3 lanes 4 lanes 5 lanes 6 lanes 7 lanes 8 lanes 9 lanes
Total bases of targets on chips 3,327,512 bp
Number of target regions 9338 (exons plus promoters)
Percentage (%) of targets covered at 1x 92.0 93.6 93.9 94.1 94.2 94.3 94.3 94.4 94.4
Percentage (%) of targets covered at 20x 18.3 53.6 68.0 74.5 78.9 81.2 82.8 86.3 87.1
Theoretical enrichment 826
Experimental enrichment 337 336 335 334 334 338 338 337 336
Efficiency (%) 40.8 40.7 40.6 40.4 40.4 40.9 40.9 40.8 40.7
Target regions include exons and promoters. Target regions were combined if the distance between two regions was <120 bases. Capture effi-
ciency is ~40%. There is nearly complete coverage of the target at 1x following a single lane of sequencing. In contrast, target coverage at 20x
increases in a nonlinear fashion and reaches 87% merging nine lanes. Note that this uses one sample as an example and there were three suc-
cessfully multiplexed samples in this set of sequenced samples, so in these lanes, other samples also were sequenced to significant coverage. We
are still optimizing bar codes and protocols to make the sequence coverage more evenly distributed among multiple samples and to eliminate failed
bar codes that occasionally occur.
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sequencing of the cDNAs from the brain is probably the
best way to detect the presence of such pathogens. Any
pathogen in the brain will likely make RNA transcripts,
and if transcripts of the same or related pathogens are
known, we should be able to detect them by searching
the public databases for the sequences that we detect.
We have shared all of our data with Bob Yolken and col-
leagues at Johns Hopkins and will continue to do so in
order to assist them in their search for environmental
factors that might be triggering the disorders.
mRNA from three brain samples were obtained from
the Stanley Medical Research Institute for a deep
sequencing of cDNA and small RNA pilot project. For
each of the samples studied, poly(A) mRNAs were iso-
lated, and the purified mRNA samples were fragmented
chemically. Double-stranded cDNAs were synthesized
using reverse transcriptase for the first strand and DNA
polymerase I for the second. Following purification, the
samples were converted into cDNA libraries using a
series of steps derived from the Paired-End Sample Prep
Kit (Illumina), with several modifications. Two rounds
of 76-cycle sequencing were conducted on each sample.
Reads were aligned back to full-length transcripts first.
Reads that had no matches in this step were collected and
aligned back to the human genome and in-house splicing
junction probes. The junction probe set was generated by
concatenating 76 bp immediately upstream of the 5′ end
of an exon and 76 bp immediately downstream from the
3′ end of another exon. Alignment quality scores were
used to choose the best alignment among reads that were
mapped to multiple locations. 
Among the three samples we studied, an average of
12,228,705 reads from two separate lanes were used to
identify cDNAs. Our analysis suggested that of the
17,962 genes to which the reads aligned, an average of
1925 known genes and 94 novel genes can be covered
across 90% of their length and at fivefold or higher depth
(Table 3). Studies on the distribution of splicing events
indicates that 40% of reads carry information from one
exon, ~13% bridge two exons, 11% from intronic ele-
ments, and 24% from intergenic elements (Fig. 3).
Known and functional noncoding RNAs are detected by
~2% of the reads. Distribution of splicing events in a nor-
mal brain sample will be conducted in the near future.
TABLE 3 Summary of Sequencing Results on Separate
Transcriptome Samples
Sample Sample Sample
D-5 D-16 D-42
Sequencing methods Paired-end
76 cycles
Number of single 7,905,719 14,928,681 13,851,716
reads used to
identify cDNAs
Number of genes hit 17,778 17,920 18,189
Number of genes with 1855 1632 2540
90% exon coverage
at 5x depth or higher
Paired-end sequencing for 76 cycles were conducted. After two
separate lanes in each patient were merged, 8–14 million reads were
used to identify cDNAs. The detected genes herein include known and
novel genes.
FIGURE 3 Distribution of splicing events
among reads remains similar among sam-
ples. This distribution was extrapolated
using two alignment tools: ELAND and
BLAT. The former uses stringent condi-
tions and is aware of quality, and the latter
is less restrictive. There are ~2000 genes
that are detected, and ~5% of these are
novel genes.
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We are interested in the identification and functional
characterization of cancer genes (oncogenes and tumor
suppressors). Our main motivation for studying cancer
genes is their proven practical value in serving as tar-
gets for new cancer therapies and as biomarkers that can
guide treatment decisions. Additionally, cancer genes
have normal functions and their characterization can
often lead to a deeper understanding of basic biology.
ONCOGENOMIC cDNA SCREEN
We have continued our systematic functional analysis
of candidate amplified oncogenes in liver cancer. To do
this, we have leveraged the National Institutes of Health
(NIH)-funded genome resource of sequence-verified
human cDNA expression vectors (the Mammalian Gene
Collection). From a select group of genes that are highly
amplified in human liver cancer samples, we have trans-
ferred cDNAs into retroviral expression vectors. We
started with 29 recurrent amplicons, including the well-
known CCND1, MET, and CDK4 amplicons, that we
had identified from the data set of 106 human hepato-
cellular carcinoma (HCC) samples analyzed by ROMA
(representational oligonucleotide microarray analysis).
From the total set of genes within these amplicons, we
obtained 126 sequenced-verified cDNA expression vec-
tors. We used retroviral transfection to introduce cDNA
expression vector pools into mouse liver epithelial cells
(PHM1) and assayed for tumor formation. The cDNAs
responsible for positive hits were identified and subse-
quently validated by individual transfections. Of the 126
cDNAs, 18 scored positive by this criteria, including
CCND1, MET, and CDK4. In contrast, none of 24 con-
trol cDNAs—chosen at random from the NCBI RefSeq
set—scored positive for tumorigenicity. We are cur-
rently assaying a larger set of control cDNAs to obtain
a better estimate of the background rate of the tumor-
promoting function in this system. Besides identifica-
tion of CCND1 from the 11q13 amplicon, we identified
two oncogenes from a recurrent amplicon located at
chromosomal region 20q.11: HCK, which has been
shown to be oncogenic in hematopoietic cells, and
POFUT1, a gene involved in Notch signaling that has
not been shown to be oncogenic in any system. We also
CANCER GENES
S. Powers A. Bakleh K. Liu E. Sawey N. Sullivan
C. Cai J. Marchica A. Song J. Zhang
M. Chanrion M. Rajaram M. Su
identified as oncogenes two largely uncharacterized
genes, one encoding a zinc finger protein, ZCCHC7,
and the other a potential element of basal transcriptional
machinery, POLR1C. 
CHARACTERIZATION OF THE
NOVEL ONCOGENE FNDC3B
We decided to drill down further with one of the novel
oncogenes discovered in the oncogenomic screen,
FNDC3B. This gene, located on the q arm of chromo-
some 3, is frequently amplified and overexpressed not
only in human liver cancer, but also in lung, pancreatic,
and breast cancers. Its expression is associated with
metastatic spread and poor prognosis in breast cancer.
There are only two papers in the literature describing
FNDC3B: one on its identification as a transcript that is
turned on during the early stages of adipocyte differenti-
ation and the other describing its requirement for postna-
tal survival of mice and a preliminary investigation of
cellular phenotypes deficient in fndc3b–/– mouse embryo
fibroblasts. We have focused on determining how
FNDC3B overexpression can cause malignant transfor-
mation. Thus far, we have determined in three different
epithelial cell types that FNDC3B overexpression malig-
nantly transforms cells, induces the epithelial–mes-
enchymal transition by both molecular and morpho-
logical criteria, and activates Akt. What is unusual about
the latter finding is that overexpression only affects phos-
phorylation of serine residue 473 and not threonine
residue 308. This is unlike growth factor activation of
Akt; instead, it resembles the effects of overexpression of
Rictor, the activating component of mTORC2. The cor-
rect localization of FNDC3B may be necessary for this
Akt-activating function because several mutants that
cause mislocalization also block Akt activation (Fig. 1).
We found that silencing expression of FNDC3B by
RNA interference (RNAi) suppresses tumorigenicity of
human cancer cell lines that have increased gene copy
number and expression. Thus, it clearly has an active
role in tumor maintenance, and further study of its onco-
genic function could provide valuable new insights into
both its normal biological role and strategies for thera-
peutically counteracting its oncogenic effects. 
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for epigenetic changes as well as the presence of func-
tional cancer genes. 
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CHARACTERIZATION OF EPIGENETIC
ALTERATIONS IN LIVER CANCER
In the past, we have studied genetic alterations, specif-
ically DNA copy-number alterations, as our main
approach to exploring cancer progression. However, it
has become increasingly clear that many of the impor-
tant alterations that occur during cancer development
are epigenetic. In the past few years, powerful new
methods for epigenomic profiling have been developed
using both array and single-molecule sequencing plat-
forms. Using these new platforms, we have begun
epigenomic profiling of both human and mouse liver
cancers and will look for regions that are commonly
altered during cancer progression. We have also reana-
lyzed our extensive data set of expression alterations
that occur in both human and mouse liver cancers to
look for statistically significant clusters of genes that
show regional alterations suggestive of underlying epi-
genetic alterations. This approach is already yielding
candidate loci that are commonly altered in both human
and mouse liver cancers that are currently being tested
FIGURE 1 Effect of overexpression of FNDC3B and FNDC3B
mutants on the activation status of Akt. Labels at left indicate the
antigen detected by the indicated immunoblot. (Lanes 1 and 2)
Untransfected and empty vector control hepatocytes; (lane 3)
wild-type FNDC3B; (lanes 4–8) five different mislocalization
mutants of FBDC3B.
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The major focus of our laboratory is to identify genetic
causes of mental illness by analysis of rare copy-num-
ber variants (CNVs) in the human genome. We have
developed an experimental design that allows us to iden-
tify rare mutations that confer high risk for disease. Our
approach is to screen the genomes of patients with schiz-
ophrenia and bipolar disorder to identify deletions and
duplications of DNA that disrupt genes. These mutations
are subsequently tested for association with disease in
families and in large samples of patients and healthy
individuals. This approach is based in part on the find-
ings of our previous genetic studies of autism spectrum
disorders (ASDs), which established an important role
for rare, spontaneously occurring CNVs in the etiology
of ASDs. We have now successfully applied this
approach to studies of schizophrenia and bipolar disor-
der. Our findings, coupled with studies by other groups,
have shown that rare CNVs have an important role in the
genetics of psychiatric disorders. Finally, most individual
CNVs that have been definitively identified to date
increase risk of mental illness by ≥10-fold, strongly sug-
gesting that these mutations have a causal role. 
Analysis of Copy-number
Variation in Schizophrenia
J. Sebat, S. McCarthy, D. Malhotra, M. Kusenda, S. Yoon
Our studies of CNVs in psychiatric disease have revealed
new insights into the genetics of mental illness. Earlier
this year, we published a paper demonstrating that rare
deletions and duplications that impact genes are signif-
icantly more frequent among individuals with schizo-
phrenia than among controls; these CNVs affect genes
involved with neural development. In addition, genomic
regions have now been identified where individual dele-
tions or duplications of genes are strongly associated
with psychiatric disorders. This research, coupled with
similar findings in neurodevelopmental disorders such
as autism and mental retardation, suggests that genetic
architecture of mental illness includes a large constella-
tion of rare severe mutations in many different genes.
GENE-COPY-NUMBER VARIATION AND ITS ROLE
IN HUMAN DISEASE
J. Sebat M. Kusenda S. McCarthy
V. Makarov V. Vacic
D. Malhotra S. Yoon
We have begun to enter a period of rapid discovery.
The key challenges that lie ahead include (1) capturing
a greater fraction of the rare genetic causes of bipolar
disorder and schizophrenia, (2) understanding the clini-
cal and biological effects of each individual mutation,
and (3) determining the functions of the individual genes
and how these different genes interact within the context
of cellular pathways. Such a unified understanding of the
biology of bipolar disorder and schizophrenia will
require integrated efforts in clinical psychiatry, neuro-
science, genetics, and computational biology. 
MICRODUPLICATION OF 16P11.2 IS ASSOCIATED
WITH SCHIZOPHRENIA
Since the publication of our initial findings, we have
made rapid progress toward identifying individual muta-
tions that confer high risk for schizophrenia. We have
definitively identified a microduplication of 16p11.2 as
a strong risk factor for schizophrenia in a sample of
1922 cases and 4062 controls (P = 5.3 x 10–5, OR [odds
ratio] = 12.8) and in a replication sample of 2645 cases
and 2420 controls (P = 0.022, OR = 8.3) (Table 1). Inter-
estingly, we confirmed earlier reports of a strong asso-
ciation of the same mutations with ASDs and a weak
association with bipolar disorder. Taken together, these
findings suggest that different psychiatric disorders may
share common genes (or even the same mutation). 
Our findings further strengthen evidence demon-
strating a role for rare copy-number variants in schizo-
phrenia. Collectively, these studies provide strong
evidence that the illness is characterized by marked
allelic and locus heterogeneity. The fact that a mutation
is present in only 0.3% of cases does not negate its
potential relevance to the broader patient population.
Schizophrenia is characterized by marked genetic het-
erogeneity. Any single mutation or locus will account
for only a small fraction of the overall genetic risk.
However, in toto, rare mutations may contribute in a
substantial portion of overall risk. Furthermore, multi-
ple rare mutations will likely impact the same or related
neurobiological systems or pathways. Characterizing
these critical brain processes will contribute substan-
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father with no immediate history of mental illness. Cur-
rently, there are many family samples available from
public and private collections; however, because these
samples were initially assembled for the purpose of link-
age analysis, very few sporadic cases were collected.
Consequently, these collections provide few trio families
needed for our study. Thus, through the work of three
clinical groups at Zucker Hillside Hospital, Johns Hop-
kins University, and the National Institute of Mental
Health, we have begun a collection of new bipolar fam-
ilies. The GEM sample is unique from most existing
DNA collections in two ways: First, a significant frac-
tion of patients are “sporadic” cases, and second,
approximately half of patients in the collection have an
early age-at-onset (age at first mania <18). This collec-
tion will be made available to the scientific community,
where it will become a valuable resource for scientists
interested in studying genetic and epigenetic causes of
sporadic or young-onset bipolar disorder.
Sample Collection. The collection of new bipolar
families has been steady, and recruitment has increased
at some sites due to greater publicity surrounding this
project. The current sample consists of 785 individuals
from 263 families.
Preliminary Results. For these studies, we are using
a higher-resolution CNV detection platform that detects
CNVs that are as small as 10 kb. Thus, we are able to reli-
ably detect 120 CNVs per genome on average, more than
twofold more than can be detected with any other plat-
form including the Affymetrix 6.0 and the Illumina 1M.
To date, whole-genome scans have been performed on
518 samples from 191 families (146 of which are com-
plete mother-father-child trios). The remaining 72 fami-
lies will be completed in spring 2009. We have begun
preliminary analyses of these data in three ways: (1) de
tially to our understanding of pathophysiology and pro-
vide important targets for treatment development. 
A Family-based Study of
Rare Structural Variants in
Bipolar Disorder
J. Sebat, D. Malhotra, M. Kusenda, S. Yoon, S. McCarthy
Our research in bipolar disorder aims to make a signif-
icant contribution to the field in two ways: by improv-
ing the scientific understanding of bipolar disorder
through genetic studies and by creating a novel genomic
resource for geneticists. To these ends, we have initiated
a genetic study—the Genetics of Early Onset Mania
(GEM). The goals of our genetic study of bipolar disor-
der are to (1) perform genome-wide analysis of copy-
number variation in bipolar families, (2) assess the
overall contribution of de novo and inherited mutations
in sporadic and familial bipolar disorder, and (3) iden-
tify novel candidate genes for further study.
Although it has been established that rare de novo
mutations contribute to the etiology of autism and schiz-
ophrenia, it is not currently known whether de novo
CNVs have a significant role in bipolar disorder. On the
basis of the existing studies, it is clear that rare de novo
CNVs occur frequently in children with severe impair-
ments in cognitive development. We do not know if the
same will necessarily be true in patients with mood dis-
orders (but otherwise normal intelligence). Therefore, we
have initiated a study to test this hypothesis empirically.
To properly investigate the role of de novo mutation
in bipolar disorder, researchers must have access to
DNA samples from “trios,” where a trio consists of a
single patient with bipolar disorder and a mother and
TABLE 1 Significant association of 16p11.2 duplications with schizophrenia
Copy-number state
3 2 1 Frequency OR Fisher
Discovery data set
schizophrenia 12 1908 1 0.63% 12.8 5.3 x 10–5
controls 2 4060 0 0.05%
Replication data set
schizophrenia 9 2636 0 0.34% 8.3 0.022
controls 1 2418 1 0.04%
Duplications of the 16p11.2 critical region (chr16:29558000-30107000, hg18 coordinates) detected by
outlier median Z-score clustering in the Discovery data set show significant association with schizophre-
nia. Odds ratios (OR) and Chi-square tests are based on copy number 3 verses the sum of copy numbers
2 and 1. Duplications are also observed significantly more in Replication data set cases than in controls.
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novo mutations in trios, (2) inherited CNVs in trios, and
(3) rare CNVs in a large sample of cases and controls.
Our preliminary results find evidence for a higher rate of
spontaneous mutation in sporadic bipolar disorder as
compared to healthy controls. Although we need to apply
our analysis to the larger sample in order to gain statisti-
cal support for our findings, the preliminary results sug-
gest that de novo CNVs contribute to bipolar disorder.
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THE HUMAN HAPLOTYPE MAP
The International Human HapMap Project (www.
hapmap.org) is an international project to map out
regions of common genetic variability in the human
genome by genotyping three major world populations
across a large number of naturally variable sites. The
resulting “haplotype map” will greatly reduce the cost
of genetic association studies to find cancer susceptibil-
ity genes and other disorders with genetic components.
Our lab is a central participant in this project in our
role as the Data Coordinating Center (DCC). We manage
the central database for the project; allocate single-
nucleotide polymorphisms (SNPs) to the 11 genotyping
centers; coordinate data submission, quality checks, and
quality control; and manage the public release of project
data. The HapMap website, which was developed in our
lab, describes the project in the five languages of the proj-
ect participants (English, French, Chinese, Japanese,
Yoruba) and provides access to the data both for bulk
download and for interactive querying and browsing.
During the past 2 years, the HapMap website has been
used for several hundred whole-genome association stud-
ies that have identified novel genes implicated in type-1
and -2 diabetes, hypertension, rheumatoid arthritis, tuber-
culosis resistance, cardiovascular disease, inflammatory
bowel disease, and other medically significant traits.
During 2008, we enhanced the HapMap website to
provide information on genetic variation in an additional
six human populations, including populations originat-
ing from the Indian subcontinent and Mexico. This will
help researchers to identify genetic risks that are spe-
cific to specific subpopulations. We have also built new
visualization and analysis tools into the website itself.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
Our lab continues to be a major developer and main-
tainer of the WormBase database (www.wormbase.org),
an online information resource for the small free-living
nematode Caenorhabditis elegans. This organism is
favored as a simple model animal because of its small
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genome size, experimental malleability, and well-under-
stood cellular anatomy. WormBase is a curated model
organism database developed as part of an international
collaboration that includes the California Institute of
Technology, Washington University at St. Louis, and the
Wellcome Trust Sanger Institute in the UK. Our lab is
responsible for the website, user interface, and software
architecture for the project.
The resource contains the complete C. elegans
genome and key annotations, including predicted genes,
alternative splicing patterns, oligonucleotide probes,
and evolutionarily conserved segments. It also contains
many other types of biological information, including
the C. elegans cell pedigree, the organism’s neuroanat -
omy, its genetic map, and the physical map from which
the genomic sequence was derived.
During 2008, we added information on several newly
sequenced nematodes, providing researchers with the
ability to identify regulatory sites that have been con-
served over evolutionary time.
REACTOME
Reactome (www.reactome.org) is a collaboration with the
European Bioinformatics Institute (EBI) and the Gene
Ontology Consortium to develop a web-accessible re -
source for curated information about biological processes.
Reactome is organized like a review journal. Bench
biologists are invited to create modules that summarize
a particular aspect of their field. Currently, summations
include DNA replication, transcription, translation,
intermediary metabolism, the cell cycle, RNA splicing,
and hemostasis. Many more modules are under way.
Modules are similar to mini-reviews, except that each
paragraph of text is reduced to a series of logical asser-
tions that is entered into a database of processes and
macromolecules. The database is then used to drive a
website that can be browsed like a textbook or searched
with queries to discover pathways and connections.
During 2008, we brought the number of genes
curated in Reactome to 3368 proteins and variants, cov-
ering ~15% of the annotated portion of the human
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genome. We supplemented this data set with functional
interaction data from microarrays, protein interaction
experiments, and other sources to create an integrated
network of functional interactions covering ~50% of the
genome. This integrated network is the largest one pub-
lished to date, containing ~200,000 known and pre-
dicted gene interactions. We have used this network to
interpret the results of several large-scale genome-rese-
quencing efforts for the brain tumor glioblastoma mul-
tiforme and pancreatic cancer and have identified a core
set of protein interactions common to both cancers (Fig.
1). This suggests the presence of a shared cancer path-
way and points to several genes that may be involved in
the development and progression of these cancers. A
paper describing these results is now under review.
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FIGURE 1 Reactome provides a tool for interpreting cancer
genome resequencing studies. In this figure, we have mapped
out the interactions among genes that are repeatedly mutated
in pancreatic cancer. Many of these genes are members of
classic cell growth and regulation signaling pathways, and
many are also mutated in another type of cancer, glioblastoma
multiforme. Genes that are particularly heavily interconnected,
such as ACTB, may be key components of a shared cancer
pathway.
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COMPARATIVE GENOMICS: A MODEL FOR
UNDERSTANDING FUNCTION THROUGH
EVOLUTION AND GENOME ORGANIZATION
The cereal genomes are believed to have diverged from
one another within the past 50–80 million years (Ma).
During this time, there have been numerous genomic
rearrangements that have occurred in cereal genomes,
such as segmental and tandem duplications, poly-
ploidization, and transposition. This is especially true for
maize, which has undergone tetraploidization and is
known to have many recent modifications to its genome
structure due to transposable elements. Previous studies
have shown that regions of conserved protein-coding
gene order between cereals represent functionally impor-
tant regions and potentially conserved phenotypes. 
The transfer of information across and within species
through comparative mapping, integration of genomic
sequence, genetic and physical maps, and phenotypes
adds significant value to existing genome-sequencing and
-mapping studies. As part of this work, our group con-
tributes to the infrastructure of Gramene (http://www.
gramene.org), a collaborative that leverages sequence and
functional information from models and sequenced plant
genomes for translational genomics in agriculture. In the
last year, our group has completed several milestones on
the Gramene project including the release of the 28th and
29th builds since 2000. Of the many improvements made,
we added to our Ensembl Genome Browser nine
sequence genomes of agronomically and scientifically
important species. Our BioMart data warehouse, used for
bulk data downloads and data mining, has been expanded
to encompass mappings, markers, ontologies, and quan-
titative trait loci (QTL). This improvement allows users to
combine searches on both phenotypes and sequences. We
have improved our gene trees and enhanced searches for
our markers and sequence database by ontology terms
and tags. Auto-complete input boxes will make useful
suggestions on user searches, and we have added a new
Gramene News blog and RSS (Really Simple Syndica-
tion) feed for users to stay abreast of our latest news. Sev-
eral new web services allow more direct access to our
databases including distributed annotation servers (DAS)
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for Gramene and Ensembl genes, QTLs via Simple
Semantic Web Architecture and Protocol (SSWAP), and
a public, read-only MySQL server hosting Ensembl,
QTL, and genes and markers/sequences databases.
SEQUENCE AND ANALYSIS OF
THE MAIZE B73 GENOME
From its domestication 8000 years ago in Central Amer-
ica to its position today as the world’s leading harvested
grain, maize has had an important role in human civi-
lization, providing food, animal feed, and biofuel. Maize
also enjoys a long and distinguished history as a model
organism owing to its rich diversity and tractable genet-
ics. The complete sequence of the maize genome would
therefore propel advances in basic research as well as
in agriculture and other industries. 
The Maize Genome Sequencing Consortium was
launched with a 3-year grant from the National Science
Foundation (NSF) to produce a complete sequence of
the maize “B73” genome. At 2.5 Gb, the maize genome
rivals that of the mammalian genome in terms of size
and is six times larger than that of rice because of its
high content of retrotransposable elements. To meet the
challenge of producing a draft sequence, the consortium
took a hierarchical approach, selecting a minimal tiling
path of bacterial artificial clones (BACs) from a 20x fin-
gerprint map and sequencing the BACs using a combi-
nation of shotgun and finishing of the unique regions of
the BACs. Our lab participates with Drs. McCombie,
Stein, and Martienssen in the Maize Sequence Consor-
tium at CSHL. Now in its third year, the project has pro-
duced complete sequences of 16,700 BAC clones
comprising ~2.8 billion nonredundant bases, all avail-
able via GenBank. 
In the past year, our laboratory has produced repeat
and gene annotations for BAC sequences that account
for 95% of the maize genome. Preliminary analysis sug-
gests that 79% of the maize genome is repetitive. The
data sets can be visualized as chromosome-level distri-
butions. The view is very similar to a Google map view
zoomed out, where we can see trends in the genomic
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Next-generation sequencing technologies enable the
sequencing of genomes at deep coverage, providing a
cost-effective means to identify genome-wide variation.
In the last year, we have developd an automated pipline
for single nucleotide polymorphism (SNP) discovery
from such sequencing data and implemented it to iden-
tify genetic variation in two important agricultural
crops: maize and grape.
In grape, we identified 470,000 SNPs, and from
these, we selected a set of 10,000 SNPs that best repre-
landscape. At the chromosome level, we observe that
genes and repeats are not evenly distributed, and there is
a direct inverse correlation between the densities of two
types of sequences: When gene density increases,
repeats decrease. Overall, we find that the ends of the
chromosome tend to be more gene rich but in a few
examples, such as chromosome 5, we find that the end
regions are gene-poor (Fig. 1). 
Until the end of this year, we have not had access to the
complete genome sequence, but we did have access to the
completed region on maize chromosome 4, where we
were able to begin some detailed analysis. From this
region, we were able to generate detailed comparative
maps between rice and maize and rice and sorghum,
which reveals that the maize genome has been largely
shaped by its history of tetraploidization subsequent to
rearrangement and duplicate gene loss (Fig. 2). Using
genes that were conserved among rice, sorghum, and
maize in this region, we were able to determine that the
overall exon size has remained the same in the three
genomes; however, the intron size in maize has increased,
due to insertion of repetitive DNA. The sequence and
gene annotations are available at the project website’s
genome browser (http://www.maizesequence.org/).
ASSAYING MOLECULAR AND FUNCTIONAL
DIVERSITY IN PLANT GENOMES
Dissection of complex traits in higher eukaryotes still
remains one of the major challenges in biology. Cur-
rently, dissecting complex traits involves either the iden-
tification of large genomic regions or the testing of one
gene at a time. At the heart of both approaches is a
requirement for segregating markers that are easily
scored and constructing appropriate populations. 
FIGURE 1 Maize chromosome 5 distribution
of genes and repeats. 
FIGURE 2 Comparative mapping of protein-coding genes in
orthologous segments of rice, sorghum, and maize. (Osj2) Rice
(japonica) chromosome 2; (Sb4) sorghum chromosome 4; (Zm4)
maize chromosome 4 (ctg182 assembly); (Zm5) maize chromo-
some 5 (homeologous region). Mappings of protein-coding genes
are based on the reciprocal best hit. 
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sent the genetic diversity across domesticated grape
varieties as well as related wild species. These 10,000
SNPs will be used as genetic markers to survey the
USDA’s germplasm repository, providing valuable
information for mapping traits such as disease resist-
ance and ultimately decreasing the crop’s heavy reliance
on fungicides. We have also analyzed almost 1 billion
reads from 27 diverse maize lines where we identified
more than 5 million SNPs. These SNPs will allow us to
characterize the genetic differences across domesticated
maize varieties as well as wild relatives to identify traits
of agronomic importance.
REGULATORY NETWORKS IN PLANTS
Plant genomes contain thousands of protein-coding and
noncoding genes that are expressed throughout the life
cycle of the plant. microRNAs (miRNAs) and tran-
scription factors (TFs) are primary regulators of differ-
ential gene expression in development and response to
stress. TFs bind to DNA cis elements to physically
repress or activate transcription, whereas miRNA
repression acts posttranscriptionally through interaction
with complementary mRNA. There are several exam-
ples in plants that involve relationships between these
regulators and the importance of their role in vegetative
growth. Teosinte branched1 (tb1) is a recessive mutant
of maize that affects plant architecture. The tb1 gene
was cloned and identified as a transcription factor and
a putative miRNA target. More recent work has shown
that miR156 and miR172 are involved in a plant phase
change from juvenile to adult phase. The dominant
corngrass1 mutant in maize was identified as an over-
expression of miR156, which maintains vegetative
traits, whereas miR172 levels are low. In our group, we
are focusing on identifying regulatory network compo-
nents and their links. In the last year, we computation-
ally predicted miRNAs from the genomes of sorghum
and maize based on conservation of sequence and sec-
ondary folding structure. To establish confidence in
these predictions, we look for expression-based support
of the full miRNA transcript as well as the mature 22-
nucleotide miRNA. We can better understand ancestral
relationships among these noncoding genes by looking
for signatures of conserved genomic locations using
orthologous protein-coding genes as anchor points for
synteny. Preliminary analyses between maize and
sorghum suggest that more than 55% of these maintain
a syntenic conserved order in these genomes. Through
the study of plant regulatory networks, we will provide
researchers and breeders resources to modify plant
developmental profiles and responses to stress that are
needed to meet the challenge of global environmental
changes and land allocation for agriculture in the
upcoming years.
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QUANTITATIVE BIOLOGY
Mathematical and statistical in sights are at the very heart of the technologies that have made possible
comparative genomic studies pioneered at CSHL. Thanks to the foresight of two major private donors,
James Simons and Henry “Hank” Greenberg, 2008 marked the unofficial launch of a new Center for
Quantitative Biology (CQB), which in the coming year will take up residence in a new building in the Hill-
 side Research Complex. This new research focus at CSHL, under the interim leadership of Michael Wigler,
reflects the importance of math and statistics in the forging of new approaches to problems and new ways
of understanding the results of biological experiments. The program is bringing together under one roof
some of the world’s most gifted mathematical minds, who will apply their insights in the formulation of
research hypotheses pertinent to the study of molecular biology. Beyond individual research applica-
tions, the work of CSHL’s quantitative biologists has the potential to revise fundamental notions of how
we think about data itself.
Gurinder S. “Mickey” Atwal and colleagues are applying insights from the physical sciences to the
study of biological phenomena. Specifically, they develop and use mathematical and computational tools
to address quantitative principles governing the be havior of correlated “many-body” biological systems.
Such systems range from molecular interactions in a single cell to the evolution of Homo sapiens. They
are now seeking to under stand evolutionary forces acting on the ge nome in the context of human dis-
eases. In collaborations with colleagues at the Institute for Advanced Study at Prince ton University, Atwal
has modeled the process by which genetic variants, or alleles, evolve. This has recently led to surprising
insights about the role that p53, a master tumor-suppressor gene, has in reproduction. This work also
bears on the question of demonstrating recent selective pressures acting on our genomes.
Partha Mitra seeks to develop an integrative picture of brain function, incorporating theory, informat-
ics, and experimental work. His theoretical interests are primarily in formalizing the treatment of biologi-
cal function using ideas and methods from engineering. In informatics work, his lab is developing
computational tools for integrative analysis of neurobiological data, spanning electrophysiological, neu-
ro anatomical, and, more recently, ge nomic data, from multiple species per taining to the brain. Mitra has
or ganized the Brain Architecture Project, a multi-institutional effort to curate information from the litera-
ture about human neuroanatomical connectivity that will also advocate for large-scale studies of con-
nectivity in model organisms. This past year, the lab launched http://brainarchitecture.org, a website
featuring full text search for more than 55,000 papers. Separately, Mitra and colleagues progressed in their
efforts to develop experimental meth od olo gies for postmortem human brain-tract tracing, a means of
tracing neuronal connections in brain areas more rapidly and over greater distances than previously pos-
sible. Mitra also recently presented results of neurobiology research demonstrating the de novo evolu-
tion of song culture in zebra finches, starting from an isolate population. 
Michael Wigler’s group uses methods for comparative genome analysis to study cancer and human
genetic disease. These methods (called representational oligonucleotide microarray analysis [ROMA] and
methylation-specific oligonucleotide microarray analysis [MOMA]) evolved from an earlier technique called
RDA (representational difference analysis), used to find tumor suppressors, oncogenes, and pathogenic
viruses. Current mi cro array-based techniques, including comparative genome hybridization (CGH), reveal
changes in the numbers of copies of sections of the genome and regions of deletion and duplication,
mutations that may underlie the evolution of cancers. Wigler’s group focuses on breast cancer and
leukemi as, and they are engaged in clinical studies with major research hospitals to discover mutation
patterns predicting treatment response and outcome. In collaboration with Jim Hicks and Gregory Han-
non at CSHL, the lab has applied microarray techniques and hybrid selection to explore the role of epi-
genetics in cancer. With Jonathan Sebat, they have made headway in the discovery of the causative
mutations in autism. Their results show that spon taneous mutation has a far great er role in autism than
previously suspected. They have developed a new theory of autism’s genetic basis that ex plains other-
wise bewildering patterns of inheritance and are testing the new genetic model in other disabling genetic
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disorders. Wigler also has spearheaded the development of the Center for Quantitative Biology at CSHL,
with initial funding from the Simons and Starr foundations.
Michael Zhang’s laboratory develops mathematical and computational methods that can be combined
with advanced experimental technologies to transform data into biological knowledge about transcription
and gene expression, work that has manifold implications for the study of cancer and many other diseases.
Their tools, used by investigators throughout CSHL and beyond, are designed to identify functional genetic
elements within molecular sequences as well as pathways that control and regulate gene expression.
Zhang’s group has developed a series of computational tools that make use of statistical pattern-recog-
nition techniques to identify exons, promoters, and posttranslational modification signals in large genomic
DNA sequences. They also study alternative splicing of exons and collaborate with other labs to charac-
terize splicing enhancers and silencers. This past year, Zhang’s team published widely cited studies on
optimization of sequencing with next-generation Solexa equipment, using software to pre dict promoter
regions at high reso lu tion, and, in collaboration with Adrian Krainer at CSHL, defining the regulatory net-
works of two related tissue-specific (brain and muscle) splicing factors, Fox-1 and Fox-2. 
Rapid growth of the research literature in genomics and molecular biology threatens the ability of sci-
entists to digest and make use of valuable data. CSHL Fellow Ivan Iossifov seeks to develop automated
methods for ex tracting, structuring, and interpreting research data. Building on text-mining methods that
he developed in his Ph.D. work, Iossifov is now focusing on using these to build representations of molec-
ular networks for humans and for two model organisms, Mus musculus (lab mouse) and Saccharomyces
cerevisiae (baker’s yeast). In collaboration with Partha Mitra at CSHL, he is also working on a means of
organizing information about connections among brain regions, work that could prove valuable in efforts
to trace the etiology of common neurodevelopmental disorders such as autism, schizophrenia, and bipo-
lar disorder.
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Our basic research philosophy is to combine theoreti-
cal, computational, and experimental approaches for the
study of complex biological systems, with a particular
focus on brain function. Efforts in our group fall into
three main areas: informatics, theory, and experimental
work. 
Our neuroinformatics research involves the applica-
tion of analytical tools to large volumes of neurobio-
logical data as well as the development of informatics
infrastructure for data and knowledge integration. Our
study in the area of theoretical engineering applies the-
ories developed in human-engineered systems to study
the theoretical principles underlying biological systems.
The final area of our research is experimental and con-
sists of collaborative studies in multiple species includ-
ing Drosoph ila, zebra finch, macaque monkey, and
human infants.
Continuing in our laboratory in 2008 were Peter
Andrews (scientific informatics manager), Hemant
Bokil (postdoctoral fellow), Haibin Wang (postdoctoral
fellow), Dan Valente (postdoctoral fellow), Jason Boh-
land (scientific informatics manager), and Caizhi Wu
(postdoctoral fellow). Vadim Pinskiy (graduate student)
and Jayant Kulkarni (postdoctoral fellow) joined us this
past year, and John Lin (scientific informatics devel-
oper) left to work in industry.
We also have close collaborative ties with multiple
research groups at CSHL and other institutions, which
currently include Dr. Nicholas D. Schiff at the Weill
Medical School of Cornell University, where Dr. Mitra
is an adjunct associate professor; a consortium of zebra
finch researchers including Ofer Tchernichovski at City
College of New York (CCNY); Josh Dubnau at CSHL to
perform an integrative analysis of memory formation in
Drosophila; the Brain Architecture Project, with col-
laborators at multiple institutions, notably Larry Swan-
son at the University of Southern California and
Michael Hawrylycz at the Allen Institute of Brain
Research; and a recently initiated collaboration with
Gregory Hannon at CSHL on improving next-genera-
tion sequencing technologies. 
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J. Kulkarni C. Wu
The Brain Architecture Project
J. Bohland, H. Bokil, C. Wu
The broad goal of the Brain Architecture Project is to
characterize human brain architecture, in particular to
describe the connectivity matrix across areas in the
brain. Project objectives include extracting knowledge
about human brain connectivity from the extant litera-
ture, placing these data in a structured database system,
and developing tools for analysis and visualization of
brain architecture. 
Before the 2009 Meeting of the Society for Neuro-
science, we launched the official project website at
http://brainarchitecture.org. The website currently con-
tains several key components: (1) access to a database
containing information about neuroanatomical connec-
tivity reported in the human brain, (2) a tool that enables
comparison of different anatomical atlases of the human
brain, and (3) two tools for searching the full text of a
large corpus (>50,000 papers) of scientific papers
related to brain architecture using a combination of key-
word or semantic queries.
We have also formed collaborations with Dr. Pavel
Osten (CSHL) and Dr. Harvey Karten (University of
California, San Diego). We have proposed launching a
connectivity project for the mouse at CSHL by devel-
oping two copies of a semiautomated experimental and
data analysis pipeline to be used in high-throughput
efforts to generate the first comprehensive circuit dia-
gram for the mouse, a species of high importance due to
its prevalent use in basic and clinical research. The pro-
posal calls for using both “conventional” neuroanatom-
ical tracers and engineered viral vectors to trace
projection patterns from 400 injection sites in triplicate.
The Brain Architecture Project hosted a meeting at
the CSHL Banbury Center in May 2008 entitled The
Architectural Logic of Mammalian CNS. At this meet-
ing, participants discussed our current understanding of
the basic large-scale organization of brain circuits in
vertebrate animals. The Brain Architecture Project team
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and cell densities). Note, for example, the division of
the mouse cortex into clusters aligned to different lam-
ina. Other aspects of our analyses have focused on the
localization of gene expression and, for diseases with
known genetic etiology, the relationship between
expression patterns of implicated genes and the brain
areas in which the disease causes pathological changes.
Toward an Integrative Model
of Memory in Drosophila
D. Valente
During the past year, we have continued the develop-
ment of a learning assay that will allow us to probe each
level of biological organization, during the learning
process, from genetics to behavior. This assay, the
Drosophila flight simulator, has been used in numerous
studies to show that flies can be conditioned to avoid
certain patterns presented to them in their visual envi-
ronment. After numerous attempts at reproducing the
published results were unsuccessful, we performed a
series of experiments aimed at addressing the major dif-
ferences between our setup and those described in the
literature. Although further investigation into these dif-
ferences has left the source of the discrepancy undeter-
mined, it has been essential in elucidating the behavior
presented our ongoing work and progress in the project
and received important guidance from many experts in
neuroanatomy and informatics. An additional major
focus of the meeting was a discussion of a community-
driven proposal for systematically determining the
mesoscale connectivity map in model organisms, start-
ing with the mouse brain.
An additional aspect of brain organization of great
interest is its genetic architecture, i.e., in what brain
areas/cell groups are specific genes expressed, and how
does the organization of gene expression relate to other
aspects of brain organization? 
We have established a relationship with researchers
from the Allen Institute for Brain Science to analyze
spatial gene expression patterns in the Allen Brain Atlas
(ABA). The ABA consists of genome-wide expression
maps for the adult mouse brain, including raw high-res-
olution images of in situ hybridization sections and
smoothed and coregistered expression volumes for each
gene. We have performed a large-scale analysis of a set
of expression volumes for ~3000 genes. In one aspect of
this analysis, we used clustering techniques to segment
the mouse brain based on the similarity of the pattern
of expression across this gene set at each voxel (spatial
location). The results, illustrated in Figure 1, indicate
that the segments that arise from clustering based on
gene expression largely align with an atlas derived from
classical neuroanatomy (e.g., by looking at cell types
FIGURE 1 Segmentation of mouse brain based on the expression patterns of 3000 genes (center and right
columns) results in clusters that largely align with classical neuroanatomical regions.
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of flies in this paradigm. Furthermore, we have used
data obtained from classical and operant conditioning
experiments to develop a more complete quantitative
phenotype for flies in these assays, and we continue to
develop new measures and metrics to assess perform-
ance in this paradigm. Most notably, we have shown the
unconditioned response of flies to the aversive stimulus
on millisecond timescales—a necessary step in under-
standing the sensorimotor integration required to create
an association during learning.
In addition to the studies of flies in flight, we have
continued the development of better methods for quan-
titative phenotyping of the locomotor and exploratory
behavior of flies in the open field. In a collaboration
with Ilan Golani of Tel Aviv University, we have devel-
oped mathematical techniques to describe the effect of
cocaine and alcohol on initiation of movement and the
effect of the drugs on movement behaviors. From this
research, two papers are currently being prepared for
publication. Furthermore, we worked on a collaboration
with François Bolduc at the University of Alberta (for-
merly of Tim Tully’s lab here at CSHL) using similar
phenotypic measures to study social interaction defects
in flies mutant for the fragile-X mental retardation gene
(Fmr1) as a model for social defects in autistic patients.
This also resulted in a paper that is currently in the sub-
mission process.
Finally, we continued our collaboration with Josh
Dubnau’s lab on the project “Experimental evolution of
rutabaga suppression: Modeling gene epistasis under-
lying behavior.” Our contribution to this project has
been a series of calculations important for the experi-
mental design, the creation of web tools for analyzing
and storing behavioral results, as well as analysis of
genotypic results to determine the elevation or suppres-
sion of allelic frequencies in response to selection. 
Alta-Cyclic: A Self-optimizing
Base Caller for Next-generation
Sequencing
Y. Erlich [in collaboration with the Hannon lab, Cold
Spring Harbor Laboratory]
This project sought to improve the base-calling procedure
for Illumina Genome Analyzers to obtain more accurate
and longer sequence reads. Such an improvement would
boost overall output per run, increase genomic coverage,
and improve the ability to detect sequence variants.
Longer reads also increase mapping precision and may
even enable de novo genome assembly.
Inspired by ideas from communication theory, we
analyzed the sequencing platform’s nonstationary dis-
tortion factors, because these accumulate throughout the
run and reduce accuracy in later sequencing cycles. We
developed a novel base caller named Alta-Cyclic, which
is designed to address these distortions. Alta-Cyclic
works in two stages: the training stage and the base-call-
ing stage. During the training stage, Alta-Cyclic learns
run-specific noise patterns according to our model and
finds an optimized solution that reduces the effect of
these noise sources. The optimization is mainly
achieved by supervised learning using a rich DNA
library with a known reference genome. Alta-Cyclic
then enters the base-calling stage and reports all of the
sequences from the run with the optimized parameters.
Benchmarking Alta-Cyclic with respect to the Illu-
mina base caller after a long run of 78 cycles revealed a
substantial increase in the number of correct base calls.
For instance, in the case of a phi-X library, Alta-Cyclic
reported more than fourfold, 78-nucleotide-long, fully
correct reads, which comprised 22% of the total
sequences. For comparison, The Illumina base caller
reported only 5% of the total sequences without any
misdetection. 
Integrative Study of Zebra
Finch Vocal Development
H. Wang
Our principal goals for this study are to provide the infor-
matics infrastructure for data management and mining,
develop signal processing algorithms, and analyze exper-
imental data from collaborating laboratories.
We applied statistical measures to the analysis of
zebra finch song from an experimental study of evolu-
tion of song culture in a laboratory setting (in collabo-
ration with the Tchernichovski lab at City College of
New York). In a recursive one-to-one training experi-
FIGURE 2 A fruit fly in the flight simulator.
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ment, an isolated adult male was used to train a young
zebra finch, which after maturity, trained yet another
young bird, and so on. We found that the songs of the
isolate tutor (ISO) were inherited (imitated) along the
training lineage, but, at the same time, they were grad-
ually and steadily transformed toward wild-type-like
songs in a few generations. In the second experiment, a
seminatural island colony of zebra finch was established
from an isolated male and three females. We were able
to observe and characterize the emergence and evolu-
tion of song culture, using the same analysis methods.
We proposed a theoretical framework to understand
how the song culture evolves through interactions
among the phenotype, the genotype, and the environ-
ment. In analogy to the parental-effect model in quanti-
tative genetics, we partitioned the phenotypic value into
genotypic and environmental components and assumed
an additive model for genetic variance. Our model illus-
trates that the song culture results from an extended
developmental process, a “multigenerational” pheno-
type partly genetically encoded in an isolated founding
population and partly in environmental variables, but
taking multiple generations to emerge.
It has long been realized that a dimensionally accu-
rate and detailed atlas of the zebra finch brain is an
essential tool. Recent progress in neuroanatomical
research has made such a digital atlas possible, driven
by the availability of automated scanning microscopes
and the ability to store and analyze tera/petabyte-scale
data sets. Through a collaboration with Harvey Karten
at the University of California, San Diego, we have
obtained high-resolution images of Nissl- and myelin-
stained zebra finch brain sections that are available at
www.zebrafinch.org/atlas as part of our informatics
infrastructure for zebra finch birdsong study.
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MAMMALIAN GENETICS
We study variations in the human genome and their
association with disease and genetic disorders. The vari-
ations we study arise when a large segment of the
genome is duplicated or deleted. Such copy-number
variations, or CNVs, can arise somatically or in the
germ line. Somatic variations are often seen in cancer,
and they distinguish cancer cells from the normal cells
of the body. They provide clues for the origin and behav-
ior of the cancer and possibly its early detection. Germ-
line variations distinguish individuals from one another
and may be inherited, in which case, they are known as
copy-number polymorphisms, or CNPs, or they may
arise spontaneously, in which case, they serve as engines
of human diversity or can cause devastating genetic dis-
orders, such as autism. 
Part of our lab uses copy-number data and DNA-
methylation status to study solid cancers, especially
breast cancer (Hicks et al., Genome Res. 16: 1465
[2006]) and B-cell chronic leukemia (Grubor et al.
2008). We seek to identify the genes most frequently
mutated in cancers and leukemias and to determine
whether genomic data can be used to predict the out-
come of the disease, its response to therapy, and the
early detection of its recurrence. Another part of our lab
studies copy-number variation that may underlie autism,
congenital heart defects, and other profound disorders
of normal human development. A large portion of the
lab is composed of quantitative/computational scientists
who work on methods for data processing, visualization,
and interpretation. 
Until recently, our studies were largely based on a
high-throughput, high-resolution, microarray technol-
ogy developed in our lab called representational
oligonucleotide microarray analysis (ROMA) (Lucito et
al., Genome Res. 12: 2291 [2003]), which itself was
based on an earlier technology developed in our lab
called representational difference analysis (RDA) (Lisit-
syn et al., Science 259: 946 [1993]). RDA was previ-
ously used to discover tumor suppressors, oncogenes,
and pathogens. ROMA is one form of a more general
technology called comparative genome hybridization,
COPY-NUMBER ANALYSIS AND HUMAN DISEASE
M. Wigler G. Alex D. Esposito J. Katz D. Levy D. Pai M. Ronemus
C. Algieri V. Grubor J. Kendall S. Marks M. Riggs J. Troge
S. Chakraborty J. Hicks A. Krasnitz J. Meth L. Rodgers B. Yamrom
K. Cook L. Hufnagel Y.-H. Lee L. Muthuswamy
Y. Eberling R. Kandasamy A. Leotta N. Navin
or CGH. Methodology is constantly evolving, and part
of our laboratory works on an extension to ROMA
called methylation detection oligonucleotide microar-
ray analysis (MOMA) used to study DNA methylation.
We still use ROMA, for example, when the amount of a
sample is limiting, but our CGH work is now mainly
based on commercial platforms that have higher reso-
lution than ROMA. We have recently been investigat-
ing the applications of high-throughput, single-mole-
cule, DNA sequencing to discover and detect copy-num-
ber variation, even at the level of single cells. 
CANCER AND LEUKEMIA
Our work in cancer applies genome analysis to both
basic and clinical problems. This year, we continued our
clinical studies on breast cancer, with an emphasis on
marker discovery and detection, that we hope will
directly benefit patient care. We participate with the
Memorial Sloan-Kettering Cancer Center and Yale Uni-
versity in the retrospective genomic analysis of breast
cancer cases from previous clinical trials designed to
discover better markers for the successful response to
chemotherapeutic drugs. Our present work suggests the
superiority of CGH to fluorescent in situ hybridization
(FISH) for the evaluation of responsiveness to Her-
ceptin. We also have continued our collaboration with
the Radium Hospital in Oslo, Norway, in clinical trials
initiated to understand the role of bone marrow
micrometastasis in the clinical outcome of breast cancer.
We use both copy-number and DNA methylation to find
markers for survival.
We continue our efforts to find cancer genes in breast
cancer, in collaboration with two Scandinavian centers,
led by Anders Zetterberg at the Karolinska Institute,
Sweden, and Anne-Lisa Borresen-Dale at the Radium
Hospital, Norway, as well as Cliff Huddis and Larry
Norton at the Memorial Sloan-Kettering Cancer Center
(MSKCC), New York. These studies have elucidated a
set of loci, called epicenters, that are the recurrent sites
for genome amplification and deletion in breast cancer.
We and many others presume that the epicenters are
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cluster into subgroups that correlate with genome and
expression profile clustering. In collaborations with
Greg Hannon and Dick McCombie at CSHL, we have
used DNA sequencing to demonstrate that there are
DNA methylation switch zones. Detection of methyla-
tion switches in these zones may facilitate cancer detec-
tion and clinical subtyping.
GENETIC DISORDERS
After our discovery that copy-number variation is com-
mon in the human gene pool (Sebat et al., Science 305:
525 [2004]), we studied the role of CNVs in human dis-
ease and, in particular, in the role of spontaneous (or de
novo) CNVs in the germ line. Our findings established
that germ-line mutation was a more significant risk fac-
tor for autism spectrum disorders than previously rec-
ognized (Sebat et al., Science 316: 445 [2007]) and
established a new approach for the further study of the
genetic basis of this and other genetic disorders, such
as schizophrenia and congenital heart disease. 
One of the de novo events we identified was a dele-
tion on 16p. This event has now been shown by two
other groups to explain perhaps as much as 1% of
autism. We assisted Alea Mills at CSHL to engineer
mice with the orthologous deletion on mouse chromo-
some 7. We are hopeful that these mice will provide ani-
mal models suitable for understanding the underlying
neuropathology of the condition and the search for pal-
liative treatments.
Analysis of autism incidence in families, a collabo-
ration with Kenny Ye at Albert Einstein School of Med-
icine, provided evidence for a unified theory of the
genetic basis for the disorder (Zhao et al., Proc. Natl.
Acad. Sci. 104: 12831 [2007]). Autism families are
divided into simplex (only one affected child) and mul-
tiplex (multiply affected children). By inspecting the
records from the AGRE consortium, we found that the
risk to a male newborn in an established multiplex fam-
ily is nearly 50%, the frequency expected of a dominant
disorder. We compute that autism incidence and sibling
concurrence rates are consistent with a model in which
new mutations with a strong contribution arise suffi-
ciently frequently to explain the majority of autism and
are passed from a resistant carrier parent to a child in a
dominant fashion. One major source of resistance is
gender. Autism has a much lower incidence in females.
We are now in the midst of a larger study of sponta-
neous mutation in autism, based on a population of sim-
plex families collected by the Simons Foundation. Early
initial results confirm our previous findings, and we
locations where the genes that drive the progression of
malignancy reside. Hence, the elucidation of these loci
may facilitate less-expensive tools for the evaluation of
the clinical state of cancers and ultimately to gene dis-
covery. 
We have continued our studies on tumor heterogene-
ity. Clues to the progression of cancer, and its clinical
profile, are missed if we assume that each individual’s
cancer is a single clone with a single molecular history.
Work in progress indicates that at least half of breast
cancers are composed of multiple clones. Our work
proves that sampling one region of the cancer for molec-
ular markers will often yield an incomplete picture of
the state of the cancer. The careful analysis of clonal
variety should yield insight into breast cancer: the order
and mechanism by which it evolves and even if it has
already metastasized.
Our studies on tumor heterogeneity have motivated
us to attempt analysis of the genome of single cancer
cells. Preliminary studies suggest that it is technically
feasible to sequence the DNA of single cells. We use the
DNA sequence reads as “counters” to determine the
amplification/deletion pattern in the genome. We are
preparing to use this method to detect the presence of
cancer cells in biopsies, which could eventually lead to
clinical tests for cancer recurrence and risk assessment. 
In our studies of B-cell chronic leukemia (CLL), a
collaboration with Nick Chiorazzi of North Shore Uni-
versity Hospital, Manhasset, New York, we have used
ROMA to identify essentially all of the known recurrent
lesions observed in that disease and discovered several
new epicenters in addition. As with breast cancer, we
now have evidence of multiple clones of common origin
in leukemia from the same patient. Using high-resolu-
tion microarrays, we also have found preliminary evi-
dence for a set of signature genomic events in CLL at a
set of transcriptional regulator genes. We are presently
investigating whether these signature events are caused
by deletion or are in some way artifacts of chromatin
restructuring specific to CLL.
We have made significant progress in our studies of
DNA methylation in cancer. We previously described a
microarray platform (MOMA) designed to detect
methylation of CpG islands (Kamalakaran et al., Nucleic
Acids Res., in press). In our studies of samples supplied
from the Radium Hospital in Norway, we have identi-
fied CpG-rich islands that change methylation state dur-
ing the initiation and progression of breast cancer. The
genome-wide methylation patterns clearly distinguish
normal tissue and tumor tissue and might be useful for
the analytic deconvolution of complex tissue mixtures
into their cellular components. The methylation patterns
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observe de novo mutation more frequently in children
with autism than in their unaffected siblings. Because
our new studies are performed with higher-resolution
microarrays, we also see many more examples of nar-
row new mutations (altering only a few genes), thus
expanding our list of good candidate genes involved in
the disorder. There is a male bias to the detection of nar-
row mutations, but we see little gender bias to detecting
broad mutations (altering many genes). Because there
should be no gender bias in the incidence of new muta-
tion, the detection biases suggest to us that at least two
contributory genes are targeted in the broad lesions,
equalizing susceptibility in males and females. One
clear benefit of our large study will be in the design of
clinical tests for genetic counseling and early detection.
Eventually, this knowledge will contribute to finding
and matching patients with the most effective therapies. 
DATA GENERATION AND ANALYSIS
The major part of our group’s effort centers on the gen-
eration, analysis, and interpretation of high-volume
data. This entails developing protocols for conducting
microarray experiments, determining quality control,
probe evaluation, signal extraction, and segmentation
(the method of “observing” copy-number variation);
comparisons of sets of experiments, including new sta-
tistical measures, data reduction, and data summary; and
construction of databases so that we can communicate
our results to other investigators. Our novel contribu-
tions include methods to attenuate system noise in array
hybridizations, parametrize hybridization performance,
detect and correctly call regions of genetic polymor-
phism, detect de novo events, classify cancers for out-
come, and define the epicenters of genetic change in
cancers and leukemias. 
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In the last year, Chao Lin finished his Ph.D. and went on
to a postdoctoral fellowship at The Rockefeller Univer-
sity. Xiaowo Wang took an assistant professor position
at Tsinghua University in China, and Dr. Andrew Smith
took a tenure-track faculty position at the University of
Southern California. Eric Domb was our URP student
from Princeton University and Will Liao was our rota-
tion student from Stony Brook University. Dr. Zhenyu
Xuan has been promoted to Research Assistant Profes-
sor and is heading the Bioinformatics Resource Service
Core Facility of the Cancer Center with Dr. Weijun Luo
and Mr. Martin Paradesi on staff. 2008 has been a very
productive year, despite the severe budget cuts from the
government.
COMBINATORIAL PATTERNS OF HISTONE
ACETYLATIONS AND METHYLATIONS IN
THE HUMAN GENOME
Histones are characterized by numerous posttransla-
tional modifications that influence gene transcription.
However, because of the lack of global distribution data
in higher eukaryotic systems, the extent to which gene-
specific combinatorial patterns of histone modifications
exist remains to be determined. In collaboration with
the Zhao Lab at NHLBI/NIH, we studied the combina-
torial patterns derived from the analysis of 39 histone
modifications in human CD4(+) T cells. Our results
indicate that a large number of patterns are associated
with promoters and enhancers. In particular, we identi-
fied a common modification module consisting of 17
modifications detected at 3286 promoters. These mod-
ifications tend to colocalize in the genome and corre-
late with one another at an individual nucleosome level.
Genes associated with this module tend to have higher
expression, and addition of more modifications to this
module is associated with further increased expression.
Our data suggest that these histone modifications may
act cooperatively to prepare chromatin for transcrip-
tional activation. This is the first comprehensive chro-
matin immunoprecipitation sequencing (ChIP-seq)
mapping of the human epigenome at the nucleosome
resolution (Wang et al. 2008).
COMPUTATIONAL GENOMICS
M.Q. Zhang N. Dimitrova W. Luo X. Wang
E. Domb M. Paradesi Z. Xuan
D. Lewis J. Rosenfeld C. Xue
W. Liao A.D. Smith C. Zhang
DEFINING THE REGULATORY NETWORK
OF THE TISSUE-SPECIFIC SPLICING
FACTORS FOX-1 AND FOX-2
The precise regulation of many alternative splicing (AS)
events by specific splicing factors is essential to deter-
mine tissue types and developmental stages. However,
the molecular basis of tissue-specific AS regulation and
the properties of splicing regulatory networks (SRNs)
are poorly understood. In collaboration with the Krainer
lab here at CSHL, we comprehensively predicted the tar-
gets of the brain- and muscle-specific splicing factor
Fox-1 (A2BP1) and its paralog Fox-2 (RBM9) and sys-
tematically defined the corresponding SRNs genome-
wide. Fox-1/2 factors are conserved from worm to
hu mans, and they specifically recognize the RNA ele-
ment UGCAUG. We integrated Fox-1/2-binding speci-
ficity with phylogenetic conservation, splicing micro -
array data, and additional computational and experimen -
tal characterization. We predicted thousands of Fox-1/2
targets with conserved binding sites, at a false discovery
rate (FDR) of ~24%, including many validated experi-
mentally, suggesting a surprisingly extensive SRN. The
preferred position of the binding sites differs according
to the AS pattern and determines either activation or
repression of exon recognition by Fox-1/2. Many pre-
dicted targets are important for neuromuscular functions
and have been implicated in several genetic diseases. We
also identified instances of binding-site creation or loss
in different vertebrate lineages and human populations,
which likely reflect fine-tuning of gene expression reg-
ulation during evolution (Zhang et al. 2008).
LARGE-SCALE NETWORK-BASED PREDICTION
OF HUMAN DISEASE GENES
Deciphering the genetic basis of human diseases is an
important goal of biomedical research. On the basis of
the assumption that phenotypically similar diseases are
caused by functionally related genes, we propose a com-
putational framework that integrates human protein–
protein interactions, disease phenotype similarities, and
known gene–phenotype associations to capture the com-
plex relationships between phenotypes and genotypes.
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TRANSCRIPTIONAL NETWORK
IN BREAST CANCER
In collaboration with the Akiyama and Aburatani labs
at the University of Tokyo, we completed an integrative
bioinformatics analysis of transcriptional regulatory
programs in breast cancer cells. To gain insights into the
transcriptional programs that drive breast cancer tumor
progression, we integrated regulatory sequence data and
expression profiles of breast cancer into a Bayesian Net-
work and searched for cis-regulatory motifs statistically
associated with given histological grades and progno-
sis. Our analysis found that motifs bound by ELK1, E2F,
NRF1, and NFY are potential regulatory motifs that
positively correlate with malignant progression of breast
cancer. 
The results suggest that these four motifs are princi-
pal regulatory motifs driving malignant progression of
breast cancer. Our method offers a more concise descrip-
tion of transcriptome diversity among breast tumors with
different clinical phenotypes (Niida et al. 2008).
MAPPING THE NEXT-GENERATION
SEQUENCING READS
Next-generation sequencing has the potential to revolu-
tionize genomics and impact all areas of biomedical sci-
ence. New technologies will make resequencing widely
available for such applications as identifying genome
variations or interrogating the oligonucleotide content of
a large sample (e.g., ChIP-seq). The increase in speed,
sensitivity, and availability of sequencing technology
brings demand for advances in computational technology
to perform associated analysis tasks. The Solexa/ Illumina
1G sequencer can produce tens of millions of reads, rang-
ing in length from ~25 to 50 nucleotides, in a single
experiment. Accurately mapping the reads back to a ref-
erence genome is a critical task in almost all applications.
Two sources of information that are often ignored when
mapping reads from the Solexa technology are the 3′ ends
of longer reads, which contain a much higher frequency
of sequencing errors, and the base-call quality scores. To
investigate whether these sources of information can be
used to improve accuracy when mapping reads, we devel-
oped the RMAP tool, which can map reads having a wide
range of lengths and allows base-call quality scores to
determine which positions in each read are more impor-
tant when mapping. We applied RMAP to analyze data
resequenced from two human bacterial artificial chro-
mosome (BAC) regions for varying read lengths and
varying criteria for use of quality scores. RMAP is freely
available for downloading at http://rulai.cshl.edu/rmap/.
In collaboration with Tsinghua University, we developed
a computational tool named CIPHER to predict and pri-
oritize disease genes, and we showed that the global
concordance between the human protein network and
the phenotype network reliably predicts disease genes.
Our method is applicable to genetically uncharacterized
phenotypes, effective in the genome-wide scan of dis-
ease genes, and is also extendable to explore gene coop-
erativity in complex diseases. The predicted genetic
landscape of more than 1000 human phenotypes reveals
the global modular organization of phenotype–genotype
relationships. The genome-wide prioritization of candi-
date genes for more than 5000 human phenotypes,
including those with undercharacterized disease loci or
even those lacking known association, is publicly
released to facilitate future discovery of disease genes
(Wu et al. 2008). This work was highlighted by a Nature
China article and was ranked number one in citations
among Molecular Systems Biology published papers in
the category.
DISEASE GENE REGULATION
In collaboration with the Nahle lab at Washington Uni-
versity, we studied CD36-dependent regulation of muscle
FoxO1 and PDK4 in the peroxisome pro lif er a tion-
activated receptor (PPAR) δ/β-mediated adaptation to
metabolic stress. The transcription factor FoxO1 con-
tributes to the metabolic adaptation to fasting by sup-
pressing muscle oxidation of glucose, sparing it for
glucose-dependent tissues. Our findings suggest that
CD36-dependent fatty acid activation of PPAR δ/β
results in the transcriptional regulation of FoxO1 as well
as PDK4, recently shown to be a direct PPAR δ/β target.
FoxO1 in turn can regulate CD36, lipoprotein lipase, and
PDK4, reinforcing the action of PPAR δ/β to increase
muscle reliance on fatty acid. The findings could have
implications in the chronic abnormalities of fatty acid
metabolism associated with obesity and diabetes (Nahle
et al. 2008). Recently, we also studied the regulation of
the PDK4 isozyme by the Rb-E2F1 complex. Loss of the
transcription factor E2F1 elicits a complex metabolic
phenotype in mice underscored by reduced adiposity and
protection from high-fat diet-induced diabetes. Our
analysis illustrates how the E2F1 mitogen directly regu-
lates PDK4 levels and influences cellular bioenergetics,
namely, mitochondrial glucose oxidation. These results
are relevant to the pathophysiology of chronic diseases
such as obesity and diabetes, where PDK4 is dysregu-
lated and could have implications pertinent to the etiol-
ogy of tumor metabolism, especially in cancers with Rb
pathway defects (Hsieh et al. 2008).
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Our results indicate that significant gains in Solexa read-
mapping performance can be achieved by considering the
information in the 3′ ends of longer reads and appropri-
ately using the base-call quality scores. The RMAP tool
will enable researchers to effectively exploit this infor-
mation in targeted resequencing projects (Smith et al.
2008). To further improve speed and sensitivity, we have
collaborated with the Li lab at the University of Waterloo,
Canada, to develop a novel spaced seed-based algorithm
called ZOOM that can be used for any platforms of
sequencing technologies, including double-end sequenc-
ing reads. It also allows gaps in read mapping. Using this
framework, we are able to map the Illumina/Solexa reads
of 15x coverage of a human genome to the reference
human genome in 1 CPU day, allowing two mismatches,
at full sensitivity. The software is freely available to non-
commercial users at http://www.bioinfor.com/zoom.
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PLANT BIOLOGY
Plant genetics has long had a major role in the advance of all areas of research at CSHL, epitomized by
the work of Nobel Laureate Barbara McClintock, who discovered transposable genetic elements—which
she called “jumping genes”—in the 1940s. The contemporary effort to understand the genetic and cell
biological mechanisms that enable plants to grow and develop has obvious implications not only for agri-
culture, but also for human health, as well as the development of next-generation biofuels and related
alternative energy sour ces. Plant geneticists at CSHL have been among the leaders of efforts to sequence
the first plant genomes, of Arabidopsis and maize, and continue to be at the center of sequencing and
genome-annotation projects involving a host of cereal crops that feed the growing population of our
planet. CSHL scientists have been among the pioneers in the study of RNAi, a gene-regulatory mecha-
nism un known only a decade ago, which has been shown, first in plants, then in other organisms, to have
a vital and evo lu tionarily ancient genome-de fending role.
David Jackson and colleagues study genes and signals that regulate plant growth and architecture.
This year, they built on past success in identifying a gene that controls communication between plant cells
via small channels called plasmodesmata. These channels, which direct the flow of nutrients and signals
through growing tissues, are regulated during development. Jack son’s team performed a ge netic screen
and found some mu tants that are affected in transport, one of which was found to affect redox signal-
ing. This suggests a mechanism through which plant cells can adjust trafficking in the channels in differ-
ent developmental stages. The lab also cloned a gene called tasselsheath, whose activity they correlated
with the shutting down of leaf growth when flowering gets under way. Jackson’s past success in de vel-
oping fluorescent-protein-tag ged maize lines bore fruit when a team that included Jackson this year iden-
tified a gene called sparse inflorescence1 that proves to be vital in the formation of corn “ears.”
Zachary Lippman’s research focuses on a universal growth habit in plants called sympodial growth,
seen in widely varying species from orchids to tomatoes to trees. It is characterized by a renewal of
growth that follows a cessation of growth following prior flowering, resulting in an array of stems. Lipp-
man’s lab seeks to understand how sympodial growth affects the vigor and reproductive success of a
plant, specifically its ability to produce vegetative shoots and flower-bearing shoots called inflorescences.
In the tomato plant and other members of the plant family to which it belongs, called Solanaceae, they
study genes that control the branching of flowering shoots and how those genes function to control
flower production. Their aim is to decipher the molecular basis of the natural variation for inflorescence
branching seen in that important family, with an eye to increasing crop yields.
Epigenetic mechanisms of gene regulation—chemical and conformational changes to chromatin bun-
dles of DNA and protein—have important impact on genome organization and inheritance and on cell
fate. These mechanisms are conserved in eukaryotes and provide an additional layer of information super-
imposed on the genetic code. Robert Martienssen, a pioneer in the study of epigenetics, investigates
mechanisms involved in gene regulation and stem cell fate in yeast and model plants including Arabi-
dopsis and maize. He and colleagues have shed light on a phenome non called position-effect variega-
tion, associated with plant color diversity and caused by inactivation of a gene positioned near densely
packed chromosomal material called heterochromatin. They have found that hetero chro matin is pro-
grammed by small RNA molecules arising from repeating genetic sequences. This past year, they
addressed a nagging conundrum: Because genes contained within heterochromatin are silenced, how
can they give rise to RNA molecules that help to modify the histone proteins around which DNA is
spooled? They solved the puzzle by tracking cells through their cycle of growth and division. They also
mapped changing epigenetic modifications enabling mobile genetic elements to run amok within a
genome.
The growing tips of plants, called meristems, contain a population of stem cells that serve as a per-
sistent source of daughter cells from which new organs arise. They also produce sig nals important for
the determination and patterning of lateral organs. Marja Timmermans and colleagues are using a
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genomic approach to study genes active in the meristem. They have used mutational analyses to iden-
 tify a protein complex that suppresses stem cell fate during organ development. This complex includes
the chromatin remodeling factor HIRA, an epigenetic regulator that helps to control stem cell identity.
This year, the lab made progress in elucidating the molecu lar mechanism through which HIRA acts,
demonstrating its role in specifying stem cell niches during em bryo genesis and, later on, after commit-
ment to differentiation, in shutting off stem cells. They also identified regulatory mechanisms that allow
for the precise spatial accumulation of developmentally important small RNAs in plants. This work
revealed that polarity in leaves is established via mobile small RNAs; a description of the mobile small
RNA, tasiR-ARF, in pattern formation suggests possible roles of other small RNAs as morphogen-like sig-
nals during development in plants and animals.
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Research in our lab is aimed at identifying novel genes,
signals, and pathways that regulate multicellular growth
and development. All organisms develop by carefully
controlling the flow of information (“signals”) that
passes between cells and tissues. We are particularly
interested in discovering these signals and finding out
how they are transmitted and how they function. As an
example, we have identified genes that control how
plant cells communicate with one another through small
channels, called plasmodesmata (PD). These channels
were described in plants more than 100 years ago, but
their central importance and how they are regulated are
just beginning to emerge. Plasmodesmata are critical
for plant growth because they allow the flow of nutri-
ents and signals through growing tissues. In the past
year, we discovered an important mechanism by which
transport through these channels is regulated via redox
signaling, and we have also found a novel chaperone
gene that regulates the specific cell-to-cell transport of
KNOTTED1, a transcription factor. KNOTTED1 is a
homeodomain protein that is expressed in plant stem
cells and is necessary to keep these cells in a pluripotent
state.
We also continue to identify maize genes with novel
roles in shoot development and plant architecture. We
have recently identified genes that control branching,
stem cell proliferation, and leaf growth. One of these,
tasselsheath1, encodes a transcription factor that
appears to have evolved a novel function in the grasses.
This gene is particularly interesting because leaf sup-
pression in the inflorescence is an important crop yield
trait. Finally, we continue to develop a collection of “flu-
orescent-protein”-tagged maize lines that are an essen-
tial resource for all maize researchers. This is the first
collection of its kind and promises to enhance maize
genetics research through characterization of develop-
mental gene pathways and identification of maize pro-
moters that are useful tools for basic research as well as
in crop improvement.
DEVELOPMENTAL BIOLOGY: STEM CELLS, SIGNALING,
AND CONTROL OF PLANT ARCHITECTURE
D. Jackson Y. Benitez E. Jimenez J. Wang
P. Bommert R. Johnston C. Whipple
K. Chen Y.K. Lee X.M. Xu
S. Choi M. Pautler J. Yuan
S. DeBlasio N. Satoh-Nagasawa T. Zadrozny
A. Goldshmidt M. Scricco
Control of Intercellular Trafficking in
Arabidopsis thaliana
Y. Benitez
Intercellular communication is essential for plant devel-
opment and environmental adaptability. PD—channels
embedded in the cell wall—connect plant cells and
enable the transport of metabolites, viral and endoge-
nous proteins, and RNAs. Recently, we identified a fac-
tor that regulates this transport by a genetic screen in
the model plant Arabidopsis thaliana. We used green
fluorescent protein (GFP) as a reporter to isolate mutant
plants affected in PD transport. GFP moves freely
between plant cells in developing plant tissues, and we
screened for mutants blocked in this transport. Five
mutants were identified and named gat (pronounced
“gate”) for “GFP-arrested trafficking.” Severe restric-
tion in transport was found in four of the mutants (gat1,
2, 4, and 5). In contrast, gat3 mutants showed a milder
block in the transport. These differences in GFP mobil-
ities were also reflected in the seedling phenotypes of
the mutants: gat1, 2, 4, and 5 arrested early after ger-
mination and developed only a short root and small leaf
primordia, but gat3 seedlings did not show any obvious
developmental defects. 
Characterization of gat1 mutants revealed that they
were defective in a thioredoxin gene, TRX-m3, involved
in cellular redox responses. Characterization of the
mutant and ectopic expression phenotypes suggested
that GAT1 regulates communication in the meristem
(where stem cells are located) and other immature tis-
sues by controlling the production of the polymer cal-
lose. Callose deposition in PD is a normal mechanism to
close down these channels during development of spe-
cific cell types that need to be isolated. Analysis of the
redox status of the mutant and the phenotype of wild-
type plants grown in oxidants suggests that this regula-
tion is dependent on the generation of reactive oxygen
species within the cell. 
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scription factor, is required in the epidermis for tri-
chome initiation and acts cell autonomously. However,
expression of a fusion between GL1 and KN1C in cells
underlying the epidermis can rescue trichomes in a gl1
mutant background because the fusion protein can traf-
fic through PDs into the epidermal cells. Thus, this sys-
tem provides a simple and tractable model to understand
how proteins traffic cell to cell. Factors critical for KN1
trafficking can be uncovered through isolating mutants
defective in trichome rescue.
As a proof of concept for our genetic strategy, com-
bining mapping and illumina-based sequencing, one
mutant with attenuated KN1 trafficking (Fig. 1) was
identified as a chaperonin gene. The chaperonin appears
to be essential for PD trafficking of certain but not all
noncell-autonomous proteins, suggesting that different
mechanisms may be involved for various trafficking
proteins. In addition, biochemical evidence suggests a
physical association between chaperonin and KN1.
The central question now is how mechanistically a
chaperonin protein may be involved in KN1 trafficking.
Chaperonins have been characterized in fungal and
mammalian systems as a key component of the cellular
chaperone machinery, facilitating efficient protein fold-
ing in the cytosol. Proteins are thought to undergo par-
tial unfolding during PD translocation, which makes the
discovery of this chaperonin particularly exciting. Even
more exciting, the hetero-oligomeric chaperonins form
a cylindrical complex with a central cavity for confining
the polypeptide chain and ensuring its proper folding.
The chaperonin central cavity and PD microchannels
have similar diameters; thus, one very exciting possi-
bility is that chaperonins or chaperonin-like proteins
may belong to the long sought-after core constituents of
Other trafficking mutants identified in this screen
(gat2, 4, and 5) also showed hyperaccumulation of reac-
tive oxygen species and callose in the root meristem,
suggesting that these mutants, together with gat1, are
components of a redox-dependent mechanism that reg-
ulates callose deposition in the PD. The identification
of the corresponding genes will provide new insights in
this mechanism.
In contrast, gat3 seems to be part of a separate mech-
anism in PD regulation. gat3 mutants behave in a dom-
inant manner and develop normally, although GFP
movement is affected throughout development. We are
now working to identify the GAT3 gene, which will shed
light on a potentially new mechanism for PD regulation. 
A Chaperonin Regulates
KNOTTED1 Cell-to-Cell
Trafficking
X.M. Xu, J. Wang, M. Scricco
Cell-to-cell communication has critical roles in speci-
fying cell fate and coordinating development in all mul-
ticellular organisms. A new paradigm for such
communication in plants is the selective trafficking of
informational macromolecules, e.g., transcription fac-
tors through PDs, channels that traverse the cell wall
and connect all plant cells. 
In addition to cell-fate specification, PDs are also
involved in viral movement, transport of metabolites,
and cell-to-cell spread of RNA interference (RNAi),
which points to their fundamental importance in coor-
dinating plant defense, metabolism, and development.
Despite the discovery of PD more than 100 years ago,
and our increasing recognition of their functional sig-
nificance, the underlying components and mechanisms
of PD trafficking remain poorly understood. Hence, an
unbiased genetic strategy is taken to dissect these
molecular components and mechanisms, using an
ingenious gain-of-trafficking system. 
The maize KNOTTED1 (KN1) homeodomain pro-
tein was the first plant protein found to selectively traf-
fic through PD, and its trafficking appears to be
important for its function in shoot stem cell mainte-
nance. A gain-of-function trafficking assay in Ara-
bidopsis was developed to demonstrate that the
carboxy-terminal region of KN1 (“KN1C”), which con-
tains the homeodomain, is necessary and sufficient for
KN1 trafficking in vivo. The trafficking assay relies on
complementation of leaf hair (trichome) development
in hairless glabra1 (gl1) mutants. GL1, a MYB tran-
FIGURE 1 A mutant in cell-to-cell transport of KNOTTED1.
Impaired PD trafficking of KN1 is demonstrated by reduced
GFP~GL1~KN1C fluorescence in the chaperonin mutant leaf epi-
dermis (outlined with dashed lines) compared to wild type (wt,
arrowed). Note normal fluorescence levels in mesophyll cell nuclei
in both samples (arrowed). Confocal images of hand-sectioned
leaf samples are shown. Bars, 20 µm.
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PDs. In support of this idea, chaperonins have been
observed to associate with membranes. To address this
possibility, fluorescent-protein-tagging assays are in
progress to investigate the precise subcellular localiza-
tion of chaperonins in Arabidopsis. Meanwhile, it is also
possible that chaperonins may function during post-
translocation protein folding and/or in maintaining pro-
teins in an unfolded state that is competent for PD
transport. The latter scenario would be analogous to
posttranslational endoplasmic reticulum (ER) translo-
cation. Various complementation experiments are under
way that aim to distinguish between these possibilities. 
In summary, a functional characterization of chaper-
onins—the first-ever factor so far known to be critical
for KN1 PD trafficking—will further our understand-
ing of developmental regulation and mechanisms of
selective cell-to-cell trafficking. In addition, it may give
mechanistic insights into this elaborate protein-folding
machinery, which is not well understood in any system
at a molecular level but has been linked to several patho-
logical states in humans, such as cancer, sensory neu-
ropathy, and Huntington’s disease.
Hormone Signaling in
Maize
S. DeBlasio, T. Zadrozny [in collaboration with A. Chan,
The J. Craig Venter Institute, and A. Sylvester, University
of Wyoming]
Similar to animal systems, hormones have a key role in
the proper growth and development of plants. The for-
mation and patterning of lateral organs (i.e., roots,
leaves, and flowers) in crop species such as maize
depend on hormonally induced changes in gene tran-
scription, which occur within meristematic stem cells.
How well these organs develop under normal and stress-
ful environmental conditions often has major effects on
important agronomic processes including crop yield and
nutritional content. 
To better understand the role hormone signaling has
in maize development, we have created stable transgenic
lines, natively expressing fluorescent-tagged versions of
proteins involved in three important hormone pathways:
auxin, cytokinin, and jasmonic acid. We use these lines
to determine the tissue specificity and subcellular local-
ization of the fusion proteins, documenting changes in
their expression patterns throughout development and
in response to various exogenous signals. Protein local-
ization is also assessed in developmentally defective
genetic backgrounds, and where possible, these fluo-
rescent protein fusion lines have been used to comple-
ment their respective mutant alleles to verify functional
activity. The lines developed thus far have provided
unprecedented microscopic views of maize cellular
architecture, and we can now study real-time dynamics
of cell structure, function, and protein localization for
~50 tagged genes.
As an example, cytokinins act to maintain the popu-
lation of stem cells within the meristem as well as pro-
mote their differentiation by interacting with
plasma-membrane-bound histidine kinase receptors.
This initiates a phosphorelay cascade within the cell
where the kinase receptor phosphorylates a histidine
phosphotransfer protein, inducing its translocation from
the cytoplasm to the nucleus where it activates B-type
response transcriptional regulators (RRs). This leads to
changes in gene expression of proteins involved in organ
differentiation, including cell elongation, chloroplast
differentiation, and cell division. B-type RRs also
induce transcription of A-type RRs that feed back to
negatively inhibit the pathway. To date, our lab has gen-
erated fluorescent-tagged lines for at least one member
of the cytokinin-specific protein families mentioned
above, as well as cytokinin oxidases, which degrade the
hormone, and putative cytokinin responsive proteins
such as the cell cycle control protein cyclin D. Prelimi-
nary results suggest that the subcellular localization of
some of these proteins may differ between organ types
and is dependent on hormone levels. For example,
ZmRR7-YFP (an A-type RR) is localized mainly in the
cytoplasm and around the nucleus of root cells. How-
ever, in leaf epidermal cells, a greater concentration of
ZmRR7-YFP was observed within the nucleus when
exogenous cytokinin was applied. During tassel devel-
opment, ZmRR7-YFP localizes to a discrete zone in the
center of the spikelet meristem, suggesting its involve-
ment in stem cell maintenance. We are currently work-
ing to create a cytokinin reporter line that will allow us
to detect changes in cytokinin levels in planta. 
We are also starting to explore the role jasmonic acid
(JA) may have in maize inflorescence development.
Although JA is better known for being a key signaling
molecule involved in plant defense responses, recent evi-
dence has shown that it is also involved in sex determi-
nation. Mutations in 13-lipoxygenase (LOX), one of the
enzymes involved in the biosynthesis of volatile com-
pounds, including JA, lead to the feminization of the
male tassel. Application of exogenous JA to developing
mutant tassels was sufficient to rescue stamen growth,
suggesting that JA is required for proper male floral
development in maize. Interestingly, our studies have
found that the natively expressed YFP (yellow fluores-
cent protein) fusion protein of another member of the
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13-lipoxygenase family, ZmLOX10, localizes to a dis-
crete domain subtending spikelet pair meristems in the
tassel. This pattern is similar to the one that we observed
for RAMOSA3, a protein involved in inflorescence
branching. At a later stage in tassel development,
ZmLOX10-YFP can be observed at the boundary
between spikelet meristem pairs. In collaboration with
Dr. Michael Kolomiets at Texas A&M University, we are
in the process of determining the function of ZmLOX10
and/or JA in early inflorescence development.
We have also generated a series of marker lines that
highlight different subcellular compartments, including
vacuole, nuclei, peroxisomes, microtubules, plastids,
and various other structures that are available to the sci-
entific community for study. We plan to use these mark-
ers to analyze changes that occur within the cell during
differentiation and development. In some cases, the
expression of fluorescent marker proteins in generated
lines is so robust that it can be observed with the naked
eye. For example, corn kernels natively expressing the
endosperm-specific-gene α-zein fused to RFP (red flu-
orescent protein) have a distinct pink color due to the
high levels of the tagged protein that have accumulated
within the kernel, making identification of transgenic
seeds as well as quantification of fusion protein levels
easy. We are currently using this line to rapidly assess
the effect that certain epigenetic mutations have on
transgene silencing. 
Regulation of Phyllotaxy
in Maize
R. Johnston, E. Jimenez
Different plant species each has a characteristic ordered
arrangement of leaves along the stem. The arrangement
of leaves on the shoot axis is termed phyllotaxy. These
patterns can be traced back to events in the shoot apical
meristem (SAM), the reservoir of stem cells at the shoot
tip that is the site of leaf initiation. The aim of our
research is to investigate the mechanisms that determine
the pattern of leaf initiation, specifically, interactions
between developmental genes and hormone signaling
pathways. The maize plant exhibits a very ordered pat-
tern of growth, making it an excellent model for the
study of phyllotaxy. Leaves of the main axis are initi-
ated singly in an alternate pattern, generating a disti-
chous phyllotaxy. aberrant phyllotaxy 1 (abph1)
mutants have an altered phyllotaxy; leaves are initiated
in pairs in a decussate pattern, rather than the normal
distichous pattern. This has been attributed to the
enlarged SAMs of abph1mutants. Previous work by our
lab has shown that abph1 encodes a cytokinin-inducible
type-A response regulator that is involved in the nega-
tive regulation of cytokinin signaling, indicating a role
for cytokinin in phyllotactic patterning. 
The plant hormone auxin is also implicated in the
regulation of leaf initiation and phyllotaxy. Polar auxin
transport is facilitated by the PIN1 family of proteins.
Recent data indicate that PIN1 and auxin levels are
reduced in abph1 embryos. To elucidate interactions
between auxin and ABPH1, we are using transgenic
lines expressing the maize PIN1 protein fused to a YFP
(ZmPIN1a-YFP) and ABPH1 fused to an RFP
(ABPH1-RFP). Confocal microscopy was used to
observe the localization of ZmPIN1a-YFP during early
development of normal and abph1 embryos. We found
that in normal embryos, ZmPIN1a-YFP is expressed at
high levels in the central and lower regions of the SAM
before initiation of the first leaf. ABPH1-RFP is
expressed in a partially overlapping domain in the cen-
tral and upper part of the SAM. 
Surprisingly, in abph1 embryos, ZmPIN1a-YFP
expression in the SAM was considerably delayed and
reduced. Similarly, ZmPIN1a-YFP expression was not
seen in the SAM before initiation of the first leaf in
these mutants. We also found that initiation of the first
leaf was delayed by approximately 1 day in abph1
embryos. ZmPIN1a-YFP was expressed at similar lev-
els and in a similar pattern in other regions of abph1
embryos, indicating that alterations in ZmPIN1a-YFP
expression were specific to the stem cell population and
confirming that the abph1 embryos that we observed
were expressing the ZmPIN1a-YFP construct. Taken
together, these observations support a model in which
reduced auxin levels and altered PIN1 localization in
the shoot meristems of abph1 mutants delay leaf initia-
tion, contributing to the enlarged stem cell pool and
altered phyllotaxy of these mutants. We previously
found that cytokinin induces ZmPIN1a expression in the
maize SAM. To determine whether this induction occurs
throughout the SAM or is confined to cells that will
form the next leaf, we quantified ZmPIN1a-YFP fluo-
rescence intensity in plants treated with cytokinin. We
found that ZmPIN1a-YFP induction occurs specifically
in the group of cells that will give rise to the next leaf.
This result provides additional evidence for cross talk
between auxin and cytokinin signaling in the regulation
of phyllotaxy.
To further understand the regulation of maize phyl-
lotaxy, we are characterizing a second mutant, Abph2,
which is dominant. However, unlike abph1, Abph2 phyl-
lotaxy is initially normal and changes to decussate at
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about leaf 5. The change to decussate phyllotaxy is often
preceded by the production of a fused leaf. Abph2
embryonic SAMs are considerably larger than normal,
suggesting that like abph1, Abph2 regulates phyllotaxy
in part through regulation of the stem cell pool.
The identity of Abph2 is not known and efforts to iden-
tify the gene by positional cloning are ongoing. Abph2
was mapped to a region between two genetic markers on
chromosome 7. Because there is a gap in the sequence
available for this region of the maize genome, we used
sequence similarity (synteny) with the rice genome and
additional genetic markers to further map Abph2 to an
interval spanning two bacterial artificial chromosomes
(BACs). The location of Abph2 on these two BACs has
been narrowed to an interval of ~180 kb containing five
predicted genes, and we are currently sequencing them
from the mutant to identify the Abph2 gene. 
In parallel with the map-based approach, we per-
formed a mutagenesis screen to identify new alleles of
Abph2. In this screen, pollen from homozygous Abph2
plants was treated with a mutagenic compound, ethyl-
methanesulfate (EMS), and used to pollinate nonmutant
plants. Seeds from these crosses were planted and
screened as seedlings. Most such plants have the domi-
nant Abph2 phenotype. However, in cases where muta-
tion has disrupted the Abph2 allele, the progeny should
appear normal. Eight such “knockout” plants were iden-
tified. Work is currently under way to sequence alleles
of candidate genes in these “knockout” lines to identify
mutations that may have caused the loss of Abph2 func-
tion. Identification of such mutations will provide fur-
ther clues to the identity of Abph2. In addition, this
approach may generate an abph2 loss-of-function
mutant that will provide information about the normal
role of this gene in plant development. 
Investigation of Molecular Mechanisms
Controlling Meristem Determinacy
and Inflorescence Branching in Maize
S. DeBlasio, A. Goldshmidt, M. Pautler
We are interested in studying the development of maize
inflorescence because its architecture is critical to repro-
ductive success. This has a wide range of implications
in hybrid seed production and ultimately crop yield. The
shape of maize inflorescence is controlled by the fate and
activity of axillary meristems, which subtend the sup-
pressed leaves of the tassel and ear. The classical ramosa
(ra1, 2, 3) mutants have highly branched inflorescences,
due to increased activity of spikelet pair meristems. RA1
and RA2 encode transcription factors, but RA3 is pre-
dicted to be a trehalose sugar metabolic enzyme.
Although RA3 is a functional trehalose-6-phosphate
phosphatase (TPP) in vitro and in vivo in yeast, trehalose
levels are unchanged in the ra3 mutant. This, together
with several other lines of evidence, suggests that RA3
could have an additional unsuspected function in maize.
First, RA3 has a discrete expression pattern subtending
axillary meristems, suggesting a developmental, rather
than general, metabolic role. Second, RA3 is genetically
upstream of RA1 and regulates its expression. Finally,
RA3 immunolocalization shows that the protein is both
nuclear and cytoplasmically localized and forms a speck-
led pattern. A yeast two-hybrid screen was conducted in
order to gain a better understanding of how RA3 func-
tions. Approximately 3.1 million clones were screened
from an inflorescence cDNA library. These results of this
screen suggest that RA3 interacts with several transcrip-
tion factors, including those belonging to the zinc finger
homeodomain (ZF-HD) class. We therefore believe that
RA3, such as some metabolic enzymes in yeast (e.g.,
hexokinase), may have an additional role in transcrip-
tional regulation.
To test this hypothesis, we plan to confirm RA3
interacting proteins in planta with immunoprecipitation
experiments using epitope-tagged transgenic lines. Fur-
ther characterization of the putative interactors, includ-
ing expression analysis via in situ hybridization and
reverse genetics, is currently in progress. We will also
directly assay whether RA3 occupies the promoter of
RA1 in vivo via chromatin immunoprecipitation (ChIP)
and explore whether nuclear localization of RA3 is
required for normal development.
As an independent genetic approach, we are mapping
a naturally occurring genetic suppressor of ra3, as well as
screening EMS-mutagenized populations for additional
modifiers. This approach should place additional factors
in the ramosa pathway and provide functional insight. We
also hope to exploit standing natural variation in maize
inbreds to screen for further modifiers of ra3.
An eventual goal is to understand the mechanisms
controlling determinacy of the spikelet pair meristems.
Previous studies showed that both auxin transport and
control of stem cell maintenance might affect meristem
determinacy. We will assess behavior of the auxin trans-
port and activity fluorescent markers in wild-type and
ramosamutants. In parallel, we will observe expression
patterns of the maize meristem maintenance genes in all
of the mutants and attempt to establish a genetic link
between ramosa mutants and auxin or meristem main-
tenance genes by double-mutant analysis. As a comple-
mentary strategy, we are using a genomics approach by
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comparing Illumina-based transcriptome profiles of
developing wild-type and mutant ears. Our analysis will
facilitate better understanding of the mechanisms con-
trolling maize meristem determinacy and potentially
define additional genes participating in the process. 
Resolving Regulatory and Metabolic
Networks in Meristem Determinacy
during Maize Inflorescence
Development
A.L. Eveland, N. Satoh-Nagasawa, D. Ware [in collaboration
with Mary Beatty and Hajime Sakai, DuPont Crop Genetics]
In maize, male and female flowers develop separately
in branched clusters called inflorescences as tassels and
ears, respectively. Inflorescence architecture is deter-
mined by the developmental fate of axillary meristems
that are composed of highly organized stem cell popu-
lations. In both immature ears and tassels, a series of
axillary meristems are initiated sequentially along a
developmental gradient. These include spikelet pair
meristems (SPM), spikelet meristems (SM), and tassel-
specific branch meristems (BM). Disruptions in SM and
SPM determinacy, as shown with a core set of mutants,
result in altered branching patterns. Genetic control of
branching, especially in the ear where kernels are borne,
has clear relevance to crop improvement programs with
respect to seed number and harvesting ability. The pur-
pose of this work is to use existing data sets and bioin-
formatics to computationally resolve regulatory and
metabolic networks that modulate developmental fate
of maize inflorescence meristems. 
RAMOSA (RA) genes specifically affect meristem
determinacy in the SPM. As mentioned in the previous
section, RA1 and RA2 encode transcription factors and
RA3 encodes a trehalose-6-phosphatase. The latter sug-
gests a putative link between developmental and meta-
bolic processes. Although genetic studies in these
mutants have identified key genes that regulate inflo-
rescence architecture and their basic molecular mecha-
nisms, links to associated metabolic and regulatory
pathways have not been resolved on a genome-wide
scale. In this study, a framework for gene expression is
constructed based on information from a series of exist-
ing data sets. These data sets include experimental
analyses of gene expression during young ear and tassel
development, as well as comparisons of transcript pro-
files among relevant mutants. Expression data were col-
lected by microarray analyses and sequence-based
transcript profiling using Illumina’s deep sequencing
platform. 
We hypothesized that a sequence-based approach to
expression profiling would enhance specificity by dis-
tinguishing between closely related transcripts and iden-
tifying new genes expressed in developing inflo -
rescences. To test this, we used Illumina’s digital gene
expression (DGE) to compare genome-wide expression
profiles in B73 (normal) and ra3 mutant maize. The
DGE tag-profiling strategy targets the 3′ ends of
expressed sequences to generate millions of 20-base
sequence reads. Read frequency of a given sequence tag
associated with a particular transcript can be used to
quantify mRNA levels. Deep sequencing of immature
ear samples yielded ~27 million reads with frequencies
spanning four orders of magnitude. Two separate restric-
tion digests (DpnII and NlaIII) were used to construct
the DGE libraries and enabled resolution of 18,154 and
25,777 unique transcripts, respectively. Approximately
80% of these unique sequences mapped perfectly to the
maize reference genome, whereas ~6% mapped to
repetitive regions. Coordinates for these mappings were
used to associate the unique sequences with gene mod-
els and annotations in maize. Our analyses identified
differentially expressed genes and resolved expression
profiles for low-expressed genes, including both RA1
and RA3. 
Current results from this study demonstrated the
effectiveness of DGE-based transcript profiling in a
highly duplicated genome such as maize and resolved
differential expression profiles that will help to define
the roles of the RA3 gene. Further analyses include com-
parisons of ra1 and ra2 mutants as well as sequential
stages of young ear and tassel development using DGE.
In addition, another Illumina-based method, RNA-seq,
will be used to sequence the entire transcriptome of
immature ear and tassel samples and will provide a scaf-
fold to anchor the short DGE tags, additional support
for annotation of expressed genes, and enhanced cover-
age of transcript variants. 
Computational methods are being used to analyze the
global expression information provided by the assem-
bled microarray- and Illumina-based data sets. These
analyses include clustering methods to identify coex-
pressed gene sets during normal developmental pro-
gression and in response to a specific mutant
background (condition dependent). On the basis of these
analyses, de novo coexpression networks will be mod-
eled. Existing genomic information, such as Gene
Ontology annotations, will be integrated to assess func-
tional commonalities among coregulated groups of
genes called modules. Comparative analyses will be
used to make functional predictions based on conserva-
tion of these coregulated gene sets with known signal-
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ing and biochemical pathways available for rice and
Arabidopsis. Existing information from these compara-
ble biological systems will be leveraged to unknown
modules in maize. 
The resulting expression framework will provide a
resource that can be continuously referenced and
updated as additional data sets become available. In
addition, this framework will further be integrated with
genome-wide sequence analyses, chromatin-binding
information, and protein–protein interaction data from
the RA genes and other key transcriptional regulators
involved in inflorescence architecture. Resulting models
will provide testable hypotheses for resolving key bio-
logical questions at the interface between development
and metabolism.
A Link between fasciated ear2
Activity, Seed Row Number,
and Maize Domestication
P. Bommert, Y.K. Lee, S. Choi
In this project, we follow a possible connection between
the activity of the fasciated ear2 gene and the remark-
able morphological changes observed along the domes-
tication of inflorescences in maize. In teosinte, the
ancestral form of maize, kernels are arranged in two
alternating rows, whereas modern elite maize hybrid
lines have up to 24 rows of seeds. Kernel row number is
dependent on the number of meristems, called spikelet
pair meristems (SPMs), initiated by the inflorescence
meristem. Our previous analysis of the fasciated ear2
(fea2) gene showed that it encodes a receptor protein
and that it is involved in the regulation of the inflores-
cence meristem, because ears of fea2 mutants develop
more than 40 rows of seed (Fig. 2).
It is tempting to speculate that the number of SPMs
is directly dependent on the size of the inflorescence
meristem. As expected, we did find a significant positive
correlation between inflorescence meristem size and
kernel row number variation based on the analysis of 15
randomly chosen maize inbred lines. This indicates that
the control of inflorescence meristem size has a strong
impact on kernel row number, which is, as mentioned
above, one of the major morphological changes between
teosinte and maize and one of the key traits in modern
breeding programs. To address whether allelic variation
in the fea2 gene also has an impact on seed row number
via the control of meristem size, we performed a high-
resolution quantitative trait locus (QTL) analysis, using
250 intermated maize recombinant inbred lines, each
grown in three repetitions in three consecutive years.
The analysis supports the hypothesis that allelic varia-
tion in fea2 regulates seed row number, because the
most significant QTL is located on maize chromosome
4, corresponding to the fea2 map position. We are cur-
rently analyzing fea2 expression levels within the inflo-
rescence meristem in the parental lines of the QTL
population and expect to find a correlation between fea2
expression level and inflorescence meristem size.
Besides this quantitative genetics approach, we were
also looking for hypomorphic or weak fea2 alleles, to
further substantiate our hypothesis. Using the maize
TILLING facility we were able to isolate four new
EMS-induced fea2 alleles, which are currently being
evaluated for a possible impact on seed row number. We
expect to find weak fea2 alleles with an increase in seed
row number, but without the abnormal fasciated pheno-
type observed in null alleles. 
We are also pursuing the isolation of other fasciated
genes in maize, such as fasciated ear3 (fea3) and com-
pact plant2 (ct2). Using ~900 ct2 F2 mutants, we have
FIGURE 2 Mutants affecting inflorescence architecture and seed row number. (Left panel) Scanning electron
micrographs of a wild-type and two third outer glume (trd) mutants of barley. trd mutants show ectopic growth
of leaves in the inflorescence (arrowed), and we have found that this gene encodes an ortholog of the maize tas-
selsheath1 gene, also identified in our lab. (Right panel) Mature ears of wild-type and the fasciated ear2 mutant
(fea2). Note that fea2 ears have an increased number of vertical seed rows on the ear. 
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narrowed down the chromosomal location of this gene
to an interval of ~250 kb on chromosome 1, which is
highly syntenic to rice and sorghum. This region is cov-
ered by two BAC clones containing eight predicted
genes. Subsequent sequencing of these genes in the ct2-
Muszynski allele led to the identification of a transposon
insertion in a lipoxygenase-encoding gene. However,
none of the other ct2 alleles showed a lesion in this gene.
We therefore isolated additional ct2 alleles via a targeted
EMS screen. By screening a total of 33,000 individu-
als, we were able to isolate three new ct2 alleles.
Sequencing of these alleles is in progress.
grassy tillers1 and tasselsheath1:
Two Genes Controlling Maize
Plant Architecture
C. Whipple, K. Chen, J. Yuan
When plants make the transition from vegetative to
reproductive growth, they undergo dramatic morpho-
logical changes. One such change that is seen in many
plant species, including the model plants maize and Ara-
bidopsis, is the suppression of leaf growth in the inflo-
rescence. These inflorescence leaves are known as
bracts, and suppression of bract growth has evolved
multiple times in diverse plant lineages. We have been
investigating the genetic mechanism controlling bract
suppression in maize to better understand how leaf
development is controlled in plants and to understand
how novel developmental pathways evolve.
We have identified several mutants representing five
distinct genes that, when mutated, fail to suppress bract
growth in maize. Two of these genes, tasselsheath1 and
tasselsheath4, have been cloned, and we are currently
investigating how they act together to control the maize
bract suppression pathway. Our results indicate that tas-
selsheath4 is expressed first and is necessary for tas-
selsheath1 expression. Mutants similar to tasselsheath1
are known in rice and barley (Fig. 2), and we have
shown that in both cases, the gene corresponding to tas-
selsheath1 gene is mutated. This indicates that bract
suppression by tasselsheath1 is a conserved mechanism
throughout the grass family. Interestingly, the genes cor-
responding to tasselsheath1 and tasselsheath4 in Ara-
bidopsis have no role in bract suppression. Because the
grasses evolved from a common ancestor that had
bracts, we are investigating the possibility that the tas-
selsheath pathway evolved early in the evolution of
grasses. How developmental pathways arise to generate
morphological novelties is a fundamental biological
question that has received little attention, and the tas-
selsheath mutants of maize represent a powerful model
to investigate this. Additionally, the emerging pathway
for bract suppression in the grasses is distinct from that
described in Arabidopsis. Because bract suppression
evolved independently in these lineages leading to the
grasses and Arabidopsis, our results suggest that there
are multiple ways to repress bract growth in plants.
In addition to our work on bract suppression, we have
been investigating a maize mutant with increased branch
number and branch length. We have shown that this
mutant is identical to the classical maize mutant grassy
tillers1, named for its profuse production of basal
branches or tillers. The grassy tillers1 gene is expressed
in young branch buds and is necessary to induce a dor-
mant state that is responsive to light cues. Plants are
unable to move, and thus, they must adjust their devel-
opmental pathways in response to environmental sig-
nals. For example, plants in the shade tend to suppress
branching and elongate in order to reach open light.
Plants sense shade by measuring the amount of far-red
wavelength light that they receive. Interestingly, grassy
tillers1 is induced by far-red light, suggesting that it is
normally turned on by shade to suppress branching.
Consequently, grassy tillers1 represents an interesting
link between plant environmental responses and an
important agronomic developmental pathway. 
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Heterochromatic silencing, gene control, and stem cell
function in plants and fission yeast provide useful mod-
els for epigenetic inheritance, differentiation, and dis-
ease in higher organisms. In fission yeast, RNA
interference (RNAi) of centromeric transcripts regulates
histone modification, whereas in Arabidopsis, methyla-
tion of transposons and repeats depends on small RNA
and chromatin remodeling. In yeast, these mechanisms
function during chromosomal replication and have a
role in epigenetic inheritance. In Arabidopsis, mobile
trans-acting small interfering RNAs (siRNAs) arise
from transposons in cultured cells and in pollen, and
they regulate cell fate via noncoding RNA in the leaf. In
addition to our work on epigenetics and development,
we continue to develop transposons and artificial
microRNA (miRNA) as tools to probe genomic func-
tion in plants. During the past year, we were joined by
graduate students Patrick Finigan and Joe Calarco, and
said goodbye to Sarahjane Locke and Eyal Gruntman.
Postdoc Klavs Hansen joined the lab from the Univer-
sity of Copenhagen, and Rebecca Schwab left for Stras-
bourg at the end of the year. Mike Regulski joined the
lab as part of the Plant Group genomics collaboration.
RNAi Guides Histone Modification
during the S Phase of Chromosomal
Replication
A. Kloc, M. Zaratiegui
For many decades after its initial characterization, hete-
rochromatin was considered to be transcriptionally inert,
but we have found that this highly condensed chromo-
somal material is transcribed, and rapidly silenced, by an
orchestrated sequence of events directed by RNAi during
the S phase of the cell cycle. Together, these findings
suggest a model of RNAi-directed epigenetic inheri-
tance. Heterochromatin remains condensed throughout
the cell division cycle and silences genes nearby, but the
mechanism by which heterochromatin is inherited has
PLANT DEVELOPMENTAL GENETICS AND
FUNCTIONAL GENOMICS
R. Martienssen A.-Y. Chang D. Irvine R. Schwab M. Tanurd
v
zi ′c
P. Finigan A. Kloc R. Shen M.W. Vaughn
E. Gruntman S. Locke J. Simorowski J. Xue
J.-J. Han U. Ramu R.K. Slotkin M. Zaratiegui
K. Hansen M. Regulski
remained obscure. Heterochromatic silencing and his-
tone H3 lysine-9 methylation (H3K9me2) depend, para-
doxically, on heterochromatic transcription and RNAi.
We have shown that heterochromatin protein 1 in fission
yeast (Swi6) is lost via phosphorylation of H3 ser-10
(H3S10) during mitosis, allowing heterochromatic tran-
scripts to transiently accumulate in S phase. Rapid pro-
cessing of these transcripts into siRNA promotes
restoration of H3K9me2 and Swi6 after replication when
cohesin is recruited. RNAi in fission yeast is inhibited
at high temperatures, providing a plausible mechanism
for epigenetic phenomena that depend on replication and
temperature, such as vernalization in plants and position-
effect variegation in animals. These results explain how
“silent” heterochromatin can be transcribed and lead to
a model for epigenetic inheritance during replication.
Mapping Mutations in Fission
Yeast Using Whole-genome
Next-generation Sequencing
D. Irvine, M.W. Vaughn [in collaboration with W.R. McCombie,
Cold Spring Harbor Laboratory; Derek Goto, Hokkaido
University; and Mitsuhiro Yanagida, Kyoto University]
Fission yeast is an important model for cell cycle and
epigenetic studies due to the ease with which genetic
mutants can be isolated. However, forward genetic
mutant screens are impaired by difficulties comple-
menting mutants with genomic libraries, whereas reverse
genetic screens generally exclude essential genes. Epi-
genetic phenotypes are typically unstable, preventing
complementation if silencing cannot be reestablished.
We have shown that resequencing the fission yeast
genome following mutagenesis can readily identify
mutations generated by forward genetic approaches.
Candidate genes were identified as functional single-
nucleotide polymorphisms (SNPs) linked to the muta-
tion and then used to recapitulate the mutant phenotype.
Next-generation genomic resequencing promises to dra-
matically enhance the power of yeast genetics, permit-
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pollen, we have found that TEs are unexpectedly reacti-
vated and transpose but only in the vegetative nucleus,
which accompanies the sperm cells but does not provide
DNA to the fertilized zygote. TE expression coincides
with down-regulation of the heterochromatin remodeler
DECREASE IN DNA METHYLATION 1 and of many
TE siRNAs. However, 21-nucleotide siRNAs from
ATHILA retrotransposons are generated in pollen and
accumulate in sperm, suggesting that siRNA from TEs
activated in the vegetative nucleus can target silencing
in gametes. We propose a conserved role for repro-
gramming in germ-line companion cells, such as nurse
cells in insects and vegetative nuclei in plants, to reveal
intact TEs in the genome and regulate their activity in
gametes.
Epigenomic Consequences
of Immortalized Cell Suspension
Culture and Polyploidy in
Arabidopsis
M. Tanurd
v
zi ′c, R.K. Slotkin, P. Finigan, E. Gruntman, M. Vaughn
[in collaboration with W. Thompson, North Carolina State
University; L. Comai, University of California, Davis; R.W.
Doerge, Purdue Unviersity; and V. Colot, Ecole Normale
Superieure, Paris, France] 
Plant cells grown in culture exhibit genetic and epige-
netic instability. In a continuously proliferating, dedif-
ferentiated cell suspension culture of Arabidopsis, we
have found that euchromatin becomes hypermethylated
and that a small percentage of these genes become asso-
ciated with heterochromatic marks. In contrast, the het-
erochromatin undergoes dramatic and very precise DNA
hypomethylation with transcriptional activation of spe-
cific TEs. High-throughput sequencing of siRNA
revealed that TEs activated in culture have increased lev-
els of 21-nucleotide siRNA, resembling pollen in this
respect (Fig. 1). In contrast, TEs that remain silent retain
the predominant 24-nucleotide siRNA class and do not
change significantly in their siRNA profiles. Increases
in euchromatic DNA methylation and 21-nucleotide
siRNA are accompanied by changes in gene expression:
loss of the DNA demethylase REPRESSOR OF
SILENCING1 (ROS1) and gain of ARGONAUTE2,
respectively; but the loss of TE DNA methylation is
selective and levels of DDM1 remain high. These results
implicate RNAi and chromatin modification in epige-
netic restructuring of the genome following the activa-
tion of TEs in immortalized cell culture. Polyploidy in
plants also results in genetic and epigenetic changes in
gene expression from generation to generation. The
ting the isolation of subtle alleles of essential genes and
alleles with quantitative effects, as well as enhancers and
suppressors of heterochromatic silencing.
Heterochromatin, Histone
Modification, and RNAi in
Fission Yeast
M. Zaratiegui, D. Irvine, K. Hansen, S. Locke, A.-Y. Chang, 
M.W. Vaughn [in collaboration with Yang Shi, Harvard Medical
School, and W. Zac Cande, University of California, Berkeley]
We are applying a combination of forward and reverse
genetics, genomics, and biochemistry to further explore
the link between RNAi, histone modification, and hete-
rochromatic silencing in the fission yeast Schizosaccha-
romyces pombe. In most eukaryotes, histone methylation
patterns regulate chromatin architecture and function:
Methylation of histone H3K9 demarcates heterochro-
matin, whereas H3K4 methylation demarcates euchro-
matin. In one example, the JmjC-domain protein Lid2 is
a trimethyl H3K4 demethylase responsible for H3K4
hypomethylation in heterochromatin. Lid2 interacts with
the histone lysine-9 methyltransferase Clr4 through the
Dos1/Clr8-Rik1 complex, which also functions in the
RNAi pathway. Disruption of the JmjC domain alone
results in severe heterochromatin defects and depletion
of siRNA, whereas overexpressing Lid2 enhances hete-
rochromatin silencing. The physical and functional link
between H3K4 demethylation and H3K9 methylation
suggests that the two reactions act in a coordinated man-
ner. Surprisingly, cross-regulation of H3K4 and H3K9
methylation in euchromatin also requires Lid2. Lid2
enzymatic activity is thus regulated through a dynamic
interplay with other histone-modification enzymes. Our
findings provide mechanistic insight into the coordina-
tion of H3K4 and H3K9 methylation.
Epigenetic Reprogramming and
Small RNA Silencing of
Transposable Elements in Pollen
K. Slotkin, M. Tanurdzic, M. Vaughn [in collaboration with J.
Becker and J. Feijo, Gulbenkian Institute, Portugal]
Heterochromatin is composed of transposable elements
(TEs) and related repeats. Like TEs, heterochromatin
silences genes located nearby and has a major role in
epigenetic regulation of the genome. The mutagenic
activity of TEs is suppressed by epigenetic silencing and
siRNAs, especially in gametes that could transmit trans-
posed elements to the next generation. In Arabidopsis
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mechanisms that underlie these changes are important
in the short term (hybrid sterility) as well as in the long
term (hybrid vigor), because polyploids are stabilized
during evolution. We are using microarrays and next-
generation Illumina sequencing to profile chromatin
modifications and small RNA in synthetic allopolyploids
from crosses between tetraploid A. thaliana and tetra -
ploid A. arenosa.
Artificial MIRNAS
R. Schwab [in collaboration with D. Weigel, Tübingen,
and W.R. McCombie and G. Hannon, Cold Spring Harbor
Laboratory]
RNAi is a powerful tool for gene discovery, and the lat-
est RNAi vectors contain short hairpins that are modi-
fied precursors of miRNAs. These produce a distinct
small RNA sequence, which can be modified and opti-
mized, and is often called artificial miRNA (amiRNA).
A systematic approach is currently being used to gen-
erate thousands of hairpins to silence the majority of
transcripts encoded by Arabidopsis. Numerous suc-
cessful applications of amiRNAs have been reported,
but ~25% of these amiRNAs did not trigger gene
silencing. We are investigating the nature of unsuc-
cessful gene silencing in Arabidopsis by directly ana-
lyzing the effect of local secondary structures in target
transcripts and also by an unbiased search for addi-
tional determinants. 
Mobile Trans-acting siRNA
in Arabidopsis
R. Schwab [in collaboration with M. Byrne, John Innes Center;
M. Crespi, Orsay; and O. Voinnet, Strasbourg]
Plants encode an additional class of small RNAs, called
trans-acting siRNAs (tasiRNAs), that posttranscription-
ally regulate protein-coding genes, as do miRNAs.
tasiRNA biogenesis requires multiple components of the
siRNA pathway and also miRNAs. We previously iso-
lated a gene-trap reporter insertion in TAS3a, which is
limited to the adaxial (upper) side but targets AUXIN
RESPONSE FACTOR (ARF) genes throughout the leaf
(CSHL Annual Report 2006). We have now shown by in
situ hybridization and reporter gene fusions that the
silencing activities of ARF-regulating tasiRNAs control
ARF activities noncell autonomously in the shoot and in
the root. In situ hybridization in mutant backgrounds
indicates that the mobile signal is likely to be either the
tasiRNA itself or an unstable double-stranded RNA
intermediate. One component of this regulatory network
is the SANT-domain gene ASYMMETRIC LEAVES1
(AS1). as1 mutants are dramatically enhanced by
mutants in the tasiRNA pathway (CSHL Annual Report
2006). We have found three additional genes, PIGGY-
BACK1 (PGY1), PGY2, and PGY3, that alter leaf pat-
terning in the absence of AS1. All three pgy mutants
develop dramatic ectopic lamina outgrowths on the
adaxial side of the leaf in an as1 mutant background.
This leaf-patterning defect is enhanced by mutations in
the adaxial homeodomain gene REVOLUTA (REV) and
is suppressed by mutations in abaxial KANADI tran-
scription factor genes. PGY1, PGY2, and PGY3 encode
cytoplasmic large-subunit ribosomal proteins L10a, L9,
and L5 and are expressed on the adaxial side of the leaf,
suggesting a role for translation.
FIGURE 1 Small RNA profiles of immortalized cell cultures of Ara-
bidopsis. Plant cells grown in suspension culture are diploid by
fluorescence-activated cell sorting (FACS) analysis (A) and are
transferred to fresh media every 7 d (B) and harvested after 16 h
(Cells7) or 4 d (Cells4). (C) Small RNA from ATHILA retrotrans-
posons are predominantly 21 nucleotides in cell culture, but 24
nucleotides in leaf and callus; 24-nucleotide small RNA from
ATLANTYS retrotransposons are unaffected in cell culture. (D)
Small RNA from ATHILA elements in leaves (left) and cell culture
(right) were matched to Watson (above) and Crick (below) strands
and are 10–100 times more abundant in cell culture. A schematic
of the ATHILA retrotransposon with LTRs (long terminal repeats)
is indicated below. 
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Maize-targeted Mutagenesis:
A Knockout Resource in Maize
J.-J. Han, M. Regulski, M. Vaughn [in collaboration with W.R.
McCombie, Cold Spring Harbor Laboratory, and P. Ferreira,
University of Rio de Janeiro]
The maize-targeted mutagenesis (MTM) population
comprises seed and tissue from 44,000 maize plants in
which Mutator transposons have been mobilized and
then stabilized genetically. Tissue was harvested in 18
two-dimensional “grids” of 48 x 48 plants each, and
genomic DNA was prepared from row and column
pools that permit cross-referencing of any individual
sample. Target sites flanking each Mutator insertion can
be amplified en masse from these pools by a ligation-
mediated polymerase chain reaction (PCR). Sequenc-
ing using next-generation Illumina GA2 paired-end
reads, followed by mapping back to the maize genome,
resulted in identification of a high proportion of the
flanking sites, including control insertions previously
recovered by conventional means. By first comparing
nonintersecting row pools, and then row and column
pools, it is possible to distinguish preexisting (parental)
insertions from new germinal insertions at row-column
intersections. We estimate that ~0.5 to 1 million inde-
pendent new insertions of Mutator elements in the gene-
rich portion of the genome can be identified with only
a few hundred sequencing reactions. 
Gene Trapping and
Chromatin Charting
in Arabidopsis
J. Simorowski, U. Ramu, R. Shen, M. Vaughn [in collaboration
with D. Spector and W.R. McCombie, Cold Spring Harbor
Laboratory, and E. Lam, Rutgers University]
Our collection of Arabidopsis gene-trap and enhancer-
trap transposon lines has grown to more than 40,000
individual insertions, more than half of which have been
mapped to the genome by PCR and sequencing. The
resulting knockouts, along with phenotypic and expres-
sion data, are made available to the public via TRAP-
PER (http://genetrap.cshl.edu/), an interactive database
and ordering system. Reporter genes are silenced by
position-effect variegation when they are located a few
kilobases from the NOR (nucleolar organizer) and
depend on histone deacetylation, but not chromatin
remodeling, mimicking nucleolar dominance in this
respect. A very sharp boundary (< 100 bp) separates
silent and active insertions near NOR4. We have
expanded this system to include gene-trap transposons
with lacR-GFP (green fluorescent protein) chromo-
some-charting beacons that enable chromosomal loca-
tions to be visualized in the nucleus. These can be used
to visually track individual loci in living plants while
simultaneously producing a genome-wide “transcription
potential map” via a common luciferase expression cas-
sette. A direct correlation between mobility constraint,
subnuclear location, and gene activity was observed in
some cases. We provide a collection of almost 300 Ara-
bidopsis lines for examining epigenetic control in liv-
ing cells within chromatin regions at the resolution of a
few kilobases (http://charting.cshl.edu). Our studies
revealed regional gene silencing near a heterochromatin
island via DNA methylation that is correlated with
mobility constraint and nucleolar association. We also
found an example of nucleolar association that does not
correlate with gene suppression, suggesting that distinct
mechanisms exist that can mediate interactions between
chromatin and the nucleolus. These studies demonstrate
the utility of this resource in unifying structural and
functional studies toward a more comprehensive model
of how global chromatin organization coordinates gene
expression.
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Plants have the distinctive ability to form new organs
throughout their lifetime, which can span hundreds or
even thousands of years. The growing tip of a plant con-
tains a population of stem cells that are located within a
specialized niche, termed the shoot apical meristem
(SAM). These stem cells divide to maintain the SAM
and to generate daughter cells from which lateral
organs, such as leaves and flowers, arise. The research in
our lab aims to dissect the genetic networks that operate
within the SAM to regulate stem cell homeostasis and to
generate and pattern leaves.
Adaxial-Abaxial Patterning by
ASYMMETRIC LEAVES1 (AS1) and AS2 
A. Husbands, F. Nogueira
Outgrowth and patterning of lateral organs in plants
depend on the specification of adaxial-abaxial (upper/
lower) polarity. We have shown that this asymmetry is
generated by a novel patterning mechanism in which
small RNAs establish opposing fates of the axis. In
maize, microRNA (miRNA) miR390 accumulates on
the adaxial (upper) side of developing leaves where it
triggers the biogenesis of TAS3-derived trans-acting
short interfering RNAs (ta-siRNAs). These confine the
accumulation of abaxial determinants, including
AUXIN RESPONSE FACTOR3 (ARF3) and miR166,
to the lower side of leaves. miR166, in turn, demarcates
the abaxial side by repressing expression of class III
homeodomain leucine zipper (HD-ZIPIII) transcription
factors that specify adaxial fate. 
Our findings indicate that the establishment of organ
polarity requires the precise spatiotemporal accumula-
tion and relative efficacy of TAS3-derived ta-siRNAs
and miR166. We are using genetic and biochemical ap -
proach es to identify genes that regulate the accumula-
tion and activities of these polarizing small RNAs. In
Arabidopsis, several lines of evidence indicate that the
DNA-binding proteins AS1 and AS2 form a complex
that contributes to organ polarity. We have used chro-
matin immunoprecipitation (ChIP) to identify polarity
PLANT DEVELOPMENTAL GENETICS
M. Timmermans D. Chitwood C. Hu E. Plavskin
M. Dotto A. Husbands A. Sarkar
F. Dupuy M. Lodha D. Skopelitis
C. Fernandez-Marco F. Nogueira
determinants that are direct AS1-AS2 targets, and these
include selected MIR166 precursors and components of
the TAS3 ta-siRNA pathway. Our ChIP results have been
verified using reporter constructs and reverse transcrip-
tase–polymerase chain reaction (RT-PCR) analysis. 
The abaxial determinants ARF3 and ARF4 are targets
for tasiR-ARFs, a subset of TAS3-derived ta-siRNAs. We
have shown that transcript levels for both ARF genes are
up-regulated in as2. Considering that TAS3 ta-siRNA
pathway components are direct targets of AS1-AS2,
these transcription factors may control ARF3 and ARF4
expression through regulation of tasiR-ARF accumula-
tion. However, mutants defective in both the tasiR-ARF
and AS1/AS2 pathways show an enhanced leaf pheno-
type, suggesting that both pathways converge to repress
ARF3 and ARF4 activity on the adaxial leaf surface. To
test the interaction between the AS1/AS2 and tasiR-ARF
pathways, we generated as2 plants expressing a tasiR-
ARF–insensitive allele of ARF3 (ARF3m). Double
mutants develop highly serrated leaves with abaxialized
ectopic leaf-like outgrowths at the margins. Double
mutants defective for AS2 and ta-siRNA biogenesis com-
ponents (e.g., as2 rdr6 or as2 sgs3) also acquire this phe-
notype, but they are significantly delayed in doing so.
Our hypothesis is that the hyperaccumulation of ARF3,
in the presence of a defective AS pathway, results in the
production of ectopic leaflets on margins. RT-PCR
experiments confirm that ARF3 levels are dramatically
higher in as2 ARF3m double mutants than in as2 rdr6 or
as2 sgs3 double mutants, which may explain why ectopic
leaflets form much earlier in this genotype. We are cur-
rently examining the putative connection among the
tasiR-ARF pathway, auxin transport, and the production
of compound leaf architecture.
The START Domain Regulates Class III
HD-ZIP Activity and Organ Polarity
A. Husbands
The HD-ZIPIII transcription factors—PHABULOSA
(PHB), PHAVOLUTA (PHV), and REVOLUTA (REV)—
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mobile and can traffic between cells from their source of
biogenesis. Using an ARF3-based sensor of tasiR-ARF
activity, we showed that tasiR-ARFs act throughout the
leaf, but more strongly on the upper (adaxial) side than
on the lower (abaxial) side. tasiR-ARFs thereby delimit
expression of the abaxial determinant ARF3 discretely
to the lower side of the leaf. In situ hybridization analy-
sis revealed that miR390, whose activity initiates tasiR-
ARF biogenesis, accumulates ubiquitously in leaves. In
contrast, the tasiR-ARF biogenesis factor ARGO-
NAUTE7 (AGO7) and the tasiR-ARF precursor TAS3A
both localize exclusively to the two adaxial-most cell
layers. Consequently, tasiR-ARF biogenesis is restricted
to the adaxial side of developing leaves where miR390
colocalizes with AGO7 and TAS3A. However, tasiR-
ARF activity is detected outside this region of biogene-
sis, indicating that tasiR-ARFs traffic from the adaxial
side to the abaxial side. Indeed, in situ hybridization
analysis revealed that tasiR-ARFs accumulate in a gra-
dient across leaves that is strongest adaxially and dissi-
pates toward the abaxial side of the leaf. This small
are required and sufficient for the specification of adaxial
cell fate. Their role as adaxial determinants was uncovered
through dominant mutations that prevent the cleavage of
PHB, PHV, and REV transcripts by miR166. Consequently,
mutant transcripts accumulate on both sides of develop-
ing leaf primordia, resulting in their adaxialization. HD-
ZIPIII proteins contain a putative START lipid/sterol-
binding domain, suggesting that the function of HD-ZIPIII
proteins may be regulated by an unknown ligand. 
Several pPHB:PHB-YFP reporter constructs were
created to address whether the START domain is indeed
important for proper PHB function. Because recessive
loss-of-function phb mutants display no distinguishing
phenotypes, pPHB:PHB-YFP reporters also carry silent
point mutations in the miR166-binding site. We then
assayed whether substitution of two highly conserved
arginine residues in the START domain or deletion of
the START domain entirely suppresses the leaf pheno-
types. Point mutations in the miR166-binding site alone
conditioned a strong adaxialized leaf phenotype in most
T1 plants, as expected. Mutations in the critical arginine
residues reduced the frequency of this extreme pheno-
type, whereas deletion of the START domain mostly
resulted in formation of normal leaves. These data sug-
gest that the START domain is critical for PHB func-
tion. We are investigating potential mechanisms through
which the START domain may regulate PHB activity,
such as (1) subcellular localization, (2) DNA-binding
affinity, and (3) protein stability. In addition, we will use
a modified yeast–one-hybrid approach to screen a
small-molecule library for putative ligands of PHB and
other HD-ZIPIII proteins.
Pattern Formation via
Small RNA Mobility
D. Chitwood, F. Nogueira [in collaboration with T. Montgomery,
Dr. M. Howell, and Dr. J. Carrington, Oregon State University,
Corvallis]
A recurring theme in pattern formation is the interpre-
tation of relative distance from a point source through
the activity of mobile, positional signals. siRNAs that
are produced upon transgene-induced gene silencing or
during viral infection are known to move systemically
throughout plants, but intercellular movement of devel-
opmentally relevant endogenous small RNAs has not
been observed. By comparing the pattern of tasiR-ARF
accumulation with the localization of tasiR-ARF bio-
genesis components (Fig. 1), we sought to determine
whether this unique class of endogenous siRNAs is
FIGURE 1 Pattern formation in leaves via small RNA mobility. (A)
Diagram of the tasiR-ARF pathway. (B) In situ hybridization using
an LNA (locked nucleic acid) probe reveals a gradient of tasiR-
ARF accumulation that is strongest on the adaxial (upper) side of
the leaf and dissipates away toward the abaxial (lower) side. (C)
Summary of the localization patterns of tasiR-ARF pathway com-
ponents. Although miR390 accumulates uniformly throughout
leaves, tasiR-ARF biogenesis is restricted to the few adaxial-most
cell layers of leaves by the localized expression of AGO7 and
TAS3A. tasiR-ARFs accumulate outside this defined domain of
biogenesis and form a gradient across leaves (B), indicative of
mobility of this small RNA (dotted arrow). The tasiR-ARF gradient
is interpreted into domains of strong and weak activities along
the adaxial-abaxial axis, leading to the polarized expression of
the abaxial determinant ARF3.
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RNA gradient is interpreted into adaxial and abaxial
domains of high and low tasiR-ARF activity that cre-
ates a discrete pattern of ARF3 expression on the abax-
ial side of the leaf (Fig. 1).
These data identify the first mobile positional signal
in adaxial-abaxial patterning of the leaf. Moreover, our
study reveals two novel RNA interference (RNAi)-based
patterning mechanisms. First, subspecialized interac-
tions between RNAi effector proteins and small RNAs,
such as that between miR390 and AGO7, can act to spa-
tially limit small RNA activity during development. Sec-
ond, the movement of small RNAs, such as tasiR-ARFs,
outside of their domain of biogenesis, precisely patterns
targets and might serve to convey positional informa-
tion, demonstrating that small RNAs can serve as
mobile, inductive signals during development. 
Dissecting Small RNA
Mobility in Plants
D. Chitwood, D. Skopelitis
An intriguing question is whether miRNAs, like endoge-
nous siRNAs, can traffic between cells. Given the scope
of miRNA-regulated gene networks in development, the
cell-to-cell movement of miRNAs would have impor-
tant implications with respect to their potential to act as
inductive signals and generators of pattern. Using in situ
hybridization and pMIR390:GUS reporter constructs,
we have shown that expression of both MIR390 precur-
sors is limited to developing leaf primordia and the
region below the SAM, whereas mature miR390 accu-
mulation extends into the meristem proper. Although
expression of artificial miRNAs from a vascular-spe-
cific promoter suggests phloem-derived miRNAs act
cell autonomously in mature leaves, the shoot apex may
provide a unique developmental context that permits the
intercellular movement of miRNAs, thus providing a
possible explanation for the disparity between the accu-
mulation patterns of miR390 and its precursors in the
meristem. At least one other miRNA, miR391, shows a
similar discrepancy between the localization pattern of
the mature miRNA and its precursor in the meristem
region. Unlike miR390, miR391 possesses a 5′ U and
is loaded into AGO1, suggesting that the possible move-
ment of miR390 would not be an outcome of its unique
recruitment into an AGO7 complex, but a general prop-
erty of miRNAs expressed beneath the SAM.
We are taking advantage of miRNA sensors to fur-
ther investigate the possible movement of miRNAs in a
variety of developmental contexts. Similar experiments
are also under way to further investigate ta-siRNA
mobility. Such experiments will reveal parameters of
small RNA mobility, such as tissue specificity and
direction and range of movement, and whether it is dose
dependent. We anticipate that small RNAs move from
cell to cell through intercellular channels known as plas-
modes mata and that unique proteins mediate mobility.
We have designed a forward genetic screen to identify
such potential small RNA mobility factors and hope to
report on these in next year’s report.
The Ancestral Role of the
ta-siRNA Pathway
E. Plavskin
Genes involved in ta-siRNA biogenesis, as well as
miR390 and the TAS3 loci themselves, are conserved in
the moss Physcomitrella patens. Even more interesting,
ta-siRNAs produced from Physcomitrella TAS3 loci tar-
get transcripts of AUXIN RESPONSE FACTOR genes.
Basal land plants such as Physcomitrella lack true
leaves, and their “leaf-like” lateral outgrowths are com-
posed of a single cell layer. The ancestral role of the
TAS3 ta-siRNA pathway will thus be distinct from its
known role in adaxial-abaxial patterning of leaves in
higher plants. To dissect the developmental processes in
moss regulated by tasiR-ARFs, we are characterizing
knockouts of genes involved in ta-siRNA biogenesis in
Physcomitrella, as well as the targets of the moss tasiR-
ARFs. This will reveal the ancestral role of this unique
small RNA pathway.
Novel ta-siRNA Loci in Maize
M. Dotto
In plants, miRNAs and ta-siRNAs form through distinct
biogenesis pathways. ta-siRNAs are derived from TAS
precursor transcripts that are cleaved by miRNA-guided
ARGONAUTE proteins, either AGO1 or AGO7. Ara-
bidopsis contains 10 members of the ARGONAUTE
family and four characterized TAS gene families (TAS1
to TAS4). AGO1 is required for the biogenesis of ta-
siRNAs from TAS1 and TAS2 loci, whereas AGO7 is
uniquely required for the biogenesis of TAS3 ta-siRNAs.
We previously identified four TAS3 loci in the maize
genome. Thus far, these are the only known maize genes
giving rise to ta-siRNAs. Our interest is to investigate
whether additional TAS loci exist in maize. We found
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that the maize genome encodes 20 AGO proteins, with
only one homolog of AGO7 and four AGO1 homologs.
We are generating transgenic plants expressing FLAG-
tagged versions of AGO7 or AGO1 to characterize the
RNAs that interact with these proteins. We expect these
to include ta-siRNAs, miRNAs that trigger ta-siRNA
production, other miRNAs, and possibly larger tran-
scripts that are targets of small RNA regulation. As a
comparison, and for additional information regarding
the small RNA pathways in maize, we will also analyze
one of the two maize AGO10 homologs. This ARG-
ONAUTE protein has been implicated in the mainte-
nance of the SAM and in the modulation of leaf
development in Arabidopsis.
Global Expression Analysis of
Meristem Function and
Leaf Initiation
A. Sarkar [in collaboration with M. Scanlon, Cornell University,
Ithaca, New York; P. Schnable, Iowa State University, Ames;
B. Buckner and D. Janick-Buckner, Truman State University,
Kirksvile, Missouri; and D. Ware, Cold Spring Harbor Laboratory]
leafbladeless1 (lbl1) encodes an essential component in
the ta-siRNA biogenesis pathway in maize. Mutations in
lbl1 lead to formation of radial, abaxialized leaves. To
gain insight into gene networks regulated by ta-siRNAs
and/or involved in adaxial-abaxial patterning, we used
laser capture microdissection coupled with microarray
analyses to compare the global gene expression profiles
in the SAM and first leaf of wild-type and lbl1mutants.
We identified 352 genes whose expression levels are sig-
nificantly altered in lbl1, including (1) components of
the ta-siRNA pathway, which suggests that potential
feedback regulation exists in this pathway; (2) known
determinants of adaxial-abaxial polarity, which is con-
sistent with the abaxialization of lbl1 leaves; (3) known
developmental regulators; and (4) novel maize genes. 
Surgical experiments and our small RNA expression
studies revealed a critical contribution by the epidermal
(L1) layer to adaxial-abaxial patterning. Interestingly,
25 genes that are differentially expressed between wild
type and lbl1 are also differentially expressed between
the L1 and subepidermal (L2) meristem layers. These
include genes predicted to function in auxin or lipid sig-
naling. In situ mRNA localization data confirm that
arf3a, a direct ta-siRNA target, localizes preferentially
to the epidermis and abaxial side of wild-type leaf pri-
mordia and is more broadly expressed in lbl1. Another
predicted auxin-regulated gene as well as a lipid-trans-
fer protein are, likewise, L1 enriched in wild-type and
ectopically expressed in lbl1 mutant apices. A role for
such signaling pathways in organ polarity has often been
postulated, but insights into these developmental mech-
anisms are lacking. 
lbl1 acts in the incipient leaf (P0) to specify adaxial
identity. We identified 47 genes that are differentially
expressed between wild-type and lbl1meristems as well
as between the incipient leaf and the SAM proper. Adax-
ial domain-enriched expression patterns of predicted
developmental regulators, such as yabby15 and seven-
absentia-like, are changed in lbl1 mutants. Expression
of a predicted developmental regulator, squamosa pro-
moter binding protein-like, is enriched in the abaxial
domain of normal leaf primordia but accumulates
ectopically in lbl1 mutants, consistent with a possible
role in adaxial-abaxial patterning. This is currently
being tested by expression analysis in other maize leaf
polarity mutants. We are also taking a bioinformatics
approach to identify potential novel ta-siRNA targets
among those genes up-regulated in lbl1 apices. This
project will provide novel insights into the gene net-
works controlled by ta-siRNAs and/or involved in leaf
polarity.
Establishment of Determinacy
during Organ Development
M. Lohda, C. Hu
Indeterminacy of the SAM is maintained in part by the
class I KNOX homeobox genes. To give rise to determi-
nate structures, such as leaves, KNOX gene expression
must be maintained in a stable “off” state throughout
lateral organ development. We have shown earlier that
this process requires a complex that includes the tran-
scription factors AS1 and AS2 as well as the chromatin-
remodeling factor HIRA. Using ChIP experiments, we
previously identified two sites in the promoters of the
Arabidopsis KNOX genes BP and KNAT2 that bind the
AS1-AS2-HIRA repressor complex. Complex binding
is mediated via the cis-regulatory motifs CWGTTD-
KMKTTGAHW. Promoter deletion analysis revealed
that both complex-binding sites are essential and act
together to maintain the “off” state of the BP promoter.
In addition, these promoter deletion studies identified a
putative leaf enhancer located between the AS1-AS2-
HIRA complex-binding sites in the BP promoter.
Indeed, when placed upstream of a minimal promoter,
this predicted enhancer region is capable of driving
reporter gene expression in leaves. On the basis of these
results, we proposed that the AS1-AS2-HIRA complex
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creates a loop around the leaf enhancer and recruits
additional chromatin-remodeling factors to repress
enhancer activity throughout organogenesis.
We have now identified a role for the CLF-MSI1-
FIE-EMF2 type of polycomb repressive complex 2
(PRC2) in the stable silencing of KNOX genes during
leaf development. Consistent with the notion that PRC2
complexes have histone H3K27 trimethylation activity,
we have identified this repressive mark on nucleosomes
at the BP and KNAT2 promoters in leaves of Arabidop-
sis, where these genes are silent. Besides, in clf mutant
plants, levels of this H3K27 trimethylation mark are
reduced and KNOX genes are misexpressed in develop-
ing leaves. In animal models, PRC1 is recruited to sites
of H3K27 trimethylation established by PRC2. In Ara-
bidopsis, LIKE HETEROCHROMATIN PROTEIN 1
(LHP1) is suggested to have a role similar to that of
PRC1. Consistent with this view, we have identified BP
and KNAT2 as direct targets of LHP1 and have shown
that KNOX genes are misexpressed in lhp1mutants. We
are currently investigating whether the AS1-AS2-HIRA
complex directs the recruitment of the PRC2 complex to
the KNOX loci. These data will provide insight into the
epigenetic mechanism that maintains stem cell home-
ostasis in plants. Because HIRA and the PRC2 com-
plexes are also implicated in the regulation of the stem
cell state in mammals, our findings in plants may pro-
vide a useful framework for future studies on HIRA-
and PcG-mediated gene silencing in mammalian embry-
onic stem cells and induced pluripotent stem cells.
Regulation of Embryonic
Patterning by HIRA
C. Fernandez-Marco, F. Dupuy [visiting Master’s student
from the Université Paris Diderot, Paris, France]
Arabidopsis plants with reduced HIRA transcript levels
develop leaves that resemble the leaves of as1 and as2
mutants and that ectopically express several KNOX
genes. However, null alleles of HIRA lead to early
embryo lethality, suggesting that HIRA regulates expres-
sion of target genes that function in developmental
processes other then the KNOX genes. To further dissect
the role of HIRA in plant development, we have isolated
12 independent hira alleles carrying substitutions in
highly conserved amino acids. These mutant alleles
exhibit a range of developmental phenotypes, including
defects in embryo, root, and vegetative development.
Thus far, much of our phenotypic analysis has focused
on hira3, which contains a point mutation in the evolu-
tionary conserved fifth WD40-repeat motif. The
endosperm is affected in hira3 mutants, showing
enlarged and irregular nuclei. In addition, hira3mutants
are marked by abnormal patterns of cell division in the
hypophysis. This highly specialized cell at the bound-
ary between embryo and extraembryonic suspensor nor-
mally divides to form a lens-shaped cell that ultimately
gives rise to the quiescent center (QC) of the root stem
cell niche. The phytohormone auxin has a key role in
the establishment of apical-basal embryo polarity, spec-
ification of the hypophysis, and the subsequent devel-
opment of the root stem cell niche.
To determine the molecular basis for the embryonic
root defects, we are taking advantage of molecular
markers to examine the effects of hira3 on cell-fate
specification and patterning of the early embryo. Pre-
liminary data show that expression of the auxin efflux
carrier PIN7 is reduced and shifted basally, such that, in
hira3, it is lost from the hypophysis and upper cells of
the suspensor. Similarly, expression of the synthetic
DR5 reporter, which marks auxin maxima, no longer
coincides with the position of the presumptive hypo -
phesis but is displaced to basal cells of the suspensor.
Finally, expression of the auxin responsive gene IAA11,
which normally marks the hypophysis, is absent in hira3
mutants. Together, these data suggest that auxin trans-
port is altered in hira3 such that an auxin maxima is no
longer established at the boundary between the proem-
bryo and suspensor and that this perturbs specification
of the hypophysal cell.
Later in root development, the QC is positioned by
the overlap between two independent inputs: PLETH -
ORA (PLT) expression, which is activated in response
to the local auxin maxima, and SCARECROW/
SHORTROOT, which have a role in radial patterning of
the root. One of the genes specifically expressed in the
QC is the homeobox gene WOX5. In situ hybridization
experiments revealed that expression of these genes is
also reduced or lost in hira3. The QC signals to adja-
cent stem cells in the root meristem to prevent their dif-
ferentiation. Although hira3 mutant embryos are not
normally viable, mutants can be rescued when fertilized
ovules are transferred onto culture medium. Consistent
with the above-mentioned defects, rescued mutant
seedlings lack a root. A similar set of defects have been
reported for the root mutants monopteros and boden-
los. We are currently testing the genetic interactions
between hira3 and mp, and further phenotypic analyses
of hira3 are still ongoing. The outcome of these exper-
iments will allow us to position HIRA in the genetic
network that patterns the root stem cell niche during
embryogenesis.
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Functional Genetics in Cancer and Stem
Cell Systems
P.J. Paddison
There are more than 200 different cell types in the
human body, each with a specialized function, which
arise during development and adult tissue homeostasis
from transient or established progenitor cells resident in
tissues and organs. Two emerging themes in disease
research emphasize why it is crucial that we understand
how cell identities are formed and maintained in mam-
mals. First is the notion that cancer cells may arise from
maligned development programs. In addition to coopt-
ing growth and survival promoting pathways, tumor
cells hijack molecular pathways that are normally
involved in developmental processes such as cell-fate
determination. The existence of cancer stem cells, which
may have vital roles in tumor progression, maintenance,
and recurrence, underscores this notion. Second is the
COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of 3 years on projects of their
own choosing. Fellows are provided with a salary, research support, and technical assistance so that they
can accomplish their goals free of distraction. The interactions among research groups at the Labora-
tory and the program of courses and meetings on diverse topics in biology contribute to a research envi-
ronment that is ideal for innovative science by these Fellows.
The success of the program is apparent from the list of distinguished alumni. Previous Cold Spring
Harbor Laboratory Fellows Adrian Krainer (1986), Scott Lowe (1995), and Marja Timmermans (1998)
are now members of the faculty at the Laboratory, and Marja is the Director of the Fellows program.
After completing her fellowship, Carol Greider (1988) joined the CSHL faculty, but after 9 years, she
moved to Johns Hopkins University School of Medicine where she is now the Daniel Nathans Professor
and Director of Molecular Biology and Genetics. Eric Richards (1989) currently heads a research group
at the Boyce Thompson Institute for Plant Research at Cornell University, and David Barford (1991) is Pro-
fessor of Molecular Biology at the Institute of Cancer Research in London. Ueli Grossniklaus (1994) also
was a member of our faculty before leaving to become a Professor at the Institute of Plant Biology, Uni-
versität Zürich, Switzerland. Térence Strick (2000) left at the end of his fellowship to become a Group
Leader at the Institut Jacques Monod, Centre National de la Recherche Scientifique and Universités de
Paris VI and VII. Both Gilbert (Lee) Henry (2000) and Ira Hall (2004) moved to Virginia upon completion of
their fellowships. Lee joined a project headed by Thomas Südhof at Howard Hughes Medical Institute’s
(HHMI) Janelia Farm in Ashburn, and Ira is Assistant Professor in the Department of Biochemistry and
Molecular Genetics at the University of Virginia in Charlottesville.
The Laboratory’s current Fellow, Patrick Paddison, joined the program in 2004. He was a graduate
student at the Watson School of Biological Sciences, where he worked in Greg Hannon’s lab on the
development of RNA interference (RNAi) libraries. As a Fellow, Patrick has been using RNAi technology
to establish the genetic requirements for embryonic stem (ES) cell self-renewal and differentiation. His
report can be found below.
Late this fall, two new Fellows joined the Lab: Florin Albeanu did his graduate studies at Harvard Uni-
versity, in the laboratories of Venki Murthy and Markus Meister, where he investigated the logic of odor
maps in the olfactory bulb of rodents. As a Fellow, Florin is taking advantage of optical imaging, elec-
trophysiology, and opto-genetic tools to understand what computations occur at the neural circuit level
in the olfactory bulb of behaving mice. Chris Vakoc joined us from Gerd Blobel’s laboratory at the Uni-
versity of Pennsylvania. As a Fellow, Chris is studying the role of histone lysine methylation in normal
and malignant hematopoiesis.
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is exclusively expressed in pluripotent cells, i.e., ESCs or
primordial germ cells (Chambers et al., Cell 113: 643
[2003]; Mitsui et al., Cell 113: 631 [2003]). To gain fur-
ther insight into ESC pluripotency networks, we per-
formed a loss-of-function RNA interference (RNAi)
screen in a Nanog-GFP (green fluorescent protein) ESC
reporter line. We identified several novel activators and
repressors of ESC self-renewal gene expression. Chief
among them were core members of the SWI/SNF com-
plex (i.e., Smarcc1 and Smarce1). In eukaryotes, the
SWI/SNF complex uses the energy from ATP hydrolysis
to alter chromatin structure and transcriptional regula-
tion by affecting interactions between chromatin and
chromatin-bound nucleosomes (Vignali et al., Mol. Cell.
Biol. 20: 1899 [2000]). SWI/SNF function has been
linked to diverse gene regulatory phenomena in eukary-
otes, ranging from mating type switching in yeast to neu-
ral development in mammals (Sudarsanam and Winston,
Trends Genet. 16: 345 [2000]; Roberts and Orkin, Nat.
Rev. Cancer 4: 133 [2004]; Lessard et al., Neuron 55:
201 [2007]). We have shown that SWI/SNF acts as both
a corepressor of self-renewal gene expression and a
coactivator of differentiation/lineage-specific genes.
Thus, SWI/SNF acts as an important and general coor-
dinator of changes in ESC fate and perhaps an integra-
tor of several distinct modes of epigenetic regulation. To
identify additional genes required for either ESC self-
renewal or lineage commitment, we have expanded this
screen to a genome-scale screen using two approaches.
The first approach involves a well-by-well siRNA screen
(9835 genes) for genes that regulate Oct4/Pou5f1 expres-
sion in mESCs under normal growth conditions. A sec-
ond approach uses bar-code array analysis of pools of
retroviruses bearing ~70,000 different shRNAs to iden-
tify those that bypass ESC differentiation (i.e., genes
required for differentiation) (Paddison et al., Nature 428:
427 [2004]). The aims of these projects are to (1) find
additional key regulatory factors governing ESC self-
renewal and differentiation, (2) characterize the SWI/
SNF-dependent epigenetic determinants of pluripotency,
and (3) identify and characterize genes that are rate-lim-
iting for hESC and iPSC derivation and self-renewal.
PUBLICATIONS
Paddison, P.J. 2008. RNA interference in mammalian cell sys-
tems. Curr. Top. Microbiol. Immunol. 320: 1–19.
notion that with the successful isolation of human
embryonic stem cells (hESCs) and induced pluripotent
stem cells (iPSCs), we can develop techniques to har-
ness their developmental potential in the laboratory for
clinical applications, such as cell replacement therapies
for neurodegeneration, spinal chord injury, liver dys-
function, severe burns, and blood disorders. 
The overall goals of the Paddison lab revolve around
using functional genetics approaches to uncover the
molecular networks that regulate mammalian cell iden-
tity. Through the use of defined in vitro embryonic and
somatic stem cell systems, we will find and characterize
gene products affecting stem cell self-renewal, differen-
tiation, proliferation, and survival. These studies will
provide insights into basic cell biology, stem cell biol-
ogy, tissue homeostasis, and signaling network design
and perhaps provide inroads for implementing targeted
cellular therapies for a range of human diseases.
To capture the dynamic interplay between nuclear
factors that modulate “epigenetic” states and contextual
factors that alter basic cellular processes in our studies,
we have incorporated sets of small interfering RNAs
(siRNAs) and short hairpin RNAs (shRNAs) targeting
~1700 predicted transcription and DNA-binding factors
and ~8000 genes with predicted enzymatic activity. Out-
lined below are three of the projects currently under way
in the lab, which seek to uncover the functional genetic
properties of embryonic stem cells (ESCs), neural stem
cells (NSCs), and transformed cells. 
SELF-RENEWAL AND LINEAGE DETERMINATION
OF ESCS 
ESCs are cell lines derived from the inner cell mass
(ICM) of blastocyst-stage mammalian embryos (Evans
and Kaufman, Nature 292: 154 [1981]; Thomson et al.,
Science 282: 1145 [1998]; Ludwig et al., Nat. Biotech-
nol. 24: 185 [2006]). They can grow indefinitely in cul-
ture and give rise to cells of all three embryonic germ
layers as well as germ cells (Keller, Genes Dev. 19: 1129
[2005]). For these reasons, ESCs hold great promise for
regenerative medicine. Some molecular details of the
ESC self-renewal network have emerged, but more in-
depth knowledge will be required to facilitate future
ESC-based clinical applications.
The homeodomain transcription factor Nanog has a
central role in maintaining the pluripotency of ESCs and
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN’S REPORT
Yet another year has flown by here at the Watson School of Biological Sciences (WSBS). It is hard to
believe that we are now in our historic tenth year! 
In October 2007, the School appointed Uwe Hilgert, Ph.D., as the School’s Assistant Dean. Dr. Hilgert had
previously been at CSHL’s Dolan DNA Learning Center (DNALC). In November 2008, Uwe returned to the
DNALC to participate in the exciting new iPlant initiative. We thank him for his
year of dedication to the School.
In fall 2008, Alyson Kass-Eisler, WSBS Postdoctoral Program Officer, was
promoted to Curriculum Director. Alyson has been with the School since
2003 and she continues to organize our postdoctoral programs and grad-
uate student curriculum. She will also have a larger role in the School’s
reporting responsibilities. Dawn Meehan, Director of Admissions and Student
Affairs, has also been with the School since 2003. Dawn has an essential role
in the successful recruitment of outstanding students worldwide. She also
brings a unique personal touch to the School to ensure that the needs of our
students are met while they pursue their rigorous studies. Kimberley Geer
rounds out “Team Watson” as our Administrative Assistant.
Faculty Changes
In 2008, we welcomed Mickey Atwal, Thomas Gingeras, Bo Li, Zachary Lippman, Pavel Osten, and Dar-
ryl Pappin to the School as new faculty members. 
Thomas Gingeras, Professor and the Head of the Functional Genomics program, comes to us as a
former Vice President of Biological Research at Affymetrix, Inc. A leader in functional genomics, his
research focuses on understanding what really defines a gene and how genomes are organized and
regulated. He has already had an impact on the teaching at the School as an instructor in the Genetics
and Genomics Specialized Disciplines course in fall 2008.
Assistant Professor Gurinder (Mickey) Atwal came to the Watson School from the Institute for
Advanced Study at Princeton University, where he was a postdoctoral fellow. Mickey is our first new hire
in the exciting field of quantitative biology. His research will integrate computational, analytical, and exper-
imental data to study the evolution and diversity of genomes.
Bo Li, an Assistant Professor, first came to CSHL as a postdoctoral fellow under the supervision of
former faculty member Professor Roberto Malinow. His research will look into the question of how glu-
tamatergic synapse dysfunction can lead to the pathogenesis of psychiatric disorders including schizo-
phrenia and depression.
Assistant Professor Zachary Lippman is a WSBS alumnus, having received his degree from the School
in 2005. Zach conducted his thesis research at CSHL under the direction of Professor Robert Mar-
tienssen. He then moved to Israel to conduct research on tomato biology under the direction of Dr. Dani
Zamir at the Hebrew University. Zach’s laboratory will focus on understanding flower development using
the tomato as a model system. We are fortunate to have Zach participate as a member of the School’s
Admissions Committee beginning with the entering class of 2009.
Pavel Osten, a new Associate Professor, came to the Laboratory from Northwestern University, where
he held an Assistant Professorship. The main research interest in Pavel’s laboratory is the identification
and analysis of brain regions, neural circuits, and connectivity pathways that are disrupted in genetic
mouse models of autism and schizophrenia.
Darryl Pappin joined the Laboratory as an Associate Professor. He was until recently a Scientific Fel-
low at Applied Biosystems, having trained at the University of Leeds in the United Kingdom. Darryl is an
Team Watson: (Left to right) Alyson Kass-Eisler, Dawn
Meehan, Leemor Joshua-Tor, and Kim Geer.
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expert in proteomics, and in addition to leading his research program analyzing complex biological sam-
ples, he will be leading the Laboratory’s proteomics core facility.
We are very excited to have each of these exciting newcomers work with our students—a few have
already become members of student Thesis Committees and several have participated as guest lectur-
ers in our fall courses. We look forward to their participation in additional WSBS activities in the future.
Four faculty members departed the Laboratory in 2008: Hollis Cline, Zachary Mainen, Roberto Mali-
now, and Vivek Mittal. As faculty members, all four served the School and its students in various roles,
including instructor, guest lecturer, rotation advisor, mentor, examiner, and thesis committee member.
Additionally, Holly Cline was a critical member of the School’s Executive Committee for 3 years. We will
miss our fellow colleagues, and we wish them well in their new endeavors.
The Fifth WSBS Graduation
Graduation is the highlight of the year, and April 13, 2008 saw the Watson School’s fifth graduation cer-
emony. The graduating class of 2008 comprised Hiroki Asari, Rebecca Bish, François Bolduc, Monica
Dus, Angélique Girard, Christopher Harvey, and Wei Wei, all from the entering class of 2003, who were
awarded the Ph.D. degree. Claire Biot and Adrienne Jones, from the entering class of 2006, were
awarded a Master’s degree. The graduation was once again a wonderful occasion, where honorary
degrees were bestowed on Nobel Laureate Dr. Eric Kandel, Microsoft cofounder Mr. Paul G. Allen, and
Professor of Neurology and Psychiatry Dr. Oliver Sacks, who gave this year’s commencement address.
As with each graduation, we extended a special welcome to the family members and friends of our
students who attend the ceremony. Among these special guests were family members who traveled
from China, France, Japan, and Italy to take part in this special event.
Graduating class of 2008: (Left to right) Wei Wei, Monica Dus, Hiroki Asari, Christopher Harvey, Angélique Girard, 
François Bolduc, Rebecca Bish, Claire Biot. (Not shown: Adrienne Jones.)
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2008 THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2002
Allison Blum, July 9, 2008
rutabega signaling in distinct circuits supports short- versus
long-term memory in Drosophila.
Thesis Examining Committee
Chair: Grigori Enikolopov
Research mentor: Josh Dubnau
Academic mentor: David Jackson
Committee member: Glenn Turner
Committee member: J. Peter Gergen, Stony Brook 
University
External examiner: J. Steven deBelle, University of 
Nevada, Las Vegas
Shu-Ling Chiu, July 14, 2008
The role of insulin receptors in the development of neuronal
structure and function.
Thesis Examining Committee
Chair: Senthil K. Muthuswamy
Research mentor: Hollis Cline
Academic mentor: Alea A. Mills
Committee member: Glenn Turner
Committee member: Linda Van Aelst
External examiner: Li-Huei Tsai, Picower Institute, MIT
ENTERING CLASS OF 2003
Monica Dus, March 19, 2008
Beyond classical RNAi: Toward an understanding of germ
cell development and transposon control in the fruitfly D.
melanogaster.
Thesis Examining Committee
Chair: Leemor Joshua-Tor
Research mentor: Gregory Hannon
Academic mentor: John R. Inglis
Committee member: Robert Martienssen
Committee member: Adrian R. Krainer
External examiner: J. Peter Gergen, Stony Brook 
University
Angélique Girard, March 17, 2008
Mammalian Piwi proteins and transposon silencing in the
male germ line.
Thesis Examining Committee
Chair: Marja Timmermans
Research mentor: Gregory Hannon
Academic mentor: Jan A. Witkowski
Committee member: Robert Martienssen
Committee member: Scott Keeny, Memorial Sloan-
Kettering Cancer Center
External examiner: Douglas L. Chalker, Washington 
University, St. Louis
Christopher Harvey, February 4, 2008
Crosstalk between nearby synapses on hippocampal den-
drites.
Thesis Examining Committee
Chair: Linda Van Aelst
Research mentor: Karel Svoboda
Academic mentor: Adrian R. Krainer
Committee member: Hollis Cline
Committee member: Roger Davis, University of Massa-
chusetts Medical School
External examiner: Steven A. Siegelbaum, Columbia 
University
2008 WSBS DOCTORAL RECIPIENTS
Thesis Academic 
Student advisor mentor Current Position
Hiroki Asari Anthony Zador Z. Josh Huang Postdoctoral fellow with Dr. Markus Meister, Harvard 
University
François Bolduc Tim Tully Hollis Cline Assistant Professor, University of Alberta, Canada
Rebecca Bish Michael P. Myers Linda Van Aelst Postdoctoral fellow with Dr. Eric Holland, Memorial-Sloan 
Kettering Cancer Center
Monica Dus Gregory Hannon John Inglis Postdoctoral fellow with Dr. Greg Suh, NYU School of 
Medicine (February 2009)
Angélique Girard Gregory Hannon Jan Witkowski Considering postdoctoral opportunities in France
Christopher Harvey Karel Svoboda Adrian Krainer Postdoctoral fellow with Dr. David Tank, Princeton 
University
Wei Wei Roberto Malinow Jan Witkowski Postdoctoral fellow with Dr. Marla Feller, University of 
California, Berkeley
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DOCTORAL THESIS RESEARCH
Academic Research 
Student mentor mentor Thesis research 
ENTERING CLASS OF 2004
Daniel H. Chitwood Alea A. Mills Marja Timmermans The contribution of small RNAs to posi-
George A. and Marjorie H. Anderson Fellow tional signaling and the establishment of 
adaxial-abaxial polarity in leaves.
Galen A. Collins Marja Timmermans William Tansey Role of ubiquitin ligases and activator destruc-
Beckman Graduate Student tion in transcription.
Oliver L. Fregoso Nicholas Tonks Adrian R. Krainer/ Proteomic analysis to elucidate the splicing and 
Seraph Foundation Fellow Michael P. Myers nonsplicing roles of SR proteins.
William Randolph Hearst Scholar
Keisha A. John Josh Dubnau Linda Van Aelst Identification of the molecular determinants con-
William Randolph Hearst Fellow and Scholar tributing to DOCK7’s role in neuronal polarity.
Shraddha S. Pai Anthony Zador Carlos D. Brody Determining the neuroanatomical loci and electri-
Charles A. Dana Fellow cal correlates of duration discrimination in the rat.
David R. Simpson Scott Lowe William Tansey Revealing insights into cancer biology with 
Beckman Graduate Student tumor-derived mutations in c-Myc.
ENTERING CLASS OF 2005
Patrick M. Finigan Senthil K. Muthuswamy Robert Martienssen Epigenetic mechanisms involved in centromere 
Beckman Graduate Student function.
Amy Y. Leung David L. Spector William Tansey Role of H2B ubiquitylation in chromatin localiza-
Beckman Graduate Student tion.
Sarahjane M. Locke Josh Dubnau Robert Martienssen Histone H3 lysine 9 methylation and RNA pro-
George A. and Marjorie H. Anderson Fellow cessing in RNAi-mediated heterochromatin 
formation in Schizosaccharomyces pombe.
Hiroshi Makino Hollis Cline Roberto Malinow Optical determination of the spatial distribution 
Elisabeth Sloan Livingston Fellow of experience-dependent bidirectional synaptic 
plasticity.
Katherine McJunkin Terri Grodzicker Scott Lowe Using negative-selection RNAi screens to iden-
Robert and Teresa Lindsay Fellow tify novel treatment strategies for hepatocellular 
carcinoma.
Frederick D. Rollins Jan A. Witkowski Gregory Hannon An RNAi screen for modifiers of cellular 
Cashin Fellow response to the targeted therapeutic Erlotinib.
Oliver Tam David Jackson Gregory Hannon The role of RNAi machinery in oocyte maturation
Bristol-Myers Squibb Fellow and embryonic development of the mouse.
Jeremy E. Wilusz John R. Inglis David L. Spector Identification and functional characterization of 
Beckman Graduate Student large nuclear retained noncoding RNAs misregu-
lated in breast cancer.
ENTERING CLASS OF 2006
Yaniv Erlich John R. Inglis Gregory Hannon microRNA target identification by systematic 
Goldberg-Lindsay Fellow sensor expression.
Eyal Gruntman Josh Dubnau Glenn Turner Olfactory perception in Drosophila.
Elisabeth Sloan Livingston Fellow
Colin Malone David J. Stewart Gregory Hannon Dissecting small RNA pathways in Drosophila.
Beckman Graduate Student
NSF Graduate Research Fellow
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DOCTORAL THESIS RESEARCH (continued)
Academic Research 
Student mentor mentor Thesis research 
Amy Rappaport William Tansey Scott Lowe Identification and characterization of tumor sup-
Barbara McClintock Fellow pressor genes in acute myeloid leukemia.
Claudio Scuoppo Scott Lowe Gregory Hannon Identification of novel oncosuppressors through 
Engelhorn Scholar an in vivo RNAi screen in the eµ-myc model.
ENTERING CLASS OF 2007
Megan Bodnar Nicholas Tonks David L. Spector The nuclear choreography of chromatin dynam-
Starr Centennial Scholar ics, gene expression, and gene repression in 
Proposal Defense: January 2009 embryonic stem cells.
Ralph Burgess Bruce Stillman Gregory Hannon Recombination hot spots: Characterizing fine-
Starr Centennial Scholar scale variation in the frequency of meiotic 
Proposal Defense: January 2009 recombination across the mammalian genome.
Joseph Calarco David Jackson Leemor Joshua-Tor/ Mechanistic insights into chromatin regulating 
David H. Koch Fellow Robert Martienssen proteins in Schizosaccharomyces pombe and 
Proposal Defense: January 2009 Arabidopsis thaliana.
Saya Ebbesen David J. Stewart Scott Lowe In vivo identification and characterization of 
Starr Centennial Scholarship novel tumor suppressors relevant to human 
Proposal Defense: January 2009 breast cancer.
Paloma Guzzardo Adrian R. Krainer Gregory Hannon A potential role for small RNAs in heterochro-
Leslie C. Quick, Jr. Fellow matin formation in Drosophila melanogaster 
Proposal Defense: January 2009 somatic cells.
Kyle Honegger John R. Inglis Glenn Turner Neuronal and circuit mechanisms creating 
Crick-Clay Fellow sparse odor representations in the mushroom 
Proposal Defense: January 2009 body of Drosophila.
Marek Kudla David Jackson Gregory Hannon 3′UTR role in posttranscriptional regulation of 
George A. and Marjorie H. Anderson Fellow gene expression.
Proposal Defense: January 2009
Michael Pautler Robert Lucito David Jackson The RAMOSA pathway and inflorescence 
William R. Miller Fellow branching in maize.
Proposal Defense: February 2009
Maria Pineda Adrian R. Krainer Raffaella Sordella Mechanism of “addiction” to receptor tyrosine 
William Randolph Hearst Scholar kinases in non-small-cell lung carcinoma.
Proposal Defense: January 2009
Yevgeniy Plavskin Jan A. Witkowski Marja Timmermans The evolution of the miR390-dependent tasiRNA
Alfred Hershey Fellow pathway and its function in the development of 
Proposal Defense: January 2009 basal land plants.
Joshua Sanders Bruce Stillman Adam Kepecs Trans-regional coordination of activity in the 
Edward and Martha Gerry Fellow mouse brain.
Proposal Defense: January 2009
Zhenxun Wang Terri Grodzicker Adrian R. Krainer Alternative splicing of pyruvate kinase M in 
A*STAR Fellow tumorigenesis.
Proposal Defense: March 2009
Petr Znamenskiy Terri Grodzicker Anthony Zador Pathways for attention and action in the auditory
David and Fanny Luke Fellow system.
Proposal Defense: January 2009
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Teaching Award
At this year’s graduation ceremony, Dr. Glenn Turner was presented with the third annual Winship Herr
Faculty Teaching Award named in honor of the School’s founding Dean. Glenn was lead instructor of the
neuroscience module of the Scientific Reasoning and Logic course and was chosen by the students for
his enthusiasm, excellence, and creativity in teaching. The following is some of what they had to say
about the recipient:
I feel that Glenn really went out of his way to make sure that this module was
enjoyable for all—from meeting with us before the module to determine what
gaps needed to be filled in, to helping us with questions during our student
paper discussion, to meeting with students before the final exam to review
practice questions.
Alumni Highlights
The scientific research achievements of WSBS students continue to be outstanding.
As a consequence, WSBS graduates are highly competitive and are moving into fac-
ulty positions much faster, on average, than are other new Ph.D.s. WSBS graduates
continue to publish in top journals and secure prestigious independent positions, fel-
lowships, and awards. The number of WSBS graduates who either have started, or will
soon start, tenure-track positions has now grown to six. Here is where are they now:Glenn Turner (front)
ALUMNI
François Bolduc, Ph.D.
Assistant Professor, University of Alberta,
Canada
François Bolduc conducted his thesis research
in Dr. Tim Tully’s laboratory. His thesis was enti-
tled “Role of fragile-X mental retardation protein
and the RNAi pathway in Drosophila learning
and memory.”
Ira Hall, Ph.D.
Assistant Professor, University of Virginia School
of Medicine
Ira Hall conducted his research in Dr. Shiv Grewal’s
laboratory. His thesis was entitled “A role for RNA
interfence in heterochromatic silencing and chro-
mosome dynamics.” Ira’s research contributed to
the prestigious AAAS Newcomb Cleveland Prize
during his time at the Watson School.
Zachary Lippman, Ph.D.
Assistant Professor, Cold Spring Harbor Labo-
ratory
Zachary Lippman conducted his thesis research
in Dr. Rob Martienssen’s laboratory. His thesis was
entitled “Transposons, heterochromatin, and epi-
genetic landscapes in Arabidopsis thaliana.” Zach
was the recipient of the prestigious Fred Hutchin-
son Cancer Research Center’s Harold M. Wein-
traub Award. Zach was also the recipient of the
Human Frontier Science Program Fellowship. He conducted his postdoc-
toral research with Dr. Dani Zamir at the Hebrew University of Jerusalem on
quantitative genetics and natural variation in tomatoes.
Patrick Paddison, Ph.D.
Assistant Professor, Fred Hutchinson Cancer
Center
Patrick Paddison conducted his thesis research
in Dr. Gregory Hannon’s laboratory. His thesis
was entitled “RNA interference in mammals: The
quest for illuminating gene function.” During his
time at the Watson School, Patrick was the recip-
ient of a U.S. Army Medical Research and Mate-
rial Comment Breast Cancer Research Program Predoctoral Fellowship.
Ji-Joon Song, Ph.D.
Assistant Professor, Korea Advanced Institute of
Science and Technology
Ji-Joon Song conducted his thesis research in
Dr. Leemor Joshua-Tor’s laboratory. His thesis
was entitled “Structural and biochemical studies
of Argonaute reveal the slicing mechanism of
RISC-RNAi effector complex.” Ji-Joon conduc-
ted postdoctoral research with Dr. Robert E.
Kingston on chromatin modification at Massachusetts General Hospital,
Harvard University. Ji-Joon was the recipient of the Jane Coffin Childs
Postdoctoral Fellowship.
Niraj Tolia, Ph.D.
Assistant Professor, Washington University
School of Medicine, St. Louis
Niraj Tolia conducted his thesis research in Dr.
Leemor Joshua-Tor’s laboratory. His thesis was
entitled “Structural and biochemical studies of
the malaria parasite Plasmodium falciparum
protein EBA-175 involved in erythrocyte inva-
sion.”
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Admissions 2008
The School received 270 applications for the 2008–2009 academic year and is deeply indebted to its
Admissions Committee, which reviewed, interviewed, and selected candidates for our doctoral program.
Joining me on the Admissions Committee for the 2008 entering class were Gregory Hannon (Chair),
Josh Dubnau, Adam Kepecs, Adrian R. Krainer, Robert Lucito, Nicholas Tonks, Lloyd Trotman, Linda Van
Aelst, and Michael Q. Zhang—a truly remarkable team!
Entering Class of 2008
On August 26, 2008, the Watson School opened its doors for the 10th
time to welcome yet another new class. This year, 15 students joined the
School: Philippe Batut, Mitchell Bekritsky, Dario Bressan, Carrie Clen-
daniel, Melanie Eckersley-Maslin, Jiahao Huang, Sang-Geol Koh, Katie
Liberatore, Ozlem Mert, Elizabeth (Beth) Nakasone, Zinaida (Zina) Per-
ova, Felix Schlesinger, Nilgun Tasdemir, Elvin Wagenblast, and Susann
Weissmueller. Reflecting CSHL’s eclectic mix of nationalities, the enter-
ing class of 2008 is also international, hailing from the United States,
France, Italy, Australia, South Korea, Turkey, Russia, and Germany. Beth,
an American, comes from almost as far away as our foreign students—
she is our first student from Hawaii.
ENTERING CLASS OF 2008
Philippe Batut, Université Paul Sabatier,
Toulouse, France
Academic mentor: Alexander Gann 
Mitchell Bekritsky, Northwestern University
Academic mentor: W. Richard McCombie
Dario Bressan, University of Pisa, Italy
Academic mentor: Gregory Hannon 
Carrie Clendaniel, Northwestern University
Academic mentor: David Jackson 
Melanie Eckersley-Maslin, University of
Sydney
Academic mentor: David L. Spector 
Jiahao Huang, University of California,
Berkeley
Academic mentor: Terri Grodzicker 
Sang-Geol Koh, Seoul National University
Academic mentor: Glenn Turner
Katie Liberatore, University of Mexico
Academic mentor: Adrian R. Krainer
Ozlem Mert, Bilkent University
Academic mentor: John R. Inglis 
Elizabeth Nakasone, University of Southern
California
Academic mentor: Alea A. Mills 
Zinaida Perova, St. Petersburg State Poly-
technic University
Academic mentor: Linda Van Aelst 
Felix Schlesinger, Jacobs University, Bremen
Academic mentor: Thomas Gingeras 
Nilgun Tasdemir, Bilkent University
Academic mentor: Josh Dubnau 
Elvin Wagenblast, University of Heidelberg
Academic mentor: Jan A. Witkowski 
Susann Weissmueller, University of Heidel-
berg
Academic mentor: Raffaella Sordella
Entering class of 2008: (Back, left to right) Jiahao Huang,
Beth Nakasone, Melanie Eckersley-Maslin, Katie Liberatore.
(Middle, left to right) Susann Weissmueller, Elvin Wagen-
blast, Felix Schlesinger, Dario Bressan, Philippe Batut,
Sang-Geol Koh. (Front, left to right) Carrie Clendaniel, Nil-
gun Tasdemir, Ozlem Mert, Zina Perova, Mitchell Bekritsky.
The 2008 entering class celebrates the holidays.
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Academic Mentoring
The Watson School takes great pride in the level of mentoring that it offers its students. One of the unique
features of our program is our two-tiered mentoring approach, whereby each student receives an aca-
demic as well as a research mentor. Entering students select a member of the research or nonresearch
faculty to serve as their academic mentor—a watchful guardian to look over and encourage the student
through their sometimes-trying doctoral education. This program continues to receive much support
from the faculty who volunteer to be academic mentors, and it has rightfully become a vital ingredient in
our success. This year’s new academic mentors for the entering class of 2008 are listed below.
The Fall Term Curriculum
Our faculty continues to do an outstanding job of developing and delivering the curriculum. For a second
year in a row, they have risen to the challenge of teaching a large class of students, and we are extremely
grateful for their considerable time and effort in maintaining the high-quality course work that we strive to
provide. The Curriculum Development and Integration Committee (CDIC)—Adrian Krainer (Chair), Z. Josh
Huang, David Jackson, Leemor Joshua-Tor, and Nicholas Tonks—continues to carefully monitor and
develop the curriculum. In addition to the outstanding course instructors and guest lecturers from within the
Laboratory, our courses also continue to attract an impressive array of guest lecturers from other institutions.
Recruiting Efforts
Recruitment for the graduate program’s 2009 class and our Undergraduate Research Program (URP)
of 2009 was once again managed by Ms. Dawn Meehan, the School’s Director for Admissions and Stu-
dent Affairs. As in years past, Dawn traveled the length and breadth of the country, representing CSHL
and WSBS. The table below details recruitment fairs and conferences in which we have participated,
together with the names of faculty, students, and administrators who represented WSBS on these occa-
sions. To further raise awareness of our programs, we also mailed more than 15,000 letters to colleges
and universities in the United States and abroad.
Interinstitutional Academic Interactions
It is important to bear in mind that many of the graduate students who pursue their thesis research at
CSHL are not in the WSBS graduate program. Indeed, a large percentage of students are from Stony
Brook University (SBU), via a program established by CSHL and SBU more than 30 years ago. WSBS
provides an on-site “home” for these students, helps to ensure that they feel part of the CSHL commu-
nity, and assists them with the complexities of performing doctoral research away from their parent insti-
tutions. The following students, listed in the box below, joined us this year. 
STUDENT MENTOR
Philippe Batut Alexander Gann
Mitchell Bekritsky W. Richard McCombie
Dario Bressan Gregory Hannon
Carrie Clendaniel David Jackson
Melanie Eckersley-Maslin David L. Spector
Jiahao Huang Terri Grodzicker
Sang-Geol Koh Glenn Turner
Katie Liberatore Adrian R. Krainer
STUDENT MENTOR
Ozlem Mert John R. Inglis
Elizabeth Nakasone Alea A. Mills
Zinaida Perova Linda Van Aelst
Felix Schlesinger Thomas Gingeras
Nilgun Tasdemir Josh Dubnau
Elvin Wagenblast Jan A. Witkowski
Susann Weissmueller Raffaella Sordella
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NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
Student CSHL research mentor Affiliation and program
Ying Cai Richard W. McCombie Stony Brook, Biomedical Engineering
Deblina Chatterjee Adrian R. Krainer Stony Brook, Molecular and Cellular Biology
Shipra Das Adrian R. Krainer Stony Brook, Genetics
Mathangi Ramesh Nicholas Tonks Stony Brook, Molecular and Cellular Biology
Yabai Song Scott Powers Stony Brook, Applied Math and Statistics
Yi Su Scott Powers Stony Brook, Applied Math and Statistics
Ruei-Ying Tzeng Adrian R. Krainer Stony Brook, Genetics
Ming Yang Nicholas Tonks Stony Brook, Biochemistry and Structural Biology
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2008 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Event Location Date WSBS representatives/titles
Rice University: Biosciences Fair Rice University January 16 Dawn Meehan, Director of Admissions and 
Student Affairs
Spelman College: Graduate School and Spelman College January 16 information sent for distribution
Summer Opportunities Fair
Wellesley College: Women in Science Fair Wellesley College February 27 information sent for distribution
22nd Symposium of The Protein Society San Diego, California July 20 Michael Pautler, Graduate Student
Graduate School Fair
University of Puerto Rico: Minority Access University of Puerto Rico September 10 Paloma Guzzardo, Graduate Student 
for Research Careers (MARC) Program 
Information Session
University of Guelph, Canada: Information University of Guelph, Canada September 11 Joseph Calarco, Graduate Student; Michael 
Session Pautler
Universidad Interamericano de Puerto Rico: Universidad Interamericano de September 11–12 Paloma Guzzaardo 
Information Session Puerto Rico 
University of Toronto: Information Session University of Toronto September 12 Joseph Calarco, Michael Pautler
XVIII Undergraduate Research Symposium: NSF/ San Juan, Puerto Rico September 12–13 Paloma Guzzardo
UMET Model Institutions for Excellence Project
Georgetown University: Information Session Georgetown University September 13 information sent for distribution
Recruit in Canada: Graduate School Fair Toronto, Canada September 13 Joseph Calarco, Michael Pautler
Hunter College: Minority Access for Research Hunter College September 17 Dr. David Jackson, Professor; Dawn Meehan
Careers (MARC) Program Information Session
Massachusetts Institute of Technology: Massachusetts Institute of September 18 Eugene Plavskin, Graduate Student; 
Career Fair Technology Hassana Oyibo, Graduate Student
Massachusetts Institute of Technology: Massachusetts Institute of September 19 Eugene Plavskin; Hassana Oyibo 
Information Session Technology
Cornell University: Information Session Cornell University September 23 Fred Rollins, Graduate Student, 
Amy Rappaport, Graduate Student
Colgate University: Information Session Colgate University September 23 Eugene Plavskin; Petr Znamenskiy, Graduate 
Student
The Johns Hopkins University: Information Session The Johns Hopkins University September 24 Jeremy Wilusz, Graduate Student
Cornell University: Graduate and Professional Cornell University September 24 Fred Rollins, Amy Rappaport
School Day
University of Maryland, Baltimore County: University of Maryland, Baltimore September 29 Keisha John, Graduate Student
Meyerhoff Scholarship Program Visit County
Big 10+ Graduate School Expo Purdue University September 29 Dawn Meehan
Notre Dame University: Information Session Notre Dame University September 30 Kyle Honegger, Graduate Student
Northwestern University: Information Session Northwestern University October 1 Kyle Honegger
University of California, Berkeley: Graduate University of California, Berkeley October 8–9 Dan Chitwood, Graduate Student
School Fair
Society for Advancement of Chicanos and Salt Lake City, Utah October 9–12 Dawn Meehan
Native Americans in Science (SACNAS)
California Institute of Technology: Career Fair California Institute of Technology October 15 David Simpson, Graduate Student
Washington University, St. Louis: Information Washington University, St. Louis October 16 Dr. Alyson Kass-Eisler, Curriculum Director
Session 
Emory University: Information Session Emory University October 20 Jeremy Wilusz
Duke University: Graduate and Professional Duke University October 22 Joshua Sanders, Graduate Student
School Day
Yale University: Information Session Yale University October 22 Dr. Robert Lucito, Assistant Professor; Dawn 
Meehan
Emory University: Graduate Schools Fair Emory University October 23 Marek Kudla, Graduate Student
Harvard University: Information Session Harvard University October 23 Dr. Robert Lucito, Dawn Meehan
Historically Black Colleges and Universities, Atlanta, Georgia October 23–25 Maria Pineda, Graduate Student
Undergraduate Program (HBCU–UP): 
National Research Conference
Annual Biomedical Conference for Minority Orlando, Florida November 5–8 Paloma Guzzardo; Dr. Adrian Krainer, Profes-
Students (ABRCMS) sor; Dawn Meehan; Maria Pineda; Hassana 
Oyibo
University of California, Santa Barbara: University of California, Santa Barbara November 6 Megan Bodnar, Graduate Student
Graduate and Professional School Day
Princeton University: Information Session Princeton University November 6 Colin Malone, Graduate Student
Princeton University: Graduate and Princeton University November 7 Colin Malone
Professional School Fair
California Forum for Diversity for Graduate University of California, Berkeley November 8 Megan Bodnar
Education: Graduate School Fair
Barry University, Minority Access for Research Barry University November 14 Maria Pineda
Careers (MARC) Program: Information Session
University of Pennsylvania: Bioengineering/ University of Pennsylvania November 13– Virtual Fair
Biotechnology Virtual Career Fair December 15
Sigma Xi Annual Conference and Research Washington, D.C. November 20–23 Amy Leung, Graduate Student
Symposium
Vassar College: Genetics and Bioinformatics Cold Spring Harbor Laboratory November 21 Dr. Robert Lucito; Dawn Meehan; Dr. Doreen 
Course Visit and Information Session Ware, Assistant Professor; Jeremy Wilusz
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A Major Change to the Graduate Student Seminar Series
In the summer of 2008, a suggestion from the SBU representative to the School’s Executive Commit-
tee, Jane Lee-Osborne, prompted us to try a new format—the Graduate Student Symposium. Instead
of meeting weekly, the graduate students now meet three times each year to hear talks and view posters
from their colleagues. Senior students present their research in formal talks, whereas the junior students
present posters in a more relaxed atmosphere. The first Symposium was held on August 28th at the Lab-
oratory’s Genome Research Center in Woodbury. The students and faculty in attendance found it to be
a great event, and the feedback generated from an online survey indicated that the new format was a
huge improvement over the weekly meetings. The Symposium is open to the entire Laboratory com-
munity, but it is run largely by the students themselves. We are grateful to the two student Chairs of the
Symposium—Jane Lee-Osborne (SBU) and Jeremy Wilusz (WSBS)—for their dedication and hard work
in helping to make this experiment a success.
Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also departures. The following graduate students and
postdoctoral fellows departed from the Laboratory during 2008:
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Postdoctoral Fellows
Anindya Bagchi
Martin Bayer
Jennifer E. Bestman
Daniel J. Bouyer
Julius F. Brennecke
James A. Demas
Ross A. Dickins
Juan M. Encinas
DingCheng Gao
Mengjuan Guo
Haiyan He
Yoshitaka Hippo
Masateru Hiramoto
Hailan Hu
Claudia Jurgensen
Helmut Kessels
Jianli Li
Susana Q. Lima
Akira Mamiya
Kevin J. Mc Donnell
Masayoshi Murakami
Elizabeth P. Murchison
Namiko Nagasawa
Fabio Nogueira
Joaquin Piriz
Eleonore A. Real
Seongho Ryu
Lucio M. Schiapparelli
Rebecca Schwab
Camile P. Semighini
Jihane Serkhane
Pranav K. Sharma
Wan Hua Shen
Khalid Siddiqui
Matthew C. Smear
Andrew D. Smith
Smita Srivastava
Rajika Thakar
Vatsala Thirumalai
Dmitry Tsigankov
Liang Wang
Shouzhen Xia
Ning Long Xu
Hong Yang
Graduate Students
Claire M. Biot
Rebecca Bish
Kasandra L. Burgos
Yen-Yu T. Chen
Yi-Chun Chen
Shu-Ling Chiu
Monica Dus
Angélique Girard
Christopher Harvey
Ivan (Shun) Ho
Sarahjane M. Locke
Daniel J. Nolan
Marissa E. Nolan
Cristian Papazoglu-
Statescu
Despina Siolas
Deepika Vasudevan
Wei Wei
Hatim A. Zariwala
Chaolin Zhang
Executive Committee 
A large measure of the Watson School’s success can be traced to the sage advice, guidance, and gov-
ernance of the School’s Executive Committee. In 2008, Lincoln Stein stepped down from the commit-
tee and was replaced by Linda Van Alest. We are grateful for the insights and advice that Lincoln brought
to the Committee as a member for 5 years. As happens each year, there was also turnover among the
student representatives. WSBS representative Eyal Gruntman completed his term and will be replaced
by Eugene Plavskin. SBU representative Jane Lee-Osborne also completed her term and was replaced
by Xiaoyun Wu. We are thankful for their honest and thoughtful advice. I wish to also thank faculty mem-
bers Terri Grodzicker, W. Richard McCombie, Alea A. Mills, David L. Spector, and Nicholas Tonks, who
continued to serve on the Executive Committee.
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External Advisory Committee
An outstanding External Advisory Committee (EAC) guides the School. This EAC comprises Dr. Keith
Yamamoto (Chair), Professor and Executive Vice Dean at the School of Medicine, University of Califor-
nia, San Francisco; Dr. Victor Corces, Professor, Department of Biology, Emory University, and Howard
Hughes Medical Institute (HHMI) Professor; Dr. Gail Mandel, Senior Scientist, Vollum Institute, Oregon
Health and Science University, and HMMI Investigator; Dr. Marguerite Mangin, Academic Programs Direc-
tor and Senior Research Associate, The Rockefeller University; Dr. Barbara Meyer, Professor of Genet-
ics and Development, University of California, Berkeley, and HHMI Investigator; and Dr. Frank Solomon,
Professor, Department of Biology and Center for Cancer Research, Massachusetts Institute of Technol-
ogy. The members of the Committee are noted for their leadership in graduate education in the biologi-
cal sciences and are recognized leaders in their fields of research. During July 10–11, 2008, members
of the EAC visited the School to review our progress since their last visit in spring 2006. As usual, the team
met with students, faculty, and administrators and the overall feeling was that the School and its unique
philosophy was indeed working. The EAC’s continued commitment to the success of the Watson School
has been irreplaceable—thank you so much!
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher of
Molecular Biology of the Cell, who died of cancer in 1991) brings to CSHL an eminent researcher and
educator to give the Gavin Borden Lecture, which is dedicated to the graduate students at the labora-
tory. Dr. Tania Baker—E.C. Whitehead Professor of Biology at the Massachusetts Institute of Technology
and Howard Hughes Medical Institute Investigator—was this year’s Gavin Borden Fellow. Her lecture
Remodeling Proteins and the Proteome by AAA+ Unfolding Machines was thoroughly enjoyed and
evoked many questions from the audience. In addition, Tania shared her experiences as a scientist dur-
ing dinner as well as at a more structured roundtable discussion with the students the following day.
The Watson School Continues to Benefit from Generous Benefactors
I am happy to report on the establishment of the new “Gonzalo Río Arronte Fellowship” to be held by a
qualified Mexican graduate student at the WSBS. Candidates for the fellowship will be preselected by the
Universidad Nacional Autónoma de México and the Fundación Gonzalo Río Arronte and presented to the
WSBS Admissions Committee, which will make the final decision on admission. The fellow will be
expected to have a role in the development of Genomic Sciences in Mexico upon completion of his or
her graduate and postdoctoral training. 
We are extremely grateful for the generous donors, whose one-time gifts or continued support made
our 2008 programs possible, including The Banbury Fund, The Arnold and Mabel Beckman Foundation,
Mr. and Mrs. Richard M. Cashin, Mr. and Mrs. Landon Clay, Mr. Curt Engelhorn, The William Stamps
Farish Fund, Lorraine G. Grace Fund, Dr. Mark Hoffman, Annette Kade Charitable Trust, Mr. and Mrs.
Robert D. Lindsay, Mr. and Mrs. David L. Luke III, Mr. and Mrs. William R. Miller, and The Rathmann Fam-
ily Foundation.
Student Achievements
WSBS students continue to impress us all of their accomplishments. They publish their research findings
in prestigious international journals and obtain fellowships to pursue their research interests. Our stu-
dents have published more than 120 papers to date, a remarkable accomplishment for a School in its
tenth year.
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2008 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS
Benetti, R., Gonzalo, S., Jaco, I., Muñoz, P., Gonzalez, S., Schoeftner, S., Murchison, E., Andl, T., Chen, T., Klatt, P., Li, E., Ser-
rano, M., Millar, S., Hannon, G., and Blasco, M.A. 2008. A mammalian microRNA cluster controls DNA methylation and telo -
mere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat. Struct. Mol. Bio. 15: 268–279.
Bish, R.A., Fregoso, O.I., Piccini, A., and Myers, M.P. 2008. Conjugation of complex polyubiquitin chains to WRNIP1. J. Proteome
Res. 7: 3481–3489. 
Bolduc, F.V., Bell, K., Cox, H., Broadie, K.S., and Tully, T. 2008. Excess protein synthesis in Drosophila fragile X mutants impairs
long-term memory. Nat. Neurosci. 11: 1143–1145. 
Brennecke, J., *Malone, C.D., *Aravin, A.A., Sachidanandam, R., Stark, A., and Hannon, G.J. 2008. An epigenetic role for mater-
nally inherited piRNAs in transposon silencing. Science 322: 1387–1392.
Burgess, D.J., Doles, J., Zender, L., Xue, W., Ma, B., McCombie, W.R., Hannon, G.J., Lowe, S.W., and Hemann, M.T. 2008. Topo-
isomerase levels determine chemotherapy response in vitro and in vivo. Proc. Natl. Acad. Sci. 105: 9053–9058.
Chen, J.F., Murchison, E.P., Tang, R., Callis, T.E., Tatsuguchi, M., Deng, Z., Rojas, M., Hammond, S.M., Schneider, M.D., Selz-
man, C.H., Meissner, G., Patterson, C., Hannon. G.J., and Wang, D.Z. 2008. Targeted deletion of Dicer in the heart leads to
dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. 6: 2111–2116.
Chiu, S.L., Chen, C.M., and Cline, H.T. 2008. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit
function in vivo. Neuron 58: 708–719.
Czech, B., *Malone, C.D., *Zhou, R., Stark, A., Schlingeheyde, C., Dus, M., Perrimon, N., Kellis, M., Wohlschlegel, J.A., Sachi-
danandam, R., Hannon, G.J., and Brennecke, J. 2008. An endogenous small interfering RNA pathway in Drosophila. Nature
453: 798–802.
Daulny, A., Geng, F., Muratani, M., Geisinger, J.M., Salghetti, S.E., and Tansey, W.P. 2008. Modulation of RNA polymerase II sub-
unit composition by ubiquitylation. Proc. Natl. Acad. Sci. 50: 19649–19654.
Erlich, Y., Mitra, P.P., Delabastide, M., McCombie, W.R., and Hannon, G.J. 2008. Alta-cyclic: A self-optimizing base caller for
next-generation sequencing. Nat. Methods 5: 679–682.
Ewald, R.C., Van Keuren-Jensen, K.R., Aizenman, C.D., and Cline, H.T. 2008. Roles of NR2A and NR2B in the development of
dendritic arbor morphology in vivo. J. Neurosci. 28: 850–861.
Girard, A. and Hannon, G.J. 2008. Conserved themes in small-RNA-mediated transposon control. Trends Cell Biol. 18: 136–
148.
Gruntman, E., Qi, Y., Slotkin, R.K., Roeder, T., Martienssen, R.A., and Sachidanandam, R. 2008. Kismeth: Analyzer of plant
methylation states through bisulfite sequencing. BMC Bioinformatics 9: 371–384.
Guo, M., Thomas, J., Collins, G., and Timmermans, M.C. 2008. Direct repression of KNOX loci by the ASYMMETRIC LEAVES1
complex of Arabidopsis. Plant Cell 20: 48–58.
Harvey, C.D., Yasuda, R., Zhong, H., and Svoboda, K. 2008. The spread of Ras activity triggered by activation of a single den-
dritic spine. Science 321: 136–140.
Harvey, C.D., Ehrhardt, A.G., Cellurale, C., Zhong, H., Yasuda, R., Davis, R.J., and Svoboda, K. 2008. A genetically encoded flu-
orescent sensor of ERK activity. Proc. Natl. Acad. Sci. 105: 19264–19269.
Hromádka, T., DeWeese, M.R., and Zador, A.M. 2008. Sparse representation of sounds in the unanaesthetized auditory cortex.
PLoS Biol. 6: e16.
Iijima, K., Chiang, H.C., Hearn, S.A., Hakker, I., Gatt, A., Shenton, C., Granger, L., Leung, A., Iijima-Ando, K., and Zhong, Y. 2008.
Ab42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE 3: e1703.
Tam, O.H., Aravin, A.A., Stein, P., Girard, A., Murchison, E.P., Cheloufi, S., Hodges, E., Anger, M., Sachidanandam, R., Schultz,
R.M., and Hannon, G.J. 2008. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature
453: 534–539.
Wilusz, J.E., Freier, S.M., and Spector, D.L. 2008. 3′ end processing of a long nuclear-retained non-coding RNA yields a tRNA-
like cytoplasmic RNA. Cell 135: 919–932.
Wu, Y., Bolduc, F.V., Bell, K., Tully, T., Fang, Y., Sehgal, A., and Fischer, J.A. 2008. A Drosophila model for Angelman Syndrome.
Proc. Natl. Acad. Sci. 105: 12399–12404.
Zhou, R., Hotta, I., Denli, A.M., Hong, P., Perrimon, N., and Hannon, G.J. 2008. Comparative analysis of Argonaute-dependent
small RNA pathways in Drosophila. Mol. Cell 32: 592–599.
*Authors contributed equally to the work.
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WSBS Family Events
Finally, I am pleased to announce that this was a great year for the WSBS students, faculty, and
administration because we celebrated some wonderful personal occasions. Shraddha Pai
(entering class of 2004) and her husband Professor Lincoln Stein became parents when they
welcomed Gayatri Sara, 6 lbs, 13 oz, on October 11. I also welcomed my own little bundle of
joy—Avery Elyssa Madison was born on August 9.
Wei Wei (entering class of 2003 and 2008 graduate), Yaniv Erlich (entering class of 2006)
Patrick Finigan (entering class of 2005), and Monica Dus (entering class of 2003 and 2008
graduate) all got married in 2008, and Allison Blum (entering class of 2002) and Katie Libera-
tore (entering class of 2008) both became engaged. Our congratulations and best wishes to
all of them.
Leemor Joshua-Tor
Professor and Dean
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SPRING CURRICULUM
Specialized Disciplines Courses
Due to unusual circumstances and scheduling issues, one of the Specialized Disciplines course from the
fall 2007 term, Cellular Structure and Function, was taught in spring 2008. The class was taught as a 1-
week intensive course and was universally enjoyed.
Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship, The Sigi Ziering Lectureship, The Martha F. Gerry 
Visiting Lectureship
INSTRUCTORS Linda Van Aelst (Lead)
Raffaella Sordella
GUEST INSTRUCTORS David L. Spector
Bruce Stillman
VISITING LECTURERS Michael Caplan, Yale University
Gregg Gundersen, Columbia University
Andrea McClatchy, Massachusetts General Hospital
Conly Rieder, Wadsworth Laboratory
Sandy Simon, The Rockefeller University
Marc Symons, The Feinstein Institute for Medical Research
With the complete genome sequence available for many organisms, there is now an increasing empha-
sis on understanding the function of the gene products. This understanding requires an increasing appre-
ciation of the structure and function of the cell as well as the dynamic associations within the cell. This
course provided a basic overview of the structural and functional organization of cells, with particular
emphasis on cellular compartmentalization and communication. Topics of focus included the cytoskele-
ton, cell adhesion and signaling, membrane transport, gene expression, and nuclear organization. In addi-
tion, the course provided insight into the basic toolbox of the cell biologist of the 21st century.
Topics in Biology
ARRANGED BY Alyson Kass-Eisler and Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship, The David Pall Visiting Lectureship, 
The Fairchild Martindale Visiting Lectureship, The Lucy and Mark Ptashne Visiting 
Lectureship, The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference Center to
explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty. These
courses include morning or evening lectures as well as afternoon sessions during which students read
assigned papers. These intensive courses are modeled on the Cold Spring Harbor Laboratory Lecture
Courses held each summer at the Banbury Conference Center. In Spring 2008, there were two such
courses: Immunology and Fundamental Concepts in Statistics.
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Immunology
Attended by the entering classes of 2004 and 2007
INSTRUCTOR Michael Dustin, New York University
VISITING LECTURER Joel Earnst, New York University
TEACHING FELLOWS Amelie Collins, New York University
Gabriel Victora, New York University
Serre-Yu Wong, New York University
Immunology is an interdisciplinary field that focuses on understanding the mechanisms by which multi-
cellular organisms defend themselves against external threats of microbial aggression and internal threats
associated with genetic instability and cellular transformation. The course focused on the unique ele-
ments of the innate immune system and the adaptive immune system. Innate immunity defends against
microbes by recognizing evolutionarily conserved molecular patterns. The adaptive immune system has
enormous flexibility in molecular recognition, but it can also target itself to cause autoimmune diseases.
The course consisted of morning faculty presentations, afternoon readings of primary research papers
and evening discussions of the research papers and related issues. The faculty presentations were in a
“chalk talk” format, with questions encouraged. The afternoon reading period provided an opportunity
for students to read two selected papers and related background information, teaching assistants (TAs)
available for questions. The evening discussions were directed by the TAs and provided the starting point
for probing intellectual and practical questions in immunology research, venturing beyond the material pre-
sented in the papers into related issues and current research. The TAs also gave short research presen-
tations to introduce students to their particular interests and three areas of current immunology research.
The course, which ran March 3–7, was developed and presented largely by Dr. Dustin, who taught at the
School for the first time.
Immunology course participants: (Front row, left to right) Joshua Sanders, Kyle Honegger, Amelie Collins, Shraddha Pai, Megan Bodnar, Michael
Dustin, Ralph Burgess. (Middle row, left to right) Joel Ernst, Garbriel Victora, Serre-Yu Wong, Oliver Fregoso, Xiaoyun Wu, Hassana Oyibo, Marek
Kudla, Zhenxun Wang, Maria Pineda, Keisha John. (Back row, left to right) Galen Collins, Petr Znamenskiy, Paloma Guzzardo, Eugene Plavskin,
David Simpson, Daniel Chitwood, Joseph Calarco, Michael Pautler. (Not shown: Saya Ebbesen.)
199-228_WSBS_2008:LAR_Template_2007  6/9/09  4:18 PM  Page 215
Fundamental Concepts in Statistics
Attended by the entering classes of 2003 and 2004
INSTRUCTOR Martina Bremmer, San Jose State University
GUEST LECTURERS Robert Martienssen, Cold Spring Harbor Laboratory
Madhu Mazumdar, Weill Cornell Medical College
TEACHING FELLOWS Tilman Achberger, Purdue University
Gayla Olbricht, Purdue University
Statistics and mathematics have become an integral part of research in many areas of biology. New tech-
nology leads to large amounts of data produced in the fields of genomics, ecology, and epidemiology.
The statistical methods required to analyze the data evolve and adapt constantly with the changing
demands. However, the underlying principles of statistical analysis remain the same. 
This course focused on the fundamental statistical concepts used in the analysis of biological data.
Emphasis was placed on statistical reasoning rather than specific formulas and computations. However,
examples of statistical applications were discussed and students were asked to apply the methods they
learned to real data sets using software. The major statistical concepts introduced in this course included
descriptive statistics, statistical inference, sampling and sampling distributions, correlation, hypothesis
testing, experimental design, regression, and ANOVA. 
The course integrated lectures by the instructor with directed reading and interpretation of statistical
analyses in publications by the students. It was accompanied by lab sections in which the students were
instructed on conducting simple statistical analyses using software. In addition, invited speakers cov-
ered special topics in the application of statistical methodology to the biological sciences. The course ran
from Sunday to Saturday, June 8–14, and was organized and largely taught by Martina Bremmer. This
relatively new WSBS course was highly anticipated by the students who overall thought that it was one
of the most useful and best organized courses they had taken.
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Fundamental Concepts in Statistics course participants: (Back row, left to right) Tilman Achberger, Colin Malone, Robert Martienssen, Martina Bre-
mer, Oliver Tam, Patrick Finigan, Hiroshi Makino, Amy Rappaport, Frederick Rollins, Wen Xue, Jeremy Wilusz, Claudio Scuoppo, Gayla Olbricht.
(Front row, left to right) Wanhe Li, Sarahjane Locke, Katherine McJunkin, Amy Leung. (Not shown: Yaniv Erlich, Eyal Gruntman, Madhu Mazumdar.)
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Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Micklos
INSTRUCTORS Amanda McBrien (Lead)
Jennifer Cutillo
Brian Lang
Jermel Watkins
Lauren Weidler
ADMINISTRATOR Carolyn Reid
As science plays an increasing part in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory’s Dolan DNA Learning Center,
where students teach laboratory courses to high school and middle school students. From these teach-
ing experiences, they learn how to communicate with nonbiologists and to inspire and educate creative
young minds. The teaching module entailed pairs of students teaching one morning or afternoon each
week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the Watson
School students the didactic process; it was not until the fifth week that the graduate students taught
on their own. At the end of the 12 weeks, the students were very excited about their teaching experience. 
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that
leads to a unique contribution to human knowledge. After the fall course term, students participate in lab-
oratory rotations. These rotations provide students and faculty the opportunity to get to know one another
and to explore possibilities for doctoral thesis research. At the end of each rotation, students make short
presentations of their studies to the other students and their rotation advisors. These talks give students
an opportunity to share their laboratory experiences and to learn how to give a scientific presentation. With
this latter goal in mind, in addition to the research mentors, the instructors of the Scientific Exposition and
Ethics core course and members of the School’s Executive Committee attend the talks and give individual
feedback to students on their presentations. This year, 20 WSBS faculty members and one research
assistant professor served as rotation mentors to our largest class to date, some mentoring more than
one student.
ROTATION MENTORS Grigori Enikolopov Raffaella Sordella
Hiro Furukawa David L. Spector
Gregory Hannon Bruce Stillman
David Jackson William Tansey
Leemor Joshua-Tor Marja Timmermans
Adam Kepecs Lloyd Trotman
Adrian R. Krainer Glenn Turner
Scott Lowe Linda Van Aelst
Robert Martienssen Matt Vaughn
Alea A. Mills Anthony Zador
Senthil K. Muthuswamy
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FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation, The William Stamps Farish
Lectureship
INSTRUCTORS Gregory Hannon (Lead)
Alexander Gann
David Jackson
Leemor Joshua-Tor
Scott Lowe
Glenn Turner
GUEST LECTURERS Josh Dubnau
Grigori Enikolopov
Hiro Furukawa
Alexei Koulakov
Robert Martienssen
Raffaella Sordella
Bruce Stillman
VISITING LECTURERS Thomas Clandinin, Stanford University
Elizabeth Lacy, Memorial Sloan-Kettering Cancer Center
William Merrick, Case Western Reserve University
Charles Sherr, St. Jude Children’s Research Hospital
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the curriculum, students (1) acquired a broad base of knowledge about the bio-
logical sciences, (2) learned the scientific method, and (3) learned how to think critically. This course
consisted of six biweekly modules, each with a different theme. Each week, students read an assigned
set of research articles, and at the end of the module, they provided written answers to a problem set
that guided them through several of the articles. Twice weekly, students attended lectures related to the
week’s topic that included concepts and fundamental information as well as experimental methods.
During each week, the students met among themselves to discuss the assigned papers not covered by
the problem set. Each week, students spent an evening discussing the assigned articles with faculty. The
module topics for this course were as follows:
Module 1 Gene Expression Module 4 Neuroscience
Module 2 Cell Proliferation and Cancer Module 5 Macromolecular Structure and Function
Module 3 Signaling in Development Module 6 NIH Study Section
The Darrell Core Course on Scientific Exposition and Ethics 
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation, The John P. and Rita M. Cleary Visiting 
Lectureship, The Seraph Foundation Visiting Lectureship, The Susan T. and Charles 
E. Harris Visiting Lectureship
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INSTRUCTORS Alea A. Mills (Lead)
Arne Stenlund
David J. Stewart
TEACHING ASSISTANTS Christopher Faehnle
Anthony Mazurek
GUEST LECTURERS Walter Goldschmidts
Jan A. Witkowski
VISITING LECTURERS Robert Charrow, Greenberg Traurig, LLP
Boyana Konforti, Editor, Nature Structural & Molecular Biology
Maddy deLeone, The Innocence Project
Susan McConnell, Stanford University
Philip Reilly, former CEO, Interleukin Genetics
Michael Rogers, The Practical Futurist, MSNB
The 2008 Scientific Exposition and Ethics (SEE) core course content remained essentially the same as
in 2007, but the composition of the instruction team changed: Alea Mills, who has taught the class for
the past 3 years, became the lead instructor, taking over from Jan Witkowski, who had been a part of
the course since its inception. Jan stepped down as an instructor to focus on his other interests, but we
were fortunate to have his continued participation in the course as a guest lecturer. Drs. Arne Stenlund
and David Stewart came on board this year for the first time as course instructors and were very well
received. They also personally enjoyed the teaching experience and learned a great deal from the won-
derful guests who visit the course each year. The faculty instructors were again joined by two postdoc-
toral fellows, Christopher Faehnle and Anthony Mazurek, as TAs, a format to which our students have
taken very well.
This core course offered instruction in the fundamental elements of scientific exposition—writing
skills and public speaking—and ethics. The ability to communicate effectively and to appreciate the
intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series of
example-based lectures and discussion groups. Writing skills included the fundamentals of modern
scientific English and the organization and preparation of papers, research abstracts, and grant appli-
cations. Oral presentation skills were taught by instructors with different modes of presentation.
Together with instructors, students critiqued formal seminar presentations at the Laboratory. Instruc-
tion and discussions about ethics included the ethical implications of biological discovery as well as
the nature and boundaries of ethical behavior of scientists and their rights and responsibilities. A pri-
mary objective of the course was that students consider exposition and ethics to be integral parts of
scientific research.
Research Topics
ORGANIZERS Kimberley Geer
Alyson Kass-Eisler
This core course provided students with an in-depth introduction to fields of research that Laboratory
scientists investigate. Students and faculty attended a weekly Research Topics seminar, at which fac-
ulty members presented their current research topics and methods of investigation each Wednesday
evening over dinner. The students learned how to approach important problems in biology. These sem-
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Gurinder (Mickey) Atwal
Josh Dubnau
Mikala Egeblad
Grigori Enikolopov
Hiro Furukawa
Thomas Gingeras
Gregory Hannon
Z. Josh Huang
David Jackson
Leemor Joshua-Tor
Adam Kepecs
Alexei Koulakov
Adrian R. Krainer
Bo Li
Zachary Lippman
Scott Lowe
Robert Lucito
Robert Martienssen
W. Richard McCombie
Alea A. Mills
Partha Mitra
Pavel Osten
Darryl Pappin
Scott Powers
Jacek Skowronski
Raffaella Sordella
David L. Spector
Arne Stenlund
Bruce Stillman
Marja Timmermans
Lloyd Trotman
Glenn Turner
Linda Van Aelst
Doreen Ware
Michael Wigler
Anthony Zador
Michael Q. Zhang
Yi Zhong
SPECIALIZED DISCIPLINES COURSES
The content of the three Specialized Disciplines in Biology (SD) courses—Genetics, Systems Neuro-
science and Cellular Structure and Function—has largely remained the same. The SD course in genet-
ics was renamed Genetics and Genomics, and lead instructor Josh Dubnau was joined by genomics
expert Thomas Gingeras as an instructor this year. The SD course Systems Neuroscience was taught by
lead instructor Anthony Zador and instructor Adam Kepecs, and the SD course Cellular Structure and
Function was taught by lead instructor Linda Van Aelst and instructor Raffaella Sordella.
Genetics and Genomics
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship, The Pfizer Lectureship, 
The George B. Rathmann Lectureship, The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Josh Dubnau (Lead)
Thomas Gingeras
GUEST LECTURER Clint Whipple, Postdoctoral Fellow, Jackson laboratory
VISITING LECTURERS Bambos Kyriacou, University of Leicester, United Kingdom
Marla Sokolowski, University of Toronto
This course placed modern human genetics and genomics into the context of classical organismal genet-
ics. History, perspective, and technique were described around four levels of analysis: naturally occurring vari-
ation, genome evolution, genetic screens, and gene epistasis. How do gene mutations help to define
biological processes? How are more complex traits genetically dissected into simpler (underlying) compo-
nents? What concepts and techniques are used to organize genes into pathways and networks? How are
genes mapped, cloned, and engineered to identify functional domains of proteins? What gene variation
exists in natural populations? What are the functional consequences of gene variation? How is it detected?
How are genomes organized and coordinately regulated? How can genomic information be cataloged,
organized, and mined? These questions and concepts were fleshed out using examples from the literature.
inars, together with the annual fall Laboratory In-House Symposium, provided students with a basis for
selecting laboratories in which to do rotations. The weekly speakers were
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Systems Neuroscience
FUNDED IN PART BY The George W. Cutting Lectureship, The Klingenstein Lectureship, 
The William R. Miller Lectureship
INSTRUCTORS Anthony Zador (Lead)
Adam Kepecs
GUEST INSTRUCTORS Alexei Koulakov
Glenn Turner
VISITING LECTURER Mayank Mehta, Brown University
This course provided an overview of key aspects of neuroscience. The emphasis was on spanning lev-
els: How can we go from molecules through cells and circuits to behavior? There were three main com-
ponents to the class: lectures, problem sets, and a final project. The last week of class was spent on
the final project, in which the students found and presented a neuroscience paper that spans levels, for
example, from the molecular to the synaptic or from the circuit level to the behavioral. 
Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship, The Sigi Ziering Lectureship, 
The Martha F. Gerry Visiting Lectureship
INSTRUCTORS Linda Van Aelst (Lead)
Raffaella Sordella
GUEST INSTRUCTORS David L. Spector
Bruce Stillman
VISITING LECTURERS Michael Caplan, Yale University
Gregg Gundersen, Columbia University
Elizabeth Miller, Columbia University
Conly Rieder, Wadsworth Laboratory
Sandy Simon, The Rockefeller University
Marc Symons, The Feinstein Institute for Medical Research
With the complete genome sequence available for many organisms, there is now an increasing empha-
sis on understanding the function of the gene products. This understanding requires an increasing
appreciation of the structure and function of the cell as well as the dynamic associations within the cell.
This course provided a basic overview of the structural and functional organization of cells, with par-
ticular emphasis on cellular compartmentalization and communication. Topics of focus included the
cytoskeleton, cell adhesion and signaling, membrane transport, gene expression, and nuclear organ-
ization. In addition, the course provided insight into the basic toolbox of the cell biologist of the 21st
century.
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POSTDOCTORAL PROGRAM
PROGRAM DIRECTOR Nicholas Tonks
PROGRAM ADMINISTRATOR Alyson Kass-Eisler
Cold Spring Harbor Laboratory (CSHL) is proud of its rich tradition in postdoctoral education and has a
deep commitment to the postdoctoral experience. CSHL has long been recognized as a place for nur-
turing young scientists, with postdoctoral researchers being an integral part of the discovery process.
Approximately 135 postdoctoral fellows work in the labs of 43 principal investigators at the Laboratory.
Current fields of research expertise include genetics; molecular, cellular, and structural biology; neuro-
science; cancer; plant biology; bioinformatics and genomics; and quantitative biology. The postdoctoral
community at CSHL is diverse and international, arriving at the Laboratory with many different back-
grounds and with needs that change during the course of the postdoctoral years. The Postdoctoral Pro-
gram Office works closely with the fellows and Laboratory administration to coordinate and organize
educational and career development activities. Dr. Alyson Kass-Eisler, Postdoctoral Program Officer, and
Dr. Nicholas Tonks, Scientific Director of the Postdoctoral Program, provide day-to-day support for the
postdoctoral program, which is overseen by the Dean of the Watson School, Dr. Leemor Joshua-Tor.
The Dean of the WSBS hosts “Dean’s teas” for trainees who have recently arrived at CSHL, with the
goal of helping fellows to make the most of their postdoctoral experience here. During these sessions,
postdoctoral fellows are provided information on the services available through the Postdoctoral Program
Office and are given copies of the excellent books by Kathy Barker, “At the Bench: A Laboratory Navi-
gator” and “At the Helm: A Laboratory Navigator,” published by Cold Spring Harbor Laboratory Press.
The Postdoctoral Program Officer meets with prospective or newly arrived fellows to inform them about
the program and to answer any questions that they may have. She also works with fellows one on one
in finding sources of funding and assisting with applications, and later, she assists senior postdocs with
identifying career opportunities and preparing application materials. On October 30, all postdoctoral fel-
lows were invited to attend a meeting of the CSHL Postdoctoral Association along with the postdoctoral
program administration—Leemor Joshua-Tor, Nick Tonks, and Alyson Kass-Eisler. The purpose of the
meeting was to bring postdoctoral fellows together to discuss ways of improving the postdoctoral expe-
rience at the Laboratory and to answer any questions or concerns about the program. A number of
great ideas were discussed and we look forward to introducing some new services in the near future.
In 2008, we held a number of courses and workshops aimed at postdoctoral fellows. For example,
in the spring, the Laboratory held a course on grant writing. The first part, led by Walter Goldschmidts
and his CSHL Office of Sponsored Research staff, focused on an introduction to grant writing and the
grant application process. During the second part of the course, CSHL faculty members William Tansey
and Linda Van Aelst gave an overview of the grant review process with their presentation True Confes-
sions of Peer Review. The third part of the course was an interactive writing session led by Dr. Philip Vas-
sallo, author of The Art of On-The-Job Writing. 
An ethics course that provided training in responsible conduct of research was also held this spring.
The course included sessions on Roles and Responsibilities Associated with Research Funding, Con-
flicts of Interest, Selling Yourself, Presentations—Engage Your Audience, and Requirements on Statisti-
cal Analysis in Publications.
Laboratory President Dr. Bruce Stillman holds an annual “Town Hall” meeting specifically for post-
doctoral fellows. This year’s Town Hall meeting took place on December 17. Among the ideas that were
discussed was the updating of the postdoctoral program website to enhance its usefulness as a net-
working tool. We will be working with a small committee of postdocs to put together suggestions for the
content and layout of this enhanced site. 
CSHL has been a member of a special ambassador recruitment program from Merck Research Lab-
oratories (MRL) since 2005. This program provides postdoctoral fellows and students at CSHL an inside
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connection to a scientist working at MRL. As a result of this program, a postdoctoral fellow from Dr.
Bruce Stillman’s laboratory, Dr. Maarten Hoek, was hired as a Research Scientist in 2007. In 2008, Dr.
Jing Li returned to the Watson School and was joined by Maarten, who presented his current work in a
seminar entitled “Proteomic Identification of Caspase Cleavage Events in Apoptotic Cells.” In addition,
nine postdoctoral fellows met with Jing and Maarten in one-on-one interviews. As a result of this pro-
gram, Dr. Zuo Zhang, a postdoctoral fellow from Dr. Adrian Krainer’s laboratory, joined MRL as a
Research Scientist at the end of 2008. The relationship between MRL and CSHL has been extremely
beneficial and we will be looking toward building additional relationships in the future.
Three years ago, the School initiated a prize for the best posters by a postdoctoral fellow and the best
poster by a graduate student at the Laboratory’s annual In-House Symposium. In addition to providing
a forum for the postdoctoral fellows to show off their research, and potentially win a prize, it gives the
entire scientific community a chance to come together and share ideas beyond the walls of their indi-
vidual laboratories. It has been a great success for both the presenters and the laboratory community
as a whole. Each “prize” is given in the form of an educational grant of $500.
During the past couple of years, we have increasingly widened the role of postdoctoral fellows in the
curricular activities of the School. Our fellows have been involved in preparing our students for the chal-
lenging fall term curriculum by working as one-on-one tutors during the summer. Throughout the fall
term, postdoctoral fellows are used as tutors for all aspects of the curriculum, providing individual and
group tutoring and participating in discussion sessions. In 2007, the Scientific Exposition and Ethics
course took further advantage of the expertise of our postdoctoral community by hiring two fellows as
TAs. These two fellows proved to be an integral part of the course by providing their expertise in dis-
cussions, editing the students’ written work, and critiquing oral presentations. This format was highly suc-
cessful and was used again in fall 2008.
This spring, we hosted a delegation from the Galicia region of Spain. Dr. Laura Sánchez Piñón, Chan-
cellor of Education, and Dr. Pilar Fernández González, Education Advisor, General Consulate of Spain, came
to the Laboratory as part of a visit to high-profile research institutions in the United States, with the goal of
gathering information to improve science in their region. Our Spanish postdocs were excited to meet with
the delegation, share their experiences at CSHL, and help to introduce our best practices to Spain.
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2008 delegation from Spain: (Left to right) Cristina Fernandez Marco, Pilar Fernández González (Education Advisor, General
Consulate of Spain), Victoria Aranda Calleja, Mikel Biurrun, Yoselin Benitez Alfonso, Xavier Roca, Laura Sánchez Piñón (Chan-
cellor of Education, Galicia, Spain), Juan Manuel Encinas, Juan Manuel Abolafia Moya, Jose Silva, Andres Canela.
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Since 2003, all postdoctoral fellows and graduate students at the Laboratory have been enrolled in
a special initiative of the New York Academy of Science (NYAS), called the Science Alliance. The Science
Alliance for graduate students and postdoctoral fellows is a consortium of universities, teaching hospi-
tals, and independent research facilities in the New York City metropolitan area that have formed a part-
nership with NYAS. The aim of the Alliance is to provide career and professional development monitoring
for postdoctoral fellows and graduate students in science and engineering, through a series of live events
and a dedicated web portal. In addition, the Science Alliance gives graduate students and postdoctoral
fellows the opportunity to network with their peers across institutions and with key leaders in academia
and industry.
To complement our local efforts, we have been involved in workshops at a national level aimed at
shaping the postdoctoral experience. The Laboratory became a founding member of the National Post-
doc Association (NPA) in 2004. In April 2008, Alyson Kass-Eisler attended the sixth annual meeting in
Boston, Massachusetts. Topics of interest to the Laboratory’s postdocs included Creating a Dynamic
Program on Responsible Conduct of Research, Providing Career Development Resources, Mentoring
Tools: A Toolbox of Ideas!, Navigating Your Career...Immigration Obstacles, Ensuring PDA Sustainabil-
ity and Growth, How to Assist Postdocs...Successful Fellowship, and NIH Pathway to Independence. 
In 2008, the WSBS also participated in the National Research Council’s Assessment of Graduate Pro-
grams, which aims to provide a metric for comparing graduate programs in similar disciplines to one
another. One component of this survey is the quality of postdoctoral programs. We look forward to see-
ing the results of this survey, which will hopefully provide another measure of the success of our program
and ways in which it can be improved. The results of the survey were initially expected in 2008, but they
are now set to be released in early spring 2009. 
Finally, two important measures of our postdoctoral program’s success are the ability of postdoctoral fel-
lows to secure individual fellowships for their training and permanent positions at the end of their training.
We are extremely proud that our postdoctoral fellows have been successful in both of these endeavors.
Current postdocs hold fellowships from a number of national, international, federal, state, and private
foundations including the American Cancer Society; Brodeur Breast Cancer Foundation; Chapman Fel-
lowship; DAAD, German Academic Exchange Service; DFG German Science Foundation; Ellison Med-
ical Foundation; Heart and Stroke Foundation; Human Frontier Science Program; Harvey L. Karp
Foundation; Lauri Strauss Leukemia Foundation; NARSAD; National Institutes of Health (NIH); New York
State Department of Health, HRSB, Breast Cancer Research and Education Program; The Patterson
Trust; Sass Foundation Fellowship; Sir Keith Murdock fellowship; The Andrew Seligson Memorial Clini-
cal Fellowship for Cancer Research; The Leukemia and Lymphoma Society; The Lymphoma Research
Foundation; United States Department of Agriculture; and the United States Department of Defense.
Three CSHL postdoctoral fellows have also been fortunate to secure career development funding
through the prestigious NIH’s Pathways to Independence Award. Alexei Aravin, a postdoctoral fellow in
Gregory Hannon’s laboratory, was named a finalist for the New York Academy of Science’s Blavatnik
Award, and Erkan Karakas, from Hiro Furukawa’s laboratory, received CSHL’s Harvey L. Karp award.
To increase the Laboratory’s fellowship funding and to bring new programs to CSHL, the School will be
submitting a new postdoctoral training grant to the NIH in May. 
In 2008, the Laboratory’s departing postdoctoral fellows went on to positions at Memorial Sloan-
Kettering Cancer Center, Merck Research Laboratories, The Walter and Eliza Hall Institute of Medical
Research (Australia), University of Minnesota, Columbia University, Max-Planck Institute (Germany), Louis
Pasteur University (France), The Champalimaud Foundation (Portugal), and Institute of Molecular Biotech-
nology (Austria), to name just a few.
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UNDERGRADUATE RESEARCH PROGRAM
PROGRAM DIRECTORS David Jackson
PROGRAM ADMINISTRATOR Dawn Meehan
Each summer, 20–25 undergraduates from around the world and across the country participate in the
CSHL summer Undergraduate Research Program (URP). More than 720 students have participated in
the URP since the program was founded in 1959. 
The fundamental objective of the program is to give students an opportunity to conduct first-rate
research. Participants learn about scientific reasoning, laboratory methods, theoretical principles, and sci-
entific communication. The specific objectives of the program are to (1) give college undergraduates a
taste of conducting original research at the cutting edge of science, (2) encourage awareness of the
physical and intellectual tools necessary for modern biological research, (3) foster an awareness of the
major questions currently under investigation in the biomedical and life sciences, and (4) promote inter-
actions with Laboratory scientists through an immersion in the research environment.
During the 10-week program, URP participants work with CSHL senior staff members on independ-
ent research projects, specifically in the areas of cancer biology, neuroscience, plant biology, cellular and
molecular biology, genetics, macromolecular structure, and bioinformatics. 
URPs work, live, eat, and play among CSHL scientists. They have a very busy academic and social cal-
endar for the summer. They attend lectures in the Goldberg Faculty Lecture Series given by CSHL faculty
members and outside faculty members including, in 2008, Dr. Stanley Maloy of San Diego State Univer-
sity and Dr. Alfred Goldberg of Harvard University. URP students also attend a Bioinformatics Workshop
Series, where they learn how to identify patterns in DNA and protein sequences and interpret them. Lec-
tures given by CSHL faculty are specifically designed for URP students. URP participants were also invited
to join Dr. and Mrs. Watson for a pizza party and Dr. and Mrs. Stillman for dinner. BBQs and pool parties,
volleyball games, sailing lessons, designing the URP tee shirt, competing in the annual CSHL Petri Dish
Race and Scavenger Hunt, and the ever-famous URP vs. PI volleyball match rounded out the engaging pro-
gram. This year was the first that the URPs beat the faculty team in volleyball—quite an accomplishment!
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Undergraduate Research Program 2008 participants in the URP tee shirt design contest: (Front row, left to right) Olga Minkina,
Yesenia Correa, Allison Baker, Anna Gilman, Susan Shen, Tzitziki Lemus Vergara. (Back row, left to right) Richard Gerrard, Eric
Domb, Jonathan Geisinger, Erin Jimenez, Daniel Kim, Walter Barry, Colleen Carlston, Ryan Ly, Xun Hou, Richard Jin, Forest
Ray, Zandra Walton, Chris Hsiung.
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At the beginning of the summer, URP students write an abstract and present a talk on their proposed
research. Concluding the program in August, URP participants prepare a final report and present their
results in a 15-minute talk at the URP Symposium. The following students, selected from 822 appli-
cants, took part in the 2008 program:
226
Erin Jimenez, University of California, Los Angeles
Advisor: Dr. Dave Jackson
Sponsor: National Science Foundation and Department of
Defense and William Townsend Porter Fund Fellowship
Further defining the location of the Abphyl2 gene by posi-
tional cloning and understanding the mechanisms con-
trolling phyllotaxy in maize with Abphyl2 mutants.
Richard Jin, Cornell University
Advisor: Dr. Rob Martienssen
Sponsor: Robert H.P. Olney Fund Fellowship
Replication initiation points in S. pombe.
Daniel Kim, Amherst College
Advisor: Dr. Adam Kepecs
Sponsor: National Science Foundation and Department of
Defense and Emanuel Ax Fund Fellowship 
Using optogenetics to study network mechanisms of θ
oscillations in the hippocampus.
Tzitziki Lemus Vergara, Universidad Nacional Auto -
noma de Mexico
Advisor: Dr. Doreen Ware
Sponsor: Former URP Fund Fellowship
Phylogenetics of the maize tetraploid genome.
Ryan Ly, Johns Hopkins University
Advisor: Dr. Partha Mitra
Sponsor: Former URP Fund Fellowship
Learning and memory in the Drosophila flight simulator.
Olga Minkina, Washington University, St. Louis
Advisor: Dr. Marja Timmermans
Sponsor: Former URP Fund Fellowship
The role of AS1/AS2 and TAS3 in determining abaxial-
adaxial leaf polarity.
Forest Ray, Hunter College
Advisor: Dr. Alea Mills
Sponsor: Hunter College Fund Fellowship
Tumor-derived mutations in CHD5.
Susan Shen, California Institute of Technology
Advisor: Dr. Josh Huang
Sponsor: Von Stade Fund Fellowship
GABA(A) receptor subcellular localization, dynamics, and
function.
Zandra Walton, Amherst College
Advisor: Dr. Senthil Muthuswamy
Sponsor: Former URP Fund Fellowship
Scribble expression in mammary epithelial cells with low
let7c miRNA.
Allison Baker, Dartmouth College
Advisor: Dr. Tony Zador
Sponsor: National Science Foundation and Department
of Defense and Libby Fellowship
A role for rat auditory cortex in attention in time to auditory
stimuli.
Walter Barry, Tufts University
Advisor: Dr. Bruce Stillman
Sponsor: William Shakespeare Fund Fellowship
Analysis of yeast replication origins via two-dimensional
gel electrophoresis.
Colleen Carlston, Harvard University
Advisor: Dr. Josh Dubnau
Sponsor: Burroughs-Wellcome Fund Fellowship
Pavlovian conditioning of the immune system.
Yesenia Correa, Oregon State University
Advisor: Dr. Scott Powers
Sponsor: National Science Foundation and Department
of Defense and C. Bliss Memorial Fund Fellowship
Influence of initial differentiated state of the normal cell on
the final tumorigenic phenotype.
Eric Domb, Princeton University
Advisor: Dr. Michael Zhang
Sponsor: National Science Foundation and Department
of Defense and Garfield Fund Fellowship
In silico detection of cis-regulatory modules.
Jonathan Geisinger, Case Western Reserve University
Advisor: Dr. William Tansey
Sponsor: H. Bentley Glass Fund Fellowship
Ubiquitylation and stability of an ubiquitin ligase RPC.
Richie Gerrard, University of St. Andrews
Advisor: Dr. David Spector
Sponsor: James D. Watson Fund Fellowship
In vivo studies of the H3K27 demethylase JmjD3.
Anna Gilman, Barnard College, Columbia University
Advisor: Dr. Scott Lowe
Sponsor: Joan Redmond Read Fund Fellowship
Dissecting tumor suppressor mechanisms using condi-
tional RNA interference.
Xun Hou, Massachusetts Institute of Technology
Advisor: Dr. Dick McCombie
Sponsor: Former URP Fund Fellowship
Identifying SNP variation of rapidly evolving genes.
Chris Hsiung, University of California, Berkeley
Advisor: Dr. Greg Hannon
Sponsor: Steamboat Foundation Fellowship
Fishing for small RNAs in Argonaute complexes.
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PARTNERS FOR THE FUTURE
PROGRAM DIRECTOR Yuri Lazebnik
PROGRAM ADMINISTRATOR Theresa Saia
The Partners for the Future Program, established by Dr. James Watson in 1990, provides an opportu-
nity for talented Long Island high school students to have hands-on experience in biomedical research
at Cold Spring Harbor Laboratory. This highly competitive program is open to Long Island high school
students in their junior year. Each high school science department chairperson may nominate up to three
students. The top candidates are interviewed by CSHL scientists and up to ten top students are cho-
sen to participate in the program. Students selected to the program are paired with a scientist mentor
and spend a minimum of ten hours per week, September through March of their senior year, conduct-
ing original research. At the conclusion, the students present their projects to an enthusiastic audience
of the students’ scientific mentors and colleagues, CSHL administrators, parents, and teachers. Although
the students learn a great deal about modern biology and state-of-the-art research techniques, the main
advantage of the program is that they are exposed to day-to-day life in a lab. Interacting with scientists
and support staff, the students learn to define and pursue a research goal while solving problems that
may occur along the way.
The 2008–2009 Partners for the Future were chosen from among 16 semifinalist nominations and they
are listed here.
Partner High School CSHL mentor Laboratory
Kay Chen Ward Melville High School Clint Whipple David Jackson
Josh Elkin Cold Spring Harbor High School Zhenyu Xuan Michael Zhang
Jon McGinn Farmingdale High School Anirban Paul Josh Huang
Elizabeth Sajewski Cold Spring Harbor High School Hysell Oviedo Tony Zador
Madeline Scircco Cold Spring Harbor High School Morgan Xu David Jackson
Catherina Yang Syosset High School Shilpi Paul Alea Mills
Patriot Yang Syosset High School Doreen Ware Doreen Ware
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2008–2009 Partners for the Future participants: (Left to right) Jon McGinn, Kay Chen, Madeline Scircco, Elizabeth
Sajewski, Josh Elkin, Patriot Yang, Catherina Yang.
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MEETINGS AND COURSES
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ACADEMIC AFFAIRS
The Meetings and Courses program at Cold Spring Harbor Labora tory serves to communicate new dis-
coveries, concepts, and methodologies to an international community of scientists. The program consists
of advanced laboratory and lecture courses, as well as large meetings and biotechnology conferences
that are held almost year round. More than 8000 scientists ranging from graduate students and postdoc-
toral fellows to senior faculty come from around the world to attend these events. A growing internation-
al program complements the main program of meetings and courses.
In 2008, 27 laboratory and lecture courses attracted more than 1230 participants (including teaching
faculty, students, and technicians). These courses covered a diverse array of topics in molecular biology,
neurobiology, structural studies, and bioinformatics. The primary aim of the courses is to teach students
the latest advances that can be immediately applied to their own research. Cour ses are always being
evaluated and updated to include the latest concepts and approaches. Increasingly, many courses fea-
ture a strong computational component as biology grows ever more interdisciplinary, incorporating
methodologies from computer science, physics, and mathematics. A new bioinformatics course on Com -
putational Cell Biolo gy was started in 2008. 
Instructors, course assistants, and course lecturers come from universities, medical schools, research
institutes, and companies around the world to teach at Cold Spring Harbor Laboratory. Their excellence
and dedication make the course program work so well. The full program of 2008 courses and instructors
are listed on the following pages. We would especially like to thank Drs. Philip Andrews, Beverley Clark,
Arshad Desai, Jeffrey Diamond, James Eber wine, Marc Freeman, Joshua La Baer, Frank Luca, Lincoln
Stein, David Threadgill, Paul Trainor, and Bing Zhang, who all retired this year after many years of service. 
Grants from a variety of sources support the courses. Core support pro vided through the recently
renew ed grant from the Howard Hughes Medical Institute remains critical to our course program. The
courses are further supported by multiple awards from the National Institutes of Health (NIH) and the
National Science Foun dation (NSF), and additional support for individual courses is provided from various
foundations and other sources. The courses also depend on equipment and reagents that are loan ed or
donated by a large number of companies. These are invaluable for making it possible to keep up with the
latest technologies.
The Laboratory held 25 academic meetings this year that brought to gether almost 7000 scientists
from around the world to discuss their latest research. The Symposium—now in its 73rd year—contin-
ues to be the flagship conference of the meetings program. This year’s meeting on Control and Regulation
of Stem Cells addressed our current understanding of the biology of pluripotent and totipotent stem cells
and featured 67 talks and 178 poster presentations. Opening night speakers included Rudolf Jaenisch,
Minx Fuller, Arturo Alvarez-Buylla, and Max Wicha. Irving Weissman presented the Reginald Harris lecture
on “Normal and neoplastic stem cells.” Elaine Fuchs enlightened a mixed audience of
scientists, lay friends, and neighbors with her Dorcas Cummings lecture on “Skin stem
cells,” and Brigid Hogan ended the meeting with a masterful and eloquent summary. We
particularly thank the Lisbon-based Champali maud Foundation for their generous sup-
port of this year’s Symposium.
A prime feature of the meetings is that there are very few invited speakers. Meetings
organizers select talks from abstracts that are submitted. This format ensures that the
latest findings will be presented and that young scientists will have the chance to
describe their work. The annual meetings on Gene Expression and Signaling in the
Immune System, The Biology of Genomes, Retroviruses, Mechanisms and Models of
Cancer, and the annual Symposium were all oversubscribed, and many others attract-
ed record attendances including the meetings on Systems Biology: Global Regulation of
Gene Expres sion; Translational Control; Axon Guidance, Synaptogenesis, and Neu ral
Plasticity; and Molecular Genetics of Aging. New meetings on Epithelial-Mesenchymal
G. Digby and T. Abrahamsson
at lab session of Imaging
Structure and Function of the
Nervous System course
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Transition, Personal Genomes, and Blood Brain Barrier Physiology were held this year. Many of these
meetings, held on a biannual basis, have become essential for those in the field. Partial support for indi-
vidual meetings is provided by grants from the NIH, NSF, foundations, and companies. Core support for
the meetings program is provided by the Laboratory’s corporate patrons, bene factors, sponsors, affiliates,
and con tributors.
The joint Cold Spring Harbor/ Wellcome Trust conference series held at the genome campus south of
Cam bridge, England expanded to include six meetings on Computation al Cell Biology, Network Biology,
Genomic Perspectives to Host-pathogen Inter actions, Genome Infor matics, Integra tive Approaches to
Brain Complexity, and Rat Genomics and Models. These conferences follow the Cold Spring Harbor model
in that the majority of talks are selected from the abstracts. They attracted 559 participants. 
Finally, 2008 saw the formal beginning of the Cold Spring Harbor Conferences Asia program, with the
incorporation of CSH Conferences Asia as a wholly owned subsidiary. The inaugural meeting of CSH Asia’s
Scientific Advisory Board held in Suzhou, China in early Octo ber brought together eminent scientists from
throughout Asia to advise the Laboratory on its new educational initiative in China and Asia.
The success of the very large number of meetings and courses is also due to the skilled work of many
Laboratory staff and faculty who contribute their expertise, efforts, and good humor to the program.
Terri Grodzicker
Dean
Academic Affairs
David Stewart
Executive Director
Meetings and Courses Program
W. Pearson (middle) instructs participants dur-
ing Computational and Comparative Genomics
course.
C. Sherr and D. Bar-Sagi, co-organizers
of the Cancer Models and Mechanisms
meeting
T. Taylor and E. Bruford celebrate their joint
win of the Genome Crossword. E. Fuchs, 2008 Dorcas Cummings lecturer
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73RD COLD SPRING HARBOR LABORATORY
SYMPOSIUM ON QUANTITATIVE BIOLOGY
Control and Regulation of Stem Cells
May 28–June 2 465 participants
ARRANGED BY Terri Grodzicker, David Stewart, and Bruce Stillman
Cold Spring Harbor Laboratory
The roots of stem cell research can be traced back to classical work in embryology and regeneration
performed in the 19th century. By the early 1900s, researchers in Europe had come to understand that
various types of blood cells derived from a particular “stem cell,” resulting in physicians’ attempts to
administer bone marrow by mouth to patients suffering from anemia and leukemia. Although such ther-
apy was unsuccessful, laboratory experiments eventually demonstrated that mice with defective mar-
row could be restored to health with infusions into the bloodstream of marrow taken from other mice,
causing physicians to speculate whether it was feasible to transplant bone marrow from one human
being to another. Early work on bone marrow transplantation—effectively, a stem cell transplant—was
dogged by problems of histocompatibility, but as the basis of the HLA system became increasingly
understood, successful bone marrow transplantation between unrelated individuals was first demon-
strated in 1973, followed by the discovery of true hematopoietic stem cells in 1978.
Stem cell research has since exploded, with the derivation of mouse embryonic stem cells in 1981,
the culturing of neural stem cells as neurospheres in 1992, and the establishment of the first human
embryonic stem cell lines in 1998. Around the same time as the isolation of human embryonic cells, a
definitive link between stem cells and cancer was established when certain leukemias were shown to
originate from hematopoietic stem cells. In the last decade, the concept of adult stem cell plasticity has
gained credence, although many findings have proved to be controversial, whereas the ethical argu-
ments for and against the use of human embryonic stem cells have been widely debated at national and
international levels. Within the last 2 years, it has been reproducibly established that an embryonic stem-
cell-like state, previously achieved only by somatic cell nuclear transfer into
enucleated oocytes (“cloning”) or by fusion with embryonic stem cells, can
be induced by reprogramming of differentiated adult cells using a simple
combination of key transcription factors.
Progress in stem cell research is now extremely intense, with more than
5000 research papers on embryonic and adult stem cells being published
in reputable scientific journals every year. It therefore seemed appropriate
to focus the 73rd Symposium on this important and rapidly developing
field, providing a unique synthesis of the exciting progress being made in
the field of stem cell biology not only for the Symposia attendees, but for a
wider global audience via interviews freely available on the World Wide
Web and through the Symposium proceedings. 
In organizing this Symposium, we relied on the assistance of Elaine
Fuchs, Rusty Gage, Greg Hannon, Ron McKay, Davor Solter, and Allan
Spradling for suggestions for speakers. Opening night speakers included
Rudolph Jaenisch, Minx Fuller, Arturo Alvarez-Buylla, and Max Wicha, and
Irving Weissman presented the Reginald Harris lecture on “Normal and
neoplastic stem cells.” Elaine Fuchs enlightened a mixed audience of sci-
entists and lay friends and neighbors with her Dorcas Cummings lecture B. Stillman, A. Denli
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on “Skin stem cells,” and Brigid Hogan ended the meeting with a masterful and eloquent summary. 
This Symposium was attended by 465 scientists from more than 30 countries, and the program
included 68 oral presentations and 177 poster presentations. We particularly thank the Lisbon-based
Champalimaud Foundation for their extensive and generous support of this year’s Symposium.
Additional funds to run this meeting were obtained from the National Institutes of Health. Financial sup-
port from the Corporate Benefactors, Sponsors, Affiliates, and Contributors of our meetings program
is essential for these Symposia to remain a success and we are most grateful for their continued sup-
port. Corporate Patrons included Pfizer Inc. Corporate Benefactors included Amgen Inc., GlaxoSmith
Kline, Merck Research Laboratories, and Novartis Institutes for BioMedical Research. Corporate
Sponsors included Agilent Technologies, Applied Biosystems, AstraZeneca, BioVentures, Inc., Bristol-
Myers Squibb Company, Genentech, Inc., Hoffmann-La Roche Inc., Invitrogen Corporation, IRX
Therapeutics Inc., Kyowa Hakko Kogyo Co., Ltd., New England BioLabs, Inc., OSI Pharmaceuticals,
Inc., Sanofi-Aventis, and Schering-Plough Research Institute; Plant Corporate Associates included
Monsanto Company, and Pioneer Hi-Bred International, Inc. Corporate Affiliates included Affymetrix.
Corporate Contributors included Epicentre Biotechnologies and Illumina. Foundations included
Hudson Alpha Institute for Biotechnology.
PROGRAM
Introduction
R. Lehmann, New York University School of Medicine, New York
Germ Cells and Epigenetics
Chairperson: B. Hogan, Duke University Medical Center,
Durham, North Carolina
Signaling in Adult Stem Cells
Chairperson: D. Melton, HHMI, Harvard University, Cambridge,
Massachusetts
Gene Expression
Chairperson: R. Young, Whitehead Institute/MIT, Cambridge,
Massachusetts
Reginald B. Harris Lecture: Normal and Neoplastic Stem
Cells
Chairperson: I. Weissman,Stanford University School of
Medicine, California
Cancer I
Chairperson: S. Morrison, University of Michigan, Ann Arbor
A. Surani, I. WeissmanB. Hogan, J. Alfred
E. Fuchs
Pluripotency in ES Cells
Chairperson: D. Solter, Max-Planck Institut für
Immunobiologie, Freiburg, Germany
Neural Stem Cells
Chairperson: J. Rich, Duke University Medical Center, Durham,
North Carolina
Dorcas Cummings Lecture: Skin Stem Cells
Elaine Fuchs, HHMI/The Rockefeller University
C. Cormier
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Cancer II
Chairperson: C. Sherr, HHMI/St. Jude Children’s Research
Hospital, Memphis, Tennessee
Germ Cells and Regeneration
Chairperson: M. Fuller, Stanford University School of Medicine,
California
Adult Stem Cells II
Chairperson: M. Buckingham, Institut Pasteur, Paris, France
Niches and Asymmetry
Chairperson: A. Spradling, Carnegie Institute of Washington,
Baltimore, Maryland
Summary
B. Hogan, Duke University Medical Center, Durham, 
North Carolina
A. Spradling, J. Greve
T. Grodzicker, R. McKay K. Zaret, R. Young J. Botelho, D. Stewart
Walking tour
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MEETINGS
PTEN Pathways and Targets
March 5–9 114 Participants
ARRANGED BY Suzanne Baker, St. Jude Children’s Research Hospital
Carlos Cordon-Cardo, Columbia University
Pier Paolo Pandolfi, Harvard University
Ramon Parsons, Columbia University
This was the second conference on PTEN Pathways and it was enor-
mously successful. The meeting brought together top scientists study-
ing the PTEN/PI3K pathway using biochemical and molecular
approaches as well as in vivo model systems. An exciting series of
talks and poster presentations addressed the complex regulation of
this signal transduction cascade and its critical role in normal develop-
ment, cancer, and other pathological disease states. The conference
provided an opportunity for researchers of all levels to come together
to discuss their latest research findings and technical approaches
toward the analysis of the PTEN pathway. Particular emphasis was
placed on pathway regulation and cross-talk, human cancer patho-
genesis, disease models, and therapy.
A total of 38 investigators presented in the nine scientific sessions,
with nearly 55 platform and poster presentations and 114 registered
attendees. The nine platform and two poster sessions were marked by dynamic and enthusiastic
exchanges of new results. In the scientific sessions, many audience members participated in the ques-
tion and answer sessions, and the poster sessions were well attended. 
Essential funding for the meeting was provided by the National Cancer Institute, a branch of the
National Institutes of Health. Myriad Genetics, Inc. also provided a $3000 prize for the student or post-
doc whose work had the highest potential impact on the understanding of human cancer. 
J. Watson, R. Parsons, C. Cordon-Cardo
L. Trotman, P. Paolo Pandolfi, F. Furnari
F. Morales, J. Molina, M. Moral
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PROGRAM
Signaling Upstream of PIP3
Signaling Downstream from PIP3
Therapeutic Targets in PI3K/PTEN Signaling
N. Leslie, B. Eickholt
I. Berenjeno, J. Guillermet-GuibertA. Ross
PTEN Pathways and Disease
PTEN Pathways and Cancer
PTEN Regulation and PTEN/PI3K Pathway Cross-talk
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Neuronal Circuits: From Structure to Function
March 13–16 176 participants
ARRANGED BY Ed Callaway, Salk Institute for Biological Sciences
Dmitri Chklovskii, Cold Spring Harbor Laboratory
Liqun Luo, Stanford University
In the quest to understand the brain, neuronal circuits represent a
central level of description. Establishing connectivity in neuronal
circuits seems to be as essential for solving the brain as having a
geographic map for planning one’s travel. Although such realiza-
tion has motivated Santiago Ramón y Cajal to describe a variety
of neuronal circuits using Golgi stains, his contributions were
technologically limited. With the recent appearance of novel mol-
ecular genetic, imaging, and computational techniques, a com-
prehensive description of the wiring diagram—an old dream of
neuroscientists—is about to become a reality. 
Because technological advances have been made in different
organisms and systems, we wanted to create a forum that brings
together researchers working on different topics, yet focusing on neuronal circuits. This meeting included
six broad slide sessions covering the olfactory system, the visual system, methods, behavior learning and
memory, motor systems and the cortex, and a very interactive poster session, including an opening mix
followed by presentations on Chemical senses, Visual system, Circuits underlying cortical function, Motor
control, and New methods for investigating structure and function of circuits.
For the second meeting of this kind, the response from the field was very enthusiastic. The meet-
ing brought together participants from all over the world, most of whom made either oral or poster pre-
sentations. Invited talks were given by Cori Bargmann, The Rockefeller University; Tobias Bonhoeffer,
Max-Planck Institute of Neurobiology; Karl Deisseroth, Stanford University; Winfried Denk, Max-Planck
Institute for Medical Research; Jeff Lichtman, Harvard University; Eve Marder, Brandeis University;
Edvard Moser, Center for the Biology of Memory; Sacha Nelson, Brandeis University; Clay Reid,
Harvard Medical School; Massimo Scanziani, University of California, San Diego; Kristin Scott,
University of California, Berkeley; Stephen Smith, Stanford Medical School; Charles Stevens, The Salk
Institute; Karel Svoboda, Janelia Farm Research Campus, HHMI; Gabor
Tamas, University of Szeged, Hungary/HHMI; Rachel Wilson, Harvard
Medical School; and Rafael Yuste, Columbia University/HHMI. The meeting
provided an important clearinghouse for ideas and approaches and helped
scientists in the field get the most up-to-date information, as well as
enabling them to meet, network, and establish collaborations. Based on the
uniformly enthusiastic comments of the participants, the intensity of the oral
and poster sessions, and the large crowds that stayed up late every night
at the bar to discuss science, the meeting was a great success.
A highlight of the meeting program was the inaugural Larry Katz
Memorial Lecture, thanks to the generous donation of many colleagues in
the field; 25 excellent nominations were received from all over the world. A
committee composed of the three organizers and Cori Bargmann selected
two speakers: Andrea Hasenstaub of the Salk Institute for Biological
Studies and Feng Zhang of Stanford University. Both gave wonderful talks
about their graduate studies.
E. Callaway, L. Luo, D. Chklovskii
C. Reid, T. Bonhoeffer, D. Bock
229-292_Meetings:Layout 1  6/9/09  4:22 PM  Page 237
238
PROGRAM
Opening Mix
D. Chklovskii, HHMI/Janelia Farm Research Campus,
Ashburn, Virginia
Cortex
E.M. Callaway, Salk Institute for Biological Studies, La Jolla,
California
Chairperson: L. Luo, Stanford University, California
Larry Katz Memorial Lectures
Introduction and Award Presentation: D. Katz and R.
Yuste
A. Hasenstaub, Salk Institute for Biological Studies
F. Zhang, Stanford University, California
Molecular Genetics Approaches
Chairperson: L. Luo, Stanford University, California
Chemical and Other Senses
Chairperson: L. Luo, Stanford University, California
Visual System/Neurogenesis
Chairperson: D. Chklovskii, HHMI/Janelia Farm Research
Campus, Ashburn, Virginia
Methods
Chairperson: E.M. Callaway, Salk Institute for Biological
Studies, La Jolla, California
S. Kuhlman, X. Wu W. Grimes, O. Ahmed
K. Scott, M.L. Vasconcelos Y. Kozorovitskiy
W. Denk, D. Chklovskii
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Epithelial–Mesenchymal Transition
March 17–20 161 Participants
ARRANGED BY Raghu Kalluri, Harvard Medical School
John D. Haley, OSI Pharmaceuticals
Senthil Muthuswamy, Cold Spring Harbor Laboratory
Epithelial–mesenchymal transition (EMT) is a biological program that induces a change in cell fate char-
acterized by a loss in the epithelial phenotype and acquisition of a mesenchymal state. EMT is essen-
tial for several developmental processes including mesoderm formation and neural tube formation and
appears to be critical for fibrosis and cancer cell progression associated with invasion and metastasis.
EMT and the accompanying increase in cell mobility is associated
with loss of expression of epithelial keratins and E-cadherins and an
increase in expression of mesenchymal keratins and integrins.
Several signal transduction pathways, such as TGF-β, Ras-MAPK,
PI3K-Akt, and Wnt, and transcription factors of the Snail family, have
been shown to be involved in regulation of EMT. 
This new meeting addressed recent advances in the understand-
ing of the cell biological and molecular mechanisms that regulate
EMT. Topics covered by the meeting included but were not limited
to biology of EMT in development, inflammation, and fibrosis; extra-
cellular signaling and cell biology of EMT; intracellular regulators of
EMT; EMT models and stem cells; and pathobiology of EMT in can-
cer progression. The meeting included two keynote addresses by
Mina Bissell (Lawrence Berkeley National Laboratory) and Robert
Weinberg (Whitehead Institute for Biomedical Research).
The meeting attracted 161 participants from more than ten countries. Oral presentations were sup-
plemented by two afternoon poster session that were extremely well attended and provided a forum
for all meeting participants, including many graduate students and postdocs, to share and discuss their
most recent data.
The meeting was supported by a generous grant from OSI Pharmaceuticals.
PROGRAM
Keynote Address 1: EMT and the Stem Cell State
Robert Weinberg, Whitehead Institute for Biomedical 
Research
S. Muthuswamy, J. Haley, R. Kalluri
M. Bissell
Keynote Address 2: Architecture and Shape Are Involved
in Matrix Metalloproteinase-induced EMT
Mina Bissell, Lawrence Berkeley National Laboratory
Biology of EMT in Development, Inflammation, and
Fibrosis
Chairpersons: R. Kalluri, Harvard Medical School, Boston,
Massachusetts; E. Williams, Monash Institute of Medical
Research, Clayton, Australia
Extracellular Signaling and Cell Biology
Chairpersons: J. Rosen, Baylor College of Medicine, 
Houston, Texas; S. Muthuswamy, Cold Spring Harbor
Laboratory
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Intracellular Regulators of EMT
Chairpersons: F. Rauscher, Wistar Institute, Philadelphia,
Pennsylvania; A. Nieto, Instituto de Neurociencias Alicante
CSIC-UMH, Spain
EMT Models and Stem Cells
Chairpersons: E.W. Thompson, St. Vincent’s Institute of
R. Weinberg, G. Longmore
Medical Research, Fitzroy, Australia; J. Condeelis, Albert
Einstein College of Medicine, Bronx, New York
Pathobiology of EMT in Cancer Progression
Chairpersons: J.P. Thiery, Institute of Molecular and Cell
Biology, Singapore; S. Dubinett, David Geffen School of
Medicine, Los Angeles, California
J. Woodgett, J. Wrana S. Barr
S. Kowli T. Grodzicker, D. Stewart, J. Rosen, M. Bissell
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CSHL/WELLCOME TRUST CONFERENCE
These conferences were held at the Hinxton Hall Conference Centre, located several miles south of
Cambridge in the United Kingdom, which forms part of the Wellcome Trust Genome Campus, together with
the Sanger Institute and the European Bioinformatics Institute. The conferences are managed jointly by Cold
Spring Harbor Laboratory and the Wellcome Trust and follow Cold Spring Harbor style in that the majority of
talks are chosen from openly submitted abstracts. The topics of the joint conference series emphasize
genomics and bioinformatics, or topics of particular interest to science in the United Kingdom or Europe.
Computational Cell Biology
March 26–29 69 participants
ARRANGED BY Benjamin Geiger, Weizmann Institute
Edda Klipp, Max-Planck Institute for Molecular Genetics
Bela Novak, Oxford Centre for Integrative Systems Biology
Following the success of the first Cold Spring Harbor Laboratory meeting on Computational Cell Biology
in March 2007, a second conference on the topic was held at the Wellcome Trust Conference Centre
on the Wellcome Trust Genome Campus in Hinxton, United Kingdom. The specific goal for this meeting
was to foster fruitful and creative dialogs between experimental cell biologists and mathematical—com-
putational modelers with common interests in the regulation of cell physiology. 
PROGRAM
Software Session
Chairperson: P. Mendes, University of Manchester, United
Kingdom
Keynote Address: Self-organization
E. Karsenti, European Molecular Biology Laboratory,
Heidelberg, Germany
Growth and Division
Chairperson: B. Novak, Oxford Centre for Integrative 
Systems Biology, United Kingdom
Motility and Cytoskeleton
Chairperson: B. Geiger, Weizmann Institute of Science,
Rehovot, Israel
Keynote Address: What does a living cell know of 
itself?
D. Bray, University of Cambridge, United Kingdom 
Microbial Physiology
Chairperson: J. Armitage, University of Oxford, United
Kingdom
Signaling
Chairperson: E. Klipp, Max-Planck Institute for Molecular
Genetics, Berlin, Germany
Software Demonstrations
Circadian Clock
Chairperson: H. Ueda, RIKEN Center for Developmental
Biology, Kobe, Japan
Development
Chairperson: A. Oates, Max-Planck Institute for Molecular Cell
Biology and Genetics, Dresden, Germany
Aerial view over the Francis Crick Auditorium and the Genome
Campus. The Sanger Institute is visible in the background.
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Network Biology
August 27–31 88 participants
ARRANGED BY Anne-Claude Gavin, European Molecular Biology Laboratory
Trey Ideker, University of California, San Diego
Marc Vidal, Dana-Farber Cancer Institute/Harvard
Marian Walhout, University of Massachusetts Medical School
This fourth conference on Network Biology was held at the Wellcome Trust Genome Campus in
Hinxton, United Kingdom and attracted an audience of senior and junior investigators and postdoctor-
al and (post)graduate researchers in a range of disciplines who sought to share existing research and
experience. The conference addressed topics including ORFeome and other clone resources; Y2H and
other binary assay maps; pull-down mass spectrometry approaches; orthogonal binary assays;
assembly/annotation; integration with phenotypic, transcriptome, and localization clustering data;
domain–domain networks; and interaction-defective genetics.
PROGRAM
Transcriptional and Posttranscriptional Gene Regulatory
Networks
Chairperson: R. Albert, Pennsylvania State University,
University Park, Pennsylvania
Keynote Address: The evolution and function of domain-
based protein interaction networks
T. Pawson, Samuel Lunenfeld Research Institute, Toronto,
Canada
Signaling and Machinery Networks
Chairperson: E. Furlong, European Molecular Biology
Laboratory, Heidelberg, Germany
Metabolic Networks
Chairperson: E. Schadt, Rosetta Inpharmatics, Merck & Co.,
Seattle, Washington
From Network to Protein Properties
Chairperson: A.-L. Barabasi, Northeastern University, Boston,
Massachusetts
Genetic Networks
Chairperson: B. Palsson, University of California, San Diego
Network Medicine
Chairperson: B. Luisi, MRC Institute of Virology, Glasgow,
United Kingdom
Genomic Perspectives to Host-pathogen Interactions
September 3–6 73 participants
ARRANGED BY Matthew Berriman, Wellcome Trust Sanger Institute
Julian Parkhill, Wellcome Trust Sanger Institute
George Weinstock, Washington University School of Medicine
This third conference covered free-living, facultative, opportunistic, epizootic, obligate, and intracellular
pathogens; lung, gastrointestinal, urogenital, skin, muscle, central nervous system, blood, and lymph
host niche/defense; and genome, biological, and ecological vectors. The conference was held at the
Hinxton Hall Conference Centre, located several miles south of Cambridge in the United Kingdom,
which forms part of the Wellcome Trust Genome Campus, together with the Sanger Centre, the
European Bioinformatics Institute, and the HGMP-MRC Resource Center. 
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PROGRAM
Microbial Evolution
Chairpersons: R. Hirt, Newcastle University, United Kingdom;
D. Conway, Medical Research Council Laboratories, The
Gambia; M. Maiden, University of Oxford, United Kingdom
Metagenomics
Chairpersons: O.C. Stine, University of Maryland School of
Medicine, Baltimore; G. Weinstock, Washington University
School of Medicine, St. Louis, Missouri
Virus Discovery
Chairpersons: E. Holmes, Pennsylvania State University,
University Park, Pennsylvania; E. Ghedin, University of
Pittsburgh, Pennsylvania
Vectors/Host
Chairpersons: D. Masiga, International Centre of Insect
Physiology and Ecology, Nairobi, Kenya; C. Hill, Purdue
University, West Lafayette, Indiana
Parasites
Chairpersons: J. Gilleard, University of Glasgow, United
Kingdom; W. Petri, University of Virginia, Charlottesville
Bacteria
Chairpersons: M. So, University of Arizona School of Medicine,
Tucson; N. Thomson, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; G. Pluschke, Swiss Tropical
Institute, Basel, Switzerland
Keynote Address
J. Farrar, Oxford University Clinical Research Unit, 
The Hospital for Tropical Diseases, Ho Chi Minh City,
Vietnam
Genome Informatics
September 10–14 169 participants
ARRANGED BY Michele Clamp, The Broad Institute of MIT and Harvard 
James Kent, University of California, Santa Cruz
Jason Swedlow, University of Dundee
This eighth conference was held at the Wellcome Trust Conference Centre on the Wellcome Trust
Genome Campus in Hinxton, United Kingdom and focused on large-scale genome informatics. Biology
is an experimental science that is experiencing an explosion of new data. This requires biologists to
increase the scale and sophistication of the information technology used for their research. The con-
ference scope encompassed the management and analysis of these data, such as whole-genome
comparisons within and among species and strains, analysis of results from high-throughput experi-
ments to uncover cellular pathways and molecular interactions, and the design of effective algorithms
to identify regulatory sequence motifs. 
PROGRAM
Pathogens and Medical Genomics
Chairpersons: P. Taschner, Leiden University Medical Center,
The Netherlands; J. Galagan, The Broad Institute of MIT and
Harvard, Cambridge, Massachusetts
Assembly and Informatics for New Sequencing
Technologies
Chairperson: R. Durbin, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Epigenomics and Gene Regulation
Chairpersons: B. Ren, Ludwig Institute for Cancer Research,
La Jolla, California; M. Eisen, University of California, Berkeley
Images, Atlases, and Reconstruction
Chairperson: M. Hawrylycz, Allen Institute for Brain Science,
Seattle, Washington
Keynote Address
J. Thornton, EMBL Outstation, Hinxton, United 
Kingdom
Data Management, Mining, Curation, and Visualization
Chairperson: J. Taylor, New York University, New York
Comparative and Evolutionary Genomics
Chairperson: A. Sidow, Stanford University School of
Medicine, California
Protein Informatics: Evolution, Interactions, and
Functional Prediction
Chairpersons: T. Hubbard, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; M. Vidal, Dana-Farber Cancer
Institute, Boston, Massachusetts
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Integrative Approaches to Brain Complexity
October 1–5 55 participants
ARRANGED BY Seth Grant, Wellcome Trust Sanger Institute
Nathaniel Heintz, HHMI/The Rockefeller University
Jeffrey Noebels, Baylor College of Medicine
This fifth conference addressed approaches ranging from molecular biology to behaving animal studies,
from single genes to complex sets of genes, from synapses to networked brain functions. Emphasis was
placed on large-scale approaches that generate accessible molecular and biological databases. The
conference was held at the Hinxton Hall Conference Centre, located several miles south of Cambridge
in the United Kingdom, which forms part of the Wellcome Trust Genome Campus, together with the
Sanger Centre, the European Bioinformatics Institute, and the HGMP-MRC Resource Center. 
PROGRAM
Welcome and Outline of Meeting
S. Grant, Wellcome Trust Sanger Institute, United Kingdom
N. Heintz, HHMI/The Rockefeller University, New York
J. Noebels, Baylor College of Medicine, Houston, Texas
Neurotransmitter Receptors
Chairperson: P. Seeburg, University of Heidelberg, 
Germany
Synaptic Computation
Chairperson: A. Silver, University College London, United
Kingdom
Dendrites
Chairperson: E. Schuman, HHMI/California Institute of
Technology, Pasadena
Modeling Neuronal Networks
Chairperson: S. Grillner, Karolinska Instituet, Stockholm,
Sweden
Francis Crick Lecture in Neuroscience
Chairperson: N. Unwin, MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom
Neural Networks
Chairperson: K. Deisseroth, Stanford University, California
Inhibitory Networks
Chairperson: H. Monyer, University of Heidelberg, Germany
Networks in Disease I and II
Chairperson: J. Noebels, Baylor College of Medicine, Houston,
Texas
Emerging Technologies
Chairperson: N. Heintz, HHMI/The Rockefeller University, New
York
Behavior
Chairperson: J. LeDoux, New York University, New York
Rat Genomics and Models
December 3–6 104 participants
ARRANGED BY Edwin Cuppen, Hubrecht Institute, The Netherlands
Norbert Hübner, Max-Delbruck Center, Germany
Anne Kwitek, University of Iowa, Ames
James Shull, University of Nebraska Medical Center
Building upon the strength of previous biennial CSHL meetings held since 1999, this first Joint Cold
Spring Harbor/Wellcome Trust conference took place in December. The meeting addressed the uses
of the rat in genetics, genomics, and disease models. The Wellcome Trust Genome Campus is situat-
ed south of Cambridge and north of Stansted Airport, within easy reach of either destination.
Attendees to the conference were treated to unusually mild weather.
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PROGRAM
Genome Biology
Chairpersons: S. Mockrin, NHLBI, National Institutes of Health,
Bethesda, Maryland; G.M. Lathrop, Centre National De
Genotypage, Evry, France
Keynote Address
A. Bradley, Wellcome Trust Sanger Institute, Hinxton, United
Kingdom
Cardiovascular/Renal Disease
Chairpersons: S. Old, NHLBI, National Institutes of Health,
Bethesda, Maryland; M. Pravenec, Czech Academy of
Sciences, Prague
Metabolism/Inflammation
Chairpersons: T. Aitman, Imperial College, London, United
Kingdom; D. Gauguier, Wellcome Trust Centre for Human
Genetics, Oxford, United Kingdom
Tumor Biology
Chairpersons: W. Dove, University of Wisconsin, Madison; J.
Shull, University of Nebraska Medical Center, Omaha
Neurosciences
Chairpersons: R. Murphy, University College London, United
Kingdom; P. Carninci, RIKEN, Yokohama, Japan
Genomic Resources
Chairpersons: X. Fernandez, European Bioinformatics Institute,
Hinxton, United Kingdom; M. Shimoyama, Medical College
of Wisconsin, Milwaukee
Emerging Technologies and Translation to Humans
Chairperson: D. Schwartz, University of Wisconsin, Madison
Wellcome Trust Conference Center, Main Conference Center and Hinxton Hall
Conference Center and Hall, side view
Hinxton Hall
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Systems Biology: Global Regulation of Gene Expression
March 27–30 289 participants
ARRANGED BY Julia Bailey-Serres, University of California, Riverside
Martha Bulyk, Brigham and Womens Hospital and Harvard Medical School
Harmen Bussemaker, Columbia University
Bing Ren, University of California, San Diego/Ludwig Institute for Cancer Research
Systems biology aims to understand the emergent properties of molecular networks in cells by using
systematic and global approaches. One of the most actively researched areas of systems biology in
recent years has been global regulation of gene expression, which coordinates complex metabolic and
developmental programs in organisms. This sixth conference, like the ones in previous years, once again
captured the rapid progress and many new discoveries in this young and exciting field. A total of 289
scientists attended the 3-day meeting, which featured 46 talks and 109 poster presentations covering
a broad range of topics. Dr. Robert Waterston, a pioneer in genome sciences,
gave a keynote speech describing the C. elegans modENCODE project that uses
an integrated approach to discern the gene regulatory networks controlling
embryogenesis of this model organism. Following this presentation was seven oral
sessions devoted to specific themes, including epigenetics, genomic regulatory
sequences, gene regulatory networks, noncoding RNAs, proteomics, and emerg-
ing technologies. Compared to previous conferences, this year’s meeting featured
prominently in four aspects: (1) Next-generation sequencing technologies have
been a key technological component in a great number of projects, and these
have stimulated the generation of a plethora of new genomic methods, computa-
tional algorithms, resources, and biological insights; (2) new imaging technologies
are allowing researchers to examine the dynamics of gene expression in vivo and
in real time and, in some cases, at a single-molecule level; (3) new resources on
transcription-factor-binding specificities have been generated, providing opportunities for systematic
analysis of gene regulatory networks in Drosophila and mammals; and (4) new computational algorithms
have been adopted to analyze the gene regulatory networks. Additionally, the speakers in these ses-
sions were generally young, with most being in the early stage of their careers. Like in the previous year,
this year’s conference also included two poster presentation sessions, and the Genome Research best-
poster prize was awarded to Rickard Sandberg (from the Karolinska Institute) for “Widespread evasion
of posttranscriptional regulation associated with proliferation.” Finally, to help computational biologists
and experimental scientists to better communicate with one another, this year’s meeting also included
a premeeting workshop that focused on introductory experimental and computational topics. 
This meeting was funded, in part, by the National Science Foundation.
246
I. Ladunga, R. Waterston
T. Degenhardt, A. Boorsma, M. Radonjic
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Keynote Address
R. Waterston, University of Washington, Seattle
Epigenetics
Chairperson: B. Ren, Ludwig Institute for Cancer Research, La
Jolla, California
Genomic Regulatory Elements I
Chairperson: H. Bussemaker, Columbia University, New York
Genomic Regulatory Elements II
Chairperson: H. Bussemaker, Columbia University, New York
Posttranscriptional Regulation
Chairperson: J. Bailey-Serres, University of California,
Riverside
Transcriptional Regulatory Networks
Chairperson: M. Zhang, Cold Spring Harbor Laboratory
Emerging Technology
Chairperson: T. Hughes, University of Toronto, Canada
Proteomics
Chairperson: M. Bulyk, Brigham and Women’s Hospital,
Harvard Medical School, Boston, Massachusetts
247
V. Kiermer, T. Chouard
M. Bulyk, J. Bailey-Serres, H. Bussemaker
B. Ren, C. Zhang
D. Ware, H. Sussman
N. Friedman, D. Gifford
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iPlant Collaborative: Grand Challenges
in Plant Sciences
April 7–9 196 participants
ARRANGED BY The iPlant Collaborative
This adjunct meeting was sponsored by The iPlant Collaborative (iPC), a major new National Science
Foundation–funded initiative in cyberinfrastructure for plant sciences. The iPC is intended to be fluid
and dynamic, using new computer, computational science, and cyberinfrastructure solutions to
address an evolving array of grand challenges in the plant sciences. It aims to be community-driven,
involving plant biologists, computer and information scientists, and engineers, as well as experts from
other disciplines, all working in integrated teams. The iPC brings together strengths in plant biology,
bioinformatics, computer science, and high-throughput computing as well as innovative approaches to
education and outreach and the study of social networks. This inaugural meeting was intended to pro-
mote discussion of a wide range of topics and to begin the process of building a community-owned,
distributed collaborative addressing compelling “grand challenges” for the plant and computing sci-
ences including (1) From molecules to whole organisms: Pathways, systems, and networks in metab-
olism, physiology, development, and organismic biology; (2) From molecules to ecosystems:
Biochemistry, genetics, population biology, and ecology; and (3) The evolutionary diversification of func-
tion: From molecular, cellular, and developmental biology to comparative genomics and phylogenetics.
The meeting was intended to be highly interactive, and parallel sessions were enthusiastically attend-
248
Interactive break-out session in Bush Auditorium
David Stewart monitoring three simultaneous live web
streams of the conference
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ed and simultaneously streamed over the internet to groups at remotes sites around the country. These
sessions allowed for energetic discussion about the development of Discovery Environments or proto-
type cyberinfrastructures for discovery, collaboration, and computational thinking in biology.
Throughout the meeting, social events provided ample opportunity for informal interactions and discus-
sions of further collaborative efforts.
This meeting was funded, in part, by the National Science Foundation.
Panel discussion D. Jackson, J.-P. Vielle-Calzada 
S. Ram, S. Smith
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Gene Expression and Signaling in the Immune System
April 22–26 472 participants
ARRANGED BY Doreen Cantrell, University of Dundee
Richard Flavell, HHMI/Yale University, New Haven
Mark Schlissel, University of California, Berkeley
Stephen Smale, University of California School of Medicine, Los Angeles
This meeting was held for the fourth time in 2008, basking in the bright
sunshine and mild temperatures of springtime. More than 470 registrants
(the largest number ever), including about 40% from outside of the United
States and 66% first-time attendees, participated in a highly engaging and
interactive 4-day meeting. Although there are many immunology meet-
ings, the unique aspect of this Cold Spring Harbor meeting is its focus on
molecular and biochemical aspects of the development and function of
the immune system. In addition, this meeting attracts a broad range of sci-
entists who use the immune system as a model to ferret out basic princi-
ples of biological regulation. Support was obtained from the NIH/NIAID as
well as from seven corporate sponsors. Talks were presented by a mix of
invited speakers and investigators selected from among a group of more
than 200 submitted abstracts. A significant number of women and junior
investigators were asked to give talks. Most speakers focused almost
exclusively on their unpublished work. A recurrent theme and scientific highlight of the meeting was the role
of chromatin structure as a target of signaling pathways in the regulation of gene expression. Keji Zhao
(National Institutes of Health) presented the results of a comprehensive genome-wide study of posttrans-
lational histone modification (20 different covalent marks in addition to the localization of RNA pol II) in T
lymphocytes that is contributing to a surprising new conceptual framework for gene regulation. Marjorie
Oettinger (MGH/Harvard Med) presented work showing that RAG2 (an essential component of the lym-
phoid V[D]J recombinase) binds specifically with K4-trimethylated histone H3 and that this interaction is
essential for normal recombinase activity in vivo. Cornelius (Kees) Murre (University of California, San Diego)
presented the first three-dimensional model of interphase structure of a complex genetic locus within
nuclear space. The product of a collaboration with physicists and mathematicians, this model based on flu-
S. Smale, S. Chan
D. Kioussis, M.A. Vidal S. Szabo, K. Mowen
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orescent in situ hybridization data helps to explain how more than 100
immunoglobulin VH gene segments distributed over greater than a
megabase of DNA can recombine with DH segments at roughly similar fre-
quencies. Finally, in the last talk of the meeting, Ruslan Medzhitov (Yale)
presented data indicating that genes responding most rapidly to inflam-
matory stimuli are “preloaded” with RNA polymerase bound to their pro-
moters and that the signal to turn on transcription consists of precise alter-
ations in local histone modifications and cofactor activity in response to
transcription factor activation. These talks highlight the relevance of the
data discussed at this meeting not just to immunology, but to the broad-
er scientific community. Oral presentations were supplemented by three
afternoon poster sessions that were extremely well attended and provid-
ed a forum for all meeting participants (including many graduate students
and postdocs) to share their most recent data. In addition, attendees took advantage of walking tours of
the CSHL campus and an evening performance by the Yale-based music group “The Cellmates.”
This meeting was funded, in part, by Abbott Bioresearch, Amgen, ChemoCentryx, Elan Pharma -
ceuticals, Eli Lilly and Company, Genetech, IRX Therapeutics, R & D Systems, Vertex Pharmaceuticals,
and the National Institute of Allergy and Infectious Disease, a branch of the National Institutes of Health.
PROGRAM
K. Rajewsky, A. Tarakhovsky
Stem Cells and Early Developmental Decisions
Chairperson: C. Guidos, Hospital for Sick Children, Toronto,
Canada
Regulation of Immune Cell Development
Chairperson: D. Baltimore, California Institute of Technology,
Pasadena
Chromatin Structure and Epigenetic Regulation
Chairperson: R. Sen, NIA/National Institutes of Health,
Baltimore, Maryland
Antigen Receptor Gene Assembly and Modification
Chairperson: M. Schlissel, University of California, Berkeley
Signal Transduction in Immune Cells
Chairperson: D. Cantrell, University of Dundee, United
Kingdom
Regulation of Lymphocyte Function I
Chairperson: R. Flavell, Yale University School of Medicine,
New Haven, Connecticut
Regulation of Lymphocyte Function II
Chairperson: D. Raulet, University of California, Berkeley
Innate Immunity
Chairperson: S. Smale, University of California School of
Medicine, Los Angeles
R. Flavell, R. Medzhitov P. Kisielow T. Mak, S. Chen-Kiang
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Molecular Chaperones and Stress Responses
April 30–May 4 299 participants
ARRANGED BY James Bardwell, HHMI/University of Michigan
F. Ulrich Hartl, Max-Planck Institute for Biochemistry
David Ron, New York University School of Medicine
This meeting continued the rich tradition of a forum where cutting-edge
analysis of molecular mechanisms of protein folding is presented in the
context of its biological importance and relevance to health.
New structural insights into the mechanisms of chaperone action
were provided, with, for the first time, two crystallographic views of an
entire DnaK/Hsp70 molecule, shedding light on the coupling of
nucleotide binding and hydrolysis to substrate binding in this highly con-
served folding machine. Significant advances were also reported in the
understanding of the related Hsp90 chaperone, this time using solution
methods. New insights were provided into the coupling of translation
with protein folding in studies that point to the role of ribosome as both
the site of mRNA translation and the earliest node in a series of folding
machines. These presentations represent an interesting evolution in
conference, attracting leaders in ribosome biology and crystallography
and students of the membrane translocon. Innovations in the time-resolved study of chaperone-assist-
ed protein folding at the single-molecule level were described, and this shed light on the action of chap-
eronins.
New insights into the cellular context of chaperone action in protein import into organelles and in
retrotranslocation of misfolded proteins from the ER were described; the latter included the first
description of a PDI chaperone dedicated to the process of ER-associated protein degradation and
talks on the role of lectins in recognizing cellular tags that mark proteins for destruction. The itinerary
of misfolded cytoplasmic proteins was described in elegant studies in yeast, integrating cell biology
with more classic chaperone biochemistry. The latter emerged as a theme at this meeting that now
encompasses a broad community of workers in diverse disciplines. 
The session devoted to diseases of misfolded proteins featured talks on interactions of prions and
misfolded poly-Q-expanded proteins with molecular chaperones, with new insight into the function of
D. Ron, A. Rousaki
J. Tatzelt, L. Bouman, J. Schlehe K. Winkelhofer, R. Morimoto
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deaggrating machines. The study of signaling pathways responsive to protein misfolding and unfolded
protein stress has been among the core interests of the meeting’s attendees, but over time, this has
evolved to encompass not only the cytosolic heat shock response, whose involvement in cancer
received coverage by several presentations, but also stress signaling from organelles. In the latter
realm, the first crystallographic study of the signaling portion of IRE1 involved in the ER stress response
was presented. 
The session on protein degradation brought new insights into the molecular mechanism of action
of the simpler bacterial ClpXP and new insights into the composition and function of the more compli-
cated proteasome. 
PROGRAM
Cellular Response to Stress
Chairperson: R. Morimoto, Northwestern University, Evanston,
Illinois
Chaperone Biochemistry and Protein Folding
Chairperson: J. Buchner, Technische Universität München,
Germany
Chaperone Function in Disease and Development
Chairperson: L. Neckers, NCI/National Institutes of Health,
Bethesda, Maryland
Diseases of Protein Misfolding
Chairperson: D. Selkoe, Harvard Medical School, Boston,
Massachusetts
Quality Control and Protein Trafficking
Chairperson: A. Johnson, Texas A&M University Health
Science Center, College Station
Regulation of the Stress Response
Chairperson: C. Gross, University of California, San Francisco
Chaperones and Proteolysis
Chairperson: D. Finley, Harvard Medical School, Boston,
Massachusetts
Poster session
C. Ruiz H. Furukawa, W. HendricksonO. Lipan
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The Biology of Genomes 
May 6–10 553 participants
ARRANGED BY Michael Ashburner, University of Cambridge
Andrew Clark, Cornell University
Kerstin Lindblad-Toh, Broad Institute
George Weinstock, Washington University 
This meeting marked the 20th annual gathering of genome sci-
entists in this setting. The past decade or so has seen remark-
able progress not only in genome sequencing, but also in the
application of sequencing technologies to a wide range of bio-
medical problems. The first two talks of this meeting
announced two new individual human sequences, and subse-
quently we heard about the sequencing of genomes of organ-
isms as different as the platypus and the parasitic wasp. There
was considerable discussion about the newly funded project to
sequence the genomes of 1000 individual humans. 
Just over 550 people from around the world attended the
meeting, with more than 370 abstracts presented describing a
broad array of topics relating to the analysis of genomes from a
number of different organisms. This was, in fact, a record atten-
dance for a Cold Spring Harbor meeting, and, unfortunately,
well over 100 people who wanted to attend, could not for rea-
sons of space. 
The session topics included areas such as biological insights from genetics and genomics of non-
human species, high-throughput genetics and genomics, cancer and func-
tional genomics, computational genomics, population genomic variation,
genetics of complex traits, and evolutionary genomics. There was consider-
able enthusiasm for the new resequencing technologies that are becoming
available and the science that these technologies will enable. Indeed, it could
be said that information acquired by means of these technologies dominated
the meeting, and all had the very real sense of a major advance having been
made in the field. 
The keynote talks were chosen to complement the major sessions of the
meeting. They were presented by Dr. Michael Levine (University of California,
Berkeley) and Dr. Michael Lynch (Indiana University, Bloomington). 
The ELSI (Ethical, Legal, and Social Implications) panel chaired by Francis
Collins focused on ethical and social implications of research on natural
selection in humans. This year's ELSI session was particularly well attended
and was addressed by senior figures in the emerging field of commercial
human genome sequencing: Dr. Kari Steffansson (deCODE), Linda Avey
(23andMe), and Dietrich Stephan (Navigenics), with academic contributions
from Kathy Hudson (Genetics and Public Policy Center) and Joseph
McInerney (National Coalition for Health Professional Education in Genetics). 
This meeting was funded, in part, by the National Human Genome Research Institute, a branch of
the National Institutes of Health, and Roche Applied Science. Interviews were supported by the
HudsonAlpha Institute for Biotechnology.
O. Bahcall, M. Ashburner
J. Watson
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PROGRAM
Functional and Cancer Genomics
Chairpersons: R. Wilson, Washington University, St. Louis,
Missouri; M. Dean, National Cancer Institute, Frederick,
Maryland
Genetics of Complex Traits
Chairpersons: M. Georges, University of Liège, Belgium; A.
DiRienzo, University of Chicago, Illinois
High-throughput Genomics and Genetics
Chairpersons: M. Vidal, Dana-Farber Cancer Institute, Harvard
Medical School, Boston, Massachusetts; S. Celniker,
Lawrence Berkeley National Laboratory, California
Computational Genomics
Chairpersons: S. Salzberg, University of Maryland, College Park;
S. Lewis, Lawrence Berkeley National Laboratory, California
ELSI Panel Discussion: Ethical, Legal, And Social
Implications of Direct-to-Consumer Genomic Test
Marketing
Moderator: Francis Collins, M.D., Ph.D., National Human
Genome Research Institute
Panelists: Kari Stefansson, Ph.D., deCODEme; Dietrich
Stephan, Ph.D., Navigenics; Linda Avey,
23andMe; Kathy Hudson, Ph.D., Genetics and
Public Policy Center; Joseph McInerney, M.S.,
National Coalition for Health Professional
Education in Genetics (NCHPEG)
Evolutionary Genomics
Chairpersons: J. Noonan, Yale University, New Haven,
Connecticut; S.L. Baldauf, University of York, United Kingdom
Genetics and Genomics of Nonhuman Species
Chairpersons: G. Barsh, Stanford University, California; W.
Warren, Washington University School of Medicine, St.
Louis, Missouri
Guest Speakers
Michael Levine, University of California, Berkeley; Michael
Lynch, Indiana University, Bloomington
Population Genomic Variation
Chairpersons: E. Eichler, University of Washington, Seattle; M.
Przeworski, University of Chicago, Illinois
Watching the meeting under the Grace tent
H. Sussman, T. Hubbard
D. Schwartz, D. Ware
T. Taylor, E. Bruford
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The Cell Cycle
May 14–18 314 participants
ARRANGED BY Orna Cohen-Fix, NIDDK, National Institutes of Health
Nicholas Dyson, Massachusetts General Hospital Cancer Center
Johannes Walter, Harvard Medical School
This ninth biannual Cell Cycle meeting was held this year at Cold
Spring Harbor. This conference is internationally recognized for its abil-
ity to bring together scientists who study cell cycle regulation in eukary-
otes ranging from yeast to humans. As usual, the meeting began with
a keynote talk from a leader in the field, and on this occasion, we were
fortunate to have Dr. Timothy Mitchison (Department of Systems
Biology at Harvard Medical School) tell us about his exciting new stud-
ies of spindle structure and dynamics. The remainder of the meeting
was organized around eight lecture sessions and two poster sessions
that focused on the major stages of the cell division cycle, with an
emphasis in each session on the molecular mechanisms that govern
cell cycle progression. Many of these sessions focused on long-stand-
ing problems in cell cycle control, including the transcriptional mecha-
nisms controlling entry in the cell cycle, the mechanisms that initiate
chromosome duplication and limit it to a single round, the mechanisms that trigger the complex events of
chromosome segregation in mitosis, and the numerous checkpoint systems that ensure that cell cycle
events occur in the correct order. For the first time, an entire session was devoted to the involvement of
proteolysis in cell cycle regulation, bringing together different perspectives from investigators who study the
role of proteolysis in a variety of cell cycle processes. Other emerging areas, including molecular insights
into the regulation of endoreduplication and the tensile properties of the kinetochore, were also represent-
ed. As always, every major model system for cell cycle analysis, including plants, was represented, and the
striking phylogenetic conservation of cell cycle regulatory mechanisms was readily evident. The meeting
also served to demonstrate the impact of whole-genome analysis on basic cell biology, and these achieve-
ments will no doubt continue to drive rapid progress in this field. It was another landmark meeting for the
cell cycle field, and the participants continue to look forward to equally exciting meetings in future years.
This meeting was funded, in part, by the National Cancer Institute, a branch of the National Institutes
of Health.
N. Dyson, O. Cohen-Fix, J. Walter
Unusual place for a poster! C. Murphy
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PROGRAM
Cell Cycle Transitions
Chairperson: D. Morgan, University of California, San
Francisco
Keynote Address: Spindle Structure and Dynamics
T. Mitchison, Harvard Medical School
G1 and the G1/S Transition
Chairpersons: C. Wittenberg, Scripps Research Institute, La
Jolla, California; P. Sicinski, Dana-Farber Cancer Institute,
Harvard Medical School, Boston, Massachusetts
DNA Replication
Chairpersons: H. Araki, National Institute of Genetics, Mishima,
Japan; P. Russell, Scripps Research Institute, La Jolla,
California
The Response to DNA Damage and Perturbation in DNA
Replication
Chairpersons: M. Michael, Harvard University, Cambridge,
Massachusetts; H. Ulrich, Cancer Research UK London
Research Institute
Cell Cycle Regulatory Pathways
Chairpersons: J. Kimble, HHMI/University of Wisconsin,
Madison; S. Kornbluth, Duke University Medical Center,
Durham, North Carolina
Mechanisms and Regulation of Chromosome
Segregation
Chairpersons: S. Biggins, Fred Hutchinson Cancer Research
Center, Seattle, Washington; K. Labib, Cancer Research
UK/Paterson Institute for Cancer Research, Manchester
Metaphase, Anaphase, and Beyond
Chairpersons: K. Gould, HHMI/Vanderbilt University, Nashville,
Tennessee; T. Orr-Weaver, Whitehead Institute/Massachu -
setts Institute of Technology, Cambridge, Massachusetts
Proteolysis in Cell Cycle Regulation
Chairpersons: P. Jackson, Stanford University School of
Medicine, California; R. King, Harvard Medical School,
Boston, Massachusetts
D. Morgan, M. Solomon
A. Lasada, I. Sumara M. De Pamphilis, J. Mendez
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Retroviruses
May 19–24 475 participants
ARRANGED BY Paul Spearman, Emory University
Alice Telesnitsky, University of Michigan
This conference focused on recent developments in basic retrovirolo-
gy, including HIV, HTLV-I, and the broad array of nonhuman retrovirus-
es. Keynote speakers were Jan Svoboda of the Academy of Sciences
of the Czech Republic and John Wills of Penn State College of
Medicine. Dr. Svoboda is one of the pioneers of retrovirology. During
the early years of RNA tumor virology, he described the unusual phe-
nomenon of Rous sarcoma virus rescue from rat XC cells through
coculture with avian cells. His work contributed to early ideas regard-
ing the existence of the provirus. Dr. Svoboda provided a stimulating
historical perspective on the field during his presentation, and he con-
tinued to make insightful comments throughout the meeting. Many
attendees commented that meeting Dr. Svoboda was one of the
meeting highlights. Dr. Wills provided the perspective of a previous
member of the retrovirus field who left to pursue discoveries in the her-
pesvirus arena. His laboratory was widely regarded as a leading laboratory studying retrovirus assem-
bly. He described the new work in herpes, inspired by lessons learned from retrovirology, about struc-
tural transitions that occur in extracellular virions upon heparin sulfate engagement, which prime her-
pesviruses for cell entry. He also made many salient points regarding the nature of scientific discovery
and what contributes to success in the scientific endeavor. Together, the two keynotes added unique
perspectives that were appreciated by all and that served to pass on the wisdom of pioneering retro-
virologists to new investigators just entering this dynamic field. This conference offers a unique oppor-
tunity for interactions of this kind, by highlighting the work of junior investigators in more than 100 short
talks while promoting the participation of senior investigators through dynamic question and answer
sessions and keynote presentations.
The conference featured ten oral sessions, each themed to reflect dynamic developments in retro-
virology. Restriction factors, especially TRIM5-α and APOBEC3G/3F, continued their prominence. One
prominent finding was the identification by the Welkin Johnson’s
laboratory of a TRIM-CypA fusion product encoded by pigtailed
macaques that is structurally distinct from a similar fusion in owl
monkeys. This second incidence of a TRIM-Cyp fusion illustrates
the strong selective pressure on host genomes for generating pro-
tective alleles against lentiviruses and suggests that TRIM-Cyp
fusions provide a particularly good mechanism for protection. The
APOBEC session was marked by continued controversy over the
role of deamination in restriction versus deaminase-independent
restriction. Structural studies of the catalytic domain of APOBEC3G
and of the SOCS box region of Vif provided interesting balance. 
A session describing late replication events, entitled “Budding
and Vpu,” highlighted the discovery of tetherin (also known as BST-
2 or CD317) as a restriction factor that acts to prevent particle
release and is overcome by Vpu. Tetherin’s discovery by Stuart Neil
in Paul Bieniasz’s lab was highlighted by Dr. Neil, followed by John
Guatelli describing his independent discovery of this factor and of
the down-regulation of cell surface tetherin by Vpu. This discovery
P. Spearman, A. Telesnitsky
J. Hicks, S. Hughes
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will undoubtedly stimulate new investigations into Vpu biology and provide a new area for targeted ther-
apy. Another example of how the host/virus standoff drives genome evolution came from the Accessory
Proteins session, which included talks about Vpx suggesting that this previously enigmatic SIV factor
also evolved to counter host antiviral responses.
Reflecting an explosion of HTLV biology, this year’s meeting featured almost an entire session of
groundbreaking talks on HTLV. The HTLV talks covered entry, transcription, new host factor interac-
tions, and animal models of pathogenesis. The Integrase session was one of the most exciting that we
have seen at this meeting. New data on LEDGF tethering of preintegration complexes to chromatin and
on mapping of functional domains were presented by the Poeschla and Engelman laboratories, as well
as others. 
Studies of viral assembly maintained a prominent role at this year’s meeting. In addition to the bud-
ding/Vpu talks, a session on RNA export and assembly highlighted the still evolving story of RNA export
roles on the targeting of Gag and viral particle formation. The final session highlighted assembly-relat-
ed issues and aspects of cell–cell transmission. The transmission of virus from infected macrophages
and dendritic cells was featured, as was the mysterious nature of “intracellular” collections of virions in
organelles bearing late endosome markers but somehow maintaining continuity with the plasma mem-
brane. The live cell imaging of particle formation was highlighted by Noel Jouvenet from the Bieniasz
laboratory, and the final talk featured provocative time-lapse images from the Benjamin Chen lab, sug-
gesting productive transfer of multiple virions en masse from producer to target T cells at junctions
called virological synapses. Although slightly underattended, participation in the final session was
stronger than in previous years, possibly due to a change in conference dates that resulted in a final
Saturday morning session, rather than on Sunday as in previous years.
This was the second year of the annual Andy Kaplan prize that commemorates Dr. Kaplan, a promi-
nent AIDS researcher who died 2 years ago. The prize was won by Dr. Cheoma Okeoma, a junior inves-
tigator working in the laboratory of Susan Ross at the University of Pennsylvania. Cheoma presented
her work on murine APOBEC3-mediated restriction of MMTV replication in infected animals.
Interestingly, the block occurs both from packaged APOBEC3 and from APOBEC3 present within the
target cell. 
Overall, these oral sessions, paired with the vigorous poster sessions as a forum for extensive dis-
cussions, provided the broad exposure to retrovirology that has marked this meeting as the one indis-
pensable yearly meeting for the basic retrovirologist. The meeting continues to provide outstanding sci-
ence in an intense and critical atmosphere while also providing a great forum for collegial discussions
and networking for investigators in the field.
B. Wohrl, J. Tozser, L. Menéndez-Arias, Z. HannaE. Urano, K. Miyauchi
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PROGRAM
Envelope/Entry/Fusion
Chairpersons: Y. Koyanagi, Kyoto University, Japan; M.
Johnson, University of Missouri, Columbia
Restriction Factors I (TRIM)
Chairpersons: C. Aiken, Vanderbilt University, Nashville,
Tennessee; T. Hatziioannou, Aaron Diamond AIDS Research
Center, New York
Pathogenesis/HTLV
Chairpersons: P. Green, Ohio State University, Columbus; K.
Jones, SAIC-Frederick, Maryland
Keynote Address
J. Svoboda, Academy of Sciences of the Czech 
Republic
RNA Export, Assembly
Chairpersons: R. Craven, Pennsylvania State University
College of Medicine, Hershey; S. Goff, Columbia University,
New York
Restriction Factors II (APOBEC/Vif)
Chairpersons: S. Sawyer, University of Texas, Austin; Y.-H.
Zheng, Michigan State University, East Lansing
Budding and Vpu
Chairpersons: J. Guatelli, University of California, San Diego;
S. Neil, King’s College London, United Kingdom
Transcription, RNA Packaging, RT
Chairpersons: J.-I. Sakuragi, Osaka University, Japan; S.
Sarafianos, University of Missouri, Columbia
Keynote Address 
J. Wills, Pennsylvania State University College of 
Medicine, Hershey
Accessory Proteins
Chairpersons: V. Planelles, University of Utah, Salt Lake City;
C. Transy, Institut Cochin INSERM U567, Paris, France
Integration
Chairpersons: D. Grandgenett, St. Louis University Health
Science Center, Missouri; M. Kvaratskhelia, Ohio State
University, Columbus
Cell Biology/Cell–Cell Transmission
Chairpersons: A. Ono, University of Michigan Medical 
School, Ann Arbor; L. Wu, Medical College of Wisconsin,
Milwaukee
K. Hrecka, M. Rits
P. Jolicoeur, G. Towers
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Glia in Health and Disease
July 17–21 181 participants
ARRANGED BY Ben Barres, Stanford University School of Medicine
Beth Stevens, Children’s Hospital/Harvard Medical School
Glial cells constitute 90% of cells in the human nervous system but
their roles in the developing adult and diseased brain are still poorly
understood. This meeting gathered students and scientists from
across the world to discuss their recent progress. In the first part of
the meeting, sessions focused on understanding the normal roles of
glia, including sessions on glial development, genetic analysis of glial
function, myelination, axon–glial interactions, and astrocyte function
at synapses and blood vessels. In the last half of the meeting, ses-
sions focused on recent progress on understanding the roles of glia
in reactive gliosis, CNS regenerative failure, and disease processes
including neurofibromatosis, multiple sclerosis, and encephalitis.
Poster sessions were well attended with active discussion. There was
again a sense of excitement that our understanding of the function of
glia is quickly moving forward, with glia having central roles in normal
brain development, function, and disease. This excitement was
reflected in the presence of several top journal editors interested in
enhancing their coverage of latest advances concerning glia.
B. Stevens, S. John
PROGRAM
Genetic Analysis of Glial Function
Chairpersons: R. Jackson, Tufts University School of
Medicine, Boston, Massachusetts; K. McCarthy, University
of North Carolina, Chapel Hill
Gliovascular Interactions
Chairpersons: M. Nedergaard, University of Rochester, 
New York; B. MacVicar, University of British Columbia,
Vancouver
Myelinating Cells
Chairpersons: M. Simons, Max-Planck Institute for
Experimental Medicine, Göttingen, Germany; W. Macklin,
Cleveland Clinic, Ohio
Glial Development
Chairpersons: C. Klambt, University of Munster, Germany;
M. Wegner, University of Erlangen-Nürnberg, Germany
Axon–Glial Interactions
Chairpersons: A. Lloyd, University College London, 
United Kingdom; K. Nave, Max-Planck Institute of
Experimental Medicine, Göttingen, Germany
J. Dugas, B. Barres
T. Sakurai, N. Takada
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Glial Function at Synapses
Chairpersons: S. Duan, Chinese Academy of Sciences,
Shanghai; C. Eroglu, Duke University Medical Center,
Durham, North Carolina
Microglia and Gliosis
Chairpersons: M. Sofroniew, University of California, Los
Angeles; S. Rivest, Université Laval, Canada
Glia and Disease
Chairpersons: R. Reynolds, Imperial College London, United
Kingdom; P. Lowenstein, Cedars-Sinai Medical Center, Los
Angeles, California
K. Tanaka, C. Eroglu
Caricaturist at work
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Mechanisms and Models of Cancer
August 13–17 430 participants
ARRANGED BY Dafna Bar-Sagi, New York University Medical Center
Ronald DePinho, Dana-Farber Cancer Institute
Jacqueline Lees, MIT Center for Cancer Research
Charles Sherr, HHMI/St. Jude’s Children’s Research Hospital
Molecular alterations in tumor-suppressor genes and onco-
genes and their associated pathways and networks contribute
in a very significant way to the development of human cancers.
The last several years have seen an enormous increase in
research dealing with cancer genes and their roles in growth
control and various stages of tumor development. This second
meeting focused on a variety of topics related to cancer genet-
ics, biology, and therapy, reflecting an increased emphasis on
integrated approaches to studying signaling in normal and can-
cer cells, as well as the use of sophisticated in vivo mouse
models to study various aspects of cancer biology. The meet-
ing emphasized new discoveries and provided an open forum
for the presentation of the latest research and results on differ-
ent aspects of research on molecular mechanisms and cell and
animal models of cancer.  The meeting featured two fascinating keynote talks on different aspects of
cancer biology by Scott Lowe (HHMI/Cold Spring Harbor Laboratory) and Celeste Simon
(HHMI/University of Pennsylvania), two poster sessions, and eight oral sessions. This meeting was
enthusiastically supported, and the lectures and poster presentations led to extensive discussions and
exchanges of information and ideas.
This conference was funded, in part, by the National Cancer Institute, a branch of the National
Institutes of Health. The meeting will be held again in the early fall of 2010.
PROGRAM
C. Sherr, D. Bar-Sago, J. Lees, R. DePinho
Stem Cells and Organismal Development
Chairpersons: T. Jacks, HHMI/Massachusetts Institute of
Technology, Cambridge; S. Morrison, University of Michigan,
Ann Arbor
Keynote Address
S. Lowe, HHMI/Cold Spring Harbor Laboratory
Mouse Models of Cancer
Chairpersons: G. Lozano, University of Texas M.D. Anderson
Cancer Center, Houston; T. van Dyke, National Cancer
Institute, Frederick, Maryland
Signaling Mechanisms
Chairpersons: J. Settleman, MGH Cancer Center, Harvard
Medical School, Boston, Massachusetts; R. Shaw, Salk
Institute for Biological Studies, La Jolla, California 
Experimental Therapeutics
Chairperson: W. Weiss, University of California, 
San Francisco
Sharing informal notes
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Microenvironment, Inflammation, and Metastasis
Chairpersons: K. Polyak, Dana-Farber Cancer Institute,
Boston, Massachusetts; Z. Werb, University of California,
San Francisco
Keynote Address
M.C. Simon, HHMI/University of Pennsylvania
Senescence and Apoptosis
Chairpersons: L. Attardi, Stanford University, California; M.
Oren, Weizmann Institute of Science, Rehovot, Israel
Cancer Genetics and Epigenetics
Chairpersons: L. Chin, Harvard Medical School, Boston,
Massachusetts; D. Felsher, Stanford University School of
Medicine, California
DNA Damage and Cell Cycle Checkpoints
Chairperson: H. Piwnica-Worms, HHMI/Washington University,
St. Louis, Missouri
D. Rebatchouk, L. Beverly
E. Boamah
C. Gorrini, M. Wilhelm
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Molecular Genetics of Bacteria and Phages
August 20–24 181 participants
ARRANGED BY Sarah Ades, Penn State University
Gary Dunny, University of Minnesota Medical School
James Hu, Texas A&M University
This meeting featured 74 oral presentations and 79 poster presen-
tations. Bacteria and phages continue to provide critical insights into
diverse areas of biology, ranging from ecology, evolution, and diver-
sity, to gene expression and development, to infectious diseases.
The meeting featured exciting presentations covering all of these
topics, along with some changes in the organization of th meeting
to emphasize different aspects of major biological problems, many
of these involving interactions among bacteria, phages, and their
ecological niches. A highlight of the meeting was the inclusion of a
keynote lecture preceding the banquet by Alan Grossman
(Massachusetts Institute of Technology), who provided an enlighten-
ing and entertaining presentation that included a wonderful mixture
of personal insights and remembrances of his previous Cold Spring
Harbor meetings, along with an exciting presentation of his current
studies of cell–cell signaling and horizontal gene transfer in Bacillus subtilis. The opening session
focused on cell biology, division, and development. The first lecture describing regulation of the FtsZ
ring assembly and its role in division of B. subtilis was presented by Richard Weart (Massachusetts
Institute of Technology), who recently completed his Ph.D. at Washington University with Petra Levin
and was the 2008 recipient of the Sternberg Thesis Prize for the best Ph.D. thesis in Prokaryotic
Molecular Genetics. Other presentation topics in this session included the molecular mechanisms of
cell lysis and division, initiation of spore coat assembly, and additional studies of the coordination
between chromosome replication and cell division. The ability
of microbes to sense and respond to various forms of stress
and damage to cellular components is essential to their con-
tinued survival, and two oral sessions were devoted to this
general topic. The many interesting presentations in this area
included a description of the increase in genetic diversity
associated with long-term starvation by Steve Finkel
(University of Southern California) and the interplay among
antibiotic-induced stress, cell–cell signaling, and programmed
cell death in Escherichia coli by Hanna Engelberg-Kulka
(Hebrew University). Stress and DNA damage also can
increase mutagenesis, recombination, and lateral gene trans-
fer, as elucidated by the presentations of Susan Rosenberg
(Baylor) and John Chen (New York University). Both bacterial
pathogenesis and phage biology were included in the
host/parasite interaction session, where the presentations
ranged from a wonderful “chalk talk” on flagellar assembly by
Kelly Hughes (University of Utah) to a description of the mech-
anisms by which the recently discovered CRISPR sequences
protect bacteria from phage infection by Matthijs Jore
(Wageningen University). One session of the conference was
A. Grossman, S. Ades
K. Gibbs, H. Engelberg-Kulka
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devoted to the mechanisms of environmental sensing and cell–cell signal-
ing, including presentations by Malcolm Winkler (Indiana University) on the
essential role of a two-component signal transduction system in pathogen-
ic Streptococcus pneumoniae and Karine Gibbs (University of Washington),
who discussed the genetic basis for self-recognition in swarming colonies of
Proteus. A traditional major focus of the phage meeting has been the micro-
bial RNA world, and this year’s conference was no exception, with three
sessions devoted to transcription initiation, elongation, termination, and pro-
cessing, as well as translational control and small RNAs as regulators and
effectors of genetic mobility. Highlights of these sessions included presenta-
tions on the interplay between Group II intron mobility and global bacterial
regulators by Marlene Belfort (Wadsworth Center, New York Department of
Health), the role of CRP in regulation of transcription of toxin genes by
George Munson, and elucidation of the conformation and dynamics of the
RNA polymerase clamp using FRET technology by Richard Ebright (HHMS,
Rutgers), which kicked off a fantastic final session.
This meeting was funded, in part, by the National Science Foundation.
PROGRAM
The Nat L. Sternberg Award
Introduction: D. Siegele, Texas A&M University; Richard B.
Weart, Massachusetts Institute of Technology
Regulation of FtsZ Ring Assembly and Cell Division in B. 
subtilis
Cell Biology, Division, and Development
Chairperson: T. Bernhardt, Harvard Medical School, Boston,
Massachusetts
Environmental Stress, Toxins, and Antitoxins
Chairperson: S. Finkel, University of Southern California, Los
Angeles
DNA Recombination, Transfer, and Damage Control
Chairperson: J. Peters, Cornell University, Ithaca, New York
Host/Parasite Interactions
Chairperson: A. Salyers, University of Illinois, Urbana
RNA Processing and RNA Regulation
Chairperson: M. Belfort, Wadsworth Center, Albany, New York
Regulation of Transcription: DNA-binding Proteins
Chairperson: D. Siegele, Texas A&M University, College Station
Sensing and Adaptation
Chairperson: M. Winkler, Indiana University, Bloomington
Keynote Address
Chairperson: A.D. Grossman, Massachusetts Institute of
Technology
Transcription from Initiation to Termination, Pausing
Along the Way
Chairperson: R. Ebright, HHMI/Rutgers University, Piscataway
K. Hughes
R. Taylor
G. Dunny, B. Buttaro
W. Szybalski, B. Stillman
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Nuclear Receptors and Disease
August 27–31 160 participants
ARRANGED BY Ronald Evans, The Salk Institute
Sohaib Khan, University of Cincinatti
Charles Sawyers, HHMI/Memorial Sloan-Kettering Cancer Center
Keith Yamamoto, University of California, San Francisco
Research on nuclear hormones and nuclear hormone receptors has long pro-
ceeded along a broad front. Classical endocrinological studies revealed the first
nuclear hormones, their physiological functions, and the clinical sequelae of defi-
ciency and excess, whereas the receptors were first detected via chemical syn-
thesis of a radiolabeled hormone, described in biochemical experiments, geneti-
cally manipulated and functionally analyzed using molecular biological procedures
and structurally defined by NMR and X-ray crystallography. These studies yielded
basic information about eukaryotic transcription, produced the most heavily pre-
scribed therapeutics as well as “reverse endocrinology” approaches to the discov-
ery of ligands, and provided insights into development and disease. This biennial
conference brings together students and established investigators—basic and
clinical, from academia, pharma, and biotech—to share and integrate ideas, con-
cepts, and approaches across this broad field. This exciting meeting, second in
the series, unveiled the structure of a full-length heterodimeric receptor; two novel
classes of compounds that may combat cancer; new determinants of selectivity
and specificity of receptor action; a pathway for control of stem cell proliferation; networks that link cir-
cadian cycling, metabolism, energy use and life span; and new coregulatory factors that either focus
or diversify receptor-mediated regulatory mechanisms. The next Cold Spring Harbor Nuclear Receptor
meeting is planned for the fall of 2010.
K. Yamamoto
F. Claessens, L. Nagy
PROGRAM
Keynote Address
K. Yamamoto, University of California, San Francisco
Thyroid Hormones and Retinoids: Mechanisms,
Physiology, and Pathology
Chairperson: B. Vennström, Karolinska Institute, Solna,
Sweden
Corticosteroids: Mechanisms, Physiology, and
Pathology
Chairperson: J. Funder, Prince Henry’s Institute of Medical
Research, Clayton, Australia
PPARs: Mechanisms, Physiology, and Pathology
Chairperson: D. Kelly, Burnham Institute for Medical Research,
La Jolla, California
Nuclear Receptor Cofactors: Mechanisms, Physiology,
and Pathology
Chairperson: B. O’Malley, Baylor College of Medicine,
Houston, Texas
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Estrogens and Progestins: Mechanisms, Physiology, and
Pathology
Chairperson: S. Fuqua, Baylor College of Medicine, Houston,
Texas
Androgens: Mechanisms, Physiology, and Pathology
Chairperson: M. Brown, Dana-Farber Cancer Institute, Boston,
Massachusetts
Nuclear Receptors in Invertebrates: Development,
Metabolism, and Life Span
Chairperson: D. Mangelsdorf, University of Texas
Southwestern Medical Center, Dallas
W. Zwart
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Translational Control
September 3–7 443 participants
ARRANGED BY Alan Hinnebusch, National Institute of Child Health & Human Development/NIH
Terri Kinzy, UMDNJ R.W. Johnson Medical School
Peter Sarnow, Stanford University
This meeting attracted more than 440 participants from around the world and included Joan Steitz as
an invited speaker, eight platform sessions, and three poster sessions that covered 360 abstracts.
Novel findings on the mechanism of translation included high-resolution structures of ribosomal com-
plexes at different stages of translation. Cryo-EM analysis of a bacterial preinitiation complex showed
fMet-tRNA and initiation factors IF1 and IF2 bound to the 30S subunit. Cryo-EM structures of pre-
translocation 70S complexes were presented that support the hybrid states model, with tRNAs in
hybrid positions between the A and P sites and P and E sites before translocation. A cryo-EM struc-
ture of Escherichia coli ribosomes in a complex with EF-Tu and aminoacyl-tRNA revealed how GTP
hydrolysis is induced by correct codon reading. Ribosomal structures were presented showing the
nascent peptide in the exit tunnel of a translating ribosome. 
There were several breakthroughs regarding soluble translation factors. In mammalian mito-
chondria, the separate functions of EF-G in elongation and ribosome recycling were assigned to
separate, albeit homologous, proteins: HMEFG1 catalyzes tRNA movement but is inactive in
ribosome recycling, whereas HMEFG2 promotes ribosome recycling but is inactive in elongation.
Mitochondrial IF2 was shown to contain an additional insert enabling it to replace both IF1 and
IF2 in E. coli cells. NMR studies led to a model of the eukaryotic scanning complex in which
eIF4G positions the helicase eIF4A at the mRNA entry channel to unwind secondary structure in
advance of the ribosome. The RNA-binding protein YB-1 was shown to impose a requirement
for PABP in forming the activated eIF4F-mRNP complex. Yeast eIF3 subunits a, b, and j were
implicated in scanning and AUG recognition, and distinct elements in eIF1A were identified with
opposing effects on scanning. A new RNA helicase DHX29 was shown to be required for scan-
ning on structured 5′ leaders, and it was reported that eIF5 acts as a GDP dissociation inhibitor
(GDI) beyond its GTPase-activating function for eIF2. Mouse eIF6 was shown to stimulate trans-
lation in vivo, and the enigmatic factor eIF5A was found to enhance elongation in yeast cells. 
Important findings on translational control elements in mRNA included a crystal structure of the
cricket paralysis virus IRES mimicking tRNA in a P/E hybrid state, explaining how it bypasses all initia-
tion factors. The eIF4G homolog DAP5 was shown to bind and stimulate cellular IRES elements in
R. Jackson
O. Fayet, M. Altmann, M. Hentze
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CDK1 and Bcl-2 mRNAs. The 3′ UTR of VEGF-A mRNA was found to contain a GAIT element whose
repressive function in interferon-treated cells is overridden in hypoxia by binding of hnRNP L.
Identification of new mRNA targets of ribosomal protein L13a has expanded GAIT-controlled mRNAs
into a posttranscriptional operon. Regarding microRNAs, snoRNAs were found to be novel sources of
microRNAs in humans and protozoans, and it was shown that the miR-34 family is induced by
p53/DNA damage and targets c-myc mRNA. It was shown that deadenylation contributes to transla-
tional repression by microRNAs in Drosophila cell-free extracts and in mammalian cells. microRNAs
were observed to activate translation in quiescent serum-starved cells and Xenopus oocytes.
In the arena of translational control in disease, there is now strong evidence for virus-driven evolution
of the antiviral eIF2α kinase PKR. It appears that eIF4GI overexpression promotes inflammatory breast
cancer by enhancing IRESs in mRNAs that promote tumor cell survival, angiogenesis, and metastasis. It
was reported that human cytomegalovirus (HCMV) induces PABP translation, and ICP27 of herpes sim-
plex virus-1 likely recruits PABP to stimulate viral mRNA translation. Novel eIF2α kinases were identified
in the parasite Toxoplasma gondii that regulate developmental stages and cellular stress responses.
New insights into connections between translation and mRNA turnover or localization were also
reported. There is evidence that mRNA decay takes place in yeast while the mRNA is still engaged in
translation. Among proteins that associate with the stress granule (SG) factor G3BP, p63 was found in
association with initiation factors, and the ubiquitin-specific protease USP10 was shown to be required
for SG but not P-body formation. SG components TIA-1 and TIAR were implicated in repressing trans-
lation of 5′TOP mRNAs during amino acid starvation. There is evidence that sequential phosphoryla-
tion and dephosphorylation of zipcode-binding protein (ZBP) represses actin mRNA translation in neu-
rons until it is transported to distal neurites and growth cones.
This meeting was funded, in part, by the National Institute of Child Health and Human Development,
a branch of the National Institutes of Health.
PROGRAM
Decay and Subcellular Structures
Chairperson: J. Lykke-Andersen, University of Colorado,
Boulder
Factors and Mechanisms
Chairperson: G. Pavitt, University of Manchester, United
Kingdom
Elongation and Termination
Chairperson: M. Rodnina, University of Witten/Herdecke,
Germany
Development, CNS, and Signaling
Chairperson: C. Bagni, Catholic University of Leuven, Belgium
miRNAs and Regulation of Factors
Chairperson: T. Preiss, Victor Chang Cardiac Research
Institute, Sydney, Australia
Ribosome Structure and Function
Chairperson: M. Yusupov, IGBMC, Illkirch, France
Viruses and Disease
Chairperson: E. Harris, University of California, Berkeley
mRNA Regulatory Elements
Chairperson: M. Holcik, Children’s Hospital of Eastern Ontario,
Ottawa, Canada
M. Gupta, K. Kleene
T. Pe’ery, N. Sonenberg
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Axon Guidance, Synaptogenesis, and Neural Plasticity
September 10–14 415 participants
ARRANGED BY Anirvan Ghosh, University of California, San Diego
Christine Holt, University of Cambridge
Alex Kolodkin, Johns Hopkins University
The human brain has billions of nerve cells (neurons) and each
neuron is typically connected to hundreds of other neurons via
synapses in a highly precise fashion. This complex neural wiring
underlies the ability of humans, and other animals, to interact with
the outside world, to learn and to perform complex behaviors.
The complexity of the brain, in fact, surpasses that of a comput-
er, and one of the major challenges for the field of neuroscience
is to understand how nerve connections are made accurately and
reliably. Connections between different regions of the brain are
first established during embryogenesis and result in the formation
of a stereotyped pattern of axon pathways or fiber tracts.
Projection neurons are often a long distance away from their
synaptic targets, and the first step in establishing connectivity is
to extend an axon tipped with a growth cone. The growth cone
is the sensory/motile apparatus responsible for steering an accurate course through the early neuroep-
ithelium of the embryonic brain. What directs the navigation of growth cones along the correct pathway?
Once the growth cone reaches its target area, it must then find the correct region to terminate and begin
to make synapses. How do axons select the correct cells with which to make synapses? Finally, after
synapses are initially made, they can be modified by activity and experi-
ence, leading to “plastic” changes that are important in key processes such
as learning and memory. What determines whether a synapse is maintained
or lost? How are these plastic changes controlled? This meeting focused
on these key issues in axon guidance, synaptogenesis, and plasticity.
In the past decade, our understanding of the mechanisms that control
axon growth and guidance, synaptogenesis, and the remodeling of neural
circuits during development has progressed rapidly from phenomenology
to the identification of specific molecular control mechanisms. Progress
has been assisted by the finding that these mechanisms are highly con-
served across evolution, so that both biochemical and genetic approach-
es in vertebrates and in invertebrates have led to mutually reinforcing dis-
coveries that have helped to fuel further advances. 
As the pace of discovery has quickened, the field has grown enormously,
making it more difficult for scientists to keep abreast of new developments. To
help facilitate communication in the field, a biennial CSHL conference series
on “Axon Guidance and Developmental Plasticity of the Nervous System” was
initiated in 1998. This year, the sixth of these meetings involved sessions
devoted to particular problems in the assembly of the nervous system, with
speakers chosen from among those submitting abstracts by Session chairs
who are leaders in the field. Other abstracts were presented as posters. 
Like the previous five meetings, the response of the field to the 2008 conference was one of over-
whelming enthusiasm: There were about 415 participants, 285 of whom submitted abstracts; 60
abstracts were selected for talks, in eight sessions. Senior researchers, starting assistant professors,
postdoctoral fellows, and graduate students were well represented as speakers and participants. All of
C. Holt, A. Kolodkin, A. Ghosh
L. Luo, N. Gray
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the major areas of research in the field were covered, as were all of the major approaches (cellular, phys-
iological, anatomical, molecular, dynamic imaging, biochemical, and genetic). In addition, there were two
keynote addresses: Professor Carla Shatz (Stanford) reviewed the history of the field of the development
of retinogeniculate and geniculocortical connections and included some of the seminal contributions
made by her own group, and Professor Paul Forscher (Yale University) focused on the cytoskeletal
dynamics in the growth cone and showed spectacular time-lapse movies of actin and microtubules illu-
minating the mechanics of growth. The meeting provided an important forum for ideas and approaches
and helped scientists in the field obtain the most up-to-date information, enabling them to meet, net-
work, and establish collaborations. At the previous meeting, a need was identified for an additional
poster session because the number and quality of abstracts submitted for posters were so high.
Therefore, this year a third poster session was introduced that was extremely well attended, and this
session went some way toward alleviating problems with overcrowding. Based on the enthusiastic com-
ments of the participants, the intensity of the oral and poster sessions, and the large crowds that stayed
late every night at the bar to discuss science, the meeting was a great success. 
This meeting was funded, in part, by the National Institute for Neurological Diseases and Stoke, a
branch of the National Institutes of Health, and Merck Research Laboratories.
PROGRAM
Axon Guidance I: Guidance Molecules
Chairpersons: A. Chedotal, CNRS, Université Paris 6, France; D.
Van Vactor, Harvard Medical School, Boston, Massachusetts
Synapse Formation I
Chairpersons: Y. Jin, University of California, San Diego; G.
Davis, University of California, San Francisco
Special Lecture: Tuning Up Circuits: Brain Waves,
Immune Genes, and Synapse Plasticity
C. Shatz, Stanford University, California
Neural Circuits and Plasticity
Chairpersons: B. Dickson, Institute of Molecular Pathology,
Vienna, Austria; M. Crair, Yale University, New Haven,
Connecticut
Axon Guidance II: Dynamics and Targeting
Chairpersons: L. Luo, Stanford University, California; M.
Tessier-Lavigne, Genentech Inc., South San Francisco,
California
Neuronal Polarity and Migration
Chairpersons: E. Stoeckli, University of Zurich, Switzerland; F.
Polleux, University of North Carolina, Chapel Hill
Axon Guidance III: Transcriptional, Translational
Control/Regeneration
Chairpersons: C. Mason, Columbia University, New York; Y.
Zou, University of California, San Diego
Synapse Formation and Dendritic Patterning
Chairpersons: K. McAllister, University of California, Davis; P.
Salinas, Imperial College London, United Kingdom
Special Lecture
P. Forscher, Yale University, New Haven, Connecticut
Axon Guidance IV: Signaling and Guidance
Chairpersons: L. Richards, University of Queensland, Australia;
S. Pfaff, The Salk Institute, La Jolla, California
Wine and cheese
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Dynamic Organization of Nuclear Function
September 17–21 294 participants
ARRANGED BY Genevieve Almouzni, Institut Curie, France
David Spector, Cold Spring Harbor Laboratory
Susan Wente, Vanderbilt University Medical Center, Tennessee
This meeting focused on the relationships between nuclear structure
and function. The opening session highlighted current studies on
gene expression and genome function, with the session chair (Andy
Belmont) giving a beautiful introduction to the session highlighting
the topic areas to be covered and critical questions relating to mod-
els of chromosome structure. He transitioned to describe his own
studies using cell lines and mouse ES cells expressing tagged BAC
transgenes to microscopically monitor chromatin structure during
differentiation. Of great interest and debate were talks focused on
new methods to pinpoint the molecular mechanisms and intranu-
clear organization underlying transcriptionally active versus inactive
chromatin. The following Thursday morning’s session, chaired by
John York, was a new addition to the program and focused on
nuclear signaling. With a novel chalk-talk approach, York introduced
the audience to the field of soluble inositol signaling and its impact on nuclear physiology. This session
highlighted the roles for signaling in regulating transcription, mRNA export, and chromatin structure.
Signaling from or at the nuclear envelope also revealed novel mechanisms for influencing nuclear enve-
lope morphology, breakdown, and cell differentiation. After a lively poster session and wine and cheese
party, Tom Misteli chaired the dynamics of chromatin, DNA replication, and repair session. 
The work presented illustrated the two faces of chromatin dynamics, that of the chromatin fiber and
of chromatin-binding proteins involved in replication and repair. A lively discussion ensued concerning
the programming of DNA replication origins and their specificity. Friday morning started with the nuclear
domains and bodies session chaired by Sui Huang. This has been a long-standing topic at the meeting;
however, this year, the talks illustrated the tremendous progress that is being made in analyzing the
S. Wente, D. Spector, G. Almouzni
Through the looking glass: Poster session in Bush Auditorium
229-292_Meetings:Layout 1  6/12/09  11:45 AM  Page 273
274
mechanisms of assembly for nuclear bodies and their functional roles. Lunch was followed by an after-
noon session on epigenetics and nuclear organization chaired by Wendy Bickmore. This session revis-
ited in more depth topics of genome control and renewed the ongoing and lively debate about repres-
sive versus activating chromatin environments within the nucleus. An evening poster session ended the
day, with discussions at the posters continuing for many more hours than anticipated. The nucleocyto-
plamic transport session started Saturday morning and was chaired by Ueli Aebi who gave a broad intro-
duction to the nuclear pore complex and transport mechanisms. The session included vigorous discus-
sions of the competing models for facilitated transport, as well as reports of new factors required for
mRNA export, tRNA shuttling, and pore complex assembly. New evidence was also presented for
changes in pore permeability and nuclear leakiness with cell differentiation and age. The afternoon ses-
sion on chromosomes and the cell cycle was ably chaired by Rebecca Heald and described the regu-
lation of mitotic chromosome dynamics as well as the roles for nuclear transport factors in cell cycle pro-
gression. The final Sunday morning session on nuclear structure and disease was chaired by Wim
Vermeulen and gave multiple direct examples of how the machinery involved in nuclear organization and
function is linked to the underpinnings of several pathophysiologic states. This included a subgroup of
talks on the newest insights into altered A-type lamin function in the premature aging disease Progeria,
as well as talks probing the molecular determinants of cancer-prone symptoms of xeroderma pigmen-
tosum and Cockayne syndrome, of the fatal bone marrow failure syndrome dyskeratosis congentia, and
of the Roberts and Cornelia de Lange developmental syndromes. 
The enthusiasm of the meeting participants was overwhelming, and it is remarkable how with each
successive meeting, the interest has grown and strengthened. It is anticipated that the CSHL 2010
Symposium will focus on “Functional Organization of the Cell Nucleus.” On the basis of success of the
past meetings, the major insights in the field, and its expansion, one can anticipate that the Symposium
will be a great success!
PROGRAM
Gene Expression and Genome Function
Chairperson: A. Belmont, University of Illinois, Urbana,
Champaign
Nuclear Signaling
Chairperson: J. York, HHMI/Duke University Medical Center,
Durham, North Carolina
Dynamics of Chromatin, DNA Replication, and Repair
Chairperson: T. Misteli, NCI/National Institutes of Health,
Bethesda, Maryland
Nuclear Domains and Bodies
Chairperson: S. Huang, Northwestern University School of
Medicine, Chicago, Illinois
Epigenetics and Nuclear Organization
Chairperson: W. Bickmore, MRC Human Genetics Unit,
Edinburgh, United Kingdom
Nucleocytoplasmic Transport
Chairperson: U. Aebi, University of Basel, Switzerland
Chromosomes and the Cell Cycle
Chairperson: R. Heald, University of California, Berkeley
Nuclear Structure and Disease
Chairperson: W. Vermeulen, Erasmus University, Rotterdam,
The Netherlands
M. Huebner, R. Zhao, J. Wilusz
O. Cohen-Fix N. Watkins
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Biotechnology: Past, Present, and Future
September 21–23 91 participants
ARRANGED BY Mila Pollock and Jan Witkowski, Cold Spring Harbor Laboratory
ADVISORS Sydney Brenner
Peter Feinstein
Lee Hood
Tom Maniatis
Richard Roberts
Biotechnology is a science that dates back to the fermentation and breeding practices of the ancient
Egyptians. The discoveries of Pasteur and Mendel in the 19th century furthered this scientific field.
Today we recognize the developments of the latter part of the 20th century as the origins of the mod-
ern biotechnology era. The application of recombinant DNA technologies sparked the “Biotech
Revolution” and ushered in the rapid growth of a new industry. This special conference was support-
ed and arranged by the Laboratory's Genentech Center for the History of Molecular Biology and
Biotechnology. The conference explored the growth of a new industry from its creation to the extraor-
dinary impact it has had on our quality of life, and it attracted prominent industry participants to exam-
ine how the scientific and business worlds came together and how they will continue to impact the
industry’s future. These scientists, entrepreneurs, and venture capitalists—all of whom were essential
to the industry’s growth—were joined by the sociologists, economists, and historians who have ana-
lyzed the extraordinary impact the products of the biotech industry have had on our lives. Sessions at
the meeting included talks and panel discussions addressing a variety of themes.
K. Murray, C. Weissmann
M. Van Montagu
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PROGRAM
Origins of Biotechnology
Keynote Addresses
R. Roberts, Biotechnology: Past, present, and future
R. Bud, Prehistory: From ancient times to 1970
Stelios Papdopoulos, Business and modern biotech:
1970–1980
Early Days in Biotechnology
C. Weissmann, Biogen
H. Heyneker, Genentech
Enabling Technology
D. Comb, Role of support companies
M. Feldman, Commercializing Cohen-Boyer: The origins of
university biotechnology transfer
P. Feinstein, Venture investing in human therapeutics
Interactions of Biotechnology and Society
R. Steinbrook, Influence of government policies
A. McHughen, Influence of public: Genetically modified organ-
isms
N. and K. Murray
R. Roberts, K. Murray
J. Leamon, DNA sequencing and personal genomes
The Raw Data: Biotechnology Documentation
K. Thibodeau, The survival and exploitation of scientific data in
cyberspace
Panel Discussion: Preserving and Accessing the History
of Biotechnology
Chairpersons: R. Bud, S. Grefshein, and M. Pollock
Lessons for the Future
G. Bohlin, Starting a biotech company in the 21st century
Y.-L. Lo, Emerging markets: Perspectives from China present-
ed by Julie Xing
M. Van Montagu, Biotechnology: Economics and the develop-
ing world
Panel Discussion: Promoting the History of
Biotechnology
Chairpersons: K. Murray, R. Olby, R. Roberts, D. Tobell, and J.
Witkowski
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Molecular Genetics of Aging
September 24–28 279 participants
ARRANGED BY Judith Campisi, Lawrence Berkeley National Laboratory
David Sinclair, Harvard University
Steven Austad, University of Texas Health Science Center
Aging is controlled by genetics and the environment and leads to
biological changes that put organisms at increasing risk for a
panoply of diseases and eventual death. Remarkable progress has
been made in recent years in establishing a molecular foundation
for understanding how genes control and influence aging and how
genetic and environmental manipulations can alter its course. This
conference provided an in-depth forum for new findings and con-
cepts in current aging research and stimulated lively discussions
on how genetic pathways interact with each other and the environ-
ment to influence aging in diverse organsims. Two sessions
focused specifically on genetics. One highlighted the growing list of
genetic pathways that influence life span in simple model organ-
isms such as nematodes and fruit flies, and the other focused on
conserved and nonconserved pathways that modulate aging and
life span in mammals. Two related session focused on how genes
that promote somatic genome stability postpone aging and age-related diseases, and how cellular
responses to genotoxic and other forms of stress drive aging phenotypes. A session was devoted to
understanding how mitochondrial function and nutrient sensing and metabolism influence aging and
the relationship between these processes and longevity. Two sessions focused on cell proliferation.
One highlighted processes that maintain proliferative homeostasis in mitotic and postmitotic tissues,
and another explored the role of stem cells in the aging of specific tissues. Finally, one session focused
on how the environment interacts with genes to influence aging, and on recent advances in develop-
S. Austad, J. Campisi, D. Sinclair
R. Taylor, H. Aguilaniu, N. Erjavec J. Witkowski, E. Blackburn
229-292_Meetings:Layout 1  6/9/09  4:22 PM  Page 277
278
ing environmental interventions in the aging process. The conference captured the excitement sur-
rounding the rapid progress that is being made in understanding the molecular bases for aging, and
highlighted the many important questions that have yet to be answered in this growing field.
This meeting was funded, in part, by the National Institute on Aging, a branch of the National
Institutes of Health. 
PROGRAM
Genetics (Simple Organisms)
Chairpersons: H. Tissenbaum, University of Massachusetts
Medical School, Worcester; S. Pletcher, Baylor College of
Medicine, Houston, Texas
Genomic Stability/Damage/Repair/Telomeres
Chairpersons: J. Vijg, Albert Einstein College of Medicine,
Bronx, New York; E. Blackburn, University of California, San
Francisco
Oral Presentations from Abstracts
S. Austad, University of Texas Health Science Center, San
Antonio; J. Campisi, Lawrence Berkeley National Laboratory,
Buck Institute for Age Research, California; D. Sinclair,
Harvard Medical School, Boston, Massachusetts
Mitochondria/Metabolism
Chairpersons: P. Rabinovitch, University of Washington,
Seattle; L. Guarente, Massachusetts Institute of Technology,
Boston
Cellular Responses: Senescence/Apoptosis/Stress
Chairpersons: J. Sedivy, Brown University, Providence, Rhode
Island; N. Sharpless, University of North Carolina, Chapel Hill
Stem Cells
Chairpersons: I. Conboy, University of Berkeley, California; K.L.
Rudolph, University of Ulm, Germany
Proliferative Homeostasis
Chairpersons: P. Hasty, University of Texas Health Science
Center, San Antonio; R. Bodmer, Burnham Institute for
Medical Research, La Jolla, California
Environment/Interventions
Chairpersons: R. Miller, University of Michigan, Ann Arbor; S.
Spindler, University of California, Riverside
Genetics (Complex Organisms)
Chairpersons: A. Brunet, Stanford University, California; J.
Hoeijmakers, Erasmus University, Rotterdam, The Netherlands
L. Guarente, S. Michan
B. Stillman, E. Blackburn
N. Sharpless, S. Primmer
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Germ Cells
October 1–5 218 participants
ARRANGED BY Anne Ephrussi, EMBL, Germany
Renee Reijo Pera, Stanford University School of Medicine
David Zarkower, University of Minnesota
This meeting began with a perspective on the female germ line and reprogramming by Dr. J. Gurdon,
with acknowledgement of the significant role that Dr. Ann McLaren has had over many years in unrav-
eling the mysteries of the germ cell. Notably, Dr. Gurdon compared the reprogramming strategies and
efficiencies from different organisms. Although commonly thought to be inefficient, somatic cell nuclear
transfer takes advantage of the oocyte and has a remarkable efficiency that can reach up to 30%–50%
in some organisms. The relationship between reprogramming by the oocyte and the production of
induced pluripotent stem cells remains elusive.
The emphasis on reprogramming continued with a
discussion of novel aspects of the oocyte-to-embryo
transition. In particular, Dr. H. Ueno demonstrated his
system to track the birth of germ cells and the size of
the founding population. Dr. M. Yao presented data
demonstrating that the mammalian Oct4 gene is
required in the oocyte-to-embryo transition, and Drs.
Chen and Seydoux discussed the regulatory activities
of CDK-1 in activating MBK-2 during the oocyte-to-
embryo transition in Caenorhabditis elegans. 
There has been remarkable progress since the last
Germ Cells meeting (in 2006) in the area of germ cell
specification in diverse organisms from planeria to
zebra fish, mice, and humans. Indeed, the use of
embryonic stem cells (both mouse and human) to dif-
ferentiate germ cells for genetic analysis was the key
focus in a number of talks and poster presentations.
Issues that have slowed progress were addressed
including markers for isolation of germ cells and E. Huebner, C. Extavour
M. McGovern, F. Marlow P. Western, J. Gurdon
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strategies to provide the niche. Numerous genes, in vivo, that are required for germ cell specification
have been identified and are well characterized including Bucky ball and Nanos2 (and homologs). 
Posttranslational mechanisms of regulation and development were featured as knowledge in this
area grows and the importance of posttranslational mechanisms becomes abundantly more clear.
Indeed, from specification to proliferation and maintenance to differentiation, posttranslational mecha-
nisms have important roles in regulating transcript abundance, availability, and protein modifications. 
The next Germ Cells meeting will be held in the fall of 2010 and will be organized by M. Fuller, J.
Eppig, and P. Newmark.
The 2008 meeting was funded, in part, by the National Institute of Child Health and Human
Development, a branch of the National Institutes of Health and Labor Foundation, and the March of
Dimes.
PROGRAM
Themes in Germ Cell Biology
Chairperson: S. Strome, University of California, Santa 
Cruz
Reprogramming and the Oocyte-to-embryo Transition
Chairperson: S. DiNardo, University of Pennsylvania School 
of Medicine, Philadelphia
Germ Cell Specification and Patterning
Chairperson: J. Kimble, HHMI/University of Wisconsin,
Madison
Germ Cell Formation In Vivo and In Vitro
Chairperson: R.S. Hawley, Stowers Institute for Biomedical
Research, Kansas City, Missouri
Germ Line Stem Cells
Chairperson: R. Lehmann, HHMI/New York University Medical
Center, New York
Epigenetic Regulation
Chairperson: A. Surani, University of Cambridge, United Kingdom
Posttranscriptional Regulation of Germ Cell
Development
Chairperson: Y. Saga, National Institute of Genetics, Mishima,
Japan
Germ-line Programs
Chairperson: A. Spradling, HHMI/Carnegie Institute, Baltimore,
Maryland
Caricaturist
D. Page, J. Mueller
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Personal Genomes
October 9–12 168 participants
ARRANGED Richard Gibbs, Baylor College of Medicine
Mary-Claire King, University of Washington
Maynard Olson, University of Washington
Lincoln Stein, Cold Spring Harbor Laboratory
Jan Witkowski, Banbury Center, Cold Spring Harbor Laboratory
This special meeting was arranged both to celebrate and to criti-
cally examine a significant milestone in human genetics—the first
“personal genomes.” Ultra-high-throughput sequencing strategies
are used in a very limited number of laboratories and few scientists,
and even fewer clinical geneticists, are familiar with the implications
of the “$1000” genome. This meeting provided an opportunity to
explore a number of important themes and a panel discussion on
the ethical, legal, and social implications (ELSI) of these rapidly
changing technologies. The critical success and timeliness of the
meeting can be judged from the measurable enthusiasm of the
audience and the appearance of two major editorials citing the
conference in considerable depth in subsequent issues of Nature
magazine. The collective decision was taken to hold the meeting
for a second time at Cold Spring Harbor in the fall of 2009. L. Stein, G. Weinstock
F. Collins, H. Sussman
R. Myers, E. Mardis
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PROGRAM
Introduction: Setting the Tone
J.D. Watson, Cold Spring Harbor Laboratory
Single Genome Sequences
Making Sense of the Content of Whole Genomes
Panel Discussion: Ethics
Chairperson: F. Collins, National Human Genome Research
Institute, Bethesda, Maryland
Applications Of Whole-genome Studies
Whole-genome Genetics
New Developments
W.R. McCombie, J. Watson
C. Bustamente, O. Bahcall
M. Banck, A. Butler
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Mouse Genetics and Genomics: Development and Disease
October 29–November 2 186 participants
ARRANGED BY Kathryn Anderson, Memorial Sloan-Kettering Cancer Center
Hiroyuki Sasaki, National Institute of Genetics
William Skarnes, Wellcome Trust Sanger Institute
Anthony Wynshaw-Boris, University of California School of Medicine, San Francisco 
This meeting is held every other year at Cold Spring Harbor
Laboratory. Researchers from across the globe from very diverse
areas of biology are united by the common use of mouse mutants in
their research. As a result, the meeting covers very diverse areas of
biology in which the contribution of mouse genetics is essential to the
progress of knowledge. The sustained interest of all participants
throughout the meeting is ensured by the commonality of techniques,
as well as by increasing evidence that basic mechanisms are con-
served across diverse experimental systems.
The meeting was organized into eleven sessions and included the
Annual Rosa Beddington Lecture given by Janet Rossant. Each ses-
sion was arranged around two to three talks of general interest, given
by both senior and more junior invited researchers. Between these
more in-depth talks, five to six speakers per session were selected from
the abstracts for more concise presentations. The meeting also included the pre-
sentation of nearly 100 posters in two afternoon sessions. It ended with a farewell
to Hiro Sasaki and Tony Wynshaw-Boris, who stepped down after 4 years as orga-
nizers of the meeting. They will be replaced by Michael Shen and Haruhiko Koseki. 
Some of the sessions have shifted in their emphasis during the past 2 years.
The growing emphasis on genetics/genomics and on human disease models,
already noted in previous years, has also continued, leading to the change in title
this year. Given the increasing importance of the mouse as a model to investigate
disease mechanisms, and the sophistication with which diseases can now be
modeled and analyzed in the mouse, the organizing committee has decided to
emphasize the link between mouse and human genetics. This year, neurogenetic
diseases were a focal point of the session featuring mouse models of human diseases. Due to the rapid
development of mouse genetic resources, there was also a mouse ES cell workshop headed by Bill
Skarnes.
This meeting was funded, in part, by the National Institute of Child Health and Human Development,
a branch of the National Institutes of Health.
A. Wynshaw-Boris, K. Anderson
H. Sasaki
PROGRAM
Germ Cells and Stem Cells
Chairperson: H. Schoeler, Max-Planck Institute for Molecular
Biology, Münster, Germany
Organogenesis
Chairperson: F. Costantini, Columbia University College of
Physicians & Surgeons, New York
Neurogenetics
Chairperson: S. McConnell, Stanford University, 
California
Epigenetics
Chairperson: H. Koseki, RIKEN Research Center for Allergy
and Immunology, Yokohama, Japan
Patterning
Chairperson: D. Kingsley, Stanford University, 
California
Genetics and Genomics
Chairperson: S. Orkin, HHMI/Children’s Hospital, Boston,
Massachusetts
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W. Skarnes
S. McConnell, J. Partanea
Mouse ES Workshop
Chairperson: W. Skarnes, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Rosa Beddington Lecture: Cell Lineage and Cell Fate in
the Early Embryo
J. Rossant, The Hospital for Sick Children, Toronto
Human Disease Models
Chairperson: J. Crawley, NIMH/National Institutes of Health,
Bethesda, Maryland
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Pharmacogenomics
November 19–22 147 participants
ARRANGED BY Michel Eichelbaum, Institute of Clinical Pharmacology, Germany
Steve Leeder, Children’s Mercy Hospital, Kansas City
Munir Pirmohamed, University of Liverpool
Dick Weinshilboum, Mayo Medical School, Minnesota
Scott Weiss, Brigham and Women’s Hospital
Roland Wolf, University of Dundee
This sixth meeting, a joint project of CSHL and the Wellcome Trust, was funded, in part,
by the National Institute of General Medical Sciences (NIGMS), one of the NIH institutes.
This series of meetings, held in alternating years on the CSHL and Sanger Centre cam-
puses, is designed to bring together scientists from disciplines that range from basic
genomics to clinical medicine who are studying the role of inheritance in variation in drug
response phenotypes—phenotypes that can range from life-threatening adverse drug
reactions to lack of the desired therapeutic drug effect. As a result, pharmacogenomics
represents a major component of the movement toward “personalized” or “individual-
ized” medicine. The opening session began with a scientific presentation by Jeremy Berg,
Director of NIGMS, followed by a presentation from Scott Weiss, Chair of the NIH-spon-
sored, multi-institutional Pharmacogenetics Research Network (PGRN), and a presenta-
tion highlighting the scientific accomplishments of the Foundation NIH (FNIH) by Dr.
Stephen Spielberg, a member of the FNIH Board. A major theme running through the
meeting was the explosive growth of the application to pharmacogenomics of genome-
wide techniques such as genome-wide association studies (GWAS) and “next-genera-
tion” DNA sequencing. Sessions devoted to cardiovascular pharmacogenomics and adverse drug
reactions were complemented by sessions that focused on pharmacogenomic GWAS, bioinformatics,
and developments in DNA sequencing, with a presentation on next-generation sequencing by Rick
Wilson, Director of the Washington University Genome Center. The PGRN sponsored a session on
pharmacogenomic mechanisms that included presentations on genome-wide studies of enhancer ele-
ments by Eddie Rubin and the pharmacogenomics of drug therapy of congestive heart failure by
R. Weinshilboum
J. Ramatoulie, M. Pirmohamed S. Leeder, K. Aitcheson
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Stephen Liggett. The major theme that emerged from the meeting was the convergence of genomic
and pharmacogenomic science as we move toward a more highly individualized use of drugs in the
treatment and/or prevention of disease.
PROGRAM
Opening Session
Chairpersons: R.M. Weinshilboum, Mayo Clinic, Rochester,
Minnesota; J.S. Leeder, Children's Mercy Hospital, Kansas
City, Missouri
Whole-genome Associations and Translational
Bioinformatics
Chairpersons: M. Eichelbaum, Dr. Margarete Fischer-Bosch-
Institute of Clinical Pharmacology, Stuttgart, Germany; C.R.
Wolf, University of Dundee, United Kingdom
Basic Genomics: DNA Sequencing and CNV
Chairpersons: M. Pirmohamed, University of Liverpool, United
Kingdom; M. Eichelbaum, Dr. Margarete Fischer-Bosch-
Institute of Clinical Pharmacology, Stuttgart, Germany
Cardiovascular Pharmacogenomics
Chairpersons: D. Roden, Vanderbilt University, Nashville,
Tennessee; A. Shuldiner, University of Maryland School of
Medicine, Baltimore
Advances in Pharmacogenomics of Adverse Drug
Reactions
Chairpersons: M. Pirmohamed, University of Liverpool, United
Kingdom; J.S. Leeder, Children’s Mercy Hospital, Kansas
City, Missouri
Mechanisms in Pharmacogenomics
Chairpersons: K. Giacomini, University of California, San
Francisco; S. Liggett, University of Maryland, Baltimore
Clinical Application of Pharmacogenomics and Public-
private Partnerships
Chairpersons: R. Valdes, University of Louisville, Kentucky; T.
Moyer, Mayo Clinic, Rochester, Minnesota
K. Skoglund, A. Snapir
Y. Garten
R. LaFond, E. Woodahl
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Blood Brain Barrier Physiology
December 1–4 67 participants
ARRANGED BY Roland J. Bainton, University of California, San Francisco
Ben Barres, Stanford University
The aim of this new Cold Spring Harbor Winter Biotechnology
Conference was to encourage new conceptual approaches and
novel methods to our understanding of the neuroprotective physiolo-
gies of blood brain barrier (BBB) structures, pairing genetics of model
organisms and associated biological methods with recent insights
into vertebrate BBB physiology and development. The conference
fostered cross-disciplinary exchange of ideas and expertise among
developmental and evolutionary biologists, vascular and BBB physi-
ologists, and disease-oriented industry scientists interested in modi-
fying or circumventing specific pathways of neuroprotection.
Keynote addresses on different aspects of BBB physiology were
given by Tom Reese and Rich Daneman.
As is traditional at Cold Spring Harbor meetings, selection of
material for oral and poster presentation was made by the organiz-
ers and individual session chairs on the basis of scientific merit. 
R. Bainton, R. Daneman
B. Barres on closed circuit television
N. Saunders
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PROGRAM
Imaging and Modeling Blood Brain Barrier during Health
and Disease
Chairpersons: M. Nedergaard, University of Rochester, New
York; A. Prat, University of Montreal, Canada
Molecular Constituents of Blood Brain Barrier
Chairpersons: G. Beitel, Northwestern University, Evanston,
Illinois; M. Furuse, Kobe University, Japan
Keynote Address
R. Daneman, Stanford University, California
Cellular Physiology of Blood Brain Barrier
Chairpersons: A. Armulik, Karolinska Institute, Stockholm,
Sweden; C. Klambt, University of Münster, Germany
VI Screening
Chairpersons: I.E. Blasig, Leibniz-Institut für Molekulare
Pharmakologie, Berlin, Germany; J. Dow, University of
Glasgow, United Kingdom
Transport and Drug Delivery
Chairpersons: B. Sarkadi, Hungarian Institute of Science,
Budapest; R. Watts, Genentech Inc., South San Francisco,
California
Keynote Address
T. Reese, NINDS/National Institutes of Health
Molecular Regulation of Blood Brain Barrier
Chairpersons: U. Gaul, The Rockefeller University, New York;
C.J. Kuo, Stanford University, California
D. Miller reviewing posters
G. Murray, S. Cohen, H. Stolp, P. Johannson
G. Galvis, A. Armulik
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Neurodegenerative Diseases: Biology and Therapeutics
December 4–7 123 participants
ARRANGED BY Sam Gandy, Mount Sinai School of Medicine
Virginia Lee, University of Pennsylvania School of Medicine
Marcy MacDonald, Massachusetts General Hospital
As many as one-half of those aged 85 years or older will develop
debilitating degenerative disease of the central nervous system,
usually characterized by a decade or more of dependent living,
accompanied by progressive failure of cognitive function and/or
coordinated movement. Although these illnesses appear most
commonly in the absence of obvious heredibility or identifiable
genetic mutations, it has been possible during the past 20 years
to discover risk-modifying DNA changes in some examples and
predictable causative changes in others. From these findings,
transgenic technology has rapidly led to the development of
mouse, fruit fly, and nematode model systems that partially reca-
pitulate the clinical abnormalities of human diseases as well as
some of the hallmark molecular and morphological pathology of
the conditions.
Rational biochemical and cell-based screens have generated lead compounds that show promise
in living animal models. Most importantly, the animal models have enabled discovery of entirely unan-
ticipated therapeutic strategies (such as amyloid β immunotherapy). Some of these rationally discov-
ered compounds and unexpected immunotherapies are now in phase II and III clinical trials. The
progress of compounds and rational strategies from the animal model to the human clinical trial; the
design, results, and conclusions of trials; and the return to the animal model with questions raised dur-
ing human trials are the areas of particular emphasis for these biannual Winter Biotechnology Meetings
instituted in December 2000, with the explicit goal of facilitating the translation of “breakthrough” sci-
ence into effective medicines.
For this meeting, eight 3- or 4-hour platform sessions were organized around
common technological themes. Chairpersons, invited speakers, and speakers
selected from submitted abstracts were drawn from the academic and pharma sec-
tors. Although the discussion of new, unpublished data was emphasized, the group
was tolerant of a wide range of intellectual property conventions. Poster presenta-
tions were also encouraged; posters were displayed for an extended period during
the meeting, and poster viewing was especially encouraged during the cocktail
hours before evening meals.
Topics in the 2008 meeting included federal and foundation perspectives on neu-
rodegenerative drug discovery, presymptomatic evaluation, imaging methodology
development, amyloid imaging in humans and mouse models, synthesizing protein
evidence from imaging, cell biology, and genetics in order to approach sporadic
neurodegenerative diseases, genetic, biochemical, and physiological markers; clin-
ical trials; innovative trial design; modulation of disease by aging, metabolic, excito-
toxic and extracellular matrix factors; protein conformational considerations
(oligomerization); and the frontotemporal dementia–motor neuron disease–parkin-
sonism spectrum of disease. Diseases considered at this meeting included
Alzheimer’s, Huntington’s, ALS, prion diseases, Parkinson’s, tauopathies, and synu-
V. Lee, D. Stewart
M. MacDonald
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cleinopathies, as well as the newly described TDP-43-related diseases. A
session was also devoted to an update on the Alzheimer’s disease neu-
roimaging initiative, and another session was devoted to genome-wide asso-
ciation studies of several major neurodegenerative diseases.
This meeting was funded, in part, by Merck Research Laboratories.
PROGRAM
NIA Alzheimer's Disease Neuroimaging Initiative (ADNI)
Update
Biomarkers in Alzheimer’s Disease
Genetic Approach to Target Discovery (GWAS)
Talks from Submitted Abstracts
Amyotrophic Lateral Sclerosis
Huntington's Disease and Dyt1 Dystonia
Update on Targets and Drug Discovery in Alzheimer’s I
Update on Targets and Drug Discovery in Alzheimer’s II
T. Klaber, P. Jaeger
J. Witkowski, J. Trojanowski
M. Fahnestock, S. Gandy
A. Cachikar, C. Masters
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Engineering Principles in Biological Systems
December 10–13 73 participants
ARRANGED BY Hana El-Samad, University of California, San Francisco
Partha Mitra, Cold Spring Harbor Laboratory
Richard Murray, California Institute of Technology
Christina Smolke, California Institute of Technology
The first meeting on Engineering Principles in Biological Systems
was held in December 2006, following an earlier planning work-
shop at the Banbury Conference Center in May of the same
year. At that meeting, attendees expressed appreciation of the
unique and broad scope of the meeting, with the aim to repeat
the meeting in December 2008. The two key ideas behind this
meeting were that theoretical principles which have been devel-
oped in the context of human engineered systems are useful in
understanding biological function and that these principles apply
across scales, from the cellular to the organismal level. In keep-
ing with these ideas, the meeting attracted researchers in a
broad range of fields, ranging from bacterial systems biology to
neural systems, with shared interest in engineering principles.
Sessions were broken up according to broad areas of engineer-
ing, including a general introduction to the field, and individual sessions on multicellular communities, evo-
lution, intracellular networks, and synthetic biology/theory. There was considerable enthusiasm among the
group for continuing this unique meeting series, and a third meeting will be held in Cambridge, United
Kingdom in fall 2009, as part of the CSHL/Wellcome Trust joint conference program.
This meeting was funded, in part, by the Center for Biological Circuit Design (CBCD) at the California
Institute of Technology.
P. Mitra, R. Rabadan
Group photo
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Introduction
P. Mitra, Cold Spring Harbor Laboratory
Multicellular Communities
Chairperson: H. El-Samad, University of California, San
Francisco
Neurobiology
Chairperson: S. Schiff, Pennsylvania State University,
University Park
Evolution
Chairperson: L. Caporale, New York, New York
Intracellular Networks I
Chairperson: R. Murray, California Institute of Technology,
Pasadena
Intracellular Networks II
Chairperson: R. Murray, California Institute of Technology,
Pasadena
Synthetic Biology and Theory
Chairperson: C. Smolke, California Institute of Technology,
Pasadena
B. Mishra, R. Rabadan
R. Greenspan
M. Atwal
M. Donahue, K. Galloway
292
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities do
not adequately teach them. Our aim is to provide intensive study in the most recent developments and
techniques in these subjects and to prepare students to enter directly into research in a particular area.
To ensure up-to-date coverage of current research work, we bring together course faculty from many
laboratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 2–15
INSTRUCTORS K. Adelman, National Institutes of Health/NIEHS, Research Triangle Park, North Carolina
R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
M. Marr, Brandeis University, Waltham, Massachusetts
ASSISTANTS S. Duellman, University of Wisconsin, Madison
D. Gilchrist, NIEHS, Research Triangle Park, North Carolina
B. Glaser, University of Wisconsin, Madison 
Y.-C. Lee, M.D. Anderson Cancer Center/University of Texas, Houston
S. Nechaev, NIEHS, Research Triangle Park, North Carolina
L. Nutt, Duke University Medical Center, Durham, North Carolina
N. Thompson, University of Wisconsin, Madison
W. Turki-Judeh, University of California, Los Angeles
K. Wright, University of California, Berkeley
J. Zamudio, University of California, Los Angeles
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 293
294
PARTICIPANTS
Block, G., M.S., Tulane University Health Sciences Center,
New Orleans, Louisiana
Chen, H., Ph.D., Washington University, St. Louis, Missouri
Folch, E., Ph.D., IIBB-CSIC, Barcelona, Spain
Foronjy, R., M.D., Columbia University, New York
Jalili, R., M.S., Stanford Genome Technology Center, Palo
Alto, California
Jendresen, C., M.S., Technical University of Denmark, 
Lyngby
Kimura, M., Ph.D., Gifu University School of Medicine, Gifu,
Japan
Kraft, E., Ph.D., Monsanto, Davis, California
Lindemos, S., M.S., University of Copenhagen, Denmark
Lu, J., M.Sc., The University of Warwick, Coventry, United
Kingdom
McLain, T., B.S., Colorado State University, Fort Collins
Santiago, R.-G., Ph.D., University of British Columbia,
Vancouver, Canada
Smith, J., B.A., University of Utah, Salt Lake City
Spivak, A., B.S., Washington University in St. Louis School of
Medicine, Missouri
Wang, M., B.S., University of Texas Southwestern Medical
Center, Dallas 
Zanic, M., Ph.D., Max-Planck Institute, Dresden, Germany
SEMINARS
Adelman, K., NIH/NIEHS, Research Triangle Park, North
Carolina: RNA polymerase is poised for development across
the genome.
Burgess, R., University of Wisconsin, Madison: Introduction to
protein purification, immunoaffinity chromatography.
Burgess, R. and Glaser, B., University of Wisconsin, Madison:
RNA polymerase-sigma factor interactions and use of LRET-
based assays for drug discovery and biochemistry.
Courey, A., University of California, Los Angeles: Multiple roles
for SUMO in cell biology and development.
Joshua-Tor, L., Cold Spring Harbor Laboratory: DNA translo-
cation: One step at a time.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Adhesion molecules and osteogenesis in prostate cancer
bone metastasis.
Marr, M., Brandeis University, Waltham, Massachusetts:
Controlling gene expression in response to extracellular sig-
nals.
This course was for scientists who were not familiar with techniques of protein isolation and character-
ization. It was a rigorous program that included laboratory work all day and a lecture with discussion
session every evening. Students became familiar with each of the major techniques in protein purifica-
tion by actually performing four separate isolations including (1) a regulatory protein from muscle tis-
sue, (2) a sequence-specific DNA-binding protein, (3) a recombinant protein overexpressed in
Escherichia coli, and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic,
and chromatographic techniques included precipitation by salts, pH, and ionic polymers; ion
exchange, gel filtration, hydrophobic interaction, and reverse phase chromatography; lectin affinity, lig-
and affinity, oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel elec-
trophoresis, and electroblotting; and high-performance liquid chromatography. Procedures were pre-
sented for solubilizing proteins from inclusion bodies and refolding them into active monomeric forms.
Methods of protein characterization were used to include immunological and biochemical assays, pep-
tide mapping, amino acid analysis, protein sequencing, and mass spectrometry. Emphasis was placed
on strategies of protein purification and characterization. Guest lecturers discussed protein structure,
modification of proteins, methodologies for protein purification and characterization, and applications
of protein biochemistry to cell and molecular biology. In addition to the non-CSHL instructors, the
course also included CSHL investigator Leemor Joshua-Tor. 
This course was supported with funds provided by the National Cancer Institute (http://www.
cancer.gov/).
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Cell and Developmental Biology of Xenopus
April 5–15
INSTRUCTORS R. Keller, University of Virginia, Charlottesville
K. Kroll, Washington University School of Medicine, St. Louis, Missouri
ASSISTANTS T. Nakayama, University of Virginia, Charlottesville
D. Shook, University of Virginia, Charlottesville
Xenopus is the leading vertebrate model for the study of gene function in development. The combina-
tion of lineage analysis, gene-knockout strategies, experimental manipulation of the embryo, and
genomic/bioinformatic techniques made it ideal for studies on the molecular control of embryo pattern-
ing, morphogenesis, and organogenesis. The course combined intensive laboratory training with daily
lectures from recognized experts in the field. Students learned both emerging technologies and classi-
cal techniques to study gene function in opus development. An important element was the informal
interaction between students and course faculty. Technologies covered included oocyte and embryo
culture, lineage analysis, and experimental manipulation of embryos; time-lapse imaging of morpho-
genesis; gain- and loss-of-function analyses using mRNAs and antisense oligos; whole-mount in situ
hybridization, immunocytochemistry, RT-PCR, and genomic/bioinformatic techniques; preparation of
transgenic embryos; and use of Xenopus tropicalis for genetic analyses. This course was designed for
those new to the Xenopus field, as well as those wanting a refresher course in the emerging technolo-
gies. The course was open to investigators from all countries.
Lecturers and assistants for the 2008 course included Ken Cho (University of California, Irvine), Jan
Christian (Oregon Health and Sciences University), Rob Grainger (University of Virginia), Richard
Harland (University of California, Berkeley), Janet Heasman (Cincinnati Children’s Hospital Research
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Foundation), Mustafa Khokha (Yale University School of Medicine), Paul Krieg (University of Arizona
College of Medicine), Takuya Nakayama (University of Virginia), and Christopher Wylie (Cincinnati
Children’s Hospital Research Foundation).
This course was supported with funds provided by the National Institute of Child Health and Human
Development (http://www.nichd.nih.gov/), the National Science Foundation (http://www.nsf.gov/), and
the Howard Hughes Medical Institute (http://www.hhmi.org/).
PARTICIPANTS
Battu, G., Ph.D., National Cancer Institute at Frederick,
Frederick, Maryland
Beyer, T., Dipl., University of Hohenheim, Stuttgart, Germany
Corsing, A., M.S., Martin-Luther University Halle/Saale,
Germany
Harding, J., M.B., Cancer Research, London, United Kingdom
Hindley, C., M.B., University of Cambridge, Cambridge, United
Kingdom
Janssens, S., M.S., VIB-Ghent University, Zwijnaarde, Belgium
Lutz, I., Ph.D., Leibniz-Institute of Freshwater Ecology and
Inland, Berlin, Germany
Mantecca, P., Ph.D., University of Milano Bicocca, Milano, Italy
Miller, R., Ph.D., University of Texas/M.D. Anderson Cancer
Center, Houston
Powell, W., Ph.D., Kenyon College, Gambier, Ohio
Richardson, W., B.Sc., Medical Research Council, Edinburgh,
United Kingdom
Schmucker, D., Ph.D., Harvard Medical School and Dana-
Farber Cancer Institute, Boston, Massachusetts
Wang, F., M.Sc., Cancer Research UK, Cambridge, United
Kingdom
Weber, T., Dipl., University of Hohenheim, Stuttgart, Germany
Widder, P., B.S., Virginia Polytechnic Institute and State
University, Blacksburg
Williams, R., B.Sc., University of East Anglia, Norwich, United
Kingdom
SEMINARS
Cho, K., University of California, Irvine: Cell adhesion and
tissue assembly during Xenopus morphogenesis.
Christian, J., Oregon Health and Science University, 
Portland: TGF-β signaling during early embryogenesis.
Grainger, R., University of Virginia, Charlottesville:
Transcriptional analysis of lens induction.
Harland, R., University of California, Berkeley: Pattern by
the organizer.
Heasman, J., Children’s Hospital Medical Center, 
Cincinnati, Ohio: Maternal control of Xenopus
development.
Keller, R., University of Virginia, Charlottesville: Cell behavior
during early morphogenesis.
Khokha, M., Yale University, New Haven, Connecticut: X. tropi-
calis and genetic analysis of development.
Krieg, P., University of Arizona College of Medicine, Tucson:
Postgastrula organogenesis.
Kroll, K., Washington University School of Medicine, St. Louis,
Missouri: Using transgenic Xenopus to study transcriptional
regulation.
Wylie, C., Children’s Hospital Research Foundation, Cincinnati,
Ohio: Xenopus as a model system.
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Workshop on Schizophrenia and Related Disorders
June 4–13
INSTRUCTORS A. Malhotra, Zucker Hillside Hospital, Glen Oaks, New York
D. Porteous, University of Edinburgh, United Kingdom
ASSISTANTS J. Barnett, Massachussets General Hospital, Boston
J. Hall, University of Edinburgh, Edinburgh, United Kingdom
This workshop provided students with the most current understanding of the molecular, cellular, and
neural systems underlying disturbances in brain function in these devastating illnesses. During the 10-
day workshop, students learned about the clinical aspects of schizophrenia, schizoaffective disorder,
and bipolar disorder and explored in detail the genetic and neurobiological underpinnings of these com-
plex psychiatric disorders. The Workshop was divided into four main sessions: Clinical overview,
Genetics and genomics, Developmental neurobiology and neural circuits, and Cognitive systems. In
addition to hearing about the most recent research in these areas, controversial topics and challenges
to basic assumptions in the field were explored and discussed. A diverse faculty brought the most up-
to-date results and theories to the students, making this workshop a valuable resource for young
researchers starting out in this fast-moving and expansive field. Not only did it help them to build the
foundation for their future research, it also introduced them to many potential collaborators working to
understand schizophrenia and similar disorders from different perspectives. 
This workshop was supported with funds provided by the Oliver Grace Fund. 
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PARTICIPANTS
Adams, A., B.S., University of Prince Edward Island,
Charlottetown, Canada
Austin, B., B.S., University of Georgia, Athens
Baker, B., B.S., University of Maryland, College Park
Bolstad, I., B.S., University of Oslo, Oslo, Norway
Carlyle, B., B.S., Edinburgh University, Edinburgh, United
Kingdom
Charych, E., Ph.D., Wyeth Research, Princeton, New Jersey
DeRosse, P., B.S., Zucker Hillside Hospital, Glen Oaks, New
York
Di Forti, M., Ph.D., Institute of Psychiatry, London, United
Kingdom
Eliasen, G., B.S., University of Aarhus, Aarhus, Denmark
Ellman, L., Ph.D., Columbia University, New York
Foster, K., Ph.D., Merck & Co, Inc., West Point, Pennsylvania
Gamo, N., B.S., Yale University, New Haven, Connecticut
Hamilton, J., B.S., Howard University, Washington, D.C.
Karlsgodt, K., Ph.D., University of California, Los Angeles
Kirtley, A., B.S., Cardiff University, United Kingdom
Labrie, V., B.S., University of Toronto, Canada
Linderholm, K., B.S., Karolinska Institute, Solna, Sweden
Oh, S.W., Ph.D., Allen Institute for Brain Science, Seattle,
Washington
Stuetz, A., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Tillmann, C., B.S., Max-Planck Institute for Brain Research,
Frankfurt, Germany
Trotman, H., B.S., Emory University, Atlanta, Georgia
Zilles, D., Ph.D., Georg-August University Goettingen,
Germany
SEMINARS
Abi-Dargham, A., Columbia University, New York: Dopamine
system.
Austin, C., National Institutes of Health, Bethesda, Maryland:
High-throughput screening and chemical genomics: Toward
new drug development for schizophrenia.
Barch, D., Washington University, St. Louis, Missouri: The
cognitive neuroscience of schizophrenia.
Barnett, J., Massachusetts General Hospital, Boston:
Introduction; genetics primer.
Benes, F., Harvard University, Cambridge, Massachusetts:
Deconstructing the trisynaptic pathway as a strategy for
defining cellular endophenotypes of schizophrenia and bipo-
lar disorder.
Cornblatt, B., The Feinstein Institute for Medical Research,
North Shore Long Island Jewish Health System, Manhasset,
New York: The schizophrenia prodrome.
Cross, A., AstraZeneca: Translational approaches, part II.
Deisseroth, K., Stanford University, California: Probing circuit
function.
Egan, M., Merck & Co, Inc., North Wales, Pennsylvania:
Translational approaches, part 1.
Grace, A., University of Pittsburgh, Pennsylvania: Summary of
neurobiology; neuroanatomical and neurophysiological
underpinnings of schizophrenia.
Hall, J., University of Edinburgh, United Kingdom: Genetic
imaging in schizophrenia; introduction; genetics primer.
Killcross, S., Cardiff University, United Kingdom: Cognitive
models of schizophrenia.
Krystal, J., Yale University, New Haven, Connecticut:
Glutamate system/GABA.
Law, A.J., University of Oxford, United Kingdom: The neureg-
ulin story.
Lehner, T., National Institutes of Mental Health, Bethesda,
Maryland; Heimer, H., Schizophrenia Forum, Providence,
Rhode Island; Brose, K., Neuron, Cambridge, Massachu-
setts; Kramer, G., NARSAD, Great Neck, New York:
Publishing, grants, resources for schizophrenia research.
Lewis, D., University of Pittsburgh, Pennsylvania: Cortical
GABA systems in schizophrenia.
Li, B., Cold Spring Harbor Laboratory: Glutamatergic synapse
and its receptors: From cognitive function to psychiatric dis-
order.
Malholtra, A., Zucker Hillside Hospital, Glen Oaks, New York:
Pharmacogenetics; innovating target testing through indus-
try-academic partnerships; overview of psychiatric genetics.
McCombie, D., Cold Spring Harbor Laboratory: Next-genera-
tion sequencing.
McIntosh, A., University of Edinburgh, United Kingdom:
Neuroimaging in psychosis.
Murray, R., Institute of Psychiatry, London, United Kingdom:
History and clinical description; neurodevelopment and
schizophrenia.
Owens, D., University of Edinburgh, United Kingdom: Clinical
phenomenology/neuropharmacology.
Petryshen, T., Massachusetts General Hospital and the Stan-
ley Center for Psychiatric Research, Broad Institute of MIT
and Harvard, Cambridge: Mouse models of schizophrenia.
Porteous, D., University of Edinburgh, United Kingdom: DISC1
genetics and biology.
Ross, C., Johns Hopkins University, Baltimore, Maryland:
Integrating neurodegenerative diseases with schizophrenia.
Sebat, J., Cold Spring Harbor Laboratory: Structural varia-
tion.
Sklar, P., Stanley Center, Massachusetts Institute of
Technology, Cambridge: Genomic approaches.
Susser, E., Columbia University, New York: Epidemiology of
schizophrenia: New directions.
Vawter, M., University of California, Irvine: Gene expression In
schizophrenia.
Weinberger, D., National Institutes of Mental Health, Rockville
Pike, Maryland: Intermediate phenotypes and schizophrenia-
associated genes.
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 298
299
Advanced Bacterial Genetics
June 4–24
INSTRUCTORS J. Kirby, University of Iowa, Iowa City
S. Lovett, Brandeis University, Waltham, Massachusetts
A. Segall, San Diego State University, California
ASSISTANTS J. Guilinger, Brandeis University, Waltham, Massachusetts
J. Klebensberger, University of New South Wales, Sydney, Australia
G. Perez, San Diego State University, California
This course presented logic and methods used in the genetic dissection of complex biological process-
es in diverse bacteria. Laboratory methods included classical mutagenesis using transposons, muta-
tor strains, and chemical and physical mutagens; detection and quantitation of gene expression
changes using various reporter genes and real-time PCR; the mapping of mutations using genetic and
physical techniques; modern approaches to the generation and analysis of targeted gene disruptions
and fusions using PCR genetic recombination and cloning methods; epitope insertion mutagenesis;
site-directed mutagenesis; and fluorescence microscopy. Key components of the course were the use
of sophisticated genetic methods in the analysis of model bacteria (including Escherichia coli,
Salmonella, Bacillus subtilis, and Myxococcus xanthus) and the use of the wealth of new genomic
sequence information to motivate these methods. 
Invited lecturers presented various genetic approaches to study bacterial mechanisms of metabo-
lism, development, and pathogenesis. Speakers in the 2008 course included Sarah Ades (Penn State
University), Lionello Bossi (Centre National Recherche Scientifique), Valerie De Crecy-Lagan (University
of Florida), Robert Edwards (San Diego State University), Thierry Emonet (Yale University), Don Ennis
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SEMINARS
Ades, S., Penn State University, University Park, Pennsylvania:
Border security: Cell envelope stress responses in gram-
negative bacteria.
Bossi, L., Centre de Genetique Moleculaire, CNRS, Gif-sur-
Yvette, France: A tale of two prophages.
DeCrecy-Lagard, V., University of Florida, Gainesville: Linking
gene and function by comparative genomics: Making sense
of the unknowns.
Edwards, R., University of Pennsylvania, Philadelphia:
Upscaling from genetics to genomics to metagenomics.
Emonet, T., Yale University, New Haven, Connecticut: Digital
and experimental investigation of a model sensory system. 
Ennis, D., University of Louisanna, Lafayette: DNA repair as an
host-pathogen interaction: Chronic mycobacterial infections
increases cancer risk; Identification of a new bacterial
pathogen from post-Katrina sediments of New Orleans.
Hughes, K., University of Utah, Salt Lake City: Coupling flagel-
lar gene regulation to assembly.
Lazazzera, B., University of Los Angeles, California: Genetic
dissection of biofilm formation by Bacillus subtilis.
Maloy, S., San Diego State University, California:
Rearrangements of the bacterial chromosome.
Newman, D., Princeton University, New Jersey: From iron
oxides to infections: Roles for redox active antibiotics in
microbial survival and development.
Schmid, M., Microcide Pharmaceuticals, Inc., Mountain View,
California: Crossing genetic studies with pharmaceutical dis-
coveries.
PARTICIPANTS
Bednarz, M., M.S., University of Illinois Urbana Champaign,
Urbana
Brigati, J., Ph.D., Maryville, College, Tennessee 
Buceta, J., Ph.D., Barcelona Science Park, Spain 
Coleman, M., B.A., Massachusetts Institute of Technology,
Cambridge
De Vooght, L., M.S., Institute of Tropical Medicine, Antwerp,
Belgium
Gaines, J., Ph.D., East Carolina University Brody School of
Medicine, Greenville, North Carolina
Ivancic Bace, I., Ph.D., Faculty of Science of Molecular
Biology, Zagreb, Croatia
Jonas, K., M.S., Karolinska Institutet, Stockholm, 
Sweden
Konings, A., B.Sc., University of Otago, Dunedin, New
Zealand
Lun, D., Ph.D., Broad Institute of MIT and Harvard,
Cambridge, Massachusetts
Meyer, A., Ph.D., Massachusetts Institute of Technology,
Cambridge
Nadell, C., B.A., Princeton University, New Jersey
Qimron, U., Ph.D., Harvard Medical School, Boston,
Massachusetts
Sathyamoorthy, V., Ph.D., Food & Drug Administration, Laurel,
Maryland
Shopsin, B., Ph.D., New York University School of Medicine,
Skirball Institute, New York
Singh, B., M.Sc., Uppsala University, Sweden
(University of Louisana), Kelly Hughes (University of Utah), Beth Lazazzera (University of California, Los
Angeles), Stanley Maloy (San Diego State University), Dianne Newman (Massachusetts Institute of
Technology), and Molly Schmid (Keck Graduate Institute). The course admits 16 students, both foreign
and U.S. residents, from diverse backgrounds and career levels for intensive (but fun) instruction in
microbial genetics. For further academic information about the course, feel free to contact the instruc-
tors via their home pages.
This course is supported with funds provided by the National Science Foundation (http://www.
nsf.gov/).
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Ion Channel Physiology
June 4–24
INSTRUCTORS B. Clark, WIBR, University College London, United Kingdom
J. Diamond, National Institutes of Health, Bethesda, Maryland
M. Farrant, University College London, United Kingdom
CO-INSTRUCTOR M. Holmgren, National Institutes of Health/NINDS, Bethesda, Maryland
ASSISTANTS J. Gruendemann, University College London, United Kingdom
J. Hardie, Northwestern University
M. Jenkins, Emory University, Atlanta, Georgia
R. Kanichay, University College London, United Kingdom
A. Scimemi, National Institutes of Health/NINDS, Bethesda, Maryland
D. Srikumar, NMU/NINDS/NIH, Bethesda, Maryland
B. Stell, Universite Paris 5, France
K. Vervaeke, University College London, United Kingdom
The primary goal of this course was to investigate, through lectures and laboratory work, the proper-
ties of ion channels that allowed neurons to perform their unique physiological functions in a variety of
neural systems. Areas of particular interest included channels that (1) are activated by neurotransmit-
ters at central and peripheral synapses, (2) are activated by voltage changes in axons and dendrites,
(3) respond to neuromodulators with changes in functional properties, or (4) are developmentally
required and regulated. The research interests of guest lecturers reflected these areas of emphasis.
The laboratory component of the course introduced students to electrophysiological approaches for
the study of ion channels in their native environments. Hands-on exercises included patch-clamp
recording of ion channel activity in acutely isolated or cultured cells or neurons in brain slice prepara-
tions. Different recording configurations were used (e.g., whole-cell, cell-free, and nucleated patches)
to examine macroscopic or single-channel activity. The advantages and disadvantages of each
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method, preparation, and recording technique were considered with respect to specific scientific ques-
tions. Admissions priority was given to students and postdocs with a demonstrated interest, specific
plans, and a supportive environment in which to apply these techniques to a defined problem. 
Guest speakers in 2008 included Francisco Bezanilla (The University of Chicago), Joshua Dudman
(Janelia Farm Research Campus), Nace Golding (The University of Texas at Austin), Dax Hoffman
(NIH/NICHD/LCSN), Jeffry Isaacson (University of California, San Diego), Amy Lee (Emory University
School of Medicine), David Linden (Johns Hopkins University School of Medicine), Eve Marder
(Brandeis University), Andreas Schaefer (Max-Planck Institut fur Medizinische Forschung), Jesper
Sjostrom (University College London), Ivan Soltesz (University of California, Irvine), and Nelson Spruston
(Northwestern University). 
This course is supported by the Howard Hughes Medical Institute (http://www.hhmi.org/). Scientists
from developing countries accepted into this course may be eligible for scholarships provided by the
International Brain Research Organization (for details, go to http://www.iac-usnc.org/ fellowships.html).
PARTICIPANTS
SEMINARS
Bezanilla, P., The University of Chicago, Illinois: Voltage sen-
sors in Na+ and K+ channels.
Clark, B., University College London, United Kingdom: Synaptic
integration.
Diamond, J., National Institutes of Health/NINDS, Bethesda,
Maryland: Synaptic transmission.
Dudman, J., Janelia Farm Research Campus, Ashburn,
Virginia: Hyperpolarization-activated current (lh).
Farrant, M., University College London, United Kingdom:
GABA receptors and inhibition.
Golding, N., The University of Texas, Austin: Intrinsic electrical
properties and action potential propagation.
Hoffman, D., National Institutes of Health/NICHD, Bethesda,
Maryland: Regulation of dendritic excitability by the activity-
dependent trafficking of voltage-gated K+ channels.
Holmgren, M., National Institutes of Health/NINDS, Bethesda,
Maryland: Gating of Na+ and K+ channels; Regulation of K+
channel inactivation.
Isaacson, J., University of California, San Diego: Olfactory
microcircuits.
Lee, A., Emory University School of Medicine, Atlanta,
Georgia: Deconstructing Ca2+ channel signaling complexes.
Linden, D., Johns Hopkins University, Baltimore, Maryland:
Glutamate receptors.
Marder, E., Brandeis University, Waltham, Massachusetts:
Variability, compensation, homeostasis, and neuromodulation
in neuronal networks.
Schaefer, A., MPI fur Medizinische Forschung, Heidelburg,
Germany: Inhibition, glutamate receptors, and order discrimi-
nation in mice.
Sjöström, J., University College London, United Kingdom:
Plasticity and LTP.
Soltesz, I., University of California, Irvine: Activity-dependent
plasticity of endocannabinoid signaling.
Baumgart, J., B.A., University of Virginia, Charlottesville
Beane, W., Ph.D., Forsyth Institute, Durham, North Carolina
Fink, A., M.A., Columbia University, New York
Gleichman, A., B.A., University of Pennsylvania, Philadelphia
Gray, E., B.A., University of California, Los Angeles
MacAskill, A., B.A., University College London, United Kingdom
Mingote, S., Ph.D., Columbia University, New York
Nguyen, T., Ph.D., University of Pittsburgh, Pennsylvania 
Schneider, E., Ph.D., Princeton University, New Jersey 
Siemens, J., B.S., University of California, San Francisco
Wilbrecht, L., Ph.D., University of California, San Francisco
Woods, G., B.S., University of California, Davis
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Molecular Embryology of the Mouse
June 4–24
INSTRUCTORS D. Threadgill, University of North Carolina, Chapel Hill
P. Trainor, Stowers Institute for Medical Research, Kansas City, Missouri
CO-INSTRUCTOR L. Pevny, University of North Carolina, Chapel Hill
ASSISTANTS C. Futtner, University of North Carolina, Chapel Hill
S. Hutton, University of North Carolina, Chapel Hill
A. Iulianella, Stowers Institute for Medical Research, Kansas City, Missouri
J. Rivera-Perez, University of Massachusetts Medical School, Worcester
L. Sandell, Stowers Institute for Medical Research, Kansas City, Missouri
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse development. Lectures provided the conceptual basis for contemporary
research in mouse embryogenesis and organogenesis, whereas laboratory practicals provided an exten-
sive hands-on introduction to mouse embryo analysis. Experimental techniques covered included in vitro
culture and manipulation of preimplantation and postimplantation embryos; embryo transfer; culture and
genetic manipulation of embryonic stem cells; production of chimeras by embryo aggregation and by ES
cell injection; and transgenesis by pronuclear microinjection. In addition, this year’s practicals featured
increased emphasis on phenotypic analysis of mutants, including techniques of histology, in situ
hybridization, immunohistochemistry, skeletal preparation, organ culture, and tissue recombination. 
Seminar speakers this year included Alexi Aravin (Cold Spring Harbor Laboratory), Richard
Behringer (University of Texas M.D. Anderson Cancer Center), Ali Brivanlou (The Rockefeller University),
Blanche Capel (Duke University Medical Center), Frank Costantini (Columbia University, College of
Physicians & Surgeons), Oliver Guillermo (St. Jude Children’s Research Hospital), Kat Hadjantonakis
(Memorial Sloan-Kettering Cancer Center), Gregory Hannon (Cold Spring Harbor Laboratory), Konrad
Hochedlinger (Massachusetts General Hospital), Monica Justice (Baylor College of Medicine), Robin
Lovell-Badge (MRC NIMR, United Kingom), Terry Magnuson (University of North Carolina, Chapel Hill),
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Andras Nagy (Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Canada), David Ornitz
(Washington University), Luis Parada (University of Texas Southwestern Medical Center), Janet Rossant
(The Hospital for Sick Children), Michael Shen (Columbia University Medical Center), Charles Sherr
(HHMI/St. Jude Children’s Research Hospital), Philippe Soriano (Fred Hutchinson Cancer Research
Center), Michelle Southard-Smith (Vanderbilt University Medical Center), Colin Stewart (National Cancer
Institute), Lori Sussel (Columbia University), Shahragim Tajbakhsh (Pasteur Institute, France), Joseph
Takahashi (HHMI/Northwestern University), Patrick Tam (Children’s Medical Research Institute,
Australia), and Richard Woychik (The Jackson Laboratory).
This course is supported with funds provided by the National Cancer Institute (http://www.cancer.gov/).
SEMINARS
Aravin, A., Cold Spring Harbor Laboratory: RNAi and mam-
malian growth control.
Behringer, R., The University of Texas M.D. Anderson Cancer
Center, Houston: Gene targeting.
Brivanlou, A., The Rockefeller University, New York: ES cell dif-
ferentiation/pluripotency.
Capel, B., Duke University Medical Center, Durham, North
Carolina: Germ cells, genital ridges, and sex determination.
Costantini, F., Columbia University, New York: Kidney organo-
genesis.
Guillermo, O., St. Jude Children’s Research Hospital,
Memphis, Tennessee: Forebrain induction/vasculogenesis/
lymphangiogenesis.
Hadjantonakis, K., Memorial Sloan-Kettering Cancer Center,
New York: Mouse imaging.
Hannon, G., Cold Spring Harbor Laboratory: RNAi and mam-
malian growth control.
Hochedlinger, K., Massachusetts General Hospital, Boston:
Nuclear reprogramming.
Justice, M., Baylor College of Medicine, Houston, Texas: ENU
mutagenesis screens and chromosome engineering.
Lovell-Badge, R., MRC National Institute for Medical
Research: Sry, sex determination, and Sox genes.
Magnuson, T., University of North Carolina, Chapel Hill:
Epigenetics.
Nagy, A., Samuel Lunenfeld Research Institute, Toronto,
Canada: Transgenics and knockouts.
Orntiz, D., Washington University, St. Louis, Missouri: Limb
and skeletal biology.
Parada, L., University of Texas Southwestern Medical Center,
Dallas: Neuroblastoma cancer tumor.
Pevny, L., University of North Carolina, Chapel Hill: Neural
stem cells neurogenesis.
Rivera-Perez, J., University of Massachusetts Medical School,
Worcester: Early postimplantation.
Rossant, J., The Hospital for Sick Children, Toronto, Canada:
Chimeras, ES cell lineages, vasculogenesis.
Shen, M., Columbia University Medical Center, New York:
RNAi prostate stem cells.
Sherr, C., HHMI/St. Jude Children’s Research Hospital,
Memphis, Tennessee: Tumorigenesis, p53, Arf.
Soriano, P., Fred Hutchinson Cancer Research Center, Seattle,
Washington: Gene traps and PDGF/Eph/Ephrin signaling.
Southard-Smith, M., Vanderbilt University, Nashville,
Tennessee: Enteric nervous system, neural crest, and gut
development.
Stewart, C., National Cancer Institute, Frederick, Maryland: ES
cells.
Sussell, L., Columbia University, New York: Pancreas organo-
genesis.
Tajbakhsh, S., Pasteur Institute, Paris, France: Myogenesis
and muscle satellite stem cells.
Takahashi, J., HHMI/Northwestern University, Evanston, Illinois:
Behavioral genetic screens and development.
Tam, P., Children’s Medical Research Institute, Sydney,
Australia: Introduction to mouse development;
Gastrulation/body plan.
Threadgill, D., University of North Carolina, Chapel Hill:
Quantitative traits.
Trainor, P., Stowers Institute for Medical Reseach, Kansas City,
Missouri: Neural crest cells and crainofacial development;
Axis establishment and polarity in preimplanation embryos.
Woychik, R., The Jackson Laboratory, Bar Harbor, Maine:
Mouse genetics.
PARTICIPANTS
Alonso, E., Ph.D. National Centre of Cardiovascular Research,
Madrid, Spain
Barili, V., M.S., San Raffaele Scientific Institute Developmental
Neurogenetics, Milan, Italy
Chandrasekhar, A., Ph.D., University of Missouri, Columbia
Ferrer Vaquer, A., M.S., University of Freiburg, Germany
Gogilotti, R., B.S., Northwestern University, Chicago, Illinois 
Mastracci, T., Ph.D., Columbia University, New York
Prajapati, R., Ph.D., London Research Institute, United Kingdom 
Rutschow, D., Dipl., University of Dundee, United Kingdom
Starmer, J., Ph.D., University of North Carolina, Chapel Hill
Tachibana-Konwalski, K., Ph.D., University of Oxford, United
Kingdom
Teixeira, C., Ph.D., New York University College of Dentistry,
New York
Tondeleir, D., M.S., University of Gent, Belgium
Turunen, H., B.S., University of Turku, Finland
Vestin, A., M.Sc., Stony Brook University, New York
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Integrative Statistical Analysis of Genome-scale Data
June 11–24
INSTRUCTORS H. Bussemaker, Columbia University, New York
V. Carey, Harvard University, Boston, Massachusetts
C. Leslie, Memorial Sloan-Kettering Cancer Center, New York
P. Mitra, Cold Spring Harbor Laboratory
M. Reimers, Virginia Commonwealth University, Richmond
ASSISTANTS M. Fazlollahi, Columbia University, New York
E. Lee, Columbia University, New York
J. Mar, Harvard University, Cambridge, Massachusetts
J. Zhang, Harvard University, Cambridge, Massachusetts
Availability of a variety of genome-scale data sets, and the need to integrate such data sets, is a central
feature of modern biological research. Experimental and computational biologists seeking to make sense
of such data sets need to have a firm grasp of the relevant statistical and analytical methodology. This
course was designed to build competence in quantitative methods for the analysis of high-throughput
molecular biology data. Topics included introduction to R and Bioconductor, review of multivariate sta-
tistics (multiple testing, regression, machine learning), survey of key high-throughput technologies (both
microarray and sequencing based), low-level microarray data analysis (quality control, normalization),
analysis based on predefined gene sets (e.g., Gene Ontology), classification and prognosis of cancer
samples by machine learning, cis-regulatory sequence analysis (motif finding, weight matrices), model-
ing of transcriptional networks through integration of mRNA expression, ChIP, and sequence data, inte-
gration of genotype (SNP) data and expression data, and integration of epigenetic (DNA methylation)
data and expression data.
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Detailed lectures and presentations by guest speakers in the morning and evening were combined
with hands-on computer tutorials in the afternoon, in which the methods covered in the lectures were
applied to actual high-throughput data for yeast and humans. Students were assumed to have a basic
familiarity with the R programming language at the start of the course.
Speakers this year included Stefan Bekiranov (University of Virginia, Charlottesville), Martha Bulyk
(Brigham and Womens Hospital and Harvard Medical School), Bruce Futcher (Stony Brook University),
Vishy Iyer (University of Texas, Austin), Robert Lucito (Cold Spring Harbor Laboratory), Trudy MacKay
(North Carolina State University), Ewy Mathe (National Cancer Institute), Adam Olshen (Memorial Sloan-
Cancer Center), Dana Pe’er (Columbia University), and John Stamatoyannopoulos (University of
Washington).
This course is supported with funds provided by the National Cancer Institute (http://www.cancer.gov/).
PARTICIPANTS
SEMINARS
Bekiranov, S., University of Virginia, Charlottesville: Intro to
high-throughput sequencing.
Bulyk, M., Brigham and Womens Hospital and Harvard
Medical School, Boston, Massachusetts: Protein binding.
Bussemaker, H., Columbia University, New York: Basic gene
set analysis; Representations TF sequence specificity;
Methods for de novo motif discovery; Transcriptional net-
works I; Transcriptional networks II; Posttranscriptional net-
works in yeast.
Futcher, B., Stony Brook University, New York
Iyer, V., University of Texas, Austin: Transcription analysis with
DNA microarrays and high-throughput sequencing; ChIP-
chip and ChIP-Seq.
Leslie, C., Memorial Sloan-Kettering Cancer Center, New York:
Cancer classifications; MEDUSA; Regulation of mRNA stabil-
ity and translation by microRNAs.
Lucito, R., Cold Spring Harbor Laboratory: Methylation
assays.
MacKay, T., North Carolina State University, Raleigh: Systems
genetics of complex traits in Drosophila.
Mitra, P., Cold Spring Harbor Laboratory: Solexa.
Olshen, A., Memorial Sloan-Kettering Cancer Center, New
York: aCGH data.
Pe’er, D., Columbia University, New York: Genetic variation
and regulatory networks.
Reimers, M., Virginia Commonwealth University, Richmond:
Advanced gene set analysis; Multiple comparisons;
Integrating epigenetic and expression data.
Snyder, M., Yale University, New Haven, Connecticut:
Transcriptional networks; Proteomics.
Bernal-Mizrachi, L., M.D., Winship Cancer Institute/Emory
University, Atlanta, Georgia
Beutler, A., Ph.D., Mount Sinai School of Medicine, New York
Brynedal, B., M.Sc., Karolinska Institutet, Stockholm, Sweden
Cesaroni, M., M.S., European Institute of Oncology, Milan, 
Italy
Crapoulet, N., Ph.D., Atlantic Cancer Research Institute, New
Brunswick, Canada
Davis, A., Ph.D., Brigham and Women’s Hospital and Harvard
Medical School, Boston, Massachusetts
Du, R., Ph.D., Harvard Medical School/Brigham and Women’s
Hospital, Boston, Massachusetts
Ge, B., Ph.D., McGill University, Montreal, Canada
Gruntman, E., M.Sc., Cold Spring Harbor Laboratory 
Hammer, P., M.Sc., University of Applied Sciences Wildau
Bioinformatics, Germany
Himes, B., Ph.D., Harvard Medical School, Boston,
Massachusetts
Jakkula, L., Ph.D., Lawrence Berkeley National Laboratory,
Berkeley, California
Klijn, C., M.Sc., Netherlands Cancer Institute, Amsterdam, The
Netherlands
Lee, C.-K., Ph.D., Allen Institute for Brain Science, Seattle,
Washington
Lu, N., M.S., Kansas State University, Manhattan
Marko, N., M.D., Cleveland Clinic, Ohio
Ottoboni, L., Ph.D., Brigham and Women’s Hospital, Harvard
Medical School, Boston, Massachusetts
Pattyn, F., Ph.D., Ghent University, Belgium
Rabin, K., M.D., Baylor College of Medicine, Houston, Texas
Ravits, J., M.D., Benaroya Research Institute, Seattle,
Washington
Shaknovich, R., M.D., Albert Einstein College of Medicine,
Bronx, New York
van Wageningen, S., M.A., University Medical Centre Utrecht,
The Netherlands
Weaver, D., Ph.D., University of Toledo, Ohio
Weinhold, N., M.Sc., Technical University of Denmark, Lyngby
Zavodszky, M., Ph.D., Michigan State University, E. Lansing
Zhao, X., M.S., University of Oslo/Radium Hospital, Norway
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Proteomics
June 11–24
INSTRUCTORS P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Institute of Proteomics, Cambridge, Massachusetts
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
ASSISTANTS A. Farley, Vanderbilt University, Nashville, Tennessee
F. Festa, Harvard Medical School, Cambridge, Massachusetts
E. Hainsworth, Harvard Medical School, Cambridge, Massachusetts
E. Simon, University of Michigan, Ann Arbor
S. Srivastava, Harvard University, Cambridge, Massachusetts
S. Volk, University of Michigan, Blissfield
This intensive laboratory and lecture course focused on two major themes in proteomics: protein profil-
ing and functional proteomics. The profiling section taught students about cutting-edge protein separa-
tion methods, including hands-on experience with two-dimensional gel electrophoresis, multidimension-
al liquid chromatography, and affinity purification of protein complexes. The course covered both MALDI
and ESI high-sensitivity mass spectrometry, including peptide mass mapping and tandem mass spec-
trometry, quantification, and phosphoproteomics. Students learned to use several informatics tools avail-
able for analyzing the data. The functional proteomics section taught students about recombinational
cloning, high-throughput protein isolation, and protein microarrays. Students used robots to execute
high-throughput methods including expression, purification, and characterization of proteins. They also
printed and analyzed their own self-assembling protein microarrays, which were used for protein–pro-
tein interaction studies. The overall aim of the course was to provide students with the fundamental
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 307
308
knowledge and hands-on experience necessary to perform and analyze proteomics experiments and to
learn to identify new opportunities in applying proteomics approaches to their own research.
Speakers in the 2008 course included Roger Biringer (Life Sciences Mass Spectrometry), Steven
Carr (Broad Institute of Harvard/Massachusetts Institute of Technology), Brian Chait (The Rockefeller
University), Pierre Chaurand (Vanderbilt University School of Medicine), Karl Clauser (Broad Institute of
Harvard/Massachusetts Institute of Technology), Illeana Cristea (Princeton University), Paul Huang
(Massachusetts Institute of Technology), Darryl Pappin (Cold Spring Harbor Laboratory), and Michael
Snyder (Yale University).
This course was supported with funds provided by the National Cancer Institute (http://www.
cancer.gov/).
SEMINARS
Carr, S., Broad Institute of Harvard/Massachusetts Institute of
Technology, Cambridge: Mass spec pipelines for biomarker
discovery.
Chait, B., The Rockefeller University, New York: Protein inter-
actions as a window into cellular function.
Chaurand, P., Vanderbilt University School of Medicine,
Nashville, Tennessee: Profiling tissues by mass spectrometry.
Clauser, K., Broad Institute/Massachusetts Institute of
Technology, Cambridge: De novo interpretation of tandem
mass spectra.
Cristea, I., The Rockefeller University, New York: Protein inter-
actions.
Huang, P., Massachusetts Institute of Technology,
Charlestown: Phosphoproteomics.
Synder, M., Yale University, New Haven, Connecticut:
Application of protein microarrays.
PARTICIPANTS
Adams, S., Ph.D., Mayo Clinic Jacksonville, Florida 
Bokowiec, M., M.A., University of Virginia, Charlottesville
Cabrejos, M.E., Ph.D., University of Chile, Santiago
Charles, R., M.D., Massachusetts General Hospital, 
Boston
Chuang, A., M.S., University of Iowa, Iowa City
Conlon, F., Ph.D., University of North Carolina, Chapel Hill
Eriksson, C., M.S., Royal Institute of Technology, Stockholm,
Sweden
Mahajan, V., Ph.D., University of Iowa, Iowa City
Moradian, A., Ph.D., Michael Smith Genome Sciences Centre,
Vancouver, Canada
Padula, M., B.S., Albert Einstein College of Medicine, Bronx,
New York
Ramos-Ortolaza, D., B.S., Mount Sinai School of Medicine,
New York
Rechavi, O., Ph.D., Tel Aviv University, Israel
Shaughnessy, D., Ph.D., NIEHS-DERT, Research Triangle
Park, North Carolina
Skaug, B., B.S., University of Texas Southwestern Medical
Center, Dallas
Soufi, B., B.Sc., Technical University of Denmark, Lyngby
Wisniewski, P., M.S., The Nencki Institute of Experimental
Biology, Warsaw, Poland
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Computational Neuroscience: Vision
June 20–July 3
INSTRUCTORS G. Boynton, University of Washington, Seattle
G. Horwitz, University of Washington, Seattle
S. Treue, German Primate Center, Goettingen, Germany
ASSISTANTS G. Field, Salk Institute, La Jolla, California
S. Hohl, University of California, San Francisco
TECHNICIAN R. Dotson, New York University, New York
Computational approaches to neuroscience will produce important advances in our understanding of
neural processing. Prominent success will come in areas where strong inputs from neurobiological,
behavioral, and computational investigation can interact. The theme of the course was that an under-
standing of the computational problems, the constraints on solutions to these problems, and the range
of possible solutions can help to guide research in neuroscience. Through a combination of lectures
and hands-on experience in a computer laboratory, this intensive course examined color vision, spatial
pattern analysis, motion analysis, oculomotor function, attention, and decision-making.
Lecturers in this year’s course included Geoffrey Boynton, David Brainard, Matteo Carandini, Marisa
Carrasco, E.J. Chichilnisky, Wilson Geisler, Joshua Gold, David Heeger, Gregory Horwitz, Bart
Krekelberg, Partha Mitra, Tony Movshon, Andrew Parker, Anitha Pasupathy, Pamela Reinagel, Eero
Simoncelli, Alex Thiele, Frank Tong, and Stefan Treue.
The course was held at the Laboratory’s Banbury Conference Center (http://www.cshl.edu/ban-
bury/) located on the North Shore of Long Island. All participants stay within walking distance of the
Center, close to the tennis court, pool, and private beach.
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PARTICIPANTS
Ayaz, A., B.S., University of California, Irvine
Brouwer, G.J., Ph.D., New York University, New York
Cohen, J., B.S., Vanderbilt University, Nashville, Tennessee
Daliri, M., Ph.D., German Primate Center, Goettingen,
Germany
Doi, T., B.S., Osaka University, Toyonaka, Japan
Elstrott, J., B.S., University of California, San Diego
Fitzgerald, J., B.S., Harvard Medical School, Boston,
Massachusetts
Girshick, A., Ph.D., New York University, New York
Hartmann, T., B.S., Rutgers University, Newark, New Jersey
Karklin, Y., B.S., New York University, New York
Kerlin, A., B.S., Harvard Medical School, Boston,
Massachusetts
Kherlopian, A., B.S., Weill Cornell Medical College, New York
Koster, U., B.S., University of Helsinki, Finland
Law, C.-T., B.S., University of Pennsylvania, Philadelphia
Manookin, M., B.S., University of Michigan, Ann Arbor
Michel, M., Ph.D., University of Texas, Austin
Muhammad, R., B.S., Massachusetts Institute of Technology,
Cambridge
Murphy, D., B.S., Baylor College of Medicine, Houston, Texas
Pestilli, F., B.S., New York University, New York
Rutledge, R., B.S., New York University, New York
Schmid, M., Ph.D., National Institutes of Mental Health,
Bethesda, Maryland
Sharan, L., B.S., Massachusetts Institute of Technology,
Cambridge
Tavassoli, A., B.S., University of California, Los Angeles
Wallisch, P., Ph.D., New York University, New York
SEMINARS
Brainard, D., University of Pennsylvania, Philadelphia:
Trichromacy.
Carandini, M., Smith-Kettlewell Eye Research Institute, San
Francisco, California: Adaptation/LGN.
Carrasco, M., New York University, New York: Attention psy-
chophysics.
Chichilnisky, E.J., The Salk Institute, La Jolla, California: Visual
procesing in the retina; Retinal population codes.
Geisler, B., University of Texas, Austin: Pattern vision and nat-
ural scenes.
Gold, J., University of Pennsylvania, Philadelphia: Decisions,
choice, and neuroeconomics.
Heeger, D., New York University, New York: V1
physiology/models; Organization of extrastriate visual cortex.
Horwitz, G., University of Washington, Seattle: V1/white noise
analysis.
Krekelberg, B., Rutgers University, Newark, New Jersey:
Population coding/decoding.
Mitra, P., Cold Spring Harbor Laboratory: Observed brain
dynamics.
Movshon, T., New York University, New York: What vision (and
this course) is all about.
Parker, A., Oxford University, United Kingdom: Stereo vision:
Physiology.
Pasupathy, A., University of Washington, Seattle: Ventral
stream, form vision.
Reinagel, P., University of California, San Diego, La Jolla: LGN
coding and natural scene statistics.
Simoncelli, E., New York University, New York: Motion model-
ing; Image statistics.
Thiele, A., Newcastle University, Newcastle Upon Tyne, United
Kingdom: MT physiology.
Tong, F., Vanderbilt University, Nashville, Tennessee: fMRI:
Advanced methods.
Treue, S., German Primate Center, Goettingen, Germany:
Attention physiology.
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Advanced Techniques in Molecular Neuroscience
June 27–July 13
INSTRUCTORS J. Eberwine, University of Pennsylvania Medical School, Philadelphia
J. Kohler, Stanford University, California
C. Lai, Scripps Research Institute, La Jolla, California
R. Lansford, California Institute of Technology, Pasadena
ASSISTANTS T. Bell, University of Pennsylvania, Philadelphia
P. Buckley, University of Pennsylvania, Philadelphia
C. Challis, Scripps Research Institute, La Jolla, California
D. Huss, California Institute of Technology, Covina, California
G. Poynter, California Institute of Technology, Pasadena, California
K. Schaukowitch, Scripps Research Institute, La Jolla, California
This newly revised laboratory and lecture course was designed to provide neuroscientists at all levels
with a conceptual and practical understanding of several of the most advanced techniques in molec-
ular neuroscience. The course curriculum was divided into three sections: an extensive and up-to-date
set of laboratory exercises, daily lectures covering the theoretical and practical aspects of the various
methods used in the laboratory, and a series of evening research seminars. The informal and interac-
tive evening lectures were given by leading molecular neuroscientists and serve to illustrate the ways
in which the various experimental approaches have been used to advance specific areas of neurobiol-
ogy. In this year’s course, the laboratory portion included topics such as an introduction to the design
and use of animal virus vectors in neurobiology; the use of small interfering RNAs (siRNAs) for regulat-
ing the expression of specific genes in neurons; practical exercises in gene delivery systems including
mammalian cell transfection protocols and single-cell electroporation techniques for targeted gene
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transfer in vivo; an introduction to overall strategies, use, and design of BAC transgenic vectors; mul-
tiplex and whole-genome expression analyses using the most recent DNA microarray technologies
(including labeled probe preparation, data analyses, mining, and interpretation); quantitative real-time
RT-PCR analyses from small numbers of cells (RNA purification, PCR optimization, interpretation of
results); single-cell PCR and cDNA library construction; and methods and application of RNA amplifi-
cation (aRNA). Each laboratory module was followed by comprehensive data analyses and interpreta-
tion, protocol troubleshooting, and suggestions for ways to improve or modify the existing technique.
Finally, course participants were introduced to bioinformatics and a wide range of internet resources
available to molecular neuroscientists.
Speakers in the 2008 course included Cori Bargmann (The Rockefeller University), Ben Barres
(Stanford University School of Medicine), Karl Deisseroth (Stanford University), Kenneth Kosik
(Neuroscience Research Institute), Jeff Lichtman (Harvard University), Pierre-Marie Lledo (Pasteur
Institute), Donald Lo (Duke Center for Drug Discovery), Joseph Loturco (University of Connecticut),
Ardem Patapoutian (The Scripps Reseach Institute), and Eduardo Rosa-Molinar (University of Puerto
Rico-Rio Piedras).
This course is supported with funds provided by the National Institute of Mental Health (http://www.
nimh.nih.gov/), the National Institute of Neurological Disorders & Stroke (http://www.ninds.nih.gov/),
and the Howard Hughes Medical Institute (http://www.hhmi.org/). Scientists from developing countries
accepted into this course may be eligible for scholarships provided by the International Brain Research
Organization (http://www.iac-usnc.org/fellowships.html).
PARTICIPANTS
Adams, S., Ph.D., Mayo Clinic Jacksonville, Florida
Corty, M., B.A., Columbia University, New York
Dagostin, A.L., University of São Paulo, Ribeirão Preto, Brazil
Djurisic, M., Ph.D., Stanford University, California 
Edgar, N., M.S., University of Pittsburgh, Pennsylvania 
Garcia-Pena, C., B.S., UNAM, Instituto de Neurobiologia,
Juriquilla, Mexico
Karlen, S., B.S., University of California, Davis
Kim, Y., Ph.D., University of Oxford, United Kingdom
Ludanyi, A., M.Sc., Institute of Experimental Medicine,
Budapest, Hungary
Luo, M., Ph.D., National Institute of Biological Sciences,
Beijing, China
Maya Vetencour, J., M.S., Scuola Normale Superiore, Pisa,
Italy
Nimmerjahn, A., Stanford University, California 
Pathak, A., M.S., SG Postgraduate Institute of Medical
Sciences, Lucknow, India
Vogelstein, J., B.S., Johns Hopkins University, Baltimore,
Maryland
Wozny, C., M.D., MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom
Zhou, C., B.S., National Institute of Biological Sciences,
Beijing, China
SEMINARS
Bargmann, C., The Rockefeller University, New York: Mixer
with FlyCourse.
Barres, B., Stanford University School of Medicine, California:
Glial cell development.
Deisseroth, K., Stanford University, California: Optogenetics
module.
Eberwine, J., University of Pennsylvania Medical School,
Philadelphia: RNA isolation from single cells.
Haas, K., University of British Columbia, Canada: Xenopus
neural transfection.
Kosik, K., Neuroscience Research Institute, Santa Barbara,
California: MicroRNAs in neural systems.
Lai, C., Scripps Research Institute, La Jolla, California: BAC
recombination module.
Lansford, R., California Institute of Technology, Pasadena:
Cloning and lentivirus module.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Analysis of “Rainbow” mice.
Lledo, P.-M., Pasteur Institute, Paris, France: Becoming an
adult olfactory neuron.
Lo, D., Duke University Medical Center, Durham, North
Carolina: BAC transfections.
Loturco, J., University of Connecticut, Storrs: RNAi module.
Patapoutian, A., Scripps Research Institute, La Jolla,
California: The fifth sense: Molecular mechanisms of temper-
ature and pain detection.
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Computational Cell Biology
June 27–July 17
INSTRUCTORS T. Elston, University of North Carolina, Chapel Hill
C. Fall, University of Illinois, Chicago 
L. Loew, University of Connecticut Health Center, Farmington
G. Smith, College of William and Mary, Williamsburg, Virginia
J. Tyson, Virginia Polytechnic Institute and State University, Blacksburg
CO-INSTRUCTORS J. Hasty, University of California, San Diego, La Jolla
A. Mogilner, University of California, Davis
J. Sible, Virginia Polytechnic Institute and State University, Blacksburg
ASSISTANTS D. Barik, Virginia Polytechnic Institute and State University, Blacksburg
B. Baumgartner, University of California, San Diego, La Jolla
P. Kraikivski, University of Connecticut Health Center, Farmington
Computational cell biology is the field of study that applies the mathematics of dynamical systems
together with computer simulation techniques to the study of cellular processes. The field encompass-
es several topics that have been studied long enough to be well established in their own right, such as
calcium signaling, molecular motors, and cell motility; the cell cycle; and gene expression during devel-
opment. In addition to providing a recognizable larger community for topics such as these, this course
provided a base for the development of newer areas of inquiry, for example, the dynamics of intracel-
lular second-messenger signaling, programmed cell death, mitotic chromosome movements, and syn-
thetic gene networks. Unlike computational genomics or bioinformatics, computational cell biology is
focused on simulation of the molecular machinery (genes–proteins–metabolites) that underlie the phys-
iological behavior (input–output characteristics) of living cells.
This 3-week course incorporated a series of didactic lectures on the mathematics of dynamical systems,
computational simulation techniques, cell biology, and molecular biology. Practicing theoreticians and exper-
imentalists rotated in for 1–3-day visits during the course to give lectures and interact with the students.
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 313
314
Midway through the course, students selected an area for independent study, and the focus of the last week
of the course was largely on these projects, supplemented by continued visiting lecturers: Reka Albert
(Pennsylvania State University), Dean Bottino (Novartis), Barbara Ehrlich (Yale University School of Medicine),
Jason Haugh (North Carolina State University), Ravi Iyengar (Mount Sinai School of Medicine), James Keener
(University of Utah), Edda Klipp (Humboldt University and Max-Planck Institute), James Lechleiter (University
of Texas Heath Sciences Center), Jennifer Linderman (University of Michigan), Charles Peskin (New York
University), Artie Sherman (National Institutes of Health/NIDDK), Stas Shvartsman (Princeton University),
Boris Slepchenko (University of Connecticut Health Center), and David Terman (Ohio State University). 
Visiting faculty will change from year to year, and the specific topics covered will vary. Potential areas
include the Fundamentals (e.g., cell biology, molecular biology, mathematical biology, and computation-
al tools), advanced topics (e.g., sniffers, buzzers, toggles, and blinkers; practical bifurcation theory;
reaction-diffusion-advection; stochastic modeling; physical chemistry of aggregation/polymerization;
mechano-chemical dynamics; sensitivity and robustness; optimization, parameter estimation); and
case studies (calcium signaling; cancer and cardiac modeling; signal transduction networks; gene
expression; apoptosis; cell cycle regulation; cytoskeletal dynamics; and neural models).
This course was supported with funds provided by the National Science Foundation, Apple
Computer (computer support), and Mathworks (MATLAB licenses).
PARTICIPANTS
Brakken-Thai, C., B.A., University of Minnesota, Minneapolis
Carpenter, R., B.S., College of William and Mary, Williamsburg,
Virginia
Coxito, P., B.S., Centre for Neuroscience and Cell Biology,
Coimbra, Portugal
de Diego, A., Ph.D., Universidad Autonoma, Madrid, Spain
Durrieu, L., M.Sc., IFIByNE, CONICET
Elsner, M., Ph.D., National Institutes of Health, NICHD,
Bethesda, Maryland
Farre, E., Ph.D., University of California, San Diego, La Jolla
Gonzales, P., B.S., National Institutes of Health/NHLBI,
Bethesda, Maryland
Hao, Y., B.S., College of William and Mary, Williamsburg, 
Virginia
Hoyos Ramirez, E., B.A., Ingenieur d’Etude, Paris,
France
Osterfield, M., Ph.D., Harvard Medical School, Boston,
Massachusetts
Picone, R., B.Sc., University College London, United Kingdom
Sanz-Rodriguez, C., B.S., Universidad Simon Bolivar, Caracus,
Venezuela
Schwemmer, M., B.A., University of California, Davis
Waks, Z., B.S., Harvard Medical School, Boston,
Massachusetts:
Wong, M., B.S., University of California, San Diego
Zamborszky, J., M.S., University of Trento CoSBi, Italy
SEMINARS
Albert, R., Pennsylvania State University, University Park:
Discrete dynamic modeling of signaling networks.
Bottino, D., Novartis Pharmaceuticals Corporation, East
Hanover, New Jersey: Pharma/cardio toxicity; Pharma/can-
cer modeling.
Ehrlich, B., Yale University, New Haven, Connecticut: IP3
receptors and Ca2+ signaling.
Haugh, J., North Carolina State University, Raleigh: Kinetic and
spatial analysis of signal transduction pathways and net-
works.
Iyengar, R., Mount Sinai School of Medicine, New York:
Network building and tracking new pathways; Spatial regula-
tion of information flow in cells.
Keener, J., University of Utah, Salt Lake City: Cardiac models.
Lechleiter, J., University of Texas, San Antonio: Biology of cal-
cium signaling.
Linderman, J., University of Michigan, Flint: Modeling G-pro-
tein-coupled receptors.
Loew, L., University of Connecticut, Storrs: Introduction to
Ca2+ models; Dendritic nucleation models.
Mogilner, A., University of California, Davis: Stochastic 
models and techniques; Force balance between 
antagonistic molecular motors; Stochastic, yet faithful,
search-and-capture mechanism in mitotic spindle 
assembly. 
Sherman, A., National Institutes of Health, Bethesda,
Maryland: Integrated Ca2+ models.
Sible, J., Virginia Polytechnic Institute, Blacksburg, Virginia:
Biology of cell signaling.
Slepchenko, B., University of Connecticut, Storrs: Membranes
and ion channels: Modeling approaches in electrophysiology.
Smith, G., College of William and Mary, Williamsburg, Virginia:
Cellular biophysics and ODEs; Reaction-diffusion and advec-
tion; Markov chain models of ion channels and calcium
release sites.
Terman, D., Ohio State University Mathematical Biosciences
Institute, Columbus: ODEs: Bifurcation continuation;
Mathematics of waves in biology.
Tyson, J., Virginia Polytechnic Institute, Blacksburg: Models of
MPF regulation; Temporal organization of the cell cycle.
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Molecular Techniques in Plant Science
June 27–July 17
INSTRUCTORS T. Brutnell, Boyce Thompson Institute, Ithaca, New York
V. Irish, Yale University, New Haven, Connecticut
E. Kellogg, University of Missouri, St. Louis
J. Normanly, University of Massachusetts, Amherst
ASSISTANTS J. Jung, Cornell University, Ithaca, New York
B. Kokturk, University of Massachusetts, Amherst
R. Reinheimer, University of Missouri, St. Louis
This course provided an intensive overview of topics in plant physiology, biochemistry, and develop-
ment, focusing on molecular genetic and analytical approaches to understanding plant biology. It
emphasized recent results from Arabidopsis, maize, and a variety of other plants including
Brachypodium nicotiana and provided an introduction to current methods used in plant molecular biol-
ogy. It was designed for scientists with some experience in molecular techniques or in plant biology
who wish to work with plants using the latest technologies in genetics, molecular biology, and bio-
chemistry. The course consisted of a vigorous lecture series, a hands-on laboratory, and informal dis-
cussions. Discussions of important topics in plant research were presented by the instructors and by
invited speakers. These seminars included plant morphology and anatomy; plant development (such
as development of flowers, leaves, male and female gametophytes, and roots); perception of light and
photomorphogenesis; cell wall biosynthesis; function and perception of hormones; and application of
research results to addressing current agronomic problems including the rapidly advancing field of cel-
lulosic biofuel production and feedstock development. Speakers provided overviews of their fields, fol-
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lowed by in-depth discussions of their own work. The laboratory sessions provided an introduction to
important techniques currently used in plant research. These included the application of light, fluores-
cence, and scanning electron microscopy to the study of plant development; mutant analysis; transient
gene expression; gene silencing; applications of fluorescent protein fusions; protein interaction and
detection; proteomics approaches; several different approaches to quantifying metabolites; and tran-
sient transformation and techniques commonly used in genetic and physical mapping. The course also
included several short workshops on important themes in plant research.
Speakers in the course included Thomas Brutnell (Boyce Thompson Institute), John Celenza
(Boston University), Savithramma Dinesh-Kumar (Yale University), Kevin Folta (University of Florida),
Erich Grotewold (Ohio State University), Stacey Harmer (University of California, Davis), Vivian Irish (Yale
University), Dave Jackson (Cold Spring Harbor Laboratory), Georg Jander (Boyce Thompson Institute),
Elizabeth “Toby” Kellogg (University of Missouri, St. Louis), Nancy Kerk (Yale University), Cris
Kuhlemeier (University of Bern), Jennifer Normanly (University of Massachusetts), Thomas Nuhse
(University of Manchester), Jocelyn Rose (Cornell University), Eric Schaller (Dartmouth College), Ian
Sussex (Yale University), and Marja Timmermans (Cold Spring Harbor Laboratory). This course was
supported with funds provided by the National Science Foundation
PARTICIPANTS
Butler, H., M.S., Dow AgroSciences, Indianapolis, Indiana
Chang, P.-C., M.S., University of Waterloo, Canada
Danielson, J., M.Sc., Lund University, Sweden
Hendrickson Culler, A., Ph.D., University of Minnesota, St. Paul
Hepworth, J., B.A., University of York, United Kingdom
Matoba, N., Ph.D., Arizona State University, Tempe
Roos, J., M.Sc., Swedish University of Agricultural Sciences,
Uppsala, Sweden
Sønderby, I., B.A., University of Copenhagen, Denmark
Sørmo, C., M.S., Norwegian University of Science and
Technology, Trondheim, Norway
Stenbaek, A., M.S., University of Copenhagen, Denmark
Whitcomb, S., B.A., The Rockefeller University, New York
Worden, S., B.S., Dow AgroSciences, Indianapolis, Indiana
SEMINARS
Benfey, P., Duke University, Durham, North Carolina: Root
development.
Brutnell, T., Boyce Thompson Institute, Ithaca, New York; Irish,
V., Yale University, New Haven, Connecticut: Workshop I:
Double mutants, genetic maps; Workshop III: Solexa
sequencing.
Brutnell, T., Boyce Thompson Institute, Ithaca, New York:
Plastids.
Celenza, J., Boston University, Massachusetts: Secondary
metabolites.
Dinesh-Kumar, S., Yale University, New Haven, Connecticut:
Plant pathogen interactions.
Folta, K., University of Florida, Gainesville: Light regulation.
Grotewold, E., University of Ohio, Columbus: Regulatory net-
works.
Harmer, S., University of California, Davis: Circadian rhythms.
Irish, V., Yale University, New Haven, Connecticut:
Reproductive development.
Jackson, D., Cold Spring Harbor Laboratory: Shoot meristem
development.
Jander, G., Boyce Thompson Institute, Ithaca, New York:
Quantitative genetics.
Kellogg, E., University of Missouri, St. Louis: Phylogenetics.
Kuhlemeier, C., University of Bern, Switzerland: Phyllotaxis.
Normanly, J., University of Massachusetts, Amherst:
Workshop III: Scientific writing.
Nuhse, T., University of Manchester, United Kingdom:
Proteomics.
Rose, J., Cornell University, Ithaca, New York: Cell walls.
Schaller, G.E., Dartmouth College, Hanover, New Hampshire:
Plant hormones.
Sheen, J., Massachusetts General Hospital, Boston: Signaling.
Sussex, I., Yale University, New Haven, Connecticut:
Introduction to plant structure.
Timmermans, M., Cold Spring Harbor Laboratory: MicroRNA
regulation.
Topp, C., University of Georgia, Atlanta
Vanzulli, S., University of Milan, Italy
Urbanowicz, B., Cornell University, Ithaca, New York: Biofuels
data analysis workshop
Vogel, J., Western Regional Research Center (USDA-ARS):
Feedstock development for biofuels.
Xie, Z., Ohio State University, Columbus: ChlP-chip data
analysis workshop.
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Neurobiology of Drosophila
June 27–July 17
INSTRUCTORS R. Allada, Northwestern University, Evanston, Illinois
M. Freeman, University of Massachusetts Medical School, Worcester
B. Zhang, University of Oklahoma, Norman
ASSISTANTS H. Bao, University of Oklahoma, Norman
R. Bernardos, University of Massachusetts Medical School, Worcester
R. Islam, University of Oklahoma, Norman
C. Pfeiffenberger, Northwestern University, Evanston, Illinois
This laboratory/lecture course is intended for researchers at all levels, from beginning graduate stu-
dents through established primary investigators who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The 3-week course was divided into the study of development,
physiology/function, and behavior. Daily seminars introduced students to a variety of research topics
and developed those topics by including recent experimental contributions and outstanding questions
in the field. Guest lecturers brought original preparations for viewing and discussion and direct labora-
tory exercises and experiments in their area of interest. The course provided students with hands-on
experience using a variety of experimental preparations that are used in the investigation of current neu-
robiological questions. The lectures and laboratories focused on both the development of the nervous
system and its role in controlling larval and adult behaviors. In addition to an exposure to the molecu-
lar genetics approaches available in Drosophila, students learned a variety of techniques including
embryo in situ hybridization, labeling of identified neurons, electrophysiology (intracellular recording and
patch clamping), optical imaging of neuronal activity, and the analysis of larval and adult behavior.
Collectively, the course provided a comprehensive and practical introduction to modern experimental
methods for studying the Drosophila nervous system. 
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This year’s lecturers included Cori Bargmann (The Rockefeller University), Richard Benton (University
of Lausanne), Heather Broihier (Case Western University), Vivian Budnik (University of Massachusetts),
John Carlson (Yale University), Sarah Certel (Harvard Medical School), Yick-Bun Chan (Harvard Medical
School), David Deitcher (Cornell University), Josh Dubnau (Cold Spring Harbor Laboratory), Aki Ejiima
(Brandeis University), Tanja Godenschwege (Florida Atlantic University), Stephen Goodwin (University of
Glasgow), Wesley Greuber (Columbia University), Randall Hewes (University of Oklahoma), Gregory
Jefferis (University of Cambridge), Haig Keshishian (Yale University), Edward Kravitz (Harvard Medical
School), Cheng-Yu Lee (University of Michigan, Life Sciences Institute), Edwin Levitan (University of
Pittsburgh), Jill Penn (Harvard Medical School), Adrian Rothenfluh (University of California, San
Francisco), Stephan Sigrist (University of Wurzburg), Sean Speese (University of Massachusetts), Glenn
Turner (Cold Spring Harbor Laboratory), Troy Zars (University of Missouri), J. Lynn Zimmerman
(University of Maryland Baltimore County), and John Zimmerman (University of Pennsylvania).
This course was supported with funds provided by the National Institute of Mental Health (http://www.
nimh.nih.gov/), the National Institute of Neurological Disorders & Stroke (http://www.ninds.nih.gov/), and
the Howard Hughes Medical Institute (http://www.hhmi.org/).
Scientists from developing countries accepted into this course may be eligible for scholarships pro-
vided by the International Brain Research Organization. For details, go to http://www.iac-usnc.org/fel-
lowships.html).
PARTICIPANTS
Caron, S., B.S., Columbia University, New York
Chen, Y.-C., B.S., University of North Carolina, Chapel Hill
Dias, B., M.S., University of Texas, Austin
Gu, T., University of Oklahoma, Norman
Hsu, Y.-W., University of Washington, Seattle
Jaiswal, M., M.Sc., Baylor College of Medicine, Houston, 
Texas
Jorchel, S., M.S., Vienna Campus Biocenter, Austria 
Kain, J., B.A., Harvard University, Cambridge, Massachusetts
Mendes, C., B.S., Columbia University, New York
Ostrovsky, A., B.S., University of Arizona, Phoenix
Rathore, K., M.S., National Centre for Biological Sciences,
TIFR, Bangalore, India
Sakurai, A., B.S., Tohoku University, Sendai, Japan
SEMINARS
Allada, R., Northwestern University, Evanston, Illinois:
Introduction; Circadian rhythms and sleep.
Bargmann, C., The Rockefeller University, New York
Benton, R., University of Lausanne, Switzerland: Odorant
decoding by single sensilla.
Broihier, H., Case Western University, Cleveland, Ohio:
Generation of neural diversity.
Budnik, V. and Speese, S., University of Massachusetts
Medical School, Worcester: Development of the NMJ.
Carlson, J., Yale University, New Haven, Connecticut: Larval
behavior.
Deitcher, D., Cornell University, Ithaca: SNAREs and transmit-
ter release.
Featherstone, D., University of Illinois, Chicago: Development
and regulation of glutamatergic signaling.
Freeman, M., University of Massachusetts Medical School,
Worcester: Fly genetics 101; Glial cell biology; Fly web
tools/informatics 101.
Godenschwege, T., Florida Atlantic University, Boca Raton: No
escape: The giant fiber system.
Goodwin, S., Glasgow University, United Kingdom: Control of
sexual behavior in Drosophila by the sex determination path-
way.
Ejima, A., Brandeis University, Waltham, Massachusetts:
Courtship and learning.
Grueber, W., Columbia University, New York: Dendrite biology.
Hewes, R., University of Oklahoma, Norman: Neuropeptide
signaling.
Jefferis, G., University of Cambridge, United Kingdom: Genetic
mosaic techniques; Olfactory system development.
Keshishian, H., Yale University, New Haven, Connecticut:
Neuronal activity and synaptic plasticity.
Kravitz, E. and Certel, S., Harvard Medical School, Boston,
Massachusetts: Aggression.
Lee, C.-Y., University of Michigan, Ann Arbor: Neural stem
cells.
Levitan, E., University of Pittsburgh, Pennsylvania: Optical
imaging of neuropeptide release.
Rothenfluh, A., University of Texas Southwestern, Dallas: Flies
and drugs.
Sigrist, S., University of Wurzburg, Germany: Shedding light
on assembly of synapse structure and function.
Turner, G., Cold Spring Harbor Laboratory: Electrophysiology
102; Neural coding in the fly brain: In vivo whole-cell patch-
clamp recording methods.
Zars, T., University of Missouri, Columbia and Dubnau, J., 
Cold Spring Harbor Laboratory: Olfactory learning and 
memory.
Zhang, B., University of Oklahoma, Norman: Electrophysiology
101; The synaptic vesicle cycle.
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Revolutionary Sequencing Technologies and Applications
July 6–17
INSTRUCTORS E. Mardis, Washington University School of Medicine, St. Louis, Missouri
G. Marth, Boston College, Chestnut Hill, Massachusetts
R. McCombie, Cold Spring Harbor Laboratory
J. McPherson, Ontario Institute for Cancer Research, Toronto, Canada
M. Zody, Broad Institute, Cambridge, Massachusetts
ASSISTANTS M. Busby, Boston College, Chestnut Hill, Massachusetts
J. Glasscock, Washington University School of Medicine, St. Louis, Missouri
E. Hodges, Cold Spring Harbor Laboratory
M. Kramer, Cold Spring Harbor Laboratory
V. Magrini, Washington University School of Medicine, St. Louis, Missouri
M. Stromberg, Boston College, Chestnut Hill, Massachusetts
During the last decade, large-scale DNA sequencing has had a marked impact on the practice of mod-
ern biology and is beginning to affect the practice of medicine. With the recent introduction of several
revolutionary sequencing technologies, costs and time lines have been reduced by orders of magni-
tude, facilitating investigators to conceptualize and perform sequencing-based projects that heretofore
were prohibitive. Furthermore, the application of these technologies to answer questions previously not
experimentally approachable is broadening their impact and application.
This intensive 12-day course explored applications of next-generation sequencing technologies,
with a focus on commercially available methods. Students were instructed in the detailed operation of
several revolutionary sequencing platforms, including sample preparation procedures, general data
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handling through pipelines, and in-depth data analysis. A diverse range of biological questions were
explored including DNA resequencing of human genomic regions (using cancer samples as a test
case), de novo DNA sequencing of bacterial genomes, and the use of these technologies in studying
small RNAs, among others. Guest lecturers highlighted their own applications of these revolutionary
technologies. 
We encouraged applicants from a diversity of scientific backgrounds, including molecular evolution,
development, neuroscience, cancer, plant biology, and microbiology.
This course was sponsored by Applied Biosystems, Illumina, and 454 Life Sciences (http://www.
454.com/).
PARTICIPANTS
Beutler, A., Ph.D., Mount Sinai School of Medicine, New York
Cattonaro, F., Ph.D., Institute of Applied Genomics, Udine,
Italy
Chen, N., B.A., Cornell University, Ithaca, New York
Cho, M., Channing Laboratory, Brigham and Women’s
Hospital, Boston, Massachusetts
Elshire, R., M.S., Cornell University, Ithaca, New York
Goes, F., M.D., Johns Hopkins University, Baltimore, 
Maryland
Jafari, N., Doctorate, Northwestern University, Chicago, Illinois
Kenny, E., Trinity College Dublin, Republic of Ireland
Khan, A., M.S., AgResearch Ltd., Dunedin, New Zealand
Kieleczawa, J., M.S., Wyeth Research, Cambridge,
Massachusetts
Kilalainen, A., M.Sc., Uppsala University, Finland
Kim, D., Ph.D., Beckman Research Institute of the City of
Hope, Duarte, California
Kinney, J., B.A., Princeton University, New Jersey 
Kuenzli, M., Functional Genomics Center, Zurich, Switzerland
Pelizzola, M., Ph.D., Yale University, New Haven, Connecticut
Rasmussen, M., M.S., University of Copenhagen, Denmark
Rose, M., Ph.D., Syngenta Biotechnology, Inc., Research
Triangle Park, North Carolina
Sengamalay, N., M.S., Institute for Genomic Sciences,
Baltimore, Maryland
Waterfall, J., Ph.D., Cornell University, Ithaca, New York
SEMINARS
Aravin, A., Cold Spring Harbor Laboratory: Discovering small
RNAs with Solexa sequencing.
Bloom, T., Broad Institute of MIT and Harvard University,
Cambridge, Massachusetts: Infrastructure and IT for next-
generation sequencing.
Egholm, M., 454 Life Sciences/Roche, Branford, Connecticut:
Future improvements to Roche/454 pyrosequencing.
Erlich, Y., Cold Spring Harbor Laboratory: Alta-cyclic: A self-
optimized Illumina base-caller.
Mardis, E., Washington University School of Medicine, St.
Louis, Missouri: Next-generation sequencing and cancer
genomics.
Meissner, A., Broad Institute, Cambridge, Massachusetts:
Dissecting direct reprogramming through integrative genomic
analysis.
Olson, J. and Becker S., Raindance Technologies, Lexington,
Massachusetts: Selective genomic amplification using
droplet-based microfluidics.
Schroth, G., Illumina, Inc., Hayward, California: Future
improvements to the Illumina Genome Analyzer.
Snyder, M., Yale University, New Haven, Connecticut: Next-
generation-based RNA-seq studies of the yeast
Saccharomyces cerevisiae.
Turner, S., Pacific Biosciences, Menlo Park, California: SMaRT
sequencing.
Watson, J., Cold Spring Harbor Laboratory: Human genome.
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Genetics of Complex Human Diseases
July 7–13
INSTRUCTORS A. Al-Chalabi, Institute of Psychiatry, Kings College, London, United Kingdom
L. Almasy, Southwest Foundation for Biomedical Research, San Antonio, Texas
Complex diseases are conditions that are influenced by the actions of multiple genes and their interac-
tions with one another and with the environment. This lecture course considered the difficulties in
studying the genetic basis of complex disorders such as diabetes, cardiovascular disease, cancer, and
autism. We discussed genetic-epidemiologic study designs, including family, parent-child trio,
case/control and adoption studies, and methods for quantifying the strength of the genetic influences
on a disease. A major focus was the identification of specific gene effects using both linkage and asso-
ciation analysis and their variants. We discussed the efficiency and robustness of different designs for
such analysis and the appropriate contexts for their use. Study design and methods for analysis of
quantitative risk factors related to complex diseases were covered, as well as the latest ideas in data
reduction such as haplotype mapping and SNP tagging. Copy-number variation as an influence on
complex disease risk and Bayesian coalescent models for the fine mapping of disease loci were also
discussed. Illustrations were provided through discussion of results from ongoing studies of a variety
complex diseases and related risk factors. 
Speakers in the course included Ingrid Borecki (Washington University), Paul De Bakker
(Massachusetts General Hospital), Toby Johnson (University of Edinburgh, United Kingdom), Marina
Kennerson (ANZAC Research Institute, New South Wales, Australia), Adrian Krainer (Cold Spring
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Harbor Laboratory), Eden Martin (University of Miami), Shaun Purcell (Kings College London, United
Kingdom), Jonathan Sebat (Cold Spring Harbor Laboratory), Pak Sham (University of Hong Kong,
China), and Janet Sinsheimer (University of California, Los Angeles).
SEMINARS
Almasy, L., Southwest Foundation for Biomedical Research,
San Antonio, Texas: Advanced linkage.
Al-Chalabi, A., Kings College London, United Kingdom:
Introduction to associational studies.
Borecki, I., Washington University School of Medicine, St.
Louis, Missouri: Genetic epidemiology.
De Bakker, P., Brigham and Women’s Hospital, Boston,
Massachusetts: GWAS meta analysis.
Johnson, T., University of Lausanne, Vaud, Switzerland:
Evolution and population genetics.
Kennerson, M., ANZAC Research Institute, New South Wales,
Australia: Introduction to linkage; Genetics linkage programs
practical.
Krainer, A., Cold Spring Harbor Laboratory: RNA in complex
disease.
Martin, E., University of Miami, Florida: Family-based association.
Neale, B., Massachusetts General Hospital, Boston: SNP
imputation.
Purcell, S., Massachusetts General Hospital, Boston:
Genome-wide association studies.
Sebat, J., Cold Spring Harbor Laboratory: Copy-number varia-
tion.
Sham, P.C., University of Hong Kong, China: Association stud-
ies: Power and multiple testing issues.
Sinsheimer, J., David Geffen School of Medicine, Los Angeles,
California: Statistics 101.
PARTICIPANTS
Asselta, R., Ph.D., University of Milan, Italy
Avenevoli, S., Ph.D., National Institute of Mental Health,
Bethesda Maryland
Bione, S., Ph.D., Institute of Molecular Genetics, Pavia, 
Italy
Creed Geraghty, J., B.S., Weill Cornell Medical College Qatar
Doha, Education City
Cutler, G., Ph.D., Amgen Informatics, South San Francisco,
California
Davis, A., Ph.D., Brigham and Women’s Hospital and Harvard
Medical School, Boston, Massachusetts
Davis, L., B.S., University of Iowa, Iowa City
Didriksen, M., Ph.D., H. Lundbeck A/S, Valby, Denmark
Ernst, F., Ph.D., University Hospital of Greifswald, Germany
Lopez, S., Ph.D., Institut de Recerca de l’Hospital de la Santa
Creu, Barcelona, Spain
Macedo Vranas, M., B.S., University of Aarhus, Denmark
Manuel Soria, J., Ph.D., Institut de Recerca de l’Hospital de la
Santa Creu, Barcelona, Spain
McKay, G., Ph.D., Queen’s University Belfast, Belfast, United
Kingdom
Mocan, E., B.S., Institute of Genetics, Chisinau, Moldava
Saito-Loftus, Y., Ph.D., Mayo Clinic, Rochester, Minnesota
Teumer, A., B.S., University of Greifswald, University Hospital,
Germany
Wiechec, E., B.S., University of Aarhus, Denmark
Yeo Han, D., B.S., University of Auckland, New Zealand 
Zedler, B., Ph.D., Philip Morris USA, Richmond, Virginia
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Workshop on Biology of Social Cognition
July 14–20
INSTRUCTORS R. Adolphs, California Institute of Technology, Pasadena
D. Skuse, University College London, United Kingdom
ASSISTANT A. Lin, California Institute of Technology, Pasadena
The past few years have seen remarkable advances in our knowledge of the genetic, molecular, and
neural factors that contribute to social behavior. At the same time, sophisticated analytical and theo-
retical approaches have helped to make sense of the data. This week-long workshop provided a com-
prehensive overview of these topics. Although the emphasis was on social cognition in humans, there
were study days dedicated to state-of-the-art presentations on comparative approaches and evolu-
tionary models. Finally, all themes were related to the clinical consequences of dysfunctional social cog-
nition and the role of translational research. The course included introductory seminars on key themes,
offered every morning. Afternoons were devoted largely to practical sessions that provided hands-on
experiments in consultation with seminar leaders, rounded off by after-dinner keynote lectures by lead-
ing scientists that reflected cutting-edge and future views related to our theme for that day. Ample
breaks allowed time for informal interactions between lecturers and students. 
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PARTICIPANTS
Bodley Scott, S., B.S., University of Nottingham, United
Kingdom
Campbell-Meiklejohn, D., Ph.D., University of Aarhus,
Denmark
Canadas, E., B.S., University of Granada, Spain
Duman, E., B.S., Biopsychology Ph.D. Program, Stony Brook
University, New York
Florentini, C., B.S., University of Geneva, Switzerland
Gao, X., Ph.D., McMaster University, Hamilton, Canada
Glaser, B., B.S., University of Geneva, Switzerland
Gupta, R., B.S., University of Iowa, Iowa City
Jones, E., B.S., University of Washington, Seattle
Lampis, V., Ph.D., San Raffaele University, Milan, Italy
Lim P., B.S., National University of Singapore
Modi, M., B.S., Emory University, Atlanta, Georgia
Oswald, T., B.S., University of Oregon, Eugene
Payne, C., B.S., Emory University/Yerkes NPRC, Atlanta, Georgia
Robinson, E., B.S., Harvard School of Public Health, Boston,
Massachusetts
Schneider, A., Ph.D., University of California, Davis, MIND
Institute, Sacramento
Scott, A., B.S., University of California, Los Angeles
Shepherd, S., B.S., Duke University, Durham, North Carolina
Van Peer, J., B.S., Leiden University, The Netherlands
Villalta-Gil, V., Ph.D., CIBERSAM-Saint John of God I+D
Foundation, Sant Boi de Llobregat, Spain
SEMINARS
Adolphs, R., California Institute of Technology, La Jolla: The
amygdala and social cognition.
Allman, J., California Institute of Technology, La Jolla: Neural
specialization for primate social behavior.
Blakemore, S., University College London, United Kingdom:
Workshop on the development of social cognition.
Bleakly, B., University of Exeter, United Kingdom: Guppies and
what they tell us about social cognition.
Cahill, L., University of California, Irvine: Sex differences in
emotion and social cognition.
Canli, T., Stony Brook University, New York: Imaging genomics.
Crawley, J., National Institutes of Heath, Bethesda, Maryland:
Social deflects in mouse models of autism.
Fisher, S. University of Oxford, United Kingdom: Tangled
webs: Tracing the connections between genes and cogni-
tion.
Fiske, S., Princeton University, New Jersey: Social neuro-
science approaches to understanding other minds.
Goldberg, T., Zucker Hillside/Feinstein Institute/ECOM, Glenn
Oaks, New York: Biology of mental illness: Deficits in social
cognitive conference.
Insel, T., National Institutes of Mental Health/NIMH, Bethesda,
Maryland: The future of research in social neuroscience.
Keysers, C., University of Groningen, The Netherlands: Mirror
neurons and the human mirror system.
Marcus, G., New York University, New York: Language and the
evolution of the human mind.
Moore, A., University of Exter, United Kingdom: Evolution of
social behavior: What we can learn from insects.
Parr, L., Emory University, Yerkes National Primate Center,
Atlanta, Georgia: Social cognition in chimpanzees.
Rangel, A., California Institute of Technology, La Jolla: An intro-
duction to neuroeconomics.
Schultz, R., University of Pennsylvania, Philadelphia Children’s
Hospital, Philadelphia: Face processing and the neural basis
of autism.
Skuse, D., University College London, United Kingdom: X-
linked genes and social cognition.
Tranel, D., University of Iowa, Des Moines: The frontal lobes
and emotions.
Young, L., Emory University, Atlanta, Georgia: Pair bonding in
voles.
Young, L., Harvard University, Cambridge, Massachusetts:
Moral choices in the social brain.
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Eukaryotic Gene Expression
July 16–August 5
INSTRUCTORS J. Espinosa, University of Colorado, Boulder
W.L. Kraus, Cornell University, Ithaca, New York
T. Oelgeschlager, Marie Curie Research Institute, Oxted, United Kingdom
A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
ASSISTANTS N. Gomes, University of Colorado, Boulder
B. Malecova, Marie Curie Research Institute, Oxted, United Kingdom
D. Ruhl, Cornell University, Ithaca, New York
M. Wu, Stowers Institute for Medical Research, Kansas City, Missouri
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the exciting area of gene regulation. The course focused on state-of-the-art strategies and
techniques used in the field. Emphasis was placed on both in vitro and in vivo protein–DNA interac-
tions and novel methodologies to study gene regulation. Students made nuclear extracts, performed
in vitro transcription reactions, and measured RNA levels using primer extension. Characterizations of
the DNA-binding properties of site-specific transcription factors were performed using electrophoretic
mobility-shift and DNase I footprinting assays. In addition, students learned techniques for the assem-
bly and analysis of chromatin in vitro. 
During the past few years, the gene regulation field has developed in vivo approaches for studying
gene regulation. In this course, students were exposed to the chromatin immunoprecipitation tech-
nique. They also used RNAi for specific knockdown experiments in mammalian cells. In addition, deter-
mining factor binding and gene expression profiles has accelerated tremendously by DNA microarray
technology. Students received hands-on training in performing and interpreting results from ChIP-chip
analyses and microarrays.
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Experience with basic recombinant DNA techniques was a prerequisite for admission to this course.
Lectures by the instructors covered the current status of the gene expression field, theoretical aspects
of the methodology, and broader issues regarding strategies for investigating the regulation of gene
expression in eukaryotes. Guest lecturers discussed contemporary problems in eukaryotic gene regu-
lation and technical approaches to their solution.
Speakers in the 2008 course included Marisa Bartolomei (University of Pennsylvania School of
Medicine), Wendy Bickmore (MRC Human Genetics Unit), Brian Dynlacht (New York University School
of Medicine), Alexander Hoffmann (University of California, San Diego), Robert Kingston (Massachusetts
General Hospital and Harvard Medical School), Tony Kouzarides (The Gurdon Institute), Michael Levine
(University of California, Berkeley), Danesh Moazed (Harvard Medical School), Frank Pugh (Pennsylvania
State University), Jeffrey Ranish (Institute for Systems Biology), Robert Roeder (The Rockefeller
University), Michael Rosenfeld (University of California, San Diego), Patrick Schuiltz (IGBMC), Mike
Snyder (Yale University), and Laszlo Tora (IGBMC).
This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Alsheikhly Dantoft, W., M.S., Stockholm University, Sweden
Anckar, J., M.Sc., Turku Centre for Biotechnology, Finland
Bonthuis, P., B.S., University of Virginia, Charlottesville
Chatzi, K., B.S., Weill Cornell Medical College, New York
Chia, D., M.D., Oregon Health & Science University, Portland
Chuang, P., M.D., Mount Sinai School of Medicine, New York
de Araujo Souza, P., Ph.D., Brazilian National Cancer Institute,
Rio de Janeiro
Elsaesser, S., Diploma, The Rockefeller University, New York
Franco, H., B.S., University of Puerto Rico School of Medicine,
San Juan
Hekilmoglu, B., M.S., Institute of Molecular Biotechnology,
Vienna, Austria
Kim, Y.J., Ph.D., Yale University School of Medicine, New
Haven, Connecticut
Lobanova, E., Ph.D., Duke University Medical Center, Durham,
North Carolina
Munoz, M., M.S., LFBM IFIBYNE, CONICET, Buenos Aires,
Argentina
Nuytemans, K., M.S., VIB: University of Antwerp, Belgium
Park, Y.P., Ph.D., National Institutes of Health, Rockville,
Maryland
Pridalova, J., M.S., Institute of Molecular Genetics AS CR,
Prague, Czech Republic
SEMINARS
Bartolomei, M., University of Pennsylvania School of Medicine,
Philadelphia: Mechanism of genomic imprinting.
Bickmore, W., MRC Human Genetics Unit, Edinburgh, United
Kingdom: Repressing gene expression at Hox loci, during
differentiation and development.
Dynlacht, B., New York University School of Medicine and
NYU Cancer Institute, New York: Transcriptional control of
cell cycle exit and differentiation.
Hoffmann, A., University of California, La Jolla: Combinatorial
and temporal codes of transcriptional activators.
Kingston, R., Massachusetts General Hospital and Harvard
Medical School, Boston: New technologies to study the
mechanisms of epigenetic regulation.
Kouzarides, T., University of Cambridge, United Kingdom:
Chromatin modifying enzymes: Function and role in cancer.
Levine, M., University of California, Berkeley: Paved PO1II and
development and cancer.
Moazed, D., Harvard Medical School, Boston, Massachusetts:
RNAi and epigenetic inheritance of heterochromatin and
cancer.
Pugh, F., Pennsylvania State University, University Park:
Genomic organization of chromatin and the transcription
machinery.
Ranish, J., Institute for Systems Biology, Seattle, Washington:
Deciphering the composition of transcription complexes by
quantitative mass spectrometry.
Roeder, R., The Rockefeller University, New York:
Transcriptional activation mechanisms in animal cells: A
largely biochemical approach.
Rosenfeld, M., University of California, San Diego, La Jolla:
Regulatory networks in cellular growth and cancer develop-
ment.
Schultz, P., IGBMC, Illkirch, France: Structural study of the
eukaryotic transcription factor TFIID by electron microscopy
and image analysis.
Snyder, M., Yale University, New Haven, Connecticut: Genomic
analysis of gene expression and regulatory networks.
Tora, L., IGBMC, Illkirch, France: Toward the understanding of
the regulation of RNA polymerase II transcription in a chro-
matin environment.
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Imaging Structure and Function in the Nervous System
July 22–August 11
INSTRUCTORS S. Thompson, University of Maryland School of Medicine, Baltimore
W. Tyler, Arizona State University, Tempe
J. Waters, Northwestern University, Chicago, Illinois
ASSISTANTS F. Albeanu, MCB, Cambridge, Massachusetts
P. Baluch, Arizona State University, Tempe
B. Clark, Wolfson Institute for Biomedical Research, London, United Kingdom
M. Histed, Harvard Medical School, Boston, Massachusetts
S. Hofer, University College London, United Kingdom
A. Kampff, Harvard University, Cambridge, Massachusetts
H. Mattison, University of Maryland, Baltimore
S. Pal, Harvard University, Cambridge, Massachusetts
B. Pichler, University College London, United Kingdom
M. Rhiannon, CNRC, Vrije Universiteit Amsterdam, The Netherlands
N. Takada, Northwestern University, Chicago, Illinois
Y. Tufail, Arizona State University, Tempe
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to use emerging imaging technologies. The primary
emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as use of different types of electronic cameras, laser-scanning systems, function-
al fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell
function, including calcium-sensitive dyes, voltage-sensitive dyes, photoactivated (“caged”) com-
pounds, and exocytosis tracers. Issues arising from the combination of imaging with electrophysiolog-
ical methods were covered. Particular weight was given to multiphoton laser-scanning microscopy and
to newly available biological fluorophores, especially green fluorescent protein (GFP) and its variants.
We used a spectrum of neural and cell biological systems, including living animals, brain slices, and
cultured cells. Applicants had a strong background in the neurosciences or in cell biology. 
Lecturers in the 2008 course included Hemant Bokil (Cold Spring Harbor Laboratory), Marcel
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Bruchez (Carnegie-Mellon University), Karl Deisseroth (Stanford University), Winfried Denk (Max-Planck
Institute for Medical Research), David DiGregorio (Universite Paris 5), Florian Engert (Harvard University),
Oliver Griesbeck (Max-Planck Institute of Neurobiology), Samuel Hess (University of Maine), Mark
Huebener (Max-Planck Institute of Neurobiology), David Kleinfeld (University of California, San Diego),
Jurgen Klingauf (Max-Planck Institute for Biophysical Chemistry), Fred Lannie (Carnegie-Mellon
University), Troy Margrie (University College London), Partha Mitra (Cold Spring Harbor Laboratory),
Thomas Mrsic-Flogel (University College London), Venkatesh Murthy (Harvard University), Valentin
Naegerl (Max-Planck Institute of Neurobiology), Timothy Ragan (Massachusetts Institute of Technology),
Karel Svoboda (Howard Hughes Medical Institute), Philbert Tsai (University of California, San Diego), and
Richard Weinberg (University of North Carolina).
This course was supported with funds provided by the National Institute of Mental Health (http://www.
ninds.nih.gov/), the National Institute of Neurological Disorders & Stroke (http://www.ninds.nih.gov/), and
the Howard Hughes Medical Institute (http://www.hhmi.org/). 
Scientists from developing countries accepted into this course may be eligible for scholarships provided
by the International Brain Research Organization. For details, go to http://www.iac-usnc.org/fellowships.htm.
PARTICIPANTS
Abrahamsson, T., M.S., CNRS, Paris, France
Alitto, H., Ph.D., University of California, Berkeley, Davis
Biro, A., M.D., University College London, United Kingdom
Branco, T., Ph.D., University College London, United Kingdom
Digby, G., M.S., Medical College of Georgia, Augusta
Frost, N., B.S., University of Maryland School of Medicine,
Baltimore
Hong, Y.K., Sc.B., Harvard University, Cambridge,
Massachusetts
Lloyd, T., Ph.D., Johns Hopkins School of Medicine,
Baltimore, Maryland
Newton, J., Ph.D., University of California, San Francisco
Sun, D., Ph.D., Massachusetts General Hospital, Boston
Szatmari, E., Ph.D., Duke University, Durham, North Carolina
Viney, T., M.Biol., Friedrich Miescher Institute, Basel,
Switzerland
SEMINARS
Bruchez, M., Carnegie-Mellon University, Pittsburgh,
Pennsylvania: New and future indicators.
Deisseroth, K., Stanford University, California: Light-triggered
activation/silencing.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Extended two-photon imaging and
block-face electron microscopy.
DiGregorio, D., Universite Paris 5, Paris, France and
Thompson, S., University of Maryland School of Medicine,
Baltimore, Maryland: Flash photolysis.
Engert, F., Harvard University, Cambridge, Massachusetts:
Light sources (filaments, arc lamps, monchromators, metal
halide lamps, LEDs, lasers, applications); Detectors (PMTs,
CCDs, APDs, applications); Shot noise; Image J.
George, N., Olympus America, Inc., Center Valley,
Pennsylvania: Objectives; BX51 optics.
Griesbeck, O., Max-Planck Institute of Neurobiology,
Martinsried, Bayen, Germany: Genetically encoded sensors.
Hess, S., University of Maine, Orono: STORM, PALM, FPALM.
Huebener, M., Max-Planck Institute of Neurobiology,
Martinsried, Germany: Intrinsic imaging.
Kilborn, K., Intelligent Imaging Innovations, Santa Monica,
California: Deconvolution and frequency-domain FLIM.
Kleinfeld, D., University of California, San Diego, La Jolla:
Spectral methods, denoising, and voltage-sensitive dyes.
Mitra, P., Cold Spring Harbor Laboratory: Numerical methods
practical, Chronux.
Klingauf, J., Max-Planck Institute for Biophysical Chemistry,
Gottingham, Germany: Fluorescence correlation 
microscopy. 
Lanni, F., Carnegie-Mellon University, Pittsburgh, Pennsylvania:
Basic microscopy; DIC, Dodt tube, etc.
Litchman, J., Harvard University, Cambridge, Massachusetts:
Confocal microscopy.
Margrie, T., University College of London, United Kingdom: Two-
photon targeted patching.
Mrsic-Flogel, T., University College London, United Kingdom:
Organic calcium indicators bulk loading.
Murthy, V., Harvard University, Cambridge, Massachusetts:
Synaptofluorins and vesicle imaging.
Nagerl, V., Max-Planck Institute of Neurobiology, Munich,
Germany: Nagerl’s nuggets.
Prabhat, P., Semrock, Inc., Rochester, New York: Filters and
dichroics.
Ragan, T., Massachusetts Institutes of Technology,
Cambridge: Fluorescence block-face imaging.
Svoboda, K., Cold Spring Harbor Laboratory: Basics of two-
photon imaging; Advanced two-photon:FRET, FLIM, two-
photon uncaging.
Tsai, P., University of California, San Diego, La Jolla: Optics
bench lab exercises: Basics Koehler; Optics bench lab exer-
cises–Scanning; Optics bench lab exercises: Confocal.
Tyler, W., Arizona State University, Tempe: Imaging soundwaves.
Waters, J., Northwestern University, Chicago, Illinois:
Homebrew microscope including laser safety; Organic calci-
um indicators; Single-cell calcium imaging in vivo.
Weinberg, R., University of North Carolina, Chapel Hill:
Electron microscopy tomography.
Witkowski, J., Cold Spring Harbor Laboratory: On doing sci-
ence: Ethics and responsible conduct.
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Yeast Genetics and Genomics
July 22–August 11
INSTRUCTORS B. Errede, University of North Carolina, Chapel Hill
F. Luca, University of Pennsylvania, Philadelphia
M. Whiteway, National Research Council of Canada, Montreal
ASSISTANTS P. Cote, NRC Biotechnology Research Institute, Montreal, Canada
S. Fuchs, University of North Carolina, Chapel Hill
Y. Song, University of Pennsylvania, Philadelphia
This course is a modern, state-of-the-art laboratory course designed to teach students the full reper-
toire of genetic approaches needed to dissect complex problems in the yeast Saccharomyces cere-
visiae. Combinations of classical genetic approaches are emphasized, including the isolation and char-
acterization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular genet-
ics techniques, including various types of yeast transformation, gene replacement with plasmids and
PCR, construction and analysis of gene fusions, and generation of mutations in cloned genes, were
also emphasized. Students used classical and molecular approaches to gain experience in identifying
and interpreting various kinds of genetics interactions including suppression and synthetic lethality.
Students were immersed in yeast genomics and performed and interpreted experiments with DNA
arrays. Attendees gained first-hand experience in modern cytological approaches such as epitope tag-
ging and imaging yeast cells using indirect immunofluorescence, GFP–protein fusions, and a variety of
fluorescent indicators for various subcellular organelles. Lectures on fundamental aspects of yeast
genetics were presented along with seminars given by outside speakers on topics of current interest. 
This year’s speakers included David Amberg (SUNY Upstate Medical University), David Botstein
(Princeton University), Dan Burke (University of Virginia), Frederick Cross (The Rockefeller University),
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Kara Dolinski (Princeton University), James Haber (Brandeis University), Mark Hochstrasser (Yale
University), Anita Hopper (Ohio State University), Mark Johnston (Washington University Medical
School), Mark Rose (Princeton University), Jeffrey Strathern (National Cancer Institute), Bik-Kwoon Tye
(Cornell University), Lois Weisman (University of Michigan), and Reed Wickner (National Institutes of
Health).
This course was supported with funds provided by National Human Genome Research Institute and
the Howard Hughes Medical Institute (http://www.hhmi.org/).
PARTICIPANTS
Bao, Y., Ph.D., M.D. Anderson Cancer Center, Smithville, 
Texas
Bowman, B., Ph.D., Mills College, Oakland, California
Browne, C., B.S., Vanderbilt University School of Medicine,
Nashville, Tennessee
Burwell, L., B.A., Cornell University, Ithaca, New York
Carter, G., Ph.D., Institute for Systems Biology, Seattle,
Washington
Gruber, J., Ph.D., University of Michigan, Ann Arbor
Hughes, C., Ph.D., The Rockefeller University, New York
Johnson, C., B.S., Washington University, St. Louis, Missouri
Kilburn, C., B.A., University of Colorado, Boulder
Lai, K.C., B.S., Stowers Institute for Medical Research,
Kansas City, Missouri
Luo, D., B.Sc., University of Birmingham, United Kingdom
McLaughlin, J., Ph.D., Rutgers University, New Brunswick,
New Jersey
Mirkin, E., Ph.D., Harvard University, Cambridge,
Massachusetts
Piotrowski, J., Ph.D., University of Montana, Missoula
Storey, J., Ph.D., Princeton University, New Jersey
Wang, G., Ph.D., University of North Carolina, Chapel Hill
SEMINARS
Amberg, D., SUNY Upstate Medical University, Syracuse, New
York: Actin crazy in the Amberg lab.
Botstein, D., Princeton University, New Jersey: Coordination of
growth rate, cell cycle, stress response, and metabolic activ-
ity in yeast.
Burke, D., University of Virginia, Charlottesville: Mitotic fidelity
and infidelity…lessons from multiple checkpoints.
Cross, F., The Rockefeller University, New York: Yeast cell
cycle.
Haber, J., Brandeis University, Waltham, Massachusetts:
Checkpoint responses and repair of a broken chromosome.
Hochstrasser, M., Yale University, New Haven, Connecticut:
Regulation of the yeast ubiquitin-proteasome system.
Hopper, A., Ohio State University, Columbus: Retrograde
nuclear accumulation of cytoplasmic tRNA: A conserved
response to nutrient deprivation.
Johnston, M., Washington University Medical School, St.
Louis, Missouri: Feasting, fasting, and fementing: Glucose
sensing and signaling in yeast.
Rose, M., Princeton University, New Jersey: Safe sex and the
single cell.
Strathern, J., National Cancer Institute, Frederick, Maryland:
The consequences of infidelity: Error-prone RNA polymerase.
Tye, B., Cornell University, Ithaca, New York: Modeling breast
cancer in yeast.
Weisman, L., University of Michigan, Ann Arbor: Yeast vacuole
inheritance: Insights into myosin-V-based movement and
phosphoinositide signaling.
Wickner, R., National Institutes of Health, Bethesda, Maryland:
Yeast prions: Biology and structure.
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Mechanisms of Neural Differentiation and Brain Tumors
July 30–August 5
INSTRUCTORS A. Guha, University of Toronto, Canada
E. Holland, Memorial Sloan-Kettering Cancer Center, New York
S. Majumuder, M.D. Anderson Cancer Center, Houston, Texas
ASSISTANT S. Sinha, M.D. Anderson Cancer Center, Houston, Texas
This 1-week discussion course provided a clinical overview of brain tumors and emphasized molecu-
lar mechanisms involved in the growth and development of brain tumors with special emphasis on
neural differentiation, signaling mechanisms, DNA replication, chromatin modulation, stem cells, mouse
models, genomics, imaging techniques, genetically modified mouse techniques, nanotechnology,
mechanism-based therapeutic strategies, and biobanks and ethical concerns. Attendees interacted
with senior investigators on a one-to-one basis in an informal environment. 
This course was supported with generous funding provided by the American Brain Tumor Association
(http://www.abta.org/).
PARTICIPANTS
Agnihotri, S., B.S., Hospital for Sick Children Institute, Toronto,
Canada
Antunes-Martins, A., Ph.D., University of Warwick, Coventry,
United Kingdom
Bralten, L., B.S., Erasmus Medical Center, Erasmus University,
Rotterdam, The Netherlands
Gu, P., Ph.D., M.D. Anderson Cancer Center, Houston, 
Texas
Hatton, B., B.S., Fred Hutchinson Cancer Research Center,
Seattle, Washington
Huang, P., Ph.D., Massachusetts Institute of Technology,
Cambridge
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Jeyaretna, D., Ph.D., Massachusetts General Hospital, 
Boston
Kaarlander, M., B.S., Uppsala University, Sweden
Khabibullin, D., B.S., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Kim, B., Ph.D., University of Toronto, Ontario, Canada
Lafaille, F., B.S., Memorial Sloan-Kettering Cancer Center,
New York
Maire, C., Ph.D., Dana Farber Cancer Institute, Boston,
Massachusetts
Meley, D., Ph.D., University of Liverpool, United Kingdom
Schreck, K., B.S., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Smith, C., Ph.D., Hospital for Sick Children, Toronto, Canada
Song, H.-R., Ph.D., Children’s Hospital of Los Angeles,
University of Southern California, Los Angeles
Sussman, C., Ph.D., Mayo Clinic, Rochester, Minnesota
Wang, J., B.S., Beckman Research Institute of the City of
Hope, Duarte, California
Wolf, A., B.S., Hospital for Sick Children, University of Toronto,
Canada
Wu, X., Ph.D., Hospital for Sick Children, Toronto, Canada
SEMINARS
Burhans, W., Roswell Park Cancer Center, Buffalo, New York:
DNA replication and cancer.
Cristea, I., Princeton University, New Jersey: Proteomic
approaches to profiling a single CNS synapse type: A new
role for phospholipid signaling in postsynaptic function.
Davis, F., University of Illinois, Chicago: Epidemiology of brain
tumors.
Eberhart, C., National Cancer Institute, Baltimore, Maryland:
Developmental signaling pathways, stem cells, and brain
tumors.
Fuller, G., M.D. Anderson Cancer Center, Houston, Texas:
Clinical overview: The role of neuropathology in contempo-
rary diagnostic and experimental neuro-oncology.
Gilbertson, R., St. Jude’s Children’s Research Hospital,
Memphis, Tennessee: How to cure brain tumors.
Gladson, C., University of Alabama, Birmingham: Regulation of
migration and angiogenesis in gliomas.
Guha, A., Toronto Western Research Institute, Canada:
Oncogenic mechanisms of EGFR mutants prevalent in
GBMs.
Gutmann, D., Washington University School of Medicine, St.
Louis, Missouri: Modeling brain tumors in mice: From cage
to clinic.
Holland, E., Memorial Sloan-Kettering Cancer Center, New
York: Trials and stem-like cells in mouse models of brain
tumors.
Jain, R., Massachusetts General Hospital, Boston: Brain tumor
angiogenesis and microenvironment.
James, C.D., University of California, Pacifica: Rodent enfrag-
ment/transplant models for the study of CNS tumors.
Kornblum, H., University of California Molecular and Medical
Pharmacology, Los Angeles: Studying self-renewal in neural
and brain tumor stem cells.
Lozano, G., University of Texas M.D. Anderson Cancer Center,
Houston: The p53 tumor suppressor pathway.
Majumder, S., University of Texas M.D. Anderson Cancer
Center, Houston: Stem cells in development/cancer.
Mietz, J., National Cancer Institute, Bethesda, Maryland:
Funding opportunities at the National Institutes of Health.
Parada, L., University of Texas Southwest Medical Center,
Dallas: Tumor suppressors (TSGs), oncogenes, and human
cancers.
Pieper, R., University of California, San Francisco: Novel
mechanisms of PTEN-mediated tumor suppression in
gliomas.
Rich, J., Duke University Medical Center, Durham, North
Carolina: Cancer stem cells and targeted therapies.
Rowitch, D., University of California, San Francisco: Hedgehog
signaling in brain tumorigenesis.
Sawaya, R.H., University of Texas M.D. Anderson Cancer
Center, Houston: When rocket science meets brain surgery.
Snyder, E., Burnham Institute, La Jolla, California: Some fun-
damental aspects of stem cell biology that might inform
tumor pathophysiology.
Stiles, C., Dana-Farber Cancer Institute, Boston,
Massachusetts: Transcription factors and malignant glioma
in mouse and man.
Van den Bent, M., Daniel Den Hoed Cancer Center,
Rotterdam, The Netherlands: Treatment of brain tumors:
Depending on histology?
Wechsler-Reya, R., Duke University Medical Center, Durham,
North Carolina: Uprooting hedges: The origin and propaga-
tion of medulloblastoma.
Weiss, W., University of California, San Francisco: PI3 kinase
in tumors of the nervous system.
Yung, W.K.A., University of Texas M.D. Anderson Cancer
Center, Houston: Molecular targeted therapies for glioblas-
toma.
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Stem Cell Technologies
August 7–13
INSTRUCTORS E. Greiner, Evotec AG, Hamburg, Germany
R. McKay, National Institutes of Health, Bethesda, Maryland
M.M. Shen, Columbia University Medical Center, New York
ASSISTANTS J. Chenoweth, National Institutes of Health, Bethesda, Maryland
This 1-week lecture course brought together leading researchers in the stem cell field. Stem cells con-
struct organs in development. They sustain tissues in the adult and restore them after injury. Because
of these properties, isolating and manipulating stem cells has become a major new element in biomed-
ical science. This lecture and discussion course covered a series of subjects including the cells of the
early embryo, the nature of germ cells, the mechanisms that control the number of stem cells, their sta-
bility, and transformation into other cell types. The clinical potential and political impact of stem cell
technology was also presented in depth by invited speakers. A key feature of the course was the easy
access to the instructors and the invited lecturers for informal discussion. The purpose of the course
was to provide participants with an opportunity to achieve an advanced understanding of the scientif-
ic and clinical importance of stem cells.
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PARTICIPANTS
Abranches, E., Ph.D., Institute of Molecular Medicine, Lisbon,
Portugal
Artus, J., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
Burgold, T., B.S., Laboratory of Stem Cell Epigenetics, Milano,
Italy
Fuchs, J., Ph.D., Children’s Hospital of Pittsburgh,
Pennsylvania
Gray, S., B.S., University of Dundee, United Kingdom
Jagadish, N., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
Larsen, E., Ph.D., National Hospital, Oslo, Norway
Leeb, M., Ph.D., Institute of Molecular Pathology, Vienna,
Austria
Ling, B., Ph.D., Stanford University, California
Narkis, G., Ph.D., National Institutes of Health, Bethesda,
Maryland
Ougland, R., B.S., Massachusetts General Hospital/Harvard
Medical School, Boston
Skotte, J., B.S., BRIC, University of Copenhagen, Denmark
Seidl, S., B.S., University of Oslo, Norway
Thomson, M., B.S., Harvard University/ Biophysics/System
Biology, Cambridge, Massachusetts
Wessel Pederson, E., Ph.D., The Norwegian Radium Hospital,
Oslo, Norway
Xie, W., B.S., University of California, Los Angeles
SEMINARS
Chaganti, R., Memorial Sloan-Kettering Cancer Center, New
York: Stem cell and differentiation-specific transcription fac-
tor networks in germ cell tumors: Relevance to embryonic
stem cells.
Chambers, I., University of Edinburgh, United Kingdom: ES
cell self-renewal.
Dym, M., Georgetown University School of Medicine,
Washington, D.C.: Male germ line stem cells I: Introduction
and biology; Male germ line stem cells II: Future potential.
Farzad, M., Agilent Technologies, Washington, D.C.: Agilent
Technologies demonstration.
Geijsen, N., Harvard Medical School/Massachusetts General
Hospital, Boston: Different flavors of pluripotency.
Hadjantonakis, K., Memorial Sloan-Kettering Cancer Center,
New York: Live imaging: Seeing is believing and revealing.
Heard, E., CNRS/ Institute Curie, Paris, France: X-chromo-
some inactivation: A model for epigenetic regulation during
embryogenesis and in ES cells.
Hendrich, B., University of Cambridge, United Kingdom:
Transcriptional control of stem cell fate.
Hochedlinger, K., Harvard Medical School, Boston,
Massachusetts: Epigenetic reprogramming and induced
pluripotency.
Impey, S., Oregon Health & Sciences University, Portland:
Genomic approaches to the analysis of transcriptional and
epigenetic networks.
McKay, R., National Institutes of Health, Bethesda, Maryland:
Stem cells and Parkinson’s disease.
Shen, M.M., Columbia University, New York: Nodal signaling
and stem cells from the early mouse embryo.
Studer, L., Memorial Sloan-Kettering Cancer Center, New
York: From epigenetic landscape to establishing lineage.
Surani, A., University of Cambridge, United Kingdom: The rela-
tionship between the germ line and pluripotent stem cells.
Testa, G., European Institute of Oncology, Milan, Italy:
Epigenetic regulation by the Polycomb and Trithorax path-
ways: From genetic hints to molecular insight.
Yamaguchi, T., Center for Cancer Research, Frederick,
Maryland: Wnt signaling, stem cells, and cell-fate determina-
tion in the mamamalian embryo.
Yu, H., Dana-Farber Cancer Institute, Boston, Massachusetts:
Mapping interactions on a genomic scale.
Zernicka-Goetz, M., University of Cambridge, United Kingdom:
Breaking symmetry in the mouse embryo: When, where, how.
Zwaka, T., Baylor College of Medicine, Houston, Texas: The
role of Ronin in pluripotency and embryogenesis.
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C. elegans
August 9–24
INSTRUCTORS S. Ahmed, University of North Carolina, Chapel Hill
A. Desai, University of California, San Diego, La Jolla
M. Zhen, Samuel Lunenfeld Research Institute, Toronto, Canada
ASSISTANTS J. Calarco, Samuel Lunenfeld Research Institute, Toronto, Canada
A. Dammermann, University of California, San Diego, La Jolla
L. Shtessel, University of North Carolina, Chapel Hill
L. Xie, Samuel Lunenfeld Research Institute, Toronto, Canada
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans Genome
Project. The course was suited both for those who have current training in molecular biology and some
knowledge of genetics but no experience with C. elegans and students with some prior worm experi-
ence who wished to expand their repertoire of expertise. The following topics were covered both in the
laboratory and by lectures from experts in the field: worm pushing, C. elegans databases and worm
bioinformatics, anatomy and development, forward genetics, chemical and transposon mutagenesis,
generation of transgenic animals, expression pattern analysis, reverse genetics, construction and
screening of deletion libraries, and RNA inactivation. The course was designed to impart sufficient
training to students in the most important attributes of the C. elegans system to enable them to embark
on their own research projects after returning to their home institutions.
Speakers in the 2008 course included Alejandro Aballay (Duke University), Cori Bargmann (The
Rockefeller University), Barbara Conradt (Dartmouth Medical School), Monica Driscoll (The State
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 335
336
University of New Jersey, Rutgers), David Fitch (New York University), Oliver Hobert (Columbia
University College of Phycians & Surgeons), Erik Jorgensen (University of Utah), Donald Moerman
(University of British Columbia), Amy Pasquinelli (University of California, San Diego), and Susan Strome
(University of California, Santa Cruz).
This course was supported with funds provided by the National Institute of Child Health and Human
Development (http://www.nichd.nih.gov/).
PARTICIPANTS
Ash, P., B.Sc., Mayo Clinic, Jacksonville, Florida
Biron, D., Ph.D., Brandeis/Harvard University, Cambridge,
Massachusetts
Bois, J., Ph.D., MPI-CBG and MPI-PKS, Dresden, 
Germany
Bonini, N., University of Pennsylvania, Howard Hughes
Medical Institute, Philadelphia
Eastwood, A., B.S., California Institute of Technology,
Pasadena
Elle, I., B.Sc., University of Southern Denmark, Odense M,
Denmark
Fang-Yen, C., Ph.D., Harvard University, Cambridge,
Massachusetts
Giordano, R., M.Sc., Inserm, Bordeaux, France
Guillily, M., B.A., Boston University, Massachusetts
Kalb, R., M.D., Children’s Hospital of Philadelphia,
Pennsylvania 
Kotak, S., Ph.D., University of Frankfurt, Germany
Leroy, M., M.S., Inserm, Paris, France
Leung, M., B.Sc., Duke University, Durham, North 
Carolina
Pollard, D., Ph.D., New York University, New York
Shimori, M., B.S., Kobe University, Japan
Wu, H.-Y., University of California, San Francisco
SEMINARS
Ahmed, S., University of North Carolina, Chapel Hill: Germ-
line immortality.
Alejandro, A., Duke University, Durham, North Carolina:
Pathogens and innate Immunity.
Arshad, D., University of California, San Diego, La Jolla: Cell
division.
Bargmann, C., The Rockefeller University, New York: Olfaction
and behavior.
Condradt, B., Dartmouth Medical School, Hanover, New
Hampshire: Programmed cell death.
Driscoll, M., Rutgers University, Piscataway, New Jersey:
Mechanosensation, neuronal death, and aging.
Fitch, D., New York University, New York: Evolution of
Caenorhabditis and other rhabditid nematodes.
Hobert, O., Columbia University, New York: microRNA and
neuronal left-right asymmetry.
Jorgensen, E., University of Utah, Salt Lake City: A simple
behavioral circuit.
Moerman, D., University of British Columbia, Vancouver,
Canada: Functional genomics.
Pasquinelli, A., University of California, San Diego, La Jolla:
microRNA biogenesis and function.
Strome, S., University of California, Santa Cruz: Germ-line
gene expression.
Zhen, M., Samuel Lunenfeld Research Institute, Toronto,
Canada: Development of the nervous system.
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X-ray Methods in Structural Biology
October 13–28
INSTRUCTORS W. Furey, V.A. Medical Center and University of Pittsburgh, Pennsylvania
G. Gilliland, Centorcor R&D, Inc., Radnor, PA
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT M. Thomas, Centocor R&D, Inc., Radnor, Pennsylvania
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensified laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who are new to macromolecular crystallogra-
phy. Topics covered included basic diffraction theory, crystallization (proteins, nucleic acids, and complex-
es), crystal characterization, X-ray sources and optics, synchrotrons, crystal freezing, data collection, data
reduction, multiple isomorphous replacement, multiwavelength anomalous diffraction, molecular replace-
ment, solvent flattening, noncrystallographic symmetry averaging, electron density interpretation, molec-
ular graphics, structure refinement, structure validation, coordinate deposition, and structure presentation.
Participants learned through extensive hands-on experiments. One or more proteins were crystallized and
the structure(s) determined by several methods, in parallel with lectures on theory and informal discus-
sions behind the techniques. Applicants were familiar with the creation and editing of simple text files on
Linux workstations using a screen-based editor (either vi or emacs).
Speakers in the 2008 course included Paul Adams (Lawrence Berkeley Laboratory), Serge Cohen
(Netherlands Cancer Institute, Amsterdam), Zbigniew Dauter (Agronne National Laboratory), Paul
Emsley (University of York, United Kingdom), Hiro Furukawa (Cold Spring Harbor Laboratory), Jeffrey
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Headd (Duke University Medical Center), Wayne Hendrickson (Columbia University), Xinhua Ji (National
Cancer Institute), Leemor Joshua-Tor (Cold Spring Harbor Laboratory), Gerard Kleywegt (University of
Uppsala, Sweden), Anastassis Perrakis (Netherlands Cancer Institute), Randy Read (University of
Cambridge, United Kingdom), David Richardson (Duke University Medical Center), Robert Sweet
(Brookhaven National Laboratory), Thomas Terwilliger (Los Alamos National Laboratory), Dale Tronrud
(University of Oregon), John Westbrook (State University of New Jersey, Rutgers), and Michael Wiener
(University of Virginia).
This course was supported with funds provided by the National Cancer Institute (http://www.can-
cer.gov/) and the Howard Hughes Medical Institute (http://www.hhmi.org/).
PARTICIPANTS
Allerston, C., Ph.D., University College London, United
Kingdom
Ash, M.-R., B.S., University of Sydney, Australia
Economou, N., Diploma, Drexel University, Philadelphia,
Pennsylvania
Fanucchi, S., Ph.D., University of the Witwatersrand, Gauteng,
South Africa
Gerratana, B., Ph.D., University of Maryland, College Park
Gilbert, N., B.S., Louisiana State University, Baton Rouge
Guttler, T., M.S., Max-Planck Institute, Gottingen, Germany
Hibbs, R., Ph.D., Oregon Health & Science University, Portland
Hook, P., Ph.D., Columbia University, New York
Hrmova, M., Ph.D., University of Adelaide, Glen Osmond,
Australia
Knauer, S., University of Bayreuth, Germany
Krey, T., Ph.D., Institut Pasteur, Paris, France
Luo, X., Ph.D., University of Texas Southwestern Medical
Center, Dallas
Napetschnig, J., M.Sc., The Rockefeller University, New York
Robinson, P., Stanford University, California 
Tidow, H., Ph.D., MRC Centre for Protein Engineering,
Cambridge, United Kingdom
Viani Puglisi, E., Ph.D., Stanford University School of Medicine,
California
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, Berkeley, California:
Structure refinement.
Cohen, S., Netherlands Cancer Institute, Amsterdam, The
Netherlands: Automated structure solution and model build-
ing.
Dauter, Z., Agronne National Laboratory, Illinois: Anomalous
data collection.
Emsley, P., University of York, United Kingdom: Model-building
tools in cool.
Furukawa, H., Cold Spring Harbor Laboratory: Structure and
function of NMDA receptors.
Hendrickson, W., Columbia University, New York: MAD phas-
ing: Theory and practice.
Ji, X., National Cancer Institute, Frederick, Maryland: Structure
of RapA, a Swi2/Snf2 protein that recycles RNA polymerase
during transcription.
Joshua-Tor, L., Cold Spring Harbor Laboratory: DNA translo-
cation: One step at a time; Structure presentation.
Kleywegt, G., University of Uppsala, Sweden: Just because it’s
in Nature, doesn’t mean it’s true…(macromolecular structure
validation).
Read, R., University of Cambridge, United Kingdom: Molecular
replacement: New structures from old; Using SAD data in
phaser.
Richardson, D., Duke University Medical Center, Durham,
North Carolina: Detection and repair of model errors using
MolProbity.
Sweet, R., Brookhaven National Laboratory, Upton, New York:
Fundamental of crystallography; X-ray sources and optics.
Terwilliger, T., Los Alamos National Laboratory, New Mexico:
Automated structure solution and model building.
Tronrud, D., University of Oregon, Eugene: Difference electron
density maps; Macromolecular refinement I; Macromolecular
refinement II.
Westbrook, J., The State University of New Jersey, Rutgers,
Pisacataway: Automating PDB deposition.
Wiener, M., University of Virginia, Charlottesville: Membrane
protein crystallization.
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Programming for Biology
October 15–28
INSTRUCTORS S. Lewis, University of California, Berkeley
S. Prochnik, DOE–Joint Genome Institute/University of California, Berkeley 
J. Tisdall, DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS D. Curiel, Pioneer Hi-Bred, Johnston, Iowa
E. Lee, Lawrence Berkeley National Laboratory, Berkeley, California
J. Leipzig, DuPont Experimental Station, Wilmington, Delaware
J. Karalius, Seminis Vegetable Seeds, Inc., Woodland, California
D. Messina, Stockholm University, Sweden 
K. Norwick, University of Illinois, Urbana-Champagne
S. Robb, University of Utah, Salt Lake City
A computer is already an indispensable tool for database searches, but the use of web-based tools
alone is not enough for today’s biologist who needs to access and work with data from myriad sources
in disparate formats. This need has become ever more important as new technologies have increased
the already exponential rate at which biological data is generated. Designed for students and
researchers with little or no prior programming experience, this 2-week course gave biologists the
bioinformatics skills necessary to exploit the abundance of biological data. 
The course was based around the Perl scripting language, because of its ease of learning and its
incredible wealth of ready-built code modules (e.g., bioperl) designed to solve common biological prob-
lems. Starting with introductory coding, and continuing with a survey of available biological libraries and
practical topics in bioinformatics, students ended by learning how to construct and run powerful and
extensible analysis pipelines in a straightforward manner. The course combined formal lectures with
hands-on sessions in which students worked to solve problem sets covering common scenarios in the
acquisition, validation, integration, analysis, and visualization of biological data. For their final projects,
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 339
340
which ran during the second week of the course, students were posed with problems using their own
data and worked with one another and the faculty to solve them. Final projects formed the basis of
publications as well as public biological websites (see, e.g., http://bio.perl.org/wiki/Deobfuscator).
The prerequisites for the course were basic knowledge of UNIX. Lectures and problem sets covering
this background material were available online from previous years and students studied this material
before starting the course. The primary focus of this course was to provide students with practical pro-
gramming experience, rather than to present a detailed description of the algorithms used in computa-
tional biology. For the latter, we recommend the Computational Genomics course (http://meetings.
cshl.edu/courses/c-ecg08.shtml).
Speakers in the 2008 course included Scott Cain, Roderic Guigo, Winston Hide, Curtis
Huttenhower, Sheldon McKay, William Pearson, Jason Stajich, Lincoln Stein, and Paul Thomas.
This course was supported by the National Human Genome Research Institute (http://www.genome.
gov/).
PARTICIPANTS
Blouin, N., M.S., University of Maine, Orono
Boucher, Y., Ph.D., Massachusetts Institute of Technology,
Cambridge
Boysen, J., B.S., New York University School of Medicine/
Skirball Institute, New York
Ellison, C., B.A., University of California, Berkeley
Eveland, A., Ph.D., Cold Spring Harbor Laboratory
Fagerberg, L., M.Sc., Royal Institute of Technology,
Stockholm, Sweden
Faria, R., Ph.D., Universitat Pompeu, Fabra, Barcelona, Spain
Fievet, B., Ph.D., Gurdon Institute/University of Cambridge,
United Kingdom
Gongora-Castillo, E., Cinvestav, Irapuato, Mexico
Gruntman, E., M.S., Cold Spring Harbor Laboratory
Irvine, D., B.S.,  Cold Spring Harbor Laboratory
Jimenez-Gomez, J., Ph.D., University of California, Davis
Krause, J., Diploma, Max-Planck Institute, Leipzig, Germany
Li, W., B.S., Cold Spring Harbor Laboratory
Metsugi, S., M.S., The Institute for Advanced Study, Princeton,
New Jersey
Meyer, M., Diploma, Max-Planck Institute, Leipzig, Germany
Ortiz-Pineda, P., B.S., University of Puerto Rico, San Juan
Perry, M., Ph.D., Ontario Institute for Cancer Research,
Canada
Ramsey, J., B.A., Cornell University, Ithaca, New York
Rodriquez, J., Ph.D., The Gurdon Institute, Cambridge, United
Kingdom
Rymarquis, L., Ph.D., University of Delaware, Newark
Woods, I., B.S., Harvard University, Cambridge,
Massachusetts
Zhuang, Y., B.S., University of Connecticut, Groton
SEMINARS
Cain, S., Cold Spring Harbor Laboratory: gbrowse: The gener-
ic genome browser.
Guigo, R., University Pompeu Fabra, Spain: Gene prediction.
Hide, W., Harvard University, Massachusetts: EST sequence
clustering and analysis.
Huttenhower, C., Princeton University, New Jersey:
Microarrays.
McKay, S., Cold Spring Harbor Laboratory: DB design + SQL;
DBI; HTML; CGI.
Pearson, W., University of Virginia, Charlottesville: Sequence
similarity.
Stajich, J., University of California, Berkeley: Bioperl I; Bioperl II.
Thomas, P., SRI International, Menlo Park, California: Protein
function prediction.
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Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 19–November 1
INSTRUCTORS V. Allan, University of Manchester, United Kingdom
K. Hu, Indiana University, Bloomington
S. Huang, Northwestern University School of Medicine, Chicago, Illinois
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
ASSISTANTS P. March, University of Manchester, United Kingdom
C. Wang, University of California, Davis
M. Wozniak, University of Manchester, United Kingdom
This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochem-
istry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well as protein
and RNA dynamics in living cells. The course emphasized the use of the latest equipment and tech-
niques in fluorescence microscopy, including confocal laser-scanning microscopy, deconvolution
methods, digital image processing, and time-lapse imaging of living specimens. The course was
designed to present students with state-of-the-art technology and scientific expertise in the use of light
microscopy to address basic questions in cellular and molecular biology. It was intended for the mol-
ecular biologist who is in need of microscopic approaches and for the cell biologist who is not familiar
with the practical application of the advanced techniques presented in the course. Among the meth-
ods presented were the preparation of tagged nucleic acid probes, fixation, detection of multiple DNA
sequences in single nuclei or chromosome spreads, comparative genomic hybridization, cellular local-
ization of RNA, localization of nucleic acids and proteins in the same cells, use of a variety of reporter
molecules and nonantibody fluorescent tags, indirect antibody labeling, detection of multiple proteins
in a single cell, and the use of GFP variants to study protein expression, localization, and dynamics.
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With each method, several experimental protocols were presented, allowing the students to assess the
relative merits of each and to relate them to their own research. Students were encouraged to bring
their own nucleic acid, protein, or antibody probes to the course, which were used in addition to those
provided by the instructors. The laboratory exercises were supplemented with lectures given by invit-
ed distinguished scientists, who presented up to the minute reports on current methods and research
using the techniques being presented.
Speakers in the 2008 course included Michael Davidson, Richard Day, Joseph Gall, Alexey
Khodjakov, Alison North, and Thomas Ried.
This course was supported with funds provided by the National Cancer Institute (http://www.can-
cer.gov/).
PARTICIPANTS
Bair, A., Ph.D., Harvard University/Massachusetts General
Hospital, Charlestown
da Fonseca Pereira, C., Ph.D., Macfarlane Burnet Institute,
Melbourne, Australia
Deglincerti, A., Laureate, Weill Cornell Medical College, New York
George, P., B.S., Virginia Tech, Blacksburg
Gilman, J., B.S., University of Colorado, Denver 
Hsiao, C.-J., Ph.D., University of Connecticut, Storrs
Jurcisek, J., B.S., The Research Institute at Nationwide
Children’s Hospital, Columbus, Ohio
Miller, J., Ph.D., University of Iowa, Iowa City
Mullers, E., B.A., Dresden International Graduate School,
Germany 
Parkhitko, A., M.S., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Plotnikova, O., M.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Recino, A., M.S., University of Bath, United Kingdom
Schmidt, C., Dipl., Cancer Research UK, London, United
Kingdom
Vijayakumar, S., Ph.D., New York University Medical Center,
New York
Wong, G., B.S., Cambridge University, United Kingdom
Zhu, Y., Ph.D., The University of Melbourne, Australia
SEMINARS
Allan, V., University of Manchester, United Kingdom: Immuno-
cytochemistry.
Davidson, M., The Florida State University, Tallahassee: A
library of fluorescent proteins for live cell imaging.
Day, R., University of Virginia, Charlottesville: Seeing colors:
Applications and limitations of the fluorescent proteins.
Gall, J., Carnegie Institution, Baltimore, Maryland: The devel-
opment of in situ hybridization.
Hu, K., Indiana University, Bloomington and Murray, J.,
University of Pennsylvania School of Medicine, 
Philadelphia: Introduction to light and fluorescence
microscopy.
Huang, S., Northwestern University School of Medicine,
Chicago, Illinois: Introduction to FISH.
Khodjakov, A., Wadworth Center, E. Greenbush, New York:
Control of daughter centriole formation.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Digital detectors and digital imaging fundamen-
tals; Microscopy of thick specimens.
North, A., The Rockefeller University, New York: Immunocyto-
chemistry on tissue sections principles and practices.
Ried, T., National Cancer Institute/National Institutes of Health,
Bethesda, Maryland: Mechanisms and consequences of
chromosomal aberrations in cancer cells.
Spector, D., Cold Spring Harbor Laboratory: Visualizing gene
expression/silencing in living cells.
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Computational and Comparative Genomics
November 5–11
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT D. Triant, Louisiana State University, Baton Rouge
Beyond BLAST and FASTA—This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
It focused on approaches for extracting the maximum amount of information from protein and DNA
sequence similarity through sequence database searches, statistical analysis, and multiple sequence
alignment. Additional topics included gene recognition (exon/intron prediction), identifying signals in
unaligned sequences, and integration of genetic and sequence information in biological databases.
The course combined lectures with hands-on exercises; students were encouraged to pose challeng-
ing sequence analysis problems using their own data. The course made extensive use of local world
wide web pages to present problem sets and the computing tools to solve them. Students used
Windows and Mac workstations attached to a UNIX server; participants were comfortable using the
Unix operating system and a Unix text editor. The course was designed for biologists seeking
advanced training in biological sequence analysis, computational biology core resource directors and
staff, and scientists in other disciplines, such as computer science, who wish to survey current
research problems in biological sequence analysis.
The primary focus of this course was the theory and practice of algorithms used in computational
biology, with the goal of using current methods more effectively and developing new algorithms.
293-350_Courses:Layout 1  6/12/09  12:36 PM  Page 343
344
Students more interested in the practical aspects of advanced software development were encouraged
to apply to the course on Programming for Biology (http://meetings.cshl.edu/courses/c-info07.shtml).
Speakers in the 2008 course included Stephen Altschul (National Library of Medicine), Michael
Ashburner (European Bioinformatics Institute), Peter Cooper (NCBI/NLM), Bert Overduin (European
Bioinformatics Institute), and Lisa Stubbs (University of Illinois).
This course was supported by the National Human Genome Research Institute (http://www.genome.
gov/).
PARTICIPANTS
Arighi, C., B.S., Protein Information Resource, Washington,
D.C.
Ayub, M., B.S., University of Dhaka, Bangladesh
Burbano, H., M.Sc., Max-Planck Institute for Evolutionary
Anthropology, Leipzig, Germany
Cao, J., Ph.D., Wyeth Research, Cambridge, Massachusetts
DeBarry, J., B.S., University of Georgia, Athens
Fatakia, S., B.S., NIDDK/National Institutes of Health,
Bethesda, Maryland
Glass, S., M.S., Wyeth Research, Cambridge, Massachusetts
Grosso, A.R., B.S., Lisbon University, Portugal
Moorthy, S., Ph.D., Perkasie, Pennsylvania
Pich, C., Ph.D., ZFIN, University of Oregon, Eugene
Roltgen, K., B.S., University of Basel, Switzerland
Ross, E., M.B.A., University of Utah, Salt Lake City
Silva, L., B.S., Rene Rachou Research Center, Belo Horizonte,
Brazil
Spinner, W., B.Sc., University of Bristol, United Kingdom
Szatkiewicz, J., Ph.D., The Jackson Laboratory, Bar Harbor,
Maine
Tang, Y.L., Ph.D., Keck Graduate Institute of Applied Life
Science, Claremont, California
SEMINARS
Altschul, S., National Library of Medicine, Bethesda, Maryland:
Statistics of sequence similarity scores; Iterated protein data-
base searches with PSI-BLAST.
Ashburner, M., European Bioinformatics Institute, Hinton,
Cambridge, United Kingdom: Biological ontologies.
Cooper, P., NCBI/NLM, Bethesda, Maryland: NCBI resources
for bioinformatics and computational biology; NCBI genome
resources.
Nowick, K., University of Illinois, Urbana: Analysis of zinc finger
expansion in vertebrate genomes.
Overduin, B., European Bioinformatics Institute, Hinxton,
Cambridge, United Kingdom: The ENSEMBL database of
genomes I; ENSEMBL II.
Pearson, W., University of Virginia, Charlottesville: Alignment 
algorithms: Large-scale alignment; Protein evolution 
and sequence similarity searching; Algorithms for 
biological sequence comparison; Hidden Markov 
models and protein profiles; Identifying consensus 
sites.
Smith, R., GlaxoSmithKline, King of Prussia, Pennsylvania:
Approaches to multiple sequence alignment/multiple align-
ment resources.
Stubbs, L., University of Illinois, Urbana: Genome comparison
biology.
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Phage Display of Proteins and Peptides
November 6–19
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, San Diego, La Jolla
ASSISTANTS S. Kacir, University of Pennsylvania, Philadelphia
I. Molano, Medical University of South Carolina, Charleston
K. Noren, New England BioLabs, Ispwich, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allowed for
the rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/
lecture course focused on the construction of combinatorial antibody libraries expressed on the sur-
face of phage and selection of desired antibodies from the library. Students learned the theoretical and
practical aspects of constructing combinatorial libraries from immune and nonimmune sources as well
as the construction of synthetic antibody libraries. Antibodies were selected from the library by pan-
ning. Production, purification, and characterization of Fab fragments expressed in Escherichia coli were
also covered. Epitopes were selected from peptide libraries and characterized. 
The lecture series, presented by a number of invited speakers, emphasized PCR of immunoglobu-
lin genes, the biology of filamentous phage, the utility of surface expression libraries, expression of anti-
bodies in E. coli and mammalian cells, antibody structure and function, catalytic antibodies, directed
protein evolution, retroviral and cell display libraries, the immunobiology of the antibody response, and
recent results on the use of antibodies in therapy. The theory and practical implications for selection
from phage-displayed libraries of random peptides, cDNA products, and semisynthetic proteins were
also explored.
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Seminar speakers in the 2008 course included Angela Belcher (Massachusetts Institute of
Technology), Germaine Fuh (Genentech, Inc.), Christopher Noren (New England BioLabs), Christoph
Rader (National Institutes of Health), Nathalie Scholler (University of Pennsylvania), Sachdev Sidhu
(University of Toronto), George Smith (University of Missouri), and Robyn Stanfield (The Scripps
Research Institute).
This course is supported with funds provided by the Howard Hughes Medical Institute (http://www.
hhmi.org/).
PARTICIPANTS
Amara, I., M.S., Institute of Biotechnology, UNAM,
Cuernavaca, Mexico
Axelsson, F., M.Sc., Lund University, Sweden
Capparelli, F., M.S., Federial University of Uberlandia, Brazil
Chang, K.-H., M.S., Green Cross Corporation, Yongin, South
Korea
Conroy, P., Ph.D., Dublin City University, United Kingdom
Ferrer-Miralles, N., Ph.D., Autonomous University of
Barcelona, Spain
Gomes, K.N., B.S., University of Sao Paulo, Brazil
Kimura, M., Ph.D., Gifu University School of Medicine, 
Japan
Kivil, A., M.A., Tallinn University of Technology, Estonia
Lam, A., B.A., OncoMed Pharmaceutical, Inc., Redwood City,
California
Morales, C., B.S., Trubion Pharmaceuticals, Seattle,
Washington
Neelamegar, S., M.Sc., Invitrogen, Bangalore, India
Nilvebrant, J., M.Sc., Royal Institute of Techology, Stockholm,
Sweden
Wadas, T., Ph.D., Washington University School of Medicine,
St. Louis, Missouri
Woelfle, M., M.D., The Feinstein Institute for Medical
Research, Manhasset, New York
Yang, M., Ph.D., Canadian Food Inspection Agency, Winnipeg,
Canada
SEMINARS
Barbas, C., The Scripps Research Institute, La Jolla, California:
Developing therapeutic strategies with phage display.
Belcher, A., Massachusetts Institute of Technology,
Cambridge: Phage as a toolkit for the synthesis and assem-
bly of materials for electronics and energy.
Fuh, G., Genentech, Inc., S. San Francisco, California:
Synthetic human antibodies and their use in biology.
Noren, C., New England BioLabs, Beverly, Massachusetts:
Phage peptide libraries: The Ph.D. for peptides.
Rader, C., National Cancer Institute/National Institutes of
Health, Bethesda, Maryland: Mining human antibody reper-
toires by phage display.
Scholler, N., University of Pennsylvania, Philadelphia: Yeast
display.
Sidhu, S., University of Toronto, Canada: Antibody phage dis-
play and chemical diversity in antigen recognition.
Siegel, D., University of Pennsylvania Medical Center, Phila-
delphia: Cell surface selection of combinatorial Fab libraries.
Silverman, G., University of California, San Diego, La Jolla:
Repertoire cloning of SLE autoantibodies.
Smith, G., University of Missouri, Columbia: Principles of affini-
ty selection; Massively parallel selections.
Stanfield, R., The Scripps Research Institute, La Jolla,
California: Structural biology of the immune system.
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The Genome Access Course
April 29–30, November 18–19
TRAINERS G. Howell, The Jackson Laboratory, Bar Harbor, Maine
B. King, The Jackson Laboratory, Bar Harbor, Maine
L. Reinholdt, The Jackson Laboratory, Bar Harbor, Maine
R. Sachidanandam, Mount Sinai School of Medicine, New York
This course is an intensive 2-day introduction to bioinformatics that was held twice in 2008 and trained
almost 43 participants in total. The core of the course was designed to cover the manipulation and
analysis of sequence information. The course was broken into modules designed to give a broad
overview of a given topic, with ample time for examples chosen by the instructors. Each module includ-
ed three parts: a discussion of theory and methods, coverage of software and web resources, and use
of selected tools with examples (including those supplied by the students). The modular design allowed
the instructors to tailor the presentation to the interests of the students. Modules included  Electronic
sequence information; Pairwise sequence comparisons; Multiple sequence alignments; Gene predic-
tion; Genome analysis; Sequence variation; Protein classification and structural analysis; Proteomics;
and Phylogenetic analysis. Applications to the course were open to all on a first-come, first-served
basis, subject to basic eligibility requirements. The course was held at the Laboratory’s Genome
Research Center at Woodbury, which is located seven miles south of the main Laboratory campus.
Each student was provided with a PC laptop with wireless modem for the duration of the course.
Students were encouraged to supply problem sets and sequences of interest to the trainers for pos-
sible incorporation as examples in the modules. Materials were made available on the web and stu-
dents continued to ask questions of the trainers as they applied what they had learned in their individ-
ual endeavors. 
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April 29–30
Allen, M., Pfizer Inc., Groton, Connecticut
Barral, J., The University of Texas Medical Branch, Galveston
Du, R., Harvard Medical School/Brigham and Women’s
Hospital, Boston, Massachusetts
Elias, L., University of California, San Francisco
Etzrodt, M., Massachusetts General Hospital, Charlestown
Gladdy, R., Memorial Sloan-Kettering Cancer Center, New York
Hebert, T., McGill University, Montreal, Canada
Hendrickson, M., Syosset Central School District, New York
Kaiser, C., The University of Texas Medical Branch, Galveston
Kim, H., Roswell Park Cancer Institute, Buffalo, New York
Kurland, I., State University of New York, Stony Brook
Laing, R., University of Glasgow, United Kingdom
Laurindo, F., Heart Institute, University São Paulo School
Medicine, Brazil
Naidu, D., State University of New York, Stony Brook
Oswald, M., Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York
Padhi, B., Health Canada, Ottawa
Sezen, U., University of Connecticut Ecology and Evolutionary
Biology, Storrs
Shoelson, B., The MathWorks, Natick, Massachusetts
November 18–19
Cardone, L., Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York
Crummett, C., Massachusetts Institute of Technology,
Cambridge
Debette, S., Boston University, Framingham Heart Study,
Boston, Massachusetts
Erblich, J., Mount Sinai School of Medicine, New York
Fox, A., Brigham and Women’s Hospital Harvard Medical
School, Boston, Massachusetts
Ghiban, C., Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York
Gottwein, E., Duke University Medical Center, Durham, North
Carolina
Guffanti, G., University of California, Irvine
Jimenez, R., Brown University, Providence, Rhode Island
June, R., University of California, San Diego
Lim, S., Bonn Medical School, Bonn, Germany
Moon, B., Columbia University, New York
O’Grady, T., Mount Sinai School of Medicine, New York
Parr, R., Texas A&M University, College Station
Pietrzykowski, A., University of Massachusetts, Worcester
Platero, H., Stanford University, Palo Alto, California
Plavskin, Y., Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York
Rebolini, D., Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York
Salih, S., University of Wisconsin, Madison
Sotos, M., Valencia University, Valencia, Spain
Svoren, E., William Harvey Research Institute, London, United
Kingdom
Tang, K.-W., University of Göteburg, Sweden
Trimble, J., St. Francis University, Loretto, Pennsylvania
Yun, C., New York University School of Medicine, New York
Zhang, Z., Cold Spring Harbor Laboratory, Cold Spring
Harbor, New York
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Title Host
January
Dr. William Kaelin, Harvard University/Dana The VHL tumor suppressor gene: Oxygen sensing Scott Lowe
Farber Cancer Institute and cancer
Dr. David Kingsley, Stanford University School Fishing for the secrets of vertebrate evolution Scott Powers
of Medicine
February
Dr. Leslie Vosshall, The Rockefeller University How insects sense odor concentration with ion Scott Powers
channels
Dr. Jonathan Widom, Northwestern University The genomic code for nucleosome positioning Leemor Joshua-Tor
March
Dr. Eileen White, Rutgers University Role of autophagy in cancer Terri Grodzicker
Dr. Benjamin Cravatt, The Scripps Research Mapping dysregulated biochemical pathways in 
Institute cancer by integrated proteomics and metabolomics Leemor Joshua-Tor
Dr. Marc Vidal, Dana-Farber Cancer Institute/ Interactome networks and human disease David Jackson
Harvard Medical School
Dr. Richard Caprioli, Vanderbilt University Molecular imaging and profiling of tissue sections Leemor Joshua-Tor
using mass spectrometry: Applications in biological
and clinical research
April
Dr. David Anderson, California Institute of Neural circuits for innate defensive behaviors in flies Zach Mainen
Technology and mice
Dr. Robert Kingston, Harvard Medical School/ Unraveling the genome using new technologies Terri Grodzicker
Massachusetts General Hospital
October
Dr. Chris Q. Doe, University of Oregon Cell polarity and spindle orientation regulate Senthil Muthuswamy
Drosophila stem cell self-renewal
Dr. Charles Zuker, University of California, Common sense about taste—From the tongue to Bruce Stillman
San Diego the brain
November
Dr. Tobias Meyer, Stanford University Logics of signaling systems that control Ca2+ Lloyd Trotman
homeostasis and cell migration
Dr. Victor Ambros, University of Massachusetts microRNA pathways in animal development Gregory Hannon
Medical School
December
Dr. Rob Phillips, California Institute of Technology A single-molecule view of biological action at a Leemor Joshua-Tor
distance
Dr. M. Geoffrey Rosenfeld, University of California, Life, death, and transformation: Movement, DNA Gregory Hannon
San Diego repeats, and ncRNAs
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings. These weekly seminars keep the CSHL staff current on the latest scientific developments and
broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar speak-
ers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in an
informal setting. 
SEMINARS
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Title
January
Jan Witkowski Eugenics, immigration, and the politicizing of science
Martin Bayer (Lukowitz Lab) Paternal control of embryonic patterning in Arabidopsis thaliana
Bill Keyes (Mills Lab) p63 regulates stem cells in cancer and aging
February
Gidon Felsen (Mainen Lab) Neural circuits for decision-making in rats
Michael Huebner (Spector Lab) Silence, please! Polycomb proteins and gene regulation
Josh Huang Construction and function of the GABA inhibitory circuits
Jonathan Sebat Analysis of genome copy-number variation in schizophrenia
Jen Bestman (Cline Lab) The RNA-binding protein CPEB controls dendrite growth and neural circuit
assembly in vivo
March
Milos Tanduric (Martienssen Lab) Selective silence:  Epigenomic variation and fluctuation in plants
Anne Daulny (Tansey Lab) Negative regulation of RNA polymerase II by ubiquitylation
Josh Dubnau Memories of a fly:  Dissection with vegetables and dogs
April
Zi Zhong Understanding of memory through Benzer’s eyes
Doreen Ware Interpreting plant genomes, a comparative journey
Lincoln Stein Genome annotation:  Farmer’s mart or Wal-Mart?”
October
Valery Krizhanovsky (Lowe Lab) Cellular senescence beyond tumor suppression
Partha Mitra Evolution of song culture in the Zebra Finch
Yoselin Benitez Alfonso (Jackson Lab) Reactive oxygen species regulate intercellular communication during plant development
Jeremy Wilusz (Spector Lab) Looking beyond classical polyadenylation:  How a noncoding RNA uses the tRNA
processing machinery to defy the dogma
November
Xavier Roca (Krainer Lab) New mechanisms of splice-site recognition:  Implications for genomics and disease
December
Emily Hodges (Hannon Lab) CliffsNotes to the genome—A portable guide for probing cancer, the epigenome, and 
ancient DNA
Michael Zhang Large-scale network-based prediction of human disease genes
Avi Rosenberg (Muthuswamy Lab) Cell shape meets cell fate in the breast
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor Laboratory’s In-House Seminars were initiated to provide a semiformal avenue for
communication between the various research groups at the Laboratory. The seminars also afford a nec-
essary opportunity for the graduate students and postgraduate staff to develop their skills in organiz-
ing, presenting, and defending their research.
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BANBURY CENTER
EXECUTIVE DIRECTOR’S REPORT
The year 2008 was unusually quiet at Banbury. Our meetings season was much shorter than usual, finishing at the end
of October. It was then that we began a major renovation of Robertson House that necessitated emptying the house
and turning it over to the Laboratory’s facilities crews and outside contractors. Times have changed and conditions that
were once acceptable are no longer so. Most significantly, air-conditioning is being installed—an upgrade that will be
much appreciated by all those who will spend the summer months here! We are taking advantage of this disruption to
rewire the house, redecorate, and upgrade Internet facilities. The house was built in 1936 so we will be in good time to
celebrate its 75th anniversary in 2011. 
As a consequence of the shortened season, there were only 18 scientific meetings in 2008 and a correspondingly
smaller number of participants: 524. Of these, 81% came from the United States, specifically from 33 states, with New
York, California, Massachusetts, and Maryland providing most of these participants. Almost one-fifth of participants
came from outside of the United States, from 16 countries. In addition to the meetings, there were six CSHL lecture
courses, and two CSHL laboratories held retreats here. We were happy to again welcome local organizations includ-
ing the Conservation Board of the Village of Lloyd Harbor, the Cold Spring Harbor School District, and the Caumsett
Foundation. So, overall, the Center was busy throughout the year.
The year 2008 marked Jim Watson’s 40th year at Cold Spring Harbor Laboratory, and to observe the occasion,
Banbury Center held three meetings on topics of special interest to Jim. The common thread of the meetings involved
topics of interesting scientific research, the results of which have important consequences for society and should help
form public policy. The titles of each were cast as questions, in the expectation that this phrasing would help focus
minds and provoke debate. Regrettably, but not surprisingly, we did not answer any of the questions. However, the
meetings brought together fascinating groups of people for very lively discussions.
 
Coffee break discussions
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The first of the three meetings was entitled How Will We Prevent Most Forms of Cancer? We have been performing
research on cancer for more than a century and since the early 1970s, we have discovered many of the genetic and
biochemical changes that turn a normal cell into a cancer cell. This knowledge is going to increase rapidly with the appli-
cation of large-scale genomic analysis of tumors. However, despite this intensive research, the number of cancers that
can at present be cured effectively and efficiently remains small. The participants explored why this is so, evaluated cur-
rent and potential therapies, asked what can be done to improve early detection, and faced the issue that some can-
cers may not be curable.
The second meeting in the series asked the question To What Age Should We Be Expected to Work? Here, the
scope of the discussions ranged from laboratory research on aging through to the economic consequences of extend-
ed life span. Considerable progress has been made in elucidating some of the genetic changes and molecular process-
es that contribute to aging in experimental organisms. Although our lives are being extended through better lifestyles
and improved health care, it seems, however, that our maximum life spans are unchanged. Is extending the human life
span an achievable or desirable goal? Should we concentrate instead on maintaining the quality of life for the extra
years that we are gaining now? That is, can we live longer and still be healthy? 
The third meeting was also of broad scope, ranging from research to social impact to educational policy: How Can
We Improve Our Brains? It is the hope of every parent that their child will be bright and intelligent. Parents work to help
their children’s brain work better by providing education and stimulation, and society as a whole makes a tremendous
commitment to the education of its young people. Are there data emerging from cognitive neuroscience that such edu-
cation programs should take into account? Are there learning regimes that might be more effective than those typical-
ly found in the classroom? At the other end of life is the hope of all of us that the normal decline in cognitive skills that
accompanies aging will be slow. Might “brain exercises” maintain our brains at a higher level of functioning? Is there
evidence that such exercises work? Are there effective pharmacological agents? In short, how can we best use the
resources of society to help our brains work better throughout our lives?
Meetings dealing with biomedical research that has important social implications seem to have been the norm at
Banbury in 2008. Who Are We? Kinship, Ancestry, and Social Identity reviewed a field that has been changing rapidly
because of technical advances in genomics and rapidly increasing public interest. Participants discussed the issue that
although genetics provides a description of human beings that reflects their biological ancestry, cultural norms provide
a description of social ancestry, and these two descriptions need not be, and often are not, the same. This has been
highlighted by the increasing use of DNA-based analysis for tracing genealogical ancestry. Here, discrepancies between
ancestry revealed by genetic analysis and assumed by cultural descent may profoundly affect individuals’ views of
themselves. The importance of the relationship between genetic and ethnic identities requires careful, rational, and crit-
ical review of what is a controversial subject. 
I began my research career working on Duchenne’s muscular dystrophy (DMD), studying cells growing in tissue
culture. At that time, no human genes, let alone genes involved in genetic disorders, had been isolated, and the
cloning in the mid 1980s of the gene involved in DMD was a landmark in human genetics. It was confidently expect-
ed, now that the protein was known and the gene was available for gene therapy, that treatments would quickly fol-
low, but that optimism was misplaced. In the succeeding years, we have learned that going from a cloned gene to a
therapy is extraordinarily difficult. However, a new therapeutic strategy has been developed that uses oligonucleotides
to direct the splicing of an mRNA so that a functional or partially functional protein is produced. This has proved to be
successful in experimental models of DMD and spinal muscular atrophy. Participants in the meeting Oligonucleotide-
directed Splicing: Therapeutic Strategies critically reviewed current progress in the field and discussed new technical
advances in the synthesis and properties of oligonucleotides. (A report of the meeting was published in Science 322:
1454–1455 [2008].)
The year 2008 was also the first time that a Banbury Center meeting was not held at Banbury! We had planned a
discussion meeting on Epigenetics: Mechanisms and Regulation, but the Robertson House renovations meant that
there was no time to have it at the Banbury estate. The Meetings and Courses office stepped in to help and arranged
for the meeting to be in the Plimpton Room on the main campus. We are very grateful to David Stewart and Val Pakaluk
for their hard work done on our behalf. The meaning of the term “epigenetics” has come to cover a very wide range of
biological processes, from dynamic short-lived chromatin-mediated gene regulation to long-term alteration of chromatin
and other extrachromosomal proteins in nonreplicating cells. Participants were encouraged to think beyond details of
molecular mechanisms and to consider how “epigenetics” should be defined. As happens whenever scientists come
together to define terms, the discussions proved to be very lively!
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For the second year, there has been a significant change in Banbury Center
staff. In May 1978, Victor McElheny was appointed as director of the Center. He
was followed, in September 1978, by the appointment of Beatrice Toliver as
administrative assistant, a position that she has held for 30 years, providing all
four Banbury directors with essential support. Bea’s knowledge of Banbury and
its operations was particularly important to me when I became director following
the tragic death of Steve Prentis. With her help, we were able to maintain and
expand the program. During the 30 years that Bea has been at Banbury, she has
become well known to the thousands of scientists who have participated in
Banbury meetings. On their behalf, as well as the Laboratory, we wish Bea the
happiest of retirements.
As always, the operations of the Banbury Center depend on many people: Ellie
Sidorenko at the Conference Room, Basia Polakowski at Robertson House, and
Mike Peluso and the grounds crew who look after the Banbury estate. We have
many interactions with David Stewart and his staff in the Meetings and Courses
office, and, of course, we could not do anything here without the work of the
Laboratory’s Culinary Services and Housekeeping.
Jan Witkowski
Executive Director
Bea Toliver
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The goal of this meeting was to explore what would be the ideal study for identifying gene–environment
interactions involved in multiple sclerosis (MS). Although associations with MS have been identified for
a few risk factors such as the HLA-DR2 gene haplotype and cigarette smoke, very little progress has
been made in explaining the specific biological role of these factors and the manner in which risk fac-
tors interact in the development of MS. However, there are reasons to hope for faster progress in the
coming years. High-throughput technologies such as genomic microarrays and new DNA sequencers
are producing data in a much more cost-effective fashion than ever before and enabling new experi-
mental strategies. Participants in the meeting were drawn from a wide variety of research areas includ-
ing MS clinical research, genetics, genomics, environmental toxicology, and epidemiology. 
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcoming Remarks: B. Greenberg, The Johns Hopkins Hospital, Baltimore, Maryland: Overview of the
agenda/schedule and objectives.
SESSION 1
Chairperson: B. Greenberg, The Johns Hopkins Hospital, Baltimore, Maryland
B. Greenberg, The Johns Hopkins Hospital, Baltimore, Maryland:
Overview of multiple sclerosis: Knowns and unknowns.
A. Bar-Or, Montreal Neurological Institute, Canada:
Immunology of multiple sclerosis.
H. Schmidt, Accelerated Cure Project for Multiple Sclerosis,
Waltham, Massachusetts: Genetics of multiple sclerosis.
S. Subramaniam, Vanderbilt Stallworth Rehabilitation Hospital,
Nashville, Tennessee: Role of DNA damage pathway in MS.
W.R. McCombie, Cold Spring Harbor Laboratory: Massively
parallel targeted resequencing: Opportunities and challenges.
SESSION 2
Chairperson: A. Ascherio, Harvard School of Public Health, Boston, Massachusetts
B. Greenberg, The Johns Hopkins Hospital, Baltimore,
Maryland: Overview of agenda and goals for the day.
S.D. Vernon, CFIDS Association of America, Charlotte, North
Carolina: Empiric delineation of patient heterogeneity to
improve diagnosis and intervention.
T. Vollmer, Barrow Neurological Institute, Phoenix, Arizona:
S. Jacobson, NINDS/National Institutes of Health, Bethesda,
Maryland: Virus associations and MS.
W.I. Lipkin, Columbia University, New York: Identifying viral
pathogens in neurological disease.
C. Hayes, University of Wisconsin, Madison: Vitamin D and MS.
B. Winstock-Guttman, SUNY University of Buffalo, New York:
Gender and MS.
D. Mohr, Northwestern University, Chicago, Illinois: Stress and
MS.
S. Schmidt, Duke Center for Human Genetics, Durham, North
Carolina: Gene–environment interaction in age-related macu-
lar degeneration: A success story.
B. Banwell, Hospital for Sick Children, Toronto, Canada:
Pediatric MS: Insights into the disease.
SESSION 3
Chairperson: T. Vollmer, Barrow Neurological Institute, Phoenix, Arizona
BANBURY CENTER MEETINGS
Genes and the Environment: New Strategies for Research on
Multiple Sclerosis
February 3–6
FUNDED BY Stanley Trotman, Jr. Trust
ARRANGED BY B. Greenberg, The Johns Hopkins Hospital
A. Mellor, Accelerated Cure Project for Multiple Sclerosis
H. Schmidt, Accelerated Cure Project for Multiple Sclerosis
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E.W. Daw, Washington University, St. Louis, Missouri:
Oligogenic modeling with environmental covariates for asso-
ciation and linkage studies.
D.W. Bigwood, Diogenix, Inc., Madison, Connecticut: Analysis
of large gene expression data sets: Strategies for identifying
novel pathogenic pathways.
M. Wigler, Cold Spring Harbor Laboratory: How might one
apply copy-number analysis to understand the genetics of
multiple sclerosis?
SESSION 4
B. Greenberg, The Johns Hopkins Hospital, Baltimore, Maryland
Discussion and revision of Protocol.
Developing a Study Protocol
Discussion initiated by B. Greenberg, The Johns Hopkins Hospital, Baltimore, Maryland: Day conclusions.
SESSION 5
Presentation of Proposed Protocol
B. Greenberg, The Johns Hopkins Hospital, Baltimore, Maryland
Biorepositories: Challenges and applications.
A. Ascherio, Harvard School of Public Health, Boston,
Massachusetts: Use of prospective cohorts in investigating
causes of disease.
D.E. Ganem, University of California, San Francisco:
Discovering novel pathogens.
Banbury Conference Center
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GEM Meeting
February 13–14
FUNDED BY The Stanley Foundation
ARRANGED BY S. Gary, Cold Spring Harbor Laboratory
358
The Genetics of Early-onset Mania (GEM) Study of Bipolar Disorder is a research project organized by
Cold Spring Harbor Laboratory and supported by a donation from Ted and Vada Stanley. This collabo-
rative project involves four institutions: CSHL, Zucker Hillside Hospital–North Shore LIJ, NIMH, and
Johns Hopkins University. The goal of this project is to identify genes that may be associated with bipo-
lar disorder by (1) performing genome-wide analysis of copy-number variation in bipolar families, (2)
assessing the overall contribution of de novo and inherited mutations in sporadic and familial bipolar dis-
order, and (3) identifying novel candidate genes for further study.
Participants in the GEM project have initiated a new collection focusing on trios (affected child plus
both parents) with the goal of collecting samples from 225 patients and their parents. This Banbury
meeting brought together the GEM collaborators to provide a project update and to address the fol-
lowing points: (1) increasing the sample size of collection, (2) the GEM database for entering clinical
F. McMahon, E. Leibenluft, T. Schulze, NIMH/National
Institutes of Health, Bethesda, Maryland
data, (3) an update on CNV analysis of these and related samples, and (4) the next steps for the proj-
ect.
Welcome, Opening Remarks: J.D. Watson, Cold Spring Harbor Laboratory
Overview and Status of GEM Project: S. Gary, Cold Spring Harbor Laboratory
Discussion for Increasing Sample Size (Protocol Changes; Identifying Existing Collections with Ability
to Collect Parental DNAs: Other Ideas?)
K. Burdick, Zucker Hillside/LIJ, Glen Oaks, New York E. Leibenluft, NIMH/National Institutes of Health, Bethesda,
Maryland
Group Discussion
Phenotype Discussion/Neurocognition Collection
J. Pearl, Data Related, NIMH/National Institutes of Health,
Bethesda, Maryland
T. Leotta and V. Makarov, Cold Spring Harbor Laboratory
Presentation about GEM Database/Website
Update on Recent Results
J. Sebat, Cold Spring Harbor Laboratory
Other Recent Findings in Genetics of Bipolar Disorder
Next Steps (Analysis, Data Sharing, etc.)
Group Discussion
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Living on Human Beings: Metagenomic Approaches and Challenges
March 2–5
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY E.F. DeLong, Massachusetts Institute of Technology
J.I. Gordon, Washington University School of Medicine
G.M. Weinstock, Washington University School of Medicine
Traditional methods of studying microorganisms begin with the isolation
of single cells from all those present in a sample, followed by their cul-
ture. This introduces the bias that only those organisms that can be cul-
tured can be studied. In contrast, metagenomics is concerned with the
characterization of the entire community of microorganisms in a sample.
This can be done because new sequencing strategies can sequence
gigabases of DNA and bioinformatics strategies can find sequences of
interest in these gigabases of sequence. There are projects under way
to examine the entire microbiota of environments such as the oceans,
soil, and air. Most excitingly, metagenomics offers the possibility of treat-
ing the human body as a set of habitats and examining the microbial
communities of each habitat, whether the mouth, skin, or gut. This
meeting was designed to define and suggest solutions to some of the
conceptual and experimental challenges that this field faces.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: Why This Meeting?: G.M. Weinstock,Washington University School of Medicine, St. Louis, Missouri
SESSION 1: Approaches for Studying Environmental Communities and Their Operations
Chairperson: B. Birren, Broad Institute, Cambridge, Massachusetts
E.F. DeLong, Massachusetts Institute of Technology,
Cambridge: Integrating microbial community genomics and
(eco)systems biology: Problems and prospects.
S.W. Chisholm, Massachusetts Institute of Technology,
Cambridge: Genome-enabled metagenomics:
Prochlorococcus as a case study.
M. Polz, Massachusetts Institute of Technology, Cambridge:
Identifying ecologically differentiated populations.
A.Z. Worden, Monterey Bay Aquarium Research Institute, Moss
Landing, California: Targeted metagenomics of marine eukaryotes.
E.G. Ruby, The University of Wisconsin, Madison, Wisconsin:
Comparative genomic analyses of a beneficial bacterial asso-
ciation: Using natural models to ask how mutualisms are
maintained.
G. Weinstock, R. Gunsalus
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SESSION 3: Microbial Evolution, Phylogeny, and Diversity
Chairperson: J. Ravel, University of Maryland School of Medicine, Rockville
N.R. Pace, University of Colorado, Boulder: Molecular microbi-
ology of the human environment.
F.E. Dewhirst, Forsyth Institute, Boston, Massachusetts: The
human oral microbiome.
R. Knight, University of Colorado, Boulder: Phylogenetically
informed community comparisons using metagenomic data.
C. M. Fraser-Liggett, University of Maryland School of
Medicine, Baltimore: Surveying human microbiome diversity:
How deep do we go?
R. Gunsalus, University of California, Los Angeles: The essen-
tial biology of the anaerobic microbial food chains.
J.K. Nicholson, Imperial College London, United Kingdom: The
microbiome-mammalian-metabolic axis in health and disease.
B. Birren, Broad Institute, Cambridge, Massachusetts:
Genome sequencing using new technologies.
S.C. Schuster, Pennsylvania State University, University Park: Next-
generation sequencing and MEGAN metagenomics analysis.
R. Lasken, J. Craig Venter Institute, San Diego, California:
High-throughput single-cell genomics pipeline: Applications
to the HMB and the hospital environment.
G.M. Weinstock, Washington University School of Medicine,
St. Louis, Missouri: The Human Microbiome Project.
SESSION 4: Technology: What’s Needed to Move Beyond Present Practices
Chairperson: E.F. DeLong, Massachusetts Institute of Technology, Cambridge
P. Hugenholtz, DOE Joint Genome Institute, Walnut Creek,
California: Resolving genetic gradients using fine-scale
metagenomics.
S. Eddy, Howard Hughes Medical Institute, Ashburn, Virginia:
Advances in large-scale protein sequence analysis: Pfam
and HMMER.
A. Godzik, The Burnham Institute, La Jolla, California:
Understanding diversity and divergence in (among others)
metagenomics data sets.
S.A. Kravitz, J. Craig Venter Institute, Rockville, Maryland:
Challenges of large-scale metagenomics data management.
SESSION 5: Informatics/Data Analysis: Attaching the Bottlenecks
Chairperson: S.C. Schuster, Pennsylvania State University, University Park
SESSION 6: Meeting Summary and General Discussion
Chairperson: J.I. Gordon, Washington University School of
Medicine, St. Louis, Missouri
SESSION 2: Approaches for Characterizing Animal Body Habitat-associated Communities and Their Operations
Chairperson: S. Eddy, Howard Hughes Medical Institute, Ashburn, Virginia
R.L. Hettich, Oak Ridge National Laboratory, Tennessee: A
proteogenomic approach for characterizing the molecular
activities of gut microbiome.
J. Ravel, University of Maryland School of Medicine, Rockville:
Genomic tools for studying the ecology of the human vagina.
H. Flint, Rowett Research Institute, Aberdeen, United
Kingdom: Molecular and cultural approaches to functional
analysis of the human intestinal microbiota.
J. Segre, National Human Genome Research Institute,
Bethesda, Maryland: Survey of skin microflora in healthy vol-
unteers.
M.J. Blaser, New York University School of Medicine, New
York: Approaches to defining the cutaneous microbiota in
health and disease.
S. Dusko Ehrlich, INRA, Jouy-en-Josas, France: MetaHIT: The
European project on metagenomics of human intestinal tract.
J. Segre, A. Gardner
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Recent Advances and a Multilevel Analysis From FMRP Biology to
Clinical Trials
March 9–12
FUNDED BY NIMH Grant to the University of Illinois
ARRANGED BY E. Berry-Kravis, Rush University Medical Center
K. Clapp, FRAXA Research Foundation
W.T. Greenough, University of Illinois
E. Klann, New York University
P.W. Vanderklish, Scripps Research Institute
Significant advances have been made in several areas of fragile X research, particularly those that shed
new light on underlying mechanisms. The meeting was designed to review these new findings and to
encourage new ideas on the basic relationships between FMRP function, the neurobiological origins of
symptoms, and potential treatments. In particular, participants discussed FMRP function and regulation;
proteomic and high-specificity FMRP target analyses; alterations in synaptic plasticity, structure, and
signaling coupled to mGluR and non-mGluR pathways; mechanistic commonalities between fragile X
and other syndromic forms of mental retardation with autism as an endophenotype; systems level
approaches to understanding fragile X syndrome and autism; and clinical trials. 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Opening Comments: K. Clapp, FRAXA Research Foundation, Newburyport, Massachusetts
SESSION 1: Fragile X Phenotypes and Underlying Neural Systems
Chairperson: M.R. Tranfaglia, FRAXA Research Foundation, Newburyport, Massachusetts
R.J. Hagerman, M.I.N.D. Institute, Sacramento, California:
Quantitative measures of CNS function for medication trials
and comments on ganaxolone study.
D.P. Kennedy, California Technology Institute, Pasadena:
Functional abnormalities of the default network in autism and
fragile X syndrome.
R. Zorovic, K. Clapp, M. Bear
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D.L. Nelson, Baylor College of Medicine, Houston, Texas:
Conditional mutations in Fmr1 and Fxrs in the mouse: An
update on genotypes and phenotypes.
J.R. Larson, University of Illinois, Chicago: Olfactory learning in
the fragile X mouse.
A. El Idrissi, College of Staten Island, New York: Potential
pharmacotherapeutic actions of taurine in a mouse model of
fragile X syndrome.
R.E. Paylor, Baylor College of Medicine, Houston, Texas: Phar -
ma co logical modification of Fmr1 KO behavioral phenotypes.
W.T. Greenough, University of Illinois, Urbana: Short tutorial:
Neurobiology of fragile X—A review.
I. Ethell, University of California, Riverside: Minocycline acceler-
ates dendritic spine maturation and alleviates behavioral
defects in animal model.
K. Broadie, Vanderbilt University and Medical School,
Nashville, Tennessee: Roles of FMRP in neuronal architecture
development and synaptogenesis.
SESSION 2: Synaptic Morphology Phenotypes and Local Network Abnormalities
Chaiperson: W.T. Greenough, University of Illinois, Urbana
D. Morris, University of Washington, Seattle: Fmr1 transcript
isoforms: Association with polyribosomes; regional and
developmental expression in brain.
M. Ramaswami, Trinity College, Dublin, Ireland: Neuronal
FMRP particles and their similarities to P bodies.
G.J. Bassell, Emory University, Atlanta, Georgia: Stimulating
travels and functions of FMRP in dendrites and axons.
S. Ceman, University of Illinois, Urbana: FMRP expression dur-
ing earned vocalizations in male zebra finch.
SESSION 3: Distribution, Functions, and Regulation of FMRP
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston, Texas
J. Darnell, The Rockefeller University, New York: Cross-linking
Co-IP (CLIP) identification of novel pre- and postsynaptic
RNA targets of FMRP.
H. Tiedge, State University of New York, Brooklyn: FMRP and
small RNAs.
J.S. Malter, University of Wisconsin, Madison: APP, Abeta, and
SESSION 4: Proteomics and FMRP mRNA Target Analyses
Chairperson: W.T. Greenough, University of Illinois, Urbana
K.M. Huber, University of Texas Southwestern Medical Center,
Dallas: Impaired excitatory drive of neocortical inhibitory neu-
rons may contribute to longer persistent activity states in
Fmr1 KO mice.
J. Lauterborn, University of California, Irvine: Hippocampal LTP
deficits in fragile X: Restoration of synaptic plasticity by BNDF.
A. Bhattacharyya, University of Wisconsin, Madison: cAMP
signaling in FX brain.
M.C. McKenna, University of Maryland School of Medicine,
Baltimore: Altered neuronal and astrocytic glutamate metab-
olism in 18-day-old Fmr 1 knockout mouse brain:
Normalization by MPEP.
R.S. Zukin, Albert Einstein College of Medicine, Bronx, New
York: Dysregulation of mTOR signaling in mouse model of
fragile X syndrome.
S.T. Warren, Emory University School of Medicine, Atlanta,
Georgia: FMRP signaling pathway mediated by phosphoryla-
tion.
I.J. Weiler, University of Illinois, Urbana-Champaign: Aberrant
phosphatase activation in fragile X syndrome.
SESSION 5: Modulation of Synaptic Plasticity and Signaling by FMRP
Chairperson: M.F. Bear, Massachusetts Institute of Technology, Cambridge
I. Ethell
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fragile X syndrome.
S.J. Tapscott, Fred Hutchinson Cancer Research Center,
Seattle, Washington: An antisense transcript spanning the
CGG repeat region of FMR1 is up-regulated in premutation
carriers but silenced in full mutation individuals.
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SESSION 6: Mechanistic Parallels between FXS and Other Neuropsychiatric Conditions
Chairperson: E. Klann, New York University, New York
E. Klann, New York University, New York: Short tutorial: Altered
translational control in fragile X model mice and other mouse
models of MR and ASD.
M.F. Bear, Massachusetts Institute of Technology, Cambridge:
Studies of protein synthesis in hippocampus.
M.A. Smith, Case Western Reserve University, Cleveland,
Ohio: Parallels between fragile X and Alzheimer’s disease.
E. Berry-Kravis, Rush University Medical Center, Chicago,
Illinois: Update on lithium treatment in fragile X syndrome.
B.A. Oostra, Erasmus Universiteit Rotterdam, The Netherlands:
The effect of mGluR5 antagonists in vitro and in vivo.
C. Erickson, Riley Hospital for Children, Indianapolis, Indiana:
Aripiprazole in fragile X patients.
F. Gasparini, Novartis Pharma AG, Basel, Switzerland:
Targeting Group I and II metabotropic glutamate receptors:
Drug discovery and potential therapeutic indications.
SESSION 7: Progress in Clinical Development
Chairperson: S.A. Warren, Emory University School of Medicine, Atlanta, Georgia
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Algebraic Statistics, Machine Learning, and Lattice Spin Models
March 16–19
FUNDED BY Clay Mathematics Institute
ARRANGED BY J. Carlson, Clay Mathematics Institute
D.A. Ellwood, Clay Mathematics Institute
P.P. Mitra, Cold Spring Harbor Laboratory
Recently, there have been exciting advances in the application of
ideas and algorithms from commutative algebra and group theory to
problems of data analysis and statistics, particularly in computation-
al genomics. However, these ideas are not yet widely known to other
communities of theorists who may benefit from these developments.
The goal of this workshop was to bring together mathematicians
working in algebraic statistics with researchers in machine learning
and statistical physics for mutual pedagogy and for exploration of
new research avenues opened up by the application of algebraic
techniques to data.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold
Spring Harbor Laboratory
SESSION 1
Chairperson: C. Myers, Cornell University, Ithaca, New York
P.A. Parrilo, Massachusetts Institute of Technology, Cambridge:
Semigroups and semidefinite programming.
R. Rabadan, Institute for Advanced Study, Princeton, New Jersey: Viruses.
SESSION 2
Chairperson: P.P. Mitra, Cold Spring Harbor Laboratory
L. Pachter, University of California, Berkeley, and S. Sullivan, Harvard
University, Cambridge, Massachusetts: Algebraic statistics tutorial.
L. Pachter, University of California, Berkeley, and S. Sullivan, Harvard
University, Cambridge, Massachusetts: Algebraic sta-
tistics tutorial (cont’d.).
Informal Discussions
SESSION 3
Chairperson: A. Sengupta, Rutgers, The State
University of New Jersey
B. Mishra, New York University, New York: Zero-one
phenomena in genome sequencing.
SESSION 4
Chairperson: D. Huse, Princeton University, New
Jersey
G. Carlsson, Stanford University, California: Algebraic
topology for data analysis.
C. Sire, Université Paul Sabatier, Toulouse, France:
Poker and statistical physics.
P. Mitra, R. Shrock
P. Parrilo, B. Mishra
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C. Lengauer, Novartis Institutes for Biomedical Research, Inc.,
Cambridge, Massachusetts: Oncology target validation—
taken seriously. 
J. Barsoum, Synta Pharmaceuticals Corporation, Lexington,
Massachusetts: Advancing Elesclomol from the lab to phase 3:
Targeting cancer by the selective induction of oxidative stress.
R. Cohen, Genentech, South San Francisco, California:
Targeted therapies: Lessons from Herceptin.
Y. Luo, Tsinghua University, Beijing, China: Molecular cancer
therapy of endostatin: The end of the beginning.
How Will We Be Able to Cure Most Cancers?
March 30–April 2
FUNDED BY OSI Pharmaceuticals, Inc.
ARRANGED BY A.J. Levine, Institute of Advanced Studies
C.L. Sawyers, Memorial Sloan-Kettering Cancer Center
R.A. Weinberg, Whitehead Institute for Biomedical Research
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
We have been performing research on cancer for more than a century and, since the early 1970s, we have
discovered many of the genetic and biochemical changes that turn a normal cell into a cancer cell.
Furthermore, our knowledge of the fundamental biology of cancer is likely to undergo another major increase
as genome-based techniques begin to be used on a massive scale to characterize the full set of molecular
changes in many tumor types. However, the number of cancers that can at present be cured effectively and
efficiently remains small. Why is this? Do cancers vary so much that a treatment specific to one patient’s can-
cer may be ineffective for another patient? What targets are currently available for drug therapy? What can
be done to increase the number? What is the potential for combination therapies? What can be done to
improve early detection? May we have to face the fact that many cancers may not be curable?
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Remarks: J.D. Watson, Cold Spring Harbor Laboratory
Introduction: The Problem: M.J. Thun, American Cancer Society, Atlanta, Georgia: Cancer trends.
SESSION 1
Chairperson: R. Weinberg, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
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D. Reinberg, New York University School of Medicine, New
York: Histone deacetylases, methylases and demethylases:
Current status, future potentials.
J. Schlessinger, Yale University School of Medicine, New
Haven, Connecticut: Developing new therapies: The example
of PLX4720 and B-RafV600E.
J. Peto, London School of Hygiene & Tropical Medicine, London,
SESSION 2
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
R.A. Weinberg, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Mechanisms of malignant pro-
gression.
P.A. Beachy, Stanford University, California: Hedgehog signal-
ing and cancer.
T. Curran, Children’s Hospital of Philadelphia, Pennsylvania:
Targeting the Sonic Hedgehog pathway in pediatric brain
tumors: Promise and problems.
SESSION 3
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
P.-P. Pandolfi, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Biochemical and genetic pathways as
sources of targets.
G. Evan, University of California, San Francisco: Targeting the
untargetable—Modeling anti-Myc therapy in mouse cancer
models.
S. Lowe, Cold Spring Harbor Laboratory: Mouse models in
cancer gene discovery and cancer therapy.
C.J. Sherr, St. Jude Children’s Research Hospital,
Memphis, Tennessee: Why BCR-ABL-induced acute lym-
phoblastic leukemia (Ph+ ALL) responds poorly to targeted
therapy.
A. Ashworth, Institute of Cancer Research, London, United
Kingdom: Synthetic lethal approaches to cancer therapy.
P. Pharoah, Strangeways Research Laboratory, Cambridge,
United Kingdom: Polygenic susceptibility in breast cancer.
SESSION 4
Chairperson: B. Clarkson, Memorial Sloan-Kettering Cancer Center, New York
G. Dranoff, Dana-Farber Cancer Institute, Boston,
Massachusetts: Balancing tumor immunity and inflammatory
pathology.
D.M. Epstein, OSI Pharmaceuticals, Inc., Farmingdale, New
York: Evidence for pathological epithelial to mesenchymal tran-
sition and an alternate rationale for multitargeting in cancer.
R. Kalluri, Harvard Medical School, Boston, Massachusetts:
Tumor microenvironment controls the rate of cancer progres-
sion and metastasis.
P. Dirks, Hospital for Sick Children, Toronto, Canada: 
Cancer stem cells as therapeutic targets.
G.F. Vande Woude, Van Andel Institute, Grand Rapids,
Michigan: Complexities and challenges: Met and malignant
progression.
SESSION 6
General Discussion: What Next?
SESSION 5
Chairperson: R.A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
B. Clarkson, J. Watson, J. Schlesinger, R. Weinberg
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United Kingdom: The costs and benefits of HPV vaccination.
M. Stratton, The Sanger Institute, Cambridge, United Kingdom:
Patterns of somatic mutation in human cancer genomes.
J.B. Hicks, Cold Spring Harbor Laboratory: Breast tumor archi-
tecture and progression analyzed by genomic method.
B. Weber, GlaxoSmithKline, Collegeville, Pennsylvania:
Genomic approach to targeted drug development.
L.C. Cantley, Harvard Medical School/Beth Israel Deaconess
Medical Center, Boston, Massachusetts: Targeting the PI3K
pathway.
A.J. Levine, Institute for Advanced Study, Princeton, New
Jersey: New methods for identifying drug targets.
C.B. Harley, Geron Corporation, Menlo Park, California:
Telomerase-based therapies: Potential to hit a stem cell target.
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Molecular Mechanisms Modulating Skeletal Muscle Mass
and Function
April 6–9
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY A.L. Goldberg, Harvard Medical School
D.J. Glass, Novartis Institutes for Biomedical Research
Many conferences have focused on the early development of skeletal muscle, the roles of satellite cells,
or contractile mechanisms; however, this conference reviewed the mechanisms for muscle homeosta-
sis in the adult animal and human. As anyone who has had a limb immobilized will appreciate, the loss
of muscle can be rapid and very hard to replace. Participants in the meeting considered questions such
as What are the molecular mechanisms that occur in response to increased exercise that result in hyper-
trophy and/or fiber-type switching, and how does inactivity lead to fiber atrophy? How are protein syn-
thesis, proteolysis, and gene expression altered in skeletal muscle during the wasting (cachexia)
induced by cancer, cardiac failure, sepsis, and renal failure? How do cytokines and hormones influence
the properties of muscle in normal and disease states? 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: Why this meeting?: A.L. Goldberg, Harvard Medical School, Boston, Massachusetts
SESSION 1: Skeletal Muscle Development and Differentiation
Chairpersons: S.-J. Lee, Johns Hopkins University School of Medicine, Baltimore, Maryland, and G. Pavlath,
Emory University School of Medicine, Atlanta, Georgia
N. Rosenthal
R. Krauss, Mount Sinai School of Medicine, New York: Role of
the Ig superfamily receptors CDo and neogenin in myogenesis.
M.A. Rudnicki, Ottawa Health Research Institute, Canada:
Molecular mechanisms regulating satellite cell function.
A. Wagers, Harvard Medical School, Boston, Massachusetts:
Regenerative potential of skeletal muscle stem cells.
G. Pavlath, Emory University School of Medicine, Atlanta,
Georgia: Molecular control of satellite cell function during
muscle growth.
K.A. Esser, University of Kentucky College of Medicine,
Lexington: Clock genes and adult skeletal muscle structure
and function.
SESSION 2: Muscle Disease and Dystrophy
Chairpersons: N. Rosenthal, European Molecular Biology Laboratory, Monterotondo, Italy, and K.P. Campbell,
University of Iowa College of Medicine, Iowa City
M.R. Capecchi, University of Utah, Salt Lake City: Role of
muscle lineage in muscle malignancy.
D.C. Guttridge, Ohio State University, Columbus: Muscle
wasting in cancer cachexia and lessons learned from
muscular dystrophy.
K.P. Campbell, University of Iowa College of Medicine,
Iowa City: Muscular dystrophy as a complex disease:
Insights from mouse models.
P. Munoz-Canoves, Centre for Genomic Regulation,
Barcelona, Spain: Cytokine-mediated skeletal muscle
hypertrophy.
N. Rosenthal, European Molecular Biology Laboratory,
Monterotondo, Italy: Enhancing muscle regeneration.
Maryland: Funding.
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D.J. Glass, Novartis Institutes for Biomedical Research,
Cambridge, Massachusetts: Signaling pathways that medi-
ate skeletal muscle atrophy and hypertrophy.
D. Attaix, Human Nutrition Research Center of Clermont-
Ferrand, Ceyrat, France: Identification of polyubiquitinated
substrates of the muscle proteasome.
M. Gautel, King’s College, London, United Kingdom:
Sarcomeric links to ubiquitination and autophagy pathways.
S. Wing, McGill University, Montreal, Canada: Role of the
USP19 deubiquitinating enzyme in muscle cell proliferation.
C. Patterson, North Carolina University, Chapel Hill: Multiple
roles of ubiquitin ligases in muscle biology.
G. Nuckolls, National Institute of Arthritis and Musculoskeletal
and Skin Diseases, Bethesda, Maryland: Funding.
SESSION 3: Ubiquitin-dependent Protein Breakdown in Muscle
Chairperson: A.L. Goldberg, Harvard Medical School, Boston, Massachusetts
A.L. Goldberg, Harvard Medical School, Boston,
Massachusetts: Contributions of the autophagic and ubiq-
uitin proteasome pathways to muscle atrophy.
M.F. Sandri, Dulbecco Telethon Institute at Venetian, Padova,
Italy: Regulation of proteolytic systems during muscle wast-
ing.
M. Spencer, University of California Los Angeles: Proteolysis
and regulation of muscle mass by calpain 3.
S. Schiaffino, Venetian Institute of Molecular Medicine,
Padova, Italy: Activity-dependent signaling pathways control-
ling muscle fiber size and type.
M.A. Ruegg, University of Basel, Switzerland: Role of the mTOR
complex 1 (mTORC1) and mTORC2 in skeletal muscle.
P. Puigserver, Harvard Medical School, Boston,
Massachusetts: Transcriptional mechanism modulating mito-
chondrial oxidative skeletal muscle function.
SESSION 4: Regulation of Protein Breakdown and Synthesis in Muscle
Chairperson: D.J. Glass, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
S.-J. Lee, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Regulation of muscle growth by myostatin.
K. Wagner, The Johns Hopkins Hospital, Baltimore, Maryland:
Clinical considerations for modulators of muscle growth.
D. Clemmons, University of North Carolina, Chapel Hill: IGF-1
and muscle cell growth and differentiation.
L.A. Leinwand, University of Colorado, Boulder: Exercise, diet,
and gender effects on skeletal muscle.
W.E. Mitch, Baylor College of Medicine, Houston, Texas: Mech an -
isms elicited by kidney disease to cause muscle protein losses.
K. Walsh, Boston University School of Medicine,
Massachusetts: Akt-mediated growth of type IIb fibers
reduces fat mass and improves metabolic parameters in
obese mice.
SESSION 5: Growth Factors and Therapeutic Challenges
Chairpersons: S. Schiaffino, Venetian Institute of Molecular Medicine, Padova, Italy, and L.A. Leinwand,
University of Colorado, Boulder
SESSION 6: Meeting Summary and General Discussion
Chairperson: D.J. Glass, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
M. Capecchi, M. Rudnicki W. Mitch, D. Attaix
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Theoretical and Experimental Approaches to Auditory
and Visual Attention
April 20–23
FUNDED BY The Swartz Foundation
ARRANGED BY H. Cohen, The Swartz Foundation
J.B. Fritz, University of Maryland
J.H. Reynolds, The Salk Institute For Biological Studies
Research in the human and macaque has provided a wealth of information on the neural mechanisms
that mediate visual attention. Recent psychoacoustic and neurophysiological studies of attention in the
auditory system, and research on interactions of visual and auditory attention, have added considerably
to this picture. These studies have found parallels with visual attention mechanisms but have also raised
new questions, such as the role of adaptive plastic changes in spectrotemporal receptive field shape
during selective attention and the nature of the coordination of attention-driven changes at multiple pro-
cessing levels from cochlea to cortex. The inherently temporal nature of auditory stimuli has also led to
interesting insights into the temporal dynamics of auditory attention. The purpose of this workshop was
to bring together experimentalists and theoreticians working in auditory and visual attention for a vibrant
discussion of current research. 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J.H. Reynolds, The Salk Institute For Biological Studies, La Jolla, California, and
J.B. Fritz, University of Maryland, College Park
SESSION 1: Experimental and Theoretical Perspectives on Attention
Chairperson: R. Desimone, Massachusetts Institute of Technology, Cambridge
K. Nakayama, Harvard University, Cambridge, Massachusetts:
Perception, cognition, and action.
S.A. Hillyard, University of California, San Diego, La Jolla:
Attention facilitates multiple features in parallel in human
visual cortex.
J. Duncan, MRC Cognition & Brain Sciences Unit, Cambridge,
United Kingdom: Selective behavior and selective attention in
the human and monkey brain.
R.H. Wurtz, National Eye Institute, National Institutes of Health,
Bethesda, Maryland: Visual gateway to cortex and its
guardian attention in the LGN and TRN.
M. Carrasco, New York University, New York: Effects of spatial
and feature-based attention: Psychophysical and neuroimag-
ing studies.
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J. Gottlieb, Columbia University, New York: Attention, motor plan-
ning, and decisions: The perspective from the parietal cortex.
S. Ganguli, University of California, San Francisco: 1-dim
dynamics of attention and decision making in LIP.
J. Mazer, Yale School of Medicine, New Haven, Connecticut:
Cortical representations of attention and salience.
SESSION 8: Visual Attention III: Attentional Control
Chairperson: J. Duncan, MRC Cognition & Brain Sciences Unit, Cambridge, United Kingdom
R. Desimone, Massachusetts Institute of Technology,
Cambridge: Neural synchrony and selective attention.
E. Neibur, Johns Hopkins University, Baltimore, Maryland:
Synchrony and the attentional state.
P. Tiesinga, University of North Carolina, Chapel Hill: Role of
interneuron diversity in the cortical circuit for attention.
J. Swartz, The Swartz Foundation, East Setauket, New York:
Closing remarks
SESSION 9: Synchrony and Attention
Chairperson: S. Treue, German Primate Center, Goettingen, Germany
L.F. Abbott, Columbia University, New York: Gating of multiple
signals through attentional modulation.
SESSION 2: Experimental and Theoretical Perspectives on Attention (cont’d.)
Chairperson: L. Itti, University of Southern California, Los Angeles
R.J. Zatorre, McGill University, Montreal, Canada: Functional
organization of human auditory cortex: Bottom-up features
and top-down processes.
E. Hafter, University of California, Berkeley: A role for memory
in shared attention.
R. Carlyon, MRC Cognition & Brain Sciences, Cambridge,
United Kingdom: Effects of attention on auditory scene
SESSION 3: Auditory Attention: Human
Chairperson: S.A. Shamma, University of Maryland, College Park
S. Treue, German Primate Center, Goettingen, Germany:
Spatial, feature, and object-based attention in area MT.
L. Itti, University of Southern California, Los Angeles:
Quantifying bottom-up and top-down influences on gaze
allocation in humans and monkeys.
L. Chelazzi, University of Verona Medical School, Italy:
Mechanisms of feature-selective attention in area V4 of the
macaque (task relevance of responses in V4).
SESSION 4: Visual Attention I: Theory and Experiment
Chairperson: R.H. Wurtz, National Eye Institute, National Institutes of Health, Bethesda, Maryland
T. Zador, Cold Spring Harbor Laboratory: Two components of
attentional modulation in rat auditory cortex.
S.A. Shamma, University of Maryland, College Park: Attention
and rapid plasticity in auditory cortex.
J.B. Fritz, University of Maryland, College Park: What is the con-
tribution of frontal cortex to an auditory attentional network?
SESSION 5: Auditory Attention I: Neurophysiology of Auditory Attention
Chairperson: R. Carlyon, MRC Cognition & Brain Sciences, Cambridge, United Kingdom
W.S. Geisler, University of Texas at Austin: Mechanisms of fixa-
tion selection evaluated using ideal observer analysis.
J.C. Martinez Trujillo, McGill University, Montreal, Canada:
Attentional modulation of sensory inputs at the level of single
neurons in MT.
P. Cavanagh, Harvard University, Cambridge, Massachusetts:
Object-based integration and moving attention.
SESSION 6: Visual Attention II
Chairperson: K. Nakayama, Harvard University, Cambridge, Massachusetts
J.H. Reynolds, The Salk Institute for Biological Studies, La
Jolla, California: Mapping the microcircuitry of attention.
J. Mitchell, The Salk Institute, San Diego, California: Attention-
dependent response modulation varies between cell classes
in macaque V4.
X.-J. Wang, Yale University School of Medicine, New Haven,
Connecticut: Stochastic and synchronous neural circuit
dynamics underlying attentional gain modulation.
SESSION 7: Cell Type Specificity
Chairperson: L. Chelazzi, University of Verona Medical School, Italy
D. Heeger, New York University, New York: The normalization
model of attention.
analysis.
B. Shinn-Cunningham, Boston University, Massachusetts: The
costs of switching auditory attention.
C. Alain, Rotman Research Institute of Baycrest Centre,
Ontario, Canada: Top-down influences on memory and
response-related activity for sound location (dual pathways,
parietal cortex, and spatial memory).
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To What Age Should We Be Expected to Work?
April 27–30
FUNDED BY Oliver Grace Professorship Fund
ARRANGED BY R.N. Butler, International Longevity Center
M.D. Hurd, Center for the Study of Aging, RAND Corporation
T.B.L. Kirkwood, Newcastle University
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Biomedical research on aging is having an impact on two rather different areas that are not yet closely
linked. On the one hand, considerable progress has been made in elucidating some of the genetic
changes and molecular processes that contribute to aging in experimental organisms such as C. ele-
gans, the fruit fly, and mice. These processes can be manipulated, prolonging the life span of these
organisms. On the other hand, our lives are being extended through better lifestyles and improved
health care, and thus we are living longer; however, it seems that our maximum life spans are
unchanged. Is extending the human life span an achievable or desirable goal? Should we concentrate
instead on maintaining the quality of life of the extra years that we are now gaining? That is, can we live
longer and still be healthy? 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Why a meeting on this topic?: J.D. Watson, Cold Spring Harbor Laboratory
SESSION 1
Chairperson: M.D. Hurd, Center for the Study of Aging, RAND, Santa Monica, California
T.B.L. Kirkwood, Newcastle University, Newcastle upon Tyne,
United Kingdom: So why does aging occur?
R.N. Butler, International Longevity Center, New York: Changing
patterns of morbidity and mortality across the life course.
V.A. Bohr, National Institute on Aging, Baltimore, Maryland:
Genome maintenance and DNA repair, changes with aging.
J.W. Shay, University of Texas Southwestern Medical Center,
Dallas: Role of telomerase in aging and cancer.
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D.C. Wallace, University of California, Irvine: Mitochondria and
the pathophysiology of aging.
S.N. Austad, University of Texas Health Science Center at San
Antonio: Comparative mechanisms of aging: An update.
J.M. Ordovas, Tufts University, Boston, Massachusetts: Gene–
environment interactions modulating the risk of age-related
disorders.
J.A. Faulkner, University of Michigan, Ann Arbor: Age-related
changes in skeletal muscles from whole muscles to single fibers.
SESSION 2
Chairperson: J.W. Shay, University of Texas Southwestern Medical Center, Dallas
T.E. Johnson, University of Colorado, Boulder: Role of stress
in specifying longevity and rate of aging.
L. Hayflick, University of California, San Francisco, The sea
ranch: Manipulating the four aspects of the finitude of life.
B.N. Ames, Children’s Hospital, Oakland, California: Delaying
(or accelerating) the degenerative diseases.
C.B. Harley, Geron Corporation, Menlo Park, California:
Telomerase-based therapies: Potential to hit a stem cell 
target.
M. Harman, Kronos Longevity Research Institute, Phoenix,
Arizona: Hormonal changes and hormone replacement in
older persons: Promise, hype, and realities.
SESSION 3
Chairperson: T.B.L. Kirkwood, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom
N. Barzilai, Albert Einstein College of Medicine, Bronx, New
York: Strategies to prevent age-related diseases through
human genetics.
T.A. Salthouse, University of Virginia, Charlottesville: Implications
of age differences in cognitive functioning for work.
R. Willis, University of Michigan, Ann Arbor: Cognitive capital
and the future of work.
H. Fillit, The Alzheimer’s Drug Discovery Foundation, New
York: Clinical implications of cognitive aging.
T.T. Perls, Boston Medical Center, Massachusetts: The cente-
narian and supercentenarian looking glass.
D.R. Weir, University of Michigan, Ann Arbor: Does health limit
work life?
SESSION 4
Chairperson: D.C. Wallace, University of California, Irvine
R. Sutch, University of California, Riverside: Working at advanced
ages. Historical evidence and economic perspectives.
K. Christensen, University of Southern Denmark, Odense:
Does extreme longevity lead to extreme levels of disability?
K. McGarry, Dartmouth College, Hanover, New Hampshire:
Preferences and selection in insurance markets: Evidence
from long-term care insurance.
M.D. Hurd, Center for the Study of Aging, RAND Corporation,
Santa Monica, California: Demographics of aging around the
world.
General Discussion: Aging in the 21st century.
SESSION 5
Chairperson: R.N. Butler, International Longevity Center, New York, 
New York
J. Watson, M. Raff
L. Hayflick, J. Witkowski
L. Lederman
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The Architectural Logic of Mammalian CNS
May 4–7
FUNDED BY The William M. Keck Foundation, National Science Foundation Grant
ARRANGED BY P.P. Mitra, Cold Spring Harbor Laboratory
L.W. Swanson, University of Southern California
This meeting was held to assess the progress of the Brain Architecture Project. The goals of the Project
are to curate human neuroanatomical connectivity information from the existing literature into a knowl-
edge base and to build suitable user and web interfaces. To complement these literature curation
efforts, and to help shape the corresponding knowledge base schemas and geometrical templates for
the user interface, it would be of great benefit to have an “outline” version of the connectivity diagram
of the mammalian brain as well as a list of “rules” that the circuitry has been observed to follow.
Participants were asked to present their overview of the architectural logic of the mammalian CNS.
These might take the form of circuit diagrams at a coarse level for the full system, more elaborate cir-
cuit diagrams for subsystems or substructures that have sufficient generality across species or across
brain regions, or specific rules. In contrast with the more familiar morphological approaches to com-
parative neuroanatomy, the meeting was concerned with the logic of the “highway map.”
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Review of Brain Architecture Project
Chairperson: P.P. Mitra, Cold Spring Harbor Laboratory
P.P. Mitra, Cold Spring Harbor Laboratory: Introduction to the
Brain Architecture Project and to the meeting theme.
J. Bohland, Cold Spring Harbor Laboratory: Progress and
future challenges for the Brain Architecture Project.
H. Bokil, Cold Spring Harbor Laboratory: Analysis of spatial
gene expression patterns in the Allen Brain Atlas.
J. Lin, Cold Spring Harbor Laboratory: A literature mining and
curation system for the Brain Architecture Project.
373
351-394_LAR_Banbury:LAR_Template_2007  6/9/09  4:42 PM  Page 373
L.W. Swanson, University of Southern California, Los Angeles:
Understanding the basic wiring diagram of the nervous system.
H.J. Karten, University of California, San Diego, La Jolla:
Conservation of microcircuitry across vertebrate phylogeny.
R. Kotter, Radboud University, Nijmegen, The Netherlands:
CoCoMac database interfaces for integrating primate brain
connectivity.
SESSION 2: Introduction to Architectural Logic Problem
Chairperson: H. Breiter, Massachusetts General Hospital, Charlestown
C.B. Saper, Beth Israel Deaconess Medical Center, Boston, Massa -
chusetts: The flip-flop switch as a motif in brain architecture.
J.L. Price, Washington University, St. Louis, Missouri:
Hierarchical organization of systems for homeostasis and
maintenance of the self.
D. Kleinfeld, University of California, San Diego: (Near) somatic
shunting as a circuit motif: Evidence from vision, somatosen-
sation, and epilepsy.
C.C. Hilgetag, Jacobs University Bremen, Germany: Relating
cortical connections to cortical architecture.
H. Barbas, Boston University, Massachusetts: Laminar-specific
prefrontal pathways for excitatory and inhibitory control.
SESSION 3: Architectural Logic Problem (cont’d.)
Chairperson: A. Graybiel, Massachusetts Institute of Technology, Cambridge
S. Haber, University of Rochester, New York: Three-dimension-
al models of fiber tracts arising from specific cortical areas
through the primate brain: Pathways to understanding
human functional circuitry.
D.C. Van Essen, Washington University School of Medicine,
St. Louis, Missouri: Cortical areas, hierarchies, and networks
in monkeys and humans.
SESSION 4: Architectural Logic Problem (cont’d.)
Chairperson: M. Hawrylycz, Allen Institute For Brain Science, Seattle, Washington
P.P. Mitra, Cold Spring Harbor Laboratory: White paper; strate-
gizing for the large-scale connectivity project.
Discussion of Architectural Logic Problem
J.D. Schmahmann, Massachusetts General Hospital, Boston:
Principles of organization of cerebral white matter pathways:
Implications for the architecture and connections of cortical
and subcortical nodes of distributed neural circuits.
N. Makris, Massachusetts General Hospital, Charlestown, and
H. Breiter, Massachusetts General Hospital, Charlestown:
Methodological and logical challenges in scaling between cir-
cuits and function.
SESSION 6: Clinical Perspectives on Brain Architecture
Chairperson: P. Freed, Columbia University, New York
D.G. Herrera, Weill Medical College of Cornell University, New
York: Clinical implications of a novel understanding of brain
architecture.
J. Safdieh, Weill Medical College of Cornell University, New
York: Circuitry in the classroom and the clinic.
SESSION 5: Architectural Logic (cont’d.)
Chairperson: P. Freed, Columbia University, New York
J. Schmahmann, H. Breiter
J. Safdieh, P. Freed
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Prion Strains: Origins, Mechanisms, and Implications for Disease
May 11–14
FUNDED BY NIAID and the Medical Research Council, United Kingdom
ARRANGED BY B. Caughey, NIAID Rocky Mountain Laboratories
J. Collinge, University College London
C. Soto, University of Texas Medical Branch
C. Weissmann, Scripps Florida
Multiple distinct strains of naturally occurring sheep scrapie can be passaged in mice. Such strains are
classically distinguished by their biological properties: They produce distinct incubation periods and pat-
terns of neuropathology in inbred lines of laboratory mice. Furthermore, strains can be reisolated in mice
after passage in intermediate species with different PrP primary structures. The widely accepted protein-
only hypothesis, if correct, must be able to explain how a single polypeptide chain could encode multiple
disease phenotypes. Clearly, understanding how a protein-only infectious agent could encode such phe-
notypic information is of wide biological interest and raises intriguing evolutionary questions. Do other
proteins behave in this way? The novel pathogenic mechanisms involved in prion propagation may be of
far wider significance and relevant to other neurological and nonneurological illnesses.
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Strains: Definition, Concepts
Chairperson: J. Collinge, University College London, United Kingdom
J. Collinge, University College London, United Kingdom: Prion
strains, transmission barriers, and neurotoxicity.
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M.H. Groschup, Federal Research Institute for Animal Health,
Greifswald-Insel Riems, Germany: Strain typing in animal
TSE cases: Criteria for strain definitions.
J. Wadsworth, University College London, London, United
Kingdom: Problems in defining human prion strains.
A. Hill, University of Melbourne, Australia: Role of PrP post-
translational modifications as markers of prion strain type.
P. Gambetti, Case Western Reserve University, Cleveland,
Ohio: Prion strains in human prion diseases.
SESSION 2: Strain Typing: Biochemical
Chairperson: J. Collinge, University College London, United Kingdom
G. Telling, University of Kentucky, Lexington: Transgenic analy-
sis of CWD strains.
U. Agrimi, Instituto Superiore di Sanita, Rome, Italy: Strain typ-
ing of animal prions in natural hosts and by transmission to
bank voles (Myodes glareolus).
H. Laude, Institut National de la Recherche Agronomique,
Jouy-en-Josas, France: Transmission of ruminant TSE to
transgenic mice: Further insight about prion strain diversity in
naturally infected hosts.
G. Zanusso, University of Verona, Italy: Intraspecies transmis-
sion of bovine amyloidotic spongiform encephalopathy.
SESSION 3: Strain Typing In Vivo and in Cell Culture
Chairperson: B. Caughey, NIAID Rocky Mountain Laboratories, Hamilton, Montana
W.K. Surewicz, Case Western Reserve University, Cleveland,
Ohio: Recombinant prion protein amyloid: Molecular struc-
ture, strains, and infectivity.
I. Baskakov, University of Maryland Biotechnology Institute,
Baltimore: Generating multiple strains of amyloid fibrils from a
single polypeptide chain.
D.S. Eisenberg, University of California, Los Angeles:
Structural studies of amyloids, prions, and strains.
R.B. Wickner, NIDDK/NIH, Bethesda, Maryland: Yeast prion
amyloid structure explains heritability of “strain” information.
SESSION 4: Structural Basis of Strain-ness
Chairperson: B. Caughey, NIAID Rocky Mountain Laboratories, Hamilton, Montana
B. Caughey, NIAID Rocky Mountain Laboratories, Hamilton,
Montana:
Ultrastructure and strain comparison of underglycosylated,
anchorless scrapie prion protein fibrils.
SESSION 5: Structural Basis of Strain-ness (cont’d.)
Chairperson: S.B. Prusiner, University of California, San Francisco
B.W. Chesebro, NIAID, Rocky Mountain Laboratories,
Hamilton, Montana: Role of anchorless prion protein in
pathogenesis induced by different scrapie strains.
I. Vorberg, Technical University of Munich, Germany: Yeast
prion aggregation propensities in mammalian cells.
J.C. Bartz, Creighton University, Omaha, Nebraska: Prion
strain interference.
D. Westaway, University of Alberta, Edmonton, Canada: The
PrP-like Shadoo protein: Misfolding and in vivo variants.
M. Jeffrey, Veterinary Laboratories Agency, Midlothian, United
Kingdom: Species, strain, and cell-associated changes in
abnormal PrP processing following prion infection.
SESSION 6: Strain Biology In Vivo
Chairperson: S.B. Prusiner, University of California, San Francisco
J. Manson, Roslin Institute, Edinburgh, United Kingdom: Prion
strains and host susceptibility.
S. Priola, Rocky Mountain Laboratories, NIAID/NIH, Hamilton,
Montana: Factors influencing in vitro and in vivo scrapie
strain phenotypes.
C. Weissmann, Scripps Florida, Jupiter: Do PrP-linked glycans
contribute to prion strain determination?
J.G. Safar, University of California, San Francisco: Conforma -
tional intermediates, clearance, and species barrier of natural
prion strains.
SESSION 7: Strain Biology In Vivo (cont’d.)
Chairperson: C. Soto, University of Texas Medical Branch, Galveston
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S.B. Prusiner, University of California, San Francisco:
Protease-sensitive and -resistant strains of synthetic prions.
C. Soto, University of Texas Medical Branch, Galveston:
Generation of multiple new prion strains by in vitro PrP repli-
cation.
SESSION 8: Strain Generation and Propagation In Vitro
Chairperson: C. Soto, University of Texas Medical Branch, Galveston
R.A. Bessen, Montana State University, Bozeman: Using lym-
phoreticular system replication-deficient prion strains to
determine routes of prion neuroinvasion.
SESSION 9: Varia
Chairperson: S.B. Prusiner, University of California, San Francisco
SESSION 10: General Discussion and Concluding Remarks
Chairperson: S.B. Prusiner, University of California, San Francisco
D. Westaway, S. Prusiner, I. Baskakov
S. Liebman
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J. Castilla, Scripps Florida, Jupiter: In vitro studies of the trans-
mission barrier.
S.W. Liebman, University of Illinois at Chicago: The birth of a
foreign prion in yeast.
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Identifying KRAS-targeted Therapeutic Approaches for Pancreatic
Cancer
June 16–17
FUNDED BY The Lustgarten Foundation for Pancreatic Cancer Research
ARRANGED BY C.J. Der, University of North Carolina, Chapel Hill
N.K. Tonks, Cold Spring Harbor Laboratory
ADDITIONAL ORGANIZERS K.A. Johnke, The Lustgarten Foundation for Pancreatic Cancer Research
R. Hruban, Johns Hopkins Medical Institutions
KRAS mutations occur in 100% of pancreatic cancers, and this meeting focused on targeting the KRAS
oncogene for novel therapeutics for pancreatic cancer treatment. Unfortunately, small GTPases such as
Ras are not classically considered “druggable” targets, and earlier anti-Ras approaches have not been
successful. Nevertheless, there is no doubt that anti-Ras therapeutics have huge potential in the treat-
ment of pancreatic cancer. Two key uncertainties in such efforts are (1) what technologies will be most
suitable for functional screens to identify targets for therapeutic intervention and (2) what model of
cell/mouse systems should be used to apply these technologies? It is the goal of this meeting to iden-
tify the best technologies and systems, so that it will be possible to establish and apply genome-wide
screens to identify novel modulators of KRAS-mediated pancreatic cancer growth.
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Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
I. R.F. Vizza, The Lustgarten Foundation, Bethpage, New York: Welcome and introduction
II. R. Hruban, Johns Hopkins Medical Institutions, Baltimore, Maryland: Goals and desired outcome of meeting
III. R. Hruban, Johns Hopkins Medical Institutions, Baltimore, Maryland: Overview of ongoing Lustgarten initiatives
IV. Model Systems
Moderator: C.J. Der, University of North Carolina, Chapel Hill
• Human model cell systems (hTERT-immortalized normal cells)
• Established pancreatic tumor cell lines
• Primary pancreatic tumor isolates
• Pancreatic tumor stem cells
V. Wrap-up and Summary
Moderator: C.J. Der, University of North Carolina, Chapel Hill
SESSION 2
I. C.J. Der, University of North Carolina, Chapel Hill: Welcome and day 1 review
II. Technical Approaches/Issues in RNAi
Moderator: B. Stillman, Cold Spring Harbor Laboratory, New York
• Targeting therapies
• Drug development and delivery
• RNAi library screening
• microRNA
• Gene arrays
• Proteomics
• Mouse models of pancreatic cancer
• Mouse-model-derived cell cultures
• Transient KRAS activation and induction of cell senescence
• Invertebrate genetic model lethality screens
A. Saltiel, K. Shannon, J. Gibbs
D. Bar-Sagi
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• Chemical libraries
• Phosphorylated proteins
• Secreted plasma proteins
• Genetic screens
III. N. Tonks, Cold Spring Harbor Laboratory: Wrap-up and summary
IV. Boxed Lunch—Continued Wrap-up
V. C.J. Der, University of North Carolina, Chapel Hill, N. Tonks, Cold
Spring Harbor Laboratory, R. Hruban, John Hopkins Medical
Institutions, Baltimore, Maryland: Summary/finalize research plan
VI. R.F. Vizza, The Lustgarten Foundation, Bethpage, New York: Closing
remarks
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Plant Genetics and Gene Regulation
September 7–10
FUNDED BY Cold Spring Harbor–Pioneer Collaborative Research Program
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory
S. Tingey, DuPont Experimental Station
Welcome: R. Martienssen, Cold Spring Harbor Laboratory, and S. Tingey, DuPont Experimental Station,
Wilmington, Delaware
Minisymposium on Plant Genetics and Development I
R.S. Poethig, M. Timmermans
S. Tingey, R. Martienssen
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R.S. Poethig, University of Pennsylvania, Philadelphia: The reg-
ulation of leaf shape in Arabidopsis thaliana.
R. Simon, Institut fur Genetik, Düsseldorf, Germany: Regulation
of plant stem cell fate by intercellular signaling.
J. Fletcher, USDA–University of California, Berkeley, Albany,
California: Polycomb and trithorax activity in Arabidopsis
organ formation: Role of the ULT1 gene.
D. Jackson, Cold Spring Harbor Laboratory: Inflorescence
architecture in maize.
Minisymposium on Plant Genetics and Development II
X.-W. Deng, Yale University, New Haven, Connecticut: An initial
analysis of maize epigenomes and their relationship with tran-
scriptional activity.
P. Green, University of Delaware, Newark: Global analysis of
miRNAs and miRNA targets.
B.C. Meyers, University of Delaware, Newark: Small RNAs of
maize and beyond.
R. Williams, DuPont experimental Station, Wilmington,
Delaware: Gene expression profiling of miRNAs.
R. Martienssen, Cold Spring Harbor Laboratory: Inheritance
and reprogramming of heterochromatin with RNAi.
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How Can We Improve Our Brains?
September 14–17
FUNDED BY The Charles A. Dana Foundation
ARRANGED BY E.R. Kandel, Columbia University
W.T. Dickens, Russell Sage Foundation
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
It is the hope of every parent that their child will be bright and intelligent.
Parents work to help their children’s brain work better through providing
education and stimulation, and society as a whole makes a tremendous
commitment to the education of its young people. Are there data emerg-
ing from cognitive neuroscience that such education programs should take
into account? Are there learning regimes that might be more effective than
those typically found in the classroom? At the other end of life, is the hope
of all of us that the normal decline in cognitive skills that accompanies aging
will be slow? Might “brain exercises” maintain our brains at a higher level of
functioning? Is there evidence that such exercises work? Are there effec-
tive pharmacological agents? In short, how can we best use the resources
of society to help our brains work better throughout our lives?
Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introductory Remarks: J.D. Watson, Cold Spring Harbor Laboratory
J. Flynn, J. Schwartz
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E.R. Kandel, Columbia University, New York: We are what
we remember: Memory and the biological basis of individ-
uality.
D.K. Detterman, Case Western Reserve University, Cleveland,
Ohio: General intelligence, achievement, and environmental
effects.
R.E. Nisbett, University of Michigan, Ann Arbor: Intelligence
and how to get it: Why schools and cultures count.
SESSION 1: Overviews
Chairperson: W.T. Dickens, Russell Sage Foundation, New York
C. Blair, New York University, New York: Improving fluid intelli-
gence.
J.J. McArdle, University of Southern California, Los Angeles:
Contemporary measurement issues in the evaluation of adult
cognition.
W.T. Dickens, Russell Sage Foundation, New York: What is g?
R. Colom, Universidad Autonoma de Madrid, Spain: 4 + 2
ways to improve our brains.
SESSION 2: Measurement
Chairperson: J.R. Flynn, University of Otago, Dunedin, New
Zealand
M.C. Potter, Massachusetts Institute of Technology,
Cambridge: Conceptual short-term memory and attention.
M. Merzenich, University of California, San Francisco: Brain
plasticity-based therapeutics.
F.P. de Lange, Radboud University, Nijmegen, The Netherlands:
Structural brain changes following psychotherapy.
J.M. Schwartz, University of California School of Medicine, Los
Angeles: Nonreductionist approaches to neuroscience:
Neuroplasticity for the coming immaterialist era.
SESSION 3: Memory and Plasticity
Chairperson: E.R. Kandel, Columbia University, New York
R.J. Haier, UCI Medical Center, Irvine, California: Neuroimaging
studies of learning: Do all brains work the same way?
D.F. Halpern, Claremont McKenna College, California: Sex dif-
ferences in intelligence and their implications for
national/state educational policies.
T.A. Salthouse, University of Virginia, Charlottesville: Mental
exercise and mental aging.
L.S. Gottfredson, University of Delaware, Newark: The fragility
of maximal performance.
E. Turkheimer, University of Virginia, Charlottesville: The rela-
tionship between poverty and the heritability of intelligence.
SESSION 4: Differences
Chairperson: D.K. Detterman, Case Western Reserve
University, Cleveland, Ohio
W. Steven Barnett, Rutgers, The State University of New
Jersey: New Brunswick: Early education’s effect on IQ and
achievement.
C.T. Ramey, Georgetown University, Washington, D.C.:
SESSION 5: Early Education
Chairperson: C. Blair, New York University, New York
D. Halpern E. Kandel
L. Gottfredson, D. Detterman
Preschool randomized controlled trials and population inter-
ventions to facilitate human competence.
L. Schweinhart, High/Scope Education Research Foundation,
Ypsilanti, Michigan: The High/Scope Perry Preschool Study
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J.R. Flynn, University of Otago, Dunedin, New Zealand: Critical
acumen: Step child of IQ tests and American education.
P.K. Kuhl, University of Washington, Seattle: How children
learn: Can (should) we try to improve it?
D. Lubinski, Vanderbilt University, Nashville, Tennessee:
Intellectually precocious youth with exceptional potential for
scientific creativity: What we currently know about maximiz-
ing their development.
E. Hunt, University of Washington, Seattle: The workplace
demands for cognition.
P.D. Zelazo, University of Minnesota, Minneapolis: Promoting
the development of executive function prefrontal cortical
function in children.
SESSION 6: Ability and Achievement
Chairperson: D.F. Halpern, Claremont McKenna College, Claremont, California
through age 40.
M. Rosario Rueda, University of Granada, Spain: Enhancing
brain function through cognitive training in young children.
J. Brooks-Gunn, National Center for Children and Families,
New York: Long-term efficacy of early childhood education
programs for poor children.
Where do we go from here?
Discussion Leaders:
E.R. Kandel, Columbia University, New York
W.T. Dickens, Russell Sage Foundation, New York
J. Watson, W. Dickens, M. Potter, R. Haier
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Nutrient Sensing in Plants: What Can Other Model Organisms Tell Us?
September 21–24
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY A.M. Jones, University of North Carolina, Chapel Hill
D.P. Schachtman, Donald Danforth Plant Science Center
Nutrient sensing in response to mineral or carbon deficiency and enrichment is an important area of bio-
logical research in multicellular eukaryotes. However, the sensing mechanisms and the components of
the signal transduction pathways that connect sensing to response are poorly elucidated. Recent
progress has been made using different model organisms, but this is still an emerging and somewhat
fragmented field of research. Therefore, the aim of this meeting was to gather together experts in the
plant field with experts using other model systems to identify parallels among eukaryotes that will help
to advance nutrient-sensing research across organisms. 
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Nutrient Sensing/Sensors
Chairperson: W.B. Frommer, Carnegie Institute for Science, Stanford
J. Thevelein, Catholic University of Louvain, Belgium:
Transceptor-mediated nutrient sensing in yeast.
M. Kielland-Brandt, Technical University of Denmark, Kgs
Lynby: Model for transporter-like nutrient sensors: Sensing a
chemical potential difference over a membrane.
W.B. Frommer, Carnegie Institute for Science, Stanford, California:
Making sense of nutrient sensing with the help of FRET sensors.
F. Tamanoi, University of California, Los Angeles: The
TSC/Rheb/TOR signaling pathway in fission yeast.
C. Meyer, Institut Jean-Pierre Bourgin (IJPB), Versailles,
France: Role in nutrient signaling of the target of rapamycin
(TOR) pathway in plants.
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S. Puig, University of Valencia, Spain: The yeast
Saccharomyces cerevisiae as a model organism to study
copper and iron deficiencies.
SESSION 2: Metal Sensing
Chairperson: M.L. Guerinot, Dartmouth College
G. Coruzzi, New York University, New York: A systems
approach to nitrogen-regulatory networks and the virtual plant.
N. von Wiren, University of Hohenheim, Germany: Ammonium
sensing in Arabidopsis roots.
B. Andre, Free University of Brussels, Belgium: Role of mem-
brane transporters in amino acid signaling in yeast.
N. Crawford, University of California, San Diego: Signaling by
inorganic nitrogen.
A. Gojon, Institut National de la Recherche Agronomique,
Montpellier, France: Nitrogen sensing by NRT1.1 and its role
in the regulation of root development in Arabidopsis.
B.G. Forde, Lancaster University, United Kingdom: Nitrate and
glutamate sensing in Arabidopsis roots.
D.R. Bush, Colorado State University, Fort Collins: Anion regu-
lation of root architecture.
SESSION 3: Nitrogen Sensing
Chairperson: N. von Wiren, University of Hohenheim, Germany
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M. Johnston, Washington University Medical School, St. Louis,
Missouri: A glucose-sensing reticulum in S. cerevisiae.
J. Sheen, Massachusetts General Hospital, Boston: Glucose
and energy signaling networks.
J. Rutter, University of Utah School of Medicine, Salt Lake
City: Regulation of glucose partitioning by pas kinase.
A.M. Jones, University of North Carolina, Chapel Hill: Glucose
sensing through a novel receptor GAP.
SESSION 5: Phosphate Sensing
Chairperson: S. Abel, University of California, Davis
SESSION 4: Sugar Sensing
Chairperson: A.M. Jones, University of North Carolina, Chapel Hill
G. Coruzzi, D. Schachtman
Carolina: The human fungal pathogen Cryptococcus neofor-
mans senses plant signals to complete its sexual cycle.
M. Bucher, University of Cologne, Germany: Signaling pathway
cross-talk in mycorrhizal phosphate uptake.
T.-J. Chiou, Agricultural Biotechnology Research Center, Taipei,
Taiwan, Republic of China: microRNAs in sensing phosphate
availability.
W.-R. Scheible, Max-Planck Institute for Molecular Plant Physiology,
Potsdam, Germany: Impact of small RNAs and long-distance sig-
naling in the regulation of macronutrient responses.
J. Paz Ares, Centro National de Biotechnologia-CSIC, Madrid,
Spain: Phosphate starvation signaling in Arabidopsis.
S. Abel, University of California, Davis: Phosphate sensing in
root development.
T. Desnos, Centre National de la Recherche Scientifique, St. Paul-
lez-Durance, France: Sensing low phosphate at the root tip.
L. Herrera-Estrella, Centro de Investigaciones y Estudios
Avanzados, Irapuato, Guanajuato, Mexico: Phosphate availabili-
ty alters lateral root development in Arabidopsis seedlings by
modulating auxin sensitivity via a TIR1-dependent mechanism.
C. Xue, Duke University Medical Center, Durham, North
M.L. Guerinot, Dartmouth College, Hanover, New Hampshire:
Metal homeostasis in Arabidopsis.
P. Leon, Instituto de Biotechnologia, UNAM, Cuervanaca,
Morelos, Mexico: Role of AB14 during sugar signaling in
Arabidopsis early seedling development.
S.C. Smeekens, University of Utrecht, The Netherlands: Sugar
signaling and reprogramming of metabolism in plants.
C. Hoffman, Boston College, Chestnut Hill, Massachusetts: An
Hsp90-Git7 requirement for glucose/cAMP signaling in
Schizosaccharomyces pombe.
SESSION 6: Potassium Sensing
Chairperson: D.P. Schachtman, Donald Danforth Plant Science Center,
St. Louis, Missouri
A. Amtmann, University of Glasgow, Scotland: Linking K nutrition to
metabolism and defense.
S. Luan, University of California, Berkeley: A calcium signaling pathway
for low-potassium response in Arabidopsis.
D.P. Schachtman, Donald Danforth Plant Science Center, St. Louis, Missouri:
Potassium signaling pathways in Arabidopsis roots.
SESSION 7: Conclusions and General Discussion
Chairpersons: A.M. Jones, University of North Carolina, Chapel Hill,
and D.P. Schachtman, Donald Danforth Plant Science Center, St.
Louis, Missouri
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Who Are We?: Kinship, Ancestry, and Social Identity
October 6–9
FUNDED BY The Richard Lounsbery Foundation
ARRANGED BY A. Chakravarti, Johns Hopkins University School of Medicine
M.W. Foster, University of Oklahoma
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Genetics provides, on the one hand, a description of human beings that reflects their
biological ancestry. On the other hand, cultural norms provide a description (often
by self-identification) of social ancestry. These two descriptions need not be, and
often are not, the same. However, clinical geneticists identify populations that are
likely to be genetically more homogeneous by grouping individuals according to their
ethnic characteristics. And in recent years, there has been a proliferation of compa-
nies offering DNA-based genealogies, established by examining a set of DNA mark-
ers, but discrepancies among ancestries revealed by genetic analysis and assumed
by cultural descent may profoundly affect individuals’ views of themselves. The
importance of the relationship between genetic and ethnic identities requires care-
ful, rational, and critical review. The advent of ever cheaper high-throughput genom-
ic techniques together with the proliferation of companies offering DNA-based
ancestry analysis highlights the need to begin discussions of this topic. 
M. Foster, J. Witkowski
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M.A. Stoneking, Max-Planck Institute for Evolutionary
Anthropology, Leipzig, Germany: Genetic variation in world-
wide human populations based on 1 million SNPs.
B.S. Weir, University of Washington, Seattle: F statistics and
principal components for ancestry and kinship inference.
D.E. Reich, Harvard Medical School, Boston, Massachusetts:
The genetic structure of 25 ethnolinguistically diverse Indian
populations and their relationship to worldwide variation.
SESSION 2: Kinship, Relationship, and Ancestry: Definitions, Measurements, and Meaning
Chairperson: K.M. Weiss, Pennsylvania State University,
University Park
M.V. Olson, University of Washington, Seattle: The right way to
view kinship is one genome segment at a time.
E. Thompson, University of Washington, Seattle: Inferring iden-
tity by descent from genomic SNP data in the absence of
pedigree structure information.
J. Sinsheimer, University of California, Los Angeles: Determining
ethnic admixture using the Mendel Software Package.
D. Serre, The Cleveland Clinic, Ohio: Clines, clades, and why it
matters.
M.F. Seldin, University of California, Davis: Ascertaining and
applying markers informative for population genetic structure
and substructure for studies of complex traits.
SESSION 3: Who Is Related to Whom? Population Features
Chairperson: M.-C. King, University of Washington, Seattle
I. Pe’er, Columbia University, New York: Whole genome, whole
population mapping of hidden relatedness.
M.D. Shriver, Pennsylvania State University, University Park:
Facial features, biogeographical ancestry, and admixture
mapping.
D.B. Goldstein, Duke University, Durham, North Carolina: Rare
and common variants in genetic history and genetic medicine.
C.D. Bustamante, Cornell University, Ithaca, New York: Global
distribution of genomic diversity underscores rich complex
history of continental human populations.
K.M. Weiss, Pennsylvania State University, University Park:
How true is fiction?
SESSION 4: Who Is Related to Whom? Individual Features
Chairperson: R. Cook-Deegan, Duke University, Durham, North Carolina
R.S. Cooper, Loyola University, Maywood, Illinois: Chronic dis-
ease has social causes.
C. Rotimi, National Human Genome Research Institute,
Bethesda, Maryland: Health disparities: Is genomics a piece
of the puzzle?
SESSION 5: Ancestry, Race, and Complex Traits
Chairperson: M.W. Foster, University of Oklahoma, Norman
General Discussion
Introduction: M.C. King, University of Washington, Seattle
Moderator:  M. Foster, University of Oklahoma, Norman
J. Bertranpetit, B. Weir
L. Jorde, University of Utah, Salt Lake City: Genetics “race”
and medicine.
S. Tishkoff, University of Pennsylvania, Philadelphia: Genetic
variation in Africa.
J. Bertranpetit, Universitat Pompeu Fabra, Barcelona, Spain:
The Basques in the European genetic landscape: Changing
views from changing genetic data and with sociological fac-
tors.
H. Ostrer, New York University, New York: Who are the Jews?
A 4000-year genetic perspective.
Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Patterns of Global Human Variation
Chairperson: M.W. Foster, University of Oklahoma, Norman
M. Olson, C. Bustamante, E. Thompson, L. Jorde, K. Weiss
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Oligonucleotide-directed Splicing: Therapeutic Strategies
October 14–17
FUNDED BY Foundation to AVI, BioPharma, Inc., Cure Duchenne Foundation, Eradicate Duchenne, and Prosensa
ARRANGED BY E.P. Hoffman, Children’s National Medical Center
A. Krainer, Cold Spring Harbor Laboratory
T.A. Partridge, Children’s National Medical Center
Although research and development of small sequence-specific
oligonucleotides as small-molecule drugs have been pursued for 25
years, it has been rather disappointing. However, very recent studies
have shown that oligonucleotides can be used to modify the splicing
patterns of pre-mRNAs in genetic disorders to produce a functional
mRNA. Such a strategy might be widely applicable. In recent years,
there have also been advances in nucleotide chemistry that have led
to oligonucleotides that retain sequence-specific antisense activity
while showing little or no protein binding or associated off-target
effects, whereas other developments have improved intracellular deliv-
ery in a larger variety of tissues and cells. In light of these recent
advances, this meeting was held to critically review progress on
oligonucleotides as therapeutic agents. The goal was to end the meet-
ing with a clearer understanding of the hurdles that remain in using
oligonucleotides as therapeutic agents and to highlight research strategies that are likely to be fruitful.
E. Hoffman, S. Takeda
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SESSION 2: Preclinical
Chairperson: T.A. Partridge, Children’s National Medical
Center, Washington, D.C.
T.A. Partridge, Children’s National Medical Center,
Washington, D.C.: Exon choice, issues in detecting efficacy.
R. Kole, AVI BioPharma, Inc., Corvallis, Oregon: Splice switch-
ing oligomers: Technology progress and application to treat-
ment of Duchenne muscular dystrophy.
S. Takeda, National Institute of Neuroscience, Tokyo, Japan:
The significance of multiexon skipping of the dystrophin gene
by morpholino treatment.
E.P. Hoffman, Children’s National Medical Center, Washington,
D.C.: Local and systemic delivery in dogs.
H. Chao, Mount Sinai School of Medicine, New York:
Spliceosome-mediated RNA trans-splicing for gene repair:
From hemophilia to muscular dystrophy.
Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Introduction: E.P. Hoffman, Children’s National Medical Center, Washington, D.C.
SESSION 1: Background
Chairperson: G.-J.B. van Ommen, Leiden University Medical
Center, The Netherlands
G.-J.B. van Ommen, Leiden University Medical Center, The
Netherlands: Cell animal and biomarker studies to improve exon
skipping for DMD and extend the approach to other genes.
A. Krainer, Cold Spring Harbor Laboratory: Splicing correction as a
therapeutic approach for spinal muscular atrophy.
R.T. Moxley, University of Rochester, New York: Myotonic dystrophy
and exon skipping.
S.D. Wilton, University of Western Australia, Perth: Oligo design and
evaluation: What can be expected?
L. Cartegni, Memorial Sloan-Kettering, New York: Modulation of alter-
native splicing in cancer.
G. Platenburg, Prosensa, Leiden, The Netherlands: Prosensa
Program.
F. Muntoni, UCL Institute of Child Health, London, United
Kingdom: Current efforts on morpholino antisense studies in
patients with Duchenne and deletions of exon 51.
P. O’Hanley, AVI BioPharma, Inc., Portland, Oregon: AVI’s clini-
cal strategy for developing PMO-based dystrophin exon-skip-
ping drugs for DMD.
C.F. Bennett, Isis Pharmaceuticals, Inc., Carlsbad, California: Thera -
peutic opportunities for oligonucleotides that modulate splicing.
SESSION 3: Clinical
Chairperson: F. Muntoni, UCL Institute of Child Health, London, United Kingdom
Q.L. Lu, Carolinas Medical Center, Charlotte, North Carolina:
Is PPMO safe to use in clinical trial and what regime should
be used?
S. Jiang, Gene Tools, LLC, Philmath, Oregon: Vivo-morpholi-
no oligomers induce potent exon skipping of dystrophin in
cardiac and skeletal muscles of mice.
T. Yokota, Children’s National Medical Center, Washington
D.C.: Exon skipping for dystrophic dogs.
S.F. Nelson, University of California Medical Center, Los
Angeles, and M. Carrie Miceli, University of California, Los
Angeles: HTS for enhancing exon skipping.
L. Garcia, Institute de Myologie, Paris, France: Dystrophin
rescue by using exon skipping and/or trans-splicing
approaches.
SESSION 4: Strategies to Increase Potency
Chairperson: F. Muntoni, UCL Institute of Child Health, London, United Kingdom
B. Wentworth, Genzyme, Framingham, Massachusetts, and C.
Nelson, Genzyme, Framingham, Massachusetts: Pathways
to clinical trials.
J. Larkindale, Muscular Dystrophy Association, Tucson,
Arizona: MDA.
B.D. Seckler, Charley’s Fund, South Egremont,
Massachusetts: Charley’s Fund.
D. Miller, CureDuchenne, Corona del Mar, California:
CureDuchenne.
W. Quirk, Foundation to Eradicate Duchenne, Inc., Alexandria,
Virginia: FED.
P. Furlong, Parent Project Muscular Dystrophy, Middletown,
Ohio: Parent Project.
SESSION 5: Promoting the Pipeline in Novel Arenas
Chairperson: G.J. Vella, Charley’s Fund, South Egremont, Massachusetts
389
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G.D. Fischbach, Simons Foundation, New York: Reduced Ach
release from type II SMA motor axons.
W. Thompson, University of Texas, Austin: Abnormal muscle
development in a mouse model of SMA.
B.D. McCabe, Columbia University Medical Center, New York:
SMN in Drosophila: Roles in NMJ Physiology.
J.M. Shefner, SUNY Upstate Medical University, Syracuse:
Motor unit number estimation in a mouse model of SMA.
M. Sahin, Children’s Hospital Boston, Massachusetts: RNA
targets of SMN in axons.
SESSION 1: Cellular Targets
Chairpersons: M. Sendtner, Universitat Wuerzburg, Germany, and G.J. Bassell, Emory University, Atlanta,
Georgia
C.-P. Ko, University of Southern California, Los Angeles: Synapse
loss in the SMN 7 mouse model of spinal muscular atrophy.
S.J. Burden, New York University Medical School, New York:
Role of SMN1 in skeletal muscle.
G.Z. Mentis, NINDS/NIH, Bethesda, Maryland: Significant
motor neuronal loss and altered synaptic input and excitabili-
ty of lumbar motor neurons in SMA mice.
R.S. Finkel, Children’s Hospital of Philadelphia, Pennsylvania:
Electrophysiological evidence for impaired neuromuscular
transmission in children with SMA.
E. Tizzano, Hospital Saint Pau, Barcelona, Spain: SMA during
human development: Different pathogenic responses of
muscle and motor neurons.
SESSION 2: Cellular Targets
Chairpersons: W. Thompson, University of Texas, Austin, and B.D. McCabe, Columbia University Medical
Center, New York
Taking on New Complexities in SMA Biology
October 19–22
FUNDED BY Spinal Muscular Atrophy Foundation
ARRANGED BY K. Chen, SMA Foundation
C.E. Henderson, Columbia University
T.M. Jessell, Columbia University
C. Joyce, SMA Foundation
M. Winberg, SMA Foundation
The goal of all those working on human genetic disorders is to devel-
op therapies that will alleviate, if not cure, the disorder. This requires
identifying therapeutic targets at different organizational levels and
determining how best to reach those targets with current or new
tools. To this end, the working sessions of this fourth SMA meeting
were organized around three themes: Cellular targets (nerve muscle,
glia, and their contacts); molecular targets (SMN2 and downstream
molecules); and functional targets (SMA phenotypes in models and
humans). The expectation was that the meeting would help to identi-
fy and promote collaborative experiments, as well as stimulate rapid
translation of research ideas into therapeutics development and clini-
cal research
Welcome and Introductions: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Singh, SMA Foundation, New York and Organizing Committee
Introduction of Keynote Speaker: D.C. DeVivo, Columbia University Medical Center, New York
Keynote Talk and Discussion: K.P. Campbell, University of Iowa College of Medicine, Iowa City
K. Klinger, T. Jessell
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G.J. Bassell, Emory University, Atlanta, Georgia: Interactions of
SMN with β-actin mRNA-binding proteins important to axon-
al growth.
C.E. Beattie, The Ohio State University, Columbus: Generating
a genetic model of SMA in zebrafish.
M. Sendtner, Universitat Wurzburg, Germany: Valproic acid, a
drug candidate for spinal muscular atrophy, blocks axon
growth and excitability in motor neurons.
H. Wichterle, Columbia University, New York: Characterization
of embryonic stem-cell-derived SMA motor neurons.
K. Eggan, Harvard University, Cambridge, Massachusetts: An
in vitro model for SMA based on the differentiation of dis-
ease-specific human embryonic stem cell lines.
SESSION 3: Cellular Targets
Chairpersons: S.R. Jaffrey, Cornell University, New York, and C.L. Lorson, University of Missouri, Columbia
L. Pellizzoni, Columbia University Medical Center, New York:
SMN and pre-mRNA splicing.
C.L. Lorson, University of Missouri, Columbia: Readthrough-
inducing compounds in SMA: SMN readthrough increases
functionality compared to SMN_7.
S. Artavanis-Tsakonas, Harvard Medical School, Boston,
Massachusetts: Modeling spinal muscular atrophy in invertebrates.
G.J. Lutz, Drexel University College of Medicine, Philadelphia,
Pennsylvania: Preclinical studies of oligonucleotide-mediated
SMN expression in mice with spinal muscular atrophy.
L.L. Rubin, Harvard University, Cambridge, Massachusetts: A
high-content screen to identify molecules and pathways that
regulate survival of motor neuron levels in motor neurons.
SESSION 4: Molecular Targets
Chairpersons: S. Paushkin, PTC Therapeutics, Inc., South Plainfield, New Jersey, and K.H. Fischbeck,
NINDS/NIH, Bethesda, Maryland
C.J. Sumner, Johns Hopkins University, Baltimore, Maryland:
Development of the motor unit in SMA mice and effects of
HDAC inhibition.
P. Aebischer, Swiss Federal Institute of Technology, Lausanne,
Switzerland: Gene therapy for SMA: Proof of principle in
transgenic mice and scale-up issues.
K.W. Klinger, Genzyme Corporation, Framingham,
Massachusetts: Possibilities for gene therapy in SMA.
P. Kaufmann, Columbia University, New York: The natural his-
tory of spinal muscular atrophy: Preliminary findings from the
PNCR study.
M. Winberg, SMA Foundation, New York: Developments in
mice: An update on Foundation preclinical activities.
SESSION 5: Functional Targets
Chairpersons: K. Chen, SMA Foundation, New York, and J.D. Porter, NINDS/NIH, Bethesda, Maryland
Closing Remarks
Moderator: T.M. Jessell, Howard Hughes Medical Institute, Columbia University, New York
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Epigenetics: Mechanisms and Regulation
December 7–10
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY S.L. Berger, Wistar Institute
R. Shiekhattar, Center for Genomic Regulation
A. Shilatifard, Stowers Institute for Medical Research
The term “epigenetics” has been used very loosely to cover states
ranging from dynamic, short-lived, chromatin-mediated regulation to
long-term alteration of chromatin and other extrachromosomal pro-
teins in nonreplicating cells. Given that epigenetics now encom-
passes such a diversity of phenomena, it was felt that a discussion
meeting was needed to reassess what phenomena are epigenetic.
Themes of the meeting included How shall epigenetics be defined—
narrowly or broadly? What are the phenotypes associated with epi-
genetics? How are epigenetic states regulated? What are the links
between epigenetics and human diseases? What are the under-
studied areas within epigenetics?
Welcome: S. Berger, Wistar Institute, Philadelphia,
Pennsylvania,
R. Shiekhattar, Center for Genomic Regulation,
Barcelona, Spain
A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
SESSION 1: Definition of “Epigenetics” and Potential Mechanisms
Chairperson: R. Shiekhattar, Center for Genomic Regulation, Barcelona, Spain
Speakers
M. Grunstein, University of California, Los Angeles School of Medicine
S. Henikoff, Fred Hutchinson Cancer Research Center, Seattle, Washington
Discussion
Speakers
R. Kingston, MGH, Harvard Medical School, Boston, Massachusetts
M. Ptashne, Memorial Sloan-Kettering Cancer Center, New York
B. Stillman, Cold Spring Harbor Laboratory
Discussion
SESSION 2: DNA-binding Factors
Chairperson: K. Struhl, Harvard Medical School, Boston, Massachusetts
Speakers
G. Felsenfeld, NIDDK/NIH, Bethesda, Maryland
V. Pirrotta, Rutgers University, Piscataway, New Jersey
K. Struhl, Harvard Medical School, Boston, Massachusetts
Discussion
Speakers
J. Widom, Northwestern University, Evanston, Illinois
R. Young, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
K. Zaret, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Discussion
R. Martienssen, D. Moazed
G. Struhl
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SESSION 3: DNA Methylation
Chairperson: M. Bartolomei, University of Pennsylvania, Philadelphia
Speakers
S. Baylin, Johns Hopkins University School of Medicine, Baltimore, Maryland
M. Bartolomei, University of Pennsylvania, Philadelphia
A. Bird, University of Edinburgh, United Kingdom
Discussion
Speakers
K. Helin, Copenhagen Biocenter, Denmark
R. Martienssen, Cold Spring Harbor Laboratory
P. Jones, University of Southern California, Los Angeles
Discussion
SESSION 4: Histone Modifications
Chairpersons: A. Shilatifard, Stowers Institute for Medical
Research, Kansas City, Missouri, and S. Berger, Wistar
Institute, Philadelphia, Pennsylvania
Speakers
S. Berger, Wistar Institute, Philadelphia, Pennsylvania
B. Bernstein, Broad Institute Pathology, Charlestown,
Massachusetts
T. Kouzarides, University of Cambridge, United Kingdom
Discussion
Speakers
D. Reinberg, New York University School of Medicine, New York
A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
Y. Zhang, Howard Hughes Medical Institute, University of North Carolina,
Chapel Hill
Discussion
SESSION 5: RNA AND RNAi
Chairperson: T. Kouzarides, University of Cambridge, United Kingdom
Speakers
S. Grewel, National Cancer Institute, National Institutes of Health, Bethesda,
Maryland
G. Hannon, Cold Spring Harbor Laboratory
M. Kuroda, Harvard University, Boston, Massachusetts
Discussion
Speakers
J. Lee, Massachusetts General Hospital, Boston
D. Moazed, Harvard Medical School, Boston, Massachusetts
R. Shiekhattar, Center for Regulation of Genome, Barcelona, Spain
Discussion
R. Kingston, M. Ptashne, A. Bird
P. Jones
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DOLAN DNA LEARNING CENTER
EXECUTIVE DIRECTOR’S REPORT
Preparing students and families to thrive in the gene age
TECHNOLOGY
ADMINISTRATION INSTRUCTION BIOMEDIA DEVELOPMENT
Lauren Correri Elna Carrasco Steven Blue Cornel Ghiban
Mary Lamont Jennifer Cutillo John Connolly Uwe Hilgert
Valerie Meszaros Natalia Hanson Eun-Sook Jeong Bruce Nash 
David Micklos Malissa Hewitt Susan Lauter Jermel Watkins
Karen Orzel Amanda McBrien Chun-hua Yang
Carolyn Reid Erin McKechnie
Ileana Rios
Tedi Setton
Jason Williams
The Dolan DNA Learning Center’s 20th birthday, on September 18, inevitably sparked some reverie
about our origins. It all actually began in 1984 with an innocent enough phone call from Fran Roberts,
the new superintendent of Cold Spring Harbor School District, inquiring how we might join forces to do
something to improve local science education. That conversation led to a proposal to the National Sci-
ence Foundation (NSF) to develop a course to train high school teachers to do recombinant DNA exper-
iments. Dejected when our proposal was turned down, I turned to Mike Glennon, principal, and Ed
Tronolone, science chairman, of the Wheatley School in East Williston. They had a simple solution: Just
ask several local school districts to fund the project!
I doubt that this tactic could have worked anywhere except on Long Island’s North Shore, but by
January 1985, eight local districts had contributed $10,000 apiece to purchase supplies and equipment.
During the next several months, I spent spare moments in Rich Roberts’ lab, working with postdoctoral
fellow Greg Freyer to develop a simple set of experiments that would allow high school students to get
their hands dirty with recombinant DNA. The experiments, which were the basis of our DNA Science lab
text, were first tested in summer 1985 at a teacher-student workshop at the Wheatley School. 
The first DNA ScienceWorkshop spanned two weeks in summer 1985 and included nearly 40 participants.  
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In 1986, we obtained funding from Citibank to develop a mobile “Vector Van”—a Ford Econoline with
a silver paint job and loaded to the ceiling with pipettes, centrifuges, and water baths. With independent
funding from small foundations and biotech start-ups, we took our DNA show on the road, conducting
week-long teacher workshops at six sites across the United States. On the last leg of the trip—from Mil-
waukee, Wisconsin, to Davis, California—the Vector Van was piloted by a German graduate student who
had just received her driver’s license, with a high school intern as copilot. That same year, we initiated a
cooperative agreement with Carolina Biological Supply Company to develop reagents and kits to accom-
pany the DNA Science curriculum. 
It is worth mentioning that I was hired by Jim Watson to start the CSHL public affairs and develop-
ment efforts, so I regarded the burgeoning education program as an advanced form of public relations.
Jim supported my moonlighting because he knew it was time for the Laboratory to take the lead in fos-
tering “DNA literacy” among the general public—just as it had led the way with professional scientists.
This was a bold move at a time when high-level scientists, here and elsewhere, were expected to con-
centrate solely on their research.
By fall of 1986, four staff members—myself, Sue Lauter, Ellen Skaggs, and Mark Bloom—were
crammed into two offices on the main floor of Grace Auditorium (now the Meetings and Courses office),
from which we ran a frenetic fusion of public affairs, development, and educational outreach. Our mod-
icum of success was not lost on Jim, who concluded that the time had quickly come for the education
program to conform to his dictum of organizational evolution: “You get bigger, or you get smaller.” He
determined that we should take over an excessed elementary school on Main Street and convert it into
a DNA museum. Of course, none of us really understood what this might entail, and I braced to answer
tough questions when a proposal was brought to the Board of Trustees for discussion. But then Dave
Botstein, outspoken chairman of biochemistry at Stanford University, rose to champion the proposal—
and the scientific trustees fell in strongly behind him. However, the notion of a stodgy museum was
roundly disdained, and all felt much better with the friendlier concept of a learning center.
Dave Micklos, Christine Bartels, and
Jeff Mondschein before the Vector
Van’s maiden voyage across the U.S.
The Vector Van approaching the Golden Gate Bridge in San Francisco
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With Fran Roberts paving the way with the Board of Education, we forged ahead with a lease/option
to buy the neo-Georgian-style building from the Cold Spring Harbor School system. Beautiful on the out-
side, it had been subdivided into a warren of temporary offices. It charmingly retained all of the original
features from its construction in 1925, including pint-sized toilets and a multipurpose auditorium with a
proscenium stage and two basketball hoops. One small problem: We had no hard cash to pay the rent,
let alone to convert this antique building into a habitat for high-level science.
With the help of CSHL Trustees, our luck turned in the spring of 1987. Mary Jeanne and Henry Har-
ris called from a golf outing to say that they would make a major gift to help pay for the first 6 month’s
rent. Dave Luke worked behind the scenes to help us obtain core support from the Josiah Macy Foun-
dation. We also achieved our first NSF grant, acquired a second Vector Van, and conducted summer
workshops at 14 locations around the country.
In the fall of 1987, we began to renovate the building. Emblematic of our goal to be a “hands-on” sci-
ence center, a 32-seat lab was the first space renovated. In the spring of 1988, we conducted the first
lab field trips during which students cut and separated viral DNA or inserted an antibiotic resistance gene
into bacteria. Soon, I was driving a 24-foot truck back and forth between Washington, D.C., loading and
unloading pieces of an exhibit, “The Search for Life,” which we had borrowed from the Smithsonian Insti-
tution’s National Museum of American History. The exhibit’s intricate system of aluminum trusses and the-
atrical lights occupied the entire front hall, gym/auditorium, and two of four original classrooms. For a time,
I had to crawl on all fours under exhibitry to get to my office. Then, there were artifacts ranging from
Audrey, the man-eating plant from the Little Shop of Horrors, to a recreation of the lab bench at which
Stanley Cohen constructed the first recombinant DNA molecule. Against all odds, everything was in place
for the official opening of the DNA Learning Center on September 18, 1988. 
The rest, as they say, is history. Since that initial grant in 1987, we have maintained continuous NSF sup-
port, and we have been lucky to have had the help of numerous prestigious funders—including the National
Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), William Randolph Hearst Foundation,
Dana Foundation, William & Flora Hewlett Foundation, Burroughs-Wellcome Fund, Amgen Foundation, OSI
Pharmaceuticals, and Pall Corporation. Major private donors—notably Helen and Charles Dolan, Claire and
Ralph Landau, Laurie Landeau, Edward Chernoff, Doris and Peter Tilles, Sandra and Stephen Lessing, and
Joan and Arthur Spiro—provided funds to reconstruct every corner of our fine old building and to assemble
our first endowment. Together, these people and institutions have provided more than $30 million in support.
During the last 20 years, the DNALC has conducted experiments with a third of a million students—
without fanfare or incident—proving the safety of DNA manipulation methods. Our DNA Science cur-
riculum and kits provided by the Carolina Biological Supply Company brought modern DNA manipulation
to millions more high school and college students. The DNALC’s model for hands-on learning, Vector
Vans, and local equipment-sharing have been replicated by numerous science centers, mobile vans, and
"footlocker" programs in the United States and elsewhere. Thus, like its parent, Cold Spring Harbor Lab-
oratory, the DNALC has projected a reputation that is considerably larger than its absolute size.
In retrospect, it seems improbable that we would have so successfully negotiated the risks of infancy
and adolescence to emerge as a mature organization. Frankly, I doubt we could have reproduced this
success elsewhere. Like others at CSHL, we clung tightly to the coattails of Jim Watson in the whirlwind
of excitement he created for DNA, and we learned from Liz Watson that proper houses of science are
rooted in our own history. Much of our success has flowed from the minds of Cold Spring Harbor Lab-
oratory’s scientists, who have shared with us their labs, their methods, and their infectious optimism. With
their continued help, I suppose that our little center will survive another 20 years.
Biomedia Studio
A two-storey addition, completed in spring 2001, more than doubled the size of the DNALC. Included in
the addition is the Biomedia Center, on the second floor, which has provided a purpose-built space to
develop internet materials for biology education. Unfortunately, money ran out on the construction proj-
ect, so for 7 years the western end of the addition remained an unfinished “attic” clogged with broken
computers, excess lab equipment, exhibit parts, and even a life-size model of a New Guinea tribesman.
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A gift from CSHL trustee Laurie Landeau has allowed us to clear out the attic and finally complete this
1000-square-foot studio space as originally intended. On November 1, we celebrated our 20th anniver-
sary with the opening of the Laurie J. Landeau Multimedia Studio. 
The DNALC internet sites are already distinguished from many other science content sites by their exten-
sive use of video, totaling nearly 20 hours of interviews with more than 200 scientists. Two new internet proj-
ects—Genes to Cognition (G2C) Online and the iPlant Collaborative—incorporate an equal volume.
Equipped with theatrical lighting and high-definition digital cameras, the Landeau Studio will increase the
professionalism of the DNALC’s internet multimedia and allow us to embark on new productions. Two Sony
XD-Cam high-definition video cameras record on a flash memory card and eliminate the time-consuming
step of digitizing recordings made on digital video tape. A camera-mounted LiteRing and Chrommatte are
the latest advancements of “greenscreen” technology, which allows us to edit a new background into the
existing video recording. The studio provides three separately lit shooting locations: a desk for news pro-
ductions, a coffee table and easy chairs for talk formats, and a lab table for experiment demonstrations. 
With this infrastructure in place, we can now work with other CSHL departments to take fullest advan-
tage of our unparalleled scientific resource—the more than 8000 scientists who visit each year to attend
meetings and courses. These thought leaders in basic and applied genetics research can be efficiently shut-
tled for interviews from the main campus or Banbury Center. In addition to adding high-quality video to
DNALC and other CSHL internet sites, the studio will provide video-conferencing capability that can keep
us in touch with the thousands of teachers who use DNALC methods. It also offers the potential to expand
our DNA Today concept to provide regular podcasts, vodcasts, and news feeds for the cable industry. 
The Landeau Studio also includes a video/sound editing room and a conference/green room. This
reconfiguration allowed us to redevelop the former conference area as a “living room” for DNALC staff.
This stylish space, with a central free-form concrete lunch counter, was conceived by DNALC multime-
dia designer Eun Sook Jeong, who also has a master’s degree in interior design. Together with the exist-
ing design bays and staff offices, the “living room” and Landeau Studio present a unified vision of a
multimedia production facility for the 21st century. 
iPlant Collaborative
During the past several years, the DNALC has worked with CSHL plant scientists to provide outreach
components for a number of research projects funded by the NSF. Several of these projects came under
the National Plant Genome Initiative to determine the entire sequence of corn and rice chromosomes. In
Bruce Stillman (left) and James Watson (right) look on as Laurie Landeau cuts
the ribbon at the dedication of the Laurie J. Landeau Multimedia Studio.
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February, this work culminated in the receipt of a $2.1 million subaward of a $50 million consortium grant
with the University of Arizona. The project will develop a national computer infrastructure to support plant
research. In an allusion to Apple’s success in making computing more personal, the iPlant Collaborative
aims to develop tools and interfaces that will place large-scale plant data sets and high-powered infor-
matics tools on any scientist’s computer desktop. 
After a spring kickoff symposium at Cold Spring Harbor Laboratory, the iPlant Collaborative hosted a
series of six workshops for plant and computation researchers to brainstorm “grand challenges” in plant
science. These workshops were hosted at Biosphere II, in Arizona, and drew together a multidisciplinary
group of computational scientists and researchers working at all levels of plant function and organization:
molecular biology, genetics, genomics, biochemistry, cell biology, physiology, plant breeding, systemat-
ics, ecology, and evolutionary biology. Beginning in 2009, Grand Challenge Teams will work with com-
puter scientists at the University of Arizona and CSHL to develop a cyberinfrastructure of Discovery
Environments, where plant researchers can share and analyze data in an unprecedented fashion. As a
member of the iPlant Education, Outreach, and Training (EOT) component, the DNALC will work with each
project team to create educational interfaces to the scientific tools and databases. In this way, students
and teachers can work with the same data, using the same tools, and at the same time as high-level plant
researchers. This will enable students to literally look over the shoulders of plant researchers as they, for
example, understand the mechanisms that could enable crop plants to rapidly respond to global climate
changes.
DNALC multimedia staff embarked on an ambitious project to help publicize the iPlant project and to doc-
ument the Grand Challenge development process. We set up a mini-video studio at the iPlant meeting at
Cold Spring Harbor Laboratory, at each of six Grand Challengeworkshops at Biosphere II, and at the Amer-
ican Society of Plant Biology Meeting in Merida, Mexico, conducting a total of 143 interviews with plant and
computational biologists. From these, we extracted 538 video clips that present a range of viewpoints on
challenges in plant biology, cyberinfrastructure, and education. A video header on the iPlant internet site
(http:// www.iplantcollaborative.org/) randomly loads clips or allows one to select specific interviews.
At year’s end, we received approval from iPlant management to embark on an EOT demonstration
project to develop an educational platform for gene annotation and comparison. Annotation is the process
of discovering the biological information contained in a DNA sequence, viewing genes in the context of a
chromosome, and relating them to other organisms. The analysis of DNA sequence entails a number of
cumulative steps—assembling short sequences into “contigs,” predicting genes and other functional ele-
ments, and merging gene evidence from RNA and other species—which is termed a “pipeline” or “work-
flow.” Although masses of free DNA and gene data are available, each step of the workflow requires a
different tool, and various tools and data sources often are not compatible. Our objective is to develop an
easy-to-use interface that will allow students to easily find DNA data and seamlessly move it through sev-
eral key stages of the annotation pipeline. We envision a desktop object that merges attributes of our
Biosphere II in Arizona made a stunning backdrop to the iPlant Collaborative Grand Challenge workshops.
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BioServers (http://www.bioservers.org/bioserver/) and Geneboy (http://www.dnai.org/geneboy/) applica-
tions. Sarah Elgin (Washington University in St. Louis), Sue Wessler (University of Georgia), and Steve
Slater (University of Wisconsin) are key collaborators on this project. 
Genes to Cognition (G2C) Online
During the year, we pushed to complete Genes to Cognition (G2C) Online, our internet site on modern
neuroscience research (http://www.g2conline.org). This site allows students to explore how thinking and
disorders of thinking result from interactions at various levels of biological function—from genes, to bio-
molecules, cells, physiology, behavior, and environment. We completed 40 video interviews and demon-
strations with neuroscience researchers from the United States and Europe, creating more than 300 new
video clips and animations for launch in March 2009. A major goal of G2C Online is to increase under-
standing of the process of science. To this end, we collaborated with researchers at the National Insti-
tute of Mental Health to develop three video modules on neuroimaging based on fMRI, MEG, and PET
technologies. In these demonstrations, researchers introduce the techniques, guide users through an
experiment, and discuss data.
We continued to develop touchstone animations that highlight key concepts of brain science. Fol-
lowing up a recommendation from our Advisory Panel, we collaborated with AXS-3D, a Toronto-based
animation studio, to develop the G2C Brain. This unique interface allows one to rotate a three-dimensional
The video interface at the iPlant Collabo-
rative website includes interview clips of
143 plant and computer scientists. 
Genes to Cognition Online is scheduled to
launch during the Dana Foundation Brain
Awareness Week in March 2009.  
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model to explore the structure and function of 29 parts of the human brain. Each structure or region
includes information on associated disorders, brain damage, case studies, and links to contemporary
research. Molecules for Memory was developed to supplement a video interview with Nobel Laureate Eric
Kandel. In this animation, users can trace the formation of a long-term memory from the generation of
presynaptic action potentials, through protein–protein interactions in the postsynaptic neuron, to the for-
mation of new synapses. This animation joins a series of high-value pieces, including the Neural Code,
a proteomics demonstration; Memory Lanes, a demonstration of how cab drivers remember routes;
Gene Knockout, an explanation of how to alter genes in mice; and the Fly School and Swimming Mice
interactive experiments. In addition to animations and video clips, we have harvested an extensive library
of articles from the Dana Foundation and a 300-word glossary.
We also collaborated with Seth Grant’s group at the Wellcome Trust Sanger Institute to develop a pro-
tein–protein interaction database (PPID) browser. This is a map tool that allows one to explore a network of
105 proteins involved in synaptic transmission. Clicking on any one of the proteins calls up a customized
abstract with links to G2C Online content and detailed information (the Allen brain atlas, NCBI gene infor-
mation, and Ensembl homology links). The browser bridges the gap between science and education, allow-
ing researchers and students to toggle between technical and popular information about a particular protein.
G2C Online’s unique site architecture extends networking software developed at MIT’s Media Lab,
which displays content as an interlinked network of dimensional content “atoms.” One can browse the
network by zooming in and out, following links between adjacent atoms, and clicking on any atom to call
up multimedia items. Our three-dimensional network is based on two-dimensional concept maps that
were developed from interviews with leading neuroscience researchers. In 2008, we redeveloped our
browser software as Simple Mapper, which allows users to build their own network maps and then link
atoms to online content from G2C or other sources. In addition to creating striking network maps, Sim-
ple Mapper can also be used to generate concept maps to assess student learning.
In the spring, Amy Niselle, a doctoral student from the University of Melbourne, joined the G2C Online
project to assist with program evaluation. She worked extensively with Danielle Sixsmith to conduct a
The 3-D brain at G2C Online includes informa-
tion on 29 structures with associated disorders
and links to current research. In Fly School, visi-
tors can perform an experiment online to test
learning in Drosophila. 
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detailed usability study with 48 Advanced Placement (AP) biology and psychology students. Data were
collected on how students interacted with the internet site, how they accessed relevant content, and
how the site helped or hindered learning. Insights from this study led to several important changes in site
design and navigation. Notably, we enabled our Flash interface to be controlled by browser back/forward
buttons (not a trivial project), and we streamlined text for easy browsing and skim reading.
Inside Cancer
With Phase I funding from an NIH Science Education Partnership Award (SEPA), we developed Inside
Cancer (www.insidecancer.org), a multimedia internet resource for understanding the molecular genetic
basis of cancer. By focusing on how researchers gain insights into the unseen world of genes and sig-
naling molecules, Inside Cancer provides examples of the science process. With Phase II funding, we are
implementing a number of improvements that support and extend syllabus-centered teaching. Notably,
we disaggregated Inside Cancer content by breaking it into individual content “atoms.” Each atom was
then entered into a content management system and annotated with metatags, including alignment with
national and state educational standards. Using this system, a teacher can identify sets of atoms that illus-
trate particular content standards or, conversely, collect items that respond to various standards as they
browse the site. 
We also developed a companion Teacher Center that includes standards alignments, as well as a tool
that allows teachers to create custom presentations with Inside Cancer content, and a wiki for developing
and exchanging lesson plans. Faculty Fellows Naomi Cook (Horace Greeley High School), Sue Holt (Life Sci-
ences Learning Center, University of Rochester), and Glen Cochrane (lead biology teacher, Half Hollow Hills
High School) developed sample lessons to “seed” the wiki. Naomi spent an extended period at the DNALC
adapting multimedia elements from other DNALC sites to expand content at Inside Cancer. 
Maize Internet Sites
During the year, we collaborated with CSHL researchers Dick McCombie and Doreen Ware, and Rick
Myers of Washington University in St. Louis to develop a mini-website describing the NSF-funded Maize
Genome Sequencing Project (http://www.dnalc.org/maize/maize.html). The site features interviews with
scientists involved in deciphering the information in the maize genome, a tour of the genome sequenc-
ing center at Washington University, an animation of the sequencing and assembly process, and a video
tutorial for using the online maize sequence browser.
In the fall, our work in plant education was further bolstered with receipt of an outreach grant from the
maize meristem collaboration between CSHL faculty member Marja Timmermans and scientists at Cor-
nell University. Under this project, the DNALC will develop a multimedia internet site, Weed to Wonder.
We will tell the remarkable story of the corn plant’s amazing rise—from a common weed, to staple food
and religious icon of Native Americans, to modern hybrid cultivar, to versatile and ubiquitous component
of processed food, to precursor of clothing and motor fuels, to pharmaceutical factory. Weed to Won-
der will celebrate this uniquely American success story and provide a case study of the interaction among
science, technology, and society (STS). The site will open an internet window on modern research on
plant genomes, as well as a time machine back into the social and scientific history of agricultural breed-
ing. The goal will be to show the continuity of research on corn—from Native American agriculturalists to
agricultural breeders, corn geneticists, plant physiologists, and molecular biologists—that has culmi-
nated in the Maize Genome Sequencing Project. In parallel with the story of human impact on the evo-
lution of the corn plant, we will also tell the story of corn’s impact on human culture.
Weed to Wonder will capitalize on the internet’s capacity to juxtapose different media, providing
options to engage people with different interests and learning styles (“intelligences”). The major site will
be complemented by serialized podcasts in audio and video formats. Video interviews will provide con-
trasting vignettes of people involved with corn at various levels. Researchers will provide understanding
of the process of science, and interviews with farmers, historians, and ethnographers will portray corn’s
role in society. Animations will be especially effective in describing experiments and bringing to life unseen
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molecular events. Multimedia content will be integrated with online experiments and bioinformatics tools
primarily developed by the DNALC with previous NSF funding. A continuum of practical experiments will
allow middle school, high school, and beginning college students to progress from classical genetic
analysis of kernel traits, through molecular genetic and bioinformatic analysis of mutations, to the exam-
ination of genome structure and evolution.
Internet Visitation
Visits to the DNALC’s family of internet sites decreased to 6.06 million in 2008—84% of the previous
year’s traffic. Although there were fewer visitors, those who came spent more time and accessed more
content than in the previous year. Ten of 12 sites saw increases in the average viewing time and served
nearly 4000 gigabytes (4 terabytes) of data, a 23% increase over 2007. DNA Interactive, our richest mul-
timedia site, alone served a total of 1.3 terabytes.
As part of a concerted effort to improve visitation, we employed LunaMetrics, a company that spe-
cializes in search engine optimization. After analyzing a representative internet site (Inside Cancer), the
consultants suggested ways to improve our metadata descriptions to make it easier for search engines
to index content. Because search engines give preferred rankings to sites with frequent updating, the con-
sultants also suggested adding blogs or news feeds to provide fresh content. We have been using these
and other insights to renovate older sites and to guide development of new sites. Many of our popular
sites have a linear story line, which makes it difficult for users to find particular multimedia atoms (ani-
mations and videos) to answer a specific question or instructional need. We are in the midst of a major
project to disaggregate linear content and provide improved metadata so that individual videos and ani-
mations can be retrieved via a search, such as Google or Yahoo. Our new G2C Online site was specifi-
cally developed as a nonlinear network of atoms with associated metadata.
We continue to get a boost from a grant from Google AdWords, a free advertising program that dis-
plays sponsored links on Google’s search results page. Our AdWords account contains a set of keywords
for each DNALC website. A search for one of the keywords displays an ad for a DNALC site as a user
“impression,” and a “click-through” is logged when a link is followed. DNA from the Beginning is our
most successful site on AdWords, logging 5,587,424 impressions and 103,294 click-throughs. In total,
DNALC sites registered 13,441,908 impressions and 175,161 click-throughs, valued at $113,224. 
The Weed to Wonder site will explore how humans change corn and how corn
changed human society.
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Faculty Training
During the year, more than 800 educators participated in professional development activities conducted
at sites around the United States and Europe. With funding from the NSF, NIH, and the Hewlett Foun-
dation, we collaborated with 14 host institutions to conduct 17 one- to five-day workshops on plant
genomics, bioinformatics, cancer biology, RNA interference, and neurobiology. Five of these workshops
were conducted at institutions with high proportions of underrepresented minorities, where 19% of par-
ticipants were African American or Hispanic. Through our HHMI-sponsored collaboration with the New
York City Department of Education, 105 teachers participated in workshops at the Harlem DNA Lab. An
additional 428 educators attended workshops at professional meetings in the United States and Europe
that covered topics including neurobiology, bioinformatics, the molecular genetics of taste and smell,
detecting genetically modified foods by PCR, DNALC online tools for education, and DNA forensics. 
At the end of July, 18 teachers from ten states attended the Amgen Leadership Symposium in Human
and Genomic Biology. The first 2 weeks of the symposium included experiments and bioinformatics exer-
cises on RNA interference (RNAi) and genetic modification of plants. Participants explored human genet-
ics by genotyping polymorphic sites in their own DNA: (1) An Alu “jumping gene” insertion on
chromosome 16 and single-nucleotide polymorphisms (SNPs) in the mitochondrial chromosome were
used to study theories of human origins and ancient migration. (2) SNPs in a taste receptor were corre-
lated with the ability to taste the bitter chemical phenylthiocarbamide (PTC). (3) Variations in a repeat
region and analysis on a DNA chip illustrated state-of-the-art methods in forensic identification. In the final
week, participants worked independently or in groups to develop lesson plans, optimize experimental
methods for classroom instruction, screen supermarket foods for genetic modifications, expand bioin-
formatics exercises, and observe DNALC methods for instructing middle school students.
We continued to provide leadership training under our long-term collaboration with the Singapore
Ministry of Education. Initiated in 2000 with a visit by Minister Teo Chee Hean, the collaboration estab-
lished licensed DNA learning centers at the Singapore Science Center and National Institute of Educa-
tion. Two junior college teachers and one high school teacher participated in the summer Leadership
Symposium, and three elementary school teachers came in November for a 2-week stay. Besides hands-
Average 
Average Change monthly Change
visit from bandwidth Visits from 2007
length 2007 (gigabytes) in 2008 (percent)
Content-based sites
Gene Almanac 9:13 +0:40 94.77 1,629,334 –15.28
DNA from the Beginning 9:32 +1:00 37.09 1,302,136 –10.29
Your Genes, Your Health 8:12 +0:32 41.45 805,683 –16.26
DNA Interactive & myDNAi 10:26 +2:02 111.56 1,151,103 –21.15
Image Archive on the American
Eugenics Movement 17:46 +1:18 11.55 607,973 –16.93
Inside Cancer 7:18 +0:09 31.35 239,942 +22.33
Inside Cancer Teacher Center 14:45 n.a. 3.03 22,251 n.a.
Laboratory/bioinformatics sites
BioServers 24:07 +7:57 2.56 135,955 –45.97
Genetic Origins 7:28 +0:24 1.57 102,738 –22.61
Greenomes 3:15 –0:12 0.54 13,312 +40.97
Dynamic Gene 7:18 +0:58 0.34 11,277 +41.21
Silencing Genomes 12:45 +4:34 0.55 29,461 +142.12
DNALC Kits/Carolina Collaboration 15:18 –0:08 2.34 5,425 +23.41
All sites 9:27 6,059,590 –15.17%
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on lab work and preclass preparation, the November contingent observed and co-taught labs alongside
DNALC instructors and visited a local elementary school. Each teacher developed a plan for translating
their experience into hands-on instruction for Singaporean students. 
Concluding Two Plant Outreach Projects
We concluded our collaboration with CSHL researcher Marja Timmermans and Cornell University’s Mike
Scanlon to encourage underrepresented minorities to teach and study plant genomics. In past sum-
mers, two Faculty Fellows spent 2 weeks working in plant genome labs at CSHL or Cornell and 1 week
working with us at the DNALC. In 2008, we conducted 1.5-day follow-up workshops hosted by Faculty
Fellows Gokhan Hacisalihoglu and Diomede Buzingo at their home institutions—Florida Agricultural &
Mechanical University (Tallahassee) and Langston University (Oklahoma). Of the 25 high school and col-
lege educators who participated in these workshops, 24% were African American or Hispanic, mirroring
their proportion among American residents (2005 census figures). Building on previous 3-day workshops
at these sites, the follow-ups introduced educators to mobile “footlockers” that include PCR and elec-
trophoresis equipment. Experiments use this equipment to test for genetically modified foods or analyze
transposon polymorphisms in maize and Arabidopsis. Participants can borrow the equipment from host
institutions for use in their classes, removing a major barrier to the implementation of modern experi-
ments in plant molecular genetics. This project was summarized in an article written by Dr. Hacisalihoglu
entitled An Innovative Plant Genomics and Gene Annotation Program for High School, Community Col-
lege, and University Faculty (CBE Life Sci. Educ. 7: 310–316).
We also completed work with Lincoln Stein and Doreen Ware on their NSF-funded Gramene project,
which provides informatics tools for analyzing and comparing grain genomes. During the project, we
developed the internet site Dynamic Gene (www.dynamicgene.org) and trained 304 high school and col-
lege faculty to use the site to annotate rice genes in their classes. Animated tutorials in the site explain
how DNA sequences encode information, how computers identify patterns that predict gene structures,
and how experimental evidence complements computer predictions to correctly identify genes. The
Annotation section provides detailed instructions on how to analyze a predicted gene with Apollo,
research software developed to analyze the Drosophila genome.
The Projects section allows students to download sections of rice chromosomes, annotate predicted
genes, and upload their results to compare with classmates or share with researchers. This provides
powerful opportunities for students to contribute to science by analyzing up-to-date biological data. This
became evident during the fall of 2008, when we used the site with Cold Spring Harbor High School
students enrolled inGenomic Biology, an advanced course offered at the DNALC. After 5 hours of instruc-
Leadership Symposium educators and DNALC staff pose for the traditional class photo. 
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tion using Apollo and other online bioinformatics tools, student groups were charged with the task of iden-
tifying and evaluating genes in different regions of rice chromosome 1. By analyzing the available evi-
dence, the 17 students were able to improve on the majority of computer-generated gene predictions and
many previously annotated genes in a 400,000 base pair region. Remarkably, students were also able
to identify four putative genes that had not previously been identified. Thus, we feel that certain novice
high school and college students can contribute to our knowledge of gene structure, while gaining first-
hand experience in modern bioinformatics.
Three New Teacher Training Workshops
RNA interference (RNAi) provides a powerful tool to move directly from DNA sequence to the analysis of
gene function in living organisms. With Phase II funding from NSF’s Course, Curriculum, and Laboratory
Improvement (CCLI) program, we expanded our efforts to bring compelling RNAi experiments into college
classrooms. Five-day Silencing Genomes Workshops were conducted in summer 2008 at Rust College
(Holly Springs, Mississippi), Austin Community College (Texas), and the Fralin Biotechnology Center at Vir-
ginia Tech (Blacksburg, Virginia). Sixty-three college instructors were trained to perform RNAi in the model
eukaryotic organism Caenorhabditis elegans. After observing mutant phenotypes and learning basic worm
“husbandry,” faculty used simple methods to induce RNAi and “single-worm PCR” to examine the mecha-
nism of RNAi—comparing the DNA of worms with identical phenotypes induced by either RNAi or a muta-
tion. They also learned open-ended methods that support student projects, using bioinformatics to identify
a target gene and then to develop their own RNAi reagents “from scratch.”
Using these methods, workshop participants collaborated to develop new targeting vectors designed
to silence 40 C. elegans genes; these will be supplemented by another 60 vectors to be developed in
workshops planned for the summer of 2009. Each vector has been entered into the Silencing Genomes
Projects page and includes its own evolving record of how it was developed and how it is used by other
students and teachers. A collection of bacterial and C. elegans strains, including these newly developed
reagents, are freely available through our online strain order system. In 2008, 88 strains were sent to
teachers in the United States, Thailand, Brazil, Poland, Singapore, and Spain to support teaching the
Silencing Genomes curriculum, reaching an estimated 2600 students.
Ninety-two high school and college faculty learned to use internet content on cancer cell biology in
health, general biology, and AP biology classes at six Inside Cancer workshops. One-day workshops
supported through the NIH SEPA program were held at Stowers Institute for Medical Research (Kansas
City, Missouri), Midland College (Texas), Fred Hutchinson Cancer Research Center (Seattle, Washing-
ton), and Kimmel Cancer Center (Philadelphia, Pennsylvania). Two workshops were also conducted in
conjunction with teacher professional conferences: National Association of Biology Teachers (Memphis,
Tennessee) and Biolink Southwest Region (Albuquerque, New Mexico).
With the support of the Hewlett Foundation, we instituted a
nationwide workshop program to disseminate G2C Online. Work-
shops were held at the DNALC, the Stowers Institute (Kansas City,
Missouri), Fred Hutchinson Center (Seattle, Washington), and St.
Louis Science Center (Missouri); 61 high school and college edu-
cators participated in 1.5-day workshops introducing up-to-date
neuroscience research, our library of multimedia items, and inter-
active experiments. Of these participants, 97% rated workshop
content as excellent or good, and mean scores on pre- and post-
knowledge tests rose from 6.57 to 8.91. 
Harlem DNA Lab
In 2008, we fulfilled our long-held goal of developing a base of operations to provide underserved schools
in New York City (NYC) enrichment opportunities identical to those offered to Long Island’s affluent
schools. In 2007, NYC Schools Chancellor Joel Klein provided us exclusive use of a 1200-square-foot
408
John Connolly (standing) leads a G2C Online educator
workshop. 
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classroom in the John S. Roberts Educational Complex (JHS 45) in East Harlem. Then, in winter 2007–
2008, the Division of School Facilities renovated the space according to our specifications, including our
signature student lab desks. With a $100,000 grant from the Jerome L. Greene Foundation, we pur-
chased equipment for elementary through advanced experiments—from dissecting and compound
microscopes to a fast PCR machine and three Agilent Bioanalyzers that allow us to type student poly-
morphisms in a single 3-hour lab. One area of the lab is specifically designed for assembling footlockers
and restocking reagent kits to be used in NYC schools.
Lab field trips began in the spring, and Harlem DNA Lab was dedicated on September 23 by NYC
Schools Chancellor Joel Klein, Howard Hughes Medical Institute (HHMI) Vice President Peter Bruns, and
CSHL President Bruce Stillman. The event was covered in the New York Post, and a video piece on NY1
featured students from the Emily Carey School.
Located at John S. Roberts Middle School, at First Avenue and 120th Street,  Harlem DNA Lab offers
the same range of high school lab field trips as offered at our Cold Spring Harbor and Lake Success facil-
ities: bacterial transformation, DNA restriction analysis, forensic DNA profiling, and human mitochondr-
ial DNA sequencing. Just over 1400 students participated in lab field trips in 2008. We extended our
409
Chancellor Joel Klein was a featured speaker at the Harlem DNA Lab opening in September.  
Bruce Stillman and Dave Micklos talk with students
at the Harlem DNA Lab opening. 
CSHL Trustee Mary Lindsay watches as students
spool DNA in a test tube.
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popular Genetics as a Model for Whole Learning (GMWL) to every John S. Roberts student, providing
three labs for each of 375 students in grades 6–8. A grant from the William T. Porter Foundation provided
scholarships for John S. Roberts students, as well as 812 students participating in field trips and sum-
mer camps. 
The capstone event for Harlem DNA Lab was the 2-week New York State Excelsior Scholars Program,
which involved 39 8th graders from Manhattan, Queens, and the Bronx. Excelsior Scholars were selected
based on standardized test scores that placed them in the top 10% of their science/math classes, teacher
recommendations, and personal statements. A week-long DNA Science camp provided intensive lab
experience for 16 high school students from around New York City. 
HHMI Teacher Professional Development
Harlem DNA Lab is also the site for a city-wide professional development program funded by HHMI. The
goal is to develop a base of teachers who can competently introduce science students to six “targeted”
experiments highlighting key techniques in genetics and biotechnology. The experiments embody key
concepts and process skills of the New York City Scope and Sequence for Science, New York State
Science Core Curriculum, AP Biology, and National Science Education Standards.
During the first year of the project, we developed a strong working group composed of DNALC and
Department of Education staff, key advisors, and six Faculty Fellows: Greg Borman, lecturer in mid-
dle/secondary science education, City University of New York and former science coordinator, Henry
Street Middle School, Manhattan; Caren Gough, New York State Science Mentor, consultant, and adjunct
faculty, Stony Brook University; Dr. Dahlia McGregor, biology teacher, South Shore High School, Brook-
lyn; Adrienne Rubin, biology teacher, Eleanor Roosevelt School, Manhattan; Kathleen Rucker, biology
teacher, Brooklyn International High School; Jerry Watkins, retired science teacher, Central Islip Union Free
School District (UFSD), Long Island. 
During the week of August 4–8, the Fellows convened at the DNALC to help develop Lab Center, an
internet site that specifically supports instruction of the six “targeted labs.” Lab Center represents a vir-
tual classroom into which a DNALC staff member enters to make a video introduction to each lab. By
clicking on objects on the whiteboard and desk, students can access (1) interactive and PDF versions
of each experiment, (2) follow-up activities, (3) scientist interviews, (4) animations, and (5) selected links.
Fellows developed formatted lesson plans that include prelab student work, detailed teacher tips, a time-
line to complete the lab in 40-minute periods, and creative postlab activities. Their input helps to ensure
that each lab builds logical connections between concepts and anticipates use in a variety of classroom
settings.
The HHMI project has the aggressive goal of providing 24 hours of certificate training to 200 teach-
ers per year. Thus, in 2008, we devoted considerable effort to developing relationships with key individ-
uals and networks that can help us to recruit teachers. Through our collaboration with the Department
of Education, our training schedule and registration materials are posted on major NYC registries for
teacher development activities. 
Visitation and Student Instruction
Annual visitation reached a new high of 40,613 in 2008. This included 20,043 students who conducted
experiments at the DNALC, DNALC West, or the Harlem DNA Lab, and 8235 students who received in-
school instruction by DNALC staff members. More than half of all experiments were conducted by mid-
dle school students under the banner of GMWL, which continues to offer quality field trip and in-school
programs for students in grades 4–8. In 2008, more than 70 public and private schools were involved in
the GMWL program.
Summer camps conducted at the DNALC, DNALC West, Harlem DNA Lab, Central Islip High School,
and SUNY Old Westbury drew 921 students. We continued our collaboration with Project Grad Long
Island, a nonprofit organization that works within economically disadvantaged students to increase high
school graduation rates. Project Grad provided daily bussing for 22 high school students from the West-
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bury UFSD to attend a week-long camp at the SUNY Old Westbury campus. This course, which included
hands-on experiments on advanced topics in DNA science and human and plant genomics, was sup-
ported by a grant from the Keyspan Foundation. Arrow Electronics provided scholarships for four 5th
grade students from the Westbury UFSD to attend Fun with DNA camps at the DNALC. As part of a con-
tinuing collaboration with Central Islip School District, Bank of America Long Island funded a Fun with
DNA camp for 18 students from the Charles Mulligan Elementary School.
In 2008, we continued the Great Moments in DNA Science tradition with 425 high school student par-
ticipants. Dr. Lloyd Trotman talked about the impact of varying PTEN expression levels in mouse mod-
els for prostate cancer. Dr. Bill Tansey explained how proteolysis contributes to important events in the
cell and how abnormal proteolysis contributes to cancer. Dr. Doreen Ware described her work in under-
standing plant genome organization, evolution, and diversity. Saturday DNA! drew 272 student and adult
participants for workshops such as Survival of the Fittest, Cancer: Inside Out, and How to Solve a Crime.
Our collaboration with the Watson School of Biological Sciences continued in 2008 with a large class
of 14 graduate students. This rotation provided the graduate students an opportunity to learn skills for
communicating with nonbiologists. During 12 half-day teaching sessions, pairs of students worked with
expert DNALC instructors to develop presentation methods that can help convey unfamiliar ideas to peo-
ple of any age or background. During the first phase of training, each student pair “shadowed” a DNALC
instructor as he/she taught a middle or high school lab and then developed a lesson plan that integrated
their perspectives into the formatted lab. In the second phase, each pair worked closely with DNALC
instructors to co-teach several labs, developing their communication skills and preparing them for inde-
pendent instruction. During the final phase, each pair was responsible for teaching an entire lab, under
the close observation of a DNALC staff member. 
DNA Sequencing Service
A unique aspect of the DNALC’s educational portfolio is the free DNA Sequencing Service and bioinfor-
matics tools that allow students to analyze a 440-nucleotide portion of their own mitochondrial chromo-
some. The mitochondrion, the organelle that produces energy for the cell, contains several copies of its
own genome; moreover, there are hundreds to thousands of mitochondria per cell. This amplification
and the fact that the noncoding (control) region of the mitochondrial genome accumulates mutations
quickly make the control region ideal for studies of human evolution and diversity. 
Using a kit distributed by Carolina Biological Supply Company, students isolate DNA from cheek cells
and then use PCR to amplify the mitochondrial control region. The student samples are then sent by
overnight mail to the DNALC, where they are prepared for sequencing by college interns Alina Duvall
(Hofstra University) and Jennifer Aiello (Long Island University, C.W. Post Campus). The student samples
then go to the CSHL Sequencing Shared Resource Facility in Woodbury, where they are sequenced on
an Applied Biosystems 3730xi Genetic Analyzer. Finally, the sequences are uploaded to the Sequence
Server database at our BioServers internet site (http://www.bioservers.org). There, students can view their
sequences and use software to align them with mitochondrial sequences from modern humans, ancient
humans, primates, and other animals. In this way, they can use their own DNA as a starting point to dis-
cover what DNA says about how humans evolved and migrated around the globe.
In 2008, we sequenced 7003 student DNA samples—a 10% increase from 2007. Samples were
received from 145 high schools, 36 community colleges, and 71 universities. On average, results were
posted on the BioServers site within 20 days of receipt. The free service is made possible by the dona-
tion of sequencing reagents by Applied Biosystems of Foster City, California.
Staff and Interns
In August, we said goodbye to high school instructor Brian Lang and middle school instructor Lauren
Weidler. We will miss them both and wish them continued success as they teach biology—Brian in the
North Shore School District and Lauren in the Plainview School District. Instructional vacancies were filled
by Jason Williams and Tedi Setton, two Long Island natives. Jason has a bachelor’s degree in biology from
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SUNY Stony Brook. He worked at CSHL’s main campus, involved in the molecular genetics of plant devel-
opment in Arabidopsis and cancer research. Tedi brings a wealth of knowledge from her undergraduate
degree in biological sciences from Wellesley College and her studies in forensic pathology at the Suffolk
County Medical Examiner’s Office. Having participated in a DNA Science summer workshop as a high
school student, Tedi’s education came full circle when she led DNA Science as an instructor! 
In the fall, we were lucky to recruit Dr. Ileana Rios to head our new Harlem DNA Lab. Ileana brings an
informed perspective to our effort to bring high-level science to underrepresented students in New York
City. Born in Spanish Harlem, only a few blocks from the Harlem Lab site, she went on to receive a B.A.
in biology from Barnard, a B.S. in cytology from SUNY Health Science Center, and a Ph.D. in molecular
biology from CUNY. Her work history spans research in cellular senescence and HIV vaccine develop-
ment, as well as teaching at the elementary, secondary, and undergraduate levels. 
We also welcomed back Dr. Uwe Hilgert after a year’s assignment as Assistant Dean of the Watson
School of Biological Sciences, where he eased a transition between Deans. Uwe returned to spearhead
the DNALC component of the iPlant Collaborative and to resume his role as scheduling tsar, maintain-
ing our increasingly complex schedule of teacher training workshops. As a microbiologist, Uwe brings to
the iPlant position formal training in plant pathology/physiology from the Max-Planck Institute for Plant
Breeding and the University of Arizona. He has practical expertise in bioinformatics education, having
worked on high school and teacher training under HHMI and NSF grants. He had a key role in develop-
ing the DNALC’s Dynamic Gene internet site, an interface that allows students to annotate the rice
genome sequence. He also knows many of the players in the iPlant leadership, having spent his post-
doctoral period at the University of Arizona before coming to CSHL in 2000. 
Lauren Correri, our new Administrative Assistant, is a native Long Islander. After graduating from Adel-
phi University and working toward a master’s degree at Sarah Lawrence College, she gained adminis-
trative experience at First Advantage, a firm specializing in insurance investigations. Her duties at the
DNALC include greeting visitors, overseeing scheduling, collecting fees, and tracking visitation.
The internship program continues to draw some of Long Island’s most talented high school and col-
lege students, engaging them in science research and providing practical laboratory experience. We were
pleased to accept a large group of new high school interns this year: Dylan Assael (Syosset), Michelle
Bobrow (Great Neck South), Nancy Desai (Hicksville), Utkarsh Sahay (North Shore), Yasmina Macer (Port -
ledge), Andrew Malmgren (Massapequa), Anastasia Minkin (Oyster Bay), Emily Troge (Our Lady of Mercy),
Kaitlin Watrud (Commack), and Kevin Wu (Jericho). Returning interns were Charmaine Brown (Westbury),
Rachel Gellerman (Cold Spring Harbor), Stephanie Parascandolo (Half Hollow Hills), and Arielle Scardino
(Kings Park). Many of our interns continued to invest their DNALC experience in their own research. Arielle
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Scardino (Kings Park) worked with Jermel Watkins to explore how a decreased expression of certain mito-
chondrial genes can be used as a biomarker for neuromuscular dysfunction.
We bid farewell to interns Seth Schortz, who started at Emory University, and Benjamin Blond, who
started at Yale University. Former high school interns Nick Wilkin (Ithaca College) and Janice Yong (Boston
University) returned to help out during college breaks. Lauren Thompson (Barnard College) again returned
to assist with summer workshops at DNALC West.
College intern Jennifer Aiello (C.W. Post University) continued to effectively manage our free DNA
Sequencing Service. She also called on her major in forensic science to help us create a popular family
workshop for Saturday DNA, Dig This!, a hands-on introduction to forensic anthropology.
Expert Advisors and Corporate Support
We are lucky to have high-level support from two advisory bodies: the Education  Committee and the Cor-
porate Advisory Board (CAB). The Education Committee formulates policy and assists with strategic
planning, whereas the CAB provides a liaison to the Long Island business community. The CAB con-
ducted its annual fund campaign and golf tournament, raising $275,000.
DNALC Committee
Chairperson: Laurie Landeau, V.M.D.
Lori Bressler Suzanne Leeds Arthur M. Spiro
Edward A. Chernoff Peter Quick Peter Tilles
Lola N. Grace Lawrence Scherr, M.D. Edward Travaglianti
Suzanne Kleinknecht Arthur Smithers Marianne Dolan Weber
Corporate Advisory Board
Chairperson: Edward A. Chernoff, Motors & Armatures Inc.
CSHL Trustee Liaison: Laurie Landeau, V.M.D.
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Michael Aboff, Aboff’s Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale Sothebys
International Realty
Jeffrey Carstens, Sovereign Bank
Richard A. Catalano, KPMG, LLP
Marian Conway, Roslyn Savings Foundation
James Chinitz, Population Diagnostics
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall Corporation
David Epstein, Ph.D., OSI Pharmaceuticals, Inc.
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business Products Centre
Lawrence Goodman, Curtis, Mallet-Prevost, Colt &
Mosle LLP
Mary Jane Helenek, Luitpold Pharmaceuticals
Arthur D. Herman, Herman Development Corporation
Diana Hoadley, JP Morgan
Robert Hoppenstedt, Bethpage Federal Credit Union
Robert Isaksen, Bank of America
Neil M. Kaufman, Davidoff, Malito & Hutcher
John C. Kean III, Kean Development Corporation
Norman Kelker, Enzo Life Sciences
Robert Keller, Keyspan Foundation
Teresa Kemp-Zielenski, United Way of Long Island
James E. Mattutat, Ingleside Investors, Inc.
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sothebys Real Estate
Frank Posillico, Rose Racanelli Realty/Aireco
Christiaan B. Reynolds
William D. Roche
Charles R. Schueler, Cablevision
Lee Shuett, Nikon Instruments
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of New York
Robert Van Nostrand, AGI Dermatics
David Widmer, Long Island Radio Group
Hans Zobel, Ziehm Medical LLC
David A. Micklos
Executive Director
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2008 Workshops, Meetings, and Collaborations
January 4 Site visit by Debra Berhans, Canisius College, Buffalo, New York
January 7 Site visit by Leo Brizuela, Agilent Technologies, Inc., Melville, New York
January 10 Watson School Orientation and Welcome Reception, DNALC
January 12 Saturday DNA!, “Survival of the Fittest” and “Blame it on the Brain,” DNALC
January 14 Meeting with Steve Barkanic, Gates Foundation, Washington, D.C.
January 16 Site visit by William Fair, Juliette Morgan, and Connie Hildesley, Alexandria Real Estate Equities, New York
January 17 Site visit by Scott Bronson, Mel Morris, and Ken White, Brookhaven National Laboratory, Upton, New York
January 18–19 NSF Dynamic Gene Workshop, Salk Institute for Biological Studies, San Diego, California
January 26 American Museum of Natural History Workshop, “Discovering the Tree of Life,” New York
February 5 DNALC Education Committee Meeting, DNALC
February 6 Site visit by David Widmer, Long Island Radio Group, Farmingdale, New York
February 6 Site visit by Lorraine Aycock and Monica Cavallo, Bank of America, Melville, New York
February 7 Site visit by Katherine Charleston Colgate, Callisto Pharmaceuticals, New York
February 7–8 BEN Collaborators Meeting, AAAS Headquarters, Washington, D.C.
February 9 Saturday DNA!, “Superbugs Uncovered” and “Immuno Exploration,” DNALC
February 11 Site visit by G2C Online Fellow Laura Maitland, AP psychology Consultant
February 19 Site visit by G2C Online Fellow Laura Maitland, AP psychology Consultant
February 21 Site visit by G2C Online Fellow Caren Gough, Education Consultant
February 27 Human DNA Fingerprinting Laboratory, members of DNALC Corporate Advisory Board, DNALC
March 5 Science Fair at John S. Roberts Educational Complex, East Harlem, New York
March 5 PBS filming of DNALC instructors for documentary, WLIW Teaching and Learning Celebration, Harlem DNA
Lab, East Harlem, New York
March 5 Site visit by Marilyn Simons and staff, Simons Foundation, New York
March 6 Site visit by Gail Bennington, Garden City Science Curriculum Coordinator; Adele Cacotti, AP Teacher, Garden City
High School; Steve Gordon, Science Research Teacher; and 25 Singaporean science research students
March 7 Meeting with Bill Fair and Connie Hildesley, Alexandria Real Estate Equities, New York
March 7–8 WNYC and WLIW Teaching and Learning Celebration, New York 
March 11 Meeting with Phillip Griffiths, Carnegie Corporation of New York and Institute for Advanced Study Commis-
sion on Math and Science Education, New York
March 12–13 Hewlett Foundation Grantee Meeting, Carnegie Mellon University, Pittsburg, Pennsylvania
March 13 New York Department of Education Science Leadership Team Meeting, CUNY, New York
March 15 Saturday DNA!, “Living in the Gene Age: Chronicles & Frontiers” and “Gram-tastic!,” DNALC
March 19 Presentation for Science Supervisors’ Association of New York City, American Museum of Natural History,
New York
March 19 Meeting with Richard Kahan, Urban Assembly, and Mort Slater, Gateway Institute for Higher Education, New York
March 19 Meeting with Jose Maldonado and Sam Silverstein, Columbia Secondary School for Math, Science, and
Engineering, New York
March 19 Site visit by Babylon High School science faculty
March 21 Site visit by G2C Online Fellow Caren Gough, Education Consultant
March 21 Site visit by Bob Wheeler, Pine Creek High School, Colorado Springs, Colorado, and Brenda Dempsey, Cas-
tle View High School, Castle Rock, Colorado
March 21–22 NSF Plant Molecular Genetics and Genomics Follow-up Workshop, Florida Agricultural & Mechanical Univer-
sity, Tallahassee, Florida
March 25 Westbury school district teacher training, DNALC
March 26 Site visit by Alister Jones and Bronwen Cowie, School of Education, University of Waikato, New Zealand 
March 27 Open House, Harlem DNA Lab, East Harlem, New York
March 27–29 National Science Teachers Association Workshops, Boston, Massachusetts
April 7–9 NSF iPlant Collaborative interviews at the iPlant Inaugural Conference: Bringing Plant and Computing Scien-
tists Together to Solve Grand Challenges, CSHL
April 7–June 13 Internship by Amy Niselle, graduate student, Melbourne, Australia, DNA Interactive and G2C Online, DNALC
April 11 NIH Inside Cancer Workshop, Biolink Southwest Regional Meeting, Albuquerque, New Mexico
April 12 Saturday DNA!, “The Mystery of Anastasia Romanov” and “Inside Cancer,” DNALC
April 12 Science Council of New York City Conference, Stuyvesant High School, Brooklyn, New York
April 15 Open House, Harlem DNA Lab, East Harlem, New York
April 14–16 Westbury school district teacher training, Westbury, New York
April 17 G2C Online Interview with Josh Dubnau, CSHL
April 18 Site visit by Lucio Pinto, Director, Tronchetti Foundation, Milan, Italy
April 22 Wellcome Trust Sanger Institute review of National Science Learning Center, York, United Kingdom
April 24 Site visit to Wellcome Trust Sanger Institute, Cambridge, United Kingdom
April 25 Site visit by Long Island Pulse magazine science fantasy contest winner, Gloria Schramm
April 29 Great Moments in DNA Science Honors Seminar: “Mutate Me Once, Permit a Tumor; Mutate Me Twice,
Inhibit,” Lloyd Trotman, CSHL
May 1 Site visit by Hisao Izawa, President, Nikon Instruments Worldwide; Lee Shuett, CAB Board Member, Execu-
tive VP Nikon; and Yoichi Kasahara, Planning General Manager, Nikon 
May 8 Site visit by Ann McDermott-Kave, Director, OSI Foundation; Morgan Browne, Chairman, OSI Foundation;
and David Epstein, DNALC CAB member and OSI vice president of oncology
May 8 G2C Online Interview with Josh Dubnau, CSHL
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May 8–9 NSF Dynamic Gene Workshop in Gene Annotation, Harlem DNA Lab, East Harlem, New York
May 10 Saturday DNA!, “Survival of the Fittest” and “A Billion Little Pieces,” DNALC
May 13 Great Moments in DNA Science Honors Seminar: “Protein Demolition: Taking Control by Taking Apart,” Bill
Tansey, CSHL
May 17 Oyster Bay Health and Science Fair, Oyster Bay, New York
May 19–21 NIH SEPA Principal Investigators Meeting, Rockville, Maryland
May 27 Great Moments in DNA Science Honors Seminar: “Genotype to Phenotype: A Closer Look at Plant Genomics,”
by Doreen Ware, CSHL
May 27 Site visit by Amy Sanders, Project Manager, Darwin 200, Wellcome Trust
May 28 Site visit by Vinford Mentar, JP Morgan Chase Global Philanthropy, New York
June 2–6 NSF Silencing Genomes Workshop, Rust College, Holly Springs, Mississippi
June 4 Site visit by Grey Ruegamer, New York Giants football team
June 7 Howard Hughes Medical Institute Fellows Meeting, DNALC 
June 9 Site visit by Kidgie Williams, Hospitality Committee for United Nations Delegations, Inc., and United Nations del-
egates’ family members, New York
June 9–13 Site visit by G2C Online Fellow Caren Gough, Education Consultant
June 11 Site visit by Rut Premsrirut, CSHL, and Michael Rialdy, Indonesia 
June 12 Site visit by G2C Online Fellow Laura Maitland, AP psychology Consultant 
June 12 Site visit by Tom Burrish, Provost, University of Notre Dame; William Doyle, Sr., Director of Development; Tom
Gibbons, Regional Director of Development, New York Metro; and John Passarelli, Notre Dame Alumni and
Board Member, DNALC
June 14 Saturday DNA!, “Cancer: Inside Out” and “Human Evolution and mtDNA,” DNALC
June 17 Fifteenth Annual Golf Tournament, Piping Rock Country Club, Locust Valley, New York
June 20–21 NSF Plant Genetics and Genomics Follow-up Workshop, Langston, Oklahoma
June 26 Site visit by Alfred Goldberg, Professor, Harvard Medical School and former CSHL URP (1961), of the Porter
Foundation
June 27–July 2 American Association of Plant Biologists, Plant Biology 2008, Mérida, Mexico
June 30–July 3 Fun with DNA Workshop, DNALC
Fun with DNA Workshop, DNALC West
Fun with DNA Workshop, Central Islip
World of Enzymes Workshop, DNALC
Plant Genomics Workshop, DNALC
July 1 Site visit by Miriam Cortes-Caminero, Director of Marketing, Laboratory Technologies, Inc., Maple Park, Illinois
July 2–8 G2C Online Interviews with Jeff Lichtman, Harvard University; Ken Kosic, University of California, Santa Barbara;
James Eberwine, University of Pennsylvania; Rusty Lansford, California Institute of Technology; and Pierre
Marie Lledo, Pasteur Institute, Paris, France, CSHL
July 7–11 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Workshop, Harlem DNA Lab
World of Enzymes Workshop, DNALC West
Genomic Biology Workshop, Central Islip
July 11–15 International Congress of Genetics, Berlin, Germany
July 14 G2C Online Interviews with Anil Malhotra, North Shore Long Island Jewish Hospital, and David Skuse, University
College, London, England, CSHL
July 14–18 World of Enzymes Workshop, DNALC
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC West
July 14–August 1 Amgen Leadership Symposium, DNALC
July 15 G2C Online Interview with Sarah Blakemore, University College, London, United Kingdom, CSHL 
July 17 Site visit by Molloy College students, Pat Mason, Group Leader
July 17 Site visit by Coleman Fung, Founder, Open Link Financial Inc., Uniondale, New York
July 17–18 G2C Online Interviews with Allen Moore, University of Exeter, England; Christian Keysers, BCN Neuroimaging
Center, Groningen, The Netherlands; and Larry Young, Emory University, Atlanta, Georgia, CSHL
July 19 G2C Online Interview with Thomas Insel, National Institute of Mental Health, Bethesda, Maryland
July 21–25 Fun with DNA Workshop, DNALC
Human Genomics Workshop, DNALC
DNA Science Workshop, United Way/Project Grad with Westbury Public Schools, Hofstra University, Westbury,
New York
Green Genes Workshop, DNALC West
DNA Science Workshop, Central Islip, New York
July 24 G2C Online Interview with Wayne Drevets, National Institute of Mental Health, Bethesda, Maryland
July 24 G2C Online Interviews with Kay Redfield Jamison and James Potash, Johns Hopkins University, Baltimore,
Maryland
July 25 G2C Online Interviews with Johan Jansma, Richard Coppola, and Wayne Drevets, National Institute of Mental
Health, Bethesda, Maryland
July 28–August 1 Fun with DNA Workshop, DNALC West
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
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August 4–8 Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC West
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC
August 4–8 Site visit by HHMI Fellows Caren Gough, Jerry Watkins, Greg Borman, Dahlia McGregor, Kathleen Rucker,
and Adrienne Rubin for Harlem Professional Development
August 4–8 NSF Silencing Genomes Workshop, Fralin Biotechnology Center, Virginia Tech, Blacksburg, Virginia
August 7 Site visit by Zaven Khachaturian, Ph.D., President and  CEO, and Ara Khachaturian, Ph.D., Chief Program
Officer, Lou Ruvo Brain Institute & Keep Memory Alive, Las Vegas, Nevada
August 7 Site visit by 17 math and science teachers, The New York Center for Teacher Development, Inc.
August 11–15 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
DNA Science Workshop, DNALC West
Excelsior Scholars Workshop, Harlem DNA Lab
August 13–15 NSF Course, Curriculum, and Laboratory Improvement Program, Principal Investigators Conference, Wash-
ington, D.C.
August 15 G2C Online Presentation, American Psychological Association, Boston, Massachusetts
August 18–22 Fun with DNA Workshop, DNALC
Genetic Horizons workshop, DNALC
DNA Science Workshop, DNALC
Human Genomics Workshop, DNALC West
Excelsior Scholars Workshop, Harlem DNA Lab
August 18–22 NSF Silencing Genomes Workshop, Biolink Texas (Austin Community College), Austin, Texas
August 22 Site visit by Taiwan Delegation: Fuh-Sheng Shieu, Huann-Shyang Lin, Sue-Joan Chang, Horn-Jiunn Sheen,
Ching-Yang Chou, Yu-Chie Wang, Tzong-Ming Wu, Sung-Tao Li, Ching-Mei Tang, Yen-Hung Pan, and
Ching-Jiun Lee
August 25–29 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
Genetic Horizons Workshop, DNALC West
DNA Science Workshop, DNALC
DNA Science Workshop, Harlem DNA Lab
August 26 Site visit by Adele Smithers-Fornaci, President, The Christopher D. Smithers Foundation, Inc., Mill Neck, New York
August 29 Site visit by Richard Gelfond, President of IMAX; Pamela Gelfond, Yale graduate; and Claudia Gelfond, Dalton
School graduate
August 29 Site visit by William Mak, Hong Kong Biotechnology Education Resource Center, Hong Kong University
September 4–5 NSF Review, Research Coordination Network, Arlington, Virginia
September 14–15 Site visit to Genome Sequencing Center, Washington University, St. Louis, Missouri
September 17–18 Site visit by Martha Narro and Lisa Howells, NSF iPlant Collaborative
September 18–19 G2C Online Workshop, Stowers Institute for Medical Research, Kansas City, Missouri
September 20 NIH Inside Cancer Workshop, Stowers Institute for Medical Research, Kansas City, Missouri
September 23 Dedication of Harlem DNA Lab, East Harlem, New York
September 24 G2C Online Interviews with Ellen Leibenluft, Danny Pine, Judy Rapaport, and Phil Shaw, National Institute of
Mental Health, Bethesda, Maryland
September 25 Site visit and presentation of grant award by Lorraine Aycock, Vice President, Market Development Manager,
and Monica Cavallo, Market Development Specialist, Bank of America of LI 
September 25 Presentation of Harlem DNA Lab programs, NYC Department of Education’s Citywide Science Leadership
Team, Wave Hill, Bronx, New York
September 26 Site visit by G2C Online Teaching Fellow Bob Keltos
September 27 HHMI Professional Development Program for NYC DOE Teachers, seminar on “DNA Structure and Isolation,”
Harlem DNA Lab, East Harlem, New York
September 30– NSF iPlant Collaborative Grand Challenge Workshops Mechanistic Basis of Plant Adaptation and Impact of 
October 3 Climate Change on Plant Productivity Biosphere 2, University of Arizona, Tucson
October 3–4 G2C Online Workshop, DNALC
October 4 HHMI Professional Development seminar “Transformation and Protein Isolation,” Harlem DNA Lab, East
Harlem, New York
October 8 Cold Spring Harbor High School Partnership Program commences
October 9 Public School meeting, McMain Secondary School, New Orleans, Louisiana
October 10–11 G2C Online Fellows Meeting, DNALC 
October 14 HHMI Professional Development seminar, “Transformation and Protein Isolation,” Harlem DNA Lab, East
Harlem, New York
October 15 NIH Inside Cancer Workshop, National Association of Biology Teachers Professional Development Confer-
ence, Memphis, Tennessee
October 16 Site visit by Piero Beneditti and 18 students, Natural Science Museum, Sardinia, Italy
October 16 G2C Online Presentation, National Association of Biology Teachers Professional Development Conference,
Memphis, Tennessee
October 18 NIH Inside Cancer Workshop, Midland College, Midland, Texas
October 24 Site visit and tour for Dorota Koczewska, Director of Mathematics and Science, District 75/Citywide Program,
New York
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October 25 HHMI Professional Development Seminar, “DNA Analysis and Forensics,” Harlem DNA Lab, East Harlem, New York
October 25 Saturday DNA!, “How to Solve a Crime,” DNALC
October 29 NY1 Interview by health reporter Kafi Drexel of Emily Carey School of students visiting Harlem DNA Lab, East
Harlem, New York
October 31– G2C Online Workshop, Fred Hutchinson Cancer Research Center, Seattle, Washington
November 1
November 1 Dedication of The Laurie J. Landeau Multimedia Studio and DNALC 20th Anniversary Celebration, DNALC 
November 2 NIH Inside Cancer Workshop, Fred Hutchinson Cancer Research Center, Seattle, Washington
November 4 HHMI Professional Development Seminar, “Using Genetics to Engage and Accelerate Student Learners,”
Harlem DNA Lab, East Harlem, New York
November 6 Site visit by Caren Gough, Teaching Fellow, G2C Online
November 7 NIH Inside Cancer Workshop, Kimmel Cancer Center, Philadelphia, Pennsylvania
November 7–8 Forensic DNA Workshop, for Biology Teachers of New Jersey, NABT, DNALC
November 7–10 NSF iPlant Collaborative Grand Challenge Workshop, Developing Common Mechanistic Models for the Plant
Sciences, Biosphere 2, University of Arizona, Tucson
November 8 HHMI Professional Development Seminar, “Variability & Inheritance,” Harlem DNA Lab, East Harlem, New
York
November 10 HHMI Professional Development Seminar, “DNA Analysis & Forensics,” Harlem DNA Lab, East Harlem, New
York
November 14 HHMI Professional Development Seminar, “PCR and Human DNA Variations, Part One,” Harlem DNA Lab,
East Harlem, New York
November 14–15 G2C Online Workshop, St. Louis Science Center, St. Louis, Missouri
November 15 Saturday DNA!, “GMO IQ,” DNALC
November 16–18 G2C Online Interviews with Rene Anand, Ohio University; Brian Bacskai, Harvard University; Randy Blakely,
Vanderbilt University; Kalanit Grill-Spector, Stanford University; Todd Sacktor, State University of New
York Downstate Medical Center, Brooklyn; Donna Wilcock, Duke University; Abraham Zangen, Weis-
mann Institute of Science, Israel; Tallie Z. Baram and Nicole Gage, University of California, Irvine; John J.
Mann, Columbia University; Lisa Monteggia, University of Texas Southwestern Medical Center; Dennis
Selkoe, Harvard University; Gul Dolen, Massachusetts Institute of Technology; Helen Myberg, Emory
University; Bruce McEwen, The Rockefeller University; and Simona Spinelli, National Institute of Health,
at The Society for Neuroscience Annual Meeting, Washington, D.C.
November 19–23 NSF iPlant Collaborative Grand Challenge Workshop, Assembling the Tree of Life to Enable the Plant Sci-
ences, Biosphere 2, University of Arizona, Tucson
November 20 G2C Online Presentation, National Science Teachers Association Meeting, Portland, Oregon
November 22 HHMI Professional Development Seminar, “PCR and Human DNA Variations, Part One,” Harlem DNA Lab,
East Harlem, New York
November 24 Team Temasel, Singapore, hosted by Briarcliff Manor High School, Harlem DNA Lab, East Harlem, New York
November 30– Singapore Primary Teachers Attachment, DNALC
December 13
December 1 G2C Online Advisory Panel Meeting, DNALC
December 4 G2C Online Presentation, National Science Teachers Association Meeting, Cincinnati, Ohio
December 4 Site visit by Andrew Tasker, Champalimaud Foundation, Lisbon, Portugal
December 6 HHMI Professional Development Seminar, “Transformation and Protein Isolation,” Harlem DNA Lab, East
Harlem, New York
December 8 HHMI Professional Development Seminar, “PCR and Human DNA Variations, Part Two,” Harlem DNA Lab,
East Harlem, New York
December 8 Site visit by Belgian Delegation: Geert Schelstraete, Jo Decuyper, Sofie Stoop, Jo De Wachter, Imke
Debecker, Ann Van Gysel, and Jan Wauters
December 8 Cold Spring Harbor High School Partnership Program Student Debate, DNALC
December 10 Northern Manhattan Coalition for Math and Science, Harlem DNA Lab, East Harlem, New York
December 12 HHMI Professional Development Seminar, “Engaging Level One and Level Two Student Learners,” Harlem
DNA Lab, East Harlem, New York
December 13 Saturday DNA!, “Dig This,” DNALC
December 15–17 NSF iPlant Collaborative Grand Challenge Workshop, Computational Morphodynamics, Biosphere 2, Univer-
sity of Arizona, Tucson
December 15 Site visit by Mike Scanlon, Cornell University, Ithaca, New York
December 18 NYC DOE Science Specialists, Harlem DNA Lab, East Harlem, New York
December 20 HHMI Professional Development Seminar, “DNA Analysis and Forensics,” Harlem DNA Lab, East Harlem, New York
December 30 Site visit by NAACP ACT-SO (Afro-Academic, Cultural, Technological, and Scientific Olympics)
Sites of Major Faculty Workshops 1985–2007
Key: Middle School High School College
ALABAMA University of Alabama, Tuscaloosa 1987–1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
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CALIFORNIA California State University, Fullerton 2000
California Institute of Technology, Pasadena 2007
Canada College, Redwood City 1997
City College of San Francisco 2006
Contra Costa County Office of Education, Pleasant Hill 2002
Foothill College, Los Altos Hills 1997
Harbor-UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute (LA BioMed), Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001, 2008
San Francisco State University 1991
San Jose State University 2005
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994, 2007
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA Armwood Senior High School, Tampa 1991
Florida Agricultural & Mechanical University, Tallahassee 2007–2008
North Miami Beach Senior High School 1991
University of Miami School of Medicine 2000
University of Western Florida, Pensacola 1991
GEORGIA Fernbank Science Center, Atlanta 1989, 2007
Morehouse College, Atlanta 1991, 1996–1997
HAWAII Kamehameha Secondary School, Honolulu 1990
IDAHO University of Idaho, Moscow 1994
ILLINOIS Argonne National Laboratory 1986–1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990–1992
National Center for Biotechnology Information, Bethesda 2002
St. John’s College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Beverly High School 1986
Biogen, Cambridge 2002
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
The Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MINNESOTA University of Minnesota, St. Paul 2005
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990–1991
Rust College, Holly Springs 2006–2008
MISSOURI St. Louis Science Center, St. Louis 2008
Stowers Institute for Medical Research, Kansas City 2002, 2008
Washington University, St. Louis 1989, 1997
NEVADA University of Nevada, Reno 1992
NEW HAMPSHIRE New Hampshire Community Technical College, Portsmouth 1999
St. Paul’s School, Concord 1986–1987
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
NEW MEXICO Biolink Southwest Regional Meeting, Albuquerque 2008
418
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NEW YORK Albany High School 1987
American Museum of Natural History, New York 2007
Bronx High School of Science 1987
Canisius College, Buffalo 2007
Cold Spring Harbor High School 1985, 1987
Columbia University, New York 1993
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
DNA Learning Center 1988–1995, 2001–
2004, 2006–2008
DNA Learning Center 1990, 1992, 1995, 2000
DNA Learning Center 1990–1992
DNA Learning Center West 2005
Fostertown School, Newburgh 1991
Harlem DNA Lab, East Harlem 2008
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
New York City Department of Education 2007
New York Institute of Technology, New York 2006
New York Institute of Technology, New York 2006
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987–1990
Stuyvesant High School, New York 1998–1999
The Rockefeller University, New York 2003
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Saranac Lake 2001
Union College, Schenectady 2004
U.S. Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Centers for Health Research, Research Triangle Park 2003
North Carolina Agricultural & Technical State University, Greensboro 2006–2007
North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
Langston University, Langston 2008
North Westerville High School 1990
OKLAHOMA Oklahoma City Community College 2000
Oklahoma City Community College 2006–2007
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
OREGON Kaiser Permanente Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
Kimmel Cancer Center, Philadelphia 2008
SOUTH CAROLINA Clemson University, Clemson 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TENNESSEE NABT Professional Development Conference, Memphis 2008
TEXAS Austin Community College–Eastview Campus, Austin 2007–2008
Austin Community College–Rio Grande Campus 2000
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Midland College, Midland 2008
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Texas A&M, Agricultural Research and Extension Center, Weslaco 2007
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
Utah Valley State College, Orem 2007
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
419
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Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
Virginia Polytechnic Institute and State University, Blacksburg 2005, 2008
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001, 2008
University of Washington, Seattle 1993, 1998
WASHINGTON, D.C Howard University 1992, 1996
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999
Marquette University, Milwaukee 1986–1987
University of Wisconsin, Madison 1988–1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
AUSTRIA Vienna Open Lab 2007 
CANADA Red River Community College, Winnipeg, Manitoba 1989
GERMANY Urania Science Center, Berlin 2008
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
MEXICO ASPB Plant Biology, Mérida 2008
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001–2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil
Uppsala University, Uppsala 2000
420
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2008 PUBLICATIONS
SERIALS
Genes & Development, Vol. 22, 1–33520 (www.genesdev.org)
Genome Research, Vol. 18, 1–2044 (www.genome.org)
Learning & Memory, Vol. 15, 1–920 (www.learnmem.org)
RNA, Vol. 14, 1–2712 (www.rnajournal.org)
Cold Spring Harbor Symposia on Quantitative Biology, Vol. 72:
Clocks and Rhythms, Bruce Stillman, David Stewart, and
Terri Grodzicker (eds.) 
Cold Spring Harbor Protocols (www.cshprotocols.org)
LABORATORY MANUALS
Basic Methods in Protein Purification and Analysis, edited by
Richard J. Simpson, Peter D. Adams, and Erica A. Golemis
Emerging Model Organisms: A Laboratory Manual, Volume 1
Proteomics: A Cold Spring Harbor Laboratory Course Manual,
Andrew J. Link, Philip Andrews, and Joshua LaBaer
Transcriptional Regulation in Eukaryotes: Concepts, Strategies,
and Techniques, Second Edition, Michael Carey, Stephen
Smale, and Craig Peterson
HANDBOOKS
C. elegans Atlas, David H. Hall and Zeynep F. Altun
A Short Guide to the Human Genome, Stewart Scherer
TEXTBOOKS
Essentials of Glycobiology, Second Edition, edited by Ajit Varki,
Richard Cummings, Jeffrey Esko, Hudson Freeze, Pamela
Stanley, Carolyn Bertozzi, Gerald Hart, and Marilynn Etzler
SCIENCE AND SOCIETY
Concerning the Origins of Malignant Tumours, Theodor Boveri,
translated and annotated by Sir Henry Harris
Experimental Heart: A Novel, Jennifer Rohn
Davenport’s Dream: 21st Century Reflections on Heredity and
Eugenics, edited by Jan A. Witkowski and John R. Inglis
Grounds for Knowledge: A Guide to Cold Spring Harbor Labo-
ratory’s Landscapes and Buildings, Introducing the Bung-
town Botanical Garden, Elizabeth L. Watson, landscape
photography by Peter Stahl
Life Illuminated: Selected Papers from Cold Spring Harbor, Vol-
ume 2, 1972–1994, edited by Jan Witkowski, Alexander
Gann, and Joseph Sambrook
My Heart vs. the Real World: Children with Heart Disease, In
Photographs & Interviews, Max Gerber
Neither Gods Nor Beasts: How Science Is Changing Who We
Think We Are, Elof A. Carlson
The Strongest Boy in the World: How Genetic Information Is
Reshaping Our Lives, Updated and Expanded, Philip R.
Reilly
OTHER
CSHL Annual Report 2007: Yearbook Edition
CSHL Annual Report 2007
Banbury Center Annual Report 2007
Watson School of Biological Sciences Annual Report 2007
WEBSITES
www.cshteaching.org (formerly www.genesandsignals.org)
http://www.evolution-textbook.org
http://www.cshl.symposium.org; Symposia, Vol. 72 added to
online Symposia website
A selection of recently published books The journal publishing program
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COLD SPRING HARBOR LABORATORY PRESS
EXECUTIVE DIRECTOR’S REPORT
In 2008, despite challenging industry conditions, Cold Spring Harbor Laboratory Press generated an oper-
ating excess of $597,000 on revenues of $11 million. The Press’ total financial contribution to the Labora-
tory for the year was more than $1.2 million. The Press also continued to fulfill its mission of publishing print
and electronic media of exceptional quality and value to the scientific community.
Journals and Online Publications
Revenue from our journals publishing program was more than 11% higher than in 2007. New institutional
journal subscriptions were gained despite a tightening market, and in the case of CSH Protocols, our newest
journal, the total institutional subscription base more than doubled. International consortia sales increased,
via agreements for representation in Latin America, Australia, and New Zealand. Subscription trials and nego-
tiations with consortia are currently in progress in Brazil, India, and Germany. Recently developed databases
of global journal subscription records are being used to examine our journals’ potential for further growth.
Impact factor analysis continues to rank our journals Genes & Development and Genome Research at
the top of their disciplines. Genome Research reached a new high of 11,224. In 2008, both these journals,
as well as RNA and Learning & Memory, received more offers of manuscripts to publish than in any previ-
ous year, placing a premium on the careful editorial selection of papers for publication. New tools are being
used to analyze the metrics of journal value, such as the impact and the Eigen factors, that are influenced
by the usage of individual papers and article types.
Regular press releases ensured that print, online, and broadcast media attention was drawn to research
findings of broad public interest published in Genes & Development and Genome Research.
A major upgrade of the online editions of our journals was completed in October. Hosted on Stanford Uni-
versity’s new “H2O” platform, CSHL Press journals are now able to interact with other online systems and
to be extended with emerging web services and technologies. One publication that has been transformed
by this upgrade is the online edition of the Annual Symposia on Quantitative Biology, which was relaunched
in a new, improved website that combines the proceedings of the meetings as published papers with author
interviews, photographs, and video sequences. The
print volume will continue to be published. A complete
electronic archive of the first 70 symposia (1933–
2004), including many classic volumes now rarely
available in print, was released in November 2008. Ini-
tial sales were strong and reached more than $45,000
in the first three months. 
Development of the new journal CSH Perspectives
continued, with a launch set for July 2009. This new
online-only publication will offer rapid access to col-
lections of articles commissioned around single top-
ics of broad scientific interest, with print publications
following as topic-specific collections are completed. 
A rebranding of the CSHL Press website is under-
way to promote the theme “Support Research and
Save.” Text and graphics will highlight discount prices
available to our web customers and detail how a por-
tion of each purchase contributes to the Lab’s
research and scientific activities. 
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Our website continues to add new features, including a Google book search tool that allows full-text
searching within most of our book titles. Search results provide limited page views along with links to web-
based information related to the book, such as citations, news articles, reviews, and blogs. Improvements
to the Press website also included the addition of new shopping cart logic to enable more effective price pro-
motions via our sale section, monthly newsletter, and special campaigns.
Initial evaluation of an additional solution for online publishing, with much lower costs, has shown poten-
tial and will be implemented in 2009, initially to bring to market a 50-volume archive of the classic Cold Spring
Harbor Monograph series, begun in 1972. The goal of this effort is to provide the Press with the capability
of publishing new online books and unique electronic media products with lower risk and better return on
the investment per title.
Books
Sixteen new books were published this year, consisting of laboratory manuals, handbooks, monographs,
and history/biographies. The list was generally strong but A Short Guide to the Human Genome, by
Stewart Scherer, constructed as a question-and-answer dialogue, was particularly well received. As a new
initiative in engaging the public with science, the Press published a novel entitled Experimental Heart by
Jennifer Rohn that portrayed science and scientists in such a real and therefore unusual way in fiction,
that the book was warmly reviewed in major scientific journals. 
We are also pleased to publish Elizabeth Watson’s beautifully designed
and illustrated guide to the landscape of the Laboratory, Grounds for
Knowledge.
Evolution, the textbook published in June 2007, continued to gain class
adoptions in America, Australia, Africa, and Europe, as well as excellent
feedback from professors. The companion website is now a rich bank of
ancillary material and additional chapters. 
During the year, a marketplace for electronic books in science finally
emerged, aided by the new Kindle publishing platform that allows content
to be read on the platform’s dedicated reader or other devices, notably
the iPhone. The first five Cold Spring Harbor titles are now available as Kin-
dle editions. 
A total of 21 new book publishing contracts were signed in 2008, with a particular focus on techniques
and topic collections that will be published both in print and on the web. The other commissioning focus,
laboratory handbooks, will be delivered as both print and downloadable electronic editions.
Collaboration with international publishers and book distributors augments the reach of our books. In
2008, the Press appointed an agent with exclusive rights to distribute our titles in India and the Indian sub-
continent, as well as a sales representative in Asia. Seven agreements were made for translation of the
Press’ titles into Chinese, German, Greek, Korean, and Japanese. 
An Anniversary
Although the first book from Cold Spring Harbor appeared in 1934—the product of Reginald Harris’
desire to extend the audience for the proceedings of the first Symposium in Quantitative Biology—a
Press with the Laboratory’s name was formally established only in 1988. The 20th anniversary year was
a chance to reflect with some pleasure on the creation of prestigious journals and some of the most
widely used books in the life sciences, during a period of unprecedented change in how scientific infor-
mation is created, delivered, and consumed. Neither a university press nor the product of a scientific
society, Cold Spring Harbor’s publishing program is unique, and the prestige of its books, journals, and
online media contribute immeasurably to the Laboratory’s reputation in the world of science. Support and
encouragement from the Laboratory’s leadership has been vital during the past decade of change and
continues to be needed as we navigate the opportunities ahead. 
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Liz Watson at a recent book signing for
Grounds for Knowledge
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Staff
The accomplishments of any publishing organization are determined by the skill and professionalism of
those who do its work. The Press is fortunate to have staff with both qualities in abundance—and receives
numerous testimonials to that fact from authors and editors. 
In 2008 we welcomed new colleagues Ann Boyle as an editor-at-large and Richard Sever as a com-
missioning editor.
A complete list of staff members of the Press as of December 2008 is printed elsewhere in this vol-
ume. I wish to thank them all for their many and varied contributions to our enterprise, with particular grat-
itude to colleagues who have managerial or supervisory responsibilities: Jan Argentine, Alex Gann, Terri
Grodzicker, Bill Keen, Wayne Manos, Marcie Siconolfi, Hillary Sussman, Linda Sussman, and Denise
Weiss. I am also grateful to Christina Lo, who has not only improved the efficiency of the Publisher’s
Office but has also brought her legal training most effectively to the tasks of contracts and foreign rights
management.
John R. Inglis
Executive Director
and Publisher
425
U.S. Embassy Cultural Affairs Officer Karen Grissette (left) donating science textbooks to Professor Paul
Gwakisa of Sokoine University of Agriculture, Tanzania, Africa. Cold Spring Harbor titles were prominent
among the books, which were provided via the American Society for Cell Biology to the Genomic Institute
Libraries, Veterinary School, and professors at the university. (Photo courtesy of the American Embassy.)
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2008
(with comparative financial information as of December 31, 2007)
2008 2007
Assets:
Cash and cash equivalents $   52,226,592 25,576,470 
Accounts receivable 2,391,572 2,669,325 
Grants receivable 8,597,399 9,037,130 
Contributions receivable, net 104,681,657 67,093,000 
Publications inventory 3,925,967 4,033,100 
Prepaid expenses and other assets 3,599,196 4,049,972 
Investments 213,424,159 333,635,052 
Investment in employee residences 4,237,194 5,446,047 
Restricted use assets 20,947,929 3,991,338 
Deposits with bond trustee 11,886,744 29,483,468 
Land, buildings and equipment, net 198,684,203 159,204,452 
Total assets $ 624,602,612 644,219,354 
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $   50,563,503 19,998,678 
Deferred revenue 3,962,000 4,003,091 
Bonds payable 97,200,000 97,200,000 
Total liabilities 151,725,503 121,201,769 
Net assets:
Unrestricted 126,126,561 219,853,852 
Temporarily restricted 179,988,153 119,623,060 
Permanently restricted 166,762,395 183,540,673 
Total net assets 472,877,109 523,017,585 
Total liabilities and net assets $ 624,602,612 644,219,354 
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2008
(with summarized financial information for the year ended December 31, 2007)
Temporarily Permanently 2008 2007
Unrestricted Restricted Restricted Total Total
Revenue and other support:
Public support—contributions and  
non-Federal grant awards $    18,753,007 71,018,809 12,906,256 102,678,072 71,633,188 
Federal grant awards 27,728,155 – – 27,728,155 30,887,232 
Indirect cost allowances 22,079,594 – – 22,079,594 19,634,082 
Investment return utilized 16,956,184 – – 16,956,184 18,299,207 
Program fees 4,634,167 – – 4,634,167 4,103,754 
Publications sales 10,998,768 – – 10,998,768 10,404,661 
Dining services 4,074,984 – – 4,074,984 3,640,595 
Rooms and apartments 3,088,435 – – 3,088,435 2,804,675 
Royalty and licensing fees 1,250,028 – – 1,250,028 1,092,311 
Miscellaneous 1,049,986 – – 1,049,986 910,490 
Net assets released from restrictions 30,575,759 (30,575,759) – – –
Total revenue and other support 141,189,067 40,443,050 12,906,256 194,538,373 163,410,195 
Expenses:
Research 69,062,315 – – 69,062,315 65,315,923 
Educational programs 15,259,681 – – 15,259,681 12,017,459 
Publications 10,764,090 – – 10,764,090 10,241,091 
Banbury Center conferences 1,309,337 – – 1,309,337 1,342,587 
Dolan DNA Learning Center programs 1,476,222 – – 1,476,222 1,413,157 
Watson School of Biological 
Sciences programs 3,138,774 – – 3,138,774 3,206,295 
General and administrative 14,545,349 – – 14,545,349 13,111,199 
Dining services 5,345,228 – – 5,345,228 5,109,292 
Total expenses 120,900,996 – – 120,900,996 111,757,003 
Excess of revenue and other support
over expenses 20,288,071 40,443,050 12,906,256 73,637,377 51,653,192 
Other changes in net assets:
Investment (loss)/return including 
amount utilized (59,296,552) (4,308,727) (29,684,534) (93,289,813) 8,259,753 
Change in fair value of interest-
rate swap (29,526,602) – – (29,526,602) (3,076,548)
Write-off of terminated bond 
insurance (961,438) – – (961,438) –
Change in net asset classification
based on change in law (24,230,770) 24,230,770 – – –
(Decrease) increase in net assets (93,727,291) 60,365,093 (16,778,278) (50,140,476) 56,836,397 
Net assets at beginning of year 219,853,852 119,623,060 183,540,673 523,017,585 466,181,188 
Net assets at end of year $  126,126,561 179,988,153 166,762,395 472,877,109 523,017,585 
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CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2008
(with comparative financial information for the year ended December 31, 2007)
2008 2007
Cash flows from operating activities:
(Decrease) increase in net assets $  (50,140,476) 56,836,397
Adjustments to reconcile increase in net assets
to net cash provided by operating activities:
Change in fair value of interest-rate swap 29,526,602 3,076,548
Depreciation and amortization 7,056,947 6,397,045
Net depreciation (appreciation) in fair value of investments 83,339,569 (17,332,229)
Contributions restricted for long-term investment (28,230,901) (9,760,257)
Changes in assets and liabilities:
Decrease in accounts receivable 277,753 325,682
Decrease (increase) in grants receivable 439,731 (1,177,750)
Increase in contributions receivable (30,956,223) (26,406,799)
Decrease (increase) in publications inventory 107,133 (201,657)
Increase in prepaid expenses and other assets (9,961) (329,586)
Decrease (increase) in restricted use assets 423,656 (392,593)
Increase (decrease) in accounts payable and accrued expenses 4,152,607 (560,202)
(Decrease) increase in deferred revenue (41,091) 417,178
Net cash provided by operating activities 15,945,346 10,891,777
Cash flows from investing activities:
Capital expenditures (46,536,698) (34,659,089)
Proceeds from sales and maturities of investments 159,193,212 84,438,846
Purchases of investments (122,321,888) (92,610,279)
Net change in investment in employee residences 1,208,853 88,191
Net cash used in investing activities (8,456,521) (42,742,331)
Cash flows from financing activities:
Permanently restricted contributions 12,906,256 6,786,787
Contributions restricted for investment in land, buildings
and equipment 15,324,645 2,973,470
(Increase) decrease in contributions receivable (6,632,434) 2,540,317
Decrease in deposits with bond trustee 17,596,724 16,531,481
(Decrease) increase in accounts payable relating to capital
expenditures (3,114,384) 5,069,642
Deposits with swap counterparty (17,380,247) –
Payment of conversion costs on bonds payable (500,701) –
Write-off of terminated bond insurance 961,438 –
Repayment of notes payable – (38,087)
Net cash provided by financing activities 19,161,297 33,863,610
Net increase in cash and cash equivalents 26,650,123 2,013,056
Cash and cash equivalents at beginning of year 25,576,470 23,563,414
Cash and cash equivalents at end of year $   52,226,593 25,576,470
Supplemental disclosures: Interest paid $     4,153,373 3,812,914
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GRANTS January 1–December 31, 2008
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2008 Funding†
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Project Support Drs. Hannon/Krainer/Lowe/ 01/01/07 12/31/11 $  4,539,728 
Stillman/Tansey
Dr. Stillman/CSHL Cancer Center Core 08/15/05 07/31/10 4,126,879 
Drs. Lowe/Hannon/S. Muthuswamy 04/01/04 03/31/09 913,567 
Dr. Huang 09/08/06 08/31/11 699,657 
Merit Award Support Dr. Tonks 08/01/91 03/31/09 668,025 
Research Support Dr. Dubnau 09/15/04 06/30/09 346,786 
Dr. Enikolopov 07/01/07 06/30/09 189,000 
Dr. Hannon 09/01/05 08/31/09 330,161 
Dr. Huang 07/15/05 04/30/09 371,658 
Dr. Joshua-Tor 07/01/07 06/30/12 412,020 
Dr. Joshua-Tor 07/01/05 06/30/09 282,059 
Dr. Joshua-Tor 02/01/06 01/31/10 308,597 
Dr. Koulakov 02/01/08 01/31/12 420,000 * 
Dr. Krainer 09/21/07 08/31/11 643,281 
Dr. Lowe 07/01/99 07/31/09 409,452 
Dr. Martienssen 08/01/07 07/31/11 412,000 
Dr. Mills 12/26/07 11/30/12 347,331 
Dr. Mitra 03/04/05 02/28/09 474,637 
Dr. Mitra 02/01/08 12/31/09 226,800 * 
Dr. Mittal 04/01/04 06/30/08 148,107 
Dr. S. Muthuswamy 03/01/03 08/31/09 240,000 
Drs. Powers/Lowe 12/02/06 11/30/11 463,709 
Dr. Sebat 04/01/07 03/31/10 711,784 
Dr. Sebat 09/30/05 07/31/10 404,440 
Dr. Skowronski 05/01/08 04/30/13 420,000 * 
Dr. D. Spector 04/01/08 03/31/11 642,308 * 
Dr. Stein 05/04/07 05/31/08 204,297 
Dr. Stein 09/25/06 06/30/09 400,072 
Dr. Stein 04/01/07 02/28/11 965,953 
Dr. Stenlund 02/01/08 01/31/12 244,999 * 
Dr. Stillman 06/01/08 05/31/12 602,420 * 
Dr. Svoboda 03/01/04 02/28/09 325,452 
Dr. Svoboda 12/04/98 11/20/09 59,466 
Dr. Tansey 05/01/07 04/30/11 378,049 
Dr. Tonks 07/01/05 06/30/09 369,649 
Dr. Tonks 07/21/06 05/31/10 289,553 
FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the federal government and through grants, capi-
tal gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2008.
* New grants awarded in 2008
† Includes direct and indirect costs
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Dr. Van Aelst 07/01/08 03/31/13 378,000 * 
Dr. Van Aelst 05/01/03 04/30/09 42,000 
Dr. Zador 09/18/08 07/31/13 357,000 * 
Dr. Zhang 05/01/08 02/28/11 700,000 * 
Dr. Zhang 08/13/07 07/31/11 319,200 
Research Subcontracts
NIH/Affymetrix, Inc. Dr. Gingeras 07/01/08 12/31/08 89,694 *
Consortium Agreement
NIH/Affymetrix, Inc. Dr. Hannon 09/27/07 12/31/08 538,398  
Consortium Agreement
NIH/Affymetrix, Inc. Dr. Gingeras 07/01/08 12/31/08 159,029 * 
Consortium Agreement
NIH/Brookhaven National Dr. Stillman 09/01/06 08/31/11 37,724 
Laboratory Consortium Agreement
NIH/Columbia University Dr. Lowe 08/18/06 07/31/11 396,086 
Consortium Agreement
NIH/Columbia University Dr. Wigler 09/01/06 05/31/10 286,067 
Consortium Agreement
NIH/Georgia Institute of Technology Dr. D. Spector 09/30/06 09/29/11 252,000 
Consortium Agreement
NIH/Ludwig Institute for Cancer Dr. Zhang 09/29/08 06/30/13 227,641 *
Research Consortium Agreement 
NIH/Memorial Sloan-Kettering Dr. Hannon 05/04/07 06/05/08 21,123 
Consortium Agreement
NIH/Memorial Sloan-Kettering Dr. Mittal 04/01/04 03/31/09 34,718 
Consortium Agreement
NIH/Oxford University Consortium Dr. Stein 03/01/06 02/28/11 155,862 
Agreement 
NIH/Rutgers University Consortium Dr. Mitra 12/08/04 11/30/09 147,668 
Agreement
NIH/University of Colorado Dr. Hannon 06/15/08 05/31/10 50,400 * 
Consortium Agreement
Fellowship Support Dr. Aravin 05/01/08 04/30/09 97,200 * 
Dr. Chicas 04/01/06 03/31/09 53,992 
Dr. Demas 02/16/07 02/15/10 23,475 
Dr. Slotkin 09/15/06 09/14/09 48,796 
Dr. Yang 03/01/06 02/28/09 53,992 
Graduate Training Support Dr. Joshua-Tor, Watson School of 07/01/02 06/30/12 205,229 
Biological Sciences
Course Support Advanced Techniques in Molecular 07/01/01 06/30/12 88,001 
Neuroscience
C. elegans 08/01/98 08/31/11 78,345 
Cell and Developmental Biology of 04/01/93 03/31/09 21,880 
Xenopus
Cellular Biology of Addiction 07/01/05 06/30/09 59,087 
Computational and Comparative 06/06/91 07/31/13 47,397 
Genomics
Eukaryotic Gene Expression 01/01/83 03/31/11 114,832 
Imaging Structure and Function in the 07/01/01 06/30/12 74,656
Nervous System 
Immunocytochemistry, In Situ 07/01/98 08/31/10 64,547 
Hybridization, and Live Cell Imaging
Integrated Data Analysis for High- 09/01/07 04/30/12 73,941 
throughput Biology
* New grants awarded in 2008
† Includes direct and indirect costs
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Molecular Embryology of the Mouse 01/01/83 03/31/11 93,481 
Neurobiology of Drosophila 07/01/01 06/30/12 60,605 
Programming for Biology 07/01/07 08/31/09 56,823 
Protein Purification and Characterization 01/01/83 03/31/11 80,564 
Proteomics 07/01/03 06/30/11 76,096 
X-ray Methods in Structural Biology 07/01/07 06/30/12 72,051 
Yeast Genetics and Genomics 07/01/07 05/31/10 48,925 
Meeting Support Axon Guidance, Synaptogenesis, and 04/01/08 03/31/09 15,000 * 
Neural Plasticity
The Biology of Genomes 04/01/08 03/31/13 36,000 * 
The Cell Cycle 03/01/06 02/28/11 4,000 
Gene Expression and Signaling in the 04/01/08 03/31/13 10,000 *
Immune System 
Germ Cells 07/01/08 06/30/13 6,000 * 
Mechanisms and Models of Cancer 08/01/08 07/31/13 6,000 * 
Molecular Chaperones and Stress 04/01/04 03/31/09 13,000 
Responses
Molecular Genetics of Aging 03/01/08 02/28/13 29,155 * 
Mouse Molecular Genetics 09/01/08 08/31/09 6,000 * 
Pharmacogenomics 08/01/04 07/31/09 21,029 
PTEN Pathways and Targets 03/01/06 02/28/11 7,000 
73rd Symposium: Control and 05/01/08 04/30/09 11,500 *
Regulation of Stem Cells 
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Hannon 09/01/06 08/31/08 400,000 
Dr. Jackson 07/01/05 06/30/10 1,033,001 
Dr. Ware 10/01/07 09/30/11 1,927,925 
Research Support Dr. Jackson 04/01/07 03/31/10 145,000 
Dr. Timmermans 09/01/06 08/31/09 140,000 
Dr. Timmermans 09/01/06 08/31/09 156,874 
Dr. Ware 06/15/08 05/31/11 262,382 * 
Dr. Zador 10/01/07 09/30/09 10,750 
Research Subcontracts
NSF/Cornell University Consortium Dr. Timmermans 09/01/08 08/31/12 514,843 *
Agreement 
NSF/New York University Consortium Drs. McCombie/Martienssen 10/01/04 09/30/09 258,759
Agreement 
NSF/North Carolina State University Drs. Martienssen/Vaughn 10/01/04 09/30/09 370,594 
Consortium Agreement
NSF/University of Arizona Consortium Drs. Stein/Ware/Martienssen/Micklos/ 02/01/08 01/31/13 1,107,559 *
Agreement Vaughn 
NSF/University of California, Berkeley, Dr. Jackson 08/01/06 07/31/11 215,394 
Consortium Agreement
NSF/University of California, Davis, Dr. Martienssen 09/01/06 08/31/10 263,712 
Consortium Agreement
NSF/University of California, Davis, Dr. Ware 09/01/08 08/31/11 103,570 *
Consortium Agreement* 
NSF/University of Florida Consortium Dr. Martienssen 08/01/07 07/31/09 102,010 
Agreement 
NSF/University of Wisconsin Drs. Stein/Ware 01/01/04 12/31/08 220,892 
Consortium Agreement
NSF/Washington University Drs. McCombie/Martienssen/Stein/Ware 11/15/05 10/31/09 782,667 
Consortium Agreement
* New grants awarded in 20088
† Includes direct and indirect costs
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Fellowship Support C. Malone 06/01/07 05/31/09 40,500 
Dr. Eveland 10/01/08 09/30/10 60,000 * 
Undergraduate Training Support Dr. Joshua-Tor, Watson School of 04/15/05 03/31/10 60,000 
Biological Sciences
Course Support Advanced Bacterial Genetics 07/15/04 06/30/09 79,398 
Cell and Developmental Biology 05/01/07 04/30/10 20,000 
of Xenopus
Computational Cell Biology 04/15/08 03/31/11 92,165 * 
Molecular Techniques in Plant Science 07/01/07 06/30/10 44,475 
Workshop on Cereal Genomics 11/01/08 10/31/09 47,384 * 
Meeting Support Molecular Genetics of Bacteria and 04/15/08 03/31/09 5,000 * 
Phages
The Plant Epigenome: Frontiers in Gene
Regulation 03/15/08 02/28/09 30,000 * 
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/08 08/31/11 136,195 * 
Dr. McCombie 09/15/04 09/14/09 222,611 
Dr. Stein 09/22/03 09/15/09 22,000 
Dr. Timmermans 09/15/06 09/14/09 137,166 
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 02/01/06 01/31/09 169,500 
Dr. Hannon 02/15/06 02/14/09 169,500 
Dr. Hannon 09/01/08 08/31/13 608,696 * 
Dr. Lazebnik 12/01/06 11/30/09 209,999 
Drs. Lucito/Tonks 08/01/08 07/31/09 504,000 * 
Dr. S. Muthuswamy 06/01/08 05/31/13 642,996 * 
Dr. Powers 07/01/07 06/30/10 168,000 
Research Subcontracts
U.S. Army/New York University Dr. Lucito 09/27/04 09/26/09 31,673 
School of Medicine Consortium
Agreement
Fellowship Support Dr. He 12/15/08 12/14/11 32,400 * 
D. Khalil 12/01/06 11/30/09 33,300 
D. Simpson 09/01/06 08/31/09 32,400 
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
Mrs. Kathryn W. Davis Dr. Hannon 01/01/08 12/31/08 400,000 * 
F.M. Kirby Foundation, Inc. Dr. Osten 12/01/08 11/30/09 100,000 * 
Program Project Support
The Leukemia & Lymphoma Society Dr. Lowe 10/01/08 09/30/13 1,250,000 *
of America 
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lukowitz/Martienssen/ 07/01/07 06/30/12 1,600,000 
Timmermans/Ware
The Simons Foundation/Autism Dr. Wigler 07/01/08 06/30/11 6,175,430 * 
* New grants awarded in 2008
† Includes direct and indirect costs
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The Simons Foundation/Center for Dr. Wigler 09/01/08 08/31/11 1,500,000 * 
Quantitative Biology
Theodore R. and Vada S. Stanley Drs. Watson/McCombie/Sebat 07/01/07 06/30/12 5,000,000 
Research Support
American Cancer Society Dr. Mills 07/01/06 06/30/10 240,000 
American Cancer Society Dr. Wigler 01/01/06 12/31/10 60,000 
American Cancer Society Dr. Wigler 01/01/05 12/31/08 10,000 
Anonymous Gift Dr. Zador 09/01/07 08/31/09 500,000 
Anonymous Gift Dr. Sebat 09/01/07 08/31/09 251,174 
Anonymous Gift Dr. Sebat 04/01/08 03/31/09 1,000 * 
Autism Speaks, Inc. Dr. Zador 07/01/07 06/30/10 150,000 
Mr. Donald E. Axinn Drs. Lowe/Hannon 01/01/08 12/31/08 250,000 * 
Geoffrey Beene Cancer Center/Sloan- Dr. Hicks 08/01/08 07/31/10 45,260 *
Kettering Institute for 
Cancer Research 
The Breast Cancer Research Foundation Dr. Wigler 10/01/08 09/30/09 250,000 * 
The Breast Cancer Research Foundation Dr. Wigler 01/01/08 12/31/08 225,000 * 
Coleman Fung Foundation Inc. Dr. Zador 02/01/07 01/31/10 50,000 
DART Neurogenomics Project Drs. Cline/Dubnau/Tully/Zhong 10/01/04 12/31/08 618,326 
The Shelby Cullom Davis Foundation Dr. Hannon 01/15/07 01/14/11 1,000,000 
Find a Cure Today (F.A.C.T.) Dr. Egeblad 12/01/08 11/30/09 30,000 * 
Families of Spinal Muscular Atrophy Dr. Krainer 03/01/07 02/28/09 98,532 
The Joni Gladowsky Breast Cancer Dr. Egeblad 12/01/08 11/30/09 40,000 * 
Foundation
Irving A. Hansen Memorial Foundation Dr. Tansey 08/01/08 07/31/09 20,000 * 
The Thomas Hartman Foundation Dr. Tonks 07/01/07 06/30/09 179,418 
Jo-Ellen and Ira Hazan Dr. Enikolopov 12/01/08 11/30/09 200,000 * 
Hearts for Cancer Dr. S. Muthuswamy 12/01/07 11/30/09 3,535 
Human Frontier Science Program Dr. Dubnau 10/01/06 09/30/09 125,000 
Isis Pharmaceuticals, Inc. Dr. Krainer 11/01/08 10/31/09 125,000 * 
Joan’s Legacy: The Joan Scarangello Dr. Sordella 12/01/07 11/30/09 50,000 
Foundation to Conquer Lung 
Cancer
Long Islanders Against Breast Cancer Dr. Wigler 2008 2,000 *
(LIABC) 
Roni Kamin-McGuffog and Charles Dr. Furukawa 01/01/08 12/31/08 1,000 *
McGuffog 
V. Kann Rasmussen Foundation Dr. Trotman 09/01/07 08/31/12 50,000 
The Karches Foundation Dr. Wigler 07/01/05 06/30/10 480,131 
W.M. Keck Foundation Dr. Mitra 07/01/06 06/30/09 500,000 
The Charles H. Leach, II Foundation Dr. Enikolopov 06/01/08 05/31/09 5,000 * 
The Long Island 2-Day Walk to Fight Dr. Egeblad 11/01/08 10/31/09 31,500 *
Breast Cancer 
Manhasset Women’s Coalition Against Dr. Egeblad 11/01/08 10/31/09 12,000 *
Breast Cancer 
Carol Marcincuk Fund Dr. Lucito 01/01/08 12/31/08 6,075 * 
The G. Harold and Leila Y. Mathers Dr. Huang 07/01/07 06/30/10 199,916 
Charitable Foundation
The Elizabeth McFarland Breast Cancer Dr. Wigler 12/01/08 11/30/09 52,533 * 
Fund
The Don Monti Memorial Research Dr. Lowe 03/01/08 02/28/09 500,000 *
Foundation 
Louis Morin Charitable Trust Drs. Kepecs/Zador 12/01/08 11/30/09 70,000 * 
Muscular Dystrophy Association, Inc. Dr. Krainer 07/01/07 06/30/10 254,000 
New York State Foundation for Science, Dr. Paddison 03/01/07 02/28/09 76,733 
Technology and Innovation
(NYSTAR)
* New grants awarded in 2008
† Includes direct and indirect costs
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New York State Stem Cell Science Drs. Enikolopov/Timmermans/Van Aelst 04/01/08 03/31/09 380,933 * 
(NYSTEM)
The Pierre and Pamela Omidyar Fund Dr. Powers 01/01/08 12/31/08 250,000 * 
Philips Research North America Drs. Wigler/Lucito 04/01/07 03/31/09 603,178 
Christina Renna Foundation, Inc. Dr. Van Aelst 01/01/08 12/31/08 25,000 * 
Diane Emdin Sachs Memorial Fund Dr. Tansey 05/01/08 04/30/09 26,630 * 
The Simons Foundation Dr. Huang 10/01/07 09/30/10 440,805 
The Simons Foundation Dr. Mills 01/01/07 12/31/09 527,437 
Mary F. Smith Family Foundation Dr. Egeblad 10/01/08 09/30/09 1,000 * 
Starr Cancer Consortium Dr. Hannon 07/01/08 06/30/10 524,071 * 
Starr Cancer Consortium Dr. Krainer 11/01/07 10/31/09 300,000 
Starr Cancer Consortium Dr. Lowe 07/01/08 06/30/10 60,000 * 
Starr Cancer Consortium Drs. Lowe/Hannon 11/01/07 10/31/09 480,000 
Starr Cancer Consortium Dr. McCombie 07/01/08 06/30/09 300,000 * 
Starr Cancer Consortium Drs. Powers/Lucito 11/01/07 10/31/09 378,343 
Starr Cancer Consortium Dr. Van Aelst 11/01/07 10/31/09 240,000 
Starr Cancer Consortium Dr. Wigler 11/01/07 10/31/09 120,000 
Starr Cancer Consortium Dr. Powers 11/01/07 10/31/09 300,000 
Swim Across America Dr. Sordella 11/01/08 10/31/09 50,000 * 
The V Foundation Dr. Powers 11/01/08 10/31/11 200,000 * 
The V Foundation Dr. Trotman 11/01/08 10/31/10 50,000 * 
Waldbaum’s Foundation Dr. Egeblad 09/01/08 08/31/09 10,000 * 
West Islip Breast Cancer Coalition for Dr. Egeblad 11/01/08 10/31/09 10,000 * 
Long Island Inc.
Whitehall Foundation, Inc. Dr. Kepecs 06/01/08 05/31/11 75,000 * 
Women in Science Dr. D. Spector 01/01/08 12/31/08 61,800 * 
Women’s Insurance Network of Long Dr. S. Muthuswamy 06/01/08 05/31/09 16,900 * 
Island
Fellowship Support
The Rita Allen Foundation Dr. Trotman 09/01/07 08/31/10 100,000 
American Association for Cancer W. Xue 09/01/08 08/31/11 30,000 *
Research 
American Cancer Society Dr. Karginov 01/01/07 12/31/09 46,000 
Autism Speaks, Inc. Dr. Xiong 10/01/08 09/30/10 44,000 * 
The Binational Agricultural Research Dr. A. Goldshmidt 10/10/08 10/19/09 37,000 * 
and Development Fund
Arnold and Mabel Beckman Foundation Watson School of Biological Sciences 09/01/05 08/31/10 350,000 
Terri Brodeur Breast Cancer Foundation Dr. Chatterjee 01/01/07 12/31/08 50,000 
Cashin Family Fund Watson School of Biological Sciences 09/01/08 08/31/09 40,000 * 
The Mary K. Chapman Foundation Dr. Kuhn 04/01/08 06/30/08 18,730 * 
The Mary K. Chapman Foundation Dr. Xu 07/01/08 03/31/09 66,270 * 
The Jane Coffin Childs Memorial Fund Dr. Kuhn 07/01/08 06/30/11 45,500 *
for Medical Research 
CSHL Association Fellowship New Investigator Support 2008 280,000 * 
The Danish Cancer Society Dr. Jensen 01/01/07 12/31/08 70,000 
Michel David-Weill Dr. Albeanu 09/01/06 08/31/09 200,000 
Ellison Medical Foundation Dr. Chien 07/01/07 06/30/09 49,250 
Engelhorn Scholarship Program Watson School of Biological Sciences 09/01/00 12/31/08 49,980 
European Molecular Biology Dr. Demir 01/01/08 06/30/08 16,591 * 
Organization 
Fondation pour la Recherche Medicale Dr. Anczukow-Camarda 01/01/08 12/31/08 32,744 * 
DFG (German Research Foundation) Dr. Zuber 02/01/06 01/31/09 3,600 
The Allen and Lola Goldring Foundation Dr. Stillman 09/01/08 08/31/09 75,000 * 
The Lita Annenberg Hazen Foundation Watson School of Biological Sciences 05/01/08 04/30/18 10,000 * 
The Heart and Stroke Foundation Dr. Boivin 07/01/06 06/30/08 19,558 
Human Frontier Science Program Dr. Kvitsiani 09/01/08 08/31/11 46,400 * 
* New grants awarded in 2008
† Includes direct and indirect costs
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Human Frontier Science Program Dr. Nadif Kasri 09/01/06 11/30/09 45,500 
Human Frontier Science Program Dr. Schalch 08/01/07 08/01/10 50,220 
The Japan Society for the Promotion Dr. Kawakami 04/01/08 03/31/10 39,000 * 
of Science (JSPS)
Annette Kade Charitable Trust Watson School of Biological Sciences 03/01/07 03/31/09 50,000 
The Karp Foundation, Inc. Dr. Karakas 10/16/08 10/15/09 50,000 * 
The Leukemia & Lymphoma Society Dr. Krizhanovsky 07/01/06 06/30/09 50,000 
The Leukemia & Lymphoma Society Dr. Semighini 07/01/08 06/30/11 55,000 * 
Merck Research Laboratories Watson School of Biological Sciences 01/01/08 12/31/08 25,000 * 
NARSAD Dr. Encinas 07/01/07 06/30/09 30,000 
NARSAD Dr. Park 07/01/08 06/30/10 30,000 * 
The Robert Leet and Clara Guthrie Dr. Demir 07/01/08 06/30/10 44,500 * 
Patterson Trust
The Robert Leet and Clara Guthrie Dr. Kvitsiani 01/15/08 08/31/08 27,813 * 
Patterson Trust
The Robert Leet and Clara Guthrie Dr. Lima 01/15/07 01/14/09 10,704 
Patterson Trust
The Robert Leet and Clara Guthrie Dr. Oviedo 01/15/08 01/14/10 50,000 *
Patterson Trust 
Spanish Ministry of Education and Dr. Fernandez-Marco 09/01/07 08/31/09 38,248 
Science
Lauri Strauss Leukemia Foundation Dr. Semighini 03/01/08 02/28/09 15,000 * 
The Swartz Foundation Dr. Zador 01/01/08 12/31/08 333,333 * 
The Swartz Foundation Drs. Koulakov/Tsigankov 01/01/08 12/31/08 55,000 * 
The Swartz Foundation Drs. Mainen/Felsen 01/01/08 12/31/08 55,000 * 
The Swartz Foundation Drs. Zador/Jaramillo 01/01/08 12/31/08 55,000 * 
The Swartz Foundation Drs. Zador/Oswald 01/01/08 12/31/08 55,000 * 
The Swartz Foundation Dr. Zador 01/01/08 12/31/08 15,000 * 
Training Support
Cornelius N. Bliss Memorial Fund Undergraduate Research Program 2008 2,700 *
Hunter College Undergraduate Research Program 2008 7,000 * 
Steamboat Foundation Undergraduate Research Program 05/01/08 04/30/09 12,000 * 
William Townsend Porter Foundation Undergraduate Research Program 04/01/08 03/31/09 10,000 * 
Course Support
American Brain Tumor Association Mechanisms of Neural Differentiation 04/01/08 03/31/09 45,000 * 
and Brain Tumors
The American Society for Cell Biology ASCB Minority Affairs Committee Grant 02/01/08 01/31/09 15,000 * 
Applied Biosystems Revolutionary Sequencing Technologies 06/01/08 05/31/09 26,000 * 
and Applications
Autism Speaks, Inc. Workshop on Biology of Social Cognition 05/01/07 06/01/10 15,000 
Howard Hughes Medical Institute Neurobiology Course Support 01/01/91 12/31/11 750,000 
IBRO–Society for Neuroscience Student Support–Course Scholarships 01/05/06 03/31/09 20,775 
Illumina, Inc. Revolutionary Sequencing Technologies 06/01/08 05/31/09 26,000 * 
and Applications
Nancy Lurie Marks Family Foundation Workshop on Biology of Social Cognition 06/01/07 06/01/10 15,000 
Novartis Institutes for BioMedical Proteomics Course Support 06/01/06 09/30/08 129,859 
Research, Inc.
Roche Diagnostics Corporation Revolutionary Sequencing Technologies 06/01/08 05/31/09 26,000 * 
and Applications
The Simons Foundation Workshop on Biology of Social Cognition 06/01/07 06/01/10 15,000 
Meeting Support
Abbott Laboratories Gene Expression and Signaling in the 01/01/08 12/31/08 5,000 * 
Immune System
* New grants awarded in 2008
† Includes direct and indirect costs
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California Institute of Technology Engineering Principles for Biological 12/01/08 11/30/09 20,000 *
Systems 
Champalimaud Foundation 73rd Symposium: Control and Regulation 03/01/08 02/28/09 175,000 *
of Stem Cells 
Chemocentryx Gene Expression and Signaling in the 01/01/08 12/31/08 2,500 *
Immune System 
Elan Pharmaceuticals, Inc. Gene Expression and Signaling in the 01/01/08 12/31/08 4,000 *
Immune System 
Genentech Gene Expression and Signaling in the 01/01/08 12/31/08 3,000 * 
Immune System
Hudson-Alpha Institute for The Biology of Genomes 03/01/07 02/29/09 24,000 
Biotechnology
IRX Therapeutics, Inc. Gene Expression and Signaling in the 01/01/08 12/31/08 1,500 * 
Immune System 
The Lalor Foundation Conference on Germ Cells–Support for 01/01/08 12/31/08 5,000 * 
Young Investigators
The Lehrman Institute Human Genome 09/01/07 08/31/08 25,000 
March of Dimes Foundation Conference on Germ Cells 08/01/08 07/31/09 3,500 * 
Merck Research Laboratories Neurodegenerative Diseases: Biology 06/01/08 05/31/09 2,000 * 
and Therapeutics
Merck Research Laboratories Molecular Genetics of Bacteria and 04/01/08 03/31/09 2,500 *
Phages 
Merck Research Laboratories Axon Guidance, Synaptogenesis, and 04/01/08 03/31/09 2,000 * 
Neural Plasticity
Merck Research Laboratories Mechanisms and Models of Cancer 01/01/08 12/31/08 25,000 * 
New York State Stem Cell Science Stem Cell Training Program 11/01/08 10/31/09 118,920 * 
(NYSTEM)
OSI Pharmaceuticals Epithelial–Mesenchymal Transition 03/01/08 02/28/09 48,265 * 
OSI Pharmaceuticals PTEN Pathways 03/01/08 02/28/09 16,735 * 
Research and Diagnostic Systems, Inc. Gene Expression and Signaling in the 01/01/08 12/31/08 2,500 * 
Immune System
Roche Diagnostics Corporation Personal Genomes Conference 10/01/08 09/30/09 25,000 * 
Roche Diagnostics Corporation The Biology of Genomes 03/01/07 02/29/09 40,000 
Schering-Plough Gene Expression and Signaling in the 01/01/08 12/31/08 2,500 * 
Immune System
Vertex Pharmaceuticals Incorporated Gene Expression and Signaling in the 01/01/08 12/31/08 2,000 * 
Immune System
Wyeth Pharmaceuticals Harnessing Immunity to Prevent and 12/01/08 11/30/09 10,000 * 
Treat Disease
Library Support
New York State 07/01/07 06/30/09 8,699 
* New grants awarded in 2008
† Includes direct and indirect costs
427-456_LAR_DEV_finances:407-442_FINANCIAL  6/9/09  5:14 PM  Page 438
439
DOLAN DNA LEARNING CENTER GRANTS
Duration 2008 
Grantor Program of Grant Funding†
FEDERAL GRANTS
National Institutes of Health Science Education Partnership Award (SEPA): Nationwide 08/07–07/09 $ 140,653
Dissemination of Inside Cancer Internet Site
National Science Foundation Course, Curriculum, and Laboratory Instruction (CCLI) 09/07–8/09 132,740
Program: Nationwide Dissemination of RNAi Curriculum
National Science Foundation Plant Genome Initiative Educational Outreach: Construction  12/05-11/08 3,939
and Nationwide Dissemination of Dynamic Gene Internet Site 
AAAS/NSF National Science Digital Library: Meta-tagging DNALC Internet 10/05–09/09 71,469
Content for BiosciEdNet
Washington University/NSF Plant Genome Initiative Educational Outreach: Multimedia 11/05–10/08 15,611
Materials on Maize Genome Sequencing
Cornell University/NSF Plant Genome Initiative Educational Outreach: Minority Fellows 09/08–08/09 13,114
and Regional Plant Genomics Footlockers
University of Arizona/NSF iPlant Collaborative: Cyberinfrastructure for the Biological Sciences 02/08–01/09 237,904
NONFEDERAL GRANTS
Amgen Foundation Amgen Leadership Symposium 04/05–12/08 $ 106,469
Dana Foundation Genes to Cognition (G2C) Online Internet Site Development 10/04–12/08 265,552
Dialog Gentechnik DNALC Licensing 2008 24,975
Hewlett Foundation Genes to Cognition (G2C) Online Internet Site Evaluation 10/05–10/09 86,702
HHMI Foundation Pre-College Science Education Initiative: NYC Teacher Training 09/07–08/09 136,971
New York State Education Dept. Excelsior Scholars Program for 7th Grade Math & Science Students 05/08–10/08 42,794
North Shore–LIJ Health System DNALC West Operating Support 2008 50,000
Porter Foundation Scholarships for Minority and Disadvantaged Students 03/08–03/10 425
The following schools each contributed $1000 or more for participation in the Curriculum Study Program:
Bellmore–Merrick Central High School District $1,250
Bethpage Union Free School District 1,500
Commack Union Free School District 3,000
East Meadow Union Free School District 1,500
Elwood Union Free School District 1,500
Fordham Preparatory School 1,500
Garden City Union Free School District 1,500
Great Neck Union Free School District 1,500
Half Hollow Hills Central School District 3,000
Harborfields Central School District 1,500
Herricks Union Free School District 3,000
Huntington Union Free School District 1,500
Island Trees Union Free School District 1,500
Jericho Union Free School District 1,500
Locust Valley Central School District $1,500
Long Beach City School District 1,500
Massapequa Union Free School District 1,500
North Shore Central School District 1,500
Oyster Bay–East Norwich School District 3,000
Plainview–Old Bethpage Central School District 1,500
Port Washington Union Free School District 1,500
Ramaz School 1,500
Sachem Central School District 1,500
South Huntington Union Free School District 1,500
Syosset Central School District 1,500
West Hempstead Union Free School District 1,500
Yeshiva University High School for Girls 1,500
Amityville Union Free School District $  1,200
Bay Shore Union Free School District 5,100
Bellmore Union Free School District 2,000
Bellmore–Merrick Central HS District 17,000
Commack Union Free School District 5,875
Deer Park Union Free School District 1,200
East Meadow Union Free School District 2,550
Elwood Union Free School District 4,200
Floral Park–Bellerose Union Free School District 6,750
Friends Academy, Locust Valley 2,350
Garden City Union Free School District 3,700
Great Neck Union Free School District 16,500
Grover Cleveland Middle School, NJ 1,200
Half Hollow Hills Central School District 7,125
Herricks Union Free School District 2,400
Holy Family Regional School, Commack 1,500
Huntington Union Free School District 6,800
Kings Park Central School District 1,137
Lindenhurst Union Free School District 1,000
Locust Valley Central School District 11,650
Long Beach City School District 1,200
Merrick Union Free School District 2,700
MS 447–The Math & Science Exploratory School, N.Y. 5,000
Mott Hall V, NYC $  2,400
North Bellmore Union Free School District 3,300
North Shore Hebrew Academy 1,000
Northport–East Northport Union Free School District 1,600
Oceanside Union Free School District 1,500
Old Westbury School of the Holy Child 3,250
Oratory School of Summit 1,200
Oyster Bay–East Norwich Central School District 2,500
Plainview–Old Bethpage Central School District 3,500
Roberto Clemente Middle School, MD 3,740
Rockville Centre Union Free School District 5,400
Roslyn Union Free School District 3,600
Scarsdale Union Free School District 9,600
St. Dominic Elementary School, Oyster Bay 4,050
St. Edward the Confessor School, Syosset 2,025
St. Isidore School, Riverhead 1,200
St. Joseph School, Garden City 1,000
Syosset Central School District 33,100
Three Village Central School District 6,000
Trinity Lutheran School, Northport 1,000
United Federation of Teachers School, NYC 2,000
Yeshiva Darchei Torah 1,600
Yeshiva of Flatbush 1,100
The following schools each contributed $1000 or more for participation in the Genetics as a Model for Whole Learning Program:
†Includes direct and indirect costs
427-456_LAR_DEV_finances:407-442_FINANCIAL  6/9/09  5:14 PM  Page 439
440
BANBURY CENTER GRANTS
Duration                2008
Grantor Program of Grant Funding
FEDERAL SUPPORT
NIH–National Institute of Allergy and Prion Strains: Origins, Mechanisms, and 2008 25,000*
Infectious Diseases; Office of Rare Diseases Implications for Disease
NIH–National Institute of Mental Health Recent Advance and a Multilevel Analysis  2008 53,914*
(through a grant to University of Illinois) from FMRP Biology to Clinical Trials
NONFEDERAL SUPPORT
Meeting Support
AVI BioPharma, Inc. Oligonucleotide-directed Splicing: Therapeutic 2008 10,800*
Strategies
Clay Mathematics Institute Algebraic Statistics, Machine Learning, and 2008 13,273*
Lattice Spin Models 
Cold Spring Harbor–Pioneer Collaborative Plant Genetics and Gene Regulation 2008 43,526
Research Program
Cure Duchenne Foundation Oligonucleotide-directed Splicing: Therapeutic 2008 10,800*
Strategies
The Dana Foundation How Can We Improve Our Brains? 2008 48,600*
Foundation to Eradicate Duchenne Oligonucleotide-directed Splicing: Therapeutic 2008 10,800*
Strategies
Oliver Grace Professorship Fund To What Age Should We Work? 2008 43,810*
The W.M. Keck Foundation The Architectural Logic of Mammalian CNS 2008 33,155
Richard Lounsbery Foundation Who Are We? Kinship, Ancestry, and Social 2008 46,767*
Identity
The Lustgarten Foundation for Pancreatic Identifying KRAS-targeted Therapeutic 2008 15,181*
Cancer Research   Approaches for Pancreatic Cancer
Medical Research Council, UK Prion Strains: Origins, Mechanisms, and
Implications for Disease 2008 29,576*
OSI Pharmaceuticals, Inc. How Will We Be Able to Cure Most Cancers? 2008 56,689*
Prosensa Oligonucleotide-directed Splicing: Therapeutic 2008 10,800*
Strategies
Spinal Muscular Atrophy Foundation Taking on New Complexities in SMA Biology 2008 54,538*
The Swartz Foundation Theoretical and Experimental Approaches to 2008 51,497*
Auditory and Visual Attention
Stanley Trotman, Jr. Trust Genes and the Environment: New Strategies 2008 22,554*
for Research on Multiple Sclerosis
* New grants awarded in 2008
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CORPORATE SPONSOR PROGRAM 
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory cam-
pus or at the Banbury Center. Without the strong foundation provided by the Program, we could neither
plan with confidence for the year’s meetings nor introduce new and unusual topics. 
We are especially grateful to the companies that joined us in 2008 as the economic difficulties began
to take effect. The year 2009 is going to be especially challenging as the number of companies shrinks
through takeovers, and companies and foundations adopt austerity measures.
The members of the Program receive special privileges in acknowledgment of their contributions. We
waive all on-site fees for 16 representatives of the Corporate Benefactors and eight representatives of the
Corporate Sponsors at our meetings. Six and three scientists, respectively, from Benefactors and
Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by invitation
of the organizers. Member companies receive gratis copies of Cold Spring Harbor Laboratory Press pub-
lications, including the journals Genes & Development, Learning & Memory, Protein Science, Genome
Research, and RNA. 
We acknowledge our Sponsors in all relevant publications, including the books of abstracts given to
each of the 8000 participants who come to the meetings each year. The names of the sponsoring com-
panies are listed on the poster describing the meetings, and this is mailed to approximately 30,000 sci-
entists throughout the world. In addition, the companies are listed on the Cold Spring Harbor Laboratory
Web site on the Meetings Office and Banbury Center pages. Members in 2008 were:
CORPORATE BENEFACTORS
Amgen Inc.
GlaxoSmithKline
Merck Research Laboratories
Novartis Institutes for BioMedical Research
PLANT CORPORATE ASSOCIATES
Monsanto Company
Pioneer Hi-Bred International, Inc.
FOUNDATIONS
HudsonAlpha Institute for Biotechnology
CORPORATE SPONSORS
Agilent Technologies, Inc.
Applied Biosystems
AstraZeneca
BioVentures, Inc.
Bristol-Myers Squibb Company
Genentech, Inc.
Hoffmann-La Roche Inc.
Invitrogen Corporation
IRX Therapeutics
Kyowa Hakko Kogyo Co., Ltd.
New England BioLabs, Inc.
OSI Pharmaceuticals, Inc.
Sanofi-Aventis
Schering-Plough Research Institute
CORPORATE AFFILIATES
Affymetrix
CORPORATE CONTRIBUTORS
Epicentre Biotechnologies
Illumina Inc.
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DEVELOPMENT
We reached an important milestone in 2008 as our campaign surpassed its $200 million goal. As a result of this campaign,
we constructed six new buildings, increasing the Laboratory's research space by more than 40%. This will allow our can-
cer programs to expand and use novel imaging technologies to determine why and how tumors metastasize. Our neuro-
science efforts will grow and increase our understanding of the complex genetic pathways involved in neurological disor-
ders, most notably autism, schizophrenia, and depression. Through significant campaign gifts from the Simons
Foundation, the Starr Foundation, and Landon and Lavinia Clay, we launched a new program in Quantitative Biology that
will focus on mining genomic data to better understand human health and disease. 
Our educational programs benefited from the campaign, which facilitated a much-needed endowment for the DNA
Learning Center, allowing for expansion with a new facility in East Harlem that opened in September. The campaign also
helped to increase funds for the Watson School of Biological Sciences with the establishment of new graduate school fel-
lowships as well as support for its heralded Undergraduate Research Program. 
We would like to thank all of our campaign participants and 2008 donors for their unwavering support and friendship.
Charles V. Prizzi, Vice President for Development
Cold Spring Harbor Laboratory is a nonprofit research and educational institution, chartered by the State of New York.
ScienceWatch, an independent rating service, has ranked the Laboratory’s molecular biology and genetics programs
number one during the last decade. Additionally, Charity Navigator, a philanthropic evaluator, has bestowed their high-
est four-star rating on the Laboratory for seven consecutive years.
Less than half of the Laboratory’s annual revenues are derived from federal grants and contracts, and thus, we rely heavily on
support from the private sector: foundations, corporations, and individuals. There are a variety of ways to give to the Laboratory:
Capital and Endowment Campaign Support: CSHL is
completing a $200 million capital and endowment cam-
paign to speed the translation of genetic discoveries into
diagnostic tests and therapeutics and to expand the Lab’s
facilities and staff. Endowment gifts can be directed toward
supporting cancer, neuroscience, or educational programs.
Capital gifts can be made to name laboratories and con-
ference rooms in one of our six new research buildings. 
Annual Fund: Donations provide funding for some of the
most determined and innovative young researchers in sci-
ence today and constitute an important investment in
innovative research in cancer, neuroscience, plant biolo-
gy, and bioinformatics.
Science Education: Donations support programs at the
DNA Learning Center, where the next generation of sci-
entists learn about genetics in an exciting and interactive
environment. 
Planned and Estate Gifts: Individuals who inform us of
their intention to make a gift to CSHL from their estate are
invited to become members of The Harbor Society.
Estate gifts help to ensure that CSHL will continue to pur-
sue its mission for many years to come. 
For additional information, please contact the Vice President for Development, Cold Spring Harbor Laboratory, One Bungtown
Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6865
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President’s Council
The President’s Council is comprised of distinguished individuals who gather each spring and fall for
stimulating discussions on scientific topics of broad public interest that are related to CSHL research.
Members of the Council contribute at least $25,000 annually to support CSHL Fellows, exceptionally
talented young scientists who show unusual potential early in their careers. 
In 2008, the Council’s meetings focused on plant biology to commemorate the 100th anniversary
of George Shull’s demonstration at CSHL of hybrid vigor in corn, which ushered in the U.S. agricultur-
al revolution. Today, CSHL plant biologists are helping to develop technologies for improving crop yield,
enhance nutritional value of food crops, and speed the development of viable biofuels. 
Our April meeting was hosted by Trustee Andrew Solomon and John Habich Solomon at their home
in New York City. The gathering featured a lecture and lab demonstration on genetically modified foods.
In October, more than 60 people gathered for a two-day meeting on biofuels. They heard in-depth talks
from leaders in industry, policy, and research on fuel consumption and energy production, which
focused on initiatives for making low-carbon biofuels an economic reality. The meeting spanned three
CSHL campuses, beginning at the Banbury Conference Center with a talk by the former president of
Shell Oil, John Hofmeister, who focuses today on challenging industry, government, and grassroots
organizations to create an alternative energy plan for the U.S, and ending with a tour of CSHL’s farm
and greenhouses and a lively talk on the history of plant research at the Laboratory.
On October 17–18, Bruce Stillman hosted CSHL’s
annual President’s Council Fall Meeting. This year’s
meeting focused on plants, biofuels, and the future
of energy.
CSHL plant scientist Rob Martienssen
(left) with President’s  Council member
Ira Hazan.
(Left to right) President Bruce Stillman with
President’s Council Co-Chair John Friedman and
John Hofmeister, former President of Shell Oil
Company, at the 2008 President’s Council Fall
Meeting.
President
Dr. Bruce Stillman
Chairpersons
Mr. and Mrs. John H. Friedman
Mr. George F. Ohrstrom
Dr. and Mrs. James M. Stone
Members
Mr. David G.P. Allan
Ms. Amy Anthony
Mr. and Mrs. Donald Everett Axinn
Mr. and Mrs. Hans E.R. Bosch
Dr. Gerald Chan
Mr. Richard Baron Cohen
Mr. and Mrs. George W. Cutting, Jr.
Mr. Michel David-Weill
Mrs. Kathryn Wasserman Davis
Mr. and Mrs. Yves C. de Balmann
Mr. David B. Ford
Dr. Leo A. Guthart
Mr. Matthew Haines
Mr. and Mrs. Charles E. Harris II
Dr. William A. Haseltine
Mr. and Mrs. Ira Hazan
Mr. and Mrs. Thomas Campbell
Jackson
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. David H. Koch
Drs. Marsha and Henry Laufer
Dr. Betsy and Mr. Bryan H.
Lawrence
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
Dr. Gillian and Mr. Eduardo Mestre
Mr. and Mrs. John D. Miller
Mr. and Mrs. Frank T. O’Keefe
Mr. and Mrs. John C. Phelan
Dr. and Mrs. Mark Ptashne
Mr. and Mrs. Roderick N. Reed
Mr. and Mrs. David Rubenstein
Mr. and Mrs. Luis E. Rinaldini
Mr. and Mrs. Alan Seligson
Drs. Marilyn and James Simons
Mr. and Mrs. Erwin P. Staller
Mrs. Cynthia R. Stebbins
Dr. and Mrs. Jerome Swartz
Mrs. Robert W. Tilney
Mr. and Mrs. Howard J. Tytel
Mr. and Mrs. Raymond Wong
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Cold Spring Harbor Laboratory Association (CSHLA)
We are grateful to members of the Cold Spring Harbor Laboratory Association who came together
often in 2008, cultivating new friends and raising unrestricted funds in support of CSHL scientists.
Despite the difficult economy, members raised over $1.1 million for the annual fund. 
Here, we mention a few highlights from a busy year: “The Lab Goes Latin” event last April was a
lively change from our traditional spring jazz benefit. We applaud Lisa and Tim Broadbent and Kate and
John Friedman for the tremendous energy and creativity that they put into this successful event. In early
June, lots of new friends hosted dinner parties for visiting and CSHL scientists after the annual
Symposium’s Dorcas Cummings lecture about skin stem cells, delivered by Elaine Fuchs, Ph.D., of The
Rockefeller University. A rainy Friday evening in September was no deterrent to the record number of
our major donors who enjoyed a lovely reception hosted by CSHL trustee Stephen Lessing and his wife
Sandra in their beautiful home. 
The year 2008 closed with the completion of Pien Bosch’s role as President of the Association
Board. We could not be more grateful for her exceptionally dedicated service to CSHL. Pien’s devotion
to CSHL’s far-reaching goal to improve human health resulted in a welcome influx of friends and sup-
porters who share her sense of privilege in having a world-renowned institution in “our backyard.”
Directors
Executive Committee
Pien Bosch, President
Timothy S. Broadbent, 
Vice President
Lynn M. Gray, Vice 
President
Sandy Tytel, Treasurer
Lynn McGrath Tone, 
Secretary
Joseph V. Amella
Joyce Bertoldo
Maria L. Brisbane
Barbara Candee
Michele Munn Celestino
Katie Charlston Colgate, Ph.D.
Suzanne DiMaio
E. Richard Droesch
Linda Ferrante
John S. Friedman
Charles B. Goodwin, M.D.
Virginia Knott
Frank T. O’Keefe
Lauryl Palatnick
David Peikon
Scott J. Ratner, M.D. 
Raymond G. Schuville
Debbie Parmet Sondock
Cathy Cyphers Soref
Pearl F. Staller
John C. Stevenson, Ph.D.
W. Fifield Whitman
Honorary Directors
John P. Cleary
George W. Cutting, Jr.
Mary D. Lindsay
Anne R. Meier
2008 CSHLA Directors
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Dolan DNA Learning Center Advisory Boards
We are lucky to have high-level support from two advisory bodies: the Education Committee and the
Corporate Advisory Board (CAB). The Education Committee formulates policy and assists with strate-
gic planning, while the CAB provides liaison to the Long Island business community. The CAB also con-
ducts an annual golf tournament and the annual fund campaign. These are the DNALC’s major sources
of unrestricted funding. In 2008, more than $275,000 was raised through these events. 
Eric Krasnoff (left), Chairman and CEO of Pall Corporation,
with friends at the 15th annual DNALC Golf Tournament
Edward A. Chernoff, Motors & Armatures
Inc., Chairman
Laurie Landeau, VMD, CSHL Trustee
Liaison
Michael Aboff, Aboff’s Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale
Sothebys International Realty
Jeffrey Carstens, Sovereign Bank
Richard A. Catalano, KPMG, LLP
Marian Conway, Roslyn Savings
Foundation
James Chinitz, Population Diagnostics
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall Corporation
David Epstein, Ph.D., OSI
Pharmaceuticals, Inc.
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business
Products Centre
Lawrence Goodman, Curtis, Mallet-
Prevost, Colt & Mosle LLP
Mary Jane Helenek, Luitpold
Pharmaceuticals
Arthur D. Herman, Herman Development
Corporation
Diana Hoadley, JP Morgan
Robert Hoppenstedt, Bethpage Federal
Credit Union
Robert Isaksen, Bank of America
Neil M. Kaufman, Davidoff, Malito &
Hutcher
John C. Kean III, Kean Development
Corporation
Norman Kelker, Enzo Life Sciences
Robert Keller, Keyspan Foundation
Teresa Kemp-Zielenski, United Way of
Long Island
James E. Mattutat, Ingleside Investors, Inc.
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sothebys
Real Estate
Frank Posillico, Rose Racanelli
Realty/Aireco
Christiaan B. Reynolds
William D. Roche
Charles R. Schueler, Cablevision
Lee Shuett, Nikon Instruments
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of
New York
Robert Van Nostrand, AGI Dermatics
David Widmer, Long Island Radio Group
Hans Zobel, Ziehm Medical LLC
DNALC Education Committee
Laurie Landeau, VMD, Chairperson
Lori Bressler
Edward Chernoff
Marianne Dolan Weber
Lola Grace
Suzanne Kleinknecht
Suzanne Leeds
Peter Quick
Lawrence Scherr, M.D.
Adele Smithers
Arthur Spiro 
Peter Tilles
Edward Travaglianti
CSHL President Bruce Stillman and Christine McInerney of the
Jerome L. Greene Foundation with a student at the newly estab-
lished Harlem DNA Lab
Corporate Advisory Board
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Contributions of $5,000,000+ (lifetime)
Anonymous*
Mr. and Mrs. Donald Everett Axinn*
Arnold and Mabel Beckman
Foundation
Mr. and Mrs. Landon T. Clay*
The Dart Foundation
Kathryn Wasserman Davis
The Kathryn Wasserman Davis
Foundation*
The DeMatteis Family Foundation*
Mr. and Mrs. Charles F. Dolan–The
Dolan Family Foundation
The William Stamps Farish Fund*
Gen*NY*sis grant from the New
York State Dormitory Authority*
The Lita Annenberg Hazen
Foundation*
Howard Hughes Medical Institute*
W.M. Keck Foundation
David H. Koch*
Lucille P. Markey Charitable Trust
Nancy Abeles Marks*
The Don Monti Memorial Research
Foundation*
NYS Empire State Development
Corporation*
The Quick Family*
The Robertson Family–Banbury
Fund*
The Simons Foundation*
Mr. and Mrs. Theodore R. Stanley*
The Starr Foundation*
Mr. and Mrs. Henry Wendt III*
Contributions of $100,000+ or
$1,000,000+ (lifetime)
Angel Foundation
Anonymous
Anonymous*
Jamie Nicholls and Fran Biondi
Charitable Trust*
Mr. and Mrs. Hans E.R. Bosch*
The Breast Cancer Research
Foundation
Bristol-Myers Squibb Company
Burroughs Wellcome Fund
Louise Parent and John Casaly*
Cedar Hill Foundation*
The Mary K. Chapman Foundation*
Edward A. Chernoff–Motors &
Armatures, Inc.*
Dr. and Mrs. Bayard Delafield
Clarkson*
Mr. and Mrs. John P. Cleary*
Mr. and Mrs. John H. Coleman*
Mr. and Mrs. Roderick H. Cushman*
The Dana Foundation*
Mr. and Mrs. Norris Darrell, Jr.*
Michel David-Weill*
Mr. and Mrs. Henry P. Davison II–
The Perkin Fund*
Ira W. DeCamp Foundation
Estate of Norman K. Dorf*
The Samuel Freeman Trust
Coleman Fung Foundation*
Mr. Robert B. Gardner, Jr.
Mr. Robert L. Garland
Drs. Joan Brooks and James Garrels*
Robert A. Gay*
Genentech, Inc.*
Kenyon Gillespie
Robert J. Glaser, M.D.*
Francis Goelet Trust*
Dr. and Mrs. Philip Goelet*
Dr. Alfred L. Goldberg*
Jacob D. Goldfield*
Florence Gould Foundation
The Grace Family*
Leo A. Guthart*
Estate of Louise A. Haberer*
The Harrison Foundation and The
Mary Anderson Harrison
Foundation*
The Thomas Hartman Foundation
for Parkinson's Research*
Janet Strauss and Jeff Hawkins*
Jo-Ellen and Ira Hazan
William Randolph Hearst
Foundation*
The William and Flora Hewlett
Foundation*
Joan’s Legacy: The Joan
Scarangello Foundation to
Conquer Lung Cancer*
Annette Kade Charitable Trust
The Karches Foundation
F.M. Kirby Foundation*
Mr. and Mrs. Walter B. Kissinger*
Mr. and Mrs. John Klingenstein–The
Esther A. & Joseph Klingenstein
Fund, Inc.
Mr. and Mrs. Townsend J. Knight
The Koshland Foundation*
Laurie J. Landeau, VMD*
The Forrest C. & Frances H. Lattner
Foundation
Mr. and Mrs. Gerard Leeds*
The Lehrman Institute*
Mr. and Mrs. Stephen M. Lessing*
Estate of Anthony Licenziato
Mary D. Lindsay*
Mr. and Mrs. Robert D. Lindsay and
Family*
The Litchfield Charitable Trust
Estate of Elisabeth Sloan Livingston*
Mr. and Mrs. David L. Luke III*
Josiah Macy, Jr. Foundation
Dr. Thomas Maniatis*
The G. Harold and Leila Y. Mathers
Charitable Foundation
Mr. and Mrs. Thomas J. McGrath*
Gillian and Eduardo Mestre*
Mr. and Mrs. William R. Miller*
New York State Office of Parks,
Recreation, and Historic
Preservation*
OSI Pharmaceuticals Foundation*
Pall Corporation*
The Pierre and Pamela Omidyar
Fund
The Pew Charitable Trusts
Mr. and Mrs. John C. Phelan*
William and Maude Pritchard
Charitable Trust
V. Kann Rasmussen Foundation*
Mr. and Mrs. Luis E. Rinaldini*
The Robertson Foundation*
Mr. and Mrs. David M. Rubenstein*
Mr. and Mrs. Alan Seligson*
The Seraph Foundation*
Dr. and Mrs. Phillip A. Sharp*
Mr. and Mrs. Herbert J. Siegel
Alfred P. Sloan Foundation
Mr. and Mrs. Howard Solomon*
Cynthia and James F. Stebbins*
St. Giles Foundation
Dr. and Mrs. James M. Stone*
Honor Roll of Donors
(Left to right) J. Craig Venter, Bill Harman, and CSHL Honorary Trustee David
Koch at the Double Helix Medals Dinner
*Gift or pledge made to the Hillside Campus Campaign 2003–2008 or a multiyear pledge
2008 Double Helix Medals recipi-
ents Marilyn and Jim Simons
The third annual Double Helix Medals Dinner was held on November 6,
2008 at the Mandarin Oriental in Manhattan. Pictured are 2008 Double Helix
Medals recipients Jim Watson (left) and J. Craig Venter (center) with
Deborah Norville and CSHL President Bruce Stillman.
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BioBay of Suzhou Venture Capital
Group 
Dr. and Mrs. Jerome Swartz–Swartz
Charitable Lead Trust
Waclaw T. Szybalski, D.Sc.*
Paul J. Taubman
Thermo Co.*
Doris M. and Peter S. Tilles
Foundation*
Universidad Nacional Autónoma de
México*
Dr. and Mrs. James D. Watson
Dr. Norton D. Zinder*
The Roy J. Zuckerberg Family
Foundation*
Contributions of $50,000+
454 Life Sciences
The Bodman Foundation
The Mary K. Chapman Foundation
Mr. and Mrs. George W. Cutting, Jr.*
The Allen and Lola Goldring
Foundation
Mr. and Mrs. John S. Grace*
Drs. Marsha and Henry Laufer
The Manhasset Women's Coalition
Against Breast Cancer*
Breast Cancer Awareness Day in
memory of Elizabeth McFarland
Louis Morin Charitable Trust*
Mr. and Mrs. George D. O'Neill
Prince Resources, LDC
Thomas C. Quick
Swim Across America–Nassau/
Suffolk*
Mr. and Mrs. Howard J. Tytel
Viacom International, Inc.
Dr. and Mrs. Michael Wigler
Contributions of $25,000+
Anonymous
Bank of America Foundation
The Berlin Family Foundation
Cashin Family Fund
Dr. Gerald Chan–The Morningside
Foundation
Mr. and Mrs. Yves C. de Balmann
Marcia Kramer Mayer and Michael
Eisenbud
F.A.C.T. (Find A Cure Today)*
Mr. and Mrs. John H. Friedman
Joni E. Gladowsky Breast Cancer
Foundation*
Dr. and Mrs. Charles B. Goodwin
Matthew Haines–The Marc Haas
Foundation
Mr. and Mrs. Thomas Campbell
Jackson
Dr. and Mrs. Irwin M. Jacobs
Mr. and Mrs. David M. Knott
Dr. Betsy and Mr. Bryan H.
Lawrence
Long Island 2-Day Walk to Fight
Breast Cancer, Inc.*
The Nancy Lurie Marks Family
Foundation
Merck Research Laboratories
Mr. and Mrs. John D. Miller
Mr. and Mrs. Douglas P. Morris
George F. Ohrstrom
Mr. and Mrs. Frank T. O'Keefe
William Townsend Porter Foundation
Christina Renna Foundation
Diane Emdin Sachs Memorial Walk
Mr. and Mrs. Erwin P. Staller
Synthetic Genomics, Inc.
Mrs. Robert W. Tilney*
Wodecroft Foundation
Mr. and Mrs. Raymond L.M. Wong
Bob and Suzanne Wright–Autism
Speaks
Contributions of $10,000+
Mr. and Mrs. Lee S. Ainslie III–
Maverick Capital Charities
Amy Anthony
Arrow Electronics, Inc.
The Bahnik Foundation
Ellen Brenner Scholarship Fund*
Dr. Steven Brenner*
Brinkmann Instruments/Eppendorf
North America
Brownstone Agency, Inc.
Mr. and Mrs. Thomas J. Calabrese,
Jr.*
Centerbrook Architects and
Planners, LLC
Mr. and Mrs. William T. Comfort
Mr. and Mrs. Elliot S. Conway
Mr. William F. Gerry–Gerry Corbett
Foundation
Mr. and Mrs. Tarrant Cutler
Pat Petersen and Staff at Daniel Gale
Sotheby's International Realty
Kathryn and Jack DiMaio
Mr. and Mrs. Constantine S.
Douzinas-Rauch Foundation
Jessie Ewing Phillips–William Ewing
Foundation
Fortunato Sons Contracting, Inc.
Mr. and Mrs. Alan C. Greenberg–
JPMorgan Chase
Mrs. Horace Hagedorn
The Irving A. Hansen Memorial
Foundation
Tania and Brian Higgins Charitable
Trust
Syde Hurdus Foundation
Drs. Nancy and Ron Israeli 
Ted Jackson–JPMorgan Chase
Paul E. Jefferson
Estate of Polly S. Kahn*
Keyspan Foundation
The Korein Foundation
Suzanne and Richard Leeds
The Fay J. Lindner Foundation*
Mary and Rob Lynn
Mr. and Mrs. Charles G. McCurdy–
Canon Communications
The Nichols Foundation
Susanne Olin
OSI Pharmaceuticals, Inc.
Laurence Polatsch Memorial Fund
Roderick N. Reed
Mr. and Mrs. John R. Reese*
Andrew Seligson Memorial Cancer
Research Fund
Laura and Harry Slatkin
Deborah K. Solbert
Debbie and Cliff Sondock
Helen Grace Spencer
Steamboat Foundation
Lauri Strauss Leukemia Foundation
Waldbaum Foundation*
Mr. and Mrs. Yichwan Wang
2008 Double Helix Medals recipient Sherry Lansing with CSHL President Bruce
Stillman (left) and Herb Siegel
CSHL Trustee Leo Guthart (right) with Kristin and John Miller at the
Double Helix Medals Dinner
On November 1, 2008, a dedication of the Laurie J. Landeau Multi media
Studio was held at the Dolan DNA Learning Center. Jim Watson (left) is pic-
tured with CSHL Trustee Laurie Landeau, DNA Learning Center Executive
Director Dave Micklos, and CSHL President Bruce Stillman.
*Gift or pledge made to the Hillside Campus Campaign 2003–2008 or a multiyear pledge
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West Islip Breast Cancer Coalition
for Long Island*
Mr. and Mrs. Richard H. Witmer, Jr.
Women's Insurance Network of
Long Island
Ziering Family Foundation
Karen and Mark Zoller
Contributions of $5,000+
Anonymous*
Aflac
AKF Group LLC
Americana Manhasset and Wheatley
Plaza
Mr. and Mrs. W. Dillaway Ayres, Jr.
Nicholas J. Bartilucci–Dvirka and
Bartilucci Consulting Engineers
Mr. and Mrs. Rodney B. Berens
Mr. and Mrs. Howard Berkowitz
Joyce Bertoldo
Bethpage Federal Credit Union
Gail A. Binderman
Lisa and Tim Broadbent
Mrs. Harry A. Brooks
Frank Brunckhorst
Mr. and Mrs. William J. Candee III
Mr. and Mrs. George W. Carmany III
Michele and Jim Celestino
Mr. and Mrs. Richard T. Cunniff
Dilworth & Barrese, LLP
Mr. and Mrs. Michael J. DiMaio
Mr. and Mrs. E. Richard Droesch–
Droesch Realty
Mr. and Mrs. Robert W. Fagiola
William Friedkin
Kate and John Friedman
Mr. and Mrs. Richard C. Gordon*
Mr. and Mrs. Austen T. Gray, Jr.
Mr. and Mrs. Randall Hack
Mrs. John W. Hadley
Dr. Mark Hoffman*
The Iovino Family Foundation
The Kapp Family Foundation
Charles Henry Leach II Foundation
Shirley and Eugene Levitt
The Fay J. Lindner Foundation*
The Litwin Foundation
Luitpold Pharmaceuticals, Inc.
Mr. and Mrs. John Macaskill
Joyce and Robert Marcus
Gary Melius–Oheka Management
Corp.
Stephen P. Munn
National Maintenance Supplies Inc.
Lauryl and Robert Palatnick
John G. Passarelli, M.D.
Dr. and Mrs. John E. Postley–New
York Physicians Foundation
Mrs. Richardson Pratt, Jr. and Family
Don Procida–All Pro Carpet Co., Inc.
The Rathmann Family Foundation*
Drs. Marjorie van de Stouwe and
Scott J. Ratner
The Roslyn Savings Foundation
Mr. and Mrs. Phillip M. Satow*
Howard Schliff
Judi Shesh Memorial Foundation
Sovereign Bank
Lee Steinberg
Dr. and Mrs. Bruce W. Stillman
The Tilles Family
Mr. and Mrs. Paul A. Vermylen, Jr.
Marjorie M. von Stade
Clear Channel Worldwide–WALK
97.5
Deborah Norville and Karl Wellner 
W.F. Whitman Family Foundation
Wolfensohn Family Foundation
Contributions of $2,500+
Mr. and Mrs. Robert H.B. Baldwin
Cristina Mariani May–Banfi Vintners
Foundation
Mr. and Mrs. David L. Banker
Richard A. and Amelia Bernstein
David Bohnett Foundation
Elizabeth B. Borden–The Black
Brook Farm Foundation
Bressler Family Foundation
Laura Breyer
Michelle Gerwin Carlson, M.D. and
Scott Carlson
Ann K. Thompson and James C.
Childress 
Mrs. Robert L. Clarkson, Jr.
Curtis, Mallet-Prevost, Colt & Mosle,
LLP
The Honorable and Mrs. Bruce S.
Gelb
Richard L. Gelfond
Mr. and Mrs. Thomas S.T. Gimbel
Rosalyn C. Gordon
Bernadette Castro and Peter Guida,
M.D.
Mr. and Mrs. Gordon S. Hargraves
Susan and Charles Harris
Hearts for Cancer 
Arthur D. Herman–Herman
Development Corporation
Interstate Mechanical Services, Inc.
The Stanley R. and Elisabeth G.
Jacobs Foundation
Mr. and Mrs. Barclay G. Jones III
Kean Development Company, Inc.
Andrea B. and Peter D. Klein
Georgie W. Lewis–Eugene F.
Williams Charitable Trust
Carol Marcinuk Fund
Marsh, Inc.
Mr. and Mrs. Clarence F. Michalis
Mr. and Mrs. John Robinson 
Miller IV
Keith M. Moffat
Mr. and Mrs. Paul Napoli
Nikon Instruments, Inc.
Mr. and Mrs. Edmond J. Nouri*
Peter M. O'Neill
Oxford & Simpson Realty Services,
Inc.
Pabco Construction Corporation
David P. Pearson
Terry and David Peikon
Terry and Howard Phipps
Liz and Anthony F. Piazza
Cecile Pickart Student Travel Award
Louise S. Pickart
Frank Posillico
Mr. and Mrs. William S. Post
Nicole and Charlie Prizzi
Mr. and Mrs. Bernard F. Reynolds
Mr. and Mrs. Raymond G. Schuville
Law Offices of Christopher Serbagi
Angelo and Constance Silveri–
Silverite Construction Co., Inc.
Mr. and Mrs. Owen T. Smith
Mr. and Mrs. Ian Kendall Wheeler
Snow
Andrew Solomon and John Habich
Solomon
Mr. and Mrs. Douglas S. Soref
Shannon Kennedy and Alan
Stephenson
*Gift or pledge made to the Hillside Campus Campaign 2003–2008 or a multiyear pledge
(Left to right) Ruth and Gerry Fischbach, Jim Simons, and Paul Nurse at the
Double Helix Medals Dinner
(Left to right) John Habich Solomon, CSHL Trustee Andrew Solomon, and CSHL
Chairman Emeritus Jim Watson at the Double Helix Medals Dinner
(Left to right) Tom Calabrese, Judy and Pat Woods, and Trudy
Calabrese at The Lab Goes Latin fundraiser
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TD Bank
Mr. and Mrs. Bart T. Tiernan
Mr. and Mrs. Stanley S. Trotman, Jr.*
Mrs. Taggart Whipple
Marilyn Monter and Wilfried
Witthuhn
Diane and Howard Wohl Family
Foundation
Ann Eden Woodward Foundation,
James A. Woods Trustee
Contributions of $1,000+
Aboff's Inc.
Advantage Title Agency, Inc.
Alpern Family Foundation
American Engineering Services
Bank of America, U.S. Trust Private
Wealth Management
Dr. and Mrs. Arthur M. Bernhang
Pam and Gene Bernstein–PGJM
Foundation
Giuseppe and L. Elizabeth Bertani
Mr. and Mrs. Michael J. Bertuch
Mr. and Mrs. Xerxes K. Bhote
Renee Fitts and David Botstein
Dr. William Braden III
Anne and Russell Byers
Peter M. Cannell
Mr. and Mrs. Harry Charlston
Mr. and Mrs. Robert W. Chasanoff
Michael Checchi
Jane H. Choate
Mr. and Mrs. David C. Clark
Ida Cole
Katharine Charlston Colgate and
John K. Colgate
Nancy and Jim Cook
Joan Walkup Corrigan
Cortel Business Solutions, Inc.
Mr. and Mrs. Christoph Cushman
Mr. and Mrs. Curtis Cushman
Davidoff Malito & Hutcher, LLP
Robert de Rothschild
Robert Demerest
Mr. and Mrs. Donald L. Deming
Mr. and Mrs. Joseph T. Donohue
Dr. Lester Dubnick
Electronix Systems
Deidre and Phil Eletto
Martin Elias
Mrs. Robert S. Emdin
Enzo Life Sciences, Inc.
Dr. and Mrs. John Wilson Espy
Lisa and Johnston Evans
Dr. Robert J. Feeney
G. Fred Fisher
Mr. and Mrs. Roger Fradin
Mr. and Mrs. Howard J. Gaber
Mr. and Mrs. E. Maxwell Geddes, Jr.
Cosby George
Mr. and Mrs. William H. Grover
Dr. and Mrs. Ronald J. Gulotta
Reverend Linda Peyton Hancock
Harweb Foundation
Amanda H. Haynes-Dale
Thomasina and Joseph Heyenoort–
Cold Spring Motors
Mr. and Mrs. John H. Hornbostel
Huntington Business Products
Centre, Inc.
Mr. and Mrs. John E. Huwiler
Mr. and Mrs. Michael Imperio
Frederic B. Ingraham
A.C. Israel Foundation, Inc.
Andy Kaplan Prize
Mr. and Mrs. Clarke R. Keough–
Donald and Marilyn Keough
Foundation
Keystone Electronics Corp.
Dr. and Mrs. Alan M. Kisner*
Mr. and Mrs. Edward M. Lamont
Carol and James Large
Mr. and Mrs. Stanley Lasky
The Lauder Foundation, Leonard
and Evelyn Lauder Fund
Mr. and Mrs. Thomas D. Lehrman
Nancy Metz and George N. Lindsay,
Jr. 
Maxine MacLean Survivors Trust
Mrs. David J. Mahoney–The Dana
Foundation
Simone Mailman
François and Ketty Maisonrouge
Marsh’s
Mr. and Mrs. Bradford Matthews
Mrs. James A. McCurdy, Jr.*
The Neil and Amy McGoldrick
Charitable Foundation
Mr. and Mrs. Charles C. McGuffog
MetLife
Mr. and Mrs. David A. Micklos
Jeffrey H. Miller/UCLA
Leo Model Foundation
Kathleen A. Mooney
John T. Moore
Richard P. and Faye Nespola
Charitable Foundation
Ruth Nussdorf
Mr. and Mrs. Michael S. O'Brien
Hugh O'Kane Electric Co.
Mr. and Mrs. Richard S. Overton
Betsy and Jeffrey Pash
Mr. and Mrs. Nicholas B. Paumgarten
Mr. and Mrs. Howard Phipps, Jr.
Louise S. Pickart
Mr. and Mrs. Robert A. Pilkington
Mr. and Mrs. Richard C. Pisano, Jr.
Paul F. Posillico
Premier Insulation Services Corp.
Mr. and Mrs. Thomas L. Pulling
Preston V. Pumphrey
Pilar and Alejandro Quentin
George A. Roche
Daryl and Steven Roth
Miriam K. Rothenberg
Mr. and Mrs. J. Wright Rumbough, Jr.
Mr. and Mrs. Henry E. Salzhauer
Mr. and Mrs. Enrique F. Senior
The Shaw Family Endowment Fund
Mr. and Mrs. Lee C. Shuett
Margaret Silver
Mr. and Mrs. H. Brooks Smith
Mary F. Smith Family Foundation*
Drs. Mona S. and David L. Spector
The Jerry and Emily Spiegel Family
Foundation, Inc.
Mr. and Mrs. James L. Spingarn
Joan and Arthur M. Spiro
Mr. and Mrs. Jeffrey T. Stevenson
Dr. and Mrs. John C. Stevenson
Dr. Ronald Swanstrom
Judith and Irwin Tantleff
Nancy B. Taylor
Mr. and Mrs. Pascal Franchot Tone
United Healthcare
Noreen Vance Fund
John B. Vermylen
Helene P. Victor
Dr. and Mrs. Robert Vizza
Elizabeth P. Munson and Robert von
Stade
Walter B. James Fund No. 2
Mr. and Mrs. Douglas A. Warner III
Mr. and Mrs. Richard Weir
Mr. and Mrs. John A. Werwaiss
Neil Westreich
Gerald I. White
Mayer Wolf
Mr. and Mrs. Irwin Young
Hans Zobel-Ziehm Medical, LLC
CSHL Scientist Mikala Egeblad (center) accepts a check from Long Island 2-Day
Walk to Fight Breast Cancer.
CSHL Trustee Don Axinn with his wife
Joan at The Lab Goes Latin fundraiser
*Gift or pledge made to the Hillside Campus Campaign 2003–2008 or a multiyear pledge
CSHL Trustee Jamie Nicholls and her husband Fran Biondi at the Double
Helix Medals Dinner
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IN HONOR OF
Donald E. Axinn
Edward A. Chernoff
Katie Colgate
Dr. Sam Friedman
Bob Gay
Doris Gittleman
Mary Goldberg
Florence Greenberg
Calla and Ralph Guild
Arthur Herman
Ben Israeli
Eileen Katz
Dr. Jeffrey Kazzaz
Virginia LaFace
Sherry Lansing
Simone Mailman
Dave Micklos
Malcolm Morley
Elizabeth Munier
Louise Parent
Louise and Stan Pickart
Pat and Jim Regan
Justin Rosati
Jennifer Rose
Blanche Seelman
Edith and Alan Seligson
Drs. Marilyn and James Simons
Gloria So
James Sommermeyer
Dr. J. Craig Venter
Caitlin Riley and Charles Wardell
Dr. James D. Watson
Barry and Arlyne Zalaznick
American Express Foundation
American Express PAC
Amgen
Analect, LLC
Avaya
Bristol-Myers Squibb Foundation
The Michael and Susan Dell Foundation
Dow Jones & Company, Inc.
Forest Laboratories, Inc.
The Henry Luce Foundation, Inc.
Honeywell
iStar Financial, Inc.
The J.P. Morgan Chase Foundation
Merrick Bank Corporation
Merrill Lynch & Company, Inc.
The Millipore Foundation
Pfizer Foundation
United Way of New York City
Verizon Foundation
WellPoint Foundation
CORPORATE AND FOUNDATION MATCHING GIFT CONTRIBUTORS
Rosemarie Amoruso
Jeremy Barkann
J. Randolph Bartholomew
Aurora and Donald Bertoldo
Barbara Delalio Bianco
Elizabeth Brdey
Ellen Brenner
Doris Brisbane
Helen Chute
Eileen DeLalio
Randie Switko Delmont
Dom Deo
Evelyn Emdin
Bob Emdin
Nancy Slaughter Gay
Joni Gladowsky
Kjell Gunderman
Zoe Halpin
Mary Jeanne and Henry Harris
Louise Herman
Arthur Himmel
Mary Reese Hoffert
Yetta Holzberg
Dr. Andy Kaplan
Denise Konrad
Edward C. Kramer
Gabriel Antonio Lara
Barbara Leeds
Richard Lohan
Rose Lucito
Lisa MacInnes
Margaret Mack
Beatriz Madero
Carol Marcincuk
Elizabeth McFarland
Alvin Meiseles
Ivan Miller
Don Monti
Paul M. Mott
Monica Mowery
Regina O’Hara
Mary Osbourne
Mr. Donald J. Parmet
Dr. Cecile Pickart
Jordan Poch
G. Jeffrey Poletti
Angelo Ragone
Louise Read
Lydia and Christopher Reeves
Mary Ellen Regan
Christina Renna
Jack Richards
Norman Rodman
Eleazer Rodriguez
Susan Rose
Diane Edmin Sachs
Joan Schmutz
Andrew Seligson
Ovadia Simha
Jeffrey Smallman
Nathan and Joseph Strobel
Irving Summit
Noreen Vance
Wendy Vander Poel Russell
Robert Waldinger
Professor Tsan-wen Wang
Ruth Weinstein
Ms. Marybeth Zoegall
IN MEMORY OF
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RESEARCH 
David L. Spector
Director of Research
Walter L. Goldschmidts
Executive Director, Sponsored
Programs
Professors
Thomas Gingeras, Professor
and Head, Functional
Genomics
Gregory Hannon,* Program
Chair, Bioinformatics and
Genetics
Z. Josh Huang
David Jackson
Leemor Joshua-Tor*
Adrian Krainer
Yuri Lazebnik
Scott Lowe,* Program Chair,
Cancer and Molecular Biology
Robert Martienssen
W. Richard McCombie
Partha Mitra
Lincoln Stein
William Tansey
Nicholas Tonks, Deputy
Director, Cancer Shared
Resources
Linda Van Aelst
Michael Wigler
Anthony Zador, Program
Chair, Neuroscience
Michael Zhang
Yi Zhong
Associate Professors
Grigori Enikolopov
Alexei Koulakov
Alea Mills
Senthil Muthuswamy
Pavel Osten
Darryl Pappin
Scott Powers
Jonathan Sebat
Jacek Skowronski
Arne Stenlund
Marja Timmermans
Assistant Professors
Gurinder Atwal
Joshua Dubnau
Hiroyasu Furukawa
Adam Kepecs
Bo Li
Zachary Lippman
Robert Lucito
Raffaella Sordella
Lloyd Trotman
Glenn Turner
Research Professor
James Hicks
Research Assistant
Professors
Matthew Vaughn
Zhenyu Xuan
Director, Research
Operations
Sydney Gary
Senior Computer
Scientists
Alexander Krasnitz
Boris Yamrom
Senior Fellow
Alexey Aravin
Quantitative Biology Fellow
Ivan Iossifov
Clinical Fellow
Timothy Pardee
Cold Spring Harbor Fellows
Dinu Florin Albeanu
Patrick Paddison
Christopher Vakoc
Research Investigators
Kenneth Chang
Carrie Davis
Diane Esposito
Yimin Hua
Sheldon McKay
Tatyana Michurina
Natalia Peunova
Michael Regulski
Mona Spector
Adjunct Professors
Hollis Cline
Peter D'Eustachio
Karel Svoboda
Adjunct Associate
Professors
Carlos Brody
Dmitri Chklovskii
Zachary Mainen
Anil Malhotra
Adjunct Assistant
Professors
Mirjana Maletic-Savatic
Lakshmi Muthuswamy
Doreen Ware, USDA Adjunct
Assistant Professor
Visiting Professor
Matthew Ridley
Visiting Scientists/
Collaborative Scientists
Aniruddha Das
Nevenka Dimitrova
Nobuhiko Hiramatsu
Sitharthan Kamalakaran
Eduardo Reis
Yalin Wang
Research Specialist I
Beicong Ma*
Gene Target Specialist
Sang Yong Kim
Database Manager,
Genomics
Christopher Zaleski
Postdoctoral Fellows
Olga Anczukow-Camarda
Victoria Aranda Calleja
Isabel Aznarez Da Silva
Yoselin Benitez Alfonso
Jennifer Beshel
Uli Bialucha
Benjamin Boettner
Benoit Boivin
Peter Bommert
Katharine Borges
Anka Bric
Chunlin Cai
Alexander Campbell
Andres Canela Rodriguez
Santanu Chakraborty
Maia Chanrion
Samit Chatterjee
Min Hsuan Chen
Muhan Chen
Shuaili Chen
Agustin Chicas
Yu-Chen Chien
Anne Daulny
Stacy DeBlasio
Ebru Demir
Camila Dos Santos
Marcela Dotto
Lukas Dow
Andrea Eveland
Christopher Faehnle
Yuda Fang
Michael Feigin
Katalin Fejes Toth*
Gidon Felsen
Cristina Fernandez Marco
Fuqiang Geng
Alexander Goldshmidt
Vladimir Grubor
Xuecui Guo
Astrid Desiree Haase
Iver Hansen
Toshihide Hige
Emily Hodges
Manzar Hossain
Tomas Hromadka
Michael Huebner
Aman Husbands
Danielle Irvine
Santiago Jaramillo Escobar
Mads Aaboe Jensen
LABORATORY MANAGEMENT
Bruce W. Stillman, President
James D. Watson, Chancellor Emeritus
W. Dillaway Ayres Jr., Chief Operating Officer
*Employee of the Howard Hughes Medical Institute
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Robyn Johnston
Erkan Karakas
Fedor Karginov
Hironori Kawakami
William Keyes
Akiko Kobayashi
Brian Kolterman
Young Koung Lee
Keerthi Krishnan
Navasona Krishnan
Valery Krizhanovsky
Sandra Kuhlman
Claus-Dieter Kuhn
Jayant Kulkarni
Prakash Kumar
John Kurland
Duda Kvitsiani
Yoon-Ha Lee
Dan Levy
Darrin Lewis
Li Li
Yang Liu Sullivan
Mukesh Lodha
Jiangteng Lu
Dheeraj Malhotra
Louis Manganas
Toma Marinov
Anthony Mazurek
Shane Edward McCarthy
Christoph Miething
Sylvain Mitelheiser
Jernej Murn
Nael Nadif Kasri
Shuang Ni
Michaela Oswald-Pisarski
Gonzalo Hugo Otazu Aldana
Hysell Oviedo
Mario Pagani
June Hee Park
Jennifer Parla
Anirban Paul
Shilpi Paul
Hongtao Qin
Ileng Ramachandran
Sachin Ranade
Ashlan Reid
Francesc Roca
Michael Saborowski
Kentaro Sahashi
Ananda Sarkar
Eric Sawey
Thomas Schalch
Ulla Schwertassek
Yi-Jun Sheu
Damianos Skopelitis
Richard Slotkin
Vihra Sotirova
Chunlao Tang
Hiroki Taniguchi
Milos Tanurdzic
Vishal Thapar
Vladimir Vacic
Vasily Vagin
Daniel Valente
Haibin Wang
Clinton Whipple
Caizhi Wu
Qiaojie Xiong
Xianfeng Xu
Zhan Yao
Miguel Zaratiegui Biurrun
Lixing Zhan
Zuo Zhang
Johannes Zuber
Graduate Students
Md Aftabul Haque
Timour Baslan
Philippe Batut
Mitchell Bekritsky
Allison Blum
Megan Bodnar
Dario Bressan
Ralph Burgess
Ying Cai
Joseph Calarco
Matthew Camiolo
Abhishek Chakraborty
An-Yun Chang
Deblina Chatterjee
Fauzia Chaudhary
Sihem Cheloufi
Hsueh-Cheng Chiang
Daniel Chitwood
Hyejin Cho
Carrie Clendaniel
Galen Collins
Gil Costa
Michael Cressy
Noelle Cutter
Benjamin Czech
Shipra Das
Ashesh Dhawale
Saya Ebbesen
Melanie Eckersley-Maslin
Yaniv Erlich
Christof Fellmann
Xin Feng
Patrick Finigan
Oliver Fregoso
Yu Fu
Eyal Gruntman
Paloma Guzzardo Tamargo
Miao He
Xingyue He
Kyle Honegger
Ikuko Hotta
Katarzyna Hrecka
Jiahao Huang
Dong-Woo Hwang
Dong Hyuk Ki
Ingrid Ibarra
Stephen Janoschka
Jong Jin Han
Keisha John
Nihan Kara
Mihriban Karaayvaz
Danny Khalil
Anna Kloc
Sang-Geol Koh
Marek Kudla
Canan Kuscu
Mary Kusenda
Matthew Lazarus
Jane Lee
Amy Leung
Wangzhi Li
Wanhe Li
Willey Liao
Katie Liberatore
Guang Lin
Baoyi Liu
Xiaofei Liu
Zhijie Liu
Alexandra Lucs
Elena Lum
Hiroshi Makino
Colin Malone
Priscilla Manzotti
Katherine McJunkin
Ozlem Mert
Antoine Molaro
Elizabeth Nakasone
Nicholas Navin
Hazeem Okunola
Ming-Hsuan Ou-Yang
Hassana Oyibo
Shraddha Pai
Michael Pautler
Zinaida Perova
Maria Pineda
Vadim Pinskiy
Yevgeniy Plavskin
Prem Premsrirut
Megha Rajaram
Mahalakshmi Ramadass
Mathangi Ramesh
Amy Rappaport
Frederick Rollins
Avi Rosenberg
Jeffrey Rosenfeld
Marlies Rossmann
Nikolay Rozhkov
Sigal Saar
Joshua Sanders
Johann Schlesinger
Claudio Scuoppo
David Simpson
Rahul Sinha
Yabai Song
Yi Su
Shuying Sun
Hongjae Sunwoo
Oliver Tam
Nilgun Tasdemir
Ruei-Ying Tzeng
Krithika Venkataraman
Assaf Vestin
Elvin Wagenblast
Lei Wang
Zhenxun Wang
Susann Weissmueller
Jeremy Wilusz
Jie Wu
Xiaoyun Wu
Chunsu Xu
Yanhua Xu
Bin Xue
Wen Xue
Ming Yang
Yang Yang
Yu-Ting Yang
Jianping Zhang
Rui Zhao
Zhen Zhao
Xin Zhou
Petr Znamenskiy
Scientific Informatics
Peter Andrews
Abhishek Bhandari
Jason Bohland
Hemant Bokil
Jer-Ming Chia
Alexander Dobin
Gopalakrishnan Gopinathrao
Assaf Gordon
Alexander Kanapin
Jude Kendall
Sohail Khan
Melissa Kramer
Anthony Leotta
Chengzhi Liang
Wei Lin
Zhenyuan Lu
Weijun Luo
Vladimir Makarov
Steven Marks
Timothy O'Connor
Deepa Pai
Martin Paradesi
Shiran Pasternak
Kandasamy Ravi
Liya Ren
Michael Ronemus
Joshua Stein
Marcela Tello-Ruiz
James Thomason
Liya Wang
Xuehong Wei
Guanming Wu
Chenghai Xue
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Seungtai Yoon
Charles Youens-Clark
Wei Zhao
Research Associates
Carmelita Bautista
Barry Burbach
Lisa Manche
Linda Rodgers
Simone Salghetti
Patricia Wendel
Xiaoqun Zhang
Laboratory Facility Managers
Sabrina Boettcher*
Stephanie Goldsmith*
Stephen Hearn
Christopher Johns
Pamela Moody
Timothy Mulligan
Joseph Simorowski
Spencer Teplin
Jennifer Troge
Ming Wang
Laboratory Manager
Martha Daddario
Scientific Administrators
Paloma Anderson
Sadie Arana
Christine Bedell
Patricia Bird
Lynn Boss*
Becky Dong
Sandra Doscher
Irene Gill
Carol Gundersen
Jo Leonardo*
Idee Mallardi
Barbara Matusik
Sandra Michelsen
Stephanie Peragallo
Special Projects
Technician 
Lori Spiegel
Laboratory Technicians
Sai Dipikaa Akshinthala
Garrick Alex
Ninche Alston
Amal Bakleh
Kimberly Bell
Kenneth Bergami
Yvonne Biesel
Jennifer Busuttil
James Byrnes
Laura Cardone
Yon Chang
Xin Cheng
Joshua Cohen
Kerry Cook
Martin Davis
Nancy Dawkins-Pisani
Margaret Falkowski
Silvia Fenoglio
Elena Ghiban
Magdalena Gierszewska
Amy Gottesman
Inessa Hakker
Chao He
Fangle Hu
Justyna Janas
Anna Jankowska
Justin Katz
So Young Kim
Kristin Lehet
Jingjing Li
Xin Xuan Lin*
Trine Lindsted
Laura Lintault*
Ying Hsiu Liu
John Marchica
Krista Marran
Senem Mavruk
Jennifer Meth
Maria Mosquera
Stephanie Muller
Ronnie Packer
Rae Hum Paik
Naman Patel
Kevin Pavon
Umamaheswari Ramu
Danea Rebolini
Michael Riggs
Patricia Roccanova
Michelle Rooks
Joseph Sarro
Stephen Schuck
Janelle Simon*
Noriko Simorowski
Tara Spencer
Meredith Taylor
Philip Tully
Eric Wang
Huaien Wang
Jing Wang
Scilla Wu
Tara Zadrozny
Lifang Zhang
Media Makers/
Laboratory Aides
Christopher Algieri
June Blanchford
Patricia Brady
Florinda Chaves
Terrance Chisum
Qiaoling He
Salvador Henriquez
Amy Ji
Hong Jie Shen
Raymond Kim
Maria Mead
Vincent Meschan
Hana Mizuno
Rulan Shen
Margaret Wallace
Research Administration
Maureen Bell
EDUCATION
Banbury Center
Jan A. Witkowski,
Executive Director
Barbara Polakowski
Eleanor Sidorenko
Beatrice Toliver
CSHL Press
John R. Inglis,
Executive Director
Barbara Acosta
Janet Argentine
Ingrid Benirschke Perkins
Cynthia Blaut
Ann Boyle
Carol Brown
Kathleen Bubbeo
Margaret Calicchia
Jane Carter
Kathleen Cirone
Laureen Connell
Heather Cosel-Pieper
Mary Cozza
David Crotty
Judith Cuddihy
Maryliz Dickerson
Joan Ebert
Maria Fairchild
Corrisa Farmer
Alexander Gann
Bibiane Garite
Lauren Heller
Pauline Henick
Nancy Hodson
Geraldine Jaitin
Kaaren Janssen
William Keen
Catherine Kelly
Delia King
Kaaren Kockenmeister
Kathryn LaForgia
Christina Lo
Kathleen MacDonald
Robert Majovski
Victor Manchiso
Wayne Manos
Jacqueline Matura
Mala Mazzullo
Michele McDonough
Mary Mulligan
Stephanie Novara
Keriaki Pollakis
Elizabeth Powers
Theodore Roeder
Nora Ruth
Mary Sabala
Susan Schaefer
Lauren Schmidt
Patricia Serpe
Richard Sever
Inez Sialiano
Marcie Siconolfi
Dorothy Sinnott
Maria Smit
Leah Steuer
Rena Steuer
Sharon Story
Hillary Sussman
Linda Sussman
Christopher Vacca
Denise Weiss
Dolan DNA Learning
Center
David A. Micklos, 
Executive Director
Helena Almberg
Stephen Blue
Elna Carrasco
John Connolly
Lauren Correri
Jennifer Cutillo
Cornel Ghiban
Malissa Hewitt
Uwe Hilgert
Eun-Sook Jeong
Mary Lamont
Susan Lauter
Amanda McBrien
Colleen McKechnie
Valerie Meszaros
Eric Nash
Carolyn Reid
Ileana Rios
Tedhar Setton
Danielle Sixsmith
Jermel Watkins
Jason Williams
Chun-hua Yang
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Library and Archives
Ludmila T. Pollock,
Executive Director
Paula Abisognio
Clare Clark
Angela Cornwell
Anthony Dellureficio
Helena Johnson
Patricia Novak
Gail Sherman
Samuel Stewart
Linda Swanson
Rhonda Veros
Carlos Viteri
Claudia Zago
Meetings and Courses
David J. Stewart, 
Executive Director
Stephen Alexander
Taimur Arif
Alfred Baman
Mark Beavers
Annie Laurie Benzie
Edward Campodonico
Joseph Carrieri
Reginald Cayo
Katiria Ceballos
Maoyen Chi
Richard Costello
Wendy Crowley
William Dickerson
Tara Egan
Bradley Frey
Constance Hallaran
Andrew Mendelsohn
Maureen Morrow
Andrea Newell
Kenneth Orff
Valerie Pakaluk
Jonathan Parsons
Lauren Postyn
Christopher Sherrow
Mary Smith
Margaret Stellabotte
Andrea Stephenson
Joshua Stewart
Andrew Sung
James Whitaker
Barbara Zane
Watson School of
Biological Sciences
Leemor Joshua-Tor, Dean
Kimberley Geer
Alyson Kass-Eisler
Dawn Meehan
Terri I. Grodzicker, Dean of
Academic Affairs
ADMINISTRATIVE
DEPARTMENTS
Comptrollers Office and
Accounting
Lari C. Russo, Vice
President, Finance and
Comptroller
Nicole Balazs
Sharon Bense
Karine Boyce
Helen Chase
Damian Desiderio
Karen Filasky
Mary Ellen Goldstein
Laura Guterman
Patricia Maroney
Alison McDermott
Mary Ann Miceli
Kari Pavlovsky
Patricia Penner
Kristine Romano
Patricia Urena
Ann Williams
Central Administration
Maureen Berejka
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Assistant Professor
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Adjunct Professor
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David Mu
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Collaborative Scientists
Brage Andresen
Michael Caudy
Hiroaki Hagiwara
Adriana Hemerly
Seung Jun Kim
Suzanne Manning
Cordula Schulz
Lea Zinck
Senior Clinical Fellow
Lars Zender
Adjunct CSHL Fellow
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Postdoctoral Fellows
Anindya Bagchi
Martin Bayer
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Computer Scientist
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